PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brownstein, JS; Freifeld, CC; Madoff, LC				Brownstein, John S.; Freifeld, Clark C.; Madoff, Lawrence C.			Digital Disease Detection - Harnessing the Web for Public Health Surveillance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brownstein, John S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Freifeld, Clark C.] Childrens Hosp Informat Program, Boston, MA USA; [Freifeld, Clark C.] MIT, Media Lab, New Media Med Grp, Cambridge, MA 02139 USA; [Madoff, Lawrence C.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Madoff, Lawrence C.] Massachusetts Dept Publ Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Department of Public Health	Brownstein, JS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		Brownstein, John S/A-1438-2011		NLM NIH HHS [G08 LM009776-01A2, G08 LM009776] Funding Source: Medline; NLM NIH HHS [G08 LM009776, G08 LM009776-01A2S1, G08 LM009776-01A2] Funding Source: Medline	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; HARRIS G, 2009, NY TIMES        0501; Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003; MARTINEZ R, 2009, PROCESO         0402; MORALES AT, 2009, JORNADA         0401; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098	9	481	496	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2153	2157		10.1056/NEJMp0900702	http://dx.doi.org/10.1056/NEJMp0900702			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19423867	Green Accepted			2022-12-28	WOS:000266206000001
J	Reimer, J; Haasen, C				Reimer, Jens; Haasen, Christian			Need-adapted HCV-treatment setting for injection drug users	LANCET			English	Editorial Material							HEPATITIS-C; PREVENTION; VIRUS; CARE		[Reimer, Jens; Haasen, Christian] Univ Hamburg, Ctr Interdisciplinary Addict Res, D-20246 Hamburg, Germany	University of Hamburg	Reimer, J (corresponding author), Univ Hamburg, Ctr Interdisciplinary Addict Res, Martinistr 52, D-20246 Hamburg, Germany.	reimer@uke.de						Anand BS, 2006, GASTROENTEROLOGY, V130, P1607, DOI 10.1053/j.gastro.2006.02.023; Edlin BR, 2005, CLIN INFECT DIS, V40, pS276, DOI 10.1086/427441; Jack K, 2009, ALIMENT PHARM THER, V29, P38, DOI 10.1111/j.1365-2036.2008.03872.x; Laine C, 2001, JAMA-J AM MED ASSOC, V285, P2355, DOI 10.1001/jama.285.18.2355; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; NEUMAN MG, 2003, ALCOHOL CLIN EXP S1, V25, pS215; Paterson BL, 2007, INT J DRUG POLICY, V18, P364, DOI 10.1016/j.drugpo.2007.02.004; Stoove MA, 2005, DRUG ALCOHOL DEPEN, V77, P81, DOI 10.1016/j.drugalcdep.2004.07.002; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wilkinson M, 2009, ALIMENT PHARM THER, V29, P29, DOI 10.1111/j.1365-2036.2008.03834.x; Wong JB, 2006, PHARMACOECONOMICS, V24, P661, DOI 10.2165/00019053-200624070-00005; Wright C, 2003, BRIT J PSYCHIAT, V183, P132, DOI 10.1192/bjp.183.2.132; Wright TL, 2007, HEPATOL RES, V37, pS294, DOI 10.1111/j.1872-034X.2007.00200.x	13	16	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2090	2091		10.1016/S0140-6736(09)60347-0	http://dx.doi.org/10.1016/S0140-6736(09)60347-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19376573				2022-12-28	WOS:000267229700007
J	Townsend, JA; Wright, DA; Winfrey, RJ; Fu, FL; Maeder, ML; Joung, JK; Voytas, DF				Townsend, Jeffrey A.; Wright, David A.; Winfrey, Ronnie J.; Fu, Fengli; Maeder, Morgan L.; Joung, J. Keith; Voytas, Daniel F.			High-frequency modification of plant genes using engineered zinc-finger nucleases	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; RESISTANCE; TOXICITY	An efficient method for making directed DNA sequence modifications to plant genes (gene targeting) is at present lacking, thereby frustrating efforts to dissect plant gene function and engineer crop plants that better meet the world's burgeoning need for food, fibre and fuel. Zinc-finger nucleases (ZFNs)-enzymes engineered to create DNA double-strand breaks at specific loci-are potent stimulators of gene targeting(1,2); for example, they can be used to precisely modify engineered reporter genes in plants(3,4). Here we demonstrate high-frequency ZFN-stimulated gene targeting at endogenous plant genes, namely the tobacco acetolactate synthase genes (ALS SuRA and SuRB), for which specific mutations are known to confer resistance to imidazolinone and sulphonylurea herbicides(5). Herbicide-resistance mutations were introduced into SuR loci by ZFN-mediated gene targeting at frequencies exceeding 2% of transformed cells for mutations as far as 1.3 kilobases from the ZFN cleavage site. More than 40% of recombinant plants had modifications in multiple SuR alleles. The observed high frequency of gene targeting indicates that it is now possible to efficiently make targeted sequence changes in endogenous plant genes.	[Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Townsend, Jeffrey A.; Wright, David A.; Winfrey, Ronnie J.; Fu, Fengli] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Voytas, DF (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	voytas@umn.edu		Voytas, Daniel/0000-0002-4944-1224	National Science Foundation; National Institutes of Health; Massachusetts General Hospital Department of Pathology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069906] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Department of Pathology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Eichtinger for help in making ZFA reagents. This work was supported by grants to D. F. V. from the National Science Foundation and to J. K. J. from the National Institutes of Health and the Massachusetts General Hospital Department of Pathology.	Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; LEE KY, 1988, EMBO J, V7, P1241, DOI 10.1002/j.1460-2075.1988.tb02937.x; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259	18	457	587	3	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					442	U161		10.1038/nature07845	http://dx.doi.org/10.1038/nature07845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404258	Green Accepted			2022-12-28	WOS:000266243700049
J	Bednarek, P; Osbourn, A				Bednarek, Pawel; Osbourn, Anne			Plant-Microbe Interactions: Chemical Diversity in Plant Defense	SCIENCE			English	Editorial Material							ARBUSCULAR MYCORRHIZAL FUNGI; DISEASE RESISTANCE; GENE-CLUSTER; ARABIDOPSIS; METABOLISM; TOMATINASE; TOMATO; BIOSYNTHESIS; PHYTOALEXINS; ANTIBIOTICS	The chemical diversity within the plant kingdom is likely to be a consequence of niche colonization and adaptive evolution. Plant-derived natural products have important functions in defense. They also have broader ecological roles and may in addition participate in plant growth and development. Recent data suggest that some antimicrobial phytochemicals may not serve simply as chemical barriers but could also have functions in defense-related signaling processes. It is important, therefore, that we should not to be too reductionist in our thinking when endeavoring to understand the forces and mechanisms that drive chemical diversification in plants.	[Bednarek, Pawel] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-5000 Cologne, Germany; [Osbourn, Anne] John Innes Ctr, Dept Metab Biol, Norwich, Norfolk, England	Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bednarek, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl Von Linne Weg 10, D-5000 Cologne, Germany.	bednarek@mpiz-koeln.mpg.de; anne.osbourn@bbsrc.ac.uk	Bednarek, Pawel/D-2561-2009	Bednarek, Pawel/0000-0002-3064-7775	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bouarab K, 2002, NATURE, V418, P889, DOI 10.1038/nature00950; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Field B, 2006, NEW PHYTOL, V172, P193, DOI 10.1111/j.1469-8137.2006.01863.x; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Geu-Flores F, 2009, PLANTA, V229, P261, DOI 10.1007/s00425-008-0825-y; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hadwiger LA, 2008, PHYTOPATHOLOGY, V98, P372, DOI 10.1094/PHYTO-98-4-0372; Ito S, 2004, FEBS LETT, V571, P31, DOI 10.1016/j.febslet.2004.06.053; Kant MR, 2007, CURR OPIN GENET DEV, V17, P519, DOI 10.1016/j.gde.2007.09.002; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kwon C, 2008, PLANT PHYSIOL, V147, P1575, DOI 10.1104/pp.108.121566; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; Mylona P, 2008, PLANT CELL, V20, P201, DOI 10.1105/tpc.107.056531; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Pareja-Jaime Y, 2008, MOL PLANT MICROBE IN, V21, P728, DOI 10.1094/MPMI-21-6-0728; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; QI X, Patent No. 2581099; QI X, Patent No. 11248986; QI X, Patent No. 06044508; QI X, 2004, Patent No. 1240312; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Sandrock RW, 2001, PHYSIOL MOL PLANT P, V58, P159, DOI 10.1006/pmpp.2001.0324; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Simons V, 2006, ANTIMICROB AGENTS CH, V50, P2732, DOI 10.1128/AAC.00289-06; SNYDER BA, 1990, SCIENCE, V248, P1637, DOI 10.1126/science.248.4963.1637; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; 2000, Patent No. 0146391; 783739; 2007, Patent No. 7186884; 2392435; 18709752; 2008, Patent No. 259077; 11940638; 2009, Patent No. 2009041932	46	235	259	6	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					746	748		10.1126/science.1171661	http://dx.doi.org/10.1126/science.1171661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423814				2022-12-28	WOS:000265832400033
J	Wilson, JM				Wilson, James M.			A History Lesson for Stem Cells	SCIENCE			English	Editorial Material							LEBERS CONGENITAL AMAUROSIS; GENE-THERAPY		Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Wilson, JM (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	wilsonjm@mail.med.upenn.edu	Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131				Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; [Anonymous], 1996, B MED ETHICS; [Anonymous], [No title captured]; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Friedmann T, 2005, PERSPECT BIOL MED, V48, P585, DOI 10.1353/pbm.2005.0089; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Thompson L, 2000, FDA Consum, V34, P19; Wilson JM, 2009, MOL GENET METAB, V96, P151, DOI 10.1016/j.ymgme.2008.12.016; 2009, ABC NEWS        0123	13	83	85	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					727	728		10.1126/science.1174935	http://dx.doi.org/10.1126/science.1174935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423804				2022-12-28	WOS:000265832400023
J	Bockenhauer, D; Feather, S; Stanescu, HC; Bandulik, S; Zdebik, AA; Reichold, M; Tobin, J; Lieberer, E; Sterner, C; Landoure, G; Arora, R; Sirimanna, T; Thompson, D; Cross, JH; van't Hoff, W; Al Masri, O; Tullus, K; Yeung, S; Anikster, Y; Klootwijk, E; Hubank, M; Dillon, MJ; Heitzmann, D; Arcos-Burgos, M; Knepper, MA; Dobbie, A; Gahl, WA; Warth, R; Sheridan, E; Kleta, R				Bockenhauer, Detlef; Feather, Sally; Stanescu, Horia C.; Bandulik, Sascha; Zdebik, Anselm A.; Reichold, Markus; Tobin, Jonathan; Lieberer, Evelyn; Sterner, Christina; Landoure, Guida; Arora, Ruchi; Sirimanna, Tony; Thompson, Dorothy; Cross, J. Helen; van't Hoff, William; Al Masri, Omar; Tullus, Kjell; Yeung, Stella; Anikster, Yair; Klootwijk, Enriko; Hubank, Mike; Dillon, Michael J.; Heitzmann, Dirk; Arcos-Burgos, Mauricio; Knepper, Mark A.; Dobbie, Angus; Gahl, William A.; Warth, Richard; Sheridan, Eamonn; Kleta, Robert			Epilepsy, Ataxia, Sensorineural Deafness, Tubulopathy, and KCNJ10 Mutations.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISTAL CONVOLUTED TUBULE; WIDE LINKAGE ANALYSIS; BARTTERS-SYNDROME; K+ CHANNEL; POTASSIUM CHANNEL; BLOOD-PRESSURE; HYPOKALEMIC ALKALOSIS; BASOLATERAL MEMBRANE; KNOCK-OUT; GENE	Background: Five children from two consanguineous families presented with epilepsy beginning in infancy and severe ataxia, moderate sensorineural deafness, and a renal salt-losing tubulopathy with normotensive hypokalemic metabolic alkalosis. We investigated the genetic basis of this autosomal recessive disease, which we call the EAST syndrome (the presence of epilepsy, ataxia, sensorineural deafness, and tubulopathy). Methods: Whole-genome linkage analysis was performed in the four affected children in one of the families. Newly identified mutations in a potassium-channel gene were evaluated with the use of a heterologous expression system. Protein expression and function were further investigated in genetically modified mice. Results: Linkage analysis identified a single significant locus on chromosome 1q23.2 with a lod score of 4.98. This region contained the KCNJ10 gene, which encodes a potassium channel expressed in the brain, inner ear, and kidney. Sequencing of this candidate gene revealed homozygous missense mutations in affected persons in both families. These mutations, when expressed heterologously in xenopus oocytes, caused significant and specific decreases in potassium currents. Mice with Kcnj10 deletions became dehydrated, with definitive evidence of renal salt wasting. Conclusions: Mutations in KCNJ10 cause a specific disorder, consisting of epilepsy, ataxia, sensorineural deafness, and tubulopathy. Our findings indicate that KCNJ10 plays a major role in renal salt handling and, hence, possibly also in blood-pressure maintenance and its regulation. N Engl J Med 2009;360:1960-70.	[Bockenhauer, Detlef; Stanescu, Horia C.; Zdebik, Anselm A.; Tobin, Jonathan; Landoure, Guida; Arora, Ruchi; Sirimanna, Tony; Thompson, Dorothy; Cross, J. Helen; van't Hoff, William; Tullus, Kjell; Klootwijk, Enriko; Hubank, Mike; Dillon, Michael J.; Kleta, Robert] UCL, Great Ormond St Hosp, London NW3 2PF, England; [Feather, Sally; Yeung, Stella; Dobbie, Angus; Sheridan, Eamonn] Univ Leeds, Leeds Hosp, Leeds, W Yorkshire, England; [Feather, Sally; Yeung, Stella; Dobbie, Angus; Sheridan, Eamonn] Univ Leeds, Bradford Teaching Hosp, Leeds, W Yorkshire, England; [Stanescu, Horia C.; Landoure, Guida; Anikster, Yair; Klootwijk, Enriko; Arcos-Burgos, Mauricio; Knepper, Mark A.; Gahl, William A.; Kleta, Robert] NIH, Bethesda, MD 20892 USA; [Bandulik, Sascha; Reichold, Markus; Lieberer, Evelyn; Sterner, Christina; Heitzmann, Dirk; Warth, Richard] Univ Regensburg, Inst Physiol, Regensburg, Germany; [Landoure, Guida] Univ Bamako, Dept Neurol, Bamako, Mali; [Al Masri, Omar] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates; [Anikster, Yair] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Arcos-Burgos, Mauricio] Univ Miami, Miami, FL USA	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Leeds; University of Leeds; National Institutes of Health (NIH) - USA; University of Regensburg; University of Bamako; Chaim Sheba Medical Center; University of Miami	Kleta, R (corresponding author), UCL, Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	r.kleta@ucl.ac.uk	Hubank, Michael JF/C-1837-2008; Bockenhauer, Detlef/C-5951-2008; Bandulik, Sascha/L-7365-2015; Knepper, Mark/AAF-8412-2020; Cross, J. Helen/ACK-3032-2022; Reichold, Markus/J-9933-2015; Bockenhauer, Detlef/AAF-6495-2020; Warth, Richard/N-7119-2014; Tullus, Kjell/C-6589-2008; Arcos-Burgos, Mauricio/H-1326-2017	Hubank, Michael JF/0000-0002-2901-0742; Bockenhauer, Detlef/0000-0001-5878-941X; Cross, J. Helen/0000-0001-7345-4829; Bockenhauer, Detlef/0000-0001-5878-941X; Warth, Richard/0000-0001-6084-0659; Thompson, Dorothy/0000-0001-5491-3911; Arcos-Burgos, Mauricio/0000-0002-8529-0574	Intramural NIH HHS [Z01 HL001285-21, Z99 HL999999, ZIA HL001285-24, Z01 HL001285-22, ZIA HL001285-23] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001285] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974] Funding Source: NIH RePORTER; Great Ormond Street Hospital Childrens Charity [V0901] Funding Source: researchfish	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Great Ormond Street Hospital Childrens Charity		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bilusic M, 2004, HYPERTENSION, V44, P695, DOI 10.1161/01.HYP.0000144542.57306.5e; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bleich M, 1999, PFLUG ARCH EUR J PHY, V438, P245, DOI 10.1007/s004240050906; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; DAWSON DC, 1990, AM J PHYSIOL, V259, pC181, DOI 10.1152/ajpcell.1990.259.2.C181; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Hunt SC, 2002, HYPERTENSION, V40, P1, DOI 10.1161/01.HYP.0000022660.28915.B1; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Kleta R, 2000, NEW ENGL J MED, V343, P661, DOI 10.1056/NEJM200008313430915; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kleta R, 2006, NEPHRON PHYSIOL, V104, P73, DOI 10.1159/000094001; KOEFOEDJOHNSEN V, 1958, ACTA PHYSIOL SCAND, V42, P298, DOI 10.1111/j.1748-1716.1958.tb01563.x; Kuffer S. W., 1966, Ergebnisse der Physiologie, V57, P1; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC2001, DOI 10.1152/ajpcell.zh0-5456-corr.2007; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Tanemoto M, 2004, AM J PHYSIOL-RENAL, V287, pF1148, DOI 10.1152/ajprenal.00203.2004; TANIGUCHI J, 1989, AM J PHYSIOL, V256, pF246, DOI 10.1152/ajprenal.1989.256.2.F246; Thiel BA, 2003, AM J HYPERTENS, V16, P151, DOI 10.1016/S0895-7061(02)03246-6; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; TSUCHIYA K, 1992, P NATL ACAD SCI USA, V89, P6418, DOI 10.1073/pnas.89.14.6418; Vallon V, 2001, J AM SOC NEPHROL, V12, P2003, DOI 10.1681/ASN.V12102003; WEST ML, 1986, MINER ELECTROL METAB, V12, P226; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200	41	381	391	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1960	1970		10.1056/NEJMoa0810276	http://dx.doi.org/10.1056/NEJMoa0810276			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420365	Green Accepted, Bronze			2022-12-28	WOS:000265784400006
J	Picard, C; McCarl, CA; Papolos, A; Khalil, S; Luthy, K; Hivroz, C; LeDeist, F; Rieux-Laucat, F; Rechavi, G; Rao, A; Fischer, A; Feske, S				Picard, Capucine; McCarl, Christie-Ann; Papolos, Alexander; Khalil, Sara; Luethy, Kevin; Hivroz, Claire; LeDeist, Francoise; Rieux-Laucat, Frederic; Rechavi, Gideon; Rao, Anjana; Fischer, Alain; Feske, Stefan			Brief Report: STIM1 Mutation Associated with a Syndrome of Immunodeficiency and Autoimmunity.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPERATED CALCIUM-ENTRY; CRAC CHANNEL; T-CELL; STORE DEPLETION; SENSOR STIM1; CA2+ INFLUX; ACTIVATION; LYMPHOCYTES; ORAI1; OLIGOMERIZATION	A mutation in ORAI1, the gene encoding the pore-forming subunit of the Ca(sup 2+)-release-activated Ca(sup 2+) (CRAC) channel, abrogates the store-operated entry of Ca(sup 2+) into cells and impairs lymphocyte activation. Stromal interaction molecule 1 (STIM1) in the endoplasmic reticulum activates ORAI1-CRAC channels. We report on three siblings from one kindred with a clinical syndrome of immunodeficiency, hepatosplenomegaly, autoimmune hemolytic anemia, thrombocytopenia, muscular hypotonia, and defective enamel dentition. Two of these patients have a homozygous nonsense mutation in STIM1 that abrogates expression of STIM1 and Ca(sup 2+) influx.	[Picard, Capucine; LeDeist, Francoise; Fischer, Alain] Hop Necker Enfants Malad, AP HP, Paris, France; [Picard, Capucine] Necker Fac, INSERM, Unite 550, Lab Genet Humaine Malad Infect, Paris, France; [Picard, Capucine; Rieux-Laucat, Frederic; Fischer, Alain] Paris Descartes Univ, Paris, France; [Hivroz, Claire; LeDeist, Francoise; Rieux-Laucat, Frederic; Fischer, Alain] INSERM, Unite 768, Paris, France; [Hivroz, Claire] Inst Curie, INSERM, Unite 653, Paris, France; [McCarl, Christie-Ann; Papolos, Alexander; Khalil, Sara; Luethy, Kevin; Feske, Stefan] NYU, Sch Med, New York, NY 10016 USA; [LeDeist, Francoise] Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [LeDeist, Francoise] Univ Montreal, Montreal, PQ, Canada; [Rechavi, Gideon] Tel Aviv Univ, Chaim Sheba Med Ctr, IL-69978 Tel Aviv, Israel; [Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Rao, Anjana] Immune Dis Inst, Boston, MA USA; [Rao, Anjana] Harvard Univ, Sch Med, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; New York University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Feske, S (corresponding author), NYU, Dept Pathol, Langone Med Ctr, 550 1st Ave, New York, NY 10016 USA.	feskes01@nyumc.org	Feske, stefan/ABB-3554-2021; Hivroz, Claire/H-2711-2014; Rieux-Laucat, Frédéric/A-7916-2017; Picard, Capucine/H-3914-2017	Feske, stefan/0000-0001-5431-8178; Hivroz, Claire/0000-0002-6794-2890; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Picard, Capucine/0000-0001-8788-5056; Luthy, Kevin/0000-0002-4510-3826	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI048213, R01 AI048213-09] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Feske S, 2008, NAT IMMUNOL, V9, P328, DOI 10.1038/ni0308-328; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Geha RS, 2007, J ALLERGY CLIN IMMUN, V120, P776, DOI 10.1016/j.jaci.2007.08.053; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; Ochs HD, 2007, IMMUNOL RES, V38, P112, DOI 10.1007/s12026-007-0022-2; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	31	372	383	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1971	1980		10.1056/NEJMoa0900082	http://dx.doi.org/10.1056/NEJMoa0900082			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420366	Green Accepted			2022-12-28	WOS:000265784400007
J	Hahn, J; Hargreaves, R; Hinde, A; Huggins, JP; Cohen, J; Gillen, D				Hahn, Joanna; Hargreaves, Ruth; Hinde, Annabel; Huggins, John P.; Cohen, Jon; Gillen, David			An academia-industry partnership in health care	LANCET			English	Editorial Material									[Gillen, David] Pfizer UK, Surrey KT20 7NS, England; [Hahn, Joanna; Hargreaves, Ruth; Hinde, Annabel] Pfizer Ltd, Surrey, England; [Huggins, John P.] Pfizer, Sandwich, Kent, England; [Cohen, Jon] Brighton & Sussex Med Sch, Brighton, E Sussex, England	Pfizer; Pfizer; Pfizer; University of Brighton; University of Sussex	Gillen, D (corresponding author), Pfizer UK, Surrey KT20 7NS, England.	David.Gillen@pfizer.com						*FAC PHARM MED, SYLL DIPL PHARM MED; GMC, 2003, TOM DOCT; Maxwell S, 2003, BRIT J CLIN PHARMACO, V55, P496, DOI 10.1046/j.1365-2125.2003.01878.x	3	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1504	1505		10.1016/S0140-6736(09)60836-9	http://dx.doi.org/10.1016/S0140-6736(09)60836-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19410698				2022-12-28	WOS:000265710300007
J	Li, SG				Li, Sheng Guang			Familial Hypercholesterolemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Gen Hosp, Chinese Peoples Liberat Army, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital	Li, SG (corresponding author), Gen Hosp, Chinese Peoples Liberat Army, Beijing 100853, Peoples R China.								0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1885	1885		10.1056/NEJMicm0707976	http://dx.doi.org/10.1056/NEJMicm0707976			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	438MU	19403906				2022-12-28	WOS:000265560300010
J	Lewin, HA				Lewin, Harris A.			It's a Bull's Market	SCIENCE			English	Editorial Material							SEQUENCE; CATTLE		[Lewin, Harris A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Lewin, Harris A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lewin, HA (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	h-lewin@uiuc.edu	LEWIN, HARRIS/HGC-6543-2022	LEWIN, HARRIS/0000-0002-1043-7287				Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; Marth G, 2003, P NATL ACAD SCI USA, V100, P376, DOI 10.1073/pnas.222673099; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Roberts RM, 2009, SCIENCE, V324, P468, DOI 10.1126/science.1168521	10	17	19	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					478	479		10.1126/science.1173880	http://dx.doi.org/10.1126/science.1173880			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390037				2022-12-28	WOS:000265411200036
J	Goldstein, DB				Goldstein, David B.			Common Genetic Variation and Human Traits	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ASSOCIATION		Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27706 USA	Duke University	Goldstein, DB (corresponding author), Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27706 USA.		Goldstein, David/AAY-8125-2020					Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	5	679	708	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1696	1698		10.1056/NEJMp0806284	http://dx.doi.org/10.1056/NEJMp0806284			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369660				2022-12-28	WOS:000265377800002
J	Das Gupta, M; Gostin, L				Das Gupta, Monica; Gostin, Lawrence			Donors' roles in building of global public goods in health	LANCET			English	Editorial Material									[Das Gupta, Monica] World Bank, Dev Res Grp, Washington, DC 20433 USA; [Gostin, Lawrence] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	The World Bank; Georgetown University	Das Gupta, M (corresponding author), World Bank, Dev Res Grp, 1818 H St NW, Washington, DC 20433 USA.	mdasgupta@worldbank.org						BARNETT DB, 2002, PRINCIPLES PUBLIC HL, P431; Brahmbhatt M, 2006, 1 INT C AV INFL HUM; Cueto Marcos, 2007, VALUE HLTH HIST PAN; DASGUPTA M, 2004, WPS3447 WORLD BANK; DASGUPTA M, 2005, WPS3787 WORLD BANK; Gostin LO, 2008, GEORGETOWN LAW J, V96, P331; HOWARDJONES N, 1981, PERSPECT BIOL MED, V24, P467; Lindsay S, 2004, HLTH NUTR POPULATION; Mubyazi G, 2004, INT J HEALTH PLAN M, V19, pS167, DOI 10.1002/hpm.776; PAHO, 2002, PUBL HLTH AM CONC RE; *PAHO BEL COUNTR O, 3 STEP TRAIN PROGR; *PAHO BEL COUNTR O, ENV PROT SUST EPS; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Rannan-Eliya R. P., 2008, GOOD PRACTICES HLTH, P311; Stern AM, 2004, JAMA-J AM MED ASSOC, V292, P1474, DOI 10.1001/jama.292.12.1474; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; WHO, 2007, EV BUS STRENGTH HLTH, P2; *WHO, THIS MONTHS B HIDD C; World Bank, 2007, HEALTHY DEVELOPMENT: THE WORLD BANK STRATEGY FOR HEALTH, NUTRITION, AND POPULATION RESULTS, P1, DOI 10.1596/978-0-8213-7193-0; *WORLD BANK, ENV STOR WAT POV WHA; *WORLD BANK, 2002, HUM DEV NETW HLTH NU, P4; World Bank, 2005, E AS UPD COUNT GLOB; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2007, WORLD HLTH REP 2007	24	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 18	2009	373	9672					1395	1397		10.1016/S0140-6736(09)60245-2	http://dx.doi.org/10.1016/S0140-6736(09)60245-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434UR	19376454	Bronze, Green Published			2022-12-28	WOS:000265300100037
J	Mikucki, JA; Pearson, A; Johnston, DT; Turchyn, AV; Farquhar, J; Schrag, DP; Anbar, AD; Priscu, JC; Lee, PA				Mikucki, Jill A.; Pearson, Ann; Johnston, David T.; Turchyn, Alexandra V.; Farquhar, James; Schrag, Daniel P.; Anbar, Ariel D.; Priscu, John C.; Lee, Peter A.			A Contemporary Microbially Maintained Subglacial Ferrous "Ocean"	SCIENCE			English	Article							TAYLOR GLACIER; DRY VALLEYS; SULFUR; OXYGEN; SULFATE; EXCHANGE; REDOX; WATER; MODEL; ICE	An active microbial assemblage cycles sulfur in a sulfate-rich, ancient marine brine beneath Taylor Glacier, an outlet glacier of the East Antarctic Ice Sheet, with Fe(III) serving as the terminal electron acceptor. Isotopic measurements of sulfate, water, carbonate, and ferrous iron and functional gene analyses of adenosine 5'-phosphosulfate reductase imply that a microbial consortium facilitates a catalytic sulfur cycle. These metabolic pathways result from a limited organic carbon supply because of the absence of contemporary photosynthesis, yielding a subglacial ferrous brine that is anoxic but not sulfidic. Coupled biogeochemical processes below the glacier enable subglacial microbes to grow in extended isolation, demonstrating how analogous organic-starved systems, such as Neoproterozoic oceans, accumulated Fe(II) despite the presence of an active sulfur cycle.	[Mikucki, Jill A.; Pearson, Ann; Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Johnston, David T.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Turchyn, Alexandra V.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Farquhar, James] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Priscu, John C.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Lee, Peter A.] Coll Charleston, Hollings Marine Lab, Charleston, SC 29412 USA	Harvard University; Harvard University; University of Cambridge; University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Montana State University System; Montana State University Bozeman; College of Charleston	Mikucki, JA (corresponding author), Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA.	jill.a.mikucki@dartmouth.edu	Johnston, David/A-9796-2010; Pearson, Ann/A-6723-2009	Johnston, David/0000-0002-2487-1084; Pearson, Ann/0000-0003-2785-8405	NSF Polar postdoctoral fellowship [OPP-0528710]; NSF [EAR-0311937, OPP-432595, OPP-0631494, OPP-0338097, OCE-0728683]; Canadian Institute for Advanced Research; Harvard Microbial Sciences Initiative; NASA [NNX07AV51G]	NSF Polar postdoctoral fellowship; NSF(National Science Foundation (NSF)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Harvard Microbial Sciences Initiative; NASA(National Aeronautics & Space Administration (NASA))	G. Eischeld and S. Fawcett assisted with oxygen isotope measurements, A. Masterson assisted with sulfur isotope measurements, and G. Gordon assisted with iron isotope measurements. We are grateful for assistance from the Crary Laboratory, Petroleum Helicopters Incorporated, and S. Carter. We would like to extend a special thanks to McMurdo personnel B. Peace and W. Hayworth. Discussions with H. Keys, M. Tranter, K. Welch, W. B. Lyons, W. Hamilton, F. MacDonald, S. Shah, and A. Knoll were helpful in formulating the ideas presented. The comments of three anonymous reviewers and A. J. Kaufman greatly improved the manuscript. This research was funded by an NSF Polar postdoctoral fellowship (OPP-0528710) to J.A.M. Additional support was provided by NSF grants EAR-0311937 (A.P.), OPP-432595 and OPP-0631494 (J.C.P.), and OPP-0338097 and OCE-0728683 (awarded to G. R. DiTullio) (P.A.L.); Canadian Institute for Advanced Research (A.V.T.); Harvard Microbial Sciences Initiative; and NASA (NNX07AV51G) (D.T.J.). DNA sequences have been submitted to GenBank with accession numbers FJ389341 to FJ389351.	Aciego SM, 2007, QUATERNARY RES, V68, P303, DOI 10.1016/j.yqres.2007.07.013; BETTS RH, 1970, CAN J CHEMISTRY, V48, P2035, DOI 10.1139/v70-339; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Black R.F., 1965, J GEOL, V73, P175, DOI [10.1086/627053, DOI 10.1086/627053]; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4773, DOI 10.1016/j.gca.2005.04.017; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; CHIBA H, 1985, GEOCHIM COSMOCHIM AC, V49, P993, DOI 10.1016/0016-7037(85)90314-X; COX SC, 1991, ANTARCT SCI, V3, P405, DOI 10.1017/S0954102091000500; ELSTON DP, 1981, ANTARCT RES SER, V33, P413, DOI DOI 10.1029/AR033P0413; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Fountain AG, 1999, BIOSCIENCE, V49, P961, DOI 10.2307/1313730; HAMILTON W, 1965, 456B GEOL SURV; Hattori S, 2000, INT J SYST EVOL MICR, V50, P1601, DOI 10.1099/00207713-50-4-1601; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hubbard A, 2004, ANN GLACIOL-SER, V39, P79, DOI 10.3189/172756404781813970; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Lyons WB, 2005, GEOCHIM COSMOCHIM AC, V69, P305, DOI 10.1016/j.gca.2004.06.040; MIKUCKI JA, 2005, THESIS MONTANA STATE; Mikucki JA, 2007, APPL ENVIRON MICROB, V73, P4029, DOI 10.1128/AEM.01396-06; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Priscu J. C, 2008, POLAR LAKES RIVERS, P119, DOI DOI 10.1093/ACPROF:OSO/9780199213887.003.0007; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Schink B, 2006, ENG LIFE SCI, V6, P228, DOI 10.1002/elsc.200620130; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Tranter M, 2005, HYDROL PROCESS, V19, P995, DOI 10.1002/hyp.5854; Turchyn AV, 2006, GEOBIOLOGY, V4, P191, DOI 10.1111/j.1472-4669.2006.00079.x; Turchyn AV, 2004, SCIENCE, V303, P2004, DOI 10.1126/science.1092296; Wilch T. M., 1993, GEOGR ANN A, V75, P331, DOI DOI 10.1080/04353676.1993.11880399	32	175	182	0	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					397	400		10.1126/science.1167350	http://dx.doi.org/10.1126/science.1167350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372431				2022-12-28	WOS:000265221600045
J	Young, LH; Wackers, FJT; Chyun, DA; Davey, JA; Barrett, EJ; Taillefer, R; Heller, GV; Iskandrian, AE; Wittlin, SD; Filipchuk, N; Ratner, RE; Inzucchi, SE				Young, Lawrence H.; Wackers, Frans J. Th.; Chyun, Deborah A.; Davey, Janice A.; Barrett, Eugene J.; Taillefer, Raymond; Heller, Gary V.; Iskandrian, Ami E.; Wittlin, Steven D.; Filipchuk, Neil; Ratner, Robert E.; Inzucchi, Silvio E.		DIAD Investigators	Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes The DIAD Study: A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMISSION COMPUTED-TOMOGRAPHY; SILENT-MYOCARDIAL-ISCHEMIA; STRESS ECHOCARDIOGRAPHY; RISK STRATIFICATION; PROGNOSTIC VALUE; HEART-DISEASE; CARDIOVASCULAR-DISEASE; PREVALENCE; MORTALITY; SYMPTOMS	Context Coronary artery disease (CAD) is the major cause of mortality and morbidity in patients with type 2 diabetes. But the utility of screening patients with type 2 diabetes for asymptomatic CAD is controversial. Objective To assess whether routine screening for CAD identifies patients with type 2 diabetes as being at high cardiac risk and whether it affects their cardiac outcomes. Design, Setting, and Patients The Detection of Ischemia in Asymptomatic Diabetics (DIAD) study is a randomized controlled trial in which 1123 participants with type 2 diabetes and no symptoms of CAD were randomly assigned to be screened with adenosine-stress radionuclide myocardial perfusion imaging (MPI) or not to be screened. Participants were recruited from diabetes clinics and practices and prospectively followed up from August 2000 to September 2007. Main Outcome Measure Cardiac death or nonfatal myocardial infarction (MI). Results The cumulative cardiac event rate was 2.9% over a mean (SD) follow-up of 4.8 (0.9) years for an average of 0.6% per year. Seven nonfatal MIs and 8 cardiac deaths (2.7%) occurred among the screened group and 10 nonfatal MIs and 7 cardiac deaths (3.0%) among the not-screened group (hazard ratio [HR], 0.88; 95% confidence interval [CI], 0.44-1.88; P=.73). Of those in the screened group, 409 participants with normal results and 50 with small MPI defects had lower event rates than the 33 with moderate or large MPI defects; 0.4% per year vs 2.4% per year (HR, 6.3; 95% CI, 1.9-20.1; P=.001). Nevertheless, the positive predictive value of having moderate or large MPI defects was only 12%. The overall rate of coronary revascularization was low in both groups: 31 (5.5%) in the screened group and 44 (7.8%) in the unscreened group (HR, 0.71; 95% CI, 0.45-1.1; P=.14). During the course of study there was a significant and equivalent increase in primary medical prevention in both groups. Conclusion In this contemporary study population of patients with diabetes, the cardiac event rates were low and were not significantly reduced by MPI screening for myocardial ischemia over 4.8 years. Trial Registration clinicaltrials.gov Identifier: NCT00769275	[Young, Lawrence H.; Wackers, Frans J. Th.; Davey, Janice A.] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06520 USA; [Inzucchi, Silvio E.] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Chyun, Deborah A.] NYU, Coll Dent, Coll Nursing, New York, NY USA; [Barrett, Eugene J.] Univ Virginia, Dept Endocrinol, Charlottesville, VA USA; [Taillefer, Raymond] Univ Montreal, Montreal, PQ, Canada; [Heller, Gary V.] Hartford Hosp, Dept Cardiol, Hartford, CT 06115 USA; [Iskandrian, Ami E.] Univ Alabama Birmingham, Dept Cardiol, Birmingham, AL USA; [Wittlin, Steven D.] Univ Rochester, Dept Endocrinol, Rochester, NY USA; [Filipchuk, Neil] Cardiol Consultants, Calgary, AB, Canada; [Ratner, Robert E.] MedStar Res Inst, Washington, DC USA	Yale University; Yale University; New York University; University of Virginia; Universite de Montreal; Hartford Hospital; University of Alabama System; University of Alabama Birmingham; University of Rochester	Wackers, FJT (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, 333 Cedar St,Fitkin 3, New Haven, CT 06520 USA.	frans.wackers@yale.edu	Inzucchi, Silvio/ABF-4121-2021; Buse, John Bernard/J-9742-2019	Buse, John Bernard/0000-0002-9723-3876	National Institute of Health [M01-RR-00125]; University of Rochester [5M01-RR-00847]; Tulane University [6M01-RR-05096]; Bristol Myers-Squibb Medical Imaging, North Billerica, Massachusetts; Astellas Pharma, Deerfield, Michigan; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000847, M01RR005096, M01RR000125] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester; Tulane University; Bristol Myers-Squibb Medical Imaging, North Billerica, Massachusetts(Bristol-Myers Squibb); Astellas Pharma, Deerfield, Michigan(Astellas Pharmaceuticals); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding/Support: This work was performed with the support of National Institute of Health grants M01-RR-00125 through the General Clinical Research Centers at Yale University, 5M01-RR-00847 through the University of Rochester, and 6M01-RR-05096 through Tulane University. In addition, The DIAD study was supported by grants from Bristol Myers-Squibb Medical Imaging, North Billerica, Massachusetts, and Astellas Pharma, Deerfield, Michigan, which also provided technetium-99m sestamibi and adenosine for study patients.	Abbott BG, 2003, J NUCL CARDIOL, V10, P9, DOI 10.1067/mnc.2002.127625; Anand DV, 2006, EUR HEART J, V27, P713, DOI 10.1093/eurheartj/ehi808; [Anonymous], 1998, Diabetes Care, V21, P1551; Bax JJ, 2007, DIABETES CARE, V30, P2729, DOI 10.2337/dc07-9927; Befler GA, 2007, J AM COLL CARDIOL, V49, P1918, DOI 10.1016/j.jacc.2007.01.079; Bigi R, 2001, DIABETES CARE, V24, P1596, DOI 10.2337/diacare.24.9.1596; Brooks MM, 2008, AM HEART J, V156, P528, DOI [10.1016/j.ahj.2008.05.015, 10.1016/j.ajh.2008.05.015]; De Lorenzo A, 2002, AM J CARDIOL, V90, P827, DOI 10.1016/S0002-9149(02)02702-9; Diamond GA, 2007, J AM COLL CARDIOL, V49, P1915, DOI 10.1016/j.jacc.2006.09.057; Faglia E, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.07.027; Faglia E, 2002, DIABETES CARE, V25, P2032, DOI 10.2337/diacare.25.11.2032; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gazzaruso C, 2002, DIABETES CARE, V25, P1418, DOI 10.2337/diacare.25.8.1418; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gibbons RJ, 2006, J NUCL CARDIOL, V13, P616, DOI 10.1016/j.nuclcard.2006.06.130; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; GIBBONS RJ, 37 AM HEART ASS TASK; Giri S, 2002, CIRCULATION, V105, P32, DOI 10.1161/hc5001.100528; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Jouven X, 2005, EUR HEART J, V26, P2142, DOI 10.1093/eurheartj/ehi376; Marwick TH, 2002, DIABETES CARE, V25, P1042, DOI 10.2337/diacare.25.6.1042; Miller TD, 2006, J AM COLL CARDIOL, V48, P761, DOI 10.1016/j.jacc.2006.04.076; Penfornis A, 2001, DIABETIC MED, V18, P900, DOI 10.1046/j.1464-5491.2001.00599.x; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Rajagopalan N, 2005, J AM COLL CARDIOL, V45, P43, DOI 10.1016/j.jacc.2004.06.078; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Rutter MK, 2007, NAT CLIN PRACT ENDOC, V3, P26, DOI 10.1038/ncpendmet0352; Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022; Vanzetto G, 1999, DIABETES CARE, V22, P19, DOI 10.2337/diacare.22.1.19; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Wackers FJT, 2007, DIABETES CARE, V30, P2892, DOI 10.2337/dc07-1250; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zellweger MJ, 2004, EUR HEART J, V25, P543, DOI 10.1016/j.ehj.2004.02.013	36	578	598	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1547	1555		10.1001/jama.2009.476	http://dx.doi.org/10.1001/jama.2009.476			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366774	Bronze, Green Accepted			2022-12-28	WOS:000265137900025
J	Sanda, MG; Kaplan, ID				Sanda, Martin G.; Kaplan, Irving D.			A 64-Year-Old Man With Low-Risk Prostate Cancer Review of Prostate Cancer Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; PHASE-III TRIAL; RADICAL PROSTATECTOMY; RADIATION-THERAPY; ANDROGEN SUPPRESSION; LOCALIZED ADENOCARCINOMA; BIOCHEMICAL RECURRENCE; BEAM RADIOTHERAPY; SEXUAL FUNCTION	Earlier detection of prostate cancer in the past decade has been accompanied by greater reduction in US prostate cancer mortality than that seen with any other cancer. Prostate cancer is usually diagnosed at early stages and is most commonly treated by prostatectomy, radiotherapy, or brachytherapy. For intermediate- and high-risk prostate cancers, randomized clinical trials have shown survival benefit subsequent to prostatectomy or to combined radiation with androgen-suppressive therapy. However, prostatectomy, radiotherapy, and brachytherapy each can lead to distinct adverse effects. Moreover, for the lowest-risk categories of early stage prostate cancer, evidence supporting an intervention is only indirect. New approaches to surveillance of prostate cancer have consequently emerged that do not eschew treatment altogether. Instead "active" surveillance aims to implement definitive intervention effectively for those low-risk cancers that show a propensity for progression as evidenced by histopathological or serological change during the surveillance interval. JAMA. 2009; 301(20): 2141-2151	[Sanda, Martin G.; Kaplan, Irving D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Sanda, MG (corresponding author), Beth Israel Deaconess Med Ctr, Div Urol, 330 Brookline Ave,Rabb 440, Boston, MA 02215 USA.	msanda@bidmc.harvard.edu	Sanda, Martin G/A-6202-2013; Sanda, Martin G/B-2023-2015		Jacqueline and Martin J. Shaevel Charitable Trust [NIH R01 CA95662]; NATIONAL CANCER INSTITUTE [R01CA095662] Funding Source: NIH RePORTER	Jacqueline and Martin J. Shaevel Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This Clinical Crossroads is made possible in part by a grant from the Jacqueline and Martin J. Shaevel Charitable Trust and by NIH R01 CA95662.	Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Andriole GL, 2009, NEW ENGL J MED, V360, P1797; BAGSHAW MA, 1965, RADIOLOGY, V85, P121, DOI 10.1148/85.1.121; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Blasko JC, 2002, SEMIN RADIAT ONCOL, V12, P81, DOI 10.1053/srao.2002.28667; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Carter CA, 2003, J CLIN ONCOL, V21, P4001, DOI 10.1200/JCO.2003.04.092; Catalona WJ, 1999, J UROLOGY, V162, P433, DOI 10.1016/S0022-5347(05)68578-3; Clement J, 2008, UROLOGY, V72, P664, DOI 10.1016/j.urology.2008.04.045; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; Crook JM, 2009, CANCER, V115, P673, DOI 10.1002/cncr.24020; D'Amico AV, 2007, J CLIN ONCOL, V25, P2420, DOI 10.1200/JCO.2006.09.3369; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Di Muzio N, 2009, INT J RADIAT ONCOL, V74, P392, DOI 10.1016/j.ijrobp.2008.08.038; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Fagerlin A, 2004, ANN INTERN MED, V140, P721, DOI 10.7326/0003-4819-140-9-200405040-00012; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; GELBLUM DY, 1999, INT J RADIAT ONCOL, V45, P39; Guillonneau B, 2000, J UROLOGY, V163, P1643, DOI 10.1016/S0022-5347(05)67512-X; Herstein A, 2005, CANCER J, V11, P385, DOI 10.1097/00130404-200509000-00005; Holmes-Rovner Margaret, 2005, BMC Med Inform Decis Mak, V5, P16, DOI 10.1186/1472-6947-5-16; Hu JC, 2008, J CLIN ONCOL, V26, P2278, DOI 10.1200/JCO.2007.13.4528; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; King CR, 2009, INT J RADIAT ONCOL, V73, P1043, DOI 10.1016/j.ijrobp.2008.05.059; Klotz L, 2006, UROL ONCOL-SEMIN ORI, V24, P46, DOI 10.1016/j.urolonc.2005.07.002; Kuban DA, 2008, INT J RADIAT ONCOL, V70, P67, DOI 10.1016/j.ijrobp.2007.06.054; Kupelian PA, 2007, INT J RADIAT ONCOL, V68, P1424, DOI 10.1016/j.ijrobp.2007.01.067; Lawton CA, 2007, INT J RADIAT ONCOL, V69, P646, DOI 10.1016/j.ijrobp.2007.04.003; Lawton CA, 2007, INT J RADIAT ONCOL, V67, P39, DOI 10.1016/j.ijrobp.2006.08.016; LEBORGNE F, 2006, INT J RADIAT ONCOL, V72, P780; Lee WR, 2007, CANCER, V109, P1506, DOI 10.1002/cncr.22560; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; Madalinska JB, 2001, J CLIN ONCOL, V19, P1619, DOI 10.1200/JCO.2001.19.6.1619; Meng MV, 2003, J UROLOGY, V170, P2279, DOI 10.1097/01.ju.0000094190.46523.b2; Menon M, 2003, UROLOGY, V61, P15, DOI 10.1016/S0090-4295(03)00116-X; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Pommier P, 2007, J CLIN ONCOL, V25, P5366, DOI 10.1200/JCO.2006.10.5171; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; QUINLAN DM, 1991, J UROLOGY, V145, P998, DOI 10.1016/S0022-5347(17)38512-9; Rabbani F, 2000, J UROLOGY, V164, P1929, DOI 10.1016/S0022-5347(05)66921-2; *RAD THER ONC GROU, NCT00063882 RAD THER; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Scherr D, 2003, UROLOGY, V61, P14, DOI 10.1016/S0090-4295(02)02395-6; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Small EJ, 2000, J CLIN ONCOL, V18, P3595, DOI 10.1200/JCO.2000.18.21.3595; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Soloway MS, 2002, J UROLOGY, V167, P112, DOI 10.1016/S0022-5347(05)65393-1; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Stone NN, 2007, J UROLOGY, V177, P1759, DOI 10.1016/j.juro.2007.01.069; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Wallace K, 2006, J CLIN ONCOL, V24, P4158, DOI 10.1200/JCO.2006.06.3875; Wallner K, 1999, INT J RADIAT ONCOL, V43, P583, DOI 10.1016/S0360-3016(98)00459-3; Warlick C, 2006, JNCI-J NATL CANCER I, V98, P355, DOI 10.1093/jnci/djj072; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Wilt TJ, 2008, J NATL CANCER I, V100, P1123, DOI 10.1093/jnci/djn259; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683; Wu AK, 2008, J UROLOGY, V180, P2415, DOI 10.1016/j.juro.2008.08.015; Zelefsky MJ, 2008, J UROLOGY, V179, P1368, DOI 10.1016/j.juro.2007.11.063; Zietman AL, 2001, J UROLOGY, V166, P1702, DOI 10.1016/S0022-5347(05)65657-1; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	68	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2141	2151		10.1001/jama.2009.674	http://dx.doi.org/10.1001/jama.2009.674			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19417179				2022-12-28	WOS:000266328800026
J	Kriaucionis, S; Heintz, N				Kriaucionis, Skirmantas; Heintz, Nathaniel			The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain	SCIENCE			English	Article							TRANSLATIONAL PROFILING APPROACH; CNS CELL-TYPES; OXIDATIVE DAMAGE; 5-METHYLCYTOSINE	Despite the importance of epigenetic regulation in neurological disorders, little is known about neuronal chromatin. Cerebellar Purkinje neurons have large and euchromatic nuclei, whereas granule cell nuclei are small and have a more typical heterochromatin distribution. While comparing the abundance of 5-methylcytosine in Purkinje and granule cell nuclei, we detected the presence of an unusual DNA nucleotide. Using thin-layer chromatography, high-pressure liquid chromatography, and mass spectrometry, we identified the nucleotide as 5-hydroxymethyl-2'-deoxycytidine (hmdC). hmdC constitutes 0.6% of total nucleotides in Purkinje cells, 0.2% in granule cells, and is not present in cancer cell lines. hmdC is a constituent of nuclear DNA that is highly abundant in the brain, suggesting a role in epigenetic control of neuronal function.	[Kriaucionis, Skirmantas; Heintz, Nathaniel] Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Kriaucionis, Skirmantas/A-2986-2015; jia, xu/A-8386-2016	Kriaucionis, Skirmantas/0000-0002-2273-5994; 	Howard Hughes Medical Institute; Simons Foundation Autism Research Initiative	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation Autism Research Initiative	We thank B. Gauthier for technical assistance; S. Mazel, C. Bare, and X. Fan for flow cytometry advice and nuclei sorts; and H. Deng and J. Fernandez for acquirement of MS data and help with HPLC. We are grateful to members of the Heintz laboratory for discussions and support. This work was supported by the Howard Hughes Medical Institute and the Simons Foundation Autism Research Initiative.	Burdzy A, 2002, NUCLEIC ACIDS RES, V30, P4068, DOI 10.1093/nar/gkf520; Cadet J, 2006, NAT CHEM BIOL, V2, P348, DOI 10.1038/nchembio0706-348; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; GOMMERSAMPT JH, 1995, FASEB J, V9, P1034, DOI 10.1096/fasebj.9.11.7649402; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; KOTHARI RM, 1976, J MOL EVOL, V7, P325, DOI 10.1007/BF01743628; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Ramsahoye Bernard H, 2002, Methods Mol Biol, V200, P9; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; ZUO SJ, 1995, NUCLEIC ACIDS RES, V23, P3239, DOI 10.1093/nar/23.16.3239	14	1926	2015	2	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					929	930		10.1126/science.1169786	http://dx.doi.org/10.1126/science.1169786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372393	Green Accepted			2022-12-28	WOS:000266048800036
J	Foltz, DR; Jansen, LET; Bailey, AO; Yates, JR; Bassett, EA; Wood, S; Black, BE; Cleveland, DW				Foltz, Daniel R.; Jansen, Lars E. T.; Bailey, Aaron O.; Yates, John R., III; Bassett, Emily A.; Wood, Stacey; Black, Ben E.; Cleveland, Don W.			Centromere-Specific Assembly of CENP-A Nucleosomes Is Mediated by HJURP	CELL			English	Article							INNER KINETOCHORE PLATE; DNA-REPLICATION INVITRO; HISTONE VARIANT H3.3; ALPHA-SATELLITE DNA; SACCHAROMYCES-CEREVISIAE; CHROMATIN REQUIRES; MITOTIC CHECKPOINT; CANCER-CELLS; IN-VITRO; PROTEIN	The centromere is responsible for accurate chromosome segregation. Mammalian centromeres are specified epigenetically, with all active centromeres containing centromere-specific chromatin in which CENP-A replaces histone H3 within the nucleosome. The proteins responsible for assembly of human CENP-A into centromeric nucleosomes during the G1 phase of the cell cycle are shown here to be distinct from the chromatin assembly factors previously shown to load other histone H3 variants. Here we demonstrate that prenucleosomal CENP-A is complexed with histone H4, nucleophosmin 1, and HJURP. Recruitment of new ENP-Aintonucleosomes at replicated centromeres is dependent on HJURP. Recognition by HJURP is mediated through the centromere targeting domain (CATD) of CENP-A, a region that we demonstrated previously to induce a unique conformational rigidity to both the subnucleosomal CENP-A heterotetramer and the corresponding assembled nucleosome. We propose HJURP to be a cell-cycle-regulated CENP-A-specific histone chaperone required for centromeric chromatin assembly.	[Foltz, Daniel R.; Jansen, Lars E. T.; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Foltz, Daniel R.; Jansen, Lars E. T.; Cleveland, Don W.] Univ Calif San Diego, Dept Cell & Mol Med, La Jolla, CA 92093 USA; [Bailey, Aaron O.; Yates, John R., III] Scripps Res Inst, La Jolla, CA 92037 USA; [Bassett, Emily A.; Wood, Stacey; Black, Ben E.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Pennsylvania	Foltz, DR (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	dfoltz@virginia.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Bailey, Aaron/ABB-8522-2021	Bailey, Aaron/0000-0001-8063-3032; Wood, Stacey/0000-0001-5805-6670; Cleveland, Don/0000-0002-1934-3682; Jansen, Lars/0000-0002-2158-0345	National Institutes of Health; Leukemia and Lymphoma Society; Burroughs Welcome Fund; Philip Morris USA Inc; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275, R01GM082989, R01GM074150, F32GM067401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Burroughs Welcome Fund(Burroughs Wellcome Fund); Philip Morris USA Inc; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Iain Cheeseman, Andrew Holland, Karen Oegema, Arshad Desai, and members of the Cleveland Lab for helpful discussion and reagents. This work was supported by grants from the National Institutes of Health to B. E.B. and D.W.C.D.R.F. was supported by a Special Fellowship from the Leukemia and Lymphoma Society. B.E.B. was supported by a Career Award in the Biomedical Sciences from the Burroughs Welcome Fund. L.E.T.J. was supported by a postdoctoral fellowship from Philip Morris USA Inc. Salary support for D.W.C. is provided by the Ludwig Institute for Cancer Research.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Chang JH, 1998, BIOCHEM J, V329, P539; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Ito T, 1996, J BIOL CHEM, V271, P25041, DOI 10.1074/jbc.271.40.25041; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luhn P, 2007, PROTEINS, V67, P479, DOI 10.1002/prot.21288; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; MANUELIDIS L, 1978, NATURE, V276, P92, DOI 10.1038/276092a0; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; WILLARD HF, 1985, AM J HUM GENET, V37, P524; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	59	471	479	3	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 1	2009	137	3					472	484		10.1016/j.cell.2009.02.039	http://dx.doi.org/10.1016/j.cell.2009.02.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410544	Green Accepted, Bronze			2022-12-28	WOS:000265677200017
J	Livingston, DM				Livingston, David M.			Complicated Supercomplexes	SCIENCE			English	Editorial Material							CANCER SUSCEPTIBILITY GENE; BREAST-CANCER; FANCONI-ANEMIA; PALB2; MUTATIONS; PARTNER		[Livingston, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA; [Livingston, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Livingston, DM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu						Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Goggins M, 1996, CANCER RES, V56, P5360; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	14	14	14	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					602	603		10.1126/science.1174839	http://dx.doi.org/10.1126/science.1174839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407191				2022-12-28	WOS:000265608800031
J	Frost, A; Unger, VM; De Camilli, P				Frost, Adam; Unger, Vinzenz M.; De Camilli, Pietro			The BAR Domain Superfamily: Membrane-Molding Macromolecules	CELL			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; AMPHIPHYSIN-2 BIN1; STRUCTURAL BASIS; FISSION YEAST; PROTEINS; CURVATURE; FAMILY; INVAGINATION	Membrane-shaping proteins of the BAR domain superfamily are determinants of organelle biogenesis, membrane trafficking, cell division, and cell migration. An upsurge of research now reveals new principles of BAR domain-mediated membrane remodeling, enhancing our understanding of membrane curvature-mediated information processing.	[Frost, Adam; Unger, Vinzenz M.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Frost, Adam; Unger, Vinzenz M.; De Camilli, Pietro] Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06510 USA; [Frost, Adam; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Unger, VM (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.	vinzenz.unger@yale.edu; pietro.decamilli@yale.edu		Frost, Adam/0000-0003-2231-2577	Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [P30 DA018343, R21 DA024101] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024101, P30DA018343] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GOLDENTHAL KL, 1984, EXP CELL RES, V152, P558, DOI 10.1016/0014-4827(84)90658-X; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KANBE T, 1989, J CELL SCI, V94, P647; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Kusumi N, 2007, CELL STRUCT FUNCT, V32, P101, DOI 10.1247/csf.07024; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McBride HM, 2008, J CELL BIOL, V183, P757, DOI 10.1083/jcb.200810184; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; ROBERTSGALBRAIT.RH, 2008, POMBE CDC15 HOMOLOGY; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	45	414	421	1	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2					191	196		10.1016/j.cell.2009.04.010	http://dx.doi.org/10.1016/j.cell.2009.04.010			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379681	Green Accepted, Bronze			2022-12-28	WOS:000265456800006
J	Grigoryan, G; Reinke, AW; Keating, AE				Grigoryan, Gevorg; Reinke, Aaron W.; Keating, Amy E.			Design of protein-interaction specificity gives selective bZIP-binding peptides	NATURE			English	Article							COILED-COIL; PDZ DOMAIN; COMPUTATIONAL REDESIGN; PREDICTION; STABILITY; INTERFACES; AFFINITY; ENERGY	Interaction specificity is a required feature of biological networks and a necessary characteristic of protein or small-molecule reagents and therapeutics. The ability to alter or inhibit protein interactions selectively would advance basic and applied molecular science. Assessing or modelling interaction specificity requires treating multiple competing complexes, which presents computational and experimental challenges. Here we present a computational framework for designing protein-interaction specificity and use it to identify specific peptide partners for human basic-region leucine zipper (bZIP) transcription factors. Protein microarrays were used to characterize designed, synthetic ligands for all but one of 20 bZIP families. The bZIP proteins share strong sequence and structural similarities and thus are challenging targets to bind specifically. Nevertheless, many of the designs, including examples that bind the oncoproteins c-Jun, c-Fos and c-Maf (also called JUN, FOS and MAF, respectively), were selective for their targets over all 19 other families. Collectively, the designs exhibit a wide range of interaction profiles and demonstrate that human bZIPs have only sparsely sampled the possible interaction space accessible to them. Our computational method provides a way to systematically analyse trade-offs between stability and specificity and is suitable for use with many types of structure-scoring functions; thus, it may prove broadly useful as a tool for protein design.	[Grigoryan, Gevorg; Reinke, Aaron W.; Keating, Amy E.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Keating, AE (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keating@mit.edu		Reinke, Aaron/0000-0001-7612-5342; Keating, Amy/0000-0003-4074-8980	NIH [GM67681]; NSF [0216437]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH award GM67681 and used computer equipment purchased under the NSF award 0216437. We thank the MIT BioMicro center for arraying instrumentation and R. T. Sauer, M. Singh, B. Tidor, M. Laub, T. A. Baker, J. H. Davis, M. S. Kay, J. R. S. Newman, W. F. DeGrado and members of the Keating laboratory, especially O. Ashenberg and T. C. S. Chen, for comments on the manuscript.	Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Ali MH, 2005, STRUCTURE, V13, P225, DOI 10.1016/j.str.2004.12.009; APGAR JR, J COMPUT CH IN PRESS; Boas FE, 2007, CURR OPIN STRUC BIOL, V17, P199, DOI 10.1016/j.sbi.2007.03.006; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deutsch JM, 1996, PHYS REV LETT, V76, P323, DOI 10.1103/PhysRevLett.76.323; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Fu XR, 2007, J MOL BIOL, V371, P1099, DOI 10.1016/j.jmb.2007.04.069; Gerdes MJ, 2006, CANCER RES, V66, P7578, DOI 10.1158/0008-5472.CAN-06-1247; Grigoryan G, 2006, J MOL BIOL, V355, P1125, DOI 10.1016/j.jmb.2005.11.036; Grigoryan G, 2006, PLOS COMPUT BIOL, V2, P551, DOI 10.1371/journal.pcbi.0020063; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kangas E, 2000, J CHEM PHYS, V112, P9120, DOI 10.1063/1.481522; Kaplan T, 2005, PLOS COMPUT BIOL, V1, P5, DOI 10.1371/journal.pcbi.0010001; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; KRYLOV D, 1995, EMBO J, V14, P5329, DOI 10.1002/j.1460-2075.1995.tb00217.x; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mason JM, 2007, BIOCHEMISTRY-US, V46, P4804, DOI 10.1021/bi602506p; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Sanchez IE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000052; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zhou F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.148103; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	38	275	281	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					859	U2		10.1038/nature07885	http://dx.doi.org/10.1038/nature07885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370028	Green Accepted			2022-12-28	WOS:000265182500036
J	Couri, CEB; Oliveira, MCB; Stracieri, ABPL; Moraes, DA; Pieroni, F; Barros, GMN; Madeira, MIA; Malmegrim, KCR; Foss-Freitas, MC; Simoes, BP; Martinez, EZ; Foss, MC; Burt, RK; Voltarelli, JC				Couri, Carlos E. B.; Oliveira, Maria C. B.; Stracieri, Ana B. P. L.; Moraes, Daniela A.; Pieroni, Fabiano; Barros, George M. N.; Madeira, Maria Isabel A.; Malmegrim, Kelen C. R.; Foss-Freitas, Maria C.; Simoes, Belinda P.; Martinez, Edson Z.; Foss, Milton C.; Burt, Richard K.; Voltarelli, Julio C.			C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; INHIBITOR; AZATHIOPRINE; SITAGLIPTIN; IV; TOLERANCE; REMISSION; SECRETION; CHILDREN; THERAPY	Context In 2007, the effects of the autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) in 15 patients with type 1 diabetes mellitus (DM) were reported. Most patients became insulin free with normal levels of glycated hemoglobin A(1c) (HbA(1c)) during a mean 18.8-month follow-up. To investigate if this effect was due to preservation of beta-cell mass, continued monitoring was performed of C-peptide levels after stem cell transplantation in the 15 original and 8 additional patients. Objective To determine C-peptide levels after autologous nonmyeloablative HSCT in patients with newly diagnosed type 1 DM during a longer follow-up. Design, Setting, and Participants A prospective phase 1/2 study of 23 patients with type 1 DM(aged 13-31 years) diagnosed in the previous 6 weeks by clinical findings with hyperglycemia and confirmed by measurement of serum levels of anti glutamic acid decarboxylase antibodies. Enrollment was November 2003-April 2008, with follow-up until December 2008 at the Bone Marrow Transplantation Unit of the School of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil. Hematopoietic stem cells were mobilized via the 2007 protocol. Main Outcome Measures C-peptide levels measured during the mixed-meal tolerance test, before, and at different times following HSCT. Secondary end points included morbidity and mortality from transplantation, temporal changes in exogenous insulin requirements, and serum levels of HbA1c. Results During a 7- to 58-month follow-up (mean, 29.8 months; median, 30 months), 20 patients without previous ketoacidosis and not receiving corticosteroids during the preparative regimen became insulin free. Twelve patients maintained this status for a mean 31 months (range, 14-52 months) and 8 patients relapsed and resumed insulin use at low dose (0.1-0.3 IU/kg). In the continuous insulin-independent group, HbA(1c) levels were less than 7.0% and mean (SE) area under the curve (AUC) of C-peptide levels increased significantly from 225.0 (75.2) ng/mL per 2 hours pretransplantation to 785.4 (90.3) ng/mL per 2 hours at 24 months posttransplantation (P<.001) and to 728.1 (144.4) ng/mL per 2 hours at 36 months (P=.001). In the transient insulin-independent group, mean (SE) AUC of C-peptide levels also increased from 148.9 (75.2) ng/mL per 2 hours pretransplantation to 546.8 (96.9) ng/mL per 2 hours at 36 months (P=.001), which was sustained at 48 months. In this group, 2 patients regained insulin independence after treatment with sitagliptin, which was associated with increase in C-peptide levels. Two patients developed bilateral nosocomial pneumonia, 3 patients developed late endocrine dysfunction, and 9 patients developed oligospermia. There was no mortality. Conclusion After a mean follow-up of 29.8 months following autologous nonmyeloablative HSCT in patients with newly diagnosed type 1 DM, C-peptide levels increased significantly and the majority of patients achieved insulin independence with good glycemic control. Trial Registration clinicaltrials.gov Identifier: NCT00315133	[Couri, Carlos E. B.; Oliveira, Maria C. B.; Stracieri, Ana B. P. L.; Moraes, Daniela A.; Pieroni, Fabiano; Barros, George M. N.; Madeira, Maria Isabel A.; Malmegrim, Kelen C. R.; Foss-Freitas, Maria C.; Simoes, Belinda P.; Foss, Milton C.; Voltarelli, Julio C.] Univ Sao Paulo, Sch Med, Dept Clin Med, BR-14049 Ribeirao Preto, Brazil; [Martinez, Edson Z.] Univ Sao Paulo, Sch Med, Dept Social Med, BR-14049 Ribeirao Preto, Brazil; [Burt, Richard K.] Northwestern Univ, Feinberg Sch Med, Div Immunotherapy, Chicago, IL 60611 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Northwestern University; Feinberg School of Medicine	Voltarelli, JC (corresponding author), Reg Blood Ctr Hemoctr, Campus USP, BR-14051140 Ribeirao Preto, Brazil.	jcvoltar@fmrp.usp.br	SIMOES, BELINDA/A-1896-2014; Foss-Freitas, Maria/AAV-5971-2021; Rodrigues, Maria Carolina Oliveira/A-2302-2012; Malmegrim, Kelen/B-8514-2012; Martinez, Edson Zangiacomi/A-3638-2008; Malmegrim, Kelen/H-1016-2015; Foss-Freitas, Maria C/F-1197-2013; Simoes, Belinda P/M-7469-2016	SIMOES, BELINDA/0000-0003-4508-8934; Foss-Freitas, Maria/0000-0002-1350-1125; Rodrigues, Maria Carolina Oliveira/0000-0003-0691-2222; Martinez, Edson Zangiacomi/0000-0002-0949-3222; Malmegrim, Kelen/0000-0002-9303-0086; Foss-Freitas, Maria C/0000-0002-1350-1125; Burt, Richard K/0000-0002-0922-4145	Brazilian Ministry of Health; FAEPA-HCRP; FUNDHERP; CAPES; FAPESP; CNPq; FINEP; Genzyme Corporation; Johnson & Johnson-LifeScan-Brazil	Brazilian Ministry of Health; FAEPA-HCRP; FUNDHERP; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Johnson & Johnson-LifeScan-Brazil(Johnson & JohnsonJohnson & Johnson USA)	Funding/Support: This work was supported by the Brazilian Ministry of Health, FAEPA-HCRP, FUNDHERP, CAPES, FAPESP, CNPq, FINEP, Genzyme Corporation, and Johnson & Johnson-LifeScan-Brazil.	Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Au WY, 2005, BONE MARROW TRANSPL, V35, P383, DOI 10.1038/sj.bmt.1704766; Burt RK, 2002, BLOOD, V99, P768, DOI 10.1182/blood.V99.3.768; CEMA M, 2008, WIEN MED WOCHENSCHR, V158, P2; COOK JJ, 1989, DIABETES, V38, P779, DOI 10.2337/diabetes.38.6.779; Couri CEB, 2006, BRAZ J MED BIOL RES, V39, P1271, DOI 10.1590/S0100-879X2006005000010; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; DUPRE J, 1988, DIABETES, V37, P1574; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; ELLIOTT RB, 1981, LANCET, V2, P631; Ross LF, 2007, JAMA-J AM MED ASSOC, V298, P285, DOI 10.1001/jama.298.3.285-a; HARRISON LC, 1985, DIABETES, V34, P1306, DOI 10.2337/diabetes.34.12.1306; Herman GA, 2005, CLIN PHARMACOL THER, V78, P675, DOI 10.1016/j.clpt.2005.09.002; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kim SJ, 2009, DIABETES, V58, P641, DOI 10.2337/db08-1101; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Mari A, 2005, J CLIN ENDOCR METAB, V90, P4888, DOI 10.1210/jc.2004-2460; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Saudek Frantisek, 2004, Rev Diabet Stud, V1, P80, DOI 10.1900/RDS.2004.1.80; SILVERSTEIN J, 1988, NEW ENGL J MED, V319, P599, DOI 10.1056/NEJM198809083191002; Skyler JS, 2007, JAMA-J AM MED ASSOC, V297, P1599, DOI 10.1001/jama.297.14.1599; Staeva-Vieira T, 2007, CLIN EXP IMMUNOL, V148, P17, DOI 10.1111/j.1365-2249.2007.03328.x; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568	25	304	330	1	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1573	1579		10.1001/jama.2009.470	http://dx.doi.org/10.1001/jama.2009.470			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366777	Bronze			2022-12-28	WOS:000265137900028
J	Park, S; Roelofs, J; Kim, W; Robert, J; Schmidt, M; Gygi, SP; Finley, D				Park, Soyeon; Roelofs, Jeroen; Kim, Woong; Robert, Jessica; Schmidt, Marion; Gygi, Steven P.; Finley, Daniel			Hexameric assembly of the proteasomal ATPases is templated through their C termini	NATURE			English	Article							19S REGULATORY PARTICLE; 26 S-PROTEASOME; 20S PROTEASOMES; STRUCTURAL BASIS; COMPLEX; YEAST; PROTEINS; SUBUNITS; PATHWAY; DEGRADATION	Substrates of the proteasome are recognized and unfolded by the regulatory particle, and then translocated into the core particle (CP) to be degraded(1). A hetero-hexameric ATPase ring, containing subunits Rpt1-6, is situated within the base subassembly of the regulatory particle(1). The ATPase ring sits atop the CP, with the Rpt carboxy termini inserted into pockets in the CP2-6. Here we identify a previously unknown function of the Rpt proteins in proteasome biogenesis through deleting the C-terminal residue from each Rpt in the yeast Saccharomyces cerevisiae. Our results indicate that assembly of the hexameric ATPase ring is templated on the CP. We have also identified an apparent intermediate in base assembly, BP1, which contains Rpn1, three Rpts and Hsm3, a chaperone for base assembly. The Rpt proteins with the strongest assembly phenotypes, Rpt4 and Rpt6, were absent from BP1. We propose that Rpt4 and Rpt6 form a nucleating complex to initiate base assembly, and that this complex is subsequently joined by BP1 to complete the Rpt ring. Our studies show that assembly of the proteasome base is a rapid yet highly orchestrated process.	[Park, Soyeon; Roelofs, Jeroen; Kim, Woong; Robert, Jessica; Gygi, Steven P.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Schmidt, Marion] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465	US National Institutes of Health (NIH) [GM043601, GM67945]; EMBO; NIH NRSA [5F32GM75737-2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084228, R37GM043601, R01GM067945, F32GM075737, R01GM043601] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. D. Orth for discussion and technical assistance, and C. Hill for discussions. We also thank J. W. Hanna, S. Elsasser and all members of Finley laboratory for comments on the manuscript. The work was supported by grants from US National Institutes of Health (NIH) to D. F. (GM043601) and S. P. G. (GM67945), an EMBO long-term fellowship to J. R. and an NIH NRSA postdoctoral fellowship (5F32GM75737-2) to S. P.	Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Guthrie C, 1991, GUIDE YEAST GENETICS; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	30	105	110	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					866	U9		10.1038/nature08065	http://dx.doi.org/10.1038/nature08065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19412160	Green Accepted			2022-12-28	WOS:000267084500044
J	Li, XS; Cai, WW; An, JH; Kim, S; Nah, J; Yang, DX; Piner, R; Velamakanni, A; Jung, I; Tutuc, E; Banerjee, SK; Colombo, L; Ruoff, RS				Li, Xuesong; Cai, Weiwei; An, Jinho; Kim, Seyoung; Nah, Junghyo; Yang, Dongxing; Piner, Richard; Velamakanni, Aruna; Jung, Inhwa; Tutuc, Emanuel; Banerjee, Sanjay K.; Colombo, Luigi; Ruoff, Rodney S.			Large-Area Synthesis of High-Quality and Uniform Graphene Films on Copper Foils	SCIENCE			English	Article							FEW-LAYER GRAPHENE; CARBON; SOLUBILITY; SURFACES	Graphene has been attracting great interest because of its distinctive band structure and physical properties. Today, graphene is limited to small sizes because it is produced mostly by exfoliating graphite. We grew large-area graphene films of the order of centimeters on copper substrates by chemical vapor deposition using methane. The films are predominantly single-layer graphene, with a small percentage (less than 5%) of the area having few layers, and are continuous across copper surface steps and grain boundaries. The low solubility of carbon in copper appears to help make this growth process self-limiting. We also developed graphene film transfer processes to arbitrary substrates, and dual-gated field-effect transistors fabricated on silicon/silicon dioxide substrates showed electron mobilities as high as 4050 square centimeters per volt per second at room temperature.	[Colombo, Luigi] Texas Instruments Inc, Dallas, TX 75243 USA; [Li, Xuesong; Cai, Weiwei; An, Jinho; Yang, Dongxing; Piner, Richard; Velamakanni, Aruna; Jung, Inhwa; Ruoff, Rodney S.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA; [Li, Xuesong; Cai, Weiwei; An, Jinho; Yang, Dongxing; Piner, Richard; Velamakanni, Aruna; Jung, Inhwa; Ruoff, Rodney S.] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA; [Kim, Seyoung; Nah, Junghyo; Tutuc, Emanuel; Banerjee, Sanjay K.] Univ Texas Austin, Dept Elect & Comp Engn, Microelect Res Ctr, Austin, TX 78758 USA	Texas Instruments; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Colombo, L (corresponding author), Texas Instruments Inc, Dallas, TX 75243 USA.	colombo@ti.com; r.ruoff@mail.utexas.edu	Banerjee, Sanjay/F-2677-2019; Jung, Inhwa/AAI-8615-2020; Ruoff, Rodney S/B-7605-2009; Nah, Junghyo/P-3761-2015; Colombo, Luigi/T-4677-2018; Piner, Richard/Y-2520-2019; Ruoff, Rodney/ABE-6532-2020	Ruoff, Rodney S/0000-0002-6599-6764; Nah, Junghyo/0000-0001-9975-239X; Colombo, Luigi/0000-0002-9048-3565; Ruoff, Rodney/0000-0002-6599-6764; Kim, Seyoung/0000-0002-0408-1165; Jung, Inhwa/0000-0002-0235-7383	Nanoelectronic Research Initiative Southwest Area Nanoelectronics Center [2006-NE-1464]; Defense Advanced Research Projects Agency Carbon Electronics for RF Applications Center; University of Texas at Austin	Nanoelectronic Research Initiative Southwest Area Nanoelectronics Center; Defense Advanced Research Projects Agency Carbon Electronics for RF Applications Center(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); University of Texas at Austin	We thank the Nanoelectronic Research Initiative (NRI Southwest Area Nanoelectronics Center, grant no. 2006-NE-1464), the Defense Advanced Research Projects Agency Carbon Electronics for RF Applications Center, and the University of Texas at Austin for support.	Banerjee SK, 2009, IEEE ELECTR DEVICE L, V30, P158, DOI 10.1109/LED.2008.2009362; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Blake P, 2008, NANO LETT, V8, P1704, DOI 10.1021/nl080649i; Coraux J, 2008, NANO LETT, V8, P565, DOI 10.1021/nl0728874; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; EIZENBERG M, 1979, J CHEM PHYS, V71, P3467, DOI 10.1063/1.438736; EIZENBERG M, 1979, SURF SCI, V82, P228, DOI 10.1016/0039-6028(79)90330-3; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; HAMILTON JC, 1980, SURF SCI, V91, P199, DOI 10.1016/0039-6028(80)90080-1; KIKOWATZ R, 1987, J VAC SCI TECHNOL A, V5, P1009, DOI 10.1116/1.574174; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Kim S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077021; Lemme MC, 2008, SOLID STATE ELECTRON, V52, P514, DOI 10.1016/j.sse.2007.10.054; Lopez GA, 2004, SCRIPTA MATER, V51, P1, DOI 10.1016/j.scriptamat.2004.03.028; MATHIEU G, 1973, SCRIPTA METALL MATER, V7, P421, DOI 10.1016/0036-9748(73)90066-5; MCLELLAN RB, 1969, SCRIPTA METALL MATER, V3, P389, DOI 10.1016/0036-9748(69)90262-2; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Ni ZH, 2007, NANO LETT, V7, P2758, DOI 10.1021/nl071254m; *NRI SW AR NAN CTR, 2006NE1464 NRI U TEX; Reina A, 2008, J PHYS CHEM C, V112, P17741, DOI 10.1021/jp807380s; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Sutter PW, 2008, NAT MATER, V7, P406, DOI 10.1038/nmat2166; Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r; Yu QK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2982585	26	9027	9411	189	7784	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1312	1314		10.1126/science.1171245	http://dx.doi.org/10.1126/science.1171245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19423775	Green Submitted			2022-12-28	WOS:000266635100041
J	Thomas, AL; Henderson, GM; Deschamps, P; Yokoyama, Y; Mason, AJ; Bard, E; Hamelin, B; Durand, N; Camoin, G				Thomas, Alex L.; Henderson, Gideon M.; Deschamps, Pierre; Yokoyama, Yusuke; Mason, Andrew J.; Bard, Edouard; Hamelin, Bruno; Durand, Nicolas; Camoin, Gilbert			Penultimate Deglacial Sea-Level Timing from Uranium/Thorium Dating of Tahitian Corals	SCIENCE			English	Article							LAST INTERGLACIAL PERIOD; VOSTOK ICE CORE; HUON PENINSULA; TERMINATION-II; CLIMATE; DURATION; RECORD; AGES; FLUCTUATIONS; VARIABILITY	The timing of sea-level change provides important constraints on the mechanisms driving Earth's climate between glacial and interglacial states. Fossil corals constrain the timing of past sea level by their suitability for dating and their growth position close to sea level. The coral-derived age for the last deglaciation is consistent with climate change forced by Northern Hemisphere summer insolation (NHI), but the timing of the penultimate deglaciation is more controversial. We found, by means of uranium/thorium dating of fossil corals, that sea level during the penultimate deglaciation had risen to similar to 85 meters below the present sea level by 137,000 years ago, and that it fluctuated on a millennial time scale during deglaciation. This indicates that the penultimate deglaciation occurred earlier with respect to NHI than the last deglacial, beginning when NHI was at a minimum.	[Thomas, Alex L.; Henderson, Gideon M.; Mason, Andrew J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Deschamps, Pierre; Bard, Edouard; Hamelin, Bruno; Durand, Nicolas; Camoin, Gilbert] Aix Marseille Univ, CEREGE UMR 6635, CNRS, IRD,Coll France, F-13545 Aix En Provence, France; [Yokoyama, Yusuke] Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; [Yokoyama, Yusuke] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Yokoyama, Yusuke] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan	University of Oxford; UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of Tokyo; University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Thomas, AL (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	alext@earth.ox.ac.uk	Bard, Edouard/G-7717-2014; Yokoyama, Yusuke/N-9623-2013; Deschamps, Pierre/M-9632-2013; Thomas, Alex/D-1028-2012	Deschamps, Pierre/0000-0003-1687-3765; Thomas, Alex/0000-0002-0734-9593; Henderson, Gideon/0000-0002-6279-7137; CAMOIN, Gilbert/0000-0002-7466-4155	UK Natural Environment Research Council; Gary Comer Abrupt Climate Change Fellowship;  [NE/D001250/1]; Natural Environment Research Council [NE/D001250/1] Funding Source: researchfish; NERC [NE/D001250/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gary Comer Abrupt Climate Change Fellowship; ; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by UK Natural Environment Research Council grant NE/D001250/1 and the Gary Comer Abrupt Climate Change Fellowship (A.L.T.). We thank the Expedition 310 scientists for the use of samples and data provided by the IODP, and R. Pearce and R. Williams at the National Oceanography Center Southampton for their assistance with XRD measurements.	Arz HW, 2007, QUATERNARY SCI REV, V26, P312, DOI 10.1016/j.quascirev.2006.07.016; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Camoin G., 2007, P IODP; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; Cheng H, 2006, GEOLOGY, V34, P217, DOI 10.1130/G22289.1; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; Eisenhauer A, 1996, GEOL RUNDSCH, V85, P606, DOI 10.1007/BF02369014; Esat TM, 2006, GEOCHIM COSMOCHIM AC, V70, P4140, DOI 10.1016/j.gca.2006.06.013; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Gallup CD, 2002, SCIENCE, V295, P310, DOI 10.1126/science.1065494; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Imbrie J., 1984, CLIMATE GEOSCIENCES, P121; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; MILANKOVITCH M, 1930, HDB KLIMATOLOGIE, V1, P1; Milne GA, 2008, QUATERNARY SCI REV, V27, P2292, DOI 10.1016/j.quascirev.2008.08.018; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; Muhs DR, 2002, QUATERNARY SCI REV, V21, P1355, DOI 10.1016/S0277-3791(01)00114-7; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Siddall M, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000226; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Siddall M, 2006, GEOLOGY, V34, P817, DOI 10.1130/G22705.1; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; STIRLING CH, 1995, EARTH PLANET SC LETT, V135, P115, DOI 10.1016/0012-821X(95)00152-3; SZABO BJ, 1994, SCIENCE, V266, P93, DOI 10.1126/science.266.5182.93; Thompson WG, 2003, EARTH PLANET SC LETT, V210, P365, DOI 10.1016/S0012-821X(03)00121-3; Thompson WG, 2006, QUATERNARY SCI REV, V25, P3207, DOI 10.1016/j.quascirev.2006.02.007; Wunsch C, 2004, QUATERNARY SCI REV, V23, P1001, DOI 10.1016/j.quascirev.2004.02.014; Yokoyama Y, 2001, EARTH PLANET SC LETT, V193, P579, DOI 10.1016/S0012-821X(01)00515-5	36	97	100	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1186	1189		10.1126/science.1168754	http://dx.doi.org/10.1126/science.1168754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19390000	Green Accepted			2022-12-28	WOS:000266410100042
J	Calcraft, PJ; Ruas, M; Pan, Z; Cheng, XT; Arredouani, A; Hao, XM; Tang, JS; Rietdorf, K; Teboul, L; Chuang, KT; Lin, PH; Xiao, R; Wang, CB; Zhu, YM; Lin, YK; Wyatt, CN; Parrington, J; Ma, JJ; Evans, AM; Galione, A; Zhu, MX				Calcraft, Peter J.; Ruas, Margarida; Pan, Zui; Cheng, Xiaotong; Arredouani, Abdelilah; Hao, Xuemei; Tang, Jisen; Rietdorf, Katja; Teboul, Lydia; Chuang, Kai-Ting; Lin, Peihui; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Wyatt, Christopher N.; Parrington, John; Ma, Jianjie; Evans, A. Mark; Galione, Antony; Zhu, Michael X.			NAADP mobilizes calcium from acidic organelles through two-pore channels	NATURE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; PANCREATIC BETA-CELLS; CA2+ RELEASE; INOSITOL TRISPHOSPHATE; RYANODINE RECEPTORS; STORES; HEART; MECHANISM; MESSENGER	Ca2+ mobilization from intracellular stores represents an important cell signalling process(1) that is regulated, in mammalian cells, by inositol-1,4,5-trisphosphate (InsP(3)), cyclic ADP ribose and nicotinic acid adenine dinucleotide phosphate (NAADP). InsP(3) and cyclic ADP ribose cause the release of Ca2+ from sarcoplasmic/endoplasmic reticulum stores by the activation of InsP(3) and ryanodine receptors (InsP(3)Rs and RyRs). In contrast, the nature of the intracellular stores targeted by NAADP and the molecular identity of the NAADP receptors remain controversial(1,2), although evidence indicates that NAADP mobilizes Ca2+ from lysosome-related acidic compartments(3,4). Here we show that two-pore channels (TPCs) comprise a family of NAADP receptors, with human TPC1 (also known as TPCN1) and chicken TPC3 (TPCN3) being expressed on endosomal membranes, and human TPC2 (TPCN2) on lysosomal membranes when expressed in HEK293 cells. Membranes enriched with TPC2 show high affinity NAADP binding, and TPC2 underpins NAADP-induced Ca2+ release from lysosome-related stores that is subsequently amplified by Ca2+-induced Ca2+ release by InsP3Rs. Responses to NAADP were abolished by disrupting the lysosomal proton gradient and by ablating TPC2 expression, but were only attenuated by depleting endoplasmic reticulum Ca2+ stores or by blocking InsP3Rs. Thus, TPCs form NAADP receptors that release Ca2+ from acidic organelles, which can trigger further Ca2+ signals via sarcoplasmic/endoplasmic reticulum. TPCs therefore provide new insights into the regulation and organization of Ca2+ signals in animal cells, and will advance our understanding of the physiological role of NAADP.	[Hao, Xuemei; Tang, Jisen; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Zhu, Michael X.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Hao, Xuemei; Tang, Jisen; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Zhu, Michael X.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Calcraft, Peter J.; Wyatt, Christopher N.; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Ruas, Margarida; Cheng, Xiaotong; Arredouani, Abdelilah; Rietdorf, Katja; Chuang, Kai-Ting; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Pan, Zui; Lin, Peihui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Hao, Xuemei] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Teboul, Lydia] MRC Harwell, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Edinburgh; University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; Peking University; MRC Harwell	Zhu, MX (corresponding author), Ohio State Univ, Dept Neurosci, 1060 Carmack Rd, Columbus, OH 43210 USA.	zhu.55@osu.ed	arredouani, abdelilah/Q-9650-2019; Teboul, Lydia/P-2428-2019; Xiao, Rui/G-1193-2011; Galione, Antony/E-5884-2011; Lin, Pei-Hui/I-3011-2015	Teboul, Lydia/0000-0002-2789-8637; Lin, Pei-Hui/0000-0002-3894-5099; arredouani, abdelilah/0000-0002-5060-916X; Pan, Zui/0000-0003-4105-901X; Xiao, Rui/0000-0001-5541-6685; Ruas, Margarida/0000-0002-4872-7618; Galione, Antony/0000-0002-4132-7646	UK Wellcome Trust [070772]; British Heart Foundation; US National Institutes of Health; American Heart Association; British Heart Foundation [FS/05/050]; US National Institutes of Health [P30-NS045758]; MRC [MC_UP_1502/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056942, R01NS042183, P30NS045758] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1502/1] Funding Source: researchfish	UK Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); British Heart Foundation(British Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the UK Wellcome Trust and the British Heart Foundation to A. G., J. P. and A. M. E., the US National Institutes of Health to M. X. Z. and J. M., and the American Heart Association to M. X. Z. A. G. was a Wellcome Senior Research Fellow in basic Biomedical Science. The work of A. M. E. was funded by a Wellcome Trust Project Grant (CNW, reference number 070772) and a British Heart Foundation Studentship (PJC, reference number FS/05/050). Part of the work of M. X. Z. was made possible by US National Institutes of Health grant P30-NS045758. We thank T. Kong and W. Li for the HepG2 cell line, O. Ogunbayo for technical assistance, and F. Platt, A. Morgan and M. Viapiano for help with the manuscript.	Anderson PAV, 2001, COMP BIOCHEM PHYS B, V129, P17, DOI 10.1016/S1096-4959(01)00376-1; Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; Bak J, 2001, CURR BIOL, V11, P987, DOI 10.1016/S0960-9822(01)00269-X; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mojzisova A, 2001, PFLUG ARCH EUR J PHY, V441, P674, DOI 10.1007/s004240000465; Morgan A. J., 2006, METHODS CALCIUM SIGN, P267; Patel S, 2000, J BIOL CHEM, V275, P36495, DOI 10.1074/jbc.C000458200; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	30	554	571	7	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					596	U130		10.1038/nature08030	http://dx.doi.org/10.1038/nature08030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387438	Green Accepted			2022-12-28	WOS:000266370500045
J	Greene, CH; Monger, BC; McGarry, LP				Greene, Charles H.; Monger, Bruce C.; McGarry, Louise P.			Some Like It Cold	SCIENCE			English	Editorial Material							NORTH-ATLANTIC		[Greene, Charles H.; Monger, Bruce C.; McGarry, Louise P.] Cornell Univ, Dept Earth & Atmospher Sci, Ocean Resources & Ecosyst Program, Ithaca, NY 14853 USA	Cornell University	Greene, CH (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ocean Resources & Ecosyst Program, Ithaca, NY 14853 USA.	chg2@cornell.edu						Belkin IM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019334; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Greene CH, 2009, OCEANOGRAPHY, V22, P210, DOI 10.5670/oceanog.2009.21; Koeller P, 2009, SCIENCE, V324, P791, DOI 10.1126/science.1170987; Loder JW, 2001, DEEP-SEA RES PT II, V48, P3, DOI 10.1016/S0967-0645(00)00080-1; *MAR EC RESP CLIM, 2001, OCEANOGRAPHY, V14, P76; Rose GA, 2000, CAN J FISH AQUAT SCI, V57, P644, DOI 10.1139/cjfas-57-3-644; Ueyama R, 2005, LIMNOL OCEANOGR, V50, P1820, DOI 10.4319/lo.2005.50.6.1820; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	9	10	10	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					733	734		10.1126/science.1173951	http://dx.doi.org/10.1126/science.1173951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423808				2022-12-28	WOS:000265832400027
J	McSween, HY; Taylor, GJ; Wyatt, MB				McSween, Harry Y., Jr.; Taylor, G. Jeffrey; Wyatt, Michael B.			Elemental Composition of the Martian Crust	SCIENCE			English	Review							THERMAL EMISSION-SPECTROSCOPY; CHEMICAL-COMPOSITION; MARS; TERRESTRIAL; ROCKS; CONSTRAINTS; ACCRETION; ORIGIN; SOILS	The composition of Mars' crust records the planet's integrated geologic history and provides clues to its differentiation. Spacecraft and meteorite data now provide a global view of the chemistry of the igneous crust that can be used to assess this history. Surface rocks on Mars are dominantly tholeiitic basalts formed by extensive partial melting and are not highly weathered. Siliceous or calc-alkaline rocks produced by melting and/or fractional crystallization of hydrated, recycled mantle sources, and silica-poor rocks produced by limited melting of alkali-rich mantle sources, are uncommon or absent. Spacecraft data suggest that martian meteorites are not representative of older, more voluminous crust and prompt questions about their use in defining diagnostic geochemical characteristics and in constraining mantle compositional models for Mars.	[McSween, Harry Y., Jr.] Univ Tennessee, Planetary Geosci Inst, Knoxville, TN 37996 USA; [McSween, Harry Y., Jr.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Taylor, G. Jeffrey] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Wyatt, Michael B.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Hawaii System; University of Hawaii Manoa; Brown University	McSween, HY (corresponding author), Univ Tennessee, Planetary Geosci Inst, Knoxville, TN 37996 USA.	mcsween@utk.edu						[Anonymous], 2005, ANTARCTIC METEORITE; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Boynton WV, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002887; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2005, NATURE, V436, P504, DOI 10.1038/nature03639; CHRISTENSEN PR, 1992, J GEOPHYS RES-PLANET, V97, P7719, DOI 10.1029/92JE00453; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Filiberto J, 2008, ICARUS, V197, P52, DOI 10.1016/j.icarus.2008.04.016; FOLEY CN, 2003, J GEOPHYS RES, V108; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Greeley R, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002401; Halliday AN, 2001, SPACE SCI REV, V96, P197, DOI 10.1023/A:1011997206080; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; Hurowitz JA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002515; LONGHI J, 1991, P LUNAR PLANET SCI, V21, P695; McBirney A.R., 2007, IGNEOUS PETROLOGY, V3rd; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002698; McSween HY, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002970; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; MCSWEEN HY, 1998, REV MINERAL, V36; Meyer C, 2006, 27672 JSC NASA; Michalski JR, 2005, ICARUS, V174, P161, DOI 10.1016/j.icarus.2004.10.022; MING DW, 2008, J GEOPHYS RES-PLANET, V113, DOI DOI 10.1029/2008JE003195; *NASA, NNG06GG36G NASA; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; OURI Y, 2003, ANTARC MET RES, V16, P80; PAPIKE JJ, 1998, REV MINERAL, V36; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; WANKE H, 1988, PHILOS T R SOC A, V325, P545, DOI 10.1098/rsta.1988.0067; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Wyatt MB, 2004, GEOLOGY, V32, P645, DOI 10.1130/G20527.1; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356; Zipfel J, 2004, METEORIT PLANET SCI, V39, pA118	36	315	319	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					736	739		10.1126/science.1165871	http://dx.doi.org/10.1126/science.1165871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423810				2022-12-28	WOS:000265832400029
J	Koek, MBG; Buskens, E; van Weelden, H; Steegmans, PHA; Bruijnzeel-Koomen, CAFM; Sigurdsson, V				Koek, Mayke B. G.; Buskens, Erik; van Weelden, Huib; Steegmans, Paul H. A.; Bruijnzeel-Koomen, Carla A. F. M.; Sigurdsson, Vigfus			Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC PLAQUE PSORIASIS; BRITISH-PHOTODERMATOLOGY-GROUP; NARROW-BAND UVB; EARLY MYCOSIS-FUNGOIDES; GROUP-WORKSHOP-REPORT; HEALTH SURVEY; 3 TIMES; THERAPY; GUIDELINES; SKIN	Objective To determine whether ultraviolet B phototherapy at home is equally safe and equally effective as ultraviolet B phototherapy in an outpatient setting for patients with psoriasis. Design Pragmatic multicentre single blind randomised clinical trial (PLUTO study). Setting Dermatology departments of 14 hospitals in the Netherlands. Participants 196 patients with psoriasis who were clinically eligible for narrowband (TL-01) ultraviolet B phototherapy. The first 105 consecutive patients were also followed for one year after therapy. Intervention Ultraviolet B phototherapy at home using a TL-01 home phototherapy unit compared with standard narrowband ultraviolet B phototherapy in an outpatient setting. Both therapies were done in a setting reflecting routine daily practice in the Netherlands. Main outcome measures The main outcome measure was effectiveness as measured by the proportion of patients with a 50% or more reduction of the baseline psoriasis area and severity index (PASI) or self administered psoriasis area and severity index (SAPASI), called the PASI 50 and SAPASI 50 (relevant treatment effect). Another outcome of effectiveness was the percentage reduction in median scores on the PASI as well as SAPASI. Also the proportions of patients reaching the PASI 75 and SAPASI 75 (successful treatment effect), and the PASI 90 and SAPASI 90 (almost complete clearance) were calculated. Other secondary outcomes were quality of life (SF-36, psoriasis disability index), burden of treatment (questionnaire), patients' preferences and satisfaction (questionnaire), and dosimetry and short term side effects (diary). Results 82% of the patients treated at home compared with 79% of the patients treated in an outpatient setting reached the SAPASI 50 (difference 2.8%, 95% confidence interval -8.6% to 14.2%), and 70% compared with 73% reached the PASI 50 (-2.3%, -15.7% to 11.1%). For patients treated at home the median SAPASI score decreased 82% (from 6.7 to 1.2) and the median PASI score decreased 74% (from 8.4 to 2.2), compared with 79% (from 7.0 to 1.4) and 70% (from 7.0 to 2.1) for patients treated in an outpatient setting. Treatment effect as defined by the mean decline in PASI and SAPASI scores was significant (P<0.001) and similar across groups (P>0.3). Total cumulative doses of ultraviolet B light were similar (51.5 v46.1 J/cm(2), difference 5.4, 95% confidence interval -5.2 to 16.0), and the occurrence of short term side effects did not differ. The burden of undergoing ultraviolet B phototherapy was significantly lower for patients treated at home (differences 1.23 to 3.01, all P <= 0.001). Quality of life increased equally regardless of treatment, but patients treated at home more often rated their experience with the therapy as "excellent" (42%, 38/90) compared with patients treated in the outpatient department (23%, 20/88; P=0.001). Conclusion Ultraviolet B phototherapy administered at home is equally safe and equally effective, both clinically and for quality of life, as ultraviolet B phototherapy administered in an outpatient setting. Furthermore, ultraviolet B phototherapy at home resulted in a lower burden of treatment and led to greater patients' satisfaction. Trial registration Current Controlled Trials ISRCTN83025173 and Clinicaltrials.gov NCT00150930.	[van Weelden, Huib; Bruijnzeel-Koomen, Carla A. F. M.; Sigurdsson, Vigfus] Univ Med Ctr Utrecht, Dept Dermatol Allergol, NL-3584 CX Utrecht, Netherlands; [Buskens, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Buskens, Erik] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Steegmans, Paul H. A.] St Antonius Hosp, Dept Dermatol, Nieuwegein, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht		author@koek.com		buskens, erik/0000-0002-6463-1106	Netherlands Organisation for Health Research and Development [945-02-017]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This study was supported by grant 945-02-017 from the Netherlands Organisation for Health Research and Development. The funder had no role in the study design; in the collection, management, analysis, and interpretation of data; in the preparation, review, or approval of the manuscript, or in the decision to submit the article for publication. The researchers are independent from the funders. Competing interests: None declared.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; ABEL EA, 1985, CUTIS, V35, P127; Barbagallo J, 2001, CUTIS, V68, P345; Biella U, 1985, Z Arztl Fortbild (Jena), V79, P531; Bilsland D, 1997, BRIT J DERMATOL, V137, P327, DOI 10.1046/j.1365-2133.1997.18441939.x; Cameron H, 2002, BRIT J DERMATOL, V147, P973, DOI 10.1046/j.1365-2133.2002.04996.x; Cameron H, 2002, BRIT J DERMATOL, V147, P957, DOI 10.1046/j.1365-2133.2002.04860.x; Carrozza P, 2000, DERMATOLOGY, V200, P35, DOI 10.1159/000018312; DARCY C, 1984, JNCI, V73, P75; Dawe RS, 1998, BRIT J DERMATOL, V138, P833; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; DRAKE LA, 1993, J AM ACAD DERMATOL, V28, P632, DOI 10.1016/S0190-9622(08)81783-5; DRAKE LA, 1994, J AM ACAD DERMATOL, V31, P643; Feldman SR, 1996, J INVEST DERMATOL, V106, P183, DOI 10.1111/1523-1747.ep12329912; Feldman SR, 1996, CUTIS, V58, P71; FINLAY AY, 1990, BRIT J DERMATOL, V123, P751, DOI 10.1111/j.1365-2133.1990.tb04192.x; FINLAY AY, 1987, CLIN EXP DERMATOL, V12, P8, DOI 10.1111/j.1365-2230.1987.tb01844.x; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; FLEISCHER AB, 1994, J INVEST DERMATOL, V102, P967, DOI 10.1111/1523-1747.ep12384205; Fleischer Alan B. Jr., 1999, Journal of Dermatology (Tokyo), V26, P210; Flytstrom I, 2008, BRIT J DERMATOL, V158, P116, DOI 10.1111/j.1365-2133.2007.08284.x; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; *GERM DERM SOC DDG, 1999, CONS LETT HOM UV TRE; GERRITSEN MJP, 2000, NED TIJDSCHR DERMATO, V10, P101; Gottlieb AB, 2004, J AM ACAD DERMATOL, V51, P534, DOI 10.1016/j.jaad.2004.02.021; Gupta G, 1999, BRIT J DERMATOL, V140, P887, DOI 10.1046/j.1365-2133.1999.02820.x; Heydendael VMR, 2003, NEW ENGL J MED, V349, P658, DOI 10.1056/NEJMoa021359; Ibbotson SH, 2004, BRIT J DERMATOL, V151, P283, DOI 10.1111/j.1365-2133.2004.06128.x; JORDAN WP, 1981, J AM ACAD DERMATOL, V4, P584, DOI 10.1016/S0190-9622(81)70061-6; Kirke SM, 2007, J INVEST DERMATOL, V127, P1641, DOI 10.1038/sj.jid.5700767; Koek Mayke B G, 2006, BMC Med Res Methodol, V6, P39, DOI 10.1186/1471-2288-6-39; Koek MBG, 2006, BRIT J DERMATOL, V154, P701, DOI 10.1111/j.1365-2133.2006.07136.x; KRICKER A, 1995, INT J CANCER, V60, P489, DOI 10.1002/ijc.2910600411; LARKO O, 1979, BRIT J DERMATOL, V101, P13, DOI 10.1111/j.1365-2133.1979.tb15286.x; Leaute-Labreze C, 2001, ARCH DERMATOL, V137, P1035; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; LOWE NJ, 1992, SEMIN DERMATOL, V11, P284; MATTO DM, 2003, MED CONTACT, V58, P950; MILSTEIN HJ, 1982, J AM ACAD DERMATOL, V6, P355, DOI 10.1016/S0190-9622(82)70029-5; Murphy GM, 1997, IRISH J MED SCI, V166, P92, DOI 10.1007/BF02944196; Naldi L, 2005, BRIT J DERMATOL, V152, P597, DOI 10.1111/j.1365-2133.2005.06563.x; Papoutsaki M, 2007, J AM ACAD DERMATOL, V57, P269, DOI 10.1016/j.jaad.2006.12.003; PARRISH JA, 1982, PHOTOCHEM PHOTOBIOL, V36, P187, DOI 10.1111/j.1751-1097.1982.tb04362.x; PAUL BS, 1983, ARCH DERMATOL, V119, P122, DOI 10.1001/archderm.119.2.122; POCOCK SJ, 1993, CLIN TRIALS PRACTICA, P66; Pocock SJ., 1993, CLIN TRIALS PRACTICA, P123; Prince A, 1994, Ned Tijdschr Geneeskd, V138, P373; RESNIK KS, 1993, J AM ACAD DERMATOL, V29, P73, DOI 10.1016/0190-9622(93)70155-M; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Sarkany RPE, 1999, BRIT J DERMATOL, V140, P195, DOI 10.1111/j.1365-2133.1999.02649.x; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; SLAPER H, 1986, PHOTODERMATOLOGY, V3, P271; SNELLMAN E, 1995, PHOTOCHEM PHOTOBIOL, V62, P769, DOI 10.1111/j.1751-1097.1995.tb08728.x; Soares Isabel, 2002, Rev Port Cardiol, V21, P1191; Spuls PI, 1997, BRIT J DERMATOL, V137, P943, DOI 10.1046/j.1365-2133.1997.19902071.x; Tanew A, 1999, ARCH DERMATOL, V135, P519, DOI 10.1001/archderm.135.5.519; *TASK FORC PSOR NE, 2008, GUID PHOT SYST THER; Trochim W.M., 2006, RES METHODS KNOWLEDG; van Vloten W A, 1993, Ned Tijdschr Geneeskd, V137, P2525; VANWEELDEN H, 1988, BRIT J DERMATOL, V119, P11; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yelverton CB, 2008, ARCH DERMATOL, V144, P1224, DOI 10.1001/archderm.144.9.1224; 2008, PRAGMATIC VERSUS EXP; 1991, NATL PSORIASIS FDN B, V22, P15	66	78	81	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2009	338								b1542	10.1136/bmj.b1542	http://dx.doi.org/10.1136/bmj.b1542			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GW	19423623	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000265969700001
J	Murdoch, AM; Thia, LP; Gupta, A; Hogg, CL				Murdoch, A. M.; Thia, L. P.; Gupta, A.; Hogg, C. L.			Endgames Picture quiz Recurrent chest infection in a 5 year old boy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY CILIARY DYSKINESIA; NITRIC-OXIDE; DISEASE; COHORT		[Thia, L. P.; Gupta, A.; Hogg, C. L.] Royal Brompton Hosp, London SW3 6NP, England; [Murdoch, A. M.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	Royal Brompton Hospital; University of Glasgow	Thia, LP (corresponding author), Royal Brompton Hosp, London SW3 6NP, England.	lthia@doctors.org.uk						Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Ferkol T, 2006, SEMIN PERINATOL, V30, P335, DOI 10.1053/j.semperi.2005.11.001; HULL J, 2008, PAEDIAT RESP MED; Jain K, 2007, CLIN RADIOL, V62, P986, DOI 10.1016/j.crad.2007.04.015; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kennedy MP, 2007, AM J ROENTGENOL, V188, P1232, DOI 10.2214/AJR.06.0965; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Narang I, 2002, THORAX, V57, P586, DOI 10.1136/thorax.57.7.586; Santamaria F, 2008, MED SCI MONITOR, V14, pCR80	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2009	338								b945	10.1136/bmj.b945	http://dx.doi.org/10.1136/bmj.b945			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GV	19420024				2022-12-28	WOS:000265969600018
J	Dunleavy, EM; Roche, D; Tagami, H; Lacoste, N; Ray-Gallet, D; Nakamura, Y; Daigo, Y; Nakatani, Y; Almouzni-Pettinotti, G				Dunleavy, Elaine M.; Roche, Daniele; Tagami, Hideaki; Lacoste, Nicolas; Ray-Gallet, Dominique; Nakamura, Yusuke; Daigo, Yataro; Nakatani, Yoshihiro; Almouzni-Pettinotti, Genevieve			HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres	CELL			English	Article							HISTONE H3 VARIANT; FISSION YEAST SCM3; BUDDING YEAST; CHROMATIN; PROTEIN; KINETOCHORE; COMPLEX; NUCLEOSOME; CHAPERONE; DNA	The histone H3 variant CenH3, called CENP-A in humans, is central in centromeric chromatin to ensure proper chromosome segregation. In the absence of an underlying DNA sequence, it is still unclear how CENP-A deposition at centromeres is determined. Here, we purified non-nucleosomal CENP-A complexes to identify direct CENP-A partners involved in such a mechanism and identified HJURP. HJURP was not detected in H3.1- or H3.3-containing complexes, indicating its specificity for CENP- A. HJURP centromeric localization is cell cycle regulated, and its transient appearance at the centromere coincides precisely with the proposed time window for new CENP- A deposition. Furthermore, HJURP downregulation leads to a major reduction in CENP-A at centromeres and impairs deposition of newly synthesized CENP-A, causing mitotic defects. We conclude that HJURP is a key factor for CENP-A deposition and maintenance at centromeres.	[Dunleavy, Elaine M.; Roche, Daniele; Lacoste, Nicolas; Ray-Gallet, Dominique; Almouzni-Pettinotti, Genevieve] Inst Curie, CNRS, Lab Nucl Dynam & Genome Plast, UMR218, F-75248 Paris 05, France; [Tagami, Hideaki; Nakatani, Yoshihiro] Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Aichi 4678501, Japan; [Nakamura, Yusuke; Daigo, Yataro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1130033, Japan	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Nagoya City University; University of Tokyo	Almouzni-Pettinotti, G (corresponding author), Inst Curie, CNRS, Lab Nucl Dynam & Genome Plast, UMR218, 26 Rue Ulm, F-75248 Paris 05, France.	genevieve.almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021; Ray-Gallet, Dominique/A-9224-2019	Almouzni, Genevieve/0000-0001-5570-0723; Daigo, Yataro/0000-0002-0915-3025	ANR [NT05-4_42267, PCV06_142302]; Ligue Nationale contre le Cancer (Equipe labellise'e la Ligue); PIC Programs; European Commission Network of Excellence Epigenome [LSHG-CT-2004-503433]; Canceropole IdF "Breast cancer and Epigenetics'' [ACI-2007]	ANR(French National Research Agency (ANR)); Ligue Nationale contre le Cancer (Equipe labellise'e la Ligue)(Institut National du Cancer (INCA) France); PIC Programs; European Commission Network of Excellence Epigenome(European CommissionEuropean Commission Joint Research Centre); Canceropole IdF "Breast cancer and Epigenetics''	We thank W. Earnshaw for CENP-C antibodies, Y. Tang for prediction on HJURP sequence, C. Baldeyron and P. LeBaccon for microscopy, D. Filipescu for GST-HJURP protein, J.P. Quivy and A. Cook for critical reading. This work and E. M. D. were supported by ANR "CenRNA'' NT05-4_42267 and ANR "FaRC'' PCV06_142302, la Ligue Nationale contre le Cancer (Equipe labellise'e la Ligue), PIC Programs ("Retinoblastome and "Replication, Instabilite chromosomique et cancer''), the European Commission Network of Excellence Epigenome (LSHG-CT-2004-503433), ACI-2007-Canceropole IdF "Breast cancer and Epigenetics.''	Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; BLOWER MD, 2002, NAT REV MOL CELL BIO, V3, P575; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Ekwall K, 2007, ANNU REV GENET, V41, P63, DOI 10.1146/annurev.genet.41.110306.130127; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; KRUDE T, 1995, EXP CELL RES, V220, P304, DOI 10.1006/excr.1995.1320; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; SHELBY RD, 2000, GENE DEV, V22, P1313; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Sullivan BA, 1998, NAT GENET, V20, P227, DOI 10.1038/3024; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	64	453	462	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					485	497		10.1016/j.cell.2009.02.040	http://dx.doi.org/10.1016/j.cell.2009.02.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410545	Bronze			2022-12-28	WOS:000265677200018
J	Miyauchi, K; Kim, Y; Latinovic, O; Morozov, V; Melikyan, GB				Miyauchi, Kosuke; Kim, Yuri; Latinovic, Olga; Morozov, Vladimir; Melikyan, Gregory B.			HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CLATHRIN-MEDIATED ENDOCYTOSIS; MEMBRANE-FUSION; T-CELLS; ENVELOPE GLYCOPROTEIN; PLASMA-MEMBRANE; VIRION FUSION; TYPE-1 ENTRY; INFECTION; CD4	Enveloped viruses that rely on a low pH-dependent step for entry initiate infection by fusing with acidic endosomes, whereas the entry sites for pH-independent viruses, such as HIV-1, have not been defined. These viruses have long been assumed to fuse directly with the plasma membrane. Here we used population-based measurements of the viral content delivery into the cytosol and time-resolved imaging of single viruses to demonstrate that complete IV-1 fusion occurred in endosomes. In contrast, viral fusion with the plasma membrane did not progress beyond the lipid mixing step. HIV-1 underwent receptor-mediated internalization long before endosomal fusion, thus minimizing the surface exposure of conserved viral epitopes during fusion and reducing the efficacy of inhibitors targeting these epitopes. We also show that, strikingly, endosomal fusion is sensitive to a dynamin inhibitor, dynasore. These findings imply that HIV-1 infects cells via endocytosis and envelope glycoprotein- and dynamin-dependent fusion with intracellular compartments.	[Miyauchi, Kosuke; Kim, Yuri; Latinovic, Olga; Morozov, Vladimir; Melikyan, Gregory B.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Miyauchi, Kosuke; Kim, Yuri; Latinovic, Olga; Morozov, Vladimir; Melikyan, Gregory B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Melikyan, GB (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	gmelikian@ihv.umaryland.edu	Serei, Virian D/B-4616-2015	Vladimir, Morozov/0000-0001-6587-572X; Morozov, Vladimir/0000-0001-7013-7115	NIH AIDS Research and Reference Reagent Program [R01 GM054787, AI053668]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	NIH AIDS Research and Reference Reagent Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Dr. T. Kirchhausen for dynasore and to Drs. C. Aiken, M. Alizon, J. Binley, J. Cunningham, M. Kielian, G. Lewis, M. Lu, W. Mothes, J. Strizki, L. Wang, and J. Young, as well as the NIH AIDS Research and Reference Reagent Program for reagents, expression vectors, and cell lines. We thank Dr. M. Reitz for his help in designing the MA-GFP-CA construct and Drs. L. Chernomordik and R. Dutch for stimulating discussions. This work was supported by NIH R01 GM054787 and AI053668 grants to G.B.M. Y.K. was partially supported by the SDG from the American Heart Association.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; FREY S, 1995, J VIROL, V69, P1462, DOI 10.1128/JVI.69.3.1462-1472.1995; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; Katen LJ, 2001, J VIROL, V75, P5018, DOI 10.1128/JVI.75.11.5018-5026.2001; Kim Y, 2006, MOL NEUROBIOL, V34, P129, DOI 10.1385/MN:34:2:129; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Marsh M, 1997, J CELL SCI, V110, P95; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; MCCLURE MO, 1988, EMBO J, V7, P513, DOI 10.1002/j.1460-2075.1988.tb02839.x; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; PAUZA CD, 1988, J CELL BIOL, V107, P959, DOI 10.1083/jcb.107.3.959; PELCHENMATTHEWS A, 1995, J VIROL, V69, P8164, DOI 10.1128/JVI.69.12.8164-8168.1995; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	47	496	508	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					433	444		10.1016/j.cell.2009.02.046	http://dx.doi.org/10.1016/j.cell.2009.02.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410541	Green Accepted, Bronze			2022-12-28	WOS:000265677200014
J	Ohinata, Y; Ohta, H; Shigeta, M; Yamanaka, K; Wakayama, T; Saitou, M				Ohinata, Yasuhide; Ohta, Hiroshi; Shigeta, Mayo; Yamanaka, Kaori; Wakayama, Teruhiko; Saitou, Mitinori			A Signaling Principle for the Specification of the Germ Cell Lineage in Mice	CELL			English	Article							ANTERIOR VISCERAL ENDODERM; EARLY MOUSE EMBRYO; EXTRAEMBRYONIC ECTODERM; AXIS FORMATION; GENERATION; REQUIREMENT; DYNAMICS; PROLIFERATION; GASTRULATION; ANTAGONISTS	Specification of the germ cell lineage is vital to development and heredity. In mice, the germ cell fate is induced in pluripotent epiblast cells by signaling molecules, yet the underlying mechanism remains unknown. Here we demonstrate that germ cell fate in the epiblast is a direct consequence of Bmp4 signaling from the extraembryonic ectoderm (ExE), which is antagonized by the anterior visceral endoderm (AVE). Strikingly, Bmp8b from the ExE restricts AVE development, thereby contributing to Bmp4 signaling. Furthermore, Wnt3 in the epiblast ensures its responsiveness to Bmp4. Serum-free, defined cultures revealed that, in response to Bmp4, competent epiblast cells uniformly expressed key transcriptional regulators Blimp1 and Prdm14 and acquired germ-cell properties, including genome-wide epigenetic reprogramming, in an orderly fashion. Notably, the induced cells contributed to both spermatogenesis and fertility of offspring. By identifying a signaling principle in germ cell specification, our study establishes a robust strategy for reconstituting the mammalian germ cell lineage in vitro.	[Ohinata, Yasuhide; Shigeta, Mayo; Yamanaka, Kaori; Saitou, Mitinori] RIKEN, Kobe Inst, Ctr Dev Biol, Chuo Ku,Lab Mammalian Germ Cell Biol, Kobe, Hyogo 6500047, Japan; [Ohta, Hiroshi; Wakayama, Teruhiko] RIKEN, Kobe Inst, Ctr Dev Biol, Chuo Ku,Lab Genom Reprogramming, Kobe, Hyogo 6500047, Japan; [Saitou, Mitinori] Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; RIKEN; Kyoto University	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@cdb.riken.jp	Ohta, Hiroshi/C-3375-2009		MEXT of Japan; JST.	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST.(Japan Science & Technology Agency (JST))	We thank B. Hogan and K. Lawson, K. Hayashi, R. Behringer, M. Nomura and En Li, and M. Yamamoto and H. Hamada, for the mutant mice for Bmp4, Smad1, Wnt3, Smad2, and FoxH1, respectively, and M. Okabe for the acro/act-EGFP transgenic strain. We also thank S. Aizawa and P. Q. Thomas for Cer1 and Hex probes, respectively. We are grateful to the Animal Resources and Genetic Engineering Units for their support in deriving and maintaining the mice, and to the Genome Resource and Analysis Unit for their support in DNA sequencing. We thank D. Sipp for his help in manuscript preparation. Y.O. is a fellow in the Special Postdoctoral Researchers Program of RIKEN. This study was supported in part by a Grant-in-Aid from the MEXT of Japan, and by a PRESTO project grant from the JST.	Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Farini D, 2005, DEV BIOL, V285, P49, DOI 10.1016/j.ydbio.2005.06.036; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; Nagy A., 2003, MANIPULATING MOUSE E; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Ohta H, 2000, DEV GROWTH DIFFER, V42, P105; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Rodriguez TA, 2005, DEVELOPMENT, V132, P2513, DOI 10.1242/dev.01847; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2009, FRONT BIOSCI-LANDMRK, V14, P1068, DOI 10.2741/3294; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaji M, 2008, J PHYS CHEM A, V112, P11306, DOI 10.1021/jp805593m; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173	39	351	372	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					571	584		10.1016/j.cell.2009.03.014	http://dx.doi.org/10.1016/j.cell.2009.03.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410550	Bronze			2022-12-28	WOS:000265677200025
J	Schmidt, C; Collette, F; Leclercq, Y; Sterpenich, V; Vandewalle, G; Berthomier, P; Berthomier, C; Phillips, C; Tinguely, G; Darsaud, A; Gais, S; Schabus, M; Desseilles, M; Dang-Vu, TT; Salmon, E; Balteau, E; Degueldre, C; Luxen, A; Maquet, P; Cajochen, C; Peigneux, P				Schmidt, Christina; Collette, Fabienne; Leclercq, Yves; Sterpenich, Virginie; Vandewalle, Gilles; Berthomier, Pierre; Berthomier, Christian; Phillips, Christophe; Tinguely, Gilberte; Darsaud, Annabelle; Gais, Steffen; Schabus, Manuel; Desseilles, Martin; Dang-Vu, Thien Thanh; Salmon, Eric; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Cajochen, Christian; Peigneux, Philippe			Homeostatic Sleep Pressure and Responses to Sustained Attention in the Suprachiasmatic Area	SCIENCE			English	Article							PSYCHOMOTOR VIGILANCE TASK; SLOW-WAVE ACTIVITY; MORNINGNESS-EVENINGNESS; CIRCADIAN PACEMAKER; PHASE; TEMPERATURE; PERFORMANCE; DEPRIVATION; MELATONIN; RHYTHMS	Throughout the day, cognitive performance is under the combined influence of circadian processes and homeostatic sleep pressure. Some people perform best in the morning, whereas others are more alert in the evening. These chronotypes provide a unique way to study the effects of sleep-wake regulation on the cerebral mechanisms supporting cognition. Using functional magnetic resonance imaging in extreme chronotypes, we found that maintaining attention in the evening was associated with higher activity in evening than morning chronotypes in a region of the locus coeruleus and in a suprachiasmatic area (SCA) including the circadian master clock. Activity in the SCA decreased with increasing homeostatic sleep pressure. This result shows the direct influence of the homeostatic and circadian interaction on the neural activity underpinning human behavior.	[Schmidt, Christina; Collette, Fabienne; Leclercq, Yves; Sterpenich, Virginie; Vandewalle, Gilles; Phillips, Christophe; Tinguely, Gilberte; Darsaud, Annabelle; Gais, Steffen; Schabus, Manuel; Desseilles, Martin; Dang-Vu, Thien Thanh; Salmon, Eric; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Peigneux, Philippe] Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium; [Schmidt, Christina; Collette, Fabienne] Univ Liege, Cognit & Behav Neurosci Ctr, B-4000 Liege, Belgium; [Berthomier, Pierre; Berthomier, Christian] PHYSIP SA, F-75011 Paris, France; [Cajochen, Christian] Univ Basel, Hosp Psychiat, Ctr Chronobiol, CH-4025 Basel, Switzerland; [Peigneux, Philippe] Univ Libre Bruxelles, Neuropsychol & Funct Neuroimaging Res Unit UR2NF, B-1050 Brussels, Belgium	University of Liege; University of Liege; University of Basel; Universite Libre de Bruxelles	Schmidt, C (corresponding author), Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium.	Christina.Schmidt@ulg.ac.be; Philippe.Peigneux@ulb.ac.be	Schabus, Manuel/C-1704-2010; Cajochen, Christian/N-6748-2014; luxen, andre/C-2116-2009; Salmon, Eric/AAE-4901-2020; Phillips, Christophe/M-3025-2017	Schabus, Manuel/0000-0001-5899-8772; Salmon, Eric/0000-0003-2520-9241; Phillips, Christophe/0000-0002-4990-425X; Dang Vu, Thien Thanh/0000-0002-7235-2721; Vandewalle, Gilles/0000-0003-2483-2752; Sterpenich, Virginie/0000-0002-2125-833X; Desseilles, Martin/0000-0003-4748-3401; , Pierre/0000-0003-3106-3357; Berthomier, Christian/0000-0002-2300-9476; Peigneux, Philippe/0000-0003-4745-1434	Belgian Fonds National de la Recherche Scientifique (FNRS); Fondation Medicale Reine Elisabeth; University of Liege; Austrian Science Fund Erwin-Schrodinger Fellowship [J2470-B02]; LUNDBECK-BCNBP; Swiss National Science Foundation; Daimler-Benz Foundation; Pole dAttraction Interuniversitaire [PAI/P504]	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; University of Liege(University of Liege); Austrian Science Fund Erwin-Schrodinger Fellowship(Austrian Science Fund (FWF)); LUNDBECK-BCNBP; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Daimler-Benz Foundation; Pole dAttraction Interuniversitaire	This study was supported by the Belgian Fonds National de la Recherche Scientifique (FNRS), the Fondation Medicale Reine Elisabeth, and the University of Liege. C.S., F.C., Y.L., V.S., G.V., C. P., G.T., A.D., M.D., T.T.D.V., E.S., E.B., and P.M. were supported by the FNRS. M.S. was supported by and Austrian Science Fund Erwin-Schrodinger Fellowship J2470-B02. C.S. was supported by the LUNDBECK-BCNBP grant, P.B. and C.B. are cofounders, employees, and shareholders of PHYSIP company, which setup Aseega software, C.C. was supported by grants from the Swiss National Science Foundation and the Daimler-Benz Foundation. P.P. was supported until 2006 by the Pole dAttraction Interuniversitaire (PAI/P504).	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Baehr EK, 2000, J SLEEP RES, V9, P117, DOI 10.1046/j.1365-2869.2000.00196.x; Cajochen C, 1999, AM J PHYSIOL-REG I, V277, pR640, DOI 10.1152/ajpregu.1999.277.3.R640; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Deboer T, 2007, SLEEP, V30, P257, DOI 10.1093/sleep/30.3.257; DIJK D J, 1987, Journal of Biological Rhythms, V2, P207, DOI 10.1177/074873048700200304; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Dinges DF, 1985, BEHAV RES METH INSTR, V17, P625, DOI DOI 10.3758/BF03200977; Drummond SPA, 2005, SLEEP, V28, P1059; Duffy JF, 1999, J INVEST MED, V47, P141; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; HORNE JA, 1980, ERGONOMICS, V23, P29, DOI 10.1080/00140138008924715; Kerkhof GA, 1996, NEUROSCI LETT, V218, P153, DOI 10.1016/S0304-3940(96)13140-2; KERKHOF GA, 1991, ELECTROEN CLIN NEURO, V78, P197, DOI 10.1016/0013-4694(91)90033-Z; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Mongrain V, 2006, EUR J NEUROSCI, V23, P497, DOI 10.1111/j.1460-9568.2005.04561.x; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; Portas CM, 1998, J NEUROSCI, V18, P8979; Taillard J, 2003, J SLEEP RES, V12, P275, DOI 10.1046/j.0962-1105.2003.00369.x; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152	27	133	137	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					516	519		10.1126/science.1167337	http://dx.doi.org/10.1126/science.1167337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390047				2022-12-28	WOS:000265411200048
J	Maynard, A				Maynard, Alan			This House believes doctors are neglecting their duty to lead health service change: Proposer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Maynard, A (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	akm3@york.ac.uk						Cochrane A.L., 1971, EFFECTIVENESS EFFICI; Department of Health and Social Security, 1976, PRIOR HLTH PERS SOC; Fisher ES, 2003, NEW ENGL J MED, V349, P1665, DOI 10.1056/NEJMe038149; Maynard A, 1997, LANCET, V349, P126, DOI 10.1016/S0140-6736(96)05153-7; The Department of Health, 2008, NHS NEXT STAG REV	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2009	338								b1578	10.1136/bmj.b1578	http://dx.doi.org/10.1136/bmj.b1578			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OO	19383755				2022-12-28	WOS:000265497000006
J	Kopan, R; Ilagan, MXG				Kopan, Raphael; Ilagan, Ma. Xenia G.			The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism	CELL			English	Review							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE CLEAVAGE; LIGAND-BINDING DOMAIN; INHIBITS TUMOR-GROWTH; T-CELL DEVELOPMENT; NEURAL STEM-CELLS; C-ELEGANS; TRANSCRIPTION COMPLEXES; O-FUCOSE; IN-VIVO	Notch signaling regulates many aspects of metazoan development and tissue renewal. Accordingly, the misregulation or loss of Notch signaling underlies a wide range of human disorders, from developmental syndromes to adult-onset diseases and cancer. Notch signaling is remarkably robust in most tissues even though each Notch molecule is irreversibly activated by proteolysis and signals only once without amplification by secondary messenger cascades. In this Review, we highlight recent studies in Notch signaling that reveal new molecular details about the regulation of ligand-mediated receptor activation, receptor proteolysis, and target selection.	[Kopan, Raphael; Ilagan, Ma. Xenia G.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Kopan, R (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	kopan@wustl.edu; ilaganmg@wustl.edu	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022	Kopan, Raphael/0000-0002-0350-2730; Ilagan, Ma Xenia/0000-0003-2888-4859	National Institutes of Health [GM55479, R21-NS06168001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. Micchelli, T. Schedl, J. Skeath, M. Vooijs, and the reviewers for their critical reading of this manuscript. We also thank A. Hart, W. Zhong, and the Ingenium Corporation for discussing unpublished results and members of the Kopan lab for helpful discussions. Our research on Notch signaling is supported by National Institutes of Health grants GM55479 (R.K.) and R21-NS06168001 (M.X.G.I.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Ambros V, 1999, DEVELOPMENT, V126, P1947; Bardin AJ, 2006, DEV CELL, V10, P245, DOI 10.1016/j.devcel.2005.12.017; Barrick D, 2006, CELL, V124, P883, DOI 10.1016/j.cell.2006.02.028; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Blat Y, 2002, BIOCHEM BIOPH RES CO, V299, P569, DOI 10.1016/S0006-291X(02)02705-5; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cave JW, 2005, CURR BIOL, V15, P94, DOI 10.1016/j.cub.2004.12.070; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen N, 2004, DEV CELL, V6, P183, DOI 10.1016/S1534-5807(04)00021-8; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; Delwig A, 2008, CELL MOL LIFE SCI, V65, P2232, DOI 10.1007/s00018-008-8127-x; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Garg V., 2005, NATURE, V21, P180; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Ghai V, 2008, DEV BIOL, V322, P334, DOI 10.1016/j.ydbio.2008.07.018; Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930; Goodfellow H, 2007, DEV CELL, V13, P593, DOI 10.1016/j.devcel.2007.08.021; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; GORDON WR, 2008, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2008-08-174748; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Kanwar R, 2008, CELL, V133, P852, DOI 10.1016/j.cell.2008.04.038; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kluppel M, 2005, BIOESSAYS, V27, P115, DOI 10.1002/bies.20187; Koelzer S, 2006, DEV BIOL, V289, P77, DOI 10.1016/j.ydbio.2005.10.008; Komatsu H, 2008, PLOS BIOL, V6, P1730, DOI 10.1371/journal.pbio.0060196; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Lai EC, 2000, DEVELOPMENT, V127, P3441; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Louvi A, 2006, DEV NEUROSCI-BASEL, V28, P5, DOI 10.1159/000090748; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Luty WH, 2007, J IMMUNOL, V179, P819, DOI 10.4049/jimmunol.179.2.819; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Masui T, 2007, GENE DEV, V21, P2629, DOI 10.1101/gad.1575207; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Neves A, 2005, DEV CELL, V8, P867, DOI 10.1016/j.devcel.2005.03.012; Neves A, 2007, DEVELOPMENT, V134, P4459, DOI 10.1242/dev.008680; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Parks AL, 2000, DEVELOPMENT, V127, P1373; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Poellinger L, 2008, CURR OPIN GENET DEV, V18, P449, DOI 10.1016/j.gde.2008.07.013; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Range RC, 2008, DEVELOPMENT, V135, P2445, DOI 10.1242/dev.018101; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Souilhol C, 2006, GENESIS, V44, P277, DOI 10.1002/dvg.20208; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Vodovar Nicolas, 2008, J Biol, V7, P7, DOI 10.1186/jbiol68; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wu J, 2007, TRENDS BIOCHEM SCI, V32, P477, DOI 10.1016/j.tibs.2007.09.002; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhou L, 2008, BLOOD, V112, P308, DOI 10.1182/blood-2007-11-115204; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	129	2411	2524	10	344	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					216	233		10.1016/j.cell.2009.03.045	http://dx.doi.org/10.1016/j.cell.2009.03.045			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379690	Bronze, Green Accepted			2022-12-28	WOS:000265456800016
J	Ramachandran, N; Munteanu, I; Wang, PX; Aubourg, P; Rilstone, JJ; Israelian, N; Naranian, T; Paroutis, P; Guo, R; Ren, ZP; Nishino, I; Chabrol, B; Pellissier, JF; Minetti, C; Udd, B; Fardeau, M; Tailor, CS; Mahuran, DJ; Kissel, JT; Kalimo, H; Levy, N; Manolson, MF; Ackerley, CA; Minassian, BA				Ramachandran, Nivetha; Munteanu, Iulia; Wang, Peixiang; Aubourg, Pauline; Rilstone, Jennifer J.; Israelian, Nyrie; Naranian, Taline; Paroutis, Paul; Guo, Ray; Ren, Zhi-Ping; Nishino, Ichizo; Chabrol, Brigitte; Pellissier, Jean-Francois; Minetti, Carlo; Udd, Bjame; Fardeau, Michel; Tailor, Chetankumar S.; Mahuran, Don J.; Kissel, John T.; Kalimo, Hannu; Levy, Nicolas; Manolson, Morris F.; Ackerley, Cameron A.; Minassian, Berge A.			RETRACTED: VMA21 Deficiency Causes an Autophagic Myopathy by Compromising V-ATPase Activity and Lysosomal Acidification (Retracted article. See vol. 142, pg. 984, 2010)	CELL			English	Article; Retracted Publication							X-LINKED MYOPATHY; RENAL TUBULAR-ACIDOSIS; EXCESSIVE AUTOPHAGY; SKELETAL-MUSCLES; SUBUNIT; MUTATIONS; PROTEIN; MICE; CARDIOMYOPATHY; OSTEOPETROSIS	X-linked myopathy with excessive autophagy (XMEA) is a childhood-onset disease characterized by progressive vacuolation and atrophy of skeletal muscle. We show that XMEA is caused by hypomorphic alleles of the VMA21 gene, that VMA21 is the diverged human ortholog of the yeast Vma21p protein, and that like Vma21p it is an essential assembly chaperone of the V-ATPase, the principal mammalian proton pump complex. Decreased VMA21 raises lysosomal pH, which reduces lysosomal degradative ability and blocks autophagy. This reduces cellular free amino acids, which upregulates the mTOR pathway and mTOR-dependent macroautophagy, resulting in proliferation of large and ineffective autolysosomes that engulf sections of cytoplasm, merge together, and vacuolate the cell. Our results uncover macroautophagic overcompensation leading to cell vacuolation and tissue atrophy as a mechanism of disease.	[Ramachandran, Nivetha; Munteanu, Iulia; Wang, Peixiang; Rilstone, Jennifer J.; Israelian, Nyrie; Naranian, Taline; Guo, Ray; Ren, Zhi-Ping; Mahuran, Don J.; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Paroutis, Paul; Tailor, Chetankumar S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Ackerley, Cameron A.] Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada; [Munteanu, Iulia; Rilstone, Jennifer J.; Minassian, Berge A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Aubourg, Pauline; Levy, Nicolas] Univ Aix Marseille 2, Fac Med Marseille, INSERM, UMR S910, F-13385 Marseille, France; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan; [Chabrol, Brigitte] CHU Timone, Hop Enfants, Unite Med Infantile, F-13385 Marseille, France; [Pellissier, Jean-Francois] Hop La Timone, Lab Anat Pathol & Neuropathol, F-13385 Marseille, France; [Minetti, Carlo] G Gaslini Inst Children, Muscular & Neurodegenerat Dis Unit, I-16147 Genoa, Italy; [Minetti, Carlo] Univ Genoa, I-16147 Genoa, Italy; [Udd, Bjame] Vaasa Cent Hosp, Dept Neurol, FIN-65130 Vaasa, Finland; [Udd, Bjame] Tampere Univ, FIN-65130 Vaasa, Finland; [Fardeau, Michel] Salpetriere Hosp, Myol Inst, F-75013 Paris, France; [Kissel, John T.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Kalimo, Hannu] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland; [Kalimo, Hannu] Univ Turku, Dept Pathol & Forens Med, FI-20520 Turku, Finland; [Manolson, Morris F.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; National Center for Neurology & Psychiatry - Japan; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; Vaasa Central Hospital; Tampere University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University System of Ohio; Ohio State University; University of Helsinki; University of Turku; University of Toronto	Minassian, BA (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	berge.minassian@sickkids.ca	Nishino, Ichizo/G-2676-2010; Minetti, Carlo/K-4666-2018; LEVY, Nicolas/J-1632-2014	Nishino, Ichizo/0000-0001-9452-112X; Minetti, Carlo/0000-0002-0640-1804; LEVY, Nicolas/0000-0001-5171-6365; Manolson, Morris/0000-0001-8755-5460	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	I.M. identified the disease gene and characterized the effects of the mutations on the gene product (Figure 1). N.R. designed and performed the functional experiments that resolved the pathogenetic mechanisms of disease (Figures 2-7). Principal funding was from the Canadian Institutes of Health Research. B.A.M. holds the Canada Research Chair in Paediatric Neurogenetics. Additional acknowledgments are available in the Supplemental Data.	Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chabrol B, 2001, NEUROMUSCULAR DISORD, V11, P376, DOI 10.1016/S0960-8966(00)00209-1; Drose S, 1997, J EXP BIOL, V200, P1; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; KALIMO H, 1988, ANN NEUROL, V23, P258, DOI 10.1002/ana.410230308; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Minassian B, 2002, STRUCTURAL MOL BASIS, P145; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Munteanu I, 2008, NEUROLOGY, V71, P951, DOI 10.1212/01.wnl.0000325991.01899.35; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Ochotny N, 2006, J BIOL CHEM, V281, P26102, DOI 10.1074/jbc.M601118200; Ostenfeld MS, 2008, AUTOPHAGY, V4, P487, DOI 10.4161/auto.5774; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Scornik OA, 1997, AM J PHYSIOL-ENDOC M, V273, pE1158; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Sharma R, 2001, BIOCHEMISTRY-US, V40, P5440, DOI 10.1021/bi0029200; STAUBER WT, 1981, EXP NEUROL, V71, P295, DOI 10.1016/0014-4886(81)90090-X; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; VILLANOVA M, 1995, ANN NEUROL, V37, P637, DOI 10.1002/ana.410370514	27	49	54	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2					235	246		10.1016/j.cell.2009.01.054	http://dx.doi.org/10.1016/j.cell.2009.01.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379691	Bronze			2022-12-28	WOS:000265456800017
J	de Melo-Martin, I				de Melo-Martin, Inmaculada			The art of medicine Vulnerability and ethics: considering our Cartesian hangover	LANCET			English	Editorial Material									Weill Cornell Med Coll, Dept Publ Hlth, Div Med Eth, New York, NY 10065 USA	Cornell University	de Melo-Martin, I (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, Div Med Eth, New York, NY 10065 USA.	imd2001@med.cornell.edu	de Melo-Martin, Inmaculada/AEE-1312-2022	de Melo-Martin, Inmaculada/0000-0001-8656-8497					0	6	6	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1244	1245		10.1016/S0140-6736(09)60715-7	http://dx.doi.org/10.1016/S0140-6736(09)60715-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432PN	19367742				2022-12-28	WOS:000265146300014
J	Benson, JR; Jatoi, I; Keisch, M; Esteva, FJ; Makris, A; Jordan, VC				Benson, John R.; Jatoi, Imail; Keisch, Martin; Esteva, Francisco J.; Makris, Andreas; Jordan, V. Craig			Early breast cancer	LANCET			English	Review							SENTINEL-LYMPH-NODE; SURGICAL ADJUVANT BREAST; 20-YEAR FOLLOW-UP; RANDOMIZED-TRIAL; ESTROGEN-RECEPTOR; GENE-EXPRESSION; CONSERVING SURGERY; AMERICAN-SOCIETY; PREOPERATIVE CHEMOTHERAPY; AROMATASE INHIBITORS	Adoption of urbanised lifestyles together with changes in reproductive behaviour might partly underlie the continued rise in worldwide incidence of breast cancer. Widespread mammographic screening and effective systemic therapies have led to a stage shift at presentation and mortality reductions in the past two decades. Loco-regional control of the disease seems to affect long-term survival, and attention to surgical margins together with improved radiotherapy techniques could further contribute to mortality gains. Developments in oncoplastic surgery and partial-breast reconstruction have improved cosmetic outcomes after breast-conservation surgery Optimum approaches for delivering chest-wall radiotherapy in the context of immediate breast reconstruction present special challenges. Accurate methods for intraoperative assessment of sentinel lymph nodes remain a clinical priority. Clinical trials are investigating combinatorial therapies that use novel agents targeting growth factor receptors, signal transduction pathways, and tumour angiogenesis. Gene-expression profiling offers the potential to provide accurate prognostic and predictive information, with selection of best possible therapy for individuals and avoidance of overtreatment and undertreatment of patients with conventional chemotherapy. Short-term presurgical studies in the neoadjuvant setting allow monitoring of proliferative indices, and changes in gene-expression patterns can be predictive of response to therapies and long-term outcome.	[Benson, John R.] Addenbrookes Hosp, Cambridge Breast Unit, Cambridge CB2 0QQ, England; [Benson, John R.] Univ Cambridge, Cambridge, England; [Jatoi, Imail] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD USA; [Keisch, Martin] Aventura Hosp, Aventura Comprehens Canc Ctr, Miami, FL USA; [Esteva, Francisco J.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Makris, Andreas] Mt Vernon Hosp, Acad Oncol Unit, Northwood HA6 2RN, Middx, England; [Jordan, V. Craig] Fox Chase Canc Ctr, Dept Med Sci, Philadelphia, PA 19111 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Uniformed Services University of the Health Sciences - USA; University of Texas System; UTMD Anderson Cancer Center; Fox Chase Cancer Center	Benson, JR (corresponding author), Addenbrookes Hosp, Cambridge Breast Unit, Hills Rd, Cambridge CB2 0QQ, England.	john.benson@addenbrookes.nhs.uk	JORDAN, V.Craig/AAX-3562-2020; Jordan, V. Craig/H-4491-2011	Esteva, Francisco J./0000-0003-2437-3920				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; Abe O, 1998, LANCET, V352, P930; ADAMI HO, 1980, BRIT J CANCER, V42, P651, DOI 10.1038/bjc.1980.298; ALBAIN KS, 2007, BREAST CANC RES TREA, V96, pA10; Anderson WF, 2005, BREAST CANCER RES TR, V90, P127, DOI 10.1007/s10549-004-3777-3; Anderson WF, 2007, CANCER CAUSE CONTROL, V18, P439, DOI 10.1007/s10552-006-0092-9; [Anonymous], 1993, Lancet, V341, P1293; Asgeirsson KS, 2003, EUR J CANCER, V39, P2462, DOI 10.1016/S0959-8049(03)00605-1; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Baynes C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1669; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Behranwala KA, 2006, J PLAST RECONSTR AES, V59, P1043, DOI 10.1016/j.bjps.2006.01.051; Belletti B, 2008, CLIN CANCER RES, V14, P1325, DOI 10.1158/1078-0432.CCR-07-4453; Benitez PR, 2007, AM J SURG, V194, P456, DOI 10.1016/j.amjsurg.2007.06.010; Benson JR, 2007, LANCET ONCOL, V8, P331, DOI 10.1016/S1470-2045(07)70103-1; Benson JR, 2005, J CLIN ONCOL, V23, P6807, DOI 10.1200/JCO.2005.02.3952; BENSON JR, 2008, ADV BREAST CANC, V5, P1; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]; BERAL V, 1995, LANCET, V345, P1642, DOI 10.1016/S0140-6736(95)90151-5; Beresford MJ, 2007, CANCER TREAT REV, V33, P48, DOI 10.1016/j.ctrv.2006.10.003; Beresford M, 2005, EXPERT REV ANTICANC, V5, P893, DOI 10.1586/14737140.5.5.893; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; BLACK LJ, 1983, LIFE SCI, V32, P1031, DOI 10.1016/0024-3205(83)90935-9; Britton PD, 1999, BREAST, V8, P5, DOI 10.1016/S0960-9776(99)90330-2; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Carlson Robert W, 2006, J Natl Compr Canc Netw, V4 Suppl 1, pS1; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; CLARK RM, 1992, JNCI-J NATL CANCER I, V84, P683, DOI 10.1093/jnci/84.9.683; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; Clarke M, 1998, LANCET, V351, P1451; Cleary MP, 1997, P SOC EXP BIOL MED, V216, P28, DOI 10.3181/00379727-216-44153B; CLEMMESEN J, 1948, BRIT J RADIOL, V21, P583, DOI 10.1259/0007-1285-21-252-583; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Cochrane RA, 2003, BRIT J SURG, V90, P1505, DOI 10.1002/bjs.4344; Colditz GA, 2005, CLIN CANCER RES, V11, p909S; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; CUTTINO LW, 2003, BRACHYTHERAPY, V2, P41; Cuzick J, 2003, RECENT RES CANCER, V163, P96; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; CUZICK J, 1985, LANCET, V2, P282; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Davidson NE, 2005, J NATL CANCER I, V97, P159, DOI 10.1093/jnci/dji049; della Rovere GQ, 2002, LANCET ONCOL, V3, P183, DOI 10.1016/S1470-2045(02)00683-6; DeMartini W, 2008, ACAD RADIOL, V15, P408, DOI 10.1016/j.acra.2007.11.006; Dixon JM, 2003, J STEROID BIOCHEM, V86, P295, DOI 10.1016/S0960-0760(03)00370-4; Eiermann W, 2001, ANN ONCOL, V12, P1527, DOI 10.1023/A:1013128213451; Ellis PA, 2007, BREAST CANCER RES TR, V106, pS21; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Esteva FJ, 2005, CLIN CANCER RES, V11, P3315, DOI 10.1158/1078-0432.CCR-04-1707; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; FISHER B, 1980, CANCER RES, V40, P3863; FORD D, 1995, BRIT J CANCER, V72, P805, DOI 10.1038/bjc.1995.417; Formenti SC, 2004, INT J RADIAT ONCOL, V60, P493, DOI 10.1016/j.ijrobp.2004.04.036; Fyles AW, 2004, NEW ENGL J MED, V351, P963, DOI 10.1056/NEJMoa040595; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gianni L, 2005, CLIN CANCER RES, V11, P8715, DOI 10.1158/1078-0432.CCR-05-0539; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Gotzsche PC, 2006, COCHRANE DB SYST REV, V3; Guarneri V, 2006, J CLIN ONCOL, V24, P1037, DOI 10.1200/JCO.2005.02.6914; Hankinson SE, 2004, BREAST CANCER RES, V6, P213, DOI 10.1186/bcr921; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; HAYES DF, 2008, NEW ENGL J MED, V21, P976; Helbich T H, 2004, Eur Radiol, V14, P383, DOI 10.1007/s00330-003-2141-z; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Holmberg L, 2008, JNCI-J NATL CANCER I, V100, P475, DOI 10.1093/jnci/djn058; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; HORTOBAGYI GN, 1988, CANCER, V62, P2507, DOI 10.1002/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; *IBTR, BREAST CANC MOD; Jackman RJ, 1999, RADIOLOGY, V210, P799, DOI 10.1148/radiology.210.3.r99mr19799; Jatoi I, 2005, J CLIN ONCOL, V23, P7836, DOI 10.1200/JCO.2004.01.0421; Jatoi I, 2003, CANCER-AM CANCER SOC, V98, P894, DOI 10.1002/cncr.11604; Jatoi I, 2003, LANCET ONCOL, V4, P251, DOI 10.1016/S1470-2045(03)01037-4; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; Jensen EV, 2003, CLIN CANCER RES, V9, P1980; Jonat W, 2006, LANCET ONCOL, V7, P991, DOI 10.1016/S1470-2045(06)70948-2; Jordan VC, 2008, EUR J CANCER, V44, P30, DOI 10.1016/j.ejca.2007.11.002; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; JORDAN VC, 1988, CANCER INVEST, V6, P589, DOI 10.3109/07357908809082124; Julian TB, 2008, J CLIN ONCOL, V26, P3338, DOI 10.1200/JCO.2007.14.0665; Keisch M, 2003, INT J RADIAT ONCOL, V55, P289, DOI 10.1016/S0360-3016(02)04277-3; Kestin LL, 2000, INT J RADIAT ONCOL, V48, P1559, DOI 10.1016/S0360-3016(00)01396-1; King TA, 2000, AM J SURG, V180, P299, DOI 10.1016/S0002-9610(00)00454-2; KOMOIKE Y, 2005, CANCER, V106, P35; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Krueger EA, 2003, INT J RADIAT ONCOL, V56, P1023, DOI 10.1016/S0360-3016(03)00183-4; Kuijt GP, 2008, BRIT J SURG, V95, P310, DOI 10.1002/bjs.5992; Kuske RR, 2006, INT J RADIAT ONCOL, V65, P45, DOI 10.1016/j.ijrobp.2005.11.027; Locker G, 2002, BREAST CANCER RES TR, V76, pS35; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Makris A, 1998, ANN ONCOL, V9, P1179, DOI 10.1023/A:1008400706949; Mameri CS, 2008, BREAST J, V14, P236, DOI 10.1111/j.1524-4741.2008.00568.x; Mamounas EP, 2005, J CLIN ONCOL, V23, P2694, DOI 10.1200/JCO.2005.05.188; Marchionni L, 2008, ANN INTERN MED, V148, P358, DOI 10.7326/0003-4819-148-5-200803040-00208; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; McCulley SJ, 2005, BRIT J PLAST SURG, V58, P889, DOI 10.1016/j.bjps.2005.03.008; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Morrow M, 2007, J AM COLL SURGEONS, V205, P362; Morrow M, 2008, J CLIN ONCOL, V26, P352, DOI 10.1200/JCO.2007.14.7314; Morrow Monica, 2006, Magn Reson Imaging Clin N Am, V14, P363, DOI 10.1016/j.mric.2006.07.006; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; MOURIDSEN H, 2008, 31 SAN ANT BREAST CA; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Naik AM, 2004, ANN SURG, V240, P462, DOI 10.1097/01.sla.0000137130.23530.19; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Padhani AR, 2005, EXPERT REV ANTICANC, V5, P239, DOI 10.1586/14737140.5.2.239; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pal A, 2008, BRIT J SURG, V95, P302, DOI 10.1002/bjs.5943; Park J, 2006, BREAST CANCER RES TR, V100, pS80; Pegram M, 2006, BREAST CANC RES TREA, V100, pA201; Perez EA, 2008, J CLIN ONCOL, V26, P1231, DOI 10.1200/JCO.2007.13.5467; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; PETREK JA, 1991, CANCER-AM CANCER SOC, V67, P869, DOI 10.1002/1097-0142(19910215)67:4<869::AID-CNCR2820670402>3.0.CO;2-Q; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; POWLES TJ, 1989, BRIT J CANCER, V60, P126, DOI 10.1038/bjc.1989.235; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Pritchard KI, 2008, J CLIN ONCOL, V26, P736, DOI 10.1200/JCO.2007.15.4716; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; RAMAZZINI B, MORBIS ARTIFICUM, P156; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Rivadeneira DE, 2000, CANCER J, V6, P331; Robson M, 2007, NEW ENGL J MED, V357, P154, DOI 10.1056/NEJMcp071286; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; SABEL MS, 2003, AM J SURG, V39, P1089; Santen RJ, 2007, ENDOCR-RELAT CANCER, V14, P169, DOI 10.1677/ERC-06-0045; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; SCHOLL SM, 1994, EUR J CANCER, V30A, P645, DOI 10.1016/0959-8049(94)90537-1; Singletary SE, 2002, AM J SURG, V184, P383, DOI 10.1016/S0002-9610(02)01012-7; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith BD, 2006, JNCI-J NATL CANCER I, V98, P681, DOI 10.1093/jnci/djj186; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Smith IC, 2002, J CLIN ONCOL, V20, P1456, DOI 10.1200/JCO.20.6.1456; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; Smith IE, 2004, NEW ENGL J MED, V351, P1021, DOI 10.1056/NEJMe048173; Smith LF, 2007, J SURG ONCOL, V96, P451, DOI 10.1002/jso.20800; Solin LJ, 2008, J CLIN ONCOL, V26, P386, DOI 10.1200/JCO.2006.09.5448; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Sparano JA, 2006, CLIN BREAST CANCER, V7, P347, DOI 10.3816/CBC.2006.n.051; STANLEY MW, 2000, AM J CLIN PATHOL, V115, pS49; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Taghian A, 2005, ANN SURG, V241, P629, DOI 10.1097/01.sla.0000157272.04803.1b; TAYLOR ME, 1995, INT J RADIAT ONCOL, V31, P753, DOI 10.1016/0360-3016(94)00480-3; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Vaidya JS, 2001, ANN ONCOL, V12, P1075, DOI 10.1023/A:1011609401132; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; Veronesi U, 2001, EUR J CANCER, V37, P2178, DOI 10.1016/S0959-8049(01)00285-4; VERONESI U, 1995, ANN SURG, V222, P612, DOI 10.1097/00000658-199511000-00002; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Vicini FA, 2003, INT J RADIAT ONCOL, V57, P1247, DOI 10.1016/S0360-3016(03)01573-6; Vicini FA, 2003, JNCI-J NATL CANCER I, V95, P1205, DOI 10.1093/jnci/djg023; Vicini F, 2008, CANCER, V112, P758, DOI 10.1002/cncr.23227; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Whelan T, 2002, J NATL CANCER I, V94, P1143; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Wolff AC, 2000, J CLIN ONCOL, V18, P1558, DOI 10.1200/JCO.2000.18.7.1558; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054; Zonderland HM, 1999, RADIOLOGY, V213, P413, DOI 10.1148/radiology.213.2.r99nv05413	180	180	192	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1463	1479		10.1016/S0140-6736(09)60316-0	http://dx.doi.org/10.1016/S0140-6736(09)60316-0			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394537				2022-12-28	WOS:000265501900036
J	Bax, L; Woittiez, AJJ; Kouwenberg, HJ; Mali, WPTM; Buskens, E; Beek, FJA; Braam, B; Huysmans, FTM; Kool, LJS; Rutten, MJCM; Doorenbos, CJ; Aarts, JCNM; Rabelink, TJ; Plouin, PF; Raynaud, A; van Montfrans, GA; Reekers, JA; van den Meiracker, AH; Pattynama, PMT; van de Ven, PJG; Vroegindeweij, D; Kroon, AA; de Haan, MW; Postma, CT; Beutler, JJ				Bax, Liesbeth; Woittiez, Arend-Jan J.; Kouwenberg, Hans J.; Mali, Willem P. T. M.; Buskens, Erik; Beek, Frederik J. A.; Braam, Branko; Huysmans, Frans T. M.; Kool, Leo J. Schultze; Rutten, Matthieu J. C. M.; Doorenbos, Cornelius J.; Aarts, Johannes C. N. M.; Rabelink, Ton J.; Plouin, Pierre-Francois; Raynaud, Alain; van Montfrans, Gert A.; Reekers, Jim A.; van den Meiracker, Anton H.; Pattynama, Peter M. T.; van de Ven, Peter J. G.; Vroegindeweij, Dammis; Kroon, Abraham A.; de Haan, Michiel W.; Postma, Cornelis T.; Beutler, Jaap J.			Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							RENOVASCULAR DISEASE; ISCHEMIC NEPHROPATHY; NATURAL-HISTORY; OSTIAL STENOSIS; BLOOD-PRESSURE; HYPERTENSION; MANAGEMENT; RATIONALE; KIDNEY; REVASCULARIZATION	Background: Little is known about the efficacy and safety of renal artery stenting in patients with atherosclerotic renal artery stenosis (ARAS) and impaired renal function. Objective: To determine the efficacy and safety of stent placement in patients with ARAS and impaired renal function. Design: Randomized clinical trial. Randomization was centralized and computer generated, and allocation was assigned by e-mail. Patients, providers, and persons who assessed outcomes were not blinded to treatment assignment. Setting: 10 European medical centers. Participants: 140 patients with creatinine clearance less than 80 mL/min per 1.73 m(2) and ARAS of 50% or greater. Intervention: Stent placement and medical treatment (64 patients) or medical treatment only (76 patients). Medical treatment consisted of antihypertensive treatment, a statin, and aspirin. Measurements: The primary end point was a 20% or greater decrease in creatinine clearance. Secondary end points included safety and cardiovascular morbidity and mortality. Results: Forty-six of 64 patients assigned to stent placement had the procedure. Ten of the 64 patients (16%) in the stent placement group and 16 patients (22%) in the medication group reached the primary end point (hazard ratio, 0.73 [95% CI, 0.33 to 1.61]). Serious complications occurred in the stent group, including 2 procedure-related deaths (3%), 1 late death secondary to an infected hematoma, and 1 patient who required dialysis secondary to cholesterol embolism. The groups did not differ for other secondary end points. Limitation: Many patients were falsely identified as having renal artery stenosis greater than 50% by noninvasive imaging and did not ultimately require stenting. Conclusion: Stent placement with medical treatment had no clear effect on progression of impaired renal function but led to a small number of significant procedure-related complications. The study findings favor a conservative approach to patients with ARAS, focused on cardiovascular risk factor management and avoiding stenting.	[Bax, Liesbeth] Univ Med Ctr Utrecht, Dept Radiol E01 132, NL-3584 CX Utrecht, Netherlands; Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; Twenteborg Hosp Almelo, Almelo, Netherlands; Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; Univ Med Ctr Nijmegen, Nijmegen, Netherlands; Jeroen Bosch Hosp, Shertogenbosch, Netherlands; Deventer Hosp, Deventer, Netherlands; Univ Med Ctr Leiden, Leiden, Netherlands; Acad Med Ctr Amsterdam, Amsterdam, Netherlands; Erasmus MC, Rotterdam, Netherlands; Maasstad Hosp, Rotterdam, Netherlands; Univ Hosp Maastricht, Maastricht, Netherlands; Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada; Hop Europeen Georges Pompidou, Paris, France	Utrecht University; Utrecht University Medical Center; University of Groningen; Radboud University Nijmegen; Jeroen Bosch Ziekenhuis; Deventer Hospital; Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Maasstad Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); University of Alberta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Bax, L (corresponding author), Univ Med Ctr Utrecht, Dept Radiol E01 132, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	w.mali@umcutrecht.nl; j.beutler@jbz.nl	Postma, C.T./L-4585-2015; Mali, Willem PThM/I-1123-2014; Rabelink, Ton J./A-5316-2008; Kool, L.J. Schultze/H-8088-2014; Peters-Bax, L./L-4575-2015; Reekers, Jim/ABF-7580-2021	Mali, Willem PThM/0000-0003-4391-0904; Rabelink, Ton J./0000-0001-6780-5186; buskens, erik/0000-0002-6463-1106	Dutch Kidney Foundation [C99.1810]; Bayer; Cordis (a Johnson & Johnson Company); Pfizer	Dutch Kidney Foundation; Bayer(Bayer AG); Cordis (a Johnson & Johnson Company); Pfizer(Pfizer)	By the Dutch Kidney Foundation ( grant C99.1810), Bayer, Cordis (a Johnson & Johnson Company), and Pfizer.	Bax L, 2003, J NEPHROL, V16, P807; Beek FJA, 1997, CARDIOVASC INTER RAD, V20, P184, DOI 10.1007/s002709900134; Beutler JJ, 2001, J AM SOC NEPHROL, V12, P1475, DOI 10.1681/ASN.V1271475; Bianchi S, 2003, AM J KIDNEY DIS, V41, P565, DOI 10.1053/ajkd.2003.50140; Cooper CJ, 2006, AM HEART J, V152, P59, DOI 10.1016/j.ahj.2005.09.011; DEAN RH, 1981, ARCH SURG-CHICAGO, V116, P1408; Harden PN, 1997, LANCET, V349, P1133, DOI 10.1016/S0140-6736(96)10093-3; Hirsch AT, 2006, J VASC INTERV RADIOL, V17, P1383, DOI 10.1097/01.RVI.0000240426.53079.46; Holden A, 2006, KIDNEY INT, V70, P948, DOI 10.1038/sj.ki.5001671; Isles CG, 1999, QJM-INT J MED, V92, P159, DOI 10.1093/qjmed/92.3.159; Ivanovic V, 2003, J VASC INTERV RADIOL, V14, P217, DOI 10.1097/01.RVI.0000058324.82956.2a; Kalra PA, 2005, KIDNEY INT, V68, P293, DOI 10.1111/j.1523-1755.2005.00406.x; Kashyap VS, 2007, J VASC SURG, V45, P101, DOI 10.1016/j.jvs.2006.08.068; Korsakas S, 2004, KIDNEY INT, V65, P251, DOI 10.1111/j.1523-1755.2004.00353.x; Leertouwer TC, 2000, RADIOLOGY, V216, P78, DOI 10.1148/radiology.216.1.r00jl0778; Mistry S, 2007, J HUM HYPERTENS, V21, P511, DOI 10.1038/sj.jhh.1002185; Murphy TP, 2004, AM J ROENTGENOL, V183, P561, DOI 10.2214/ajr.183.3.1830561; Plouin PF, 1998, HYPERTENSION, V31, P823, DOI 10.1161/01.HYP.31.3.823; Rabelink TJ, 2007, KIDNEY INT, V72, P926, DOI 10.1038/sj.ki.5002414; REES CR, 1991, RADIOLOGY, V181, P507, DOI 10.1148/radiology.181.2.1924796; Rocha-Singh KJ, 2002, CATHETER CARDIO INTE, V57, P135, DOI 10.1002/ccd.10296; Rundback JH, 1998, J VASC INTERV RADIOL, V9, P413, DOI 10.1016/S1051-0443(98)70292-1; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; SCHREIBER MJ, 1984, UROL CLIN N AM, V11, P383; Shannon HM, 1998, AM J ROENTGENOL, V171, P217, DOI 10.2214/ajr.171.1.9648792; Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757; Textor SC, 2008, J AM SOC NEPHROL, V19, P656, DOI 10.1681/ASN.2007111204; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; Vasbinder GBC, 2001, ANN INTERN MED, V135, P401, DOI 10.7326/0003-4819-135-6-200109180-00009; Vasbinder GBC, 2004, ANN INTERN MED, V141, P674, DOI 10.7326/0003-4819-141-9-200411020-00007; WHEATLEY K, 2008, 41 ANN M SCI EXP PHI; WOLLENWEBER J, 1968, AM J CARDIOL, V21, P60, DOI 10.1016/0002-9149(68)90014-3; ZIERLER RE, 1994, J VASC SURG, V19, P250, DOI 10.1016/S0741-5214(94)70100-8	33	445	475	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					840	U41		10.7326/0003-4819-150-12-200906160-00119	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00119			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19414832	Green Published			2022-12-28	WOS:000267164800003
J	Montori, VM; Fernandez-Balsells, M				Montori, Victor M.; Fernandez-Balsells, Merce			Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?	ANNALS OF INTERNAL MEDICINE			English	Article							MULTIFACTORIAL INTERVENTION; VASCULAR COMPLICATIONS; BLOOD-GLUCOSE; MEDICATIONS; MORTALITY; TRIALS	Some diabetes guidelines set low glycemic control goals for patients with type 2 diabetes mellitus (such as a hemoglobin A(1c) level as low as 6.5% to 7.0%) to avoid or delay complications. Our review and critique of recent large randomized trials in patients with type 2 diabetes suggest that tight glycemic control burdens patients with complex treatment programs, hypoglycemia, weight gain, and costs and offers uncertain benefits in return. We believe clinicians should prioritize supporting well-being and healthy lifestyles, preventive care, and cardiovascular risk reduction in these patients. Glycemic control efforts should individualize hemoglobin A1c targets so that those targets and the actions necessary to achieve them reflect patients' personal and clinical context and their informed values and preferences.	[Montori, Victor M.] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA; Hosp Univ Girona Doctor J Trueta, Girona, Spain	Mayo Clinic; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Montori, VM (corresponding author), Mayo Clin, Knowledge & Encounter Res Unit, Plummer 3-35,200 1st St SW, Rochester, MN 55905 USA.	kerunit@mayo.edu	Fernández-Balsells, Mercè/AHC-4689-2022	Fernández-Balsells, Mercè/0000-0001-8221-4237; Montori, Victor/0000-0003-0595-2898	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo Government of Spain [BA08/90035]	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo Government of Spain(Instituto de Salud Carlos III)	The American Diabetes Association awarded Dr. Montori a Clinician Investigator grant in 2004. Novo Nordisk, a maker of insulin, subvented the American Diabetes Association granting program but did not have direct contact with the investigators and did not play any role in the awarding of the grant to the research team. Dr. Fernandez-Balsells has received grant support from the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo (BA08/90035), Government of Spain.	Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Breslin M, 2008, PATIENT EDUC COUNS, V73, P465, DOI 10.1016/j.pec.2008.07.024; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Farmer A, 2007, BMJ-BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE; Friedrich Jan O, 2009, BMC Res Notes, V2, P5, DOI 10.1186/1756-0500-2-5; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; MEINERT CL, 1970, DIABETES, V19, P789; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; O'Kane MJ, 2008, BRIT MED J, V336, P1174, DOI 10.1136/bmj.39534.571644.BE; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Safford MM, 2008, BMJ-BRIT MED J, V336, P1263, DOI 10.1136/bmj.a245; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shichiri M, 2000, DIABETES CARE, V23, pB21; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	20	115	116	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2009	150	11					803	W144		10.7326/0003-4819-150-11-200906020-00008	http://dx.doi.org/10.7326/0003-4819-150-11-200906020-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452HC	19380837				2022-12-28	WOS:000266530000007
J	Stone, GW; Lansky, AJ; Pocock, SJ; Gersh, BJ; Dangas, G; Wong, SC; Witzenbichler, B; Guagliumi, G; Peruga, JZ; Brodie, BR; Dudek, D; Mockel, M; Ochala, A; Kellock, A; Parise, H; Mehran, R				Stone, Gregg W.; Lansky, Alexandra J.; Pocock, Stuart J.; Gersh, Bernard J.; Dangas, George; Wong, S. Chiu; Witzenbichler, Bernhard; Guagliumi, Giulio; Peruga, Jan Z.; Brodie, Bruce R.; Dudek, Dariusz; Moeckel, Martin; Ochala, Andrzej; Kellock, Alison; Parise, Helen; Mehran, Roxana		HORIZONS-AMI Trial Investigators	Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOLLOW-UP; RANDOMIZED-TRIALS; CORONARY-ARTERY; OFF-LABEL; THROMBOSIS; OUTCOMES; SAFETY; ANGIOPLASTY; EFFICACY; REGISTRY	Background: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI). Methods: We randomly assigned, in a 3:1 ratio, 3006 patients presenting with ST-segment elevation myocardial infarction to receive paclitaxel-eluting stents (2257 patients) or otherwise identical bare-metal stents (749 patients). The two primary end points of the study were the 12-month rates of target-lesion revascularization for ischemia (analysis powered for superiority) and a composite safety outcome measure of death, reinfarction, stroke, or stent thrombosis (powered for noninferiority with a 3.0% margin). The major secondary end point was angiographic evidence of restenosis at 13 months. Results: Patients who received paclitaxel-eluting stents, as compared with those who received bare-metal stents, had significantly lower 12-month rates of ischemia-driven target-lesion revascularization (4.5% vs. 7.5%; hazard ratio, 0.59; 95% confidence interval [CI], 0.43 to 0.83; P=0.002) and target-vessel revascularization (5.8% vs. 8.7%; hazard ratio, 0.65; 95% CI, 0.48 to 0.89; P=0.006), with noninferior rates of the composite safety end point (8.1% vs. 8.0%; hazard ratio, 1.02; 95% CI, 0.76 to 1.36; absolute difference, 0.1 percentage point; 95% CI, -2.1 to 2.4; P=0.01 for noninferiority; P=0.92 for superiority). Patients treated with paclitaxel-eluting stents and those treated with bare-metal stents had similar 12-month rates of death (3.5% and 3.5%, respectively; P=0.98) and stent thrombosis (3.2% and 3.4%, respectively; P=0.77). The 13-month rate of binary restenosis was significantly lower with paclitaxel-eluting stents than with bare-metal stents (10.0% vs. 22.9%; hazard ratio, 0.44; 95% CI, 0.33 to 0.57; P<0.001). Conclusions: In patients with ST-segment elevation myocardial infarction who were undergoing primary PCI, implantation of paclitaxel-eluting stents, as compared with bare-metal stents, significantly reduced angiographic evidence of restenosis and recurrent ischemia necessitating repeat revascularization procedures. No safety concerns were apparent at 1 year. (ClinicalTrials.gov number, NCT00433966.) N Engl J Med 2009;360:1946-59.	[Stone, Gregg W.; Lansky, Alexandra J.; Dangas, George; Kellock, Alison; Parise, Helen; Mehran, Roxana] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; [Stone, Gregg W.; Lansky, Alexandra J.; Dangas, George; Wong, S. Chiu; Kellock, Alison; Parise, Helen; Mehran, Roxana] New York Presbyterian Hosp, New York, NY USA; [Wong, S. Chiu] Weill Cornell Med Ctr, New York, NY USA; [Pocock, Stuart J.] London Sch Hyg & Trop Med, London, England; [Gersh, Bernard J.] Mayo Clin, Rochester, MN USA; [Witzenbichler, Bernhard] Charite Campus Benjamin Franklin, Berlin, Germany; [Moeckel, Martin] Charite Campus Virchow Klinikum, Berlin, Germany; [Guagliumi, Giulio] Osped Riuniti Bergamo, I-24100 Bergamo, Italy; [Peruga, Jan Z.] Med Univ Lodz, Lodz, Poland; [Dudek, Dariusz] Jagiellonian Univ, Krakow, Poland; [Ochala, Andrzej] Med Univ Silesia, Katowice, Poland; [Brodie, Bruce R.] LeBauer Cardiovasc Res Fdn, Greensboro, NC USA; [Brodie, Bruce R.] Moses Cone Hosp, Greensboro, NC USA	Cardiovascular Research Foundation (CRF); Columbia University; NewYork-Presbyterian Hospital; Cornell University; University of London; London School of Hygiene & Tropical Medicine; Mayo Clinic; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ospedali Riuniti di Bergamo; Medical University Lodz; Jagiellonian University; Medical University Silesia; LeBauer-Brodie Center for Cardiovascular Research & Education; Moses Cone Memorial Hospital	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Fl, New York, NY 10022 USA.	gs2184@columbia.edu	Ochala, Andrzej/AAH-3855-2020; Mockel, Martin/AAC-2600-2019; Suryapranata, H./H-8095-2014; Mehran, Roxana/ABF-4160-2021; Witzenbichler, Bernhard/ABC-2525-2021; Guagliumi, Giulio/K-8006-2016	Mockel, Martin/0000-0002-7691-3709; Parise, Helen/0000-0001-7761-4973; Banning, Adrian/0000-0002-2842-7861; Ochala, Andrzej/0000-0002-2484-967X; Witzenbichler, Bernhard/0000-0001-9322-1926; Mendiz, Oscar/0000-0002-5268-0429				Beohar N, 2007, JAMA-J AM MED ASSOC, V297, P1992, DOI 10.1001/jama.297.18.1992; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, AM J CARDIOL, V99, P1027, DOI 10.1016/j.amjcard.2006.11.070; de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057; De Luca G, 2008, INT J CARDIOL, V126, P37, DOI 10.1016/j.ijcard.2007.03.112; De Luca G, 2009, INT J CARDIOL, V133, P213, DOI 10.1016/j.ijcard.2007.12.040; HANNAN EL, OUTCOMES DRUG ELUTIN; Lansky A, 1999, TXB INTERVENTIONAL C, P725; Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mehran R, 2008, AM HEART J, V156, P44, DOI 10.1016/j.ahj.2008.02.008; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Pinto DS, 2006, J AM COLL CARDIOL, V48, P32, DOI 10.1016/j.jacc.2006.02.060; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; ten Berg JM, 2001, J AM COLL CARDIOL, V38, P1061, DOI 10.1016/S0735-1097(01)01476-0; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; VAGAONESCU I, MULTICENTER NEW JERS; Valgimigli M, 2007, J AM COLL CARDIOL, V50, P138, DOI 10.1016/j.jacc.2007.04.029; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001	23	347	357	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1946	1959		10.1056/NEJMoa0810116	http://dx.doi.org/10.1056/NEJMoa0810116			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420364	Green Accepted			2022-12-28	WOS:000265784400005
J	Lorgis, L; Zeller, M; Dentan, G; Sicard, P; Buffet, P; L'Huillier, I; Beer, JC; Vincent-Martin, M; Makki, H; Gambert, P; Cottin, Y				Lorgis, L.; Zeller, M.; Dentan, G.; Sicard, P.; Buffet, P.; L'Huillier, I.; Beer, J. C.; Vincent-Martin, M.; Makki, H.; Gambert, P.; Cottin, Y.		RICO Survey Working Grp	Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE CORONARY SYNDROMES; ARTERY-DISEASE; HEART-FAILURE; OLDER-ADULTS; AGE; MORTALITY; EVENTS; PREDICTORS; EXPRESSION; PROATRIAL	Objective To examine the influence of age on the predictive value of N-terminal pro-brain natriuretic (NT-proBNP) peptide assay in acute myocardial infarction. Design Prospective observational study. Setting All intensive care units in one French region. Participants 3291 consecutive patients admitted for an acute myocardial infarction, from the RICO survey (a French regional survey for acute myocardial infarction). Main outcome measure Cardiovascular death at 1 year. Results Among the 3291 participants, mean age was 68 (SD 14) years and 2356 (72%) were men. In the study population, the median NT-proBNP concentration was 1053 (interquartile range 300-3472) pg/ml. Median values for age quarters 1 to 4 were 367 (119-1050), 696 (201-1950), 1536 (534-4146), and 3774 (1168-9724) pg/ml (P<0.001). A multiple linear regression analysis was done to determine the factors associated with the propeptide concentrations in the overall population. NT-proBNP was mainly associated with age, left ventricular ejection fraction, creatinine clearance, female sex, hypertension, diabetes, and anterior wall infarction. At one year's follow-up, 384 (12%) patients had died from all causes and 372 (11%) from cardiovascular causes. In multivariate analysis, NT-proBNP remained strongly associated with the outcome, beyond traditional risk factors including creatinine clearance and left ventricular ejection fraction, in each age group except in the youngest one (<54 years) (P=0.29). The addition of NT-proBNP significantly improved the performance of the statistical model in the overall study population (-2log likelihood 3179.58 v 3099.74, P<0.001) and in each age quarter including the upper one (1523.52 v 1495.01, P<0.001). The independent discriminative value of NT-proBNP compared with the GRACE score was tested by a diagonal stratification using the median value of the GRACE score and NT-proBNP in older patients (upper quarter). Such stratification strikingly identified a high risk group-patients from the higher NT-proBNP group and with a high risk score-characterised by a risk of death of almost 50% at one year. Conclusions In this large contemporary non-selected cohort of patients with myocardial infarction, NT-proBNP concentration had incremental prognostic value even in the oldest patients, above and beyond the GRACE risk score and traditional biomarkers after acute myocardial infarction. These data further support the potential interest of clinical trials specifically assessing NT-proBNP measurement as a guide to current treatment strategies, as well as novel strategies, in older patients with acute myocardial infarction.	[Lorgis, L.; Buffet, P.; L'Huillier, I.; Beer, J. C.; Cottin, Y.] Univ Hosp, Dept Cardiol, Dijon, France; [Zeller, M.; Sicard, P.] Univ Burgundy, Lab Cardiovasc & Expt Physiopathol & Pharmacol, Dijon, France; [Dentan, G.] Clin Fontaine, Dept Cardiol, Fontaine Les Dijon, France; [Vincent-Martin, M.] Reg Hosp, Dept Cardiol, Beaune, France; [Makki, H.] Reg Hosp, Dept Cardiol, Chatillon Sur Seine, France; [Gambert, P.] Univ Hosp, Dept Med Biochem, Dijon, France	CHU Dijon Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne	Lorgis, L (corresponding author), CHU Dijon, Serv Cardiol, Bd Lattre Tassigny, F-21034 Dijon, France.	luc.lorgis@chu-dijon.fr	Sicard, Pierre/B-1637-2010; Sicard, Pierre/N-7310-2018; COTTIN, YVES/ABA-4622-2020	Sicard, Pierre/0000-0001-8100-9792; Sicard, Pierre/0000-0001-5837-3916; 	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Union Regionale des Caisses d'Assurance Maladie de Bourgogne; Agence Regionale d'Hospitalisation de Bourgogne	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Union Regionale des Caisses d'Assurance Maladie de Bourgogne; Agence Regionale d'Hospitalisation de Bourgogne	This work was supported by the University Hospital of Dijon and the Association de Cardiologie de Bourgogne and by grants from the Union Regionale des Caisses d'Assurance Maladie de Bourgogne and the Agence Regionale d'Hospitalisation de Bourgogne.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Barakat K, 1999, LANCET, V353, P955, DOI 10.1016/S0140-6736(98)07114-1; Batchelor WB, 2000, J AM COLL CARDIOL, V36, P723, DOI 10.1016/S0735-1097(00)00777-4; CLARK BA, 1991, AM J HYPERTENS, V4, P500, DOI 10.1093/ajh/4.6.500; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Davis KM, 1996, J GERONTOL A-BIOL, V51, pM95, DOI 10.1093/gerona/51A.3.M95; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; Drewniak W, 2008, KARDIOL POL, V66, P750; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Galvani M, 2004, EUR J HEART FAIL, V6, P327, DOI 10.1016/j.ejheart.2004.01.006; Giannessi D, 2001, J ENDOCRINOL INVEST, V24, P8, DOI 10.1007/BF03343802; HONG M, 1992, BIOL CHEM H-S, V373, P213, DOI 10.1515/bchm3.1992.373.1.213; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; JEMBERG T, 2002, J AM COLL CARDIOL, V40, P437; Jernberg T, 2003, J AM COLL CARDIOL, V42, P1909, DOI 10.1016/j.jacc.2003.07.015; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Levin ER, 1998, NEW ENGL J MED, V339, P321; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Martinez-Rumayor A, 2008, AM J CARDIOL, V101, p3A, DOI 10.1016/j.amjcard.2007.11.012; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; Mueller C, 2007, J AM COLL CARDIOL, V50, P215, DOI 10.1016/j.jacc.2007.04.035; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 2002, AM J CARDIOL, V89, P463, DOI 10.1016/S0002-9149(01)02271-8; Pearte CA, 2006, CIRCULATION, V113, P2177, DOI 10.1161/CIRCULATIONAHA.105.610352; Raizada V, 2001, MOL CELL BIOCHEM, V216, P137, DOI 10.1023/A:1011027231702; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Richards AM, 2003, CIRCULATION, V107, P2786, DOI 10.1161/01.CIR.0000070953.76250.B9; Sayama H, 1999, CORONARY ARTERY DIS, V10, P537, DOI 10.1097/00019501-199910000-00016; Sinclair H, 2007, SCOT MED J, V52, P8, DOI 10.1258/rsmsmj.52.3.8; Tahir SM, 2008, AM J CARDIOL, V101, P930, DOI 10.1016/j.amjcard.2007.11.040; Verges B, 2008, DIABETES METAB, V34, pS10, DOI 10.1016/S1262-3636(08)70097-1; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195	36	35	37	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2009	338								b1605	10.1136/bmj.b1605	http://dx.doi.org/10.1136/bmj.b1605			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GV	19420032	Green Published, hybrid			2022-12-28	WOS:000265969600003
J	Rennie, D; Chalmers, I				Rennie, Drummond; Chalmers, Iain			Assessing Authority	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIALS; MYOCARDIAL-INFARCTION		[Chalmers, Iain] James Lind Lib, Oxford, England			drummond.rennie@ucsf.edu						ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Chalmers I, 2002, EVAL HEALTH PROF, V25, P12, DOI 10.1177/0163278702025001003; CHALMERS I, 1993, MILBANK Q, V71, P411, DOI 10.2307/3350409; CHALMERS I, 1993, DOING MORE GOOD HARM, P156; CHALMERS I, LANCET IN PRESS; CHALMERS TC, 1955, J CLIN INVEST, V34, P1163, DOI 10.1172/JCI103164; CHALMERS TC, 1977, NEW ENGL J MED, V297, P1091, DOI 10.1056/NEJM197711172972004; FEDERMAN DJ, 1992, NEW ENGL J MED, V327, P1316; Glass G.V., 1976, EDUC RES, V10, P3; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; MULROW CD, 1987, ANN INTERN MED, V106, P485, DOI 10.7326/0003-4819-106-3-485; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; PETROSINO A, CFF MOSTELLER 1916 2; SACKETT D, 1955 CLIN TRIAL REPO; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806	15	14	15	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1819	1821		10.1001/jama.2009.559	http://dx.doi.org/10.1001/jama.2009.559			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441AU	19417202				2022-12-28	WOS:000265742500035
J	Cals, JWL; Butler, CC; Hopstaken, RM; Hood, K; Dinant, GJ				Cals, Jochen W. L.; Butler, Christopher C.; Hopstaken, Rogier M.; Hood, Kerenza; Dinant, Geert-Jan			Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE COUGH; GENERAL-PRACTICE; PRESCRIBING STRATEGIES; MANAGEMENT; RESISTANCE; ADULTS; GPS; PROCALCITONIN; INTERVENTION; CONSULTATION	Objective To assess the effect of general practitioner testing for C reactive protein (disease approach) and receiving training in enhanced communication skills (illness approach) on antibiotic prescribing for lower respiratory tract infection. Design Pragmatic, 2 x 2 factorial, cluster randomised controlled trial. Setting 20 general practices in the Netherlands. Participants 40 general practitioners from 20 practices recruited 431 patients with lower respiratory tract infection. Main outcome measures The primary outcome was antibiotic prescribing at the index consultation. Secondary outcomes were antibiotic prescribing during 28 days' follow-up, reconsultation, clinical recovery, and patients' satisfaction and enablement. Interventions General practitioners' use of C reactive protein point of care testing and training in enhanced communication skills separately and combined, and usual care. Results General practitioners in the C reactive protein test group prescribed antibiotics to 31% of patients compared with 53% in the no test group (P=0.02). General practitioners trained in enhanced communication skills prescribed antibiotics to 27% of patients compared with 54% in the no training group (P<0.01). Both interventions showed a statistically significant effect on antibiotic prescribing at any point during the 28 days' follow-up. Clinicians in the combined intervention group prescribed antibiotics to 23% of patients (interaction term was nonsignificant). Patients' recovery and satisfaction were similar in all study groups. Conclusion Both general practitioners' use of point of care testing for C reactive protein and training in enhanced communication skills significantly reduced antibiotic prescribing for lower respiratory tract infection without compromising patients' recovery and satisfaction with care. A combination of the illness and disease focused approaches may be necessary to achieve the greatest reduction in antibiotic prescribing for this common condition in primary care. Trial registration Current Controlled Trials ISRCTN85154857.	[Cals, Jochen W. L.; Hopstaken, Rogier M.; Dinant, Geert-Jan] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Butler, Christopher C.; Hood, Kerenza] Cardiff Univ, Sch Med, Dept Publ Hlth & Primary Care, Cardiff, Wales; [Hopstaken, Rogier M.] Hlth Care Ctr Eindhoven, Fdn Primary Hlth, Eindhoven, Netherlands; [Hood, Kerenza] Cardiff Univ, Sch Med, SE Wales Trials Unit, Cardiff, Wales	Maastricht University; Cardiff University; Cardiff University	Cals, JWL (corresponding author), Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, POB 616, NL-6200 MD Maastricht, Netherlands.	j.cals@hag.unimaas.nl	Hood, Kerenza/C-2528-2008; Cals, Jochen WL/A-1262-2007	Hood, Kerenza/0000-0002-5268-8631; Cals, Jochen WL/0000-0001-9550-5674; Butler, Christopher/0000-0002-0102-3453; Hopstaken, Rogier/0000-0002-8357-5197	Netherlands Organisation for Health Research and Development [945-04010]; Netherlands Organisation for Health Research and Development as a MD-medical research trainee; Wales Office for Research and Development	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organisation for Health Research and Development as a MD-medical research trainee(Netherlands Organization for Health Research and Development); Wales Office for Research and Development	This trial was funded by the Netherlands Organisation for Health Research and Development (grant 945-04010). JWLC is supported by a grant from the Netherlands Organisation for Health Research and Development as a MD-medical research trainee. KH is funded by the Wales Office for Research and Development. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Altiner A, 2004, FAM PRACT, V21, P500, DOI 10.1093/fampra/cmh505; Altiner A, 2007, J ANTIMICROB CHEMOTH, V60, P638, DOI 10.1093/jac/dkm254; Andre M, 2004, SCAND J INFECT DIS, V36, P192, DOI 10.1080/00365540410019372; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Bradley JS, 2007, LANCET INFECT DIS, V7, P68, DOI 10.1016/S1473-3099(06)70689-2; Briel M, 2006, SWISS MED WKLY, V136, P241; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Butler CC, 2001, J ANTIMICROB CHEMOTH, V48, P435, DOI 10.1093/jac/48.3.435; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Cals J, 2006, J FAM PRACTICE, V55, P545; Cals JWL, 2007, BRIT J GEN PRACT, V57, P942, DOI 10.3399/096016407782605027; Cals JWL, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-15; Cals JWL, 2007, PATIENT EDUC COUNS, V68, P270, DOI 10.1016/j.pec.2007.06.014; Campbell MJ, 2004, BMJ-BRIT MED J, V328, P654, DOI 10.1136/bmj.328.7441.654; Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Coenen S, 2004, J ANTIMICROB CHEMOTH, V54, P661, DOI 10.1093/jac/dkh374; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; DahlerEriksen BS, 1997, CLIN CHEM, V43, P2064; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; Diederichsen HZ, 2000, SCAND J PRIM HEALTH, V18, P39; Dinant GJGJ, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-53; Engstrom S, 2004, SCAND J INFECT DIS, V36, P213, DOI 10.1080/00365540310018842; Fischer Thomas, 2005, BMC Fam Pract, V6, P6, DOI 10.1186/1471-2296-6-6; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; Hak E, 2006, FAM PRACT, V23, P291, DOI 10.1093/fampra/cmi121; Holm A, 2007, BRIT J GEN PRACT, V57, P555; Hopstaken RM, 2003, BRIT J GEN PRACT, V53, P358; Howie JGR, 1998, FAM PRACT, V15, P165, DOI 10.1093/fampra/15.2.165; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kuyvenhoven MM, 2000, BRIT J GEN PRACT, V50, P133; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Little P, 1997, BRIT MED J, V315, P350; Macfarlane J, 1997, RESP MED, V91, P427, DOI 10.1016/S0954-6111(97)90258-4; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; McIsaac WJ, 2000, MED DECIS MAKING, V20, P33, DOI 10.1177/0272989X0002000104; McWhinney I, 1997, TXB FAMILY MED; Melbye H, 1988, Scand J Prim Health Care, V6, P111, DOI 10.3109/02813438809009300; Mollison J, 2000, J Epidemiol Biostat, V5, P339; Montgomery Alan A, 2003, BMC Med Res Methodol, V3, P26, DOI 10.1186/1471-2288-3-26; NORDBERG P, 2005, ANTIBACTERIAL DRUG R, P1; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Rollnick S, 2002, MED EDUC, V36, P377, DOI 10.1046/j.1365-2923.2002.01174.x; Rollnick S, 2001, FAM PRACT, V18, P506, DOI 10.1093/fampra/18.5.506; Samore MH, 2005, JAMA-J AM MED ASSOC, V294, P2305, DOI 10.1001/jama.294.18.2305; Schappert SM, 2006, VITAL HLTH STAT, V13, P1; Smith SM, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD000245.PUB2]; Stewart M, 2003, PATIENT CENTERED MED; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; Verheij T. J. M., 2003, HUISARTS WET, V46, P496; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553; Welschen I, 2004, BRIT MED J, V329, P431, DOI 10.1136/bmj.38182.591238.EB; Wood F, 2007, FAM PRACT, V24, P427, DOI 10.1093/fampra/cmm040; Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705	62	291	298	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2009	338								b1374	10.1136/bmj.b1374	http://dx.doi.org/10.1136/bmj.b1374			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GT	19416992	hybrid, Green Published			2022-12-28	WOS:000265969400001
J	Hotez, PJ; Fenwick, A; Savioli, L; Molyneux, DH				Hotez, Peter J.; Fenwick, Alan; Savioli, Lorenzo; Molyneux, David H.			Rescuing the bottom billion through control of neglected tropical diseases	LANCET			English	Editorial Material							LYMPHATIC FILARIASIS; COGNITIVE FUNCTION; SCHOOL-CHILDREN; HOOKWORM; HEALTH; IMPACT; SCHISTOSOMIASIS; INFECTIONS; PROGRAMS; TRACHOMA		[Hotez, Peter J.] George Washington Univ, Washington, DC 20037 USA; [Hotez, Peter J.] Sabin Vaccine Inst, Washington, DC USA; [Fenwick, Alan] Univ London Imperial Coll Sci Technol & Med, Schistosomiasis Control Initiat, London, England; [Savioli, Lorenzo] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Molyneux, David H.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	George Washington University; Imperial College London; World Health Organization; Liverpool School of Tropical Medicine; University of Liverpool	Hotez, PJ (corresponding author), George Washington Univ, 2300 Eye St NW,Ross Hall Room 736, Washington, DC 20037 USA.	mtmpjh@gwumc.edu		Hotez, Peter/0000-0001-8770-1042				Adhikari SR, 2003, ACTA TROP, V88, P1, DOI 10.1016/S0001-706X(03)00156-6; Amazigo U, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P215; [Anonymous], 2006, PREV CHEM HUM HELM C; Benton B, 1998, ANN TROP MED PARASIT, V92, pS33, DOI 10.1080/00034989859537; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Beyrer C, 2007, LANCET, V370, P619, DOI 10.1016/S0140-6736(07)61301-4; Bleakley H, 2007, Q J ECON, V122, P73, DOI 10.1162/qjec.121.1.73; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Cook JA, 2008, NEW ENGL J MED, V358, P1777, DOI 10.1056/NEJMp0708546; Frick KD, 2003, AM J TROP MED HYG, V69, P1; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; HOTEZ PJ, 2008, FORGOTTEN PEOPLE FOR, P215; Ichimori K, 2007, TRENDS PARASITOL, V23, P36, DOI 10.1016/j.pt.2006.11.005; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; NOKES C, 1992, PARASITOLOGY, V104, P539, DOI 10.1017/S0031182000063800; Obengui, 1989, COMMON WEALTH EC CRO, V34, P44; Perera M, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000128; Powell-Jackson T, 2007, HEALTH POLICY PLANN, V22, P353, DOI 10.1093/heapol/czm024; Ramaiah KD, 2000, ANN TROP MED PARASIT, V94, P353, DOI 10.1080/00034983.2000.11813550; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Sakti H, 1999, TROP MED INT HEALTH, V4, P322, DOI 10.1046/j.1365-3156.1999.00410.x; *WHO, 2008, PROC ESS MED EXP PRE; *WHO, PREV CHEM DAT JAN 20; WHO, 2002, WORLD HLTH REP, V35, pS72; *WHO CART CTR, 2008, GLOB HLTH UN M MAY 8; World Health Organization, 2004, BURD DIS DALYS CAUS; [No title captured]; [No title captured]	35	575	592	1	81	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1570	1575		10.1016/S0140-6736(09)60233-6	http://dx.doi.org/10.1016/S0140-6736(09)60233-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19410718				2022-12-28	WOS:000265710300036
J	Kimura, Y; Yashiroda, H; Kudo, T; Koitabashi, S; Murata, S; Kakizuka, A; Tanaka, K				Kimura, Yoko; Yashiroda, Hideki; Kudo, Tai; Koitabashi, Sumiko; Murata, Shigeo; Kakizuka, Akira; Tanaka, Keiji			An Inhibitor of a Deubiquitinating Enzyme Regulates Ubiquitin Homeostasis	CELL			English	Article							MULTIVESICULAR BODY PATHWAY; YEAST 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; POLYUBIQUITIN GENE; PROTEIN-DEGRADATION; GLOBAL ANALYSIS; IN-VIVO; DOA4; ISOPEPTIDASE; MECHANISMS	The dynamic and reversible process of ubiquitin modification controls various cellular activities. Ubiquitin exists as monomers, unanchored chains, or protein-conjugated forms, but the regulation of these interconversions remains largely unknown. Here, we identified a protein designated Rfu1 (regulator of free ubiquitin chains 1), which regulates intracellular concentrations of monomeric ubiquitins and free ubiquitin chains in Saccharomyces cerevisiae. Rfu1 functions as an inhibitor of Doa4, a deubiquitinating enzyme. Rapid loss of free ubiquitin chains upon heat shock, a condition in which more proteins require ubiquitin conjugation, was mediated in part by Doa4 and Rfu1. Thus, regulation of ubiquitin homeostasis is controlled by a balance between a deubiquitinating enzyme and its inhibitor. We propose that free ubiquitin chains function as a ubiquitin reservoir that allows maintenance of monomeric ubiquitins at adequate levels under normal conditions and rapid supply for substrate conjugation under stress conditions.	[Kimura, Yoko; Yashiroda, Hideki; Kudo, Tai; Koitabashi, Sumiko; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan; [Kakizuka, Akira] Kyoto Univ, JST, Lab Funct Biol, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Kyoto 6068501, Japan; [Yashiroda, Hideki; Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Tokyo 1130033, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Kyoto University; University of Tokyo	Kimura, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	kimura-yk@igakuken.or.jp	Yashiroda, Hideki/Y-7641-2019; Murata, Shigeo/A-1426-2010; Kimura, Yoko/E-6845-2013	Murata, Shigeo/0000-0002-3177-3503; Kimura, Yoko/0000-0002-3054-9753	Research on Priority Area; Ministry of Education, Culture, Science and Technology of Japan; Target Protein Project of MEXT; Takeda Science Foundation	Research on Priority Area; Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Target Protein Project of MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank T. Fujita for his initial support and C. Takahashi, H. Ueno, and T. Hasegawa for technical support. We also thank D. Botstein, K. Matsumoto, K. Umebayashi, R. Hirata, A. Nakano, Y. Saeki, S. Ito, and A. Amerik for materials, Y. Saeki, K. Umebayashi, R. Hirata, A. Nakano, A. Toh-e, Y. Yoshida, and N. Matsuda for discussion, and A. Toh- e for comments on the manuscript. This work was supported by Grants-in-Aid for Scientific Research on Priority Area (to Y.K.), Specially Promoted Research (to K.T.) from the Ministry of Education, Culture, Science and Technology of Japan, the Target Protein Project of MEXT (to K.T.), and Takeda Science Foundation (to K.T.).	Amerik A, 2006, J CELL BIOL, V175, P825, DOI 10.1083/jcb.200605134; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; CHEN YP, 1995, BBA-MOL CELL RES, V1268, P59, DOI 10.1016/0167-4889(95)00044-S; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Fiorani P, 2004, J BIOL CHEM, V279, P21271, DOI 10.1074/jbc.M312338200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; JOHNSON ES, 1995, J BIOL CHEM, V270, P17422; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kimura Y, 2001, GENES CELLS, V6, P887, DOI 10.1046/j.1365-2443.2001.00472.x; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Papa FR, 1999, MOL BIOL CELL, V10, P741, DOI 10.1091/mbc.10.3.741; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Singer JD, 1996, MOL CELL BIOL, V16, P1356; Stryer L, 1981, BIOCHEMISTRY; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Woolford Jr JL, 1991, MOL CELLULAR BIOL YE, P587; Xu P, 2008, ANAL CHEM, V80, P3438, DOI 10.1021/ac800016w	48	68	71	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 1	2009	137	3					549	559		10.1016/j.cell.2009.02.028	http://dx.doi.org/10.1016/j.cell.2009.02.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410548	Bronze			2022-12-28	WOS:000265677200023
J	Smith, KF; Behrens, M; Schloegel, LM; Marano, N; Burgiel, S; Daszak, P				Smith, Katherine F.; Behrens, Michael; Schloegel, Lisa M.; Marano, Nina; Burgiel, Stas; Daszak, Peter			Reducing the Risks of the Wildlife Trade	SCIENCE			English	Editorial Material							MONKEYPOX		[Smith, Katherine F.] Brown Univ, Providence, RI 02912 USA; [Smith, Katherine F.; Schloegel, Lisa M.; Daszak, Peter] Wildlife Trust, New York, NY 10001 USA; [Behrens, Michael] Pacific Lutheran Univ, Tacoma, WA 98447 USA; [Schloegel, Lisa M.] Kingston Univ, Sch Life Sci, Kingston upon Thames KT1 2EE, Surrey, England; [Marano, Nina] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Burgiel, Stas] Global Invas Species Programme, Alexandria, VA 22301 USA	Brown University; Pacific Lutheran University; Kingston University; Centers for Disease Control & Prevention - USA	Smith, KF (corresponding author), Brown Univ, Providence, RI 02912 USA.	katherine_smith@brown.edu; daszak@wildlifetrust.org	daszak, peter/U-4588-2017	daszak, peter/0000-0002-2046-5695				Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P561; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Defenders of Wildlife, 2007, BROK SCREENS REG LIV; DEPOORTER M, 2008, IN DEPTH REV ONGOING; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Fowler AJ, 2007, FRONT ECOL ENVIRON, V5, P353, DOI 10.1890/1540-9295(2007)5[353:FOTLAT]2.0.CO;2; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; SCHLOEGEL LM, BIOL CONSER IN PRESS; Vitousek PM, 1996, AM SCI, V84, P468; 2003, FED REG, V68, P36566	15	172	180	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					594	595		10.1126/science.1174460	http://dx.doi.org/10.1126/science.1174460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	439DW	19407185				2022-12-28	WOS:000265608800025
J	Hezode, C; Forestier, N; Dusheiko, G; Ferenci, P; Pol, S; Goeser, T; Bronowicki, JP; Bourliere, M; Gharakhanian, S; Bengtsson, L; McNair, L; George, S; Kieffer, T; Kwong, A; Kauffman, RS; Alam, J; Pawlotsky, JM; Zeuzem, S				Hezode, Christophe; Forestier, Nicole; Dusheiko, Geoffrey; Ferenci, Peter; Pol, Stanislas; Goeser, Tobias; Bronowicki, Jean-Pierre; Bourliere, Marc; Gharakhanian, Shahin; Bengtsson, Leif; McNair, Lindsay; George, Shelley; Kieffer, Tara; Kwong, Ann; Kauffman, Robert S.; Alam, John; Pawlotsky, Jean-Michel; Zeuzem, Stefan		PROVE2 Study Team	Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; ALPHA-2B PLUS RIBAVIRIN; INHIBITOR; VX-950	BACKGROUND In patients with chronic infection with hepatitis C virus (HCV) genotype 1, treatment with peginterferon alfa and ribavirin for 48 weeks results in rates of sustained virologic response of 40 to 50%. Telaprevir is a specific inhibitor of the HCV serine protease and could be of value in HCV treatment. METHODS A total of 334 patients who had chronic infection with HCV genotype 1 and had not been treated previously were randomly assigned to receive one of four treatments involving various combinations of telaprevir (1250 mg on day 1, then 750 mg every 8 hours), peginterferon alfa-2a (180 mu g weekly), and ribavirin (dose according to body weight). The T12PR24 group (81 patients) received telaprevir, peginterferon alfa-2a, and ribavirin for 12 weeks, followed by peginterferon alfa-2a and ribavirin for 12 more weeks. The T12PR12 group (82 patients) received telaprevir, peginterferon alfa-2a, and ribavirin for 12 weeks. The T12P12 group (78 patients) received telaprevir and peginterferon alfa-2a without ribavirin for 12 weeks. The PR48 (control) group (82 patients) received peginterferon alfa-2a and ribavirin for 48 weeks. The primary end point, a sustained virologic response (an undetectable HCV RNA level 24 weeks after the end of therapy), was compared between the control group and the combined T12P12 and T12PR12 groups. RESULTS The rate of sustained virologic response for the T12PR12 and T12P12 groups combined was 48% (77 of 160 patients), as compared with 46% (38 of 82) in the PR48 (control) group (P = 0.89). The rate was 60% (49 of 82 patients) in the T12PR12 group (P = 0.12 for the comparison with the PR48 group), as compared with 36% (28 of 78 patients) in the T12P12 group (P = 0.003; P = 0.20 for the comparison with the PR48 group). The rate was significantly higher in the T12PR24 group (69% [56 of 81 patients]) than in the PR48 group (P = 0.004). The adverse events with increased frequency in the telaprevir-based groups were pruritus, rash, and anemia. CONCLUSIONS In this phase 2 study of patients infected with HCV genotype 1 who had not been treated previously, one of the three telaprevir groups had a significantly higher rate of sustained virologic response than that with standard therapy. Response rates were lowest with the regimen that did not include ribavirin. (ClinicalTrials.gov number, NCT00372385.)	[Hezode, Christophe; Pawlotsky, Jean-Michel] Univ Paris 12, Hop Henri Mondor, AP HP, F-94010 Creteil, France; [Hezode, Christophe; Pawlotsky, Jean-Michel] Hop Henri Mondor, INSERM, Unite 955, F-94010 Creteil, France; [Pol, Stanislas] Univ Paris 05, INSERM, Unite 567, Paris, France; [Pol, Stanislas] Cochin Hosp Paris, AP HP, Paris, France; [Bronowicki, Jean-Pierre] Univ Hosp Nancy, INSERM, Unite 724, Vandoeuvre Les Nancy, France; [Bourliere, Marc] St Joseph Hosp, Marseille, France; [Forestier, Nicole; Zeuzem, Stefan] JW Goethe Univ Hosp, Frankfurt, Germany; [Goeser, Tobias] Univ Hosp Cologne, Cologne, Germany; [Dusheiko, Geoffrey] Royal Free Hosp, London, England; [Ferenci, Peter] Med Univ Vienna, Vienna, Austria; [Gharakhanian, Shahin; Bengtsson, Leif; McNair, Lindsay; George, Shelley; Kieffer, Tara; Kwong, Ann; Kauffman, Robert S.; Alam, John] Vertex Pharmaceut, Cambridge, MA USA	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Cologne; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Medical University of Vienna; Vertex Pharmaceuticals	Pawlotsky, JM (corresponding author), Hop Henri Mondor, Dept Virol, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	jean-michel.pawlotsky@hmn.aphp.fr	Hezode, Christophe/U-4659-2018; Zeuzem, Stefan/AAE-7435-2019; Yang, Chen/G-1379-2010; Pawlotsky, Jean-Michel/R-8159-2018; Mathurin, Philippe/A-9121-2018; Dusheiko, Geoffrey M/C-7677-2010	Mathurin, Philippe/0000-0003-3447-2025; McNair, Lindsay/0000-0003-2458-8550; Pawlotsky, Jean-Michel/0000-0003-0745-7559	Vertex Pharmaceuticals	Vertex Pharmaceuticals(Vertex Pharmaceuticals)	Supported by Vertex Pharmaceuticals.	[Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Bronowicki JP, 2006, GASTROENTEROLOGY, V131, P1040, DOI 10.1053/j.gastro.2006.07.022; Chevaliez S, 2007, J VIROL, V81, P7732, DOI 10.1128/JVI.00382-07; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Ferenci P, 2005, J HEPATOL, V43, P425, DOI 10.1016/j.jhep.2005.04.009; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hofmann WP, 2007, GASTROENTEROLOGY, V132, P921, DOI 10.1053/j.gastro.2006.12.005; Hultgren C, 1998, J GEN VIROL, V79, P2381, DOI 10.1099/0022-1317-79-10-2381; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; LAMARRE D, 2003, NATURE, V20, P246; Lawitz E, 2008, J HEPATOL, V49, P163, DOI 10.1016/j.jhep.2008.03.027; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Markland W, 2000, ANTIMICROB AGENTS CH, V44, P859, DOI 10.1128/AAC.44.4.859-866.2000; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pawlotsky JM, 2004, GASTROENTEROLOGY, V126, P703, DOI 10.1053/j.gastro.2003.12.002; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013	20	844	887	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1839	1850		10.1056/NEJMoa0807650	http://dx.doi.org/10.1056/NEJMoa0807650			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403903	Green Published			2022-12-28	WOS:000265560300006
J	Parry, M; Lowe, J; Hanson, C				Parry, Martin; Lowe, Jason; Hanson, Clair			Overshoot, adapt and recover	NATURE			English	Editorial Material									[Parry, Martin] IPCCs 2007 Working Grp II Assessment, London, England; [Lowe, Jason] Met Off, Exeter EX1 3PB, Devon, England; [Hanson, Clair] 2007 IPCC Working Grp II Tech Support Unit, Norwich, Norfolk, England; [Hanson, Clair] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England	Met Office - UK; Met Office - UK; Hadley Centre; University of East Anglia	Parry, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London SW7 2AR, England.	martin@mlparry.com	Lowe, Jason/GQI-4036-2022	Aerts, Jeroen/0000-0002-2162-5814				ACKERMAN F, ENERGY POLI IN PRESS; European Commission, 2007, LIM GLOB CLIM CHANG; IPCC, 2007, CLIMATE CHANGE 2007; Lowe JA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014012; Parry M., 2008, NATURE REPORTS CLIMA, DOI [DOI 10.1038/CLIMATE.2008.50, 10.1038/climate.2008.50]; Stern Nicholas, 2006, STERN REV EC CLIMATE; UNFCC, 2007, INV FIN FLOWS ADDR C	7	95	98	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1102	1103		10.1038/4581102a	http://dx.doi.org/10.1038/4581102a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441FL	19407775				2022-12-28	WOS:000265754600018
J	Cubbon, RM; Witte, KKA				Cubbon, Richard M.; Witte, Klaus K. A.			Cardiac resynchronisation therapy for chronic heart failure and conduction delay	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; VENTRICULAR SYSTOLIC DYSFUNCTION; CARE-HF TRIAL; RESYNCHRONIZATION THERAPY; ATRIAL-FIBRILLATION; MORTALITY; DYSSYNCHRONY; METAANALYSIS; PREVALENCE; SYMPTOMS		[Cubbon, Richard M.; Witte, Klaus K. A.] Univ Leeds, Div Cardiovasc & Diabet Res, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Witte, KKA (corresponding author), Univ Leeds, Div Cardiovasc & Diabet Res, Leeds LS2 9JT, W Yorkshire, England.	klauswitte@hotmail.com		Witte, Klaus/0000-0002-7146-7105				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Chattopadhyay S, 2008, EUR J HEART FAIL, V10, P412, DOI 10.1016/j.ejheart.2008.02.004; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Clark AL, 2008, EUR J HEART FAIL, V10, P696, DOI 10.1016/j.ejheart.2008.05.001; Cleland JGF, 2008, HEART, V94, P278, DOI 10.1136/hrt.2007.128991; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland J, 2008, J AM COLL CARDIOL, V52, P438, DOI 10.1016/j.jacc.2008.04.036; Cleland JGF, 2006, EUR HEART J, V27, P1928, DOI 10.1093/eurheartj/ehl099; Cowie MR, 1997, EUR HEART J, V18, P208; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; Desai AS, 2004, JAMA-J AM MED ASSOC, V292, P2874, DOI 10.1001/jama.292.23.2874; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Foley PWX, 2008, EUROPACE, V10, P1302, DOI 10.1093/europace/eun263; Freemantle N, 2006, EUR J HEART FAIL, V8, P433, DOI 10.1016/j.ejheart.2005.11.014; Healey JS, 2007, EUR HEART J, V28, P1746, DOI 10.1093/eurheartj/ehl438; Khan NK, 2007, EUR J HEART FAIL, V9, P491, DOI 10.1016/j.ejheart.2006.11.003; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Thackray SDR, 2003, EUR HEART J, V24, P1143, DOI 10.1016/S0195-668X(03)00199-4; Upadhyay GA, 2008, J AM COLL CARDIOL, V52, P1239, DOI 10.1016/j.jacc.2008.06.043; Uretsky BF, 2008, J CARD FAIL, V14, P670, DOI 10.1016/j.cardfail.2008.06.001; Witte KKA, 2006, J CARD FAIL, V12, P199, DOI 10.1016/j.cardfail.2005.12.003; Witte KK, 2008, CAN J CARDIOL, V24, P379, DOI 10.1016/S0828-282X(08)70601-9; Witte KKA, 2008, EUR J HEART FAIL, V10, P1224, DOI 10.1016/j.ejheart.2008.09.017; Yao GQ, 2007, EUR HEART J, V28, P42, DOI 10.1093/eurheartj/ehl382; Yap YG, 2007, HEART, V93, P832, DOI 10.1136/hrt.2006.102186; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	31	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2009	338								b1265	10.1136/bmj.b1265	http://dx.doi.org/10.1136/bmj.b1265			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JV	19401320				2022-12-28	WOS:000265697500003
J	Subramanian, SV; Ackerson, LK; Smith, GD; John, NA				Subramanian, S. V.; Ackerson, Leland K.; Smith, George Davey; John, Neetu A.			Association of Maternal Height With Child Mortality, Anthropometric Failure, and Anemia in India	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT; RISK-FACTORS; NUTRITIONAL-STATUS; MALNUTRITION; DETERMINANTS; GROWTH; OLD	Context Prior research on the determinants of child health has focused on contemporaneous risk factors such as maternal behaviors, dietary factors, and immediate environmental conditions. Research on intergenerational factors that might also predispose a child to increased health adversity remains limited. Objective To examine the association between maternal height and child mortality, anthropometric failure, and anemia. Design, Setting, and Population We retrieved data from the 2005-2006 National Family Health Survey in India ( released in 2008). The study population constitutes a nationally representative cross-sectional sample of singleton children aged 0 to 59 months and born after January 2000 or January 2001 (n=50 750) to mothers aged 15 to 49 years from all 29 states of India. Information on children was obtained by a face-to-face interview with mothers, with a response rate of 94.5%. Height was measured with an adjustable measuring board calibrated in millimeters. Demographic and socioeconomic variables were considered as covariates. Modified Poisson regression models that account for multistage survey design and sampling weights were estimated. Main Outcome Measures Mortality was the primary end point; underweight, stunting, wasting, and anemia were included as secondary outcomes. Results In adjusted models, a 1-cm increase in maternal height was associated with a decreased risk of child mortality (relative risk [RR], 0.978; 95% confidence interval [CI], 0.970-0.987; P < .001), underweight (RR, 0.971; 95% CI, 0.968-0.974; P < .001), stunting (RR, 0.971; 95% CI, 0.968-0.0973; P < .001), wasting (RR, 0.989; 95% CI, 0.984-0.994; P < .001), and anemia (RR, 0.998; 95% CI, 0.997-0.999; P=.02). Children born to mothers who were less than 145 cm in height were 1.71 times more likely to die (95% CI, 1.37-2.13) (absolute probability, 0.09; 95% CI, 0.07-0.12) compared with mothers who were at least 160 cm in height (absolute probability, 0.05; 95% CI, 0.04-0.07). Similar patterns were observed for anthropometric failure related to underweight and stunting. Paternal height was not associated with child mortality or anemia but was associated with child anthropometric failure. Conclusion In a nationally representative sample of households in India, maternal height was inversely associated with child mortality and anthropometric failure.	[Subramanian, S. V.; John, Neetu A.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ackerson, Leland K.] Univ Massachusetts, Sch Hlth & Environm, Dept Community Hlth & Sustainabil, Lowell, MA USA; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Lowell; University of Bristol	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; John, Neetu/0000-0001-8983-1211; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health Career Development Award [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	National Institutes of Health Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr Subramanian is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275).	Alasfoor D, 2007, J HEALTH POPUL NUTR, V25, P359; Amin Nurul, 1993, Indian Journal of Pediatrics, V60, P269, DOI 10.1007/BF02822189; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; [Anonymous], 2008, WORLDW PREV AN 1993; Back S, 2004, POINT CARE, V3, P60, DOI DOI 10.1097/01.poc.0000127152.03809.87; BAQUI AH, 1994, EUR J CLIN NUTR, V48, P349; Bhalotra S, 2008, J ECONOMETRICS, V143, P274, DOI 10.1016/j.jeconom.2007.10.005; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLOSSNER M, 2007, WHO ANTHRO PERSONAL; Casapia M, 2007, BRIT J NUTR, V98, P1259, DOI 10.1017/S0007114507795272; Cohen JC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-1; Faber M, 2007, J HEALTH POPUL NUTR, V25, P285; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hirve S S, 1994, Indian Pediatr, V31, P1221; Huntsman AC, 2007, ANN HUM BIOL, V34, P411, DOI 10.1080/03014460701366373; International Institute for Population Sciences, 2006, ANTHR AN HIV TEST FI; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Malik Sushma, 1997, Indian Journal of Pediatrics, V64, P373, DOI 10.1007/BF02845207; Mamiro PS, 2005, J HEALTH POPUL NUTR, V23, P222; Martin RM, 2004, EPIDEMIOLOGY, V15, P308, DOI 10.1097/01.ede.0000120042.16363.e3; Mavalankar D V, 1994, Indian Pediatr, V31, P1205; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; *ORC MACR, 2005, HIV TEST LAB MAN DEM; PANANDIKER VAP, 1997, POLITICS BACKWARDNES, P88; Rikimaru T, 1998, J NUTR SCI VITAMINOL, V44, P391, DOI 10.3177/jnsv.44.391; Seckler D., 1982, NEWER CONCEPTS NUTR, P127; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Steckel RH, 2008, J ECON PERSPECT, V22, P129, DOI 10.1257/jep.22.1.129; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Uchimura TT, 2003, REV SAUDE PUBL, V37, P397, DOI 10.1590/S0034-89102003000400002; United Nations Children's Fund, 2008, STAT WORLDS CHILDR 2; Veena SR, 2004, PAEDIATR PERINAT EP, V18, P361, DOI 10.1111/j.1365-3016.2004.00579.x; Vitolo MR, 2008, J PEDIAT-BRAZIL, V84, P251, DOI [10.2223/JPED.1776, 10.1590/S0021-75572008000300011]; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; Webb E, 2008, J EPIDEMIOL COMMUN H, V62, P351, DOI 10.1136/jech.2006.056457; World Health Organization, 2006, WHO CHILD GROWTH STA; Zhang X, 2007, J PEDIATR-US, V150, P603, DOI 10.1016/j.jpeds.2007.01.048; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	163	164	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1691	1701		10.1001/jama.2009.548	http://dx.doi.org/10.1001/jama.2009.548			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383960	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000265350700025
J	Watts, G				Watts, Geoff			Feature Neurology Brain connections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2009	338								b1317	10.1136/bmj.b1317	http://dx.doi.org/10.1136/bmj.b1317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TI	19366757				2022-12-28	WOS:000265296600004
J	Leclercq, P; Loly, C; Delanaye, P; Garweg, C; Lambermont, B				Leclercq, Philippe; Loly, Catherine; Delanaye, Pierre; Garweg, Christophe; Lambermont, Bernard			Green urine	LANCET			English	Editorial Material									[Leclercq, Philippe; Loly, Catherine; Delanaye, Pierre; Garweg, Christophe; Lambermont, Bernard] Univ Liege, CHU Sart Tilman, Dept Intens Care Med, B-4000 Liege, Belgium	University of Liege	Leclercq, P (corresponding author), Univ Liege, CHU Sart Tilman, Dept Intens Care Med, B-4000 Liege, Belgium.	pleclercq@chu.ulg.ac.be	Koratala, Abhilash/H-8482-2019; Delanaye, Pierre/T-4225-2019	Koratala, Abhilash/0000-0001-5801-3574; Delanaye, Pierre/0000-0002-1480-5761; Leclercq, Philippe/0000-0002-1447-224X				BOWLING P, 1981, JAMA-J AM MED ASSOC, V246, P216, DOI 10.1001/jama.246.3.216; Lepenies J, 2000, NEPHROL DIAL TRANSPL, V15, P725, DOI 10.1093/ndt/15.5.725; RAYMOND JR, 1988, SOUTHERN MED J, V81, P837, DOI 10.1097/00007611-198807000-00008	3	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1462	1462		10.1016/S0140-6736(09)60309-3	http://dx.doi.org/10.1016/S0140-6736(09)60309-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394536	Bronze			2022-12-28	WOS:000265501900035
J	Ramchandani, P; Psychogiou, L				Ramchandani, Paul; Psychogiou, Lamprini			Paternal psychiatric disorders and children's psychosocial development	LANCET			English	Review							EXTERNALIZING BEHAVIOR PROBLEMS; POSTNATALLY DEPRESSED MOTHERS; SUBSTANCE-ABUSING FATHERS; PARENTAL MENTAL-HEALTH; MAJOR DEPRESSION; POSTPARTUM DEPRESSION; DIFFERENTIAL SUSCEPTIBILITY; ANXIETY DISORDERS; COGNITIVE-DEVELOPMENT; 5-YEAR-OLD CHILDREN	Psychiatric disorders of parents are associated with an increased risk of psychological and developmental difficulties in their children. Most research has focused on mothers, neglecting psychiatric disorders affecting fathers. We review findings on paternal psychiatric disorders and their effect on children's psychosocial development. Most psychiatric disorders that affect fathers are associated with an increased risk of behavioural and emotional difficulties in their children, similar in magnitude to that due to maternal psychiatric disorders. Some findings indicate that boys are at greater risk than girls, and that paternal disorders, compared with maternal disorders, might be associated with an increased risk of behavioural rather than emotional problems. Improved paternal mental health is likely to improve children's wellbeing and life course.	[Ramchandani, Paul; Psychogiou, Lamprini] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford	Ramchandani, P (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	paul.ramchandani@psych.ox.ac.uk	Ramchandani, Paul/O-5340-2014	Ramchandani, Paul/0000-0003-3646-2410	Wellcome Trust [078434]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Alan Stein and Vicky Webb for helpful comments on earlier drafts of this article. This work was funded by the Wellcome Trust through a fellowship awarded to PR (grant number 078434).	Bakermans-Kranenburg MJ, 2007, J CHILD PSYCHOL PSYC, V48, P1160, DOI 10.1111/j.1469-7610.2007.01801.x; Ballard C, 1996, INT REV PSYCHIATR, V8, P65, DOI 10.3109/09540269609037818; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beardslee WR, 1998, J AM ACAD CHILD PSY, V37, P1134, DOI 10.1097/00004583-199811000-00012; Beardslee WR, 2003, PEDIATRICS, V112, pE119, DOI 10.1542/peds.112.2.e119; Beck CT, 1998, ARCH PSYCHIAT NURS, V12, P12, DOI 10.1016/S0883-9417(98)80004-6; Belsky J, 1998, DEV PSYCHOPATHOL, V10, P301, DOI 10.1017/S095457949800162X; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bogels S, 2008, CLIN PSYCHOL REV, V28, P539, DOI 10.1016/j.cpr.2007.07.011; Bogels SM, 2008, COGNITION EMOTION, V22, P522, DOI 10.1080/02699930801886706; Bowlby J, 1997, ATTACHMENT LOSS ATTA; Bronte-Tinkew J, 2007, J FAM ISSUES, V28, P61, DOI 10.1177/0192513X06293609; Cabrera NJ, 2000, CHILD DEV, V71, P127, DOI 10.1111/1467-8624.00126; CARRO MG, 1993, DEV PSYCHOPATHOL, V5, P567, DOI 10.1017/S0954579400006167; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cassano M, 2006, J CLIN CHILD ADOLESC, V35, P583, DOI 10.1207/s15374424jccp3504_10; Chen YY, 2005, J STUD ALCOHOL, V66, P66, DOI 10.15288/jsa.2005.66.66; Christensen HB, 2000, EUR CHILD ADOLES PSY, V9, P219, DOI 10.1007/s007870070046; Connell AM, 2002, PSYCHOL BULL, V128, P746, DOI 10.1037//0033-2909.128.5.746; Cooper PJ, 2006, J AFFECT DISORDERS, V93, P205, DOI 10.1016/j.jad.2006.03.017; Cummings EM, 2005, J CHILD PSYCHOL PSYC, V46, P479, DOI 10.1111/j.1469-7610.2004.00368.x; Currier D, 2006, J AFFECT DISORDERS, V95, P51, DOI 10.1016/j.jad.2006.04.014; Das Eiden R, 2002, DEV PSYCHOPATHOL, V14, P253, DOI 10.1017/S0954579402002043; Das Eiden R, 2001, ALCOHOL CLIN EXP RES, V25, P1621, DOI 10.1097/00000374-200111000-00010; Dierker LC, 1999, J AM ACAD CHILD PSY, V38, P280, DOI 10.1097/00004583-199903000-00015; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Dunn J, 2004, J CHILD PSYCHOL PSYC, V45, P659, DOI 10.1111/j.1469-7610.2004.00261.x; Eiden RD, 2004, J STUD ALCOHOL, V65, P309, DOI 10.15288/jsa.2004.65.309; ENGLE PL, 1998, SOCIAL POLICY REPORT; Fals-Stewart W, 2004, J FAM PSYCHOL, V18, P319, DOI 10.1037/0893-3200.18.2.319; Federman DD, 2006, NEW ENGL J MED, V354, P1507, DOI 10.1056/NEJMra052529; Field TM, 1999, INF MENTAL HLTH J, V20, P322, DOI 10.1002/(SICI)1097-0355(199923)20:3<322::AID-IMHJ8>3.0.CO;2-T; Flouri E, 2008, CHILD CARE HLTH DEV, V34, P152, DOI 10.1111/j.1365-2214.2007.00752.x; Flouri E, 2004, BRIT J EDUC PSYCHOL, V74, P141, DOI 10.1348/000709904773839806; Forman DR, 2007, DEV PSYCHOPATHOL, V19, P585, DOI 10.1017/S0954579407070289; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Goodman JH, 2004, J ADV NURS, V45, P26, DOI 10.1046/j.1365-2648.2003.02857.x; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; GOODYER IM, 1993, J CHILD PSYCHOL PSYC, V34, P1409, DOI 10.1111/j.1469-7610.1993.tb02099.x; Gordon JA, 2004, ANNU REV NEUROSCI, V27, P193, DOI 10.1146/annurev.neuro.27.070203.144212; GOTTESMAN II, 1976, SCHIZOPHRENIA BULL, V2, P360, DOI 10.1093/schbul/2.3.360; Gross HE, 2008, J ABNORM CHILD PSYCH, V36, P693, DOI 10.1007/s10802-008-9224-x; Halligan SL, 2007, J AFFECT DISORDERS, V97, P145, DOI 10.1016/j.jad.2006.06.010; Hammen C, 2004, J AM ACAD CHILD PSY, V43, P994, DOI 10.1097/01.chi.0000127588.57468.f6; Hart S, 1997, INF MENTAL HLTH J, V18, P436, DOI 10.1002/(SICI)1097-0355(199724)18:4<436::AID-IMHJ9>3.0.CO;2-I; Harter SL, 2000, CLIN PSYCHOL REV, V20, P311, DOI 10.1016/S0272-7358(98)00084-1; Hay DF, 2001, J CHILD PSYCHOL PSYC, V42, P871, DOI 10.1111/1469-7610.00784; Henin A, 2005, BIOL PSYCHIAT, V58, P554, DOI 10.1016/j.biopsych.2005.06.010; Hillegers MH, 2005, BIPOLAR DISORD, V7, P344, DOI 10.1111/j.1399-5618.2005.00215.x; Hogan DM, 1998, J CHILD PSYCHOL PSYC, V39, P609, DOI 10.1111/1469-7610.00361; Jaeger E, 2000, ADDICTION, V95, P267, DOI 10.1046/j.1360-0443.2000.95226713.x; Jaffee SR, 2003, CHILD DEV, V74, P109, DOI 10.1111/1467-8624.t01-1-00524; Jenkins R, 2003, INT REV PSYCHIATR, V15, P29, DOI 10.1080/0954026021000045921; Johnson SL, 2000, J CONSULT CLIN PSYCH, V68, P4, DOI 10.1037/0022-006X.68.1.4; Kane P, 2004, CLIN PSYCHOL REV, V24, P339, DOI 10.1016/j.cpr.2004.03.004; Kelley ML, 2004, J AM ACAD CHILD PSY, V43, P621, DOI 10.1097/00004583-200405000-00016; Kelvin RG, 1996, J CHILD PSYCHOL PSYC, V37, P543, DOI 10.1111/j.1469-7610.1996.tb01440.x; Kilic EZ, 2003, FAM PROCESS, V42, P485, DOI 10.1111/j.1545-5300.2003.00485.x; Klein DN, 2005, PSYCHOL MED, V35, P353, DOI 10.1017/S0033291704003587; Lamb M. E., 2004, ROLE FATHER CHILD DE, V4th; LANG AR, 1989, J ABNORM PSYCHOL, V98, P294, DOI 10.1037/0021-843X.98.3.294; Larsen SB, 1999, SCAND J WORK ENV HEA, V25, P74; Leinonen JA, 2003, J CHILD PSYCHOL PSYC, V44, P227, DOI 10.1111/1469-7610.t01-1-00116; Lewinsohn PM, 2005, PSYCHOL MED, V35, P1493, DOI 10.1017/S0033291705005350; LEWIS C, 2006, CONNECTING STRANDS D; Loukas A, 2003, J ABNORM PSYCHOL, V112, P119, DOI 10.1037/0021-843X.112.1.119; Loukas A, 2001, J ABNORM CHILD PSYCH, V29, P91, DOI 10.1023/A:1005281011838; Low SA, 2005, J FAM PSYCHOL, V19, P394, DOI 10.1037/0893-3200.19.3.394; Lyons- Ruth K., 2002, CHILD REARING AM CHA; Malone SM, 2002, ALCOHOL CLIN EXP RES, V26, P1823, DOI 10.1097/01.ALC.0000042222.59908.F9; Masi G, 2003, CHILD PSYCHIAT HUM D, V33, P245, DOI 10.1023/A:1021408714741; Meltzer H., 2000, MENTAL HLTH CHILDREN; Merikangas KR, 1998, J CHILD PSYCHOL PSYC, V39, P711, DOI 10.1017/S0021963098002522; Mojtabai R, 2004, PSYCHOL MED, V34, P623, DOI 10.1017/S0033291703001764; Montgomery CM, 2006, SOC SCI MED, V62, P2411, DOI 10.1016/j.socscimed.2005.10.026; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray L, 1999, J CHILD PSYCHOL PSYC, V40, P1259, DOI 10.1111/1469-7610.00542; Murray L, 1996, J CHILD PSYCHOL PSYC, V37, P927, DOI 10.1111/j.1469-7610.1996.tb01490.x; MURRAY L, 1993, J CHILD PSYCHOL PSYC, V34, P1083, DOI 10.1111/j.1469-7610.1993.tb01775.x; Murray L., 2003, UNIPOLAR DEPRESSION; Murray L, 2007, J CHILD PSYCHOL PSYC, V48, P45, DOI 10.1111/j.1469-7610.2006.01657.x; Paulson JF, 2006, PEDIATRICS, V118, P659, DOI 10.1542/peds.2005-2948; Pelham WE, 1999, ALCOHOL RES HEALTH, V23, P292; Phares V, 2005, AM PSYCHOL, V60, P735, DOI 10.1037/0003-066X.60.7.735; Phares V., 2002, CHILDREN DEPRESSED P, P203; Pilowsky DJ, 2008, AM J PSYCHIAT, V165, P1136, DOI 10.1176/appi.ajp.2008.07081286; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Ramchandani PG, 2008, J AM ACAD CHILD PSY, V47, P390, DOI 10.1097/CHI.0b013e31816429c2; Renk K, 2007, J ADOLESCENCE, V30, P467, DOI 10.1016/j.adolescence.2006.05.001; Rutter M, 2005, J AM ACAD CHILD PSY, V44, P3, DOI 10.1097/01.chi.0000145374.45992.c9; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; RUTTER M, 1989, PREVENTION MENTAL DI, P157; Sarkadi A, 2008, ACTA PAEDIATR, V97, P153, DOI 10.1111/j.1651-2227.2007.00572.x; Schudlich TDD, 2004, J FAM PSYCHOL, V18, P171, DOI 10.1037/0893-3200.18.1.171; Shiner R, 2003, J CHILD PSYCHOL PSYC, V44, P2, DOI 10.1111/1469-7610.00101; Sinclair D, 1998, BRIT J PSYCHIAT, V172, P58, DOI 10.1192/bjp.172.1.58; Sohr-Preston SL, 2006, CLIN CHILD FAM PSYCH, V9, P65, DOI 10.1007/s10567-006-0004-2; Solantaus T, 2004, DEV PSYCHOL, V40, P412, DOI 10.1037/0012-1649.40.3.412; Sonuga-Barke EJS, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00009; Stein A, 2006, AM J PSYCHIAT, V163, P899, DOI 10.1176/appi.ajp.163.5.899; Stein A, 2008, RUTTERS CHILD ADOLES; STEINHAUSEN HC, 1984, J AM ACAD CHILD PSY, V23, P465, DOI 10.1016/S0002-7138(09)60326-5; Van Zeijl J, 2007, J FAM PSYCHOL, V21, P626, DOI 10.1037/0893-3200.21.4.626; Velderman MK, 2006, J FAM PSYCHOL, V20, P266, DOI 10.1037/0893-3200.20.2.266; Wilhelm K, 2003, J AFFECT DISORDERS, V75, P155, DOI 10.1016/S0165-0327(02)00040-X; Yeung WJ, 2001, J MARRIAGE FAM, V63, P136, DOI 10.1111/j.1741-3737.2001.00136.x	107	240	242	2	82	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					646	653		10.1016/S0140-6736(09)60238-5	http://dx.doi.org/10.1016/S0140-6736(09)60238-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19411102				2022-12-28	WOS:000269222600025
J	Becker, RC				Becker, Richard C.			The importance of VTE prevention after orthopaedic surgery	LANCET			English	Editorial Material							VENOUS THROMBOEMBOLISM; RISK		Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27705 USA	Duke University	Becker, RC (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27705 USA.	richard.becker@duke.edu						Ashrani AA, 2009, J THROMB THROMBOLYS, V28, P465, DOI 10.1007/s11239-009-0309-3; Deitelzweig SB, 2008, THROMB HAEMOSTASIS, V100, P810, DOI 10.1160/TH08-04-0248; Douketis JD, 2009, J THROMB HAEMOST, V7, P546, DOI 10.1111/j.1538-7836.2008.03268.x; Hsu ES, 2009, AM J THER, V16, P147, DOI 10.1097/MJT.0b013e3181715671; Nutescu EA, 2008, ANN PHARMACOTHER, V42, P1216, DOI 10.1345/aph.1L135; Prandoni P, 2009, BRIT J HAEMATOL, V145, P286, DOI 10.1111/j.1365-2141.2009.07601.x; Shbaklo H, 2009, THROMB HAEMOSTASIS, V101, P505, DOI 10.1160/TH08-08-0511; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; Zhu TN, 2009, ARTERIOSCL THROM VAS, V29, P298, DOI 10.1161/ATVBAHA.108.182428	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 16	2009	373	9676					1661	1662		10.1016/S0140-6736(09)60832-1	http://dx.doi.org/10.1016/S0140-6736(09)60832-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RP	19411101				2022-12-28	WOS:000266209800004
J	Horvath, J; Szalai, I; De Kepper, P				Horvath, Judit; Szalai, Istvan; De Kepper, Patrick			An Experimental Design Method Leading to Chemical Turing Patterns	SCIENCE			English	Article							SPATIAL BISTABILITY; CHLORINE-DIOXIDE; OSCILLATIONS; SYSTEMS	Chemical reaction-diffusion patterns often serve as prototypes for pattern formation in living systems, but only two isothermal single-phase reaction systems have produced sustained stationary reaction-diffusion patterns so far. We designed an experimental method to search for additional systems on the basis of three steps: (i) generate spatial bistability by operating autoactivated reactions in open spatial reactors; (ii) use an independent negative-feedback species to produce spatiotemporal oscillations; and (iii) induce a space-scale separation of the activatory and inhibitory processes with a low-mobility complexing agent. We successfully applied this method to a hydrogen-ion autoactivated reaction, the thiourea-iodate-sulfite (TuIS) reaction, and noticeably produced stationary hexagonal arrays of spots and parallel stripes of pH patterns attributed to a Turing bifurcation. This method could be extended to biochemical reactions.	[Horvath, Judit; De Kepper, Patrick] Univ Bordeaux, CNRS, Ctr Rech Paul Pascal, F-33600 Pessac, France; [Szalai, Istvan] Eotvos Lorand Univ, Inst Chem, Lab Nonlinear Chem Dynam, H-1518 Budapest 112, Hungary	Centre de Recherche Paul Pascal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Eotvos Lorand University; Hungarian Academy of Sciences	De Kepper, P (corresponding author), Univ Bordeaux, CNRS, Ctr Rech Paul Pascal, 115 Ave Schweitzer, F-33600 Pessac, France.	dekepper@crpp-bordeaux.cnrs.fr	Szalai, István/A-2837-2009; Horváth, Judit/K-3834-2017; Szalai, István/M-3083-2019	Szalai, István/0000-0002-1859-1043; Horváth, Judit/0000-0003-3799-1007; Szalai, István/0000-0002-1859-1043	French Agence National de la Recherche; French Hungarian Centre Nationale de la Recherche Scientifique Magyar Tudomanyos Akademia collaboration program [21420]; Hungarian funds Orszagos Tudomanyos Kutatasi Alapprogram [49666, 67701]; Bolyai Fellowship	French Agence National de la Recherche(French National Research Agency (ANR)); French Hungarian Centre Nationale de la Recherche Scientifique Magyar Tudomanyos Akademia collaboration program; Hungarian funds Orszagos Tudomanyos Kutatasi Alapprogram(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Fellowship(Hungarian Academy of Sciences)	We acknowledge the support from the French Agence National de la Recherche, the French Hungarian Centre Nationale de la Recherche Scientifique Magyar Tudomanyos Akademia collaboration program (21420), and the Hungarian funds Orszagos Tudomanyos Kutatasi Alapprogram (49666 and 67701). I.S. thanks the support of the Bolyai Fellowship. We thank J. Boissonade and P. Borckmans for fruitful discussions.	BENYAICH K, 2005, THESIS U LIBRE BRUXE; Blanchedeau P, 2000, PHYSICA D, V147, P283, DOI 10.1016/S0167-2789(00)00169-X; BOISSONADE J, 1980, J PHYS CHEM-US, V84, P501, DOI 10.1021/j100442a009; Boissonade J, 2001, FARADAY DISCUSS, V120, P353, DOI 10.1039/b103240m; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; De Wit A, 1999, ADV CHEM PHYS, V109, P435, DOI 10.1002/9780470141687.ch5; Epstein I.R., 1998, INTRO NONLINEAR CHEM; Epstein IR, 2005, CHAOS, V15, DOI 10.1063/1.2102447; FIELD RJ, 1972, J AM CHEM SOC, V94, P8649, DOI 10.1021/ja00780a001; Hagberg A, 1994, CHAOS, V4, P477, DOI 10.1063/1.166047; Horvath D, 1997, J CHEM SOC FARADAY T, V93, P4301, DOI 10.1039/a705895k; LEE KJ, 1993, SCIENCE, V261, P192, DOI 10.1126/science.261.5118.192; LENGYEL I, 1992, P NATL ACAD SCI USA, V89, P3977, DOI 10.1073/pnas.89.9.3977; Meinhardt H., 1982, MODELS BIOL PATTERN; Murray J. D., 2001, MATH BIOL, V18; Pearson JE, 1992, CHAOS, V2, DOI 10.1063/1.165893; RABAI G, 1987, REACT KINET CATAL L, V33, P23, DOI 10.1007/BF02066694; Rudovics B, 1999, J PHYS CHEM A, V103, P1790, DOI 10.1021/jp983210v; Strier DE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001053; Strier DE, 2005, J PHYS CHEM A, V109, P1357, DOI 10.1021/jp046138b; Szalai I, 2006, PHYS CHEM CHEM PHYS, V8, P1105, DOI 10.1039/b515620c; Szalai I, 2004, J PHYS CHEM A, V108, P5315, DOI 10.1021/jp049168n; Szalai I, 2008, CHAOS, V18, DOI 10.1063/1.2912719; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Viranyi Z, 2007, J PHYS CHEM A, V111, P8090, DOI 10.1021/jp0723721	25	155	155	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					772	775		10.1126/science.1169973	http://dx.doi.org/10.1126/science.1169973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423823				2022-12-28	WOS:000265832400042
J	Gabrielli, A; Avvedimento, EV; Krieg, T				Gabrielli, Armando; Avvedimento, Enrico V.; Krieg, Thomas			Mechanisms of Disease: Scleroderma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GROWTH-FACTOR-BETA; PROGRESSIVE SYSTEMIC-SCLEROSIS; ENDOTHELIAL PROGENITOR CELLS; OXYGEN SPECIES PRODUCTION; NADPH OXIDASE COMPLEX; REACTIVE OXYGEN; TGF-BETA; INCREASED EXPRESSION; UP-REGULATION; IN-VITRO		[Gabrielli, Armando] Univ Politecn Marche, Sect Clin Med, Dept Med Sci & Surg, Ancona, Italy; [Gabrielli, Armando] Osped Riuniti, Ancona, Italy; [Avvedimento, Enrico V.] Univ Naples Federico II, CNR, Inst Endocrinol & Expt Oncol, Dept Mol & Cellular Biol & Pathol, Naples, Italy; [Krieg, Thomas] Univ Cologne, Dept Dermatol, D-5000 Cologne, Germany	Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Cologne	Gabrielli, A (corresponding author), Univ Politecn Marche, Sect Clin Med, Dept Med Sci & Surg, Via Tronto 10, Ancona, Italy.	a.gabrielli@univpm.it	Gabrielli, Armando/AAC-3173-2019					Agarwal SK, 2008, RHEUM DIS CLIN N AM, V34, P17, DOI 10.1016/j.rdc.2007.10.001; Akhmetshina A, 2008, FASEB J, V22, P2214, DOI 10.1096/fj.07-105627; Allanore Y, 2007, CLIN EXP RHEUMATOL, V25, P60; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Avouac J, 2008, ANN RHEUM DIS, V67, P1455, DOI 10.1136/ard.2007.082131; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bellocq A, 1999, AM J RESP CELL MOL, V21, P128, DOI 10.1165/ajrcmb.21.1.3379; Brinckmann J, 2001, J INVEST DERMATOL, V117, P269, DOI 10.1046/j.0022-202x.2001.01414.x; Chifflot H, 2008, SEMIN ARTHRITIS RHEU, V37, P223, DOI 10.1016/j.semarthrit.2007.05.003; Cipriani P, 2007, ARTHRITIS RHEUM-US, V56, P1994, DOI 10.1002/art.22698; Cracowski JL, 2001, ARTHRITIS RHEUM-US, V44, P1143, DOI 10.1002/1529-0131(200105)44:5<1143::AID-ANR196>3.0.CO;2-#; Das R, 2007, FREE RADICAL BIO MED, V42, P541, DOI 10.1016/j.freeradbiomed.2006.11.020; Davies CA, 2006, HUM PATHOL, V37, P190, DOI 10.1016/j.humpath.2005.10.007; Derk CT, 2003, AUTOIMMUN REV, V2, P181, DOI 10.1016/S1568-9972(03)00005-3; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P4203, DOI 10.1002/art.23074; Distler O, 2004, CIRC RES, V95, P109, DOI 10.1161/01.RES.0000134644.89917.96; DUNCAN MR, 1991, J INVEST DERMATOL, V97, P686, DOI 10.1111/1523-1747.ep12483971; Eckes B, 1996, BIOCHEM J, V315, P549, DOI 10.1042/bj3150549; Englert H, 1999, AUST NZ J MED, V29, P36, DOI 10.1111/j.1445-5994.1999.tb01586.x; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; FLEISCHMAJER R, 1991, LAB INVEST, V64, P791; FLEISCHMAJER R, 1980, J AM ACAD DERMATOL, V2, P161, DOI 10.1016/S0190-9622(80)80396-3; FLEISCHMAJER R, 1977, ARCH DERMATOL, V113, P1661, DOI 10.1001/archderm.113.12.1661; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Gardner H, 1999, J CELL SCI, V112, P263; GAY S, 1989, J INVEST DERMATOL, V92, P301, DOI 10.1111/1523-1747.ep12276895; Gilliam Anita C., 2008, V10, P258, DOI 10.1159/000131502; Goyal P, 2004, FREE RADICAL BIO MED, V36, P1279, DOI 10.1016/j.freeradbiomed.2004.02.071; Haddad JJ, 2002, RESP RES, V3, DOI 10.1186/rr190; HARRISON NK, 1991, AM REV RESPIR DIS, V144, P706, DOI 10.1164/ajrccm/144.3_Pt_1.706; Hasegawa M, 1997, J RHEUMATOL, V24, P328; Hasegawa M, 1998, J RHEUMATOL, V25, P308; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; Hebbar M, 2000, ARTHRITIS RHEUM-US, V43, P889, DOI 10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5; Helmbold P, 2004, J CUTAN PATHOL, V31, P431, DOI 10.1111/j.0303-6987.2004.00203.x; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Holland JA, 1998, ENDOTHELIUM-NEW YORK, V6, P113, DOI 10.3109/10623329809072198; HOSKINS LC, 1962, AM J MED, V33, P459, DOI 10.1016/0002-9343(62)90241-3; Hunzelmann N, 2008, RHEUMATOLOGY, V47, P1185, DOI 10.1093/rheumatology/ken179; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Indolfi C, 1996, NAT MED, V2, P634, DOI 10.1038/nm0696-634; IVARSSON M, 1993, J INVEST DERMATOL, V101, P216, DOI 10.1111/1523-1747.ep12364810; Kahaleh B, 2008, RHEUM DIS CLIN N AM, V34, P57, DOI 10.1016/j.rdc.2007.12.004; Kawakami T, 1998, J INVEST DERMATOL, V110, P47, DOI 10.1046/j.1523-1747.1998.00073.x; Kim YK, 2006, CELL SIGNAL, V18, P236, DOI 10.1016/j.cellsig.2005.04.008; KLARESKOG L, 1990, ARTHRITIS RHEUM, V33, P1534, DOI 10.1002/art.1780331011; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Kuwana M, 2004, LANCET, V364, P603, DOI 10.1016/S0140-6736(04)16853-0; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; LEROY EC, 1988, J RHEUMATOL, V15, P202; LEROY EC, 1974, J CLIN INVEST, V54, P880, DOI 10.1172/JCI107827; Loubiere LS, 2005, RHEUMATOLOGY, V44, P318, DOI 10.1093/rheumatology/keh489; Magro L, 2008, BONE MARROW TRANSPL, V42, P757, DOI 10.1038/bmt.2008.252; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marshall C, 1996, AM J RESP CELL MOL, V15, P633, DOI 10.1165/ajrcmb.15.5.8918370; Mavilia C, 1997, AM J PATHOL, V151, P1751; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; MEDSGER TA, 1997, ARTHRITIS ALLIED CON, P1433; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Meyer OC, 2007, J RHEUMATOL, V34, P104; Mikko M, 2008, CLIN EXP IMMUNOL, V151, P317, DOI 10.1111/j.1365-2249.2007.03565.x; Mimura Y, 2005, AM J PATHOL, V166, P1451, DOI 10.1016/S0002-9440(10)62362-0; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Nietert PJ, 2000, CURR OPIN RHEUMATOL, V12, P520, DOI 10.1097/00002281-200011000-00008; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; PERLISH JS, 1988, J INVEST DERMATOL, V90, P48, DOI 10.1111/1523-1747.ep12462561; PRESCOTT RJ, 1992, J PATHOL, V166, P255, DOI 10.1002/path.1711660307; Rajkumar VS, 2005, ARTHRITIS RES THER, V7, pR1113, DOI 10.1186/ar1790; Rajkumar VS, 1999, ARTHRITIS RHEUM-US, V42, P930, DOI 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1; Reveille John D, 2003, Curr Rheumatol Rep, V5, P160, DOI 10.1007/s11926-003-0045-1; Rosenbloom J, 2000, ARTHRITIS RHEUM-US, V43, P1624, DOI 10.1002/1529-0131(200007)43:7<1624::AID-ANR28>3.3.CO;2-5; ROUMM AD, 1984, ARTHRITIS RHEUM, V27, P645, DOI 10.1002/art.1780270607; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Sakkas LI, 2002, J IMMUNOL, V168, P3649, DOI 10.4049/jimmunol.168.7.3649; Sambo P, 2001, ARTHRITIS RHEUM-US, V44, P2653, DOI 10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1; Sambo P, 1999, J INVEST DERMATOL, V112, P78, DOI 10.1046/j.1523-1747.1999.00476.x; Scheja A, 2000, RHEUMATOLOGY, V39, P1110, DOI 10.1093/rheumatology/39.10.1110; Seru R, 2004, J NEUROCHEM, V91, P613, DOI 10.1111/j.1471-4159.2004.02754.x; Servettaz A, 2007, ANN RHEUM DIS, V66, P1202, DOI 10.1136/ard.2006.067504; Sgonc R, 1996, J CLIN INVEST, V98, P785, DOI 10.1172/JCI118851; Shephard P, 2004, THROMB HAEMOSTASIS, V92, P262, DOI 10.1160/TH03-11-0669; SILVERSTEIN JL, 1988, ARCH DERMATOL, V124, P1379, DOI 10.1001/archderm.124.9.1379; SNAPPER CM, 1993, J IMMUNOL, V151, P4625; Sondergaard K, 1998, BRIT J RHEUMATOL, V37, P304; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; Stellos K, 2008, PHARMACOL REP, V60, P101; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Sullivan DE, 2008, J IMMUNOTOXICOL, V5, P145, DOI 10.1080/15476910802085822; Sundberg C, 1996, LAB INVEST, V74, P452; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga JA, 2008, RHEUM DIS CLIN N AM, V34, P115, DOI 10.1016/j.rdc.2007.11.002; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; YAMAKAGE A, 1992, J EXP MED, V175, P1227, DOI 10.1084/jem.175.5.1227	103	1071	1108	0	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1989	2003		10.1056/NEJMra0806188	http://dx.doi.org/10.1056/NEJMra0806188			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420368				2022-12-28	WOS:000265784400009
J	Greenlee, M; Wingo, CS; McDonough, AA; Youn, JH; Kone, BC				Greenlee, Megan; Wingo, Charles S.; McDonough, Alicia A.; Youn, Jang-Hyun; Kone, Bruce C.			Narrative Review: Evolving Concepts in Potassium Homeostasis and Hypokalemia	ANNALS OF INTERNAL MEDICINE			English	Review							CORTICAL COLLECTING DUCT; RENAL EXCRETION; ORAL POTASSIUM; BLOOD-PRESSURE; K RESTRICTION; RAT-KIDNEY; PLASMA K+; INSULIN; ALDOSTERONE; CHANNEL	Humans are intermittently exposed to large variations in potassium intake, which range from periods of fasting to ingestion of potassium-rich meals. These fluctuations would abruptly alter plasma potassium concentration if not for rapid mechanisms, primarily in skeletal muscle and the liver, that buffer the changes in plasma potassium concentration by means of transcellular potassium redistribution and feedback control of renal potassium excretion. However, buffers have capacity limits, and even robust feedback control mechanisms require that the perturbation occur before feedback can initiate corrective action. In contrast, feedforward control mechanisms sense the effect of disturbances on the system's homeostasis. This review highlights recent experimental insights into the participation of feedback and feedforward control mechanisms in potassium homeostasis. New data make clear that feedforward homeostatic responses activate when decreased potassium intake is sensed, even when plasma potassium concentration is still within the normal range and before frank hypokalemia ensues, in addition to the classic feedback activation of renal potassium conservation when plasma potassium concentration decreases. Given the clinical importance of dyskalemias in patients, these novel experimental paradigms invite renewed clinical inquiry into this important area.	[Kone, Bruce C.] Univ Florida, Coll Med, Gainesville, FL 32610 USA; Dept Vet Affairs Med Ctr, Gainesville, FL USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	State University System of Florida; University of Florida; University of Southern California	Kone, BC (corresponding author), Univ Florida, Coll Med, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	bkone@ufl.edu		Mitzelfelt, Megan/0000-0002-6578-3670	National Institutes of Health [R01 DK47981, R01 DK075065, R01 DK49750]; Department of Veterans Affairs [R01 DK34316, R21 DK080233]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034316, R01DK049750, R01DK047981, R01DK057678, R21DK080233, R01DK075065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By National Institutes of Health grants R01 DK47981 and R01 DK075065 (Dr. Kone), R01 DK49750 and the Department of Veterans Affairs (Dr. Wingo), R01 DK34316 (Dr. McDonough), and R21 DK080233 (Dr. Youn).	Babilonia E, 2007, J AM SOC NEPHROL, V18, P2037, DOI 10.1681/ASN.2006121333; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; CALO L, 1995, NEPHRON, V69, P253, DOI 10.1159/000188466; CAMPEN TJ, 1983, PFLUG ARCH EUR J PHY, V399, P93, DOI 10.1007/BF00663903; Chen P, 2006, AM J PHYSIOL-CELL PH, V290, pC1355, DOI 10.1152/ajpcell.00501.2005; DEFRONZO RA, 1980, AM J PHYSIOL, V238, pE421, DOI 10.1152/ajpendo.1980.238.5.E421; ELLIOTT P, 1989, J HUM HYPERTENS, V3, P323; FIELD MJ, 1984, J CLIN INVEST, V74, P1792, DOI 10.1172/JCI111598; Gennari FJ, 1998, NEW ENGL J MED, V339, P451, DOI 10.1056/NEJM199808133390707; Gheeraert PJ, 2006, EUR HEART J, V27, P2499, DOI 10.1093/eurheartj/ehl218; Giebisch G, 2007, KIDNEY INT, V72, P397, DOI 10.1038/sj.ki.5002288; Grundy D, 2005, J PEDIATR GASTR NUTR, V41, pS7, DOI 10.1097/01.scs.0000180286.58988.cf; Hevener AL, 2001, DIABETES, V50, P399, DOI 10.2337/diabetes.50.2.399; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Khosla N, 2006, SEMIN NEPHROL, V26, P434, DOI 10.1016/j.semnephrol.2006.10.004; KONE BC, 2002, ACID BASE ELECT DISO, P381; KRISHNA GG, 1991, ANN INTERN MED, V115, P77, DOI 10.7326/0003-4819-115-2-77; Lee FN, 2007, AM J PHYSIOL-RENAL, V293, pF541, DOI 10.1152/ajprenal.00427.2006; McDonough AA, 2005, SEMIN NEPHROL, V25, P335, DOI 10.1016/j.semnephrol.2005.03.009; McDonough AA, 2002, AM J PHYSIOL-RENAL, V282, pF967, DOI 10.1152/ajprenal.00360.2001; Meyer JW, 2002, AM J PHYSIOL-HEART C, V283, pH1846, DOI 10.1152/ajpheart.00083.2002; Morita H, 2000, AM J PHYSIOL-REG I, V278, pR1134, DOI 10.1152/ajpregu.2000.278.5.R1134; Pavlov I.P., 1927, CONDITIONED REFLEXES; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; RABINOWITZ L, 1977, AM J PHYSIOL, V233, pF213, DOI 10.1152/ajprenal.1977.233.3.F213; RABINOWITZ L, 1988, AM J PHYSIOL, V254, pR357, DOI 10.1152/ajpregu.1988.254.2.R357; Reungjui S, 2008, J AM SOC NEPHROL, V19, P125, DOI 10.1681/ASN.2007030261; Riggs JE, 2002, NEUROL CLIN, V20, P227, DOI 10.1016/S0733-8619(03)00060-4; Sansom SC, 2007, KIDNEY INT, V72, P529, DOI 10.1038/sj.ki.5002438; Schnermann J, 2008, KIDNEY INT, V74, P418, DOI 10.1038/ki.2008.145; STANTON B, 1987, J CLIN INVEST, V79, P198, DOI 10.1172/JCI112783; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsuchiya Y, 2004, AM J PHYSIOL-REG I, V286, pR591, DOI 10.1152/ajpregu.00559.2003; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Wall SM, 2006, AM J PHYSIOL-RENAL, V290, pF409, DOI 10.1152/ajprenal.00309.2005; Wang WH, 2004, ANNU REV PHYSIOL, V66, P547, DOI 10.1146/annurev.physiol.66.032102.112025; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; Zhang Y, 2008, AM J PHYSIOL-CELL PH, V294, pC765, DOI 10.1152/ajpcell.00528.2007; Zheng D, 2008, AM J PHYSIOL-CELL PH, V294, pC126, DOI 10.1152/ajpcell.00464.2007; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa	41	53	54	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					619	U9		10.7326/0003-4819-150-9-200905050-00008	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414841	Green Accepted			2022-12-28	WOS:000265903800006
J	Kiser, AK; Pronovost, PJ				Kiser, Ava K.; Pronovost, Peter J.			Management of Diseases Without Current Treatment Options Something Can Be Done	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESPIRATORY-DISTRESS-SYNDROME; RETINITIS-PIGMENTOSA; SURVIVORS		[Kiser, Ava K.] Johns Hopkins Univ, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kiser, AK (corresponding author), 550 N Broadway,6th Floor, Baltimore, MD 21205 USA.	abittne1@jhmi.edu	Bittner, Ava/AAK-8778-2021	Bittner, Ava/0000-0002-9498-2230	NEI NIH HHS [K23 EY018356-02, K23 EY018356] Funding Source: Medline; NINR NIH HHS [P30 NR008995-05, P30 NR008995] Funding Source: Medline; NATIONAL EYE INSTITUTE [K23EY018356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P30NR008995] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Kiser AK, 2008, CLIN EXP OPTOM, V91, P166, DOI 10.1111/j.1444-0938.2007.00224.x; Ormel J, 1997, PSYCHOL MED, V27, P1065, DOI 10.1017/S0033291797005321; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	10	4	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1708	1709		10.1001/jama.2009.506	http://dx.doi.org/10.1001/jama.2009.506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435NN	19383962	Green Accepted			2022-12-28	WOS:000265350700027
J	McWilliams, JM; Meara, E; Zaslavsky, AM; Ayanian, JZ				McWilliams, J. Michael; Meara, Ellen; Zaslavsky, Alan M.; Ayanian, John Z.			Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U. S. Trends From 1999 to 2006 and Effects of Medicare Coverage	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; NUTRITION EXAMINATION SURVEY; ACUTE MYOCARDIAL-INFARCTION; PAY-FOR-PERFORMANCE; RACIAL DISPARITIES; NATIONAL-HEALTH; HYPERTENSION PREVALENCE; UNINSURED ADULTS; UNITED-STATES; US ADULTS	Background: Efforts to improve the care of cardiovascular disease and diabetes or expand insurance coverage for adults with these conditions may reduce differences in clinical outcomes. Objective: To assess recent national trends in disease control, trends in sociodemographic differences in control, and changes in sociodemographic differences after age 65 years associated with near-universal Medicare coverage. Design: Observational and quasi-experimental analyses of repeated cross-sectional data. Setting: National Health and Nutrition Examination Survey, 1999 to 2006. Participants: Adults age 40 to 85 years with relevant clinical conditions. Measurements: Blood pressure control (< 140/90 mm Hg) and mean systolic blood pressure among adults with hypertension (n = 4521); glycemic control (hemoglobin A(1c) levels < 7.0%) and mean hemoglobin A1c levels among those with diabetes (n = 1733); and total cholesterol level control (< 5.2 mmol/L [< 200 mg/dL]) and mean total cholesterol levels among those with coronary heart disease, stroke, or diabetes (n = 2928). Temporal trends in these measures were compared by race, ethnicity, and education, and sociodemographic differences were compared above and below eligibility for Medicare at age 65 years. Results: Disease control improved significantly between 1999 and 2006 for all 6 measures ( P < 0.001). These trends did not differ by race or ethnicity or by education ( P >= 0.185 for group-time interactions), except that white-Hispanic differences in glycemic control widened (P = 0.042). Black-white differences in systolic blood pressure were smaller among adults age 65 to 85 years than among adults age 40 to 64 years (reduction in difference, 4.2 mm Hg; P = 0.009). Black-white differences in hemoglobin A(1c) levels were also smaller after age 65 years (reduction in difference, 0.7%; P = 0.005), as were Hispanic-white differences (reduction in difference, 0.7%; P = 0.007) and differences between less and more educated adults (reduction in difference, 0.5%; P = 0.033). Limitation: Data were cross-sectional, and estimates may have been biased by coincidental events at age 65 years, such as retirement, that may affect disease control. Conclusion: Control of blood pressure and glucose and cholesterol levels has improved since 1999 for adults with cardiovascular disease and diabetes, but racial, ethnic, or socioeconomic differences have not narrowed significantly. Medicare coverage after age 65 years is associated with reductions in these differences.	[McWilliams, J. Michael; Meara, Ellen; Zaslavsky, Alan M.; Ayanian, John Z.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; National Bureau of Economic Research	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu		Meara, Ellen/0000-0003-0211-1970	Commonwealth Fund [20060485]	Commonwealth Fund	By The Commonwealth Fund (grant no. 20060485).	ABRAIDOLANZA AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI DOI 10.2105/AJPH.89.10.1543; Anderson GF, 2005, NEW ENGL J MED, V353, P305, DOI 10.1056/NEJMsb044133; Andrulis DP, 1998, ANN INTERN MED, V129, P412, DOI 10.7326/0003-4819-129-5-199809010-00012; [Anonymous], 2004, 10365 NBER; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Blumenthal D, 2007, NEW ENGL J MED, V356, P2527, DOI 10.1056/NEJMhpr066212; Blustein J, 2008, JAMA-J AM MED ASSOC, V299, P814, DOI 10.1001/jama.299.7.814; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CARD D, 2007, 3668 NAT BUR EC RES; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Chaturvedi N, 1997, LANCET, V349, P1787, DOI 10.1016/S0140-6736(96)10244-0; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2003, LANCET, V361, P2005; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Decker SL, 2005, J HUM RESOUR, V40, P948, DOI 10.3368/jhr.XL.4.948; FIHN SD, 1988, J GEN INTERN MED, V3, P356, DOI 10.1007/BF02595794; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Fiscella K, 2008, ANN FAM MED, V6, P497, DOI 10.1370/afm.873; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Friedberg MW, 2007, J GEN INTERN MED, V22, P1385, DOI 10.1007/s11606-007-0234-0; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; *I MED, 2002, UN TREATM CONFR RAC; *I MED, 2004, INS AM HLTH PRINC R; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2001, COV MATT INS HLTH CA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; KEELER EB, 1985, JAMA-J AM MED ASSOC, V254, P1926; Landon BE, 2008, MED CARE RES REV, V65, P167, DOI 10.1177/1077558707310208; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; Ma J, 2005, ARCH INTERN MED, V165, P1354, DOI 10.1001/archinte.165.12.1354; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McGuire TG, 2006, HEALTH SERV RES, V41, P1979, DOI 10.1111/j.1475-6773.2006.00583.x; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Mehrotra A, 2006, ANN INTERN MED, V145, P826, DOI 10.7326/0003-4819-145-11-200612050-00007; *NAT CTR HLTH STAT, 2007, DHHS PUBL; *NCHS, 2003, NAT HLTH NUTR EX SUR; [NCHS] National Center for Health Statistics, 1999, NAT HLTH NUTR EX SUR; *NHANES, 2006, AN REP GUID 2006; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Sequist TD, 2006, ARCH INTERN MED, V166, P675, DOI 10.1001/archinte.166.6.675; Simantov E, 2001, HEALTH AFFAIR, V20, P139, DOI 10.1377/hlthaff.20.4.139; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US PREV SERV TASK, 2007, AHRQ PUBL; Vargas CM, 1997, PREV MED, V26, P678, DOI 10.1006/pmed.1997.0190; Wennberg JE, 2007, HEALTH AFFAIR, V26, P1575, DOI 10.1377/hlthaff.26.6.1575; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yusuf S, 2000, NEW ENGL J MED, V342, P145	79	263	264	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					505	W90		10.7326/0003-4819-150-8-200904210-00005	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437AD	19380852				2022-12-28	WOS:000265457000001
J	Narimatsu, M; Bose, R; Pye, M; Zhang, L; Miller, B; Ching, P; Sakuma, R; Luga, V; Roncari, L; Attisano, L; Wrana, JL				Narimatsu, Masahiro; Bose, Rohit; Pye, Melanie; Zhang, Liang; Miller, Bryan; Ching, Peter; Sakuma, Rui; Luga, Valbona; Roncari, Luba; Attisano, Liliana; Wrana, Jeffrey L.			Regulation of Planar Cell Polarity by Smurf Ubiquitin Ligases	CELL			English	Article							NEURAL-TUBE DEFECTS; INNER-EAR; HAIR-CELLS; LOOP-TAIL; SIGNALING SPECIFICITY; CONVERGENT EXTENSION; STRABISMUS/VAN-GOGH; FLOOR PLATE; PCP PATHWAY; DROSOPHILA	Planar cell polarity (PCP) is critical for morphogenesis in metazoans. PCP in vertebrates regulates stereocilia alignment in neurosensory cells of the cochlea and closure of the neural tube through convergence and extension movements (CE). Noncanonical Wnt morphogens regulate PCP and CE in vertebrates, but the molecular mechanisms remain unclear. Smurfs are ubiquitin ligases that regulate signaling, cell polarity and motility through spatiotemporally restricted ubiquitination of diverse substrates. Here, we report an unexpected role for Smurfs in controlling PCP and CE. Mice mutant for Smurf1 and Smurf2 display PCP defects in the cochlea and CE defects that include a failure to close the neural tube. Further, we show that Smurfs engage in a non-canonical Wnt signaling pathway that targets the core PCP protein Prickle1 for ubiquitin-mediated degradation. Our work thus uncovers ubiquitin ligases in a mechanistic link between noncanonical Wnt signaling and PCP/CE.	[Miller, Bryan; Ching, Peter; Attisano, Liliana] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Bose, Rohit; Luga, Valbona; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Miller, Bryan; Ching, Peter; Attisano, Liliana] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Narimatsu, Masahiro; Bose, Rohit; Pye, Melanie; Zhang, Liang; Sakuma, Rui; Luga, Valbona; Roncari, Luba; Wrana, Jeffrey L.] Mt Sinai Hosp, Ctr Syst Biol, Samuel Lunenfeld Res Inst, Toronto, ON M5S 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Attisano, L (corresponding author), Univ Toronto, Dept Biochem, 160 Coll St, Toronto, ON M5S 3E1, Canada.	liliana.attisano@utoronto.ca; wrana@mshri.on.ca	Bose, Rohit/O-9825-2018; Wrana, Jeffrey/F-8857-2013	Bose, Rohit/0000-0002-6785-0697; ZHANG, Liang/0000-0003-3100-8593	Canadian Institutes of Health Research (CIHR) [77690, 74692, 12860]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank Dr. W. Rod Hardy and the ES and transgenic core facilities at Samuel Lunenfeld Research Institute/Toronto Centre for Phenogenomics for supporting generation of ES clones and diploid/tetraploid chimeras. We thank Siyuan Song for technical assistance, Dr. H. McNeill and the members of Drs. Wrana's and Attisano's labs for helpful comments and discussion. This work was supported by grants to L.A. (#77690) and J.L.W. (#74692, #12860) from the Canadian Institutes of Health Research (CIHR). L.A. and J.L.W. hold Canadian Research Chairs, and J.L.W. is an International Scholar of the Howard Hughes Medical Institute.	Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jiang D, 2005, CURR BIOL, V15, P79; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lewis J, 2002, J NEUROBIOL, V53, P190, DOI 10.1002/neu.10124; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Penton A, 2002, GENETICS, V161, P747; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wu J, 2008, MECH DEVELOP, V125, P30, DOI 10.1016/j.mod.2007.10.006; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P3203, DOI 10.1242/dev.008177; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	45	249	255	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					295	307		10.1016/j.cell.2009.02.025	http://dx.doi.org/10.1016/j.cell.2009.02.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379695	Bronze			2022-12-28	WOS:000265456800022
J	Kendall, T; McGoey, L; Jackson, E				Kendall, Tim; McGoey, Linsey; Jackson, Emily			If NICE was in the USA	LANCET			English	Editorial Material									[Kendall, Tim] Natl Collaborating Ctr Mental Hlth, London, England; [Kendall, Tim] Royal Coll Psychiatrists, Res Unit, London SW1X 8PG, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [McGoey, Linsey] Univ Oxford, Inst Sci Innovat & Soc, Said Business Sch, Oxford, England; [Jackson, Emily] London Sch Econ, London WC2A 2AE, England	University of London; University College London; University of Oxford; University of London; London School Economics & Political Science	Kendall, T (corresponding author), Natl Collaborating Ctr Mental Hlth, London, England.	tim.kendall@shsc.nhs.uk		Jackson, Emily/0000-0002-2052-2776; McGoey, Linsey/0000-0002-4404-2574				GODLEE F, 2009, BRIT MED J, V338, P344; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kondro W, 2004, CAN MED ASSOC J, V170, P783, DOI 10.1503/cmaj.1040213; Littlejohns P, 2009, LANCET ONCOL, V10, P417, DOI 10.1016/S1470-2045(09)70077-4; McGoey L, 2009, J MED ETHICS, V35, P107, DOI 10.1136/jme.2008.025361; MHRA, 2003, SEL SER REUPT INH SS; N ational Institute for Health and Clinical Excellence, 2005, DEPR CHILDR YOUNG PE; *NIH CLIN EXC, 2004, DEPR MAN DEPR PRIM S; Rawlins MD, 2009, LANCET, V374, P351, DOI 10.1016/S0140-6736(09)60616-4; Sainsbury R, 2009, LANCET ONCOL, V10, P315, DOI 10.1016/S1470-2045(09)70080-4; Strahlman E, 2009, LANCET, V373, P1319, DOI 10.1016/S0140-6736(09)60613-9; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	13	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					272	273		10.1016/S0140-6736(09)60781-9	http://dx.doi.org/10.1016/S0140-6736(09)60781-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19394077				2022-12-28	WOS:000268508200007
J	Santolik, O; Chum, J				Santolik, Ondrej; Chum, Jaroslav			The Origin of Plasmaspheric Hiss	SCIENCE			English	Editorial Material							RADIATION; WHISTLERS; CHORUS		[Santolik, Ondrej; Chum, Jaroslav] Inst Atmospher Phys, Prague, Czech Republic; [Santolik, Ondrej] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic	Czech Academy of Sciences; Institute of Atmospheric Physics of the Czech Academy of Sciences; Charles University Prague	Santolik, O (corresponding author), Inst Atmospher Phys, Prague, Czech Republic.	ondrej.santolik@mff.cuni.cz	Santolik, Ondrej/F-7766-2014; Chum, Jaroslav/G-9514-2014	Santolik, Ondrej/0000-0002-4891-9273; Chum, Jaroslav/0000-0002-0486-0679				Abel B, 1998, J GEOPHYS RES-SPACE, V103, P2385, DOI 10.1029/97JA02919; Andronov A.A., 1964, GEOMAGN AERONOMY+, V4, P233; Bortnik J, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009316; Bortnik J, 2009, SCIENCE, V324, P775, DOI 10.1126/science.1171273; Bortnik J, 2008, NATURE, V452, P62, DOI 10.1038/nature06741; Chum J, 2005, ANN GEOPHYS-GERMANY, V23, P3727, DOI 10.5194/angeo-23-3727-2005; CHURCH SR, 1983, J GEOPHYS RES-SPACE, V88, P7941, DOI 10.1029/JA088iA10p07941; DRAGANOV AB, 1992, GEOPHYS RES LETT, V19, P233, DOI 10.1029/91GL03167; *GACR, GACR205091253; Green JL, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010495; Horne RB, 2005, NATURE, V437, P227, DOI 10.1038/nature03939; KENNEL CF, 1966, J GEOPHYS RES, V71, P1, DOI 10.1029/JZ071i001p00001; Meredith NP, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011707; STOREY LRO, 1953, PHILOS T R SOC S-A, V246, P113, DOI 10.1098/rsta.1953.0011; VANALLEN JA, 1959, J GEOPHYS RES, V64, P1683, DOI 10.1029/JZ064i011p01683	15	19	19	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					729	730		10.1126/science.1172878	http://dx.doi.org/10.1126/science.1172878			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423805				2022-12-28	WOS:000265832400024
J	Malone, CD; Brennecke, J; Dus, M; Stark, A; McCombie, WR; Sachidanandam, R; Hannon, GJ				Malone, Colin D.; Brennecke, Julius; Dus, Monica; Stark, Alexander; McCombie, W. Richard; Sachidanandam, Ravi; Hannon, Gregory J.			Specialized piRNA Pathways Act in Germline and Somatic Tissues of the Drosophila Ovary	CELL			English	Article							GYPSY ENDOGENOUS RETROVIRUS; SELFISH GENETIC ELEMENTS; MELANOGASTER GERMLINE; INFECTIOUS RETROVIRUS; TRANSPOSABLE ELEMENTS; CELL MAINTENANCE; FEMALE GERMLINE; POLAR GRANULES; STEM-CELLS; PIWI	In Drosophila gonads, Piwi proteins and associated piRNAs collaborate with additional factors to form a small RNA-based immune system that silences mobile elements. Here, we analyzed nine Drosophila piRNA pathway mutants for their impacts on both small RNA populations and the subcellular localization patterns of Piwi proteins. We find that distinct piRNA pathways with differing components function in ovarian germ and somatic cells. In the soma, Piwi acts singularly with the conserved flamenco piRNA cluster to enforce silencing of retroviral elements that may propagate by infecting neighboring germ cells. In the germline, silencing programs encoded within piRNA clusters are optimized via a slicer-dependent amplification loop to suppress a broad spectrum of elements. The classes of transposons targeted by germline and somatic piRNA clusters, though not the precise elements, are conserved among Drosophilids, demonstrating that the architecture of piRNA clusters has coevolved with the transposons that they are tasked to control.	[Malone, Colin D.; Brennecke, Julius; Dus, Monica; McCombie, W. Richard; Sachidanandam, Ravi; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Malone, Colin D.; Brennecke, Julius; Dus, Monica; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] Harvard Univ, Cambridge, MA 02141 USA; [Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Stark, Alexander/D-1473-2012; Brennecke, Julius/T-5883-2019; Hannon, Gregory/AAB-3568-2019; sachidanandam, ravi/Q-6916-2019; Brennecke, Julius/C-1626-2015	Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; sachidanandam, ravi/0000-0001-9844-4459; Brennecke, Julius/0000-0002-5141-0814; McCombie, W. Richard/0000-0003-1899-0682	Watson School of Biological Sciences; National Science Foundation Graduate Research Fellowship; Ernst Schering foundation; Human Frontier Science Program; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ernst Schering foundation; Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Hannon laboratory for helpful discussions and Oliver Tam for computational assistance. We are grateful to Michelle Rooks, Emily Hodges, Danea Rebolini, Laura Cardone, and Mike Regulski ( Cold Spring Harbor Laboratory) for help with deep sequencing. We also thank Attilio Pane and Trudi Schupbach for providing the zuc and squ fly stocks. C. D. M. is a Beckman fellow of the Watson School of Biological Sciences and is supported by a National Science Foundation Graduate Research Fellowship. J.B. is supported by a fellowship from the Ernst Schering foundation. M. D. is an Engelhorn fellow of the Watson School of Biological Sciences. A. S. is supported by a Human Frontier Science Program postdoctoral fellowship. This work was supported in part from grants from the National Institutes of Health to G.J.H. and W.R.M. and a kind gift from Kathryn W. Davis ( G.J.H.).	ALMUKHTAR KA, 1971, J EMBRYOL EXP MORPH, V26, P195; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Barbosa V, 2007, GENETICS, V176, P1967, DOI 10.1534/genetics.106.069575; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chalvet F, 1999, EMBO J, V18, P2659, DOI 10.1093/emboj/18.9.2659; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Desset S, 2003, GENETICS, V164, P501; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; KIM A, 1994, P NATL ACAD SCI USA, V91, P1285, DOI 10.1073/pnas.91.4.1285; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Lecher P, 1997, J GEN VIROL, V78, P2379; LI C, 2009, CELL IN PRESS, V137, DOI DOI 10.1016/J.CELL.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Lin HF, 1997, DEVELOPMENT, V124, P2463; LUNING KG, 1981, HEREDITAS, V95, P181; MAHOWALD AP, 1968, J EXP ZOOL, V167, P237, DOI 10.1002/jez.1401670211; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Murchison EP, 2008, GENOME RES, V18, P995, DOI 10.1101/gr.073056.107; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pelisson A, 2007, MOL BIOL EVOL, V24, P498, DOI 10.1093/molbev/msl176; PRUDHOMME N, 1995, GENETICS, V139, P697; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; SCHUPBACH T, 1991, GENETICS, V129, P1119; Shpiz S, 2007, MOL BIOL EVOL, V24, P2535, DOI 10.1093/molbev/msm205; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; Song SU, 1997, DEVELOPMENT, V124, P2789; SONG SU, 1994, GENE DEV, V8, P2046, DOI 10.1101/gad.8.17.2046; SPRADLING AC, 1993, CELL, V72, P649, DOI 10.1016/0092-8674(93)90393-5; Styhler S, 1998, DEVELOPMENT, V125, P1569; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vagin Vasily V, 2004, RNA Biol, V1, P54; WilschBrauninger M, 1997, J CELL BIOL, V139, P817, DOI 10.1083/jcb.139.3.817; Wilson JE, 1996, DEVELOPMENT, V122, P1631	58	594	613	4	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					522	535		10.1016/j.cell.2009.03.040	http://dx.doi.org/10.1016/j.cell.2009.03.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19395010	Bronze, Green Accepted			2022-12-28	WOS:000265677200021
J	Tirosh, I; Reikhav, S; Levy, AA; Barkai, N				Tirosh, Itay; Reikhav, Sharon; Levy, Avraham A.; Barkai, Naama			A Yeast Hybrid Provides Insight into the Evolution of Gene Expression Regulation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; DROSOPHILA; PATTERNS; CIS	During evolution, novel phenotypes emerge through changes in gene expression, but the genetic basis is poorly understood. We compared the allele-specific expression of two yeast species and their hybrid, which allowed us to distinguish changes in regulatory sequences of the gene itself (cis) from changes in upstream regulatory factors (trans). Expression divergence between species was generally due to changes in cis. Divergence in trans reflected a differential response to the environment and explained the tendency of certain genes to diverge rapidly. Hybrid-specific expression, deviating from the parental range, occurred through novel cis-trans interactions or, more often, through modified trans regulation associated with environmental sensing. These results provide insights on the regulatory changes in cis and trans during the divergence of species and upon hybridization.	[Reikhav, Sharon; Levy, Avraham A.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Tirosh, Itay; Reikhav, Sharon; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Levy, AA (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	avi.levy@weizmann.ac.il; naama.barkai@weizmann.ac.il			Helen and Martin Kimmel Award for Innovative Investigations; Kahn Fund for Systems Biology at the Weizmann Institute of Science; Israeli Ministry of Science; Bi-national Science Foundation; European Research Council	Helen and Martin Kimmel Award for Innovative Investigations; Kahn Fund for Systems Biology at the Weizmann Institute of Science; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Bi-national Science Foundation(US-Israel Binational Science Foundation); European Research Council(European Research Council (ERC)European Commission)	We thank J. Berman, Y. Eshed, N. Sigal, A. Sheperberg, and members of our groups for discussions and comments. This work was supported by the Helen and Martin Kimmel Award for Innovative Investigations and grants from the Kahn Fund for Systems Biology at the Weizmann Institute of Science, the Israeli Ministry of Science, the Bi-national Science Foundation, and the European Research Council (Ideas) (to N.B). A.A.L. holds the Gilbert de Botton chair of Plant Science. Microarray data has been deposited at the Gene Expression Omnibus with accession number GSE14708 [NCBI GEO] .	Brown KM, 2008, MOL ECOL, V17, P2985, DOI 10.1111/j.1365-294X.2008.03765.x; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Landry CR, 2007, HEREDITY, V99, P483, DOI 10.1038/sj.hdy.6801045; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Springer NM, 2007, PLANT CELL, V19, P2391, DOI 10.1105/tpc.107.052258; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Wang DY, 2007, GENOME RES, V17, P1161, DOI 10.1101/gr.6328907; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	18	275	276	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					659	662		10.1126/science.1169766	http://dx.doi.org/10.1126/science.1169766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407207				2022-12-28	WOS:000265608800050
J	Athappan, G; Ariyamuthu, VK				Athappan, Ganesh; Ariyamuthu, Venkatesh Kumar			Chvostek's Sign and Carpopedal Spasm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Athappan, Ganesh] Tufts Sch Med, Caritas St Elizabeths Med Ctr, Boston, MA 02135 USA; [Ariyamuthu, Venkatesh Kumar] Madras Med Coll & Govt Gen Hosp, Madras 600020, Tamil Nadu, India	St. Elizabeth's Medical Center; Madras Medical College & General Hospital	Athappan, G (corresponding author), Tufts Sch Med, Caritas St Elizabeths Med Ctr, Boston, MA 02135 USA.	ganeshathappan@gmail.com	ARIYAMUTHU, VENKATESH KUMAR/AAF-2955-2021; Ariyamuthu, Venkatesh/AAC-6449-2021; Ariyamuthu, Venkatesh Kumar/W-5290-2019						0	4	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					E24	E24		10.1056/NEJMicm074227	http://dx.doi.org/10.1056/NEJMicm074227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403899				2022-12-28	WOS:000265560300011
J	Ford, N; Mills, E; Calmy, A				Ford, Nathan; Mills, Edward; Calmy, Alexandra			GLOBAL HEALTH Rationing Antiretroviral Therapy in Africa - Treating Too Few, Too Late	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUB-SAHARAN AFRICA		[Ford, Nathan] MSF, Med Unit, Cape Town, South Africa; [Ford, Nathan] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Mills, Edward] Univ Ottawa, Canada Res Chair Global Hlth, Ottawa, ON, Canada; [Calmy, Alexandra] Univ Hosp Geneva, Infect Dis Serv, HIV Unit, Geneva, Switzerland; [Calmy, Alexandra] MSF Int, MSF Access Campaign, Geneva, Switzerland	Doctors Without Borders; University of Cape Town; University of Ottawa; University of Geneva; Doctors Without Borders	Ford, N (corresponding author), MSF, Med Unit, Cape Town, South Africa.							Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Moreno S, 2009, INT J TUBERC LUNG D, V13, P150; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9	5	21	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1808	1810		10.1056/NEJMp0902820	http://dx.doi.org/10.1056/NEJMp0902820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	438MU	19403900				2022-12-28	WOS:000265560300002
J	Barraclough, K				Barraclough, Kevin			Diagnosis in General Practice Chronic cough in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERTUSSIS; ASTHMA; MANAGEMENT; DISEASE				Barraclough, K (corresponding author), Hoyland House, Painswick GL6 6RD, Stroud, England.	k.barraclough@btinternet.com						Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cockcroft DW, 1997, ANN ALLERG ASTHMA IM, V79, P226, DOI 10.1016/S1081-1206(10)63006-2; CULLINAN P, 1992, RESP MED, V86, P143, DOI 10.1016/S0954-6111(06)80231-3; Dicpinigaitis PV, 2006, CHEST, V129, p169S, DOI 10.1378/chest.129.1_suppl.169S; Dicpinigaitis PV, 2004, THORAX, V59, P71; Glasziou P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1312; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; Kardos P, 1996, Pneumologie, V50, P437; Kastelik JA, 2005, EUR RESPIR J, V25, P235, DOI 10.1183/09031936.05.00140803; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Morice AH, 2003, THORAX, V58, P901, DOI 10.1136/thorax.58.10.901; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; Palombini BC, 1999, CHEST, V116, P279, DOI 10.1378/chest.116.2.279; Thomas PF, 2000, MED J AUSTRALIA, V173, P74, DOI 10.5694/j.1326-5377.2000.tb139246.x; *WHO, 2008, ALL RH ITS IMP ASTHM; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704	18	3	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2009	338								b1218	10.1136/bmj.b1218	http://dx.doi.org/10.1136/bmj.b1218			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OR	19395418				2022-12-28	WOS:000265497300002
J	Justman, QA; Serber, Z; Ferrell, JE; El-Samad, H; Shokat, KM				Justman, Quincey A.; Serber, Zach; Ferrell, James E., Jr.; El-Samad, Hana; Shokat, Kevan M.			Tuning the Activation Threshold of a Kinase Network by Nested Feedback Loops	SCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CELL-CYCLE; SWITCH; MATURATION; OOCYTES; MODULE; MEMORY	Determining proper responsiveness to incoming signals is fundamental to all biological systems. We demonstrate that intracellular signaling nodes can tune a signaling network's response threshold away from the basal median effective concentration established by ligand-receptor interactions. Focusing on the bistable kinase network that governs progesterone-induced meiotic entry in Xenopus oocytes, we characterized glycogen synthase kinase-3b (GSK-3 beta) as a dampener of progesterone responsiveness. GSK-3 beta engages the meiotic kinase network through a double-negative feedback loop; this specific feedback architecture raises the progesterone threshold in correspondence with the strength of double-negative signaling. We also identified a marker of nutritional status, L-leucine, which lowers the progesterone threshold, indicating that oocytes integrate additional signals into their cell-fate decisions by modulating progesterone responsiveness.	[El-Samad, Hana] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Justman, Quincey A.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Justman, Quincey A.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Justman, Quincey A.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Serber, Zach; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	El-Samad, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	helsamad@biochem.ucsf.edu; shokat@cmp.ucsf.edu			NIH [AI49006, GM46383]; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI049006, R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Yue for providing Mos and cyclin protein; N. L. Salimi for help with statistics; J. J. Fleming and P. M. England for help with oocytes; and A. W. Murray, R. D. Mullins, J. A. Blair, and E. C. Garner for critical reading of the manuscript. Funding from NIH grant AI49006 (to K.M.S.), the Sandler Family Supporting Foundation (to H.E.), and NIH grant GM46383 (to J.E.F.).	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fisher DL, 1999, DEVELOPMENT, V126, P567; FORTUNE JE, 1983, DEV BIOL, V99, P502, DOI 10.1016/0012-1606(83)90299-3; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gebauer F, 1997, BIOESSAYS, V19, P23, DOI 10.1002/bies.950190106; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; O'Neill DJ, 2004, BIOORGAN MED CHEM, V12, P3167, DOI 10.1016/j.bmc.2004.04.010; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	21	40	40	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					509	512		10.1126/science.1169498	http://dx.doi.org/10.1126/science.1169498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390045	Green Accepted			2022-12-28	WOS:000265411200046
J							US Preventive Serv Task Force	Counseling and Interventions to Prevent Tobacco Use and Tobacco-Caused Disease in Adults and Pregnant Women: U. S. Preventive Services Task Force Reaffirmation Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Reaffirmation of the 2003 U. S. Preventive Services Task Force (USPSTF) recommendation on counseling to prevent tobacco use. Methods: The USPSTF reviewed new evidence in the U. S. Public Health Service's 2008 clinical practice guideline and determined that the net benefits of tobacco cessation interventions in adults and pregnant women remain well established. Recommendations: Ask all adults about tobacco use and provide tobacco cessation interventions for those who use tobacco products. (Grade A recommendation) Ask all pregnant women about tobacco use and provide augmented, pregnancy-tailored counseling for those who smoke. (Grade A recommendation)	[US Preventive Serv Task Force] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA	Agency for Healthcare Research & Quality	US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA.				USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	ACOG Committee on Health Care for Underdeserved Women, 2005, Obstet Gynecol, V106, P883; *AM AC FAM PHYS, 2005, TOB US PREV CESS; Centers for Disease Control and Prevention, GUID COMM PREV SERV; FIORE MC, 2000, CLIN PRACT GUID; Fiore MC, 2008, TREATING TOBACCO USE; Kattapong VJ, 1998, AM J PREV MED, V15, P160, DOI 10.1016/S0749-3797(98)00036-1; U.S. Preventive Services Task Force, 2003, COUNS PREV TOB US TO	7	140	143	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					551	W99		10.7326/0003-4819-150-8-200904210-00009	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380855				2022-12-28	WOS:000265457000005
J	Haritoglou, C; Gerss, J; Sauerland, C; Kampik, A; Ulbig, MW				Haritoglou, Christos; Gerss, Joachim; Sauerland, Cristina; Kampik, Anselm; Ulbig, Michael W.		CALDIRET Study Grp	Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial	LANCET			English	Article							ANTIOXIDANT PROPERTIES; RETINOPATHY; PROGRESSION; INHIBITION	Background Medical treatment for diabetic retinopathy could have an important role in prevention of complications such as visual loss. We aimed to assess the effect of calcium dobesilate on occurrence of diabetic macular oedema. Methods We undertook a randomised, double-blind, placebo-controlled, multicentre study in 40 centres in 11 countries. We enrolled outpatients with adult-onset type 2 diabetes and mild-to-moderate non-proliferative diabetic retinopathy, and randomly allocated them via sealed envelopes either calcium dobesilate (1500 mg per day) or placebo. The primary endpoint was development of clinically significant macular oedema (CSME) within a follow-up period of 5 years. Patients who dropped out of the study early were censored. Analysis was by intention to treat. Findings We enrolled 635 patients. 324. were randomly allocated calcium dobesilate and 311 were assigned placebo. in the calcium dobesilate group, 86 patients developed CSME compared with 69 in the placebo group. Accounting for censored cases, estimated cumulative 5-year CSME probability was 35% and 28%, respectively (hazard ratio 1.32, 95% CI 0.96- 1.81; p=0.0844). Adverse events did not differ between treatment groups (78 [24%] on calcium dobesilate and 90 [29%] with placebo). No relevant drug-related complications were noted. Nine patients (3%) died in the calcium dobesilate group and eight (3%) deaths were recorded on placebo. Interpretation Calcium dobesilate did not reduce the risk of development of CSME. Funding Sanofi; OM Pharma; and Synthelabo.	[Haritoglou, Christos; Kampik, Anselm; Ulbig, Michael W.] Univ Munich, Dept Ophthalmol, D-80336 Munich, Germany; [Gerss, Joachim; Sauerland, Cristina] Univ Munster, Dept Med Informat & Biomath, Munster, Germany	University of Munich; University of Munster	Haritoglou, C (corresponding author), Univ Munich, Dept Ophthalmol, D-80336 Munich, Germany.	christos.haritoglou@med.uni-muenchen.de	Sauerland, Maria Cristina/A-4154-2014; Gerß, Joachim WO/B-5702-2013; Tronko, Mykola/AAQ-3327-2021	Tronko, Mykola/0000-0001-7421-0981	Sanofi, France; OM Pharma, Switzerland; Synthelabo, France	Sanofi, France(Sanofi-Aventis); OM Pharma, Switzerland; Synthelabo, France	The CALDIRET study was financed by Sanofi, France, OM Pharma, Switzerland, and Synthelabo, France.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Aiello LP, 2007, ARCH OPHTHALMOL-CHIC, V125, P318; Allain H, 2004, DRUG SAFETY, V27, P649, DOI 10.2165/00002018-200427090-00003; [Anonymous], 1991, OPHTHALMOLOGY, V98, P807; [Anonymous], 1991, Ophthalmology, V98, P786; Berthet P, 1999, INT J CLIN PRACT, V53, P631; Brunet J, 1998, FUND CLIN PHARMACOL, V12, P205, DOI 10.1111/j.1472-8206.1998.tb00943.x; Brunet J, 1998, EUR J PHARMACOL, V358, P213, DOI 10.1016/S0014-2999(98)00604-9; CASLEYSMITH JR, 1988, ANGIOLOGY, V39, P853, DOI 10.1177/000331978803901001; DITTMAR P, 1979, KLIN MONATSBL AUGENH, V174, P753; Garay Ricardo P, 2005, Treat Endocrinol, V4, P221, DOI 10.2165/00024677-200504040-00003; Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11; Ishida S, 2003, INVEST OPHTH VIS SCI, V44, P2155, DOI 10.1167/iovs.02-0807; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; KLEIN R, 1984, AM J EPIDEMIOL, V119, P54, DOI 10.1093/oxfordjournals.aje.a113725; KOLTRINGER P, 1988, INT J CLIN PHARM TH, V26, P500; Lameynardie S, 2005, EUR J PHARMACOL, V510, P149, DOI 10.1016/j.ejphar.2005.01.015; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lang GE, 2004, OPHTHALMOLOGE, V101, P290, DOI 10.1007/s00347-003-0903-2; LEITE EB, 1990, INT OPHTHALMOL, V14, P81, DOI 10.1007/BF00154206; MICHAL M, 1988, THROMB RES, V51, P593, DOI 10.1016/0049-3848(88)90143-0; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Padilla E, 2005, DIABETES-METAB RES, V21, P132, DOI 10.1002/dmrr.487; Ribeiro ML, 2006, GRAEF ARCH CLIN EXP, V244, P1591, DOI 10.1007/s00417-006-0318-2; SCHMIDT M, 1989, ARZNEIMITTELFORSCH, V39-1, P493; Shannon H, 2000, NEW ENGL J MED, V342, P381; Szabo ME, 2001, EUR J PHARMACOL, V428, P277, DOI 10.1016/S0014-2999(01)01196-7; Tejerina, 1999, Int J Angiol, V8, P16; Tejerina T, 1998, GEN PHARMACOL-VASC S, V31, P357, DOI 10.1016/S0306-3623(98)00040-8; VOJNIKOVIC B, 1991, OPHTHALMIC RES, V23, P12, DOI 10.1159/000267080; 1985, ARCH OPHTHALMOL-CHIC, V103, P1796	32	40	45	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2009	373	9672					1364	1371		10.1016/S0140-6736(09)60218-X	http://dx.doi.org/10.1016/S0140-6736(09)60218-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434UR	19376452				2022-12-28	WOS:000265300100034
J	Berkowitz, RS; Goldstein, DP				Berkowitz, Ross S.; Goldstein, Donald P.			Molar Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GESTATIONAL TROPHOBLASTIC DISEASE; COMPLETE HYDATIDIFORM MOLE; UNDETECTABLE HCG LEVELS; FOLLOW-UP; ORAL-CONTRACEPTIVES; NATURAL-HISTORY; LOW-RISK; DIAGNOSIS; NEOPLASIA; MANAGEMENT	A healthy 37-year-old woman presents at 10 weeks of pregnancy with vaginal bleeding. Physical examination shows that the uterine size is appropriate for gestational age. The level of serum human chorionic gonadotropin (hCG) is 22,000 mIU per milliliter. Ultrasonography does not show an identifiable fetal heartbeat. After receiving a clinical diagnosis of missed abortion, the patient undergoes evacuation of the uterus; pathological examination indicates a complete molar pregnancy. How should this case be managed?	[Berkowitz, Ross S.] Brigham & Womens Hosp, Div Gynecol Oncol, Dept Obstet & Gynecol, Boston, MA 02115 USA; Trophoblast Tumor Registry, New England Trophoblast Dis Ctr, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Berkowitz, RS (corresponding author), Brigham & Womens Hosp, Div Gynecol Oncol, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.	rberkowitz@partners.org						AZUMA C, 1991, GYNECOL ONCOL, V40, P29, DOI 10.1016/0090-8258(91)90080-O; BAGSHAWE KD, 1986, LANCET, V2, P673; Batorfi J, 2004, EUR J OBSTET GYN R B, V112, P95, DOI 10.1016/S0301-2115(03)00274-4; Benson CB, 2000, ULTRASOUND OBST GYN, V16, P188, DOI 10.1046/j.1469-0705.2000.00201.x; Berkowitz R.S., 1997, GESTATIONAL TROPHOBL, P127; BERKOWITZ RS, 1981, OBSTET GYNECOL, V58, P474; BERKOWITZ RS, 1991, J REPROD MED, V36, P40; BERKOWITZ RS, 1985, OBSTET GYNECOL, V66, P677; Berkowitz RS, 1996, NEW ENGL J MED, V335, P1740, DOI 10.1056/NEJM199612053352306; Costa HLFF, 2006, GYNECOL ONCOL, V100, P579, DOI 10.1016/j.ygyno.2005.09.031; CURRY SL, 1989, AM J OBSTET GYNECOL, V160, P805, DOI 10.1016/0002-9378(89)90295-0; CURRY SL, 1975, OBSTET GYNECOL, V45, P1; CZERNOBILSKY B, 1982, OBSTET GYNECOL, V59, P75; Felemban AA, 1998, J REPROD MED, V43, P11; Feltmate CM, 2003, OBSTET GYNECOL, V101, P732, DOI 10.1016/S0029-7844(03)00009-7; Feltmate CM, 2006, J REPROD MED, V51, P902; FINE C, 1989, OBSTET GYNECOL, V73, P414; Fukunaga M, 2002, HUM PATHOL, V33, P1188, DOI 10.1053/hupa.2002.129421; Garrett LA, 2008, J REPROD MED, V53, P481; GENEST DR, 1991, OBSTET GYNECOL, V78, P402; Genest DR, 2002, J REPROD MED, V47, P342; GOLDSTEIN DP, 1982, GESTATIONAL TROPHOBL, P143; Hancock BW, 2006, J REPROD MED, V51, P764; Hancock BW, 2002, J REPROD MED, V47, P347; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kerkmeijer LGW, 2007, GYNECOL ONCOL, V106, P142, DOI 10.1016/j.ygyno.2007.03.010; KIM DS, 1986, OBSTET GYNECOL, V67, P690, DOI 10.1097/00006250-198605000-00017; KOHORN EI, 1984, CLIN OBSTET GYNECOL, V27, P181, DOI 10.1097/00003081-198403000-00025; KOHORN EI, 1982, OBSTET GYNECOL, V59, P78; Kohorn EI, 2002, J REPROD MED, V47, P445; Lavie I, 2005, AM J OBSTET GYNECOL, V192, P1362, DOI 10.1016/j.ajog.2004.12.080; Limpongsanurak S, 2001, J REPROD MED, V46, P110; LURAIN JR, 1983, AM J OBSTET GYNECOL, V145, P591, DOI 10.1016/0002-9378(83)91202-4; MENCZER J, 1980, OBSTET GYNECOL, V55, P346, DOI 10.1097/00006250-198003000-00015; Montes M, 1996, AM J CLIN PATHOL, V105, P411; MORROW CP, 1984, CLIN OBSTET GYNECOL, V27, P211, DOI 10.1097/00003081-198403000-00028; MORROW CP, 1977, AM J OBSTET GYNECOL, V128, P424, DOI 10.1016/0002-9378(77)90562-2; Mosher R, 1998, J REPROD MED, V43, P21; NAUMOFF P, 1981, RADIOLOGY, V140, P467, DOI 10.1148/radiology.140.2.7255725; Paradinas FJ, 1996, HISTOPATHOLOGY, V28, P101, DOI 10.1046/j.1365-2559.1996.247295.x; Pisal N, 2004, BJOG-INT J OBSTET GY, V111, P1449, DOI 10.1111/j.1471-0528.2004.00339.x; ROMERO R, 1985, OBSTET GYNECOL, V66, P553; Sebire NJ, 2003, PEDIATR DEVEL PATHOL, V6, P69, DOI 10.1007/s10024-002-0079-9; Soper JT, 2004, GYNECOL ONCOL, V93, P575, DOI 10.1016/j.ygyno.2004.05.013; SOTOWRIGHT V, 1995, OBSTET GYNECOL, V86, P775, DOI 10.1016/0029-7844(95)00268-V; STONE M, 1979, BRIT J OBSTET GYNAEC, V86, P782, DOI 10.1111/j.1471-0528.1979.tb10694.x; SZULMAN AE, 1978, AM J OBSTET GYNECOL, V132, P20, DOI 10.1016/0002-9378(78)90792-5; SZULMAN AE, 1982, OBSTET GYNECOL, V59, P597; SZULMAN AE, 1978, AM J OBSTET GYNECOL, V131, P665, DOI 10.1016/0002-9378(78)90829-3; Thaker HM, 2004, J REPROD MED, V49, P630; WENZEL L, 1992, GYNECOL ONCOL, V46, P74, DOI 10.1016/0090-8258(92)90200-3; Wiesma S, 2006, AUST NZ J OBSTET GYN, V46, P119, DOI 10.1111/j.1479-828X.2006.00539.x; Wiesma S, 2006, AUST NZ J OBSTET GYN, V46, P112, DOI 10.1111/j.1479-828X.2006.00538.x; Wolfberg AJ, 2006, OBSTET GYNECOL, V108, P393, DOI 10.1097/01.AOG.0000227754.12848.4e; Wolfberg AJ, 2004, OBSTET GYNECOL, V104, P551, DOI 10.1097/01.AOG.0000136099.21216.45; YAMASHITA K, 1979, AM J OBSTET GYNECOL, V135, P597, DOI 10.1016/S0002-9378(16)32983-0	56	149	161	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1639	1645		10.1056/NEJMcp0900696	http://dx.doi.org/10.1056/NEJMcp0900696			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369669				2022-12-28	WOS:000265178000008
J	Jiao, LY; Zhang, L; Wang, XR; Diankov, G; Dai, HJ				Jiao, Liying; Zhang, Li; Wang, Xinran; Diankov, Georgi; Dai, Hongjie			Narrow graphene nanoribbons from carbon nanotubes	NATURE			English	Article							FEW-LAYER GRAPHENE	Graphene nanoribbons (GNRs) are materials with properties distinct from those of other carbon allotropes(1-5). The all-semiconducting nature of sub-10-nm GNRs could bypass the problem of the extreme chirality dependence of the metal or semiconductor nature of carbon nanotubes (CNTs) in future electronics(1,2). Currently, making GNRs using lithographic(3,4,6), chemical(7-9) or sonochemical(1) methods is challenging. It is difficult to obtain GNRs with smooth edges and controllable widths at high yields. Here we show an approach to making GNRs by unzipping multi-walled carbon nanotubes by plasma etching of nanotubes partly embedded in a polymer film. The GNRs have smooth edges and a narrow width distribution (10-20 nm). Raman spectroscopy and electrical transport measurements reveal the high quality of the GNRs. Unzipping CNTs with well-defined structures in an array will allow the production of GNRs with controlled widths, edge structures, placement and alignment in a scalable fashion for device integration.	[Jiao, Liying; Zhang, Li; Wang, Xinran; Diankov, Georgi; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Jiao, Liying; Zhang, Li; Wang, Xinran; Diankov, Georgi; Dai, Hongjie] Stanford Univ, Adv Mat Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@stanford.edu	Wang, Xinran/E-8392-2010; Jiao, Liying/C-6307-2011; Dai, Hongjie/ABC-4574-2021	Wang, Xinran/0000-0002-3975-1667; 	Microelectronics Advanced Research Corporation - Materials, Structures, and Devices Center; Intel; US Office of Naval Research	Microelectronics Advanced Research Corporation - Materials, Structures, and Devices Center; Intel(Intel Corporation); US Office of Naval Research(Office of Naval Research)	This work was supported by Microelectronics Advanced Research Corporation - Materials, Structures, and Devices Center, Intel and the US Office of Naval Research.	Barone V, 2006, NANO LETT, V6, P2748, DOI 10.1021/nl0617033; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; Ci L, 2008, NANO RES, V1, P116, DOI 10.1007/s12274-008-8020-9; Cresti A, 2008, NANO RES, V1, P361, DOI 10.1007/s12274-008-8043-2; Dai HJ, 2002, SURF SCI, V500, P218, DOI 10.1016/S0039-6028(01)01558-8; Datta SS, 2008, NANO LETT, V8, P1912, DOI 10.1021/nl080583r; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Jiao LY, 2008, J AM CHEM SOC, V130, P12612, DOI 10.1021/ja805070b; Jiao LY, 2008, J PHYS CHEM C, V112, P9963, DOI 10.1021/jp802713j; Jorio A., 2008, ADV TOPICS SYNTHESIS; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Lin YM, 2008, NANO LETT, V8, P2119, DOI 10.1021/nl080241l; Lin YM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.161409; Moser J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789673; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Ni ZH, 2008, NANO RES, V1, P273, DOI 10.1007/s12274-008-8036-1; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Tapaszto L, 2008, NAT NANOTECHNOL, V3, P397, DOI 10.1038/nnano.2008.149; Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803; WINTERS HF, 1983, J VAC SCI TECHNOL B, V1, P469, DOI 10.1116/1.582629; Yang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.186801; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	29	1981	2064	16	1444	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					877	880		10.1038/nature07919	http://dx.doi.org/10.1038/nature07919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370031				2022-12-28	WOS:000265182500040
J	Kukushkin, IV; Smet, JH; Scarola, VW; Umansky, V; von Klitzing, K				Kukushkin, Igor V.; Smet, Jurgen H.; Scarola, Vito W.; Umansky, Vladimir; von Klitzing, Klaus			Dispersion of the Excitations of Fractional Quantum Hall States	SCIENCE			English	Article							FILLED LANDAU-LEVEL; COLLECTIVE EXCITATIONS; ELECTRON-GAS; HELIUM II; SUPERFLUIDITY; SYSTEM	The rich correlation physics in two-dimensional (2D) electron systems is governed by the dispersion of its excitations. In the fractional quantum Hall regime, excitations involve fractionally charged quasi particles, which exhibit dispersion minima at large momenta referred to as rotons. These rotons are difficult to access with conventional techniques because of the lack of penetration depth or sample volume. Our method overcomes the limitations of conventional methods and traces the dispersion of excitations across momentum space for buried systems involving small material volume. We used surface acoustic waves, launched across the 2D system, to allow incident radiation to trigger these excitations at large momenta. Optics probed their resonant absorption. Our technique unveils the full dispersion of such excitations of several prominent correlated ground states of the 2D electron system, which has so far been inaccessible for experimentation.	[Kukushkin, Igor V.; Smet, Jurgen H.; von Klitzing, Klaus] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Kukushkin, Igor V.] Russian Acad Sci, Inst Solid State Phys, Chernogolovka 142432, Russia; [Scarola, Vito W.] Univ Calif Berkeley, Pitzer Ctr Theoret Chem, Berkeley, CA 94720 USA; [Scarola, Vito W.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Scarola, Vito W.] ETH, CH-8093 Zurich, Switzerland; [Umansky, Vladimir] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	Max Planck Society; Russian Academy of Sciences; Osipyan Institute of Solid State Physics RAS; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich; Weizmann Institute of Science	Smet, JH (corresponding author), Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany.	j.smet@fkf.mpg.de	von Klitzing, Klaus/AAH-2988-2022; Scarola, Vito/AAG-7503-2019; von Klitzing, Klaus/AFM-0585-2022; Umansky, Vladimir/P-1334-2019; Scarola, Vito/G-5412-2012	Scarola, Vito/0000-0002-8653-2723; Umansky, Vladimir/0000-0001-5727-2064; Scarola, Vito/0000-0002-8653-2723	Deutsche Forschungsgemeinschaft; German Israeli Foundation; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We acknowledge financial support from the Deutsche Forschungsgemeinschaft, the German Israeli Foundation, and the Bundesministerium fur Bildung und Forschung.	BATKE E, 1985, PHYS REV LETT, V54, P2367, DOI 10.1103/PhysRevLett.54.2367; dePicciotto R, 1997, NATURE, V389, P162, DOI 10.1038/38241; GIRVIN SM, 1985, PHYS REV LETT, V54, P581, DOI 10.1103/PhysRevLett.54.581; GIRVIN SM, 1986, PHYS REV B, V33, P2481, DOI 10.1103/PhysRevB.33.2481; HALPERIN BI, 1993, PHYS REV B, V47, P7312, DOI 10.1103/PhysRevB.47.7312; Heinonen O, 1998, COMPOSITE FERMIONS U; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; KALLIN C, 1984, PHYS REV B, V30, P5655, DOI 10.1103/PhysRevB.30.5655; Kapitza PL, 1941, PHYS REV, V60, P354, DOI 10.1103/PhysRev.60.354; KOHN W, 1961, PHYS REV, V123, P1242, DOI 10.1103/PhysRev.123.1242; Kukushkin IV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.066403; Kukushkin IV, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.126807; Kukushkin IV, 2004, APPL PHYS LETT, V85, P4526, DOI 10.1063/1.1815068; Landau L, 1941, PHYS REV, V60, P356, DOI 10.1103/PhysRev.60.356; PINCZUK A, 1993, PHYS REV LETT, V70, P3983, DOI 10.1103/PhysRevLett.70.3983; PINCZUK A, 1995, AM PHYS SOC, V40, P515; Prange R. E., 1990, QUANTUM HALL EFFECT; RASOLT M, 1986, PHYS REV B, V34, P5530, DOI 10.1103/PhysRevB.34.5530; Saminadayar L, 1997, PHYS REV LETT, V79, P2526, DOI 10.1103/PhysRevLett.79.2526; Scarola VW, 2000, PHYS REV B, V61, P13064, DOI 10.1103/PhysRevB.61.13064; SIMON SH, 1993, PHYS REV B, V48, P17368, DOI 10.1103/PhysRevB.48.17368; SOHN LL, 1995, SOLID STATE COMMUN, V93, P897, DOI 10.1016/0038-1098(94)00828-0; YARNELL JL, 1959, PHYS REV, V113, P1379, DOI 10.1103/PhysRev.113.1379; Zeitler U, 1999, PHYS REV LETT, V82, P5333, DOI 10.1103/PhysRevLett.82.5333	26	84	87	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1044	1047		10.1126/science.1171472	http://dx.doi.org/10.1126/science.1171472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407145				2022-12-28	WOS:000266246700034
J	Papp, SB; Choi, KS; Deng, H; Lougovski, P; van Enk, SJ; Kimble, HJ				Papp, Scott B.; Choi, Kyung Soo; Deng, Hui; Lougovski, Pavel; van Enk, S. J.; Kimble, H. J.			Characterization of Multipartite Entanglement for One Photon Shared Among Four Optical Modes	SCIENCE			English	Article							CONTINUOUS VARIABLE SYSTEMS; QUANTUM INFORMATION; EXPERIMENTAL TESTS; ATOMIC ENSEMBLES; BELLS THEOREM; LINEAR OPTICS; COMMUNICATION; CRITERION; STATE	Access to genuine multipartite entanglement of quantum states enables advances in quantum information science and also contributes to the understanding of strongly correlated quantum systems. We report the detection and characterization of heralded entanglement in a multipartite quantum state composed of four spatially distinct optical modes that share one photon, a so-called W state. By randomizing the relative phase between bipartite components of the W state, we observed the transitions from four- to three- to two-mode entanglement with increasing phase noise. These observations are possible for our system because our entanglement verification protocol makes use of quantum uncertainty relations to detect the entangled states that span the Hilbert space of interest.	[Papp, Scott B.; Choi, Kyung Soo; Kimble, H. J.] CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA; [Deng, Hui] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Lougovski, Pavel; van Enk, S. J.] Univ Oregon, Dept Phys, Eugene, OR 97403 USA	California Institute of Technology; University of Michigan System; University of Michigan; University of Oregon	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA.	hjkimble@caltech.edu	Choi, Kyung Soo/C-6073-2008; Deng, Hui/AAD-6979-2020; Deng, Hui/E-8950-2010	Choi, Kyung Soo/0000-0003-0757-1183; Deng, Hui/0000-0003-0629-3230; Deng, Hui/0000-0003-0629-3230; Lougovski, Pavel/0000-0002-9229-1444	IARPA; NSF; NGST; Center for the Physics of Information at Caltech	IARPA; NSF(National Science Foundation (NSF)); NGST; Center for the Physics of Information at Caltech	We gratefully acknowledge critical discussions with J. Laurat, P. Zoller, and J. Ye. This research is supported by IARPA, by NSF, and by NGST. S.P. and H.D. acknowledge support as Fellows of the Center for the Physics of Information at Caltech.	ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Choi KS, 2008, NATURE, V452, P67, DOI 10.1038/nature06670; Chou CW, 2007, SCIENCE, V316, P1316, DOI 10.1126/science.1140300; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; GAO WB, 2008, PREPRINT; GUHNE O, 2008, PREPRINT; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Hillery M, 1999, PHYS REV A, V59, P1829, DOI 10.1103/PhysRevA.59.1829; Hofmann HF, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.032103; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; LOUGOVSKI P, 2009, PREPRINT; Nha H, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.062328; Nielsen Michael A., 2002, QUANTUM COMPUTATION; RECK M, 1994, PHYS REV LETT, V73, P58, DOI 10.1103/PhysRevLett.73.58; Roos CF, 2004, SCIENCE, V304, P1478, DOI 10.1126/science.1097522; Simon R, 2000, PHYS REV LETT, V84, P2726, DOI 10.1103/PhysRevLett.84.2726; van Enk SJ, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052318; Verstraete F, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052112; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Zoller P, 2005, EUR PHYS J D, V36, P203, DOI 10.1140/epjd/e2005-00251-1	29	100	101	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					764	768		10.1126/science.1172260	http://dx.doi.org/10.1126/science.1172260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423821				2022-12-28	WOS:000265832400040
J	Ho, CS; Gostin, LO				Ho, Christina S.; Gostin, Lawrence O.			The Social Face of Economic Growth China's Health System in Transition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE-SYSTEM		[Ho, Christina S.; Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; *CHIIN MED DOCT AS, 2006, DOCT PAT REL SURV RE; Communist Party of China Central Committee, 2009, IMPL PLAN REC PRIOR; Communist Party of China Central Committee and State Council of China, 2009, OP CPC CENTR COMM ST; DING N, 2005, CHINA DEV REV S1, V7, P25; HSIAO WCL, 1995, SOC SCI MED, V41, P1047, DOI 10.1016/0277-9536(94)00421-O; Liu YL, 2004, B WORLD HEALTH ORGAN, V82, P532; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; *MIN HLTH CTR HLTH, 2004, PEOPL REP CHIN AN RE; Popkin BM, 2008, HEALTH AFFAIR, V27, P1064, DOI 10.1377/hlthaff.27.4.1064; Shi G, 2005, CHINA DEV REV S1, V7, P51; Watts J, 2008, LANCET, V371, P292, DOI 10.1016/S0140-6736(08)60151-8; *WORLD BANK, 2005, STAT WORLD BANK PRES	14	17	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1809	1811		10.1001/jama.2009.555	http://dx.doi.org/10.1001/jama.2009.555			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441AU	19417198				2022-12-28	WOS:000265742500031
J	Mattson-DiCecca, AA; Reynolds, E				Mattson-DiCecca, Anna A.; Reynolds, Eileen			Update: A 60-Year-Old Woman With Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Reynolds EE, 2003, JAMA-J AM MED ASSOC, V290, P2182; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1808	1808		10.1001/jama.2009.507	http://dx.doi.org/10.1001/jama.2009.507			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19417197				2022-12-28	WOS:000265742500030
J	Nakagawa, T; Lomb, DJ; Haigis, MC; Guarente, L				Nakagawa, Takashi; Lomb, David J.; Haigis, Marcia C.; Guarente, Leonard			SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea Cycle	CELL			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; RAT-LIVER MITOCHONDRIA; CALORIE RESTRICTION; LIFE-SPAN; LYSINE ACETYLATION; CELL-SURVIVAL; SACCHAROMYCES-CEREVISIAE; GLUTAMATE-DEHYDROGENASE; CAENORHABDITIS-ELEGANS; DEPENDENT DEACETYLASE	Sirtuins are NAD-dependent protein deacetylases that connect metabolism and aging. In mammals, there are seven sirtuins (SIRT1-7), three of which are associated with mitochondria. Here, we show that SIRT5 localizes in the mitochondrial matrix and interacts with carbamoyl phosphate synthetase 1 (CPS1), an enzyme, catalyzing the initial step of the urea cycle for ammonia detoxification and disposal. SIRT5 deacetylates CPS1 and upregulates its activity. During fasting, NAD in liver mitochondria increases, thereby triggering SIRT5 deacetylation of CPS1 and adaptation to the increase in amino acid catabolism. Indeed, SIRT5 KO mice fail to upregulate CPS1 activity and show elevated blood ammonia during fasting. Similar effects occur during long-term calorie restriction or a high protein diet. These findings demonstrate SIRT5 plays a pivotal role in ammonia detoxification and disposal by activating CPS1.	[Nakagawa, Takashi; Guarente, Leonard] MIT, Paul F Glenn Lab Sci Aging, Cambridge, MA 02139 USA; [Nakagawa, Takashi; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lomb, David J.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lomb, David J.; Haigis, Marcia C.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Guarente, L (corresponding author), MIT, Paul F Glenn Lab Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605	Human Frontier Science Program; National Institutes of Health (NIH); Paul F. Glenn Foundation; NATIONAL INSTITUTE ON AGING [R01AG015339, R01AG011119] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Eric Bell, Huan-chung Chang, Sergiy Libert, and Gizem Donmez for reading the manuscript and Shin-ichiro Imai for valuable comments. We also thank Fred Alt, David Lombard and Raul Mostovslavsky for sharing the SIRT5 KO mice, Danica Chen for SIRT3 KO mice, Jun-ichi Miyazaki for the gift of pCAG plasmid and Su-Ju Lin for technical comments on NAD/NADH measurement. This work was supported by a grant from Human Frontier Science Program to T. N. and grants from the National Institutes of Health (NIH) and the Paul F. Glenn Foundation to L.G. L.G. is a consultant for Sirtris Pharmaceuticals.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; EXTON JH, 1972, J BIOL CHEM, V247, P4996; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; HAUSSINGER D, 1990, BIOCHEM J, V267, P281; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MCGIVAN JD, 1976, BIOCHEM J, V154, P415, DOI 10.1042/bj1540415; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Nuzum CT, 1976, UREA CYCLE, P325; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; SCHIMKE RT, 1962, J BIOL CHEM, V237, P459; SCHIMKE RT, 1962, J BIOL CHEM, V237, P1921; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Stanley CA, 2004, MOL GENET METAB, V81, pS45, DOI 10.1016/j.ymgme.2003.10.013; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Wraith JE, 2001, ARCH DIS CHILD, V84, P84, DOI 10.1136/adc.84.1.84; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yefimenko I, 2005, J MOL BIOL, V349, P127, DOI 10.1016/j.jmb.2005.03.078; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	58	558	587	5	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					560	570		10.1016/j.cell.2009.02.026	http://dx.doi.org/10.1016/j.cell.2009.02.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410549	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000265677200024
J	Stegemann, S; Bock, R				Stegemann, Sandra; Bock, Ralph			Exchange of Genetic Material Between Cells in Plant Tissue Grafts	SCIENCE			English	Article								Tissue grafting includes applications ranging from plant breeding to animal organ transplantation. Donor and recipient are generally believed to maintain their genetic integrity, in that the grafted tissues are joined but their genetic materials do not mix. We grafted tobacco plants from two transgenic lines carrying different marker and reporter genes in different cellular compartments, the nucleus and the plastid. Analysis of the graft sites revealed the frequent occurrence of cells harboring both antibiotic resistances and both fluorescent reporters. Our data demonstrate that plant grafting can result in the exchange of genetic information via either large DNA pieces or entire plastid genomes. This observation of novel combinations of genetic material has implications for grafting techniques and also provides a possible path for horizontal gene transfer.	[Stegemann, Sandra; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany	Max Planck Society	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Muhlenberg 1, D-14476 Potsdam, Germany.	rbock@mpimp-golm.mpg.de	Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940	Bundesministerium fur Bildung und Forschung	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank M. Lohse and D. Karcher for providing transgenic lines, Y. Weber for technical assistance, and D. Karcher for help with identifying markers. This research was financed by the Bundesministerium fur Bildung und Forschung.	Beddie A. D., 1942, T P R SOC NZ, V71, P199; BRABEC F, 1954, PLANTA, V44, P562, DOI 10.1007/BF01937601; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Lucas WJ, 2004, NAT REV MOL CELL BIO, V5, P712, DOI 10.1038/nrm1470; OHTA Y, 1975, EUPHYTICA, V24, P355, DOI 10.1007/BF00028201; Stange C, 2004, FUNCT PLANT BIOL, V31, P149, DOI 10.1071/FP03160	7	202	236	7	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					649	651		10.1126/science.1170397	http://dx.doi.org/10.1126/science.1170397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407205				2022-12-28	WOS:000265608800046
J	Wijnen, H				Wijnen, Herman			A Circadian Loop asSIRTs Itself	SCIENCE			English	Editorial Material							PPAR-GAMMA; CLOCK; SIRT1; PGC-1-ALPHA; METABOLISM; EXPRESSION; BMAL1		Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Virginia	Wijnen, H (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	hw9u@virginia.edu	Wijnen, Herman/N-8391-2019; Wijnen, Herman/B-8860-2013	Wijnen, Herman/0000-0002-8710-5176; Wijnen, Herman/0000-0002-8710-5176	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078339] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078339, R01 GM078339-03, R01 GM78839] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	14	28	31	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					598	599		10.1126/science.1174132	http://dx.doi.org/10.1126/science.1174132			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407188				2022-12-28	WOS:000265608800028
J	Dobson, JE				Dobson, Jerome E.			Big Brother has evolved	NATURE			English	Editorial Material									Univ Kansas, Dept Geog, Lawrence, KS 66045 USA	University of Kansas	Dobson, JE (corresponding author), Univ Kansas, Dept Geog, Lawrence, KS 66045 USA.	dobson@ku.edu						Dobson JE, 2007, GEOGR REV, V97, P307, DOI 10.1111/j.1931-0846.2007.tb00508.x; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958	2	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					968	968		10.1038/458968a	http://dx.doi.org/10.1038/458968a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436KL	19396123	Bronze			2022-12-28	WOS:000265412900017
J	Sainz, M; del Pozo, JG; Arias, LHM; Carvajal, A				Sainz, Maria; Garcia del Pozo, Javier; Martin Arias, Luis H.; Carvajal, Alfonso			Drug Point Strontium ranelate may cause alopecia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BISPHOSPHONATES		[Carvajal, Alfonso] Univ Valladolid, Fac Med, Inst Farmacoepidemiol, Reg Ctr Pharmacovigilance Castilla & Leon, E-47005 Valladolid, Spain	Universidad de Valladolid	Carvajal, A (corresponding author), Univ Valladolid, Fac Med, Inst Farmacoepidemiol, Reg Ctr Pharmacovigilance Castilla & Leon, Ramon & Cajal 7, E-47005 Valladolid, Spain.	carvajal@ife.uva.es	MARTIN ARIAS, LUIS/H-6438-2015; Sainz-Gil, María/V-5390-2017	MARTIN ARIAS, LUIS/0000-0002-3815-8781; Sainz-Gil, María/0000-0002-4353-055X				Hunt N, 2005, BRIT MED J, V331, P951, DOI 10.1136/bmj.331.7522.951; Lenzer J, 2008, BRIT MED J, V336, P117, DOI 10.1136/bmj.39461.527650.4E; POWIS SJA, 1976, BRIT MED J, V2, P1166, DOI 10.1136/bmj.2.6045.1166; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009	4	6	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2009	338								b1494	10.1136/bmj.b1494	http://dx.doi.org/10.1136/bmj.b1494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OP	19386675				2022-12-28	WOS:000265497100005
J	Plenio, MB				Plenio, Martin B.			Less Is More	SCIENCE			English	Editorial Material							QUANTUM; ENTANGLEMENT; TOMOGRAPHY		[Plenio, Martin B.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2PG, England; [Plenio, Martin B.] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London SW7 2PG, England	Imperial College London; Imperial College London	Plenio, MB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2PG, England.	m.plenio@imperial.ac.uk	Meyer, John/AAQ-2198-2020; Plenio, Martin B/Y-8282-2019	Meyer, John/0000-0003-3565-7435; Plenio, Martin B/0000-0003-4238-8843				Altepeter JB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.193601; BELL M, 2001, BELL FDN QUANTUM MEC; Boyd S., 2004, COVEX OPTIMIZATION; D'Ariano GM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250407; Eisert J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/3/046; Emerson J, 2007, SCIENCE, V317, P1893, DOI 10.1126/science.1145699; Guhne O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.110502; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Plenio MB, 2007, QUANTUM INF COMPUT, V7, P1; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; VOGEL K, 1989, PHYS REV A, V40, P2847, DOI 10.1103/PhysRevA.40.2847	14	6	6	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					342	343		10.1126/science.1170616	http://dx.doi.org/10.1126/science.1170616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372417				2022-12-28	WOS:000265221600026
J	Trinquier, A; Elliott, T; Ulfbeck, D; Coath, C; Krot, AN; Bizzarro, M				Trinquier, Anne; Elliott, Tim; Ulfbeck, David; Coath, Christopher; Krot, Alexander N.; Bizzarro, Martin			Origin of Nucleosynthetic Isotope Heterogeneity in the Solar Protoplanetary Disk	SCIENCE			English	Article							SYSTEM; TI; ANOMALIES; TITANIUM; ALLENDE; AL-26	Stable-isotope variations exist among inner solar system solids, planets, and asteroids, but their importance is not understood. We report correlated, mass-independent variations of titanium-46 and titanium-50 in bulk analyses of these materials. Because titanium-46 and titanium-50 have different nucleosynthetic origins, this correlation suggests that the presolar dust inherited from the protosolar molecular cloud was well mixed when the oldest solar system solids formed, but requires a subsequent process imparting isotopic variability at the planetary scale. We infer that thermal processing of molecular cloud material, probably associated with volatile-element depletions in the inner solar system, resulted in selective destruction of thermally unstable, isotopically anomalous presolar components, producing residual isotopic heterogeneity. This implies that terrestrial planets accreted from thermally processed solids with nonsolar isotopic compositions.	[Trinquier, Anne; Ulfbeck, David; Krot, Alexander N.; Bizzarro, Martin] Univ Copenhagen, Natl Hist Museum Denmark, Ctr Stars & Planets, DK-1350 Copenhagen, Denmark; [Elliott, Tim; Coath, Christopher] Univ Bristol, Dept Earth Sci, Bristol Isotope Grp, Bristol BS8 1RJ, Avon, England; [Krot, Alexander N.] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Copenhagen; University of Bristol; University of Hawaii System; University of Hawaii Manoa	Bizzarro, M (corresponding author), Univ Copenhagen, Natl Hist Museum Denmark, Ctr Stars & Planets, DK-1350 Copenhagen, Denmark.	bizzarro@snm.ku.dk	Bizzarro, Martin/I-8701-2012; Trinquier, Anne/AAH-1911-2021; Bizzarro, Martin/M-7474-2019	Bizzarro, Martin/0000-0001-9966-2124; Bizzarro, Martin/0000-0001-9966-2124; trinquier, anne/0000-0002-3959-0090; Elliott, Tim/0000-0002-0984-0191; Coath, Christopher/0000-0002-6520-2223	Danish National Research Foundation; Danish Natural Science Research Council; University of Copenhagen's Programme of Excellence; Science and Technology Facilities Council [ST/F002734/1] Funding Source: researchfish; STFC [ST/F002734/1] Funding Source: UKRI	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council(Danish Natural Science Research Council); University of Copenhagen's Programme of Excellence; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Financial support for this project was provided by the Danish National Research Foundation, the Danish Natural Science Research Council, and the University of Copenhagen's Programme of Excellence. We thank J. Connelly, G. Huss, H. Haack, F. Richter, R. Mendybaev, and B. Meyer for discussion.	Andreasen R, 2007, ASTROPHYS J, V665, P874, DOI 10.1086/518819; Birck JL, 2004, REV MINERAL GEOCHEM, V55, P25, DOI 10.2138/gsrmg.55.1.25; Bizzarro M, 2004, NATURE, V431, P275, DOI 10.1038/nature02882; Bland PA, 2005, P NATL ACAD SCI USA, V102, P13755, DOI 10.1073/pnas.0501885102; Bogdanovski O., 2002, LUNAR PLANET SCI, V33, P1802; Clayton D., 2003, HDB ISOTOPES COSMOS; GOSWAMI JN, 2005, CHONDRITES PROTOPLAN, P485; Huss GR, 2003, GEOCHIM COSMOCHIM AC, V67, P4823, DOI 10.1016/j.gca.2003.07.019; IRELAND TR, 1988, GEOCHIM COSMOCHIM AC, V52, P2827, DOI 10.1016/0016-7037(88)90150-0; Leya I, 2008, EARTH PLANET SC LETT, V266, P233, DOI 10.1016/j.epsl.2007.10.017; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; NIEDERER FR, 1985, GEOCHIM COSMOCHIM AC, V49, P835, DOI 10.1016/0016-7037(85)90176-0; NIEDERER FR, 1981, GEOCHIM COSMOCHIM AC, V45, P1017, DOI 10.1016/0016-7037(81)90128-9; NIEMEYER S, 1981, EARTH PLANET SC LETT, V53, P211, DOI 10.1016/0012-821X(81)90155-2; Palme H, 2005, TREATISE GEOCHEM, V1, P41; ROTARU M, 1992, NATURE, V358, P465, DOI 10.1038/358465a0; Thrane K, 2006, ASTROPHYS J, V646, pL159, DOI 10.1086/506910; Trinquier A, 2008, GEOCHIM COSMOCHIM AC, V72, P5146, DOI 10.1016/j.gca.2008.03.023; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Zinner E, 2007, GEOCHIM COSMOCHIM AC, V71, P4786, DOI 10.1016/j.gca.2007.07.012	21	399	403	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					374	376		10.1126/science.1168221	http://dx.doi.org/10.1126/science.1168221			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372428				2022-12-28	WOS:000265221600038
J	Frolov, SM; Luscher, S; Yu, W; Ren, Y; Folk, JA; Wegscheider, W				Frolov, S. M.; Luescher, S.; Yu, W.; Ren, Y.; Folk, J. A.; Wegscheider, W.			Ballistic spin resonance	NATURE			English	Article							MAGNETIC-FIELDS; SEMICONDUCTORS; INJECTION	The phenomenon of spin resonance has had far-reaching influence since its discovery 70 years ago(1). Electron spin resonance driven by high-frequency magnetic fields has enhanced our understanding of quantum mechanics, and finds application in fields as diverse as medicine and quantum information(2). Spin resonance can also be induced by high-frequency electric fields in materials with a spin orbit interaction; the oscillation of the electrons creates a momentum-dependent effective magnetic field acting on the electron spin(3-9). Here we report electron spin resonance due to a spin orbit interaction that does not require external driving fields. The effect, which we term ballistic spin resonance, is driven by the free motion of electrons that bounce at frequencies of tens of gigahertz in micrometre-scale channels of a two-dimensional electron gas. This is a frequency range that is experimentally challenging to access in spin resonance, and especially difficult on a chip. The resonance is manifest in electrical measurements of pure spin currents(10)-we see a strong suppression of spin relaxation length when the oscillating spin-orbit field is in resonance with spin precession in a static magnetic field. These findings illustrate how the spin-orbit interaction can be harnessed for spin manipulation in a spintronic circuit(11), and point the way to gate-tunable coherent spin rotations in ballistic nanostructures without external alternating current fields.	[Frolov, S. M.; Luescher, S.; Yu, W.; Ren, Y.; Folk, J. A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z4, Canada; [Wegscheider, W.] Univ Regensburg, Inst Angew & Expt Phys, D-93040 Regensburg, Germany	University of British Columbia; University of Regensburg	Folk, JA (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z4, Canada.	jfolk@physics.ubc.ca	Folk, Joshua A/E-6287-2017; Wegscheider, Werner H/D-1493-2010; REn, Yuan/O-2733-2013	Folk, Joshua A/0000-0003-4455-5609; REn, Yuan/0000-0001-5397-7841	NSERC; CFI; CIFAR; Deutsche Forschungsgemeinschaft (DFG) [SPP 1285]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation); CIFAR(Canadian Institute for Advanced Research (CIFAR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank M. Berciu, M. Duckheim, J. C. Egues, D. Loss and G. Usaj for conversations. Work at UBC was supported by NSERC, CFI and CIFAR. W. W. acknowledges financial support by the Deutsche Forschungsgemeinschaft (DFG) in the framework of the programme 'Halbleiter-Spintronik' (SPP 1285).	BELL RL, 1962, PHYS REV LETT, V9, P52, DOI 10.1103/PhysRevLett.9.52; Duckheim M, 2006, NAT PHYS, V2, P195, DOI 10.1038/nphys238; Frolov SM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.116802; Jedema FJ, 2001, NATURE, V410, P345, DOI 10.1038/35066533; JOHNSON M, 1985, PHYS REV LETT, V55, P1790, DOI 10.1103/PhysRevLett.55.1790; Kato Y, 2004, NATURE, V427, P50, DOI 10.1038/nature02202; Koop EJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.056602; KOOP EJ, 2008, CONFINEMENT ENHANCED; Meier L, 2007, NAT PHYS, V3, P650, DOI 10.1038/nphys675; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Perel V, 1972, SOV PHYS-SOLID STATE, V13, P3023; Potok RM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.266602; Rabi II, 1938, PHYS REV, V53, P318, DOI 10.1103/PhysRev.53.318; Rashba EI, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126405; Rashba EI., 1960, FIZ TVERD TELA, V2, P1224; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Zavoisky E, 1945, J PHYS-USSR, V9, P245	18	76	76	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					868	871		10.1038/nature07873	http://dx.doi.org/10.1038/nature07873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370029	Green Submitted			2022-12-28	WOS:000265182500038
J	Feachem, RGA; Phillips, AA				Feachem, Richard G. A.; Phillips, Allison A.			Malaria: 2 years in the fast lane	LANCET			English	Editorial Material									[Feachem, Richard G. A.; Phillips, Allison A.] UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Feachem, RGA (corresponding author), UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA.	feachemr@globalhealth.ucsf.edu						[Anonymous], GLOB MAL ACT PLAN MA; BARRETT C, 2009, BRISBANE TIMES  0210; *EXXONMOBIL, AFR HLTH IN; Feachem RGA, 2009, SHRINKING MALARIA MA; GATES B, 2007, BILL M GAT MAL FOR S; *GLOB FUND FIGHT A, GRANT PORTF FUND DEC; Greenwood BM, 2008, TRENDS PARASITOL, V24, P449, DOI 10.1016/j.pt.2008.07.002; *PATH, MACEPA MAL CONTR PAR; PAYNE DM, 2008, 1 LADY L BUSH RAISE; *USAID, 2008, PRES MAL IN PROGR PA; *WORLD BANK BOOST, 2007, SCAL UP IMP SUFI 2 Y; World Health Organization, 2009, FIN CRIS GLOB HLTH, DOI 10.1186/1744-8603-5-17	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1409	1411		10.1016/S0140-6736(09)60801-1	http://dx.doi.org/10.1016/S0140-6736(09)60801-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437QL	19394520				2022-12-28	WOS:000265501900009
J	Shinde, V; Bridges, CB; Uyeki, TM; Shu, B; Balish, A; Xu, XY; Lindstrom, S; Gubareva, LV; Deyde, V; Garten, RJ; Harris, M; Gerber, S; Vagasky, S; Smith, F; Pascoe, N; Martin, K; Dufficy, D; Ritger, K; Conover, C; Quinlisk, P; Klimov, A; Bresee, JS; Finelli, L				Shinde, Vivek; Bridges, Carolyn B.; Uyeki, Timothy M.; Shu, Bo; Balish, Amanda; Xu, Xiyan; Lindstrom, Stephen; Gubareva, Larisa V.; Deyde, Varough; Garten, Rebecca J.; Harris, Meghan; Gerber, Susan; Vagasky, Susan; Smith, Forrest; Pascoe, Neal; Martin, Karen; Dufficy, Deborah; Ritger, Kathy; Conover, Craig; Quinlisk, Patricia; Klimov, Alexander; Bresee, Joseph S.; Finelli, Lyn			Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005-2009	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JANUARY-FEBRUARY 1976; FORT-DIX; VIRUS-INFECTION; TRANSMISSION; RESISTANCE; WORLDWIDE; WORKERS; SPREAD; PIGS	Background Triple-reassortant swine influenza A (H1) viruses - containing genes from avian, human, and swine influenza viruses - emerged and became enzootic among pig herds in North America during the late 1990s. Methods We report the clinical features of the first 11 sporadic cases of infection of humans with triple-reassortant swine influenza A (H1) viruses reported to the Centers for Disease Control and Prevention, occurring from December 2005 through February 2009, until just before the current epidemic of swine-origin influenza A (H1N1) among humans. These data were obtained from routine national influenza surveillance reports and from joint case investigations by public and animal health agencies. Results The median age of the 11 patients was 10 years (range, 16 months to 48 years), and 4 had underlying health conditions. Nine of the patients had had exposure to pigs, five through direct contact and four through visits to a location where pigs were present but without contact. In another patient, human-to-human transmission was suspected. The range of the incubation period, from the last known exposure to the onset of symptoms, was 3 to 9 days. Among the 10 patients with known clinical symptoms, symptoms included fever (in 90%), cough (in 100%), headache (in 60%), and diarrhea (in 30%). Complete blood counts were available for four patients, revealing leukopenia in two, lymphopenia in one, and thrombocytopenia in another. Four patients were hospitalized, two of whom underwent invasive mechanical ventilation. Four patients received oseltamivir, and all 11 recovered from their illness. Conclusions From December 2005 until just before the current human epidemic of swine-origin influenza viruses, there was sporadic infection with triple-reassortant swine influenza A (H1) viruses in persons with exposure to pigs in the United States. Although all the patients recovered, severe illness of the lower respiratory tract and unusual influenza signs such as diarrhea were observed in some patients, including those who had been previously healthy.	[Shinde, Vivek; Bridges, Carolyn B.; Uyeki, Timothy M.; Shu, Bo; Balish, Amanda; Xu, Xiyan; Lindstrom, Stephen; Gubareva, Larisa V.; Deyde, Varough; Garten, Rebecca J.; Klimov, Alexander; Bresee, Joseph S.; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Shinde, Vivek; Dufficy, Deborah] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA 30333 USA; [Shinde, Vivek] Ctr Dis Control & Prevent, Prevent Med Residency Program, Atlanta, GA 30333 USA; [Harris, Meghan; Quinlisk, Patricia] Iowa Dept Publ Hlth, Des Moines, IA 50319 USA; [Gerber, Susan; Ritger, Kathy] Chicago Dept Publ Hlth, Chicago, IL USA; [Vagasky, Susan] Michigan Dept Community Hlth, Lansing, MI USA; [Smith, Forrest] Ohio Dept Hlth, Columbus, OH 43266 USA; [Pascoe, Neal] Texas Dept State Hlth Serv, Austin, TX USA; [Martin, Karen] Minnesota Dept Hlth, St Paul, MN USA; [Conover, Craig] Illinois Dept Publ Hlth, Springfield, IL 62761 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chicago Department of Public Health; MDHHS - Michigan Department of Health & Human Services; Texas Department of State Health Services; Minnesota Department of Health (MHD)	Finelli, L (corresponding author), Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd,NE Mailstop A-32, Atlanta, GA 30333 USA.	lfinelli@cdc.gov	Finelli, Lyn/AAK-2360-2020					Adiego Sancho B., 2009, EURO SURVEILL, V14; BASTIEN N, 2009, J CLIN MICROBIO 0401; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; *CSTE, 2007, COUNC STAT TERR EP P; DACSO CC, 1984, J CLIN MICROBIOL, V20, P833, DOI 10.1128/JCM.20.4.833-835.1984; GAYDOS JC, 1977, J INFECT DIS, V136, pS363, DOI 10.1093/infdis/136.Supplement_3.S363; GAYDOS JC, 1977, J INFECT DIS, V136, pS356, DOI 10.1093/infdis/136.Supplement_3.S356; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Gregg M B, 1980, Ann N Y Acad Sci, V353, P45, DOI 10.1111/j.1749-6632.1980.tb18904.x; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; HINSHAW VS, 1978, VIROLOGY, V84, P51, DOI 10.1016/0042-6822(78)90217-9; HODDER RA, 1977, J INFECT DIS, V136, pS369, DOI 10.1093/infdis/136.Supplement_3.S369; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KENDAL AP, 1983, J CLIN MICROBIOL, V18, P930, DOI 10.1128/JCM.18.4.930-934.1983; Kendal AP, 1982, CONCEPTS PROCEDURES; Kimura K, 1998, MAYO CLIN PROC, V73, P243, DOI 10.4065/73.3.243; Ma W, 2009, J MOL GENET MED, V3, P158; MCKINNEY WP, 1990, ARCH INTERN MED, V150, P213, DOI 10.1001/archinte.150.1.213; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; *NAT AGR STAT SERV, 2008, USDA Q HOGS PIGS REP; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; OBRIEN RJ, 1977, J INFECT DIS, V136, pS390, DOI 10.1093/infdis/136.Supplement_3.S390; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; Olsen CW, 2002, EMERG INFECT DIS, V8, P814, DOI 10.3201/eid0808.010474; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Olsen CW, 2006, DIS SWINE, V9, P469; PATRIARCA PA, 1984, AM J EPIDEMIOL, V119, P152, DOI 10.1093/oxfordjournals.aje.a113733; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Robinson JL, 2007, EMERG INFECT DIS, V13, P1865, DOI 10.3201/eid1312.070615; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Shope R E, 1931, J Exp Med, V54, P373, DOI 10.1084/jem.54.3.373; SMITH TF, 1976, NEW ENGL J MED, V294, P708, DOI 10.1056/NEJM197603252941308; THOMPSON RL, 1976, NEW ENGL J MED, V295, P714, DOI 10.1056/NEJM197609232951307; TOP FH, 1977, J INFECT DIS, V136, pS376, DOI 10.1093/infdis/136.Supplement_3.S376; VINCENT AL, 2009, VET MICROBIOL   0106; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; WELLS DL, 1991, JAMA-J AM MED ASSOC, V265, P478, DOI 10.1001/jama.265.4.478; Wentworth DE, 1997, J INFECT DIS, V175, P7, DOI 10.1093/infdis/175.1.7; WENTWORTH DE, 1994, J VIROL, V68, P2051, DOI 10.1128/JVI.68.4.2051-2058.1994	43	433	490	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2616	2625		10.1056/NEJMoa0903812	http://dx.doi.org/10.1056/NEJMoa0903812			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19423871				2022-12-28	WOS:000267060000006
J	Gubernator, NG; Zhang, H; Staal, RGW; Mosharov, EV; Pereira, DB; Yue, M; Balsanek, V; Vadola, PA; Mukherjee, B; Edwards, RH; Sulzer, D; Sames, D				Gubernator, Niko G.; Zhang, Hui; Staal, Roland G. W.; Mosharov, Eugene V.; Pereira, Daniela B.; Yue, Minerva; Balsanek, Vojtech; Vadola, Paul A.; Mukherjee, Bipasha; Edwards, Robert H.; Sulzer, David; Sames, Dalibor			Fluorescent False Neurotransmitters Visualize Dopamine Release from Individual Presynaptic Terminals	SCIENCE			English	Article							VESICULAR MONOAMINE TRANSPORTER; NEURONS; AMPHETAMINES; TRANSMITTER; PROBABILITY; GRANULES; NICOTINE; SYNAPSE	The nervous system transmits signals between neurons via neurotransmitter release during synaptic vesicle fusion. In order to observe neurotransmitter uptake and release from individual presynaptic terminals directly, we designed fluorescent false neurotransmitters as substrates for the synaptic vesicle monoamine transporter. Using these probes to image dopamine release in the striatum, we made several observations pertinent to synaptic plasticity. We found that the fraction of synaptic vesicles releasing neurotransmitter per stimulus was dependent on the stimulus frequency. A kinetically distinct "reserve" synaptic vesicle population was not observed under these experimental conditions. A frequency-dependent heterogeneity of presynaptic terminals was revealed that was dependent in part on D2 dopamine receptors, indicating a mechanism for frequency-dependent coding of presynaptic selection.	[Zhang, Hui; Staal, Roland G. W.; Mosharov, Eugene V.; Pereira, Daniela B.; Yue, Minerva; Sulzer, David] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Zhang, Hui; Staal, Roland G. W.; Mosharov, Eugene V.; Pereira, Daniela B.; Yue, Minerva; Sulzer, David] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Zhang, Hui; Staal, Roland G. W.; Mosharov, Eugene V.; Pereira, Daniela B.; Yue, Minerva; Sulzer, David] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Gubernator, Niko G.; Balsanek, Vojtech; Vadola, Paul A.; Sames, Dalibor] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Mukherjee, Bipasha; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA; [Mukherjee, Bipasha; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Sch Med, San Francisco, CA 94143 USA; [Sulzer, David] New York Psychiat Inst, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.	ds43@columbia.edu; sames@chem.columbia.edu	Pereira, Daniela/AAZ-5285-2021	B. Pereira, Daniela/0000-0003-4872-5505; Staal, Roland/0000-0002-2857-2241	The G. Harold and Leila Y. Mathers Charitable Foundation; Columbia Universitys Research Initiatives in Science and Engineering; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Picower and Parkinsons Disease Foundations; National Alliance for Research on Schizophrenia and Depression; Michael J. Fox Foundation; National Parkinson Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007418] Funding Source: NIH RePORTER	The G. Harold and Leila Y. Mathers Charitable Foundation; Columbia Universitys Research Initiatives in Science and Engineering; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Picower and Parkinsons Disease Foundations; National Alliance for Research on Schizophrenia and Depression(NARSAD); Michael J. Fox Foundation; National Parkinson Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Burke for 6-OHDA injections and advice, M. Sonders for discussion, M. Siu for imaging analysis programming, and J. Schmoranzer for technical support with the TIRFM setup. Columbia University has applied for a patent on fluorescent false neurotransmitters. D. Sames thanks The G. Harold and Leila Y. Mathers Charitable Foundation and Columbia Universitys Research Initiatives in Science and Engineering. D. Sulzer thanks the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the Picower and Parkinsons Disease Foundations. H.Z. thanks the National Alliance for Research on Schizophrenia and Depression. R.H.E. thanks the Michael J. Fox Foundation, the National Parkinson Foundation, NIDA, and NIMH.	Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Chen G, 2005, J AM CHEM SOC, V127, P4544, DOI 10.1021/ja0428457; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; KOPIN IJ, 1968, ANNU REV PHARMACOLOG, V8, P377, DOI 10.1146/annurev.pa.08.040168.002113; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Oo TF, 2002, EXP NEUROL, V175, P1, DOI 10.1006/exnr.2002.7881; Partilla JS, 2006, J PHARMACOL EXP THER, V319, P237, DOI 10.1124/jpet.106.103622; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; SULZER D, 1990, NEURON, V5, P797, DOI 10.1016/0896-6273(90)90339-H; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	23	147	154	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1441	1444		10.1126/science.1172278	http://dx.doi.org/10.1126/science.1172278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19423778	Green Accepted			2022-12-28	WOS:000266878700045
J	Mehta, R; Steinkraus, KA; Sutphin, GL; Ramos, FJ; Shamieh, LS; Huh, A; Davis, C; Chandler-Brown, D; Kaeberlein, M				Mehta, Ranjana; Steinkraus, Katherine A.; Sutphin, George L.; Ramos, Fresnida J.; Shamieh, Lara S.; Huh, Alexander; Davis, Christina; Chandler-Brown, Devon; Kaeberlein, Matt			Proteasomal Regulation of the Hypoxic Response Modulates Aging in C-elegans	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIFE-SPAN; DIETARY RESTRICTION; LONGEVITY; PROTEOTOXICITY; PROTEIN; DAF-16; FAMILY; ADAPTATION; EXTENSION	The Caenorhabditis elegans von Hippel-Lindau tumor suppressor homolog VHL-1 is a cullin E3 ubiquitin ligase that negatively regulates the hypoxic response by promoting ubiquitination and degradation of the hypoxic response transcription factor HIF-1. Here, we report that loss of VHL-1 significantly increased life span and enhanced resistance to polyglutamine and beta-amyloid toxicity. Deletion of HIF-1 was epistatic to VHL-1, indicating that HIF-1 acts downstream of VHL-1 to modulate aging and proteotoxicity. VHL-1 and HIF-1 control longevity by a mechanism distinct from both dietary restriction and insulin-like signaling. These findings define VHL-1 and the hypoxic response as an alternative longevity and protein homeostasis pathway.	[Mehta, Ranjana; Steinkraus, Katherine A.; Ramos, Fresnida J.; Shamieh, Lara S.; Huh, Alexander; Davis, Christina; Chandler-Brown, Devon; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Sutphin, George L.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@u.washington.edu	Sutphin, George L./AAE-6151-2020	Sutphin, George/0000-0002-3659-4678	Alzheimers Association [IIRG-07-60158]; Glenn/AFAR (American Federation for Aging Research) award; NIH [1R01AG031108-01, P30AG013280]; Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING [P30AG013280, R01AG031108] Funding Source: NIH RePORTER	Alzheimers Association(Alzheimer's Association); Glenn/AFAR (American Federation for Aging Research) award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank B. Kennedy and P. Kapahi for helpful discussion. Strains were provided by the Caenorhabditis Genetics Center. This work was supported by Alzheimers Association grant IIRG-07-60158, a Glenn/AFAR (American Federation for Aging Research) Breakthroughs in Gerontology award, and NIH grant 1R01AG031108-01 to M.K. R.M. and K.A.S. were supported by postdoctoral fellowships from the Hereditary Disease Foundation. G.L.S., L.S.S., and F.J.R. were supported by NIH grant P30AG013280. M.K. is an Ellison Medical Foundation New Scholar in Aging.	Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105	25	168	210	5	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1196	1198		10.1126/science.1173507	http://dx.doi.org/10.1126/science.1173507			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19372390	Green Accepted			2022-12-28	WOS:000266410100045
J	Shukla, VK; Doyon, Y; Miller, JC; DeKelver, RC; Moehle, EA; Worden, SE; Mitchell, JC; Arnold, NL; Gopalan, S; Meng, XD; Choi, VM; Rock, JM; Wu, YY; Katibah, GE; Zhifang, G; McCaskill, D; Simpson, MA; Blakeslee, B; Greenwalt, SA; Butler, HJ; Hinkley, SJ; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD				Shukla, Vipula K.; Doyon, Yannick; Miller, Jeffrey C.; DeKelver, Russell C.; Moehle, Erica A.; Worden, Sarah E.; Mitchell, Jon C.; Arnold, Nicole L.; Gopalan, Sunita; Meng, Xiangdong; Choi, Vivian M.; Rock, Jeremy M.; Wu, Ying-Ying; Katibah, George E.; Zhifang, Gao; McCaskill, David; Simpson, Matthew A.; Blakeslee, Beth; Greenwalt, Scott A.; Butler, Holly J.; Hinkley, Sarah J.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.			Precise genome modification in the crop species Zea mays using zinc-finger nucleases	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MEDIATED TRANSFORMATION; GENE; EXPRESSION; MAIZE; CLEAVAGE; SEQUENCE; CELLS; MUTAGENESIS; DISRUPTION	Agricultural biotechnology is limited by the inefficiencies of conventional random mutagenesis and transgenesis. Because targeted genome modification in plants has been intractable(1), plant trait engineering remains a laborious, time-consuming and unpredictable undertaking. Here we report a broadly applicable, versatile solution to this problem: the use of designed zinc-finger nucleases (ZFNs) that induce a double-stranded break at their target locus(2). We describe the use of ZFNs to modify endogenous loci in plants of the crop species Zea mays. We show that simultaneous expression of ZFNs and delivery of a simple heterologous donor molecule leads to precise targeted addition of an herbicide-tolerance gene at the intended locus in a significant number of isolated events. ZFN-modified maize plants faithfully transmit these genetic changes to the next generation. Insertional disruption of one target locus, IPK1, results in both herbicide tolerance and the expected alteration of the inositol phosphate profile in developing seeds. ZFNs can be used in any plant species amenable to DNA delivery; our results therefore establish a new strategy for plant genetic manipulation in basic science and agricultural applications.	[Shukla, Vipula K.; Worden, Sarah E.; Mitchell, Jon C.; Arnold, Nicole L.; Zhifang, Gao; McCaskill, David; Simpson, Matthew A.; Blakeslee, Beth; Greenwalt, Scott A.; Butler, Holly J.] Dow AgroSci, Indianapolis, IN 46268 USA; [Doyon, Yannick; Miller, Jeffrey C.; DeKelver, Russell C.; Moehle, Erica A.; Gopalan, Sunita; Meng, Xiangdong; Choi, Vivian M.; Rock, Jeremy M.; Wu, Ying-Ying; Katibah, George E.; Hinkley, Sarah J.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Point Richmond Tech Ctr, Richmond, CA 94804 USA	Dow Chemical Company	Shukla, VK (corresponding author), Dow AgroSci, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.	vkshukla@dow.com		Rock, Jeremy/0000-0002-9310-951X; Gregory, Philip/0000-0001-9249-2468; Doyon, Yannick/0000-0002-3889-9563				Armstrong C. L., 1991, Maize Genetics Cooperation News Letter, P92; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; BUSCHER BAP, 1995, J CHROMATOGR A, V712, P235, DOI 10.1016/0021-9673(95)00202-X; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; GORDONKAMM WJ, 1990, PLANT CELL, V2, P603, DOI 10.1105/tpc.2.7.603; Hsu FF, 2003, J MASS SPECTROM, V38, P447, DOI 10.1002/jms.457; Iida S, 2005, PLANT MOL BIOL, V59, P205, DOI 10.1007/s11103-005-2162-x; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; MADDALONI M, 1989, NUCLEIC ACIDS RES, V17, P7532, DOI 10.1093/nar/17.18.7532; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; MCELROY D, 1990, PLANT CELL, V2, P163, DOI 10.1105/tpc.2.2.163; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petolino JF, 2000, PLANT CELL REP, V19, P781, DOI 10.1007/s002999900180; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 2002, PLANT MOL BIOL, V48, P173, DOI 10.1023/A:1013761821763; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Skoglund E, 1997, J AGR FOOD CHEM, V45, P431, DOI 10.1021/jf9603238; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Sun YJ, 2007, PLANT PHYSIOL, V144, P1278, DOI 10.1104/pp.107.095455; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; WOHLLEBEN W, 1988, GENE, V70, P25, DOI 10.1016/0378-1119(88)90101-1; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x	44	565	686	3	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					437	U156		10.1038/nature07992	http://dx.doi.org/10.1038/nature07992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404259				2022-12-28	WOS:000266243700048
J	Sotelo, J; Perez-Padilla, R				Sotelo, Julio; Perez-Padilla, Rogelio			Personal View The flu epidemic in Mexico: the challenges for doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sotelo, Julio] Inst Hlth & Specialty Hosp Mexico, Mexico City, DF, Mexico; [Perez-Padilla, Rogelio] Natl Inst Resp Dis Mexico, Mexico City, DF, Mexico		Sotelo, J (corresponding author), Inst Hlth & Specialty Hosp Mexico, Mexico City, DF, Mexico.	jsotelo@unam.mx							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2009	338								b1820	10.1136/bmj.b1820	http://dx.doi.org/10.1136/bmj.b1820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GT	19416996				2022-12-28	WOS:000265969400007
J	Borgdorff, MW; Small, PM				Borgdorff, Martien W.; Small, Peter M.			Scratching the surface of ignorance on MDR tuberculosis	LANCET			English	Editorial Material							RESISTANCE		[Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands; [Small, Peter M.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Small, Peter M.] Inst Syst Biol, Seattle, WA USA	University of Amsterdam; Academic Medical Center Amsterdam; Bill & Melinda Gates Foundation; Institute for Systems Biology (ISB)	Borgdorff, MW (corresponding author), Univ Amsterdam, Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands.	m.w.borgdorff@amc.uva.nl						[Anonymous], 2008, 4 WHO; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; Cohen T, 2008, AM J RESP CRIT CARE, V177, P1302, DOI 10.1164/rccm.200801-175PP; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; World Health Organization, 2008, WHO POL STAT MOL LIN; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	16	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2009	373	9678					1822	1824		10.1016/S0140-6736(09)60557-2	http://dx.doi.org/10.1016/S0140-6736(09)60557-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19375157				2022-12-28	WOS:000266616400005
J	Hare, TA; Camerer, CF; Rangel, A				Hare, Todd A.; Camerer, Colin F.; Rangel, Antonio			Self-Control in Decision-Making Involves Modulation of the vmPFC Valuation System	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; COGNITIVE CONTROL; LIMITED-RESOURCE; WORKING-MEMORY; REWARD; DELAY; CONFLICT; PERFORMANCE	Every day, individuals make dozens of choices between an alternative with higher overall value and a more tempting but ultimately inferior option. Optimal decision-making requires self-control. We propose two hypotheses about the neurobiology of self-control: (i) Goal-directed decisions have their basis in a common value signal encoded in ventromedial prefrontal cortex (vmPFC), and (ii) exercising self-control involves the modulation of this value signal by dorsolateral prefrontal cortex (DLPFC). We used functional magnetic resonance imaging to monitor brain activity while dieters engaged in real decisions about food consumption. Activity in vmPFC was correlated with goal values regardless of the amount of self-control. It incorporated both taste and health in self-controllers but only taste in non-self-controllers. Activity in DLPFC increased when subjects exercised self-control and correlated with activity in vmPFC.	[Hare, Todd A.; Camerer, Colin F.; Rangel, Antonio] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology	Hare, TA (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	thare@hss.caltech.edu	Hare, Todd/AAE-8574-2019; Hare, Todd A/E-7091-2017	Hare, Todd/0000-0002-0260-2772; Hare, Todd A/0000-0002-0260-2772	Moore Foundation; Economic Research Service of the U.S. Department of Agriculture on Behavioral Health Economics Research on Dietary Choice and Obesity	Moore Foundation(Gordon and Betty Moore Foundation); Economic Research Service of the U.S. Department of Agriculture on Behavioral Health Economics Research on Dietary Choice and Obesity	This work was funded by the Moore Foundation and the Economic Research Service of the U.S. Department of Agriculture on Behavioral Health Economics Research on Dietary Choice and Obesity.	Ainslie G, 2003, J EXP ANAL BEHAV, V79, P37, DOI 10.1901/jeab.2003.79-37; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Campbell-Meiklejohn DK, 2008, BIOL PSYCHIAT, V63, P293, DOI 10.1016/j.biopsych.2007.05.014; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Monterosso J, 2007, DRUG ALCOHOL DEPEN, V90, pS100, DOI 10.1016/j.drugalcdep.2006.09.004; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Vohs KD, 2008, J PERS SOC PSYCHOL, V94, P883, DOI 10.1037/0022-3514.94.5.883; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Watanabe M, 2005, EXP BRAIN RES, V166, P263, DOI 10.1007/s00221-005-2358-y	28	1236	1271	11	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					646	648		10.1126/science.1168450	http://dx.doi.org/10.1126/science.1168450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	439DW	19407204	Green Accepted			2022-12-28	WOS:000265608800045
J	Segal, BH				Segal, Brahm H.			MEDICAL PROGRESS Aspergillosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEMATOPOIETIC STEM-CELL; INVASIVE PULMONARY ASPERGILLOSIS; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; LIPOSOMAL AMPHOTERICIN-B; FUNGAL-INFECTIONS; TRANSPLANT RECIPIENTS; ANTIFUNGAL THERAPY; GALACTOMANNAN ANTIGENEMIA; IMMUNOSUPPRESSIVE THERAPY; ITRACONAZOLE PROPHYLAXIS		[Segal, Brahm H.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Segal, Brahm H.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Segal, BH (corresponding author), Roswell Pk Canc Inst, Dept Med, Elm & Carlton Sts, Buffalo, NY 14263 USA.	brahm.segal@roswellpark.org	Segal, Brahm/AAW-2706-2020					Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Benjamin DK, 2006, ANTIMICROB AGENTS CH, V50, P632, DOI 10.1128/AAC.50.2.632-638.2006; BINDER RE, 1982, MEDICINE, V61, P109, DOI 10.1097/00005792-198203000-00005; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Bowden R, 2002, CLIN INFECT DIS, V35, P359, DOI 10.1086/341401; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Caillot D, 2001, J CLIN ONCOL, V19, P253, DOI 10.1200/JCO.2001.19.1.253; Caillot D, 1997, J CLIN ONCOL, V15, P139, DOI 10.1200/JCO.1997.15.1.139; Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986; Chandrasekar PH, 2005, CLIN INFECT DIS, V40, pS392, DOI 10.1086/429333; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Cornely OA, 2007, CLIN INFECT DIS, V44, P1289, DOI 10.1086/514341; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Denning DW, 2006, J INFECTION, V53, P337, DOI 10.1016/j.jinf.2006.03.003; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Einsele H, 2008, CLIN MICROBIOL INFEC, V14, P37, DOI 10.1111/j.1469-0691.2008.01980.x; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Filler SG, 2005, CLIN INFECT DIS, V41, pS208, DOI 10.1086/430000; Gallin JI, 2003, NEW ENGL J MED, V348, P2416, DOI 10.1056/NEJMoa021931; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gavalda J, 2005, CLIN INFECT DIS, V41, P52, DOI 10.1086/430602; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gonzalez Antonio V, 2008, J Natl Compr Canc Netw, V6, P175; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Hadjiliadis D, 2002, CHEST, V121, P128, DOI 10.1378/chest.121.1.128; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Hogaboam CM, 2004, J LEUKOCYTE BIOL, V75, P805, DOI 10.1189/jlb.0703325; Hohl TM, 2008, J INFECT DIS, V198, P176, DOI 10.1086/589304; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Hong Y, 2006, ANTIMICROB AGENTS CH, V50, P935, DOI 10.1128/AAC.50.3.935-942.2006; Jantunen E, 1997, BONE MARROW TRANSPL, V19, P801, DOI 10.1038/sj.bmt.1700737; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kontoyiannis DP, 2005, J INFECT DIS, V191, P1350, DOI 10.1086/428780; Lamaris GA, 2008, J INFECT DIS, V198, P186, DOI 10.1086/589305; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levine S J, 1992, Semin Respir Infect, V7, P81; Madan T, 2001, J CLIN INVEST, V107, P467, DOI 10.1172/JCI10124; Maertens J, 2004, CLIN INFECT DIS, V39, P1563, DOI 10.1086/423381; Maertens J, 2006, CANCER, V107, P2888, DOI 10.1002/cncr.22348; Maertens Johan, 2008, J Natl Compr Canc Netw, V6, P183; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Marr KA, 2004, CLIN INFECT DIS, V39, P797, DOI 10.1086/423380; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martino R, 2006, BLOOD, V108, P2928, DOI 10.1182/blood-2006-03-008706; Marty FM, 2006, TRANSPL INT, V19, P2, DOI 10.1111/j.1432-2277.2005.00218.x; Marty FM, 2007, ANN INTERN MED, V147, P70, DOI 10.7326/0003-4819-147-1-200707030-00018; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Meersseman W, 2008, AM J RESP CRIT CARE, V177, P27, DOI 10.1164/rccm.200704-606OC; Miceli MH, 2007, CANCER-AM CANCER SOC, V110, P112, DOI 10.1002/cncr.22738; Montagnoli C, 2006, J IMMUNOL, V176, P1712, DOI 10.4049/jimmunol.176.3.1712; Morgan J, 2005, MED MYCOL, V43, pS49, DOI 10.1080/13693780400020113; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; MOUY R, 1994, J PEDIATR-US, V125, P998, DOI 10.1016/S0022-3476(05)82023-2; Nash G, 1997, HUM PATHOL, V28, P1268, DOI 10.1016/S0046-8177(97)90200-8; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Nucci M, 2008, CLIN INFECT DIS, V46, P1426, DOI 10.1086/587101; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Odabasi Z, 2004, CLIN INFECT DIS, V39, P199, DOI 10.1086/421944; Pagano L, 2007, CLIN INFECT DIS, V45, P1161, DOI 10.1086/522189; Pagano L, 2007, CLIN INFECT DIS, V44, P1524, DOI 10.1086/517849; Pascual A, 2008, CLIN INFECT DIS, V46, P201, DOI 10.1086/524669; Pascual A, 2007, ANTIMICROB AGENTS CH, V51, P137, DOI 10.1128/AAC.00957-06; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Ramirez-Ortiz ZG, 2008, INFECT IMMUN, V76, P2123, DOI 10.1128/IAI.00047-08; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rivera A, 2006, IMMUNITY, V25, P665, DOI 10.1016/j.immuni.2006.08.016; Roilides E, 2001, J INFECT DIS, V183, P518, DOI 10.1086/318077; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sambatakou H, 2006, AM J MED, V119; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; Segal BH, 2006, CLIN INFECT DIS, V42, P507, DOI 10.1086/499811; Segal BH, 2006, AM J RESP CRIT CARE, V173, P707, DOI 10.1164/rccm.200505-727SO; Segal BH, 1998, MEDICINE, V77, P345, DOI 10.1097/00005792-199809000-00004; Segal BH, 1997, RHEUM DIS CLIN N AM, V23, P219, DOI 10.1016/S0889-857X(05)70327-6; Segal Brahm H, 2008, J Natl Compr Canc Netw, V6, P122; Seibel NL, 2005, ANTIMICROB AGENTS CH, V49, P3317, DOI 10.1128/AAC.49.8.3317-3324.2005; Shaukat A, 2005, MYCOPATHOLOGIA, V159, P181, DOI 10.1007/s11046-004-5495-0; Siddiqui S, 2007, CLIN INFECT DIS, V45, P673, DOI 10.1086/520985; Singh N, 2006, LIVER TRANSPLANT, V12, P1205, DOI 10.1002/lt.20756; Smith J, 2006, ANTIMICROB AGENTS CH, V50, P1570, DOI 10.1128/AAC.50.4.1570-1572.2006; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Stergiopoulou T, 2007, AM J CLIN PATHOL, V127, P349, DOI 10.1309/UJRV9DLC11RM3G8R; Stevens DA, 2000, NEW ENGL J MED, V342, P756, DOI 10.1056/NEJM200003163421102; Stevens DA, 2004, CLIN INFECT DIS, V38, P158; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Sullivan K M, 2001, Hematology Am Soc Hematol Educ Program, P392, DOI 10.1182/asheducation-2001.1.392; Tan K, 2006, J CLIN PHARMACOL, V46, P235, DOI 10.1177/0091270005283837; Trifilio S, 2007, CANCER, V109, P1532, DOI 10.1002/cncr.22568; Ullmann AJ, 2007, NEW ENGL J MED, V357, P428; Ullmann AJ, 2007, NEW ENGL J MED, V356, P335, DOI 10.1056/NEJMoa061098; van Burik JAH, 2004, CLIN INFECT DIS, V39, P1407, DOI 10.1086/422312; van Burik JAH, 2007, BIOL BLOOD MARROW TR, V13, P1487, DOI 10.1016/j.bbmt.2007.08.049; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Walsh TJ, 2007, CLIN INFECT DIS, V44, P2, DOI 10.1086/508774; Walsh TJ, 2005, ANTIMICROB AGENTS CH, V49, P4536, DOI 10.1128/AAC.49.11.4536-4545.2005; Wark PAB, 2003, J ALLERGY CLIN IMMUN, V111, P952, DOI 10.1067/mai.2003.1388; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Wheat LJ, 2008, EUR J CLIN MICROBIOL, V27, P245, DOI 10.1007/s10096-007-0437-7; Woods G, 2007, CANCER-AM CANCER SOC, V110, P830, DOI 10.1002/cncr.22863; Zaas AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000101; Zarember KA, 2007, J IMMUNOL, V178, P6367, DOI 10.4049/jimmunol.178.10.6367; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	112	485	514	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1870	1884		10.1056/NEJMra0808853	http://dx.doi.org/10.1056/NEJMra0808853			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403905				2022-12-28	WOS:000265560300009
J	Petrenko, VV; Smith, AM; Brook, EJ; Lowe, D; Riedel, K; Brailsford, G; Hua, Q; Schaefer, H; Reeh, N; Weiss, RF; Etheridge, D; Severinghaus, JP				Petrenko, Vasilii V.; Smith, Andrew M.; Brook, Edward J.; Lowe, Dave; Riedel, Katja; Brailsford, Gordon; Hua, Quan; Schaefer, Hinrich; Reeh, Niels; Weiss, Ray F.; Etheridge, David; Severinghaus, Jeffrey P.			(CH4)-C-14 Measurements in Greenland Ice: Investigating Last Glacial Termination CH4 Sources	SCIENCE			English	Article							ATMOSPHERIC CH4; METHANE SOURCES; RADIOCARBON; CLIMATE; MARGIN; CARBON; RECORD; C-14	The cause of a large increase of atmospheric methane concentration during the Younger Dryas-Preboreal abrupt climatic transition (similar to 11,600 years ago) has been the subject of much debate. The carbon-14 (C-14) content of methane ((CH4)-C-14) should distinguish between wetland and clathrate contributions to this increase. We present measurements of (CH4)-C-14 in glacial ice, targeting this transition, performed by using ice samples obtained from an ablation site in west Greenland. Measured (CH4)-C-14 values were higher than predicted under any scenario. Sample (CH4)-C-14 appears to be elevated by direct cosmogenic C-14 production in ice. C-14 of CO was measured to better understand this process and correct the sample (CH4)-C-14. Corrected results suggest that wetland sources were likely responsible for the majority of the Younger Dryas-Preboreal CH4 rise.	[Petrenko, Vasilii V.; Weiss, Ray F.; Severinghaus, Jeffrey P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Smith, Andrew M.; Hua, Quan] ANSTO, Menai, NSW 2234, Australia; [Brook, Edward J.] Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA; [Lowe, Dave; Riedel, Katja; Brailsford, Gordon; Schaefer, Hinrich] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Reeh, Niels] Tech Univ Denmark, Natl Space Inst, DTU Space, DK-2800 Kongens Lyngby, Denmark; [Etheridge, David] CSIRO, Marine & Atmospher Res, Aspendale, Vic 3195, Australia	University of California System; University of California San Diego; Scripps Institution of Oceanography; Australian Nuclear Science & Technology Organisation; Oregon State University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Technical University of Denmark; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Petrenko, VV (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	vasilii.petrenko@colorado.edu	Etheridge, David M/B-7334-2013; Hua, Quan/F-9593-2014; Brook, Edward/AAB-7807-2021	Hua, Quan/0000-0003-0179-8539; Smith, Andrew/0000-0002-9193-2617; Schaefer, Hinrich/0000-0002-1163-2818; Petrenko, Vasilii/0000-0002-0263-8759; Etheridge, David/0000-0001-7970-2002	NSF [OPP0221470, OPP0221410]; Packard Fellowship; American Chemical Society [PRF 42551-AC2]; ANSTO Cosmogenic Climate Archives of the Southern Hemisphere project; New Zealand Foundation of Science and Technology [C01X0703]; Australian Climate Change Science Program	NSF(National Science Foundation (NSF)); Packard Fellowship(The David & Lucile Packard Foundation); American Chemical Society(American Chemical Society); ANSTO Cosmogenic Climate Archives of the Southern Hemisphere project; New Zealand Foundation of Science and Technology; Australian Climate Change Science Program	This work was supported by NSF grants OPP0221470 (to J.P.S.) and OPP0221410 (to E.J.B.), a Packard Fellowship (to J.P.S.), an American Chemical Society grant PRF 42551-AC2 (to H.S. and E.J.B.), the ANSTO Cosmogenic Climate Archives of the Southern Hemisphere project, the New Zealand Foundation of Science and Technology (contract C01X0703), and the Australian Climate Change Science Program. We thank D. Ferretti and P. Franz for making 13CH4 measurements; the Keeling laboratory for the use of a CO2 extraction line; G. Emanuel for advice with 14CO2 processing; M. Headly for Kr/Ar and Xe/Ar measurements; D. Lal for valuable discussions; A. Williams, V. Levchenko, R. Moss, T. Bromley, and R. Martin for assistance with sample processing; J. Melton, M. Arsenault, P. Rose, N. Ness, and K. Ranke for help with field sampling; and Z. Wang and J. Mak for 13C of CO measurements. The manuscript was improved by suggestions from E. Nesbit and one anonymous reviewer.	Archer D, 2007, BIOGEOSCIENCES, V4, P521, DOI 10.5194/bg-4-521-2007; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Dlugokencky EJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006035; Etiope G, 2004, ATMOS ENVIRON, V38, P3099, DOI 10.1016/j.atmosenv.2004.04.002; EVANS IM, 1970, THESIS U CAMBRIDGE C; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Kvenvolden KA, 2005, MAR PETROL GEOL, V22, P579, DOI 10.1016/j.marpetgeo.2004.08.004; LAL D, 1990, NATURE, V346, P350, DOI 10.1038/346350a0; MARTINERIE P, 1995, J GEOPHYS RES-ATMOS, V100, P14291, DOI 10.1029/95JD00826; Milkov AV, 2005, ORG GEOCHEM, V36, P681, DOI 10.1016/j.orggeochem.2005.01.010; NISBET EG, 1990, CAN J EARTH SCI, V27, P148, DOI 10.1139/e90-012; Petrenko VV, 2008, J GLACIOL, V54, P233, DOI 10.3189/002214308784886135; Petrenko VV, 2008, RADIOCARBON, V50, P53, DOI 10.1017/S0033822200043368; Petrenko VV, 2006, QUATERNARY SCI REV, V25, P865, DOI 10.1016/j.quascirev.2005.09.005; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; REEH N, 1991, GLOBAL PLANET CHANGE, V90, P373, DOI 10.1016/0921-8181(91)90003-F; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Rossler K, 1984, Adv Space Res, V4, P83, DOI 10.1016/0273-1177(84)90548-9; Schaefer H, 2006, SCIENCE, V313, P1109, DOI 10.1126/science.1126562; Schaefer H, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002889; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; THOMPSON AM, 1993, TELLUS B, V45, P242, DOI 10.1034/j.1600-0889.1993.t01-2-00003.x; WAHLEN M, 1989, SCIENCE, V245, P286, DOI 10.1126/science.245.4915.286; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924; Walter KM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000569; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Winckler G, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014013	29	70	72	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					506	508		10.1126/science.1168909	http://dx.doi.org/10.1126/science.1168909			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390044				2022-12-28	WOS:000265411200045
J	McColl, K				McColl, Karen			Public Health Betting on health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												karen@karenmccoll.co.uk						[Anonymous], 2009, BBC NEWS        0115; Ashraf N, 2006, Q J ECON, V121, P635, DOI 10.1162/qjec.2006.121.2.635; Bosch-Capblanch X, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004808.pub3; GINE X, WORKING PAPER PUT YO; TAROZZI A, COMMITMENT MECH COMP; Thaler RH., 2021, NUDGE FINAL EDITION	6	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2009	338								b1456	10.1136/bmj.b1456	http://dx.doi.org/10.1136/bmj.b1456			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OQ	19389740				2022-12-28	WOS:000265497200001
J	Rybczynski, N; Dawson, MR; Tedford, RH				Rybczynski, Natalia; Dawson, Mary R.; Tedford, Richard H.			A semi-aquatic Arctic mammalian carnivore from the Miocene epoch and origin of Pinnipedia	NATURE			English	Article							PHYLOGENY; IMPACT	Modern pinnipeds (seals, sea lions and the walrus) are semi-aquatic, generally marine carnivores the limbs of which have been modified into flippers. Recent phylogenetic studies using morphological and molecular evidence support pinniped monophyly, and suggest a sister relationship with ursoids(1,2) (for example bears) or musteloids(3-7) (the clade that includes skunks, badgers, weasels and otters). Although the position of pinnipeds within modern carnivores appears moderately well resolved, fossil evidence of the morphological steps leading from a terrestrial ancestor to the modern marine forms has been weak or contentious. The earliest well-represented fossil pinniped is Enaliarctos, a marine form with flippers, which had appeared on the northwestern shores of North America by the early Miocene epoch(8,9). Here we report the discovery of a nearly complete skeleton of a new semi-aquatic carnivore from an early Miocene lake deposit in Nunavut, Canada, that represents a morphological link in early pinniped evolution. The new taxon retains a long tail and the proportions of its fore-and hindlimbs are more similar to those of modern terrestrial carnivores than to modern pinnipeds. Morphological traits indicative of semi-aquatic adaptation include a forelimb with a prominent deltopectoral ridge on the humerus, a posterodorsally expanded scapula, a pelvis with relatively short ilium, a shortened femur and flattened phalanges, suggestive of webbing. The new fossil shows evidence of pinniped affinities and similarities to the early Oligocene Amphicticeps from Asia and the late Oligocene and Miocene Potamotherium from Europe. The discovery suggests that the evolution of pinnipeds included a freshwater transitional phase, and may support the hypothesis that the Arctic was an early centre of pinniped evolution.	[Rybczynski, Natalia] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Dawson, Mary R.] Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; [Tedford, Richard H.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Rybczynski, N (corresponding author), Canadian Museum Nat, POB 3443 STN D, Ottawa, ON K1P 6P4, Canada.	nrybczynski@mus-nature.ca						Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Baskin Jon A., 1998, P152, DOI 10.1017/CBO9780511529924.011; Bebej RM, 2009, J MAMM EVOL, V16, P77, DOI 10.1007/s10914-008-9099-1; BERTA A, 1989, SCIENCE, V244, P60, DOI 10.1126/science.244.4900.60; DARWIN C, 1880, ORIGIN SPECIES MEANS, P180; DAVIES JL, 1958, GEOGR REV, V48, P474, DOI 10.2307/211670; Demere TA, 2003, B AM MUS NAT HIST, P32, DOI 10.1206/0003-0090(2003)279<0032:C>2.0.CO;2; Finarelli J, 2008, J MAMM EVOL, V15, P231, DOI 10.1007/s10914-008-9074-x; FISH FE, 1994, J MAMMAL, V75, P989, DOI 10.2307/1382481; Fish Frank E., 2001, P261; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; FLYNN JJ, 1988, PHYLOGENY CLASSIFICA, V2, P73; Hunt Robert M. Jr, 1994, Proceedings of the San Diego Society of Natural History, V29, P57; JESSBERGER EK, 1988, METEORITICS, V23, P233, DOI 10.1111/j.1945-5100.1988.tb01285.x; Matthew W. D., 1915, Annals of the New York Academy of Sciences, V24; Mitchell E., 1973, Bulletin Am Mus nat Hist, V151, P203; Mors Thomas, 2000, Senckenbergiana Lethaea, V80, P257; Orlov J. A., 1933, Travaux de l'Institut Paleozoologique Acad Sci URSS, V2, P165; Sato JJ, 2006, ZOOL SCI, V23, P125, DOI 10.2108/zsj.23.125; SAVAGE R. J. G., 1957, PROC ZOOL SOC LONDON, V129, P151; SCHMIDT-KITTLER N, 1981, Eclogae Geologicae Helvetiae, V74, P753; Sherlock SC, 2005, METEORIT PLANET SCI, V40, P1777, DOI 10.1111/j.1945-5100.2005.tb00146.x; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; TEDFORD RH, 1976, SYST ZOOL, V25, P363, DOI 10.2307/2412511; Tedford Richard H., 2004, P169; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Wang XM, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)483[0001:AAAACF]2.0.CO;2; WHITLOCK C, 1990, ARCTIC, V43, P324; WOLSAN M, 1993, ACTA THERIOL, V38, P345, DOI 10.4098/AT.arch.93-29; [No title captured]	30	76	79	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1021	1024		10.1038/nature07985	http://dx.doi.org/10.1038/nature07985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396145				2022-12-28	WOS:000265412900041
J	Unterreithmeier, QP; Weig, EM; Kotthaus, JP				Unterreithmeier, Quirin P.; Weig, Eva M.; Kotthaus, Joerg P.			Universal transduction scheme for nanomechanical systems based on dielectric forces	NATURE			English	Article							NANOELECTROMECHANICAL SYSTEMS; PARAMETRIC RESONANCE; MOTION; ACTUATION; OSCILLATOR; NOISE; NEMS	Any polarizable body placed in an inhomogeneous electric field experiences a dielectric force. This phenomenon is well known from the macroscopic world: a water jet is deflected when approached by a charged object. This fundamental mechanism is exploited in a variety of contexts-for example, trapping microscopic particles in an optical tweezer(1), where the trapping force is controlled via the intensity of a laser beam, or dielectrophoresis(2), where electric fields are used to manipulate particles in liquids. Here we extend the underlying concept to the rapidly evolving field of nanoelectromechanical systems(3,4) (NEMS). A broad range of possible applications are anticipated for these systems(5,6,7), but drive and detection schemes for nanomechanical motion still need to be optimized(8,9). Our approach is based on the application of dielectric gradient forces for the controlled and local transduction of NEMS. Using a set of on-chip electrodes to create an electric field gradient, we polarize a dielectric resonator and subject it to an attractive force that can be modulated at high frequencies. This universal actuation scheme is efficient, broadband and scalable. It also separates the driving scheme from the driven mechanical element, allowing for arbitrary polarizable materials and thus potentially ultralow dissipation NEMS10. In addition, it enables simple voltage tuning of the mechanical resonance over a wide frequency range, because the dielectric force depends strongly on the resonator-electrode separation. We use the modulation of the resonance frequency to demonstrate parametric actuation(11,12). Moreover, we reverse the actuation principle to realize dielectric detection, thus allowing universal transduction of NEMS. We expect this combination to be useful both in the study of fundamental principles and in applications such as signal processing and sensing.	[Unterreithmeier, Quirin P.; Weig, Eva M.; Kotthaus, Joerg P.] Univ Munich, Fak Phys, D-80539 Munich, Germany; [Unterreithmeier, Quirin P.; Weig, Eva M.; Kotthaus, Joerg P.] Univ Munich, CeNS, D-80539 Munich, Germany	University of Munich; University of Munich	Kotthaus, JP (corresponding author), Univ Munich, Fak Phys, Geschwister Scholl Pl 1, D-80539 Munich, Germany.	kotthaus@lmu.de	Kotthaus, Jorg P/A-7674-2010; Weig, Eva M/E-9973-2010	Weig, Eva M/0000-0003-4294-8601	Deutsche Forschungsgemeinschaft [Ko 416/18]; German Excellence Initiative via the Nanosystems Initiative Munich (NIM); LMUexcellent; LMUinnovativ	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative via the Nanosystems Initiative Munich (NIM); LMUexcellent; LMUinnovativ	Financial support by the Deutsche Forschungsgemeinschaft via project Ko 416/18, the German Excellence Initiative via the Nanosystems Initiative Munich (NIM) and LMUexcellent as well as LMUinnovativ is gratefully acknowledged.	Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853; Azak NO, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2776981; Bargatin I, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709620; Brown KR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137205; Cleland AN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070501; Ekinci KL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927327; Ekinci KL, 2005, SMALL, V1, P786, DOI 10.1002/smll.200500077; GADELHAK M, 2001, MEMS HDB, P15; Gillespie DT, 1996, AM J PHYS, V64, P225, DOI 10.1119/1.18210; Huang XMH, 2003, NATURE, V421, P496, DOI 10.1038/421496a; Jensen K, 2008, NAT NANOTECHNOL, V3, P533, DOI 10.1038/nnano.2008.200; Jones T. B., 1995, ELECTROMECHANICS PAR; Knobel RG, 2003, NATURE, V424, P291, DOI 10.1038/nature01773; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Li MW, 2008, NAT NANOTECHNOL, V3, P88, DOI 10.1038/nnano.2008.26; Li M, 2008, NATURE, V456, P480, DOI 10.1038/nature07545; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Lifshitz R, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.134302; Mahboob I, 2008, NAT NANOTECHNOL, V3, P275, DOI 10.1038/nnano.2008.84; Masmanidis SC, 2007, SCIENCE, V317, P780, DOI 10.1126/science.1144793; Nayfeh A H, 1995, NONLINEAR OSCIL; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Rhoads JF, 2005, J VIB ACOUST, V127, P423, DOI 10.1115/1.2013301; RUGAR D, 1991, PHYS REV LETT, V67, P699, DOI 10.1103/PhysRevLett.67.699; Sampathkumar A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208381; Sekaric L, 2002, SENSOR ACTUAT A-PHYS, V101, P215, DOI 10.1016/S0924-4247(02)00149-8; Spletzer M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216889; Tang HX, 2002, APPL PHYS LETT, V81, P3879, DOI 10.1063/1.1516237; Verbridge SS, 2006, J APPL PHYS, V99, DOI 10.1063/1.2204829; Zhang WH, 2003, APPL PHYS LETT, V82, P130, DOI 10.1063/1.1534615	30	184	190	3	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1001	1004		10.1038/nature07932	http://dx.doi.org/10.1038/nature07932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396140	Green Submitted			2022-12-28	WOS:000265412900036
J	Wind, JJ; Leiphart, JW				Wind, Joshua J.; Leiphart, James W.			Bilateral Subacute Subdural Hematomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wind, Joshua J.; Leiphart, James W.] George Washington Univ, Washington, DC 20037 USA	George Washington University	Wind, JJ (corresponding author), George Washington Univ, Washington, DC 20037 USA.	jwind@gwu.edu	Wind, Joshua J/D-5480-2013	Wind, Joshua J/0000-0003-3443-8476					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					E23	E23		10.1056/NEJMicm0708110	http://dx.doi.org/10.1056/NEJMicm0708110			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19387014				2022-12-28	WOS:000265377800012
J	Curtis, JP; Luebbert, JJ; Wang, YF; Rathore, SS; Chen, J; Heidenreich, PA; Hammill, SC; Lampert, RI; Krumholz, HM				Curtis, Jeptha P.; Luebbert, Jeffrey J.; Wang, Yongfei; Rathore, Saif S.; Chen, Jersey; Heidenreich, Paul A.; Hammill, Stephen C.; Lampert, Rachel I.; Krumholz, Harlan M.			Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	81st Annual Scientific Session of the American-Heart-Association	NOV 08-12, 2008	New Orleans, LA	Amer Heart Assoc			CARDIAC-RESYNCHRONIZATION THERAPY; MYOCARDIAL-INFARCTION; SURGEON SPECIALTY; COMPLICATIONS; MORTALITY; TRACK; RISK; CARE; ICD	Context Allowing nonelectrophysiologists to perform implantable cardioverter-defibrillator (ICD) procedures is controversial. However, it is not known whether outcomes of ICD implantation vary by physician specialty. Objective To determine the association of implanting physician certification with outcomes following ICD implantation. Design, Setting, and Patients Retrospective cohort study using cases submitted to the ICD Registry performed between January 2006 and June 2007. Patients were grouped by the certification status of the implanting physician into mutually exclusive categories: electrophysiologists, nonelectrophysiologist cardiologists, thoracic surgeons, and other specialists. Hierarchical logistic regression models were developed to determine the independent association of physician certification with outcomes. Main Outcome Measures In-hospital procedural complication rates and the proportion of patients meeting criteria for a defibrillator with cardiac resynchronization therapy (CRT-D) who received that device. Results Of 111 293 ICD implantations included in the analysis, 78 857 (70.9%) were performed by electrophysiologists, 24 399 (21.9%) by nonelectrophysiologist cardiologists, 1862 (1.7%) by thoracic surgeons, and 6175 (5.5%) by other specialists. Compared with patients whose ICD was implanted by electrophysiologists, patients whose ICD was implanted by either nonelectrophysiologist cardiologists or thoracic surgeons were at increased risk of complications in both unadjusted (electrophysiologists, 3.5% [2743/78 857]; nonelectrophysiologist cardiologists, 4.0% [970/24 399]; thoracic surgeons, 5.8% [108/1862]; P < .001) and adjusted analyses (relative risk [RR] for nonelectrophysiologist cardiologists, 1.11 [95% confidence interval {CI}, 1.01-1.21]; RR for thoracic surgeons, 1.44 [ 95% CI, 1.15-1.79]). Among 35 841 patients who met criteria for CRT-D, those whose ICD was implanted by physicians other than electrophysiologists were significantly less likely to receive a CRT-D device compared with patients whose ICD was implanted by an electrophysiologist in both unadjusted (electrophysiologists, 83.1% [21 303/25 635]; nonelectrophysiologist cardiologists, 75.8% [5950/7849]; thoracic surgeons, 57.8% [269/465]; other specialists, 74.8% [1416/1892]; P < .001) and adjusted analyses ( RR for nonelectrophysiologist cardiologists, 0.93 [95% CI, 0.91-0.95]; RR for thoracic surgeons, 0.81 [95% CI, 0.74-0.88]; RR for other specialists, 0.97 [95% CI, 0.94-0.99]). Conclusions In this registry, nonelectrophysiologists implanted 29% of ICDs. Overall, implantations by a nonelectrophysiologist were associated with a higher risk of procedural complications and lower likelihood of receiving a CRT-D device when indicated compared with patients whose ICD was implanted by an electrophysiologist.	[Curtis, Jeptha P.; Wang, Yongfei; Chen, Jersey; Lampert, Rachel I.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Rathore, Saif S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Sch Publ Hlth, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Luebbert, Jeffrey J.] Thomas Jefferson Univ, Sch Med, Dept Internal Med, Cardiol Sect, Philadelphia, PA 19107 USA; [Heidenreich, Paul A.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Hammill, Stephen C.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Yale University; Yale University; Yale University; Yale University; Yale University; Jefferson University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Mayo Clinic	Curtis, JP (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, POB 208017, New Haven, CT 06520 USA.	jeptha.curtis@yale.edu	, Harlan/AAI-2875-2020; Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR024139, UL1 RR024139-01] Funding Source: Medline; NIGMS NIH HHS [T32 GM007205-35, T32 GM007205] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Khatib SM, 2008, CIRC-ARRHYTHMIA ELEC, V1, P240, DOI 10.1161/CIRCEP.108.777888; Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063; Austin PC, 2003, AM HEART J, V145, P27, DOI 10.1067/mhj.2003.23; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Chen J, 2006, J GEN INTERN MED, V21, P238, DOI 10.1111/j.1525-1497.2006.00326.x; Curtis AB, 2005, J AM COLL CARDIOL, V46, P1541, DOI 10.1016/j.jacc.2005.07.029; Curtis AB, 2004, HEART RHYTHM, V1, P371, DOI 10.1016/j.hrthm.2004.08.003; Day JD, 2005, HEART RHYTHM, V2, P1161, DOI 10.1016/j.hrthm.2005.08.025; Earle CC, 2006, J NATL CANCER I, V98, P172, DOI 10.1093/jnci/djj019; Feasby TE, 2002, ARCH NEUROL-CHICAGO, V59, P1877, DOI 10.1001/archneur.59.12.1877; Goodney PP, 2005, ANN SURG, V241, P179; Gorcsan J, 2008, J AM SOC ECHOCARDIOG, V21, P191, DOI 10.1016/j.echo.2008.01.003; Hammill SC, 2004, HEART RHYTHM, V1, P376, DOI 10.1016/j.hrthm.2004.08.002; Hammill SC, 2008, HEART RHYTHM, V5, P1359, DOI 10.1016/j.hrthm.2008.07.015; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; *ICD REG, IMPL CARD DEF REG V1; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; MEIER B, 2006, NY TIMES        0801, pC6; Meier Barry, 2006, N Y Times Web, pC6; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Olshansky B, 2006, PACE, V29, P627, DOI 10.1111/j.1540-8159.2006.00410.x; Reynolds MR, 2006, J AM COLL CARDIOL, V47, P2493, DOI 10.1016/j.jacc.2006.02.049; Upadhyay GA, 2008, J AM COLL CARDIOL, V52, P1239, DOI 10.1016/j.jacc.2008.06.043; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	29	122	125	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1661	1670		10.1001/jama.2009.547	http://dx.doi.org/10.1001/jama.2009.547			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	435NN	19383957	Green Accepted			2022-12-28	WOS:000265350700022
J	Massel, D; Teefy, PJ				Massel, David; Teefy, Patrick J.			Transfer for PCI reduces 30-day mortality more than on-site thrombolysis in STEMI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MYOCARDIAL-INFARCTION		[Massel, David; Teefy, Patrick J.] London Hlth Sci Ctr, London, ON, Canada	London Health Sciences Centre	Massel, D (corresponding author), London Hlth Sci Ctr, London, ON, Canada.							Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-4	10.7326/0003-4819-150-8-200904210-02004	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391209				2022-12-28	WOS:000265457000019
J	Wieffer, M; Maritzen, T; Haucke, V				Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker			SnapShot: Endocytic Trafficking	CELL			English	Editorial Material							MEMBRANE		[Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker] Free Univ Berlin, D-1000 Berlin, Germany; [Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker] Charite Univ Med Berlin, D-13353 Berlin, Germany; [Haucke, Volker] Leibniz Inst Mol Pharmacol, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wieffer, M (corresponding author), Free Univ Berlin, D-1000 Berlin, Germany.			Haucke, Volker/0000-0003-3119-6993; Maritzen, Tanja/0000-0003-4993-0340				Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Puertollano R, 2004, EMBO REP, V5, P942, DOI 10.1038/sj.embor.7400249; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003	10	45	45	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2							382.e1	10.1016/j.cell.2009.04.012	http://dx.doi.org/10.1016/j.cell.2009.04.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379701	Bronze			2022-12-28	WOS:000265456800030
J	Rawlins, MD				Rawlins, Michael D.			The decade of NICE	LANCET			English	Editorial Material							CLINICAL EXCELLENCE; PRACTICE GUIDELINES; NATIONAL INSTITUTE; HEALTH-CARE; QUALITY		Natl Inst Hlth & Clin Excellence, London WC1V, England	National Institute for Health & Care Excellence	Rawlins, MD (corresponding author), Natl Inst Hlth & Clin Excellence, MidCity Pl,71 High Holborn, London WC1V, England.	michael.rawlins@nice.org.uk						*DEP HLTH, 1998, 1 CLASS SERV QUAL NE; Department of Health, 2008, NHS NEXT STAG REV OU; Drummond M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3182; Gaebel W, 2005, BRIT J PSYCHIAT, V187, P248, DOI 10.1192/bjp.187.3.248; HOPE J, 2005, DAILY MAIL LOND 1026, P1; Morrison DS, 2009, J PUBLIC HEALTH-UK, V31, P127, DOI 10.1093/pubmed/fdn107; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; NICE, 2017, HYP IMPR BLOOD PRESS; *NICE, 2008, NAT IMPL PROGR; *NICE, 2005, LONG ACT REV CONTR E, P1; *NICE, 2002, SCH COR INT TREATM M; *NICE, 2004, HYP PERS HIGH BLOOD; *NICE, 2008, ANT PROPH INF END CG; Rawlins M, 1999, LANCET, V353, P1079, DOI 10.1016/S0140-6736(99)02381-8; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Speight J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b85; WILKINSON E, 2009, BBC NEWS	17	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 25	2009	374	9686					351	352		10.1016/S0140-6736(09)60616-4	http://dx.doi.org/10.1016/S0140-6736(09)60616-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19394075				2022-12-28	WOS:000268508200032
J	Liu, J; Cao, L; Chen, JC; Song, SW; Lee, IH; Quijano, C; Liu, HJ; Keyvanfar, K; Chen, HQ; Cao, LY; Ahn, BH; Kumar, NG; Rovira, II; Xu, XL; van Lohuizen, M; Motoyama, N; Deng, CX; Finkel, T				Liu, Jie; Cao, Liu; Chen, Jichun; Song, Shiwei; Lee, In Hye; Quijano, Celia; Liu, Hongjun; Keyvanfar, Keyvan; Chen, Haoqian; Cao, Long-Yue; Ahn, Bong-Hyun; Kumar, Neil G.; Rovira, Ilsa I.; Xu, Xiao-Ling; van Lohuizen, Maarten; Motoyama, Noboru; Deng, Chu-Xia; Finkel, Toren			Bmi1 regulates mitochondrial function and the DNA damage response pathway	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; REPAIR; PROLIFERATION; SENESCENCE; INK4A; MICE; P16(INK4A); TARGET; GROWTH	Mice deficient in the Polycomb repressor Bmi1 develop numerous abnormalities including a severe defect in stem cell self-renewal, alterations in thymocyte maturation and a shortened lifespan. Previous work has implicated de-repression of the Ink4a/Arf (also known as Cdkn2a) locus as mediating many of the aspects of the Bmi1(-/-) phenotype. Here we demonstrate that cells derived from Bmi1(-/-) mice also have impaired mitochondrial function, a marked increase in the intracellular levels of reactive oxygen species and subsequent engagement of the DNA damage response pathway. Furthermore, many of the deficiencies normally observed in Bmi1(-/-) mice improve after either pharmacological treatment with the antioxidant N-acetylcysteine or genetic disruption of the DNA damage response pathway by Chk2 (also known as Chek2) deletion. These results demonstrate that Bmi1 has an unexpected role in maintaining mitochondrial function and redox homeostasis and indicate that the Polycomb family of proteins can coordinately regulate cellular metabolism with stem and progenitor cell function.	[Liu, Jie; Cao, Liu; Song, Shiwei; Lee, In Hye; Quijano, Celia; Liu, Hongjun; Chen, Haoqian; Cao, Long-Yue; Ahn, Bong-Hyun; Kumar, Neil G.; Rovira, Ilsa I.; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA; [Cao, Liu; Keyvanfar, Keyvan] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Kumar, Neil G.] NIH, Howard Hughes Med Inst, Res Scholar Program, Bethesda, MD 20892 USA; [Xu, Xiao-Ling; Deng, Chu-Xia] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Motoyama, Noboru] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Geriatr Med, Aichi 4748522, Japan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Netherlands Cancer Institute; National Center for Geriatrics & Gerontology	Finkel, T (corresponding author), NHLBI, Translat Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	Liu.Cao@nih.gov; finkelt@nih.gov	deng, chuxia/N-6713-2016; LEE, IN HYE/T-2714-2019	LEE, IN HYE/0000-0003-2334-3594	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 HL005012-11] Funding Source: Medline; NIA NIH HHS [R00 AG032356] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037, ZICHL005906, ZIAHL005012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056011, ZIADK056009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG032356] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Smith AL, 2005, J GERONTOL A-BIOL, V60, P448, DOI 10.1093/gerona/60.4.448; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104	38	368	381	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					387	U100		10.1038/nature08040	http://dx.doi.org/10.1038/nature08040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404261	Green Accepted			2022-12-28	WOS:000266243700037
J	Boothroyd, CE; Dreesen, O; Leonova, T; Ly, KI; Figueiredo, LM; Cross, GAM; Papavasiliou, FN				Boothroyd, Catharine E.; Dreesen, Oliver; Leonova, Tatyana; Ly, K. Ina; Figueiredo, Luisa M.; Cross, George A. M.; Papavasiliou, F. Nina			A yeast-endonuclease-generated DNA break induces antigenic switching in Trypanosoma brucei	NATURE			English	Article							VSG EXPRESSION SITE; AFRICAN TRYPANOSOMES; SURFACE-ANTIGENS; GENE-EXPRESSION; TRANSCRIPTION; ACTIVATION; SEQUENCES; COPIES; END	Trypanosoma brucei is the causative agent of African sleeping sickness in humans and one of the causes of nagana in cattle. This protozoan parasite evades the host immune system by antigenic variation, a periodic switching of its variant surface glycoprotein (VSG) coat. VSG switching is spontaneous and occurs at a rate of about 10(-2)-10(-3) per population doubling in recent isolates from nature, but at a markedly reduced rate (10(-5)-10(-6)) in laboratory-adapted strains(1-3). VSG switching is thought to occur predominantly through gene conversion, a form of homologous recombination initiated by a DNA lesion that is used by other pathogens (for example, Candida albicans, Borrelia sp. and Neisseria gonorrhoeae) to generate surface protein diversity, and by B lymphocytes of the vertebrate immune system to generate antibody diversity. Very little is known about the molecular mechanism of VSG switching in T. brucei. Here we demonstrate that the introduction of a DNA double-stranded break (DSB) adjacent to the similar to 70-base-pair ( bp) repeats upstream of the transcribed VSG gene increases switching in vitro similar to 250-fold, producing switched clones with a frequency and features similar to those generated early in an infection. We were also able to detect spontaneous DSBs within the 70-bp repeats upstream of the actively transcribed VSG gene, indicating that a DSB is a natural intermediate of VSG gene conversion and that VSG switching is the result of the resolution of this DSB by break-induced replication.	[Boothroyd, Catharine E.; Leonova, Tatyana; Ly, K. Ina; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA; [Dreesen, Oliver; Figueiredo, Luisa M.; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Papavasiliou, FN (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA.	papavas@rockefeller.edu	Cross, George A M/B-7444-2011; Figueiredo, Luisa Miranda/C-3908-2018; Dreesen, Oliver/AAJ-2132-2020	Cross, George A M/0000-0003-1374-6955; Figueiredo, Luisa Miranda/0000-0002-5752-6586; 	the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R01AI021729]; C. H. Revson Foundation; German National Academic Foundation; Otto Ritter Foundation; W. M. Keck Foundation; Irma T. Hirschl Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729, R01AI085973] Funding Source: NIH RePORTER	the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); C. H. Revson Foundation; German National Academic Foundation; Otto Ritter Foundation; W. M. Keck Foundation(W.M. Keck Foundation); Irma T. Hirschl Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards from the C. H. Revson Foundation ( to C. E. B.), the German National Academic Foundation ( to K. I. L.), the Otto Ritter Foundation ( to K. I. L.), the W. M. Keck Foundation ( to F. N. P.), the Irma T. Hirschl Foundation ( to F. N. P.) and by grant number R01AI021729 from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health ( to G. A. M. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the NIH.	Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; BERNARDS A, 1981, CELL, V27, P497, DOI 10.1016/0092-8674(81)90391-3; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; DELANGE T, 1985, EMBO J, V4, P3299, DOI 10.1002/j.1460-2075.1985.tb04080.x; DELANGE T, 1982, NATURE, V299, P451, DOI 10.1038/299451a0; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Dreesen O, 2006, EUKARYOT CELL, V5, P2114, DOI 10.1128/EC.00059-06; Dreesen O, 2006, MOL CELL BIOL, V26, P4911, DOI 10.1128/MCB.00212-06; Glover L, 2008, NUCLEIC ACIDS RES, V36, P2608, DOI 10.1093/nar/gkn104; Glover L, 2007, NUCLEIC ACIDS RES, V35, P872, DOI 10.1093/nar/gkl1100; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; HOEIJMAKERS JHJ, 1980, NATURE, V284, P78, DOI 10.1038/284078a0; Horn D, 1997, MOL BIOCHEM PARASIT, V84, P189, DOI 10.1016/S0166-6851(96)02794-6; Horn D, 2004, CURR MOL MED, V4, P563, DOI 10.2174/1566524043360078; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; McCulloch R, 1997, MOL CELL BIOL, V17, P833, DOI 10.1128/MCB.17.2.833; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; Ohshima K, 1996, J BIOL CHEM, V271, P16784, DOI 10.1074/jbc.271.28.16784; Robinson NP, 1999, MOL CELL BIOL, V19, P5839; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Turner CMR, 1997, FEMS MICROBIOL LETT, V153, P227, DOI 10.1111/j.1574-6968.1997.tb10486.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386	30	107	108	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					278	U168		10.1038/nature07982	http://dx.doi.org/10.1038/nature07982			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19369939	Green Accepted			2022-12-28	WOS:000266036100047
J	Jones, MK; Liu, XY				Jones, Martin K.; Liu, Xinyi			Origins of Agriculture in East Asia	SCIENCE			English	Editorial Material							RICE DOMESTICATION; CHINA; CULTIVATION; RIVER		[Jones, Martin K.; Liu, Xinyi] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England	University of Cambridge	Jones, MK (corresponding author), Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England.	mkj12@cam.ac.uk	liu, xinyi/GWZ-8739-2022					Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Brown TA, 2009, TRENDS ECOL EVOL, V24, P103, DOI 10.1016/j.tree.2008.09.008; Crawford G., 2007, DONGFANG KAOGU, V3, P247; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; GARRIS AJ, 2005, GENETICS, V74, P21; Hunt HV, 2008, VEG HIST ARCHAEOBOT, V17, pS5, DOI 10.1007/s00334-008-0187-1; Jiang LP, 2006, ANTIQUITY, V80, P355, DOI 10.1017/S0003598X00093674; Jin G., 2007, NONGYE KAOGU, V4, P11; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li XQ, 2007, SCI CHINA SER D, V50, P1707, DOI 10.1007/s11430-007-0066-0; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Liu XY, 2009, ANTIQUITY, V83, P82, DOI 10.1017/S0003598X00098100; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Willcox G, 2008, VEG HIST ARCHAEOBOT, V17, P313, DOI 10.1007/s00334-007-0121-y; Zhao Z., 2005, KAOGU, V454, P522; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524	20	78	98	7	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					730	731		10.1126/science.1172082	http://dx.doi.org/10.1126/science.1172082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	442HN	19423806				2022-12-28	WOS:000265832400025
J	Esslinger, C; Walter, H; Kirsch, P; Erk, S; Schnell, K; Arnold, C; Haddad, L; Mier, D; von Boberfeld, CO; Raab, K; Witt, SH; Rietschel, M; Cichon, S; Meyer-Lindenberg, A				Esslinger, Christine; Walter, Henrik; Kirsch, Peter; Erk, Susanne; Schnell, Knut; Arnold, Claudia; Haddad, Leila; Mier, Daniela; von Boberfeld, Carola Opitz; Raab, Kyeon; Witt, Stephanie H.; Rietschel, Marcella; Cichon, Sven; Meyer-Lindenberg, Andreas			Neural Mechanisms of a Genome-Wide Supported Psychosis Variant	SCIENCE			English	Article							SCHIZOPHRENIA		[Esslinger, Christine; Kirsch, Peter; Haddad, Leila; Mier, Daniela; Raab, Kyeon; Meyer-Lindenberg, Andreas] Univ Heidelberg, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Walter, Henrik; Schnell, Knut] Univ Bonn, Div Med Psychol, D-53105 Bonn, Germany; [Walter, Henrik; Erk, Susanne; Schnell, Knut; Arnold, Claudia; von Boberfeld, Carola Opitz] Univ Bonn, Dept Psychiat & Psychotherapy, D-53105 Bonn, Germany; [Witt, Stephanie H.; Rietschel, Marcella] Univ Heidelberg, Dept Genet Epidemiol Psychiat, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53105 Bonn, Germany; [Cichon, Sven] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; University of Bonn; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; University of Bonn	Meyer-Lindenberg, A (corresponding author), Univ Heidelberg, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, J5, D-68159 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de	Walter, Henrik/O-2612-2013; Cichon, Sven/H-8803-2013; Kirsch, Peter/C-2499-2008; Cichon, Sven/B-9618-2014; Meyer-Lindenberg, Andreas/H-1076-2011	Cichon, Sven/0000-0002-9475-086X; Kirsch, Peter/0000-0002-0817-1248; Cichon, Sven/0000-0002-9475-086X; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Erk, Susanne/0000-0003-0961-3543; Mier, Daniela/0000-0003-2518-7492; Walter, Henrik/0000-0002-9403-6121	Bundesministerium fur Bildung und Forschung; Deutsche Forschungemeinschaft [SFB 636-B7]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungemeinschaft(German Research Foundation (DFG))	Funding was provided by Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz plus MooDs) and Deutsche Forschungemeinschaft (SFB 636-B7). We thank T. Paul, B. Newport, D. Gass, O. Grimm, and C. Sauer for data acquisition; T. Demirakca and M. Ruf for technical support; and T. Schulze and M. Nothen for helpful discussion.	Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Rasetti R, 2009, AM J PSYCHIAT, V166, P216, DOI 10.1176/appi.ajp.2008.08020261; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005	6	319	339	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					605	605		10.1126/science.1167768	http://dx.doi.org/10.1126/science.1167768			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407193				2022-12-28	WOS:000265608800033
J	Green, DR; Kroemer, G				Green, Douglas R.; Kroemer, Guido			Cytoplasmic functions of the tumour suppressor p53	NATURE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; CELL-DEATH; BCL-XL; APOPTOSIS; AUTOPHAGY; ACTIVATION; TRANSLOCATION; NUCLEAR; ABSENCE; GENES	The principal tumour-suppressor protein, p53, accumulates in cells in response to DNA damage, oncogene activation and other stresses. It acts as a nuclear transcription factor that transactivates genes involved in apoptosis, cell cycle regulation and numerous other processes. An emerging area of research unravels additional activities of p53 in the cytoplasm, where it triggers apoptosis and inhibits autophagy. These previously unknown functions contribute to the mission of p53 as a tumour suppressor.	[Green, Douglas R.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Kroemer, Guido] Univ Paris Sud, Paris 11, France	St Jude Children's Research Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org; kroemer@igr.fr	Green, Douglas R/N-8083-2018; Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	Green, Douglas R/0000-0002-7332-1417; KROEMER, Guido/0000-0002-9334-4405	NIH; American Lebanese and Syrian Associated Charities; Ligue contre le Cancer; INCa; Canceropole; ANR; ANRS; Active p53; Apo-Sys EU networks; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, R01AI047891, R01AI044828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Ligue contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Canceropole(Region Ile-de-France); ANR(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Active p53; Apo-Sys EU networks; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors' own work is supported by NIH and the American Lebanese and Syrian Associated Charities (to D.R.G.) and by Ligue contre le Cancer, INCa, Canceropole, ANR, ANRS and the Active p53 and Apo-Sys EU networks (to G.K.).	Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Endo H, 2006, BIOCHEM SOC T, V34, P1283, DOI 10.1042/BST0341283; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Johnson TM, 2008, P NATL ACAD SCI USA, V105, P1215, DOI 10.1073/pnas.0706764105; Kakudo Y, 2005, CANCER RES, V65, P2108, DOI 10.1158/0008-5472.CAN-04-2935; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Morselli E, 2008, CELL CYCLE, V7, P3056, DOI 10.4161/cc.7.19.6751; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Pimkina J, 2009, J BIOL CHEM, V284, P2803, DOI 10.1074/jbc.M804705200; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Tang XW, 2007, J CLIN INVEST, V117, P3753, DOI 10.1172/JCI32481; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Xu HB, 2006, BIOCHEM BIOPH RES CO, V341, P938, DOI 10.1016/j.bbrc.2005.12.227; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	40	804	836	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1127	1130		10.1038/nature07986	http://dx.doi.org/10.1038/nature07986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407794	Green Accepted			2022-12-28	WOS:000265754600038
J	Sessions, OM; Barrows, NJ; Souza-Neto, JA; Robinson, TJ; Hershey, CL; Rodgers, MA; Ramirez, JL; Dimopoulos, G; Yang, PL; Pearson, JL; Garcia-Blanco, MA				Sessions, October M.; Barrows, Nicholas J.; Souza-Neto, Jayme A.; Robinson, Timothy J.; Hershey, Christine L.; Rodgers, Mary A.; Ramirez, Jose L.; Dimopoulos, George; Yang, Priscilla L.; Pearson, James L.; Garcia-Blanco, Mariano A.			Discovery of insect and human dengue virus host factors	NATURE			English	Article							WEST-NILE-VIRUS; ALPHA-GLUCOSIDASE INHIBITORS; JAPANESE ENCEPHALITIS-VIRUS; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; NUCLEAR-LOCALIZATION; ENDOCYTIC PATHWAY; BAFILOMYCIN A1; INFECTED-CELLS; AEDES-AEGYPTI	Dengue fever is the most frequent arthropod-borne viral disease of humans, with almost half of the world's population at risk of infection(1). The high prevalence, lack of an effective vaccine, and absence of specific treatment conspire to make dengue fever a global public health threat(1,2). Given their compact genomes, dengue viruses (DENV-1-4) and other flaviviruses probably require an extensive number of host factors; however, only a limited number of human, and an even smaller number of insect host factors, have been identified(3-10). Here we identify insect host factors required for DENV-2 propagation, by carrying out a genome-wide RNA interference screen in Drosophila melanogaster cells using a well-established 22,632 double-stranded RNA library. This screen identified 116 candidate dengue virus host factors (DVHFs). Although some were previously associated with flaviviruses (for example, V-ATPases and alpha-glucosidases)(3-5,7,9,10), most of the DVHFs were newly implicated in dengue virus propagation. The dipteran DVHFs had 82 readily recognizable human homologues and, using a targeted short-interfering-RNA screen, we showed that 42 of these are human DVHFs. This indicates notable conservation of required factors between dipteran and human hosts. This work suggests new approaches to control infection in the insect vector and the mammalian host.	[Sessions, October M.; Robinson, Timothy J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Sessions, October M.; Barrows, Nicholas J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA; [Barrows, Nicholas J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Duke RNAi Facil, Durham, NC 27710 USA; [Barrows, Nicholas J.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Robinson, Timothy J.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA; [Robinson, Timothy J.] Duke Univ, Med Ctr, Program Mol Canc Biol, Durham, NC 27710 USA; [Souza-Neto, Jayme A.; Ramirez, Jose L.; Dimopoulos, George] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Souza-Neto, Jayme A.; Ramirez, Jose L.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Hershey, Christine L.; Rodgers, Mary A.; Yang, Priscilla L.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Garcia-Blanco, Mariano A.] Duke NUS Grad Med Sch, Programin Emerging Infect Dis, Singapore 169547, Singapore	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; National University of Singapore	Pearson, JL (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	pears016@mc.duke.edu; garci001@mc.duke.edu	Souza-Neto, Jayme A/E-7841-2010	Souza-Neto, Jayme A/0000-0001-9281-894X; Ramirez, Jose Luis/0000-0001-9607-1097; Rodgers, Mary/0000-0001-8815-8651; Dimopoulos, George/0000-0001-6755-8111	National Institutes of Health (NIH) [RO1 GM067761, R21-AI64925, 5U54-AI057157-05S, 1RO1AI076442, 1R01AI061576-01, 1SA0RR024572-1]; American Society of Microbiology; Johns Hopkins Malaria Research Institute; North Carolina Biotechnology Center; Duke Center for RNA Biology; Duke University School of Medicine; Institute of Genome Sciences and Policy; Duke Comprehensive Cancer Center [5P30-CA14236]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064925, R01AI076442, R01AI061576, T32AI007417, R21AI090188, U54AI057157, U54AI057159, R01AI078997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063845] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Microbiology; Johns Hopkins Malaria Research Institute; North Carolina Biotechnology Center; Duke Center for RNA Biology; Duke University School of Medicine; Institute of Genome Sciences and Policy; Duke Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. de Silva, C. Lambeth, E. Wagner, F. Scholle, P. Florez de Sessions, J. Umbach, S. Braderick, B. Cullen, J. Nevins, M. Marengo, M. Gromeier, R. Wharton, D. Gubler, E. E. Ooi and S. Vasudevan, and members of the Triangle Flavivirology Group for reagents, time and insights. M. A. G.-B. thanks the late R. Shope for his inspiration and mentorship. We thank the Drosophila RNAi Screening Center (Harvard Medical School), which is funded by National Institutes of Health (NIH) grant RO1 GM067761, for expert assistance. We give special thanks to B. Mathey-Prevot for his support, advice and expertise, and for pointing out the important overlap of our screen with others previously published. We acknowledge funding from the NIH (R21-AI64925 and 5U54-AI057157-05S to M. A. G.-B., 1RO1AI076442 to P. L. Y., and 1R01AI061576-01 to G. D.); the American Society of Microbiology (to J. L. R.); and Johns Hopkins Malaria Research Institute (to J. A. S.-N.). M. A. R. is a Karnovsky Fellow. P. L. Y. acknowledges an award from the Giovanni Armenise-Harvard Foundation. We also acknowledge funding from the North Carolina Biotechnology Center, NIH (1SA0RR024572-1 to M. A. G.-B.), Duke Center for RNA Biology, Duke University School of Medicine, Institute of Genome Sciences and Policy, and Duke Comprehensive Cancer Center (5P30-CA14236) in support of the RNAi facility.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Andoh T, 1998, J NEUROVIROL, V4, P627, DOI 10.3109/13550289809114229; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Chapel C, 2006, J GEN VIROL, V87, P861, DOI 10.1099/vir.0.81503-0; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Littleton JT, 2000, J CELL BIOL, V150, pF77, DOI 10.1083/jcb.150.2.F77; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Nawa M, 1998, ARCH VIROL, V143, P1555, DOI 10.1007/s007050050398; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0; Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06	30	288	295	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1047	1050		10.1038/nature07967	http://dx.doi.org/10.1038/nature07967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396146	Green Submitted, Green Accepted			2022-12-28	WOS:000265412900047
J	Creutzfeldt, C; Tirschwell, D				Creutzfeldt, Claire; Tirschwell, David			Early surgery improves outcomes in patients with primary supratentorial intracerebral hemorrhage	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Creutzfeldt, Claire; Tirschwell, David] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Creutzfeldt, C (corresponding author), Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA.		Creutzfeldt, Claire/AAA-1282-2020	Tirschwell, David/0000-0002-8059-2901				Mendelow AD, 2005, LANCET, V365, P387	1	0	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-10	10.7326/0003-4819-150-8-200904210-02010	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391224				2022-12-28	WOS:000265457000025
J	Greenstone, M				Greenstone, Michael			Self-monitored, home-based pulmonary rehab was noninferior to outpatient, hospital-based rehab for COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Castle Hill Hosp, Cottingham, E Yorks, England	University of Hull	Greenstone, M (corresponding author), Castle Hill Hosp, Cottingham, E Yorks, England.								0	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-7	10.7326/0003-4819-150-8-200904210-02007	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391218				2022-12-28	WOS:000265457000022
J	Shekelle, PG				Shekelle, Paul G.			Supplementation with vitamin E or vitamin C did not differ from placebo for major cardiovascular events and mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PREVENTION; DISEASE; METAANALYSIS		W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Shekelle, PG (corresponding author), W Los Angeles Vet Affairs Med Ctr, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.							Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Shekelle PG, 2004, J GEN INTERN MED, V19, P380, DOI 10.1111/j.1525-1497.2004.30090.x; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9	4	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-12	10.7326/0003-4819-150-8-200904210-02012	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391226				2022-12-28	WOS:000265457000027
J	Wang, XR; Li, XL; Zhang, L; Yoon, Y; Weber, PK; Wang, HL; Guo, J; Dai, HJ				Wang, Xinran; Li, Xiaolin; Zhang, Li; Yoon, Youngki; Weber, Peter K.; Wang, Hailiang; Guo, Jing; Dai, Hongjie			N-Doping of Graphene Through Electrothermal Reactions with Ammonia	SCIENCE			English	Article							CARBON; TRANSISTORS; DEPENDENCE; NANOTUBES; FILMS; GAS	Graphene is readily p-doped by adsorbates, but for device applications, it would be useful to access the n-doped material. Individual graphene nanoribbons were covalently functionalized by nitrogen species through high-power electrical joule heating in ammonia gas, leading to n-type electronic doping consistent with theory. The formation of the carbon-nitrogen bond should occur mostly at the edges of graphene where chemical reactivity is high. X-ray photoelectron spectroscopy and nanometer-scale secondary ion mass spectroscopy confirm the carbon-nitrogen species in graphene thermally annealed in ammonia. We fabricated an n-type graphene field-effect transistor that operates at room temperature.	[Wang, Xinran; Li, Xiaolin; Zhang, Li; Wang, Hailiang; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Wang, Xinran; Li, Xiaolin; Zhang, Li; Wang, Hailiang; Dai, Hongjie] Stanford Univ, Adv Mat Lab, Stanford, CA 94305 USA; [Yoon, Youngki; Guo, Jing] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL 32611 USA; [Weber, Peter K.] Lawrence Livermore Natl Lab, Div Chem Sci, Livermore, CA 94550 USA	Stanford University; Stanford University; State University System of Florida; University of Florida; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@stanford.edu	Yoon, Youngki/B-1451-2009; Weber, Peter Kilian/AAP-9517-2020; Wang, Xinran/E-8392-2010; Dai, Hongjie/ABC-4574-2021; Wang, Hailiang/O-6364-2017; Li, jiayu/H-3827-2014	Weber, Peter Kilian/0000-0001-6022-6050; Wang, Xinran/0000-0002-3975-1667; Wang, Hailiang/0000-0003-4409-2034; Li, jiayu/0000-0003-2639-213X	Microelectronics Advanced Research Corporation Materials, Structures, and Devices Focus Center; Intel; Office of Naval Research (ONR).; NSF; U.S. Department of Energy [DE-AC52-07NA27344]	Microelectronics Advanced Research Corporation Materials, Structures, and Devices Focus Center; Intel(Intel Corporation); Office of Naval Research (ONR).(Office of Naval Research); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported in part by the Microelectronics Advanced Research Corporation Materials, Structures, and Devices Focus Center; Intel; and Office of Naval Research (ONR). The work done at the University of Florida was supported in part by NSF and ONR. The work at LLNL was performed under the auspices of the U.S. Department of Energy, contract DE-AC52-07NA27344.	Avouris P, 2002, ACCOUNTS CHEM RES, V35, P1026, DOI 10.1021/ar010152e; Brintlinger T, 2002, APPL PHYS LETT, V81, P2454, DOI 10.1063/1.1509113; Calizo I, 2007, NANO LETT, V7, P2645, DOI 10.1021/nl071033g; Cervantes-Sodi F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165427; Chen JH, 2008, NAT PHYS, V4, P377, DOI 10.1038/nphys935; Gunlycke D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2783196; Gunlycke D, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2718515; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Li XL, 2008, NAT NANOTECHNOL, V3, P538, DOI 10.1038/nnano.2008.210; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Martel R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.256805; Moser J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789673; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pop E, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717855; Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; *US DOE, DEAC5207NA27344 US D; Wang XR, 2008, J AM CHEM SOC, V130, P8152, DOI 10.1021/ja8023059; Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803; Woo HS, 2000, APPL PHYS LETT, V77, P1393, DOI 10.1063/1.1290275; Yan QM, 2007, NANO LETT, V7, P1469, DOI 10.1021/nl070133j; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhao P, 2008, NANO RES, V1, P395, DOI 10.1007/s12274-008-8039-y	25	1838	1896	26	1785	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					768	771		10.1126/science.1170335	http://dx.doi.org/10.1126/science.1170335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423822				2022-12-28	WOS:000265832400041
J	Fischer, TP; Burnard, P; Marty, B; Hilton, DR; Furi, E; Palhol, F; Sharp, ZD; Mangasini, F				Fischer, T. P.; Burnard, P.; Marty, B.; Hilton, D. R.; Fueri, E.; Palhol, F.; Sharp, Z. D.; Mangasini, F.			Upper-mantle volatile chemistry at Oldoinyo Lengai volcano and the origin of carbonatites	NATURE			English	Article							MIDOCEAN RIDGE; NOBLE-GASES; SUBDUCTION; CO2; HE; FRACTIONATION; GEOCHEMISTRY; SYSTEMATICS; SOLUBILITY; INSIGHTS	Carbonatite lavas are highly unusual in that they contain almost no SiO2 and are >50 per cent carbonate minerals. Although carbonatite magmatism has occurred throughout Earth's history, Oldoinyo Lengai, in Tanzania, is the only currently active volcano producing these exotic rocks(1). Here we show that volcanic gases captured during an eruptive episode at Oldoinyo Lengai are indistinguishable from those emitted along mid-ocean ridges, despite the fact that Oldoinyo Lengai carbonatites occur in a setting far removed from oceanic spreading centres. In contrast to lithophile trace elements, which are highly fractionated by the immiscible phase separation that produces these carbonatites, volatiles (CO2, He, N-2 and Ar) are little affected by this process. Our results demonstrate that a globally homogenous reservoir exists in the upper mantle and supplies volatiles to both mid-ocean ridges and continental rifts. This argues against an unusually C-rich mantle being responsible for the genesis of Na-rich carbonatite and its nephelinite source magma at Oldoinyo Lengai. Rather, these carbonatites are formed in the shallow crust by immiscibility from silicate magmas (nephelinite), and are stable under eruption conditions as a result of their high Na contents.	[Fischer, T. P.; Sharp, Z. D.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Burnard, P.; Marty, B.; Palhol, F.] Nancy Univ, CNRS, INSU, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; [Hilton, D. R.; Fueri, E.] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; [Mangasini, F.] Univ Dar Es Salaam, Dept Min & Mineral Proc Engn, Dar Es Salaam, Tanzania	University of New Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Dar es Salaam	Fischer, TP (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, MSC03 2040,1 Univ New Mexico, Albuquerque, NM 87131 USA.	fischer@unm.edu	Füri, Evelyn/AFT-7364-2022; Hilton, David/B-7611-2008; Füri, Evelyn/N-7691-2016	Füri, Evelyn/0000-0002-7680-2478; Füri, Evelyn/0000-0002-7680-2478	CNRS-INSU; US National Science Foundation [EAR-0439122]; University of New Mexico [EAR-0537618, EAR-0827352]; Tanzania Commission for Science and Technology [2005-217-NA-2005-74]; Directorate For Geosciences [0827352] Funding Source: National Science Foundation	CNRS-INSU(Centre National de la Recherche Scientifique (CNRS)); US National Science Foundation(National Science Foundation (NSF)); University of New Mexico; Tanzania Commission for Science and Technology; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We would like to thank CNRS-INSU for financial support, the French Embassy in Dar Es Salaam and The University of New Mexico Research Allocation Committee for support of field work, the US National Science Foundation for analytical support at the Scripps Institution of Oceanography (EAR-0439122) and the University of New Mexico (EAR-0537618, EAR-0827352). We thank the Tanzania Commission for Science and Technology for granting research permission (2005-217-NA-2005-74) for this study. We thank C. Ballentine for a thorough review that greatly helped to improve this paper.	Bell K., 1995, IAVCEI P VOLCANOLOGY, P100; BRANTLEY SL, 1995, GEOLOGY, V23, P933, DOI 10.1130/0091-7613(1995)023<0933:MCDEFO>2.3.CO;2; Brauer K, 2004, GEOCHIM COSMOCHIM AC, V68, P4935, DOI 10.1016/j.gca.2004.05.032; Burnard P, 1999, EARTH PLANET SC LETT, V174, P199, DOI 10.1016/S0012-821X(99)00254-X; Burnard P, 2005, GEOCHIM COSMOCHIM AC, V69, pA433; Burnard P, 1997, SCIENCE, V276, P568, DOI 10.1126/science.276.5312.568; Cartigny P, 2008, EARTH PLANET SC LETT, V265, P672, DOI 10.1016/j.epsl.2007.11.011; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Dasgupta R, 2007, J PETROL, V48, P2093, DOI 10.1093/petrology/egm053; DAWSON JB, 1962, NATURE, V195, P1075, DOI 10.1038/1951075a0; Dixon JE, 1995, J PETROL, V36, P1607; Fischer TP, 2002, SCIENCE, V297, P1154, DOI 10.1126/science.1073995; GENGE MJ, 1995, GEOCHIM COSMOCHIM AC, V59, P927, DOI 10.1016/00167-0379(50)00100-; Giggenbach W.F., 1996, MONITORING MITIGATIO, P221, DOI [10.1007/978-3-642-80087-0_7, DOI 10.1007/978-3-642-80087-0_7]; Gilfillan SM, 2008, GEOCHIM COSMOCHIM AC, V72, P1174, DOI 10.1016/j.gca.2007.10.009; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; Hilton DR, 2002, REV MINERAL GEOCHEM, V47, P319, DOI 10.2138/rmg.2002.47.9; Holland G, 2006, NATURE, V441, P186, DOI 10.1038/nature04761; JAMBON A, 1986, GEOCHIM COSMOCHIM AC, V50, P401, DOI 10.1016/0016-7037(86)90193-6; KELLER J, 1995, IAVCEI P VOLCANOLOGY, V4, P70; Marty B, 1999, GEOCHIM COSMOCHIM AC, V63, P3619, DOI 10.1016/S0016-7037(99)00169-6; Marty B, 1998, CHEM GEOL, V145, P233, DOI 10.1016/S0009-2541(97)00145-9; Newell DL, 2005, GSA TODAY, V15, P4, DOI [10.1130/1052-5173(2005)0152.0.CO;2, DOI 10.1130/1052-5173(2005)0152.0.CO;2, DOI 10.1130/1052-5173(2005)015[4:CSLBTM]2.0.CO;2]; Peeters F, 2003, GEOCHIM COSMOCHIM AC, V67, P587, DOI 10.1016/S0016-7037(02)00969-9; Pepin RO, 2006, EARTH PLANET SC LETT, V250, P470, DOI 10.1016/j.epsl.2006.08.014; PETERSON TD, 1989, CONTRIB MINERAL PETR, V102, P336, DOI 10.1007/BF00373727; Pik R, 2006, CHEM GEOL, V226, P100, DOI 10.1016/j.chemgeo.2005.09.016; Porcelli D, 2002, REV MINERAL GEOCHEM, V47, P411, DOI 10.2138/rmg.2002.47.11; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; SANO Y, 1995, CHEM GEOL, V119, P265, DOI 10.1016/0009-2541(94)00097-R; Sano Y, 2001, CHEM GEOL, V171, P263, DOI 10.1016/S0009-2541(00)00252-7; Shaw AM, 2003, EARTH PLANET SC LETT, V214, P499, DOI 10.1016/S0012-821X(03)00401-1; WYLLIE PJ, 1989, CARBONATITES GENESIS, P500	33	109	116	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					77	80		10.1038/nature07977	http://dx.doi.org/10.1038/nature07977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424154				2022-12-28	WOS:000265801300032
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling No gifts, please, we're doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 7	2009	338								b1835	10.1136/bmj.b1835	http://dx.doi.org/10.1136/bmj.b1835			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GW	19423621				2022-12-28	WOS:000265969700004
J	Balco, G				Balco, Greg			The Geographic Footprint of Glacier Change	SCIENCE			English	Editorial Material							VARIABILITY		Berkeley Geochronol Ctr, Berkeley, CA 94709 USA	Berkeley Geochronolgy Center	Balco, G (corresponding author), Berkeley Geochronol Ctr, Berkeley, CA 94709 USA.	balcs@bgc.org						Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; DENTON G H, 1973, Quaternary Research (Orlando), V3, P155, DOI 10.1016/0033-5894(73)90040-9; Hormes A, 2006, GEOGR ANN A, V88A, P281, DOI 10.1111/j.0435-3676.2006.00301.x; Reichert BK, 2002, J CLIMATE, V15, P3069, DOI 10.1175/1520-0442(2002)015<3069:RGREIV>2.0.CO;2; Rupper S, 2008, J CLIMATE, V21, P5384, DOI 10.1175/2008JCLI2219.1; Schaefer JM, 2009, SCIENCE, V324, P622, DOI 10.1126/science.1169312	6	5	5	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					599	600		10.1126/science.1172468	http://dx.doi.org/10.1126/science.1172468			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407189				2022-12-28	WOS:000265608800029
J	Gehring, NH; Lamprinaki, S; Kulozik, AE; Hentze, MW				Gehring, Niels H.; Lamprinaki, Styliani; Kulozik, Andreas E.; Hentze, Matthias W.			Disassembly of Exon Junction Complexes by PYM	CELL			English	Article							NONSENSE-MEDIATED DECAY; MESSENGER-RNA DECAY; MOLECULAR INSIGHTS; MAMMALIAN-CELLS; TRANSLATION; PROTEIN; REVEALS; INHIBITION; INTRONS; NUCLEUS	Exon junction complexes (EJCs) are deposited onto mRNAs during splicing, serve as positional landmarks for the intron exon structure of genes, and direct posttranscriptional processes in the cytoplasm. EJC removal and recycling by translation are ill understood and have been attributed to ribosomal passage. This work identifies the ribosome-associated protein PYM as an EJC disassembly factor and defines its mechanism of function. Whereas EJC assembly intermediates are resistant to PYM, fully assembled EJCs are dissociated from spliced mRNAs by PYM. This disassembly involves PYM binding to the EJC proteins MAGOH-Y14. PYM overexpression in cells disrupts EJC association with spliced mRNA and inhibits nonsense-mediated mRNA decay. In cells depleted of PYM, EJCs accumulate on spliced mRNAs and EJC protein recycling is impaired. Hence, PYM is an EJC disassembly factor that acts both in vitro and in living cells, and that antagonizes important EJC functions.	[Gehring, Niels H.; Lamprinaki, Styliani; Kulozik, Andreas E.; Hentze, Matthias W.] Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Gehring, Niels H.; Lamprinaki, Styliani; Kulozik, Andreas E.; Hentze, Matthias W.] European Mol Biol Lab, D-69120 Heidelberg, Germany; [Gehring, Niels H.; Kulozik, Andreas E.] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Gehring, Niels H.; Lamprinaki, Styliani; Hentze, Matthias W.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Gehring, NH (corresponding author), Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany.	niels.gehring@med.uni.heidelberg.de; hentze@embl.de	Hentze, Matthias W/V-3980-2017; Kulozik, Andreas/AAO-2432-2020	Hentze, Matthias W/0000-0002-4023-7876; 	EMBL International PhD Programme; Deutsche Forschungsgemeinschaft [KU563/11-1]; Manfred Lautenschlarger Research Prize	EMBL International PhD Programme; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Manfred Lautenschlarger Research Prize	We thank Nicole Echner for excellent technical assistance, Pavel Ivanov and Kent Duncan for critical reading of the manuscript, and members of our laboratories for advice and discussion. We are grateful to Elisa Izaurralde and Yanping Zhang for the kind gift of antibodies, and Miles Wilkinson for kindly providing TCR-beta expression plasmids. S.L. acknowledges a fellowship from the EMBL International PhD Programme. This work was funded by a grant (KU563/11-1) from the Deutsche Forschungsgemeinschaft (to N.H.G. and A.E.K.), and by funds from the Manfred Lautenschlarger Research Prize (to A.E.K. and M.W.H.).	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; DeLano Scientific, 2002, PYMOL MOL GRAPH SYST; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Forler D, 2003, NAT BIOTECHNOL, V21, P89, DOI 10.1038/nbt773; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kataoka N, 2004, J BIOL CHEM, V279, P7009, DOI 10.1074/jbc.M307692200; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	36	131	134	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					536	548		10.1016/j.cell.2009.02.042	http://dx.doi.org/10.1016/j.cell.2009.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410547	Bronze			2022-12-28	WOS:000265677200022
J	Golde, TE; Kukar, TL				Golde, Todd E.; Kukar, Thomas L.			Avoiding Unintended Toxicity	SCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE; SECRETASE; APH-1		[Golde, Todd E.; Kukar, Thomas L.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Golde, TE (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	tgolde@mayo.edu; kukar.thomas@mayo.edu	Kukar, Thomas/AAW-2612-2021	Kukar, Thomas/0000-0002-3750-6262	NIA NIH HHS [R00 AG032362, K99 AG032362-01A1, K99 AG032362] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R00AG032362, K99AG032362] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; Golde TE, 2006, J NEUROCHEM, V99, P689, DOI 10.1111/j.1471-4159.2006.04211.x; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Mayer SC, 2008, J MED CHEM, V51, P7348, DOI 10.1021/jm801252w; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591	14	5	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					603	604		10.1126/science.1174267	http://dx.doi.org/10.1126/science.1174267			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407192				2022-12-28	WOS:000265608800032
J	Spizzo, R; Nicoloso, MS; Croce, CM; Calin, GA				Spizzo, Riccardo; Nicoloso, Milena S.; Croce, Carlo M.; Calin, George A.			SnapShot: MicroRNAs in Cancer	CELL			English	Editorial Material									[Spizzo, Riccardo] MD Anderson Canc Ctr, Houston, TX 77030 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Spizzo, R (corresponding author), MD Anderson Canc Ctr, Houston, TX 77030 USA.		Young, Richard A/F-6495-2012; Calin, George/E-9390-2011; Nicoloso, Milena S/K-6411-2012; Spizzo, Riccardo/V-1057-2019	Young, Richard A/0000-0001-8855-8647; Nicoloso, Milena S/0000-0003-4231-9303; Spizzo, Riccardo/0000-0001-7772-0960; Calin, George/0000-0001-6704-5615				Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347	9	203	210	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 1	2009	137	3					586	U204		10.1016/j.cell.2009.04.040	http://dx.doi.org/10.1016/j.cell.2009.04.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410551	Bronze			2022-12-28	WOS:000265677200026
J	Gibbs, RA; Taylor, JF; Van Tassell, CP; Barendse, W; Eversoie, KA; Gill, CA; Green, RD; Hamernik, DL; Kappes, SM; Lien, S; Matukumalli, LK; McEwan, JC; Nazareth, LV; Schnabel, RD; Taylor, JF; Weinstock, GM; Wheeler, DA; Ajmone-Marsan, P; Barendse, W; Boettcher, PJ; Caetano, AR; Garcia, JF; Hanotte, O; Mariani, P; Skow, LC; Williams, JL; Caetano, AR; Diallo, B; Green, RD; Hailemariam, L; Hanotte, O; Martinez, ML; Morris, CA; Silva, LOC; Spelman, RJ; Taylor, JF; Mulatu, W; Zhao, KY; Abbey, CA; Agaba, M; Araujo, FR; Bunch, RJ; Burton, J; Gill, CA; Gorni, C; Olivier, H; Harrison, BE; Luff, B; Machado, MA; Mariani, P; Morris, CA; Mwakaya, J; Plastow, G; Sim, W; Skow, LC; Smith, T; Sonstegard, TS; Spelman, RJ; Taylor, JF; Thomas, MB; Valentini, A; Williams, P; Womack, J; Wooliams, JA; Liu, Y; Qin, X; Worley, KC; Gao, C; Gill, CA; Jiang, HY; Liu, Y; Moore, SS; Nazareth, LV; Ren, YR; Song, XZ; Bustamante, CD; Hernandez, RD; Muzny, DM; Nazareth, LV; Patil, S; Lucas, AS; Fu, Q; Kent, MP; Moore, SS; Vega, R; Abbey, CA; Gao, C; Gill, CA; Green, RD; Matukumalli, LK; Matukumalli, A; McWilliam, S; Schnabel, RD; Sclep, G; Ajmone-Marsan, P; Bryc, K; Bustamante, CD; Choi, J; Gao, H; Grefenstette, JJ; Murdoch, B; Stella, A; Villa-Angulo, R; Wright, M; Aerts, J; Jann, O; Negrini, R; Sonstegard, TS; Williams, JL; Taylor, JF; Villa-Angulo, R; Goddard, ME; Hayes, BJ; Barendse, W; Bradley, DG; Boettcher, PJ; Bustamante, CD; da Silva, MB; Lau, LPL; Liu, GE; Lynn, DJ; Panzitta, F; Sclep, G; Wright, M; Dodds, KG				Gibbs, Richard A.; Taylor, Jeremy F.; Van Tassell, Curtis P.; Barendse, William; Eversoie, Kallye A.; Gill, Clare A.; Green, Ronnie D.; Hamernik, Debora L.; Kappes, Steven M.; Lien, Sigbjorn; Matukumalli, Lakshmi K.; McEwan, John C.; Nazareth, Lynne V.; Schnabel, Robert D.; Taylor, Jeremy F.; Weinstock, George M.; Wheeler, David A.; Ajmone-Marsan, Paolo; Barendse, William; Boettcher, Paul J.; Caetano, Alexandre R.; Garcia, Jose Fernando; Hanotte, Olivier; Mariani, Paola; Skow, Loren C.; Williams, John L.; Caetano, Alexandre R.; Diallo, Boubacar; Green, Ronnie D.; Hailemariam, Lemecha; Hanotte, Olivier; Martinez, Mario L.; Morris, Chris A.; Silva, Luiz O. C.; Spelman, Richard J.; Taylor, Jeremy F.; Mulatu, Woudyalew; Zhao, Keyan; Abbey, Colette A.; Agaba, Morris; Araujo, Flabio R.; Bunch, Rowan J.; Burton, James; Gill, Clare A.; Gorni, Chiara; Olivier, Hanotte; Harrison, Blair E.; Luff, Bill; Machado, Marco A.; Mariani, Paola; Morris, Chris A.; Mwakaya, Joel; Plastow, Graham; Sim, Warren; Skow, Loren C.; Smith, Timothy; Sonstegard, Tad S.; Spelman, Richard J.; Taylor, Jeremy F.; Thomas, Merle B.; Valentini, Alessio; Williams, Paul; Womack, James; Wooliams, John A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Gao, Chuan; Gill, Clare A.; Jiang, Huaiyang; Liu, Yue; Moore, Stephen S.; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Bustamante, Carlos D.; Hernandez, Ryan D.; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Kent, Matthew P.; Moore, Stephen S.; Vega, Richard; Abbey, Colette A.; Gao, Chuan; Gill, Clare A.; Green, Ronnie D.; Matukumalli, Lakshmi K.; Matukumalli, Aruna; McWilliam, Sean; Schnabel, Robert D.; Sclep, Gert; Ajmone-Marsan, Paolo; Bryc, Katarzyna; Bustamante, Carlos D.; Choi, Jungwoo; Gao, Hong; Grefenstette, John J.; Murdoch, Brenda; Stella, Alessandra; Villa-Angulo, Rafael; Wright, Mark; Aerts, Jan; Jann, Oliver; Negrini, Riccardo; Sonstegard, Tad S.; Williams, John L.; Taylor, Jeremy F.; Villa-Angulo, Rafael; Goddard, Mike E.; Hayes, Ben J.; Barendse, William; Bradley, Daniel G.; Boettcher, Paul J.; Bustamante, Carlos D.; da Silva, Marcos Barbosa; Lau, Lilian P. L.; Liu, George E.; Lynn, David J.; Panzitta, Francesca; Sclep, Gert; Wright, Mark; Dodds, Ken G.			Genome-Wide Survey of SNP Variation Uncovers the Genetic Structure of Cattle Breeds	SCIENCE			English	Article							MISSENSE MUTATION; MILK-YIELD; IDENTIFICATION; SELECTION; ORIGIN; SCANS; QTL	The imprints of domestication and breed development on the genomes of livestock likely differ from those of companion animals. A deep draft sequence assembly of shotgun reads from a single Hereford female and comparative sequences sampled from six additional breeds were used to develop probes to interrogate 37,470 single-nucleotide polymorphisms (SNPs) in 497 cattle from 19 geographically and biologically diverse breeds. These data show that cattle have undergone a rapid recent decrease in effective population size from a very large ancestral population, possibly due to bottlenecks associated with domestication, selection, and breed formation. Domestication and artificial selection appear to have left detectable signatures of selection within the cattle genome, yet the current levels of diversity within breeds are at least as great as exists within humans.	[Van Tassell, Curtis P.; Matukumalli, Lakshmi K.; Sonstegard, Tad S.; Matukumalli, Lakshmi K.; Matukumalli, Aruna; Sonstegard, Tad S.; da Silva, Marcos Barbosa; Liu, George E.] ARS, USDA, Bovine Funct Genom Lab, BARC E, Beltsville, MD 20705 USA; [Gibbs, Richard A.; Nazareth, Lynne V.; Weinstock, George M.; Wheeler, David A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Jiang, Huaiyang; Liu, Yue; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Vega, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gibbs, Richard A.; Nazareth, Lynne V.; Weinstock, George M.; Wheeler, David A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Jiang, Huaiyang; Liu, Yue; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Vega, Richard] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Taylor, Jeremy F.; Schnabel, Robert D.; Taylor, Jeremy F.; Taylor, Jeremy F.; Taylor, Jeremy F.; Schnabel, Robert D.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Barendse, William; Barendse, William; Bunch, Rowan J.; Harrison, Blair E.; Sim, Warren; Thomas, Merle B.; Williams, Paul; McWilliam, Sean; Barendse, William] CSIRO, Livestock Ind, St Lucia, Qld 4067, Australia; [Barendse, William; Barendse, William; Bunch, Rowan J.; Harrison, Blair E.; Sim, Warren; Thomas, Merle B.; McWilliam, Sean; Barendse, William] Univ New England, CRC, Beef Genet Technol, Armidale, NSW 2351, Australia; [Eversoie, Kallye A.] Alliance Anim Genome Res, Bethesda, MD 20816 USA; [Gill, Clare A.; Abbey, Colette A.; Gill, Clare A.; Gao, Chuan; Gill, Clare A.; Abbey, Colette A.; Gao, Chuan; Gill, Clare A.; Choi, Jungwoo] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Green, Ronnie D.; Kappes, Steven M.; Green, Ronnie D.; Olivier, Hanotte; Green, Ronnie D.] ARS, USDA, Natl Program Staff, Beltsville, MD 20705 USA; [Hamernik, Debora L.] USDA Cooperat State Res Educ & Extens Serv, Washington, DC 20250 USA; [Lien, Sigbjorn; Kent, Matthew P.] Norwegian Univ Life Sci, Ctr Integrat Genet, N-1432 As, Norway; [Lien, Sigbjorn; Kent, Matthew P.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; [Matukumalli, Lakshmi K.; Matukumalli, Lakshmi K.; Grefenstette, John J.; Villa-Angulo, Rafael; Villa-Angulo, Rafael] George Mason Univ, Dept Bioinformat & Computat Biol, Manassas, VA USA; [McEwan, John C.; Dodds, Ken G.] AgResearch, Anim Genom, Invermay 9053, Mosgiel, New Zealand; [Ajmone-Marsan, Paolo; Ajmone-Marsan, Paolo; Negrini, Riccardo] Univ Cattolica Sacro Cuore, Ist Zootecn, I-29100 Piacenza, Italy; [Boettcher, Paul J.; Garcia, Jose Fernando; Boettcher, Paul J.] IAEA, Joint United Nations FAO, Div Nucl Tech Food & Agr, A-1400 Vienna, Austria; [Caetano, Alexandre R.; Caetano, Alexandre R.] Embrapa Genet Resources & Biotechnol Ctr, BR-70770900 Brasilia, DF, Brazil; [Garcia, Jose Fernando] UNESP, Dept Anim Prod & Hlth, IAEA, Collaborat Ctr Anim Genom & Bioinformat, BR-16050680 Aracatuba, SP, Brazil; [Hanotte, Olivier; Hanotte, Olivier; Agaba, Morris] Int Livestock Res Inst, Nairobi 00100, Kenya; [Skow, Loren C.; Skow, Loren C.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biol Sci, College Stn, TX 77843 USA; [Williams, John L.; Wooliams, John A.; Aerts, Jan; Jann, Oliver; Williams, John L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin E25 9PS, Midlothian, Scotland; [Diallo, Boubacar] Direct Natl Elevage, Conakry, Guinea; [Hailemariam, Lemecha] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Martinez, Mario L.; Machado, Marco A.; da Silva, Marcos Barbosa] Embrapa Dairy Cattle Ctr, BR-36038330 Juiz De Fora, MG, Brazil; [Morris, Chris A.; Morris, Chris A.] AgResearch, Anim Genom, Hamilton 3240, New Zealand; [Silva, Luiz O. C.; Araujo, Flabio R.] Embrapa Beef Cattle Ctr, BR-79002970 Campo Grande, MS, Brazil; [Spelman, Richard J.; Spelman, Richard J.] LIC, Res & Dev, Hamilton 3240, New Zealand; [Mulatu, Woudyalew] Int Livestock Res Inst, Addis Ababa, Ethiopia; [Zhao, Keyan; Bustamante, Carlos D.; Hernandez, Ryan D.; Bryc, Katarzyna; Bustamante, Carlos D.; Gao, Hong; Wright, Mark; Bustamante, Carlos D.; Wright, Mark] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Burton, James] Univ Edinburgh Summerhall, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Plastow, Graham; Moore, Stephen S.; Moore, Stephen S.; Murdoch, Brenda] Univ Alberta, AgFor Ctr 410, Edmonton, AB T6G 2P5, Canada; [Smith, Timothy] ARS, USDA, US Meat Anim Res Ctr, Mol Genet Res Unit, Clay Ctr, NE 68933 USA; [Valentini, Alessio] Univ Tuscia, Dipartimento Prod Anim, I-01100 Viterbo, Italy; [Womack, James] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Aerts, Jan] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Goddard, Mike E.] Univ Melbourne, Fac Land & Food Resources, Parkville, Vic 3010, Australia; [Bradley, Daniel G.; Lau, Lilian P. L.; Lynn, David J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Lynn, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; University of Missouri System; University of Missouri Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New England; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Norwegian University of Life Sciences; Norwegian University of Life Sciences; George Mason University; AgResearch - New Zealand; Catholic University of the Sacred Heart; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; CGIAR; International Livestock Research Institute (ILRI); Texas A&M University System; Texas A&M University College Station; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Ethiopian Institute of Agricultural Research (EIAR); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); AgResearch - New Zealand; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CGIAR; International Livestock Research Institute (ILRI); Cornell University; University of Edinburgh; University of Alberta; United States Department of Agriculture (USDA); Tuscia University; Texas A&M University System; Texas A&M University College Station; Wellcome Trust Sanger Institute; University of Melbourne; Trinity College Dublin; Simon Fraser University	Van Tassell, CP (corresponding author), ARS, USDA, Bovine Funct Genom Lab, BARC E, Beltsville, MD 20705 USA.	agibbs@bcm.tmc.edu; taylorjerr@missouri.edu; curt.vantassell@ars.usda.gov	Stella, Alessandra/AAY-7322-2020; Weinstock, George M/C-6314-2013; Wheeler, David A/M-9740-2018; Gao, Chuan/A-8808-2015; Caetano, Alexandre Rodrigues/B-5227-2017; Eversole, Kellye/AAN-6141-2020; Aerts, Jan/AAQ-6949-2020; valentini, alessio/L-3970-2013; Bradley, Daniel G/A-3240-2012; Van Tassell, Curtis P./O-4247-2019; McWilliam, Sean M/H-8978-2013; McEwan, John/A-1143-2008; Villa-Angulo, Rafael/I-5937-2015; Hayes, Ben J/L-3308-2016; Gill, Clare/R-3677-2019; stella, Alessandra/ABB-1952-2021; stella, Alessandra/AAG-6401-2021; Hanotte, Olivier/B-4669-2013; Barendse, William J/D-8608-2011; Liu, George/K-3371-2019; Moore, Stephen S/F-5285-2013; AJMONE MARSAN, Paolo/M-2466-2018	Weinstock, George M/0000-0002-2997-4592; Wheeler, David A/0000-0002-9056-6299; Gao, Chuan/0000-0002-1399-8450; Caetano, Alexandre Rodrigues/0000-0002-3419-7337; Eversole, Kellye/0000-0002-8784-4913; Aerts, Jan/0000-0002-6416-2717; valentini, alessio/0000-0003-4733-7519; Van Tassell, Curtis P./0000-0002-8416-2087; McWilliam, Sean M/0000-0002-3148-0428; McEwan, John/0000-0003-4801-6207; Villa-Angulo, Rafael/0000-0002-7698-6617; Hayes, Ben J/0000-0002-5606-3970; Gill, Clare/0000-0003-2640-1825; stella, Alessandra/0000-0003-2850-3964; stella, Alessandra/0000-0003-2850-3964; Barendse, William J/0000-0002-5464-0658; Liu, George/0000-0003-0192-6705; Schnabel, Robert/0000-0001-5018-7641; Zhao, Keyan/0000-0002-8800-2304; Bustamante, Carlos D./0000-0002-4187-7920; Goddard, Michael/0000-0001-9917-7946; NEGRINI, Riccardo/0000-0002-8735-0286; Wright, Mark/0000-0001-8036-1161; Hanotte, Olivier/0000-0002-2877-4767; Worley, Kim/0000-0002-0282-1000; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Williams, John/0000-0001-5188-7957; Skow, Loren/0000-0001-8998-359X; Bradley, Daniel G/0000-0001-7335-7092; Plastow, Graham/0000-0002-3774-3110; Moore, Stephen/0000-0002-9758-166X; Dodds, Ken/0000-0002-9347-6379; Lynn, David/0000-0003-4664-1404; mariani, paola/0000-0002-5604-4550	National Human Genome Research Institute of the National Institutes of Health; U.S. Department of Agricultures Agricultural Research Service (USDA-ARS); Cooperative State Research, Education and Extension Service (USDA CSREES); Research Council of Norway; American Angus Association; American Hereford Association; American Jersey Cattle Association; AgResearch (New Zealand); Australian Brahman Breeders Association; Beefmaster Breeders United; The Brazilian Agricultural Research Corporation (Embrapa); Brown Swiss Association; Commonwealth Scientific and Industrial Research Organization; Dairy InSight; GENO Breeding and Artificial Insemination Association-Norway; Herd Book/France Limousin Selection; Holstein Association USA; International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna; International Livestock Research Institute-Kenya; Italian Piedmontese Breeders-Parco Tecnologico Padano; Italian Romagnola Society-Universita Cattolica del Sacro Cuore; Livestock Improvement Corporation; Meat and Wool New Zealand; North American Limousin Foundation; Red Angus Association of America; Roslin Institute for UK Guernsey; Sygen (now Genus); BBSRC [BBS/E/R/00001618, BBS/E/D/05191130, BBS/E/R/00001610] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/R/00000673, BBS/E/D/05191130, BBS/E/R/00001610, BBS/E/R/00001618, BBS/B/05710] Funding Source: researchfish	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); U.S. Department of Agricultures Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Cooperative State Research, Education and Extension Service (USDA CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Research Council of Norway(Research Council of Norway); American Angus Association; American Hereford Association; American Jersey Cattle Association; AgResearch (New Zealand); Australian Brahman Breeders Association; Beefmaster Breeders United; The Brazilian Agricultural Research Corporation (Embrapa); Brown Swiss Association; Commonwealth Scientific and Industrial Research Organization; Dairy InSight; GENO Breeding and Artificial Insemination Association-Norway; Herd Book/France Limousin Selection; Holstein Association USA; International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna(International Atomic Energy Agency); International Livestock Research Institute-Kenya(CGIAR); Italian Piedmontese Breeders-Parco Tecnologico Padano; Italian Romagnola Society-Universita Cattolica del Sacro Cuore; Livestock Improvement Corporation(Livestock Improvement Corporation); Meat and Wool New Zealand; North American Limousin Foundation; Red Angus Association of America; Roslin Institute for UK Guernsey; Sygen (now Genus); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Bovine Hapmap Consortium funded by the National Human Genome Research Institute of the National Institutes of Health, U.S. Department of Agricultures Agricultural Research Service (USDA-ARS) and Cooperative State Research, Education and Extension Service (USDA CSREES), the Research Council of Norway, as well as: American Angus Association, American Hereford Association, American Jersey Cattle Association, AgResearch (New Zealand), Beef CRC and Meat and Livestock Australia for the Australian Brahman Breeders Association, Beefmaster Breeders United, The Brazilian Agricultural Research Corporation (Embrapa), Brown Swiss Association, Commonwealth Scientific and Industrial Research Organization, Dairy InSight, GENO Breeding and Artificial Insemination Association-Norway, Herd Book/France Limousin Selection, Holstein Association USA, International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna, International Livestock Research Institute-Kenya, Italian Piedmontese Breeders-Parco Tecnologico Padano, Italian Romagnola Society-Universita Cattolica del Sacro Cuore, Livestock Improvement Corporation, Meat and Wool New Zealand. North American Limousin Foundation, Red Angus Association of America, Roslin Institute for UK Guernsey, and Sygen (now Genus). See SOM for additional acknowledgements. The genome sequence (AAFC03000000) and SNPs (SOM) are available from NCBI.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Barendse W, 2007, GENETICS, V176, P2601, DOI 10.1534/genetics.107.074328; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barendse W, 2004, AUST J EXP AGR, V44, P669, DOI 10.1071/EA02156; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Clutton-Brock J., 1999, NATURAL HIST DOMESTI; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Kappes SM, 2000, J ANIM SCI, V78, P3053; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schreiber A, 1999, J HERED, V90, P165, DOI 10.1093/jhered/90.1.165; SVED J A, 1971, Theoretical Population Biology, V2, P125; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	22	599	637	5	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					528	532		10.1126/science.1167936	http://dx.doi.org/10.1126/science.1167936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390050	Green Accepted, Green Published			2022-12-28	WOS:000265411200051
J	Bendkowsky, V; Butscher, B; Nipper, J; Shaffer, JP; Low, R; Pfau, T				Bendkowsky, Vera; Butscher, Bjoern; Nipper, Johannes; Shaffer, James P.; Loew, Robert; Pfau, Tilman			Observation of ultralong-range Rydberg molecules	NATURE			English	Article							COLLISIONS; ATOMS; STATES; CS; RB	Rydberg atoms have an electron in a state with a very high principal quantum number, and as a result can exhibit unusually long-range interactions. One example is the bonding of two such atoms by multipole forces to form Rydberg-Rydberg molecules with very large internuclear distances(1-3). Notably, bonding interactions can also arise from the low-energy scattering of a Rydberg electron with negative scattering length from a ground-state atom(4,5). In this case, the scattering-induced attractive interaction binds the ground-state atom to the Rydberg atom at a well-localized position within the Rydberg electron wavefunction and thereby yields giant molecules that can have internuclear separations of several thousand Bohr radii(6-8). Here we report the spectroscopic characterization of such exotic molecular states formed by rubidium Rydberg atoms that are in the spherically symmetric s state and have principal quantum numbers, n, between 34 and 40. We find that the spectra of the vibrational ground state and of the first excited state of the Rydberg molecule, the rubidium dimer Rb(5s)-Rb(ns), agree well with simple model predictions. The data allow us to extract the s-wave scattering length for scattering between the Rydberg electron and the ground-state atom, Rb(5s), in the low-energy regime (kinetic energy, <100meV), and to determine the lifetimes and the polarizabilities of the Rydberg molecules. Given our successful characterization of s-wave bound Rydberg states, we anticipate that p-wave bound states(9), trimer states(10) and bound states involving a Rydberg electron with large angular momentum-so-called trilobite molecules(5)-will also be realized and directly probed in the near future.	[Bendkowsky, Vera; Butscher, Bjoern; Nipper, Johannes; Shaffer, James P.; Loew, Robert; Pfau, Tilman] Univ Stuttgart, Phys Inst 5, D-70569 Stuttgart, Germany; [Shaffer, James P.] Univ Oklahoma, Homer L Dodge Dept Phys & Astron, Norman, OK 73072 USA	University of Stuttgart; University of Oklahoma System; University of Oklahoma - Norman	Bendkowsky, V (corresponding author), Univ Stuttgart, Phys Inst 5, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	v.bendkowsky@physik.uni-stuttgart.de; t.pfau@physik.uni-stuttgart.de	Pfau, Tilman/G-1774-2011; Loew, Robert/I-8206-2014	Pfau, Tilman/0000-0003-3272-3468; 	Deutsche Forschungsgemeinschaft [PF 381/4-1]; Landesstiftung Baden-Wurttemberg; Carl Zeiss foundation; Alexander von Humboldt foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesstiftung Baden-Wurttemberg; Carl Zeiss foundation; Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	We would like to thank C. Greene and J. M. Rost for discussions and P. Kollmann for his contribution in the early stage of the experiment. This work is supported by the Deutsche Forschungsgemeinschaft as part of the SFB/TRR21 and under contract PF 381/4-1, and by the Landesstiftung Baden-Wurttemberg. B. B. acknowledges support from the Carl Zeiss foundation and J. P. S. thanks the Alexander von Humboldt foundation for financial support.	Bahrim C, 2001, J PHYS B-AT MOL OPT, V34, pL195, DOI 10.1088/0953-4075/34/6/107; BARBIER L, 1986, PHYS REV A, V34, P2710, DOI 10.1103/PhysRevA.34.2710; Boisseau C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.133004; CALEF DF, 1983, J CHEM PHYS, V78, P4145, DOI 10.1063/1.445091; DEPRUNELE E, 1987, PHYS REV A, V35, P496, DOI 10.1103/PhysRevA.35.496; DU NY, 1987, PHYS REV A, V36, P971, DOI 10.1103/PhysRevA.36.971; FABRIKANT II, 1993, J PHYS B-AT MOL OPT, V26, P2533, DOI 10.1088/0953-4075/26/16/011; FABRIKANT II, 1986, J PHYS B-AT MOL OPT, V19, P1527, DOI 10.1088/0022-3700/19/10/021; Farooqi SM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.183002; Fermi E., 1934, NUOVO CIMENTO, V11, P157, DOI DOI 10.1007/BF02959829; Greene CH, 2000, PHYS REV LETT, V85, P2458, DOI 10.1103/PhysRevLett.85.2458; Greene CH, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.233002; Hamilton EL, 2002, J PHYS B-AT MOL OPT, V35, pL199, DOI 10.1088/0953-4075/35/10/102; Heidemann R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163601; Johnson TA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.113003; Khuskivadze AA, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.042709; Le Roy R J, 2007, CP663 U WAT; Leonard J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.073203; Li WH, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.052502; Liu ICH, 2006, EUR PHYS J D, V40, P65, DOI 10.1140/epjd/e2006-00098-x; LOW R, 2007, APPARATUS EXCITATION; MOLOF RW, 1974, PHYS REV A, V10, P1131, DOI 10.1103/PhysRevA.10.1131; OMONT A, 1977, J PHYS-PARIS, V38, P1343, DOI 10.1051/jphys:0197700380110134300; Overstreet KR, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.011403; Reetz-Lamour M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.253001; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.083201; STWALLEY WC, 1978, PHYS REV LETT, V41, P1164, DOI 10.1103/PhysRevLett.41.1164; VALIRON P, 1984, J PHYS B-AT MOL OPT, V17, P2803, DOI 10.1088/0022-3700/17/14/011	29	298	300	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					1005	U76		10.1038/nature07945	http://dx.doi.org/10.1038/nature07945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396141				2022-12-28	WOS:000265412900037
J	Klionsky, DJ				Klionsky, Daniel J.			Crohn's Disease, Autophagy, and the Paneth Cell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATG16L1		Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053396, R01 GM053396-19] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383	5	38	39	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1785	1786		10.1056/NEJMcibr0810347	http://dx.doi.org/10.1056/NEJMcibr0810347			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369659	Green Accepted			2022-12-28	WOS:000265377800015
J	Tonelli, M; Klarenbach, S; Rose, C; Wiebe, N; Gill, J				Tonelli, Marcello; Klarenbach, Scott; Rose, Caren; Wiebe, Natasha; Gill, John			Access to Kidney Transplantation Among Remote- and Rural-Dwelling Patients With Kidney Failure in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC REVASCULARIZATION SERVICES; ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; URBAN AREAS; INDICATORS; HOSPITALS; RESIDENCE; LOCATION; SCOTLAND; CANADA	Context US residents with end-stage renal disease ( ESRD) may live far away from the closest transplant center, which could compromise their access to kidney transplantation. Objective To assess access to kidney transplantation as a function of distance from the closest transplant center or as a function of rural rather than urban residence. Design, Setting, and Participants Observational study of 699 751 adult patients with kidney failure who had initiated renal replacement in the United States between 1995 and 2007 and were thus placed on a prospective mandatory registry list. Main Outcome Measures Time to placement on the kidney transplant waiting list and time to kidney transplantation, both measured at the start of renal replacement. Results During a median follow-up of 2.0 years (range, 0.0-12.5 years), 122 785 (17.5%) patients received a kidney transplant. Median distance to the closest transplant center was 15 miles. Participants were classified into distance categories by miles from a transplant center with 0 to 15 miles serving as the referent category. Compared with the referent category, the adjusted hazard ratios of deceased or living donor transplantation within each category follows: 16 to 50 miles, 1.03 (95% CI, 1.02-1.05); 51 to 100 miles, 1.11 (95% CI, 1.09-1.12); 101 to 136 miles, 1.14 (95% CI, 1.11-1.17); 137 to 231 miles, 1.16 (95% CI, 1.13-1.20); 232 to 310 miles, 1.20 (95% CI, 1.12-1.28); and more than 310 miles, 1.16 (95% CI, 1.09-1.23). When residence location was classified using rural-urban commuter areas, 79.6% of patients lived in urban; 10.3%, micropolitan; and 10.0%, rural areas. Compared with those living in metropolitan areas, the adjusted hazard ratios of deceased or living donor transplantation among patients residing in micropolitan communities was 1.13 (95% CI, 1.11-1.15) and 1.15 (95% CI, 1.13-1.18) for rural areas. Results were similar for both deceased donor and living donor transplantation and were consistent in multiple sensitivity analyses. Conclusion Remote or rural residence was not associated with increased time to kidney transplantation among people treated for ESRD in the United States.	[Tonelli, Marcello; Klarenbach, Scott; Wiebe, Natasha] Univ Alberta, Dept Med, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello] Univ Alberta, Div Crit Care Med, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello; Klarenbach, Scott] Inst Hlth Econ, Edmonton, AB, Canada; [Rose, Caren; Gill, John] St Pauls Hosp, Div Nephrol, Vancouver, BC V6Z 1Y6, Canada; [Gill, John] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA USA	University of Alberta; University of Alberta; University of Alberta; St. Paul's Hospital; University of Saskatchewan; Tufts Medical Center	Tonelli, M (corresponding author), Univ Alberta, Dept Med, 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2B7, Canada.	mtonelli-admin@med.ualberta.ca	Wiebe, Natasha/V-7803-2019; Tonelli, Marcello/B-3028-2009	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187	Alberta Heritage Foundation for Medical Research; Alberta Health and Wellness and the University of Alberta; Canadian Institutes of Health Research; Michael Smith Foundation for Medical Research	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Alberta Health and Wellness and the University of Alberta(University of Alberta); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Medical Research(Michael Smith Foundation for Health Research)	Funding/Support: Drs Tonelli and Klarenbach were supported by Population Health Investigator Awards from the Alberta Heritage Foundation for Medical Research and by a joint initiative between Alberta Health and Wellness and the University of Alberta. Dr Tonelli was also supported by a New Investigator Award from the Canadian Institutes of Health Research. Dr Gill was supported by the Michael Smith Foundation for Medical Research.	Alexander GC, 2001, AM J KIDNEY DIS, V37, P321, DOI 10.1053/ajkd.2001.21297; Axelrod DA, 2008, JAMA-J AM MED ASSOC, V299, P202, DOI 10.1001/jama.2007.50; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; BLACK N, 1995, J EPIDEMIOL COMMUN H, V49, P408, DOI 10.1136/jech.49.4.408; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Brabyn L., 2004, CARTOGRAPHICA, V39, P41, DOI [10.3138/TH62-2668-3273-3344, DOI 10.3138/TH62-2668-3273-3344]; Brabyn Lars, 2002, Int J Health Geogr, V1, P3, DOI 10.1186/1476-072X-1-3; Ellison MD, 2003, TRANSPLANTATION, V76, P1389, DOI 10.1097/01.TP.0000090332.30050.BA; Gamm LD, 2003, RURAL HLTH PEOPLE 20; Gregory PM, 2000, MED CARE, V38, P45, DOI 10.1097/00005650-200001000-00006; Grubesic Tony H, 2006, Int J Health Geogr, V5, P58, DOI 10.1186/1476-072X-5-58; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; Kasiske BL, 2008, AM J TRANSPLANT, V8, P647, DOI 10.1111/j.1600-6143.2007.02130.x; KASISKE BL, 1995, J AM SOC NEPHROL, V6, P1; Larson RC, 1981, URBAN OPERATIONS RES; LEESE GP, 1993, BRIT MED J, V306, P187, DOI 10.1136/bmj.306.6871.187; Leira EC, 2008, ARCH NEUROL-CHICAGO, V65, P887, DOI 10.1001/archneur.65.7.887; Levin KA, 2006, AM J PUBLIC HEALTH, V96, P145, DOI 10.2105/AJPH.2004.051193; Loubeau P R, 2001, Prog Transplant, V11, P291; Lutfiyya MN, 2007, INT J QUAL HEALTH C, V19, P141, DOI 10.1093/intqhc/mzm010; Neylan JF, 1999, J AM SOC NEPHROL, V10, P2237; Oniscu GC, 2003, BRIT MED J, V327, P1261, DOI 10.1136/bmj.327.7426.1261; Pong RW, 2002, CAN J PUBLIC HEALTH, V93, pS52, DOI 10.1007/BF03405119; Seidel JE, 2004, CAN J CARDIOL, V20, P517; Sheikh K, 2001, ARCH INTERN MED, V161, P737, DOI 10.1001/archinte.161.5.737; Tonelli M, 2006, CAN MED ASSOC J, V175, P478, DOI 10.1503/cmaj.051356; Turnbull J, 2008, BRIT J GEN PRACT, V58, P471, DOI 10.3399/bjgp08X319431; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	28	68	68	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1681	1690		10.1001/jama.2009.545	http://dx.doi.org/10.1001/jama.2009.545			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383959				2022-12-28	WOS:000265350700024
J	Jensen, DM; Marcellin, P; Freilich, B; Andreone, P; Di Bisceglie, A; Brandao-Mello, CE; Reddy, R; Craxi, A; Martin, AO; Teuber, G; Messinger, D; Thommes, JA; Tietz, A				Jensen, Donald M.; Marcellin, Patrick; Freilich, Bradley; Andreone, Pietro; Di Bisceglie, Adrian; Brandao-Mello, Carlos E.; Reddy, Rajender; Craxi, Antonio; Martin, Antonio Olveira; Teuber, Gerlinde; Messinger, Diethelm; Thommes, James A.; Tietz, Andreas			Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-alpha 2b A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							INTERFERON-ALPHA-2B PLUS RIBAVIRIN; SUSTAINED VIRAL RESPONSE; PEGYLATED INTERFERON-ALPHA-2B; NONRESPONDERS; COMBINATION; ALPHA-2A; EFFICACY; THERAPY; TELAPREVIR; MANAGEMENT	Background: Many patients with chronic hepatitis C have not responded to therapy with pegylated interferon plus ribavirin. Objective: To evaluate use of peginterferon-alpha 2a plus ribavirin to re-treat nonresponders to peginterferon-alpha 2b plus ribavirin. Design: Randomized, parallel-group trial conducted between September 2003 and February 2007. Patients and researchers were not blinded to intervention assignment. Random assignment was centralized, computer-generated, and stratified by geographic region, hepatitis C virus (HCV) genotype, and histologic diagnosis. Setting: 106 international centers. Patients: 950 nonresponders to 12 or more weeks of therapy with peginterferon-alpha 2b plus ribavirin. Intervention: Peginterferon-alpha 2a, 360 mu g/wk, for 12 weeks, then 180 mu g/wk to complete 72 weeks (group A) or 48 weeks (group B), or peginterferon-alpha 2a, 180 mu g/wk for 72 weeks (group C) or 48 weeks (group D). All patients received ribavirin, 1000 or 1200 mg/d. Measurements: Sustained virologic response (SVR), defined as un-detectable (< 50 IU/mL) HCV RNA levels 24 weeks after the end of treatment. Results: The SVR rates in groups A (n = 317), B (n = 156), C (n = 156), and D (n = 313) were 16%, 7%, 14%, and 9%, respectively relative risk [RR] for group A vs. group D [the primary comparison], 1.80 [95% CI, 1.17 to 2.77]; P = 0.006). Extended treatment duration increased SVR rates (16% for 72 weeks [groups A and C] vs. 8% for 48 weeks [groups B and D]; RR, 2.00 [CI, 1.32 to 3.02]; P < 0.001). Complete viral suppression (HCV RNA level < 50 IU/mL) at week 12 was achieved in 21% of patients in groups A and B and 13% of those in groups C and D. Rates of SVR were 49% (77 of 157 patients) and 4% (32 of 719 patients) among those with and without complete viral suppression at week 12, respectively. Limitation: Nonresponders to peginterferon-alpha 2a plus ribavirin were not evaluated. Conclusion: Re-treating nonresponders to therapy with peginterferon-alpha 2b plus ribavirin for 72 weeks significantly increases SVR rates compared with re-treating them for 48 weeks. The overall SVR rate was low, but patients who are most likely to respond to re-treatment can be identified at week 12.	Univ Chicago Hosp, Ctr Liver Dis, Chicago, IL 60637 USA; Hop Beaujon, Ctr Rech Biol Bichat Beaujon CRB3, Clichy, France; Liver & Pancreas Inst Kansas City, Kansas City, MO USA; Univ Bologna, Bologna, Italy; St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA; Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; Univ Penn, Philadelphia, PA 19104 USA; Univ Palermo, Palermo, Italy; Hosp La Paz, Madrid, Spain; Univ Frankfurt Hosp, Frankfurt, Germany; IST, Mannheim, Germany; Roche, Nutley, NJ USA; Roche, Basel, Switzerland	University of Chicago; University of Illinois System; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Bologna; Saint Louis University; Universidade Federal do Rio de Janeiro; University of Pennsylvania; University of Palermo; Hospital Universitario La Paz; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Roche Holding; Roche Holding	Jensen, DM (corresponding author), Univ Chicago, Med Ctr, Ctr Liver Dis, 5841 S Maryland Ave,MC 7120, Chicago, IL 60637 USA.	djensen@medicine.bsd.uchicago.edu	Andreone, Pietro/K-8050-2016; Craxi, Antonio/K-9529-2016	Andreone, Pietro/0000-0002-4794-9809; Craxi, Antonio/0000-0002-4480-9544	Roche, Basel, Switzerland	Roche, Basel, Switzerland(Roche Holding)	By Roche, Basel, Switzerland.	Berg C, 2006, J VIRAL HEPATITIS, V13, P435, DOI 10.1111/j.1365-2893.2006.00727.x; Bergmann JF, 2007, LIVER INT, V27, P1217, DOI 10.1111/j.1478-3231.2007.01540.x; Carr C, 2007, LIVER INT, V27, P1111, DOI 10.1111/j.1478-3231.2007.01535.x; *CTR DRUG EV RES, 2006, SUMM MIN ANT DRUG AD; Diago M, 2007, ALIMENT PHARM THER, V26, P1131, DOI 10.1111/j.1365-2036.2007.03470.x; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P225, DOI 10.1053/j.gastro.2005.11.011; Ferenci P, 2001, EUR J GASTROEN HEPAT, V13, P699, DOI 10.1097/00042737-200106000-00014; Fried MW, 2008, HEPATOLOGY, V48, P1033, DOI 10.1002/hep.22448; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Herrine SK, 2005, DIGEST DIS SCI, V50, P719, DOI 10.1007/s10620-005-2563-3; HOFFMANLAROCHE F, 2008, PEGASYS PEGINTERFERO; Jacobson IM, 2005, AM J GASTROENTEROL, V100, P2453, DOI 10.1111/j.1572-0241.2005.00282.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; Marcellin P, 2008, HEPATOLOGY, V48, p1147A; Mathew A, 2006, DIGEST DIS SCI, V51, P1956, DOI 10.1007/s10620-006-9192-3; McHutchison JG, 2008, HEPATOLOGY, V48, p431A; Moucari R, 2007, J HEPATOL, V46, P596, DOI 10.1016/j.jhep.2006.10.016; Poynard T, 2008, J HEPATOL, V48, pS369, DOI 10.1016/S0168-8278(08)60990-3; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Sherman M, 2006, GUT, V55, P1631, DOI 10.1136/gut.2005.083113; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P947; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Tong MJ, 1998, J VIRAL HEPATITIS, V5, P323, DOI 10.1046/j.1365-2893.1998.00120.x; Zeuzem S, 2008, HEPATOLOGY, V48, p418A; 2007, PEGINTRON SUMMARY PR	27	151	160	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					528	W97		10.7326/0003-4819-150-8-200904210-00007	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00007			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380853				2022-12-28	WOS:000265457000003
J	Hawton, K; van Heeringen, K				Hawton, Keith; van Heeringen, Kees			Suicide	LANCET			English	Review							SEROTONIN REUPTAKE INHIBITORS; DELIBERATE SELF-HARM; TERM-FOLLOW-UP; COMPLETED SUICIDE; RISK-FACTORS; MAJOR DEPRESSION; OLDER-PEOPLE; PSYCHOLOGICAL AUTOPSY; PERSONALITY-TRAITS; MEDIA GUIDELINES	Suicide receives increasing attention worldwide, with many countries developing national strategies for prevention. Rates of suicide vary greatly between countries, with the greatest burdens in developing countries. Many more men than women die by suicide. Although suicide rates in elderly people have fallen in many countries, those in young people have risen. Rates also vary with ethnic origin, employment status, and occupation. Most people who die by suicide have psychiatric disorders, notably mood, substance-related, anxiety, psychotic, and personality disorders, with comorbidity being common. Previous self-harm is a major risk factor. Suicide is also associated with physical characteristics and disorders and smoking. Family history of suicidal behaviour is important, as are upbringing, exposure to suicidal behaviour by others and in the media, and availability of means. Approaches to suicide prevention include those targeting high-risk. groups and population strategies. There are, however, many challenges to large-scale prevention, especially in developing countries.	[Hawton, Keith] Warneford Hosp, Univ Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England; [van Heeringen, Kees] Ghent Univ Hosp, Univ Dept Psychiat, Unit Suicide Res, B-9000 Ghent, Belgium	University of Oxford; Ghent University; Ghent University Hospital	Hawton, K (corresponding author), Warneford Hosp, Univ Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Rezaeian, Mohsen/C-6513-2008; van Heeringen, Kees/H-2384-2013; Patten, Scott/B-4434-2011; Obafunwa, John/K-5244-2019	Rezaeian, Mohsen/0000-0003-3070-0166; van Heeringen, Kees/0000-0001-5801-194X; Patten, Scott/0000-0001-9871-4041; Obafunwa, John/0000-0001-6014-168X	Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust; National Institute for Health Research	Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank Lesley Sutton for her help with the references. KH is supported by Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust and by the National Institute for Health Research. The views expressed in this paper are solely those of the authors.	Ager E, 2007, PSYCHOL MED, V37, P1131, DOI 10.1017/S0033291707000487; Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; [Anonymous], 2000, INT HDB SUICIDE ATTE; ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193; Bennewith O, 2007, BRIT J PSYCHIAT, V190, P266, DOI 10.1192/bjp.bp.106.027136; Biddle L, 2008, BRIT MED J, V336, P800, DOI 10.1136/bmj.39525.442674.AD; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Blood R. W., 2001, SUICIDE MEDIA CRITIC; Bondy B, 2006, MOL PSYCHIATR, V11, P336, DOI 10.1038/sj.mp.4001803; Brent DA, 2003, AM J PSYCHIAT, V160, P1486, DOI 10.1176/appi.ajp.160.8.1486; Brent DA, 2003, AM BEHAV SCI, V46, P1192, DOI 10.1177/0002764202250662; BRENT DA, 1994, J AM ACAD CHILD PSY, V33, P1080, DOI 10.1097/00004583-199410000-00003; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Brown M, 1997, BRIT MED J, V315, P286, DOI 10.1136/bmj.315.7103.286; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Cavanagh JTO, 1999, SOC PSYCH PSYCH EPID, V34, P645, DOI 10.1007/s001270050187; Chishti P, 2003, EUR J PUBLIC HEALTH, V13, P108, DOI 10.1093/eurpub/13.2.108; Chiu HFK, 2004, ACTA PSYCHIAT SCAND, V109, P299, DOI 10.1046/j.1600-0447.2003.00263.x; Chou YJ, 2003, INT J EPIDEMIOL, V32, P1007, DOI 10.1093/ije/dyg296; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Conner KR, 2004, ALCOHOL CLIN EXP RES, V28, p6S, DOI 10.1097/01.ALC.0000127410.84505.2A; Conwell Y., 2005, PREVENTION TREATMENT, P221; Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297; Coryell W, 2005, J CLIN PSYCHIAT, V66, P412, DOI 10.4088/JCP.v66n0401; Coryell W, 2001, AM J PSYCHIAT, V158, P748, DOI 10.1176/appi.ajp.158.5.748; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; Denning DG, 2000, SUICIDE LIFE-THREAT, V30, P282; Duberstein P R, 1995, Int Psychogeriatr, V7, P183, DOI 10.1017/S1041610295001967; Duberstein PR, 1997, CLIN PSYCHOL-SCI PR, V4, P359, DOI 10.1111/j.1468-2850.1997.tb00127.x; Ernst C, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-7; Fazel S, 2005, LANCET, V366, P1301, DOI 10.1016/S0140-6736(05)67325-4; Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107; FORTUNE SA, 2007, TXB CULTURAL PSYCHIA, P255; Foster T, 1997, BRIT J PSYCHIAT, V170, P447, DOI 10.1192/bjp.170.5.447; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Goodyer I, 2007, BMJ-BRIT MED J, V335, P142, DOI 10.1136/bmj.39224.494340.55; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Gould MS, 2005, JAMA-J AM MED ASSOC, V293, P1635, DOI 10.1001/jama.293.13.1635; GOULD MS, 1990, AM J EPIDEMIOL, V131, P71, DOI 10.1093/oxfordjournals.aje.a115487; GOULD MS, 1986, NEW ENGL J MED, V315, P690, DOI 10.1056/NEJM198609113151107; Gunnell D, 2005, INT J EPIDEMIOL, V34, P433, DOI 10.1093/ije/dyh398; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; HARRIS EC, 1994, MEDICINE, V73, P281, DOI 10.1097/00005792-199411000-00001; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Harriss L, 2005, BRIT J PSYCHIAT, V186, P60, DOI 10.1192/bjp.186.1.60; Harwood D, 2006, INT J GERIATR PSYCH, V21, P363, DOI 10.1002/gps.1473; Harwood D, 2001, INT J GERIATR PSYCH, V16, P155, DOI 10.1002/1099-1166(200102)16:2<155::AID-GPS289>3.0.CO;2-0; Harwood DMJ, 2006, PSYCHOL MED, V36, P1265, DOI 10.1017/S0033291706007872; Hawton K, 2000, BRIT J PSYCHIAT, V177, P463, DOI 10.1192/bjp.177.5.463; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hawton K, 2005, J CLIN PSYCHIAT, V66, P693, DOI 10.4088/JCP.v66n0604; Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; Hawton K, 1998, J AFFECT DISORDERS, V50, P269; Hawton K, 1999, BRIT MED J, V318, P972, DOI 10.1136/bmj.318.7189.972; Hawton K, 2005, PREVENTION TREATMENT, P293; Hegerl U, 2006, PSYCHOL MED, V36, P1225, DOI 10.1017/S003329170600780X; Hemmingsson T, 2003, INT J EPIDEMIOL, V32, P1000, DOI 10.1093/ije/dyg203; Hunt IM, 2003, BRIT J PSYCHIAT, V183, P155, DOI 10.1192/bjp.183.2.155; James A, 2004, ACTA PSYCHIAT SCAND, V110, P408, DOI 10.1111/j.1600-0447.2004.00384.x; Jokinen J, 2007, PSYCHIAT RES, V150, P297, DOI 10.1016/j.psychres.2006.12.001; Jollant F, 2005, AM J PSYCHIAT, V162, P304, DOI 10.1176/appi.ajp.162.2.304; Jollant F, 2008, AM J PSYCHIAT, V165, P740, DOI 10.1176/appi.ajp.2008.07081239; Kellner CH, 2005, AM J PSYCHIAT, V162, P977, DOI 10.1176/appi.ajp.162.5.977; Kelly S, 1998, Popul Trends, P29; Khan A, 2002, J AFFECT DISORDERS, V68, P183, DOI 10.1016/S0165-0327(01)00354-8; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; KREITMAN N, 1976, BRIT J PREV SOC MED, V30, P86; Levi F, 2003, ACTA PSYCHIAT SCAND, V108, P341, DOI 10.1034/j.1600-0447.2003.00147.x; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; Magnusson PKE, 2005, AM J PSYCHIAT, V162, P1373, DOI 10.1176/appi.ajp.162.7.1373; Malone KM, 2003, AM J PSYCHIAT, V160, P773, DOI 10.1176/appi.ajp.160.4.773; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; March JS, 2007, ARCH GEN PSYCHIAT, V64, P1132; McGirr A, 2008, PSYCHOL MED, V38, P407, DOI 10.1017/S0033291707001419; McKenzie K, 2003, BRIT J PSYCHIAT, V183, P100, DOI 10.1192/bjp.183.2.100; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Meehan J, 2006, BRIT J PSYCHIAT, V188, P129, DOI 10.1192/bjp.188.2.129; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Meyer JH, 2004, ARCH GEN PSYCHIAT, V61, P1271, DOI 10.1001/archpsyc.61.12.1271; MICHEL K, 2000, CRISIS, V21, P1; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; Mishara BL, 2007, CRISIS, V28, P10, DOI 10.1027/0227-5910.28.S1.10; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Naito Ayumi, 2007, Clin Child Psychol Psychiatry, V12, P583, DOI 10.1177/1359104507080990; *NAT COLL CTR MENT, 2008, CLIN GUID NAT COLL C, V23; Neeleman J, 1999, PSYCHOL MED, V29, P429, DOI 10.1017/S003329179800806X; Niederkrotenthaler T, 2007, AUST NZ J PSYCHIAT, V41, P419, DOI 10.1080/00048670701266680; Oquendo MA, 2006, ACTA PSYCHIAT SCAND, V114, P151, DOI 10.1111/j.1600-0447.2006.00829.x; Oquendo MA, 2004, LANCET, V364, P1102, DOI 10.1016/S0140-6736(04)17115-8; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Partonen T, 1999, BRIT J PSYCHIAT, V175, P259, DOI 10.1192/bjp.175.3.259; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Pirkis J, 1998, BRIT J PSYCHIAT, V173, P462, DOI 10.1192/bjp.173.6.462; Pirkis J, 2006, CRISIS, V27, P82, DOI 10.1027/0227-5910.27.2.82; Platt S., 2000, INT HDB SUICIDE ATTE, P303; Portzky G, 2006, J CHILD PSYCHOL PSYC, V47, P910, DOI 10.1111/j.1469-7610.2006.01595.x; Pritchard C, 2005, INT J GERIATR PSYCH, V20, P17, DOI 10.1002/gps.1213; Qin P, 2002, LANCET, V360, P1126, DOI 10.1016/S0140-6736(02)11197-4; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Riordan DV, 2006, BRIT J PSYCHIAT, V189, P502, DOI 10.1192/bjp.bp.105.015974; Routley V, 2007, CRISIS, V28, P28, DOI 10.1027/0227-5910.28.S1.28; RUTZ W, 1992, ACTA PSYCHIAT SCAND, V85, P83, DOI 10.1111/j.1600-0447.1992.tb01448.x; Salib E, 2006, BRIT J PSYCHIAT, V188, P416, DOI 10.1192/bjp.bp.105.009118; Sarwer DB, 2007, AM J PSYCHIAT, V164, P1006, DOI 10.1176/appi.ajp.164.7.1006; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Selakovic-Bursic Slavica, 2006, Arch Suicide Res, V10, P225, DOI 10.1080/13811110600582406; Silverman MM, 2006, SUICIDE LIFE-THREAT, V36, P519, DOI 10.1521/suli.2006.36.5.519; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; SONNECK G, 1994, SOC SCI MED, V38, P453, DOI 10.1016/0277-9536(94)90447-2; Spirito A, 2006, ANNU REV CLIN PSYCHO, V2, P237, DOI 10.1146/annurev.clinpsy.2.022305.095323; Stack S, 2003, J EPIDEMIOL COMMUN H, V57, P238, DOI 10.1136/jech.57.4.238; STANLEY M, 1983, LANCET, V1, P214; Szanto K, 2007, ARCH GEN PSYCHIAT, V64, P914, DOI 10.1001/archpsyc.64.8.914; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; Terao T, 2002, LANCET, V360, P1892, DOI 10.1016/S0140-6736(02)11761-2; Tiihonen J, 2006, BRIT MED J, V333, P224, DOI 10.1136/bmj.38881.382755.2F; van Heeringen C, 2003, J AFFECT DISORDERS, V74, P149, DOI 10.1016/S0165-0327(01)00482-7; Vijayakumar L, 1999, ACTA PSYCHIAT SCAND, V99, P407, DOI 10.1111/j.1600-0447.1999.tb00985.x; VIJAYAKUMAR L, 2005, PREVENTION TREATMENT, P335; Voracek M, 2008, ACTA PSYCHIAT SCAND, V118, P259, DOI 10.1111/j.1600-0447.2008.01238.x; Waern M, 2002, BMJ-BRIT MED J, V324, P1355, DOI 10.1136/bmj.324.7350.1355; Warshaw MG, 2000, AM J PSYCHIAT, V157, P1876, DOI 10.1176/appi.ajp.157.11.1876; Wasserman D., 2005, WORLD PSYCHIATRY, V4, P114; Wheeler BW, 2008, BMJ-BRIT MED J, V336, P542, DOI 10.1136/bmj.39462.375613.BE; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; WHO, 1989, WORLD HLTH STAT; World Health Organization, 2002, WORLD REPORT VIOLENC; Yang GH, 2005, BIOMED ENVIRON SCI, V18, P379; Yip PSF, 2000, BRIT J PSYCHIAT, V177, P366, DOI 10.1192/bjp.177.4.366; Yip PSF, 2008, SUICIDE ASIA CAUSES; Zahl DL, 2004, BRIT J PSYCHIAT, V185, P70, DOI 10.1192/bjp.185.1.70; Zivin K, 2007, AM J PUBLIC HEALTH, V97, P2193, DOI 10.2105/AJPH.2007.115477	144	1299	1338	6	337	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2009	373	9672					1372	1381		10.1016/S0140-6736(09)60372-X	http://dx.doi.org/10.1016/S0140-6736(09)60372-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434UR	19376453				2022-12-28	WOS:000265300100035
J	Schachter, DT				Schachter, David T.			Prosthetic Mitral Valve with Partial Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Madigan Army Med Ctr, Tacoma, WA 98431 USA	Madigan Army Medical Center	Schachter, DT (corresponding author), Madigan Army Med Ctr, Tacoma, WA 98431 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					E22	E22		10.1056/NEJMicm040909	http://dx.doi.org/10.1056/NEJMicm040909			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369662				2022-12-28	WOS:000265178000011
J	Kaddis, JS; Olack, BJ; Sowinski, J; Cravens, J; Contreras, JL; Niland, JC				Kaddis, John S.; Olack, Barbara J.; Sowinski, Janice; Cravens, James; Contreras, Juan L.; Niland, Joyce C.			Human Pancreatic Islets and Diabetes Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIAL GROWTH-FACTOR; QUALITY-OF-LIFE; BETA-CELL; TRANSPLANTATION; LANGERHANS; XENOTRANSPLANTATION; INFLAMMATION; APOPTOSIS; VARIABLES; MODELS	Human islet research is crucial to understanding the cellular biology of the pancreas in developing therapeutic options for diabetes patients and in attempting to prevent the development of this disease. The national Islet Cell Resource Center Consortium provides human pancreatic islets for diabetes research while simultaneously addressing the need to improve islet isolation and transplantation technologies. Since its inception in 2001, the consortium has supplied 297.6 million islet equivalents to 151 national and international scientists for use in clinical and laboratory projects. Data on the volume, quality, and frequency of shipments substantiate the importance of human islets for diabetes research, as do the number of funded grants for beta-cell projects and publications produced as a direct result of islets supplied by this resource. Limitations in using human islets are discussed, along with the future of islet distribution centers. The information presented here is instructive to clinicians, basic science investigators, and policy makers who determine the availability of funding for such work. Organ procurement coordinators also may find the information useful in explaining to donor families why research consent is so valuable.	[Kaddis, John S.; Olack, Barbara J.; Sowinski, Janice; Cravens, James; Niland, Joyce C.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA 91010 USA; [Contreras, Juan L.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL USA	City of Hope; University of Alabama System; University of Alabama Birmingham	Kaddis, JS (corresponding author), City Hope Natl Med Ctr, Dept Informat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jkaddis@coh.org		Olack, Barbara/0000-0001-6645-8215; Kaddis, John/0000-0002-6752-7670	National Center for Research Resources (NCRR); National Institute of Diabetes and Digestive and Kidney Diseases; US National Institutes of Health (NIH); NCRR [U42 RR 017673, U42 RR 023246]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR023246, U42RR017673] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding/Support: This work was funded by the cooperative efforts of the National Center for Research Resources (NCRR) and the National Institute of Diabetes and Digestive and Kidney Diseases, a component of the US National Institutes of Health (NIH), in conjunction with the generous contributions of the Juvenile Diabetes Research Foundation. Messrs Kaddis and Cravens, Mss Olack and Sowinski, and Dr Niland are supported by grants U42 RR 017673 (J.C.N.) and U42 RR 023246 (J.L.C.) from the NCRR.	Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a; Ballian N, 2007, WORLD J SURG, V31, P705, DOI 10.1007/s00268-006-0719-8; BALLINGER WF, 1972, SURGERY, V72, P175; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bhonde R, 2007, INDIAN J MED RES, V125, P425; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cure P, 2008, TRANSPLANTATION, V85, P801, DOI 10.1097/TP.0b013e318166a27b; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dufrane D, 2006, XENOTRANSPLANTATION, V13, P204, DOI 10.1111/j.1399-3089.2006.00275.x; Eftat S, 2008, ADV DRUG DELIVER REV, V60, P114, DOI 10.1016/j.addr.2007.08.033; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Elliott RB, 2000, CELL TRANSPLANT, V9, P895, DOI 10.1177/096368970000900616; Goss JA, 2004, TRANSPLANTATION, V77, P462, DOI 10.1097/01.TP.0000100397.86756.A3; GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3; Hanley NA, 2008, MOL CELL ENDOCRINOL, V288, P79, DOI 10.1016/j.mce.2008.03.001; Hanley SC, 2008, TRANSPLANTATION, V85, P950, DOI 10.1097/TP.0b013e3181683df5; Hering BJ, 2007, AM J TRANSPLANT, V7, P205; Hohmeier HE, 2005, NAT BIOTECHNOL, V23, P1231, DOI 10.1038/nbt1005-1231; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Huang XL, 2008, ENDOCR REV, V29, P603, DOI 10.1210/er.2008-0006; Ichii H, 2007, AM J TRANSPLANT, V7, P1010, DOI 10.1111/j.1600-6143.2006.01687.x; *INT SOC CELL THER, RISK BOV SPONG ENC B; *ISI WEB KNOWL, WEB SCI J IMP REP TO; *JUV DIAB RES FDN, JUV DIAB RES FDN INT; Knazek Richard A, 2002, Diabetes Technol Ther, V4, P551, DOI 10.1089/152091502760306652; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; LAKEY JR, 2006, HUM ISL IS TRANSP TE; Lakey JRT, 1996, TRANSPLANTATION, V61, P1047, DOI 10.1097/00007890-199604150-00010; Markmann JF, 2008, AM J TRANSPLANT, V8, P1588, DOI 10.1111/j.1600-6143.2008.02305.x; Meivar-Levy I, 2003, TRENDS ENDOCRIN MET, V14, P460, DOI 10.1016/j.tem.2003.10.006; Movahedi B, 2008, DIABETES, V57, P2128, DOI 10.2337/db07-1705; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; *NAT SCI FDN, NAT SCI FDN AW SEARC; NIH RePORTER, NIH RES PORTF ONL RE; O'Neil JJ, 2003, CELL TRANSPLANT, V12, P883, DOI 10.3727/000000003771000110; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; *OPTN, OPTN NAT DAT REP; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Pileggi A, 2006, ANN NY ACAD SCI, V1079, P383, DOI 10.1196/annals.1375.059; Qian D, 2007, COMPUT STAT DATA AN, V51, P5494, DOI 10.1016/j.csda.2007.02.030; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; Ryan EA, 2004, DIABETES, V53, P955, DOI 10.2337/diabetes.53.4.955; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Toso C, 2007, TRANSPLANTATION, V84, P664, DOI 10.1097/01.tp.0000280550.01028.89; Valdes-Gonzalez RA, 2005, EUR J ENDOCRINOL, V153, P419, DOI 10.1530/eje.1.01982; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; Yang Z, 2004, TRANSPL P, V36, P1532, DOI 10.1016/j.transproceed.2004.04.075; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; ZOON KC, LETT TRANSPLANT CTR	56	44	46	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1580	1587		10.1001/jama.2009.482	http://dx.doi.org/10.1001/jama.2009.482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366778	Green Accepted			2022-12-28	WOS:000265137900029
J	Wang, RH; Farrona, S; Vincent, C; Joecker, A; Schoof, H; Turck, F; Alonso-Blanco, C; Coupland, G; Albani, MC				Wang, Renhou; Farrona, Sara; Vincent, Coral; Joecker, Anika; Schoof, Heiko; Turck, Franziska; Alonso-Blanco, Carlos; Coupland, George; Albani, Maria C.			PEP1 regulates perennial flowering in Arabis alpina	NATURE			English	Article							ARABIDOPSIS-THALIANA; VERNALIZATION; GENE; FLC; PROTEIN; EVOLUTION; REPRESSOR; TRIMETHYLATION; BRASSICACEAE; METHYLATION	Annual plants complete their life cycle in one year and initiate flowering only once, whereas perennials live for many years and flower repeatedly. How perennials undergo repeated cycles of vegetative growth and flowering that are synchronized to the changing seasons has not been extensively studied(1). Flowering is best understood in annual Arabidopsis thaliana 2,3, but many closely related species, such as Arabis alpina(4,5), are perennials. We identified the A. alpina mutant perpetual flowering 1 (pep1), and showed that PEP1 contributes to three perennial traits. It limits the duration of flowering, facilitating a return to vegetative development, prevents some branches from undergoing the floral transition allowing polycarpic growth habit, and confers a flowering response to winter temperatures that restricts flowering to spring. Here we show that PEP1 is the orthologue of the A. thaliana gene FLOWERING LOCUS C (FLC). The FLC transcription factor inhibits flowering until A. thaliana is exposed to winter temperatures(6,7), which trigger chromatin modifications that stably repress FLC transcription(8-11). In contrast, PEP1 is only transiently repressed by low temperatures, causing repeated seasonal cycles of repression and activation of PEP1 transcription that allow it to carry out functions characteristic of the cyclical life history of perennials. The patterns of chromatin modifications at FLC and PEP1 differ correlating with their distinct expression patterns. Thus we describe a critical mechanism by which flowering regulation differs between related perennial and annual species, and propose that differences in chromatin regulation contribute to this variation.	[Wang, Renhou; Farrona, Sara; Vincent, Coral; Joecker, Anika; Schoof, Heiko; Turck, Franziska; Coupland, George; Albani, Maria C.] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Alonso-Blanco, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, E-28049 Madrid, Spain	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	coupland@mpiz-koeln.mpg.de; albani@mpiz-koeln.mpg.de	Turck, Franziska/G-1240-2013; Schoof, Heiko/Y-7073-2018; Alonso-Blanco, Carlos/F-8864-2016; Coupland, George/AAP-8609-2020	Turck, Franziska/0000-0002-4982-5949; Schoof, Heiko/0000-0002-1527-3752; Alonso-Blanco, Carlos/0000-0002-4738-5556; Coupland, George/0000-0001-6988-4172; Albani, Maria/0000-0002-8215-020X; Farrona, Sara/0000-0002-6855-2237	Max Planck Society	Max Planck Society(Max Planck Society)	The authors would like to thank P. Sharma for growing plants and R. Bruggmann for running the gene prediction pipeline. The laboratories of H. S. and G. C. are partly funded by a core grant from the Max Planck Society.	Ansell SW, 2008, MOL ECOL, V17, P2245, DOI 10.1111/j.1365-294X.2008.03739.x; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Battey NH, 2000, J EXP BOT, V51, P1769, DOI 10.1093/jexbot/51.352.1769; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Beilstein MA, 2006, AM J BOT, V93, P607, DOI 10.3732/ajb.93.4.607; Bena G, 1998, P ROY SOC B-BIOL SCI, V265, P1141, DOI 10.1098/rspb.1998.0410; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Aloia M, 2008, NEW PHYTOL, V178, P755, DOI 10.1111/j.1469-8137.2008.02404.x; DIOMAIUTO J, 1988, Phytomorphology, V38, P163; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Foster T, 2003, ANN BOT-LONDON, V92, P199, DOI 10.1093/aob/mcg120; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Schranz ME, 2002, GENETICS, V162, P1457; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Thomas H, 2000, J EXP BOT, V51, P1781, DOI 10.1093/jexbot/51.352.1781; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	41	263	269	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					423	U138		10.1038/nature07988	http://dx.doi.org/10.1038/nature07988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19369938	Green Published			2022-12-28	WOS:000266243700045
J	Ntoukakis, V; Mucyn, TS; Gimenez-lbanez, S; Chapman, HC; Gutierrez, JR; Balmuth, AL; Jones, AME; Rathjen, JP				Ntoukakis, Vardis; Mucyn, Tatiana S.; Gimenez-lbanez, Selena; Chapman, Helen C.; Gutierrez, Jose R.; Balmuth, Alexi L.; Jones, Alexandra M. E.; Rathjen, John P.			Host Inhibition of a Bacterial Virulence Effector Triggers Immunity to Infection	SCIENCE			English	Article							E3 UBIQUITIN LIGASE; PROGRAMMED CELL-DEATH; SYRINGAE PV. TOMATO; PLANT IMMUNITY; III EFFECTOR; NEGATIVE REGULATION; PROTEIN-KINASE; PTO KINASE; AVRPTOB; PHOSPHORYLATION	Plant pathogenic bacteria secrete effector proteins that attack the host signaling machinery to suppress immunity. Effectors can be recognized by hosts leading to immunity. One such effector is AvrPtoB of Pseudomonas syringae, which degrades host protein kinases, such as tomato Fen, through an E3 ligase domain. Pto kinase, which is highly related to Fen, recognizes AvrPtoB in conjunction with the resistance protein Prf. Here we show that Pto is resistant to AvrPtoB-mediated degradation because it inactivates the E3 ligase domain. AvrPtoB ubiquitinated Fen within the catalytic cleft, leading to its breakdown and loss of the associated Prf protein. Pto avoids this by phosphorylating and inactivating the AvrPtoB E3 domain. Thus, inactivation of a pathogen virulence molecule is one mechanism by which plants resist disease.	[Ntoukakis, Vardis; Mucyn, Tatiana S.; Gimenez-lbanez, Selena; Chapman, Helen C.; Gutierrez, Jose R.; Balmuth, Alexi L.; Jones, Alexandra M. E.; Rathjen, John P.] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Rathjen, JP (corresponding author), Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	john.rathjen@tsl.ac.uk	Gutierrez-Pulgar, Jose/AAC-1281-2020; Jones, Alexandra/B-5227-2009; Ntoukakis, Vardis/C-6296-2012; rathjen, john p/C-9327-2009; Gimenez-Ibanez, Selena/B-1172-2017	Jones, Alexandra/0000-0003-2571-8708; Ntoukakis, Vardis/0000-0003-0069-6004; rathjen, john p/0000-0003-4073-8088; Gimenez-Ibanez, Selena/0000-0002-5453-8565	Biotechnology and Biological Science Research Council [BB/D00456X/1]; Gatsby Charitable foundation; Biotechnology and Biological Sciences Research Council [BB/D00456X/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L. Serazetdinova for help with mass spectroscopy and G. Martin (Cornell University) for bacterial strains and RG-pto11 mutant seeds. Part of this work was funded by a Biotechnology and Biological Science Research Council grant BB/D00456X/1 to J.P.R. We gratefully acknowledge the support of the Gatsby Charitable foundation.	Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Abramovitch RB, 2005, FEMS MICROBIOL LETT, V245, P1, DOI 10.1016/j.femsle.2005.02.025; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Andriotis VME, 2006, J BIOL CHEM, V281, P26578, DOI 10.1074/jbc.M603197200; Balmuth A, 2007, PLANT J, V51, P978, DOI 10.1111/j.1365-313X.2007.03199.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Lin NC, 2006, APPL ENVIRON MICROB, V72, P702, DOI 10.1128/AEM.72.1.702-712.2006; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; SALMERON JM, 1994, PLANT CELL, V6, P511, DOI 10.1105/tpc.6.4.511; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tatematsu K, 2008, J BIOL CHEM, V283, P11575, DOI 10.1074/jbc.M706961200; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2	24	92	94	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					784	787		10.1126/science.1169430	http://dx.doi.org/10.1126/science.1169430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423826				2022-12-28	WOS:000265832400046
J	Rout, ME; Callaway, RM				Rout, Marnie E.; Callaway, Ragan M.			An Invasive Plant Paradox	SCIENCE			English	Editorial Material							ECOSYSTEM CARBON; SOIL BIOTA		[Rout, Marnie E.; Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Rout, ME (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	marnie.rout@mso.umt.edu						Blank RR, 2008, INVAS PLANT SCI MANA, V1, P226, DOI 10.1614/IPSM-07-026.1; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Gomez-Aparicio L, 2008, ECOL MONOGR, V78, P69, DOI 10.1890/06-2036.1; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Liao CZ, 2007, ECOSYSTEMS, V10, P1351, DOI 10.1007/s10021-007-9103-2; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; Rout ME, 2009, PLANT SOIL, V315, P163, DOI 10.1007/s11104-008-9740-z; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Vanderhoeven S, 2005, PLANT SOIL, V275, P169, DOI 10.1007/s11104-005-1257-0; VANDERPUTTEN WH, 1993, NATURE, V362, P53; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87	16	89	93	8	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					734	735		10.1126/science.1173651	http://dx.doi.org/10.1126/science.1173651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423809				2022-12-28	WOS:000265832400028
J	Wolff, T; Witkop, CT; Miller, T; Syed, SB				Wolff, Tracy; Witkop, Catherine Takacs; Miller, Therese; Syed, Shamsuzzoha B.			Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Update of the Evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							DIETARY-FOLATE; ACID/MULTIVITAMIN SUPPLEMENTATION; MULTIPLE BIRTHS; VITAMIN USE; RISK; PREGNANCY; FORTIFICATION; COHORT	Background: Neural tube defects (NTDs) are among the most common birth defects in the United States. In 1996, the U. S. Preventive Services Task Force (USPSTF) recommended that all women planning a pregnancy or capable of conception take a supplement containing folic acid to reduce the risk for NTDs. Purpose: To search for new evidence published since 1996 on the benefits and harms of folic acid supplementation for women of childbearing age to prevent neural tube defects in offspring, to inform an updated USPSTF recommendation. Data Sources: MEDLINE and Cochrane Central Register of Controlled Trials searches from January 1995 through December 2008, recent systematic reviews, reference lists of retrieved articles, and expert suggestions. Study Selection: English-language randomized, controlled trials; cohort studies; case-control studies; systematic reviews; and meta-analyses were selected if they provided information on the benefits and harms of folic acid supplementation in women of childbearing age to reduce NTDs in offspring. Data Extraction: All studies were reviewed, abstracted, and rated for quality by using predefined USPSTF criteria. Data Synthesis: Four observational studies reported benefit of reduction of risk for NTDs associated with folic acid-containing supplements. Differences in study type and methods prevent the calculation of a summary of the reduction in risk. The one included study on harms reported that the association of twinning with folic acid intake disappeared after adjustment for in vitro fertilization and underreporting of folic acid intake. Limitations: The evidence on dose was limited. No evidence was found on the potential harm of masking vitamin B-12 deficiency in women of childbearing age. The search focused on the association of NTDs with supplementation only and therefore does not provide a comprehensive review of the effects of folic acid on all possible outcomes or of the effects of dietary intake of folic acid. Conclusion: New observational evidence supports previous evidence from a randomized, controlled trial that folic acid-containing supplements reduce the risk for NTD-affected pregnancies. The association of folic acid use with twin gestation may be confounded by fertility interventions.	[Wolff, Tracy; Witkop, Catherine Takacs; Miller, Therese; Syed, Shamsuzzoha B.] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA	Agency for Healthcare Research & Quality	Wolff, T (corresponding author), US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA.							Bentley TGK, 2006, AM J PUBLIC HEALTH, V96, P2040, DOI 10.2105/AJPH.2005.067371; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Czeizel A. E., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P175; Czeizel AE, 1996, TERATOLOGY, V53, P345, DOI 10.1002/(SICI)1096-9926(199606)53:6&lt;345::AID-TERA5&gt;3.0.CO;2-Z; Czeizel AE, 2004, BIRTH DEFECTS RES A, V70, P853, DOI 10.1002/bdra.20086; Czeizel AE, 2004, AM J OBSTET GYNECOL, V191, P790, DOI 10.1016/j.ajog.2004.02.018; Ericson A, 2001, Twin Res, V4, P63, DOI 10.1375/twin.4.2.63; Goh YI, 2006, J OBSTET GYNAECOL CA, V28, P680, DOI 10.1016/S1701-2163(16)32227-7; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Kallen B, 2004, EARLY HUM DEV, V80, P143, DOI 10.1016/j.earlhumdev.2004.06.002; Kallen BAJ, 2002, REPROD TOXICOL, V16, P327, DOI 10.1016/S0890-6238(02)00041-2; Li Z, 2003, LANCET, V361, P380, DOI 10.1016/S0140-6736(03)12390-2; Locksmith GJ, 1998, OBSTET GYNECOL, V91, P1027, DOI 10.1016/S0029-7844(98)00060-X; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; LUMLEY J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001056.pub2, 10.1002/14651858.CD001056, DOI 10.1002/14651858.CD001056]; Mathews T, 2007, TRENDS SPINA BIFIDA; Medveczky E, 2004, EUR J OBSTET GYN R B, V115, P178, DOI 10.1016/j.ejogrb.2003.12.010; Mills JL, 2003, AM J CLIN NUTR, V77, P1474, DOI 10.1093/ajcn/77.6.1474; Moore LL, 2003, EPIDEMIOLOGY, V14, P200; [Preventive Services Task Force US US Preventive Services Task Force], 1996, GUID CLIN PREV SERV, P467; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Shaw GM, 1996, JAMA-J AM MED ASSOC, V275, P1093, DOI 10.1001/jama.275.14.1093; Shaw GM, 2002, EPIDEMIOLOGY, V13, P625, DOI 10.1097/00001648-200211000-00005; Shaw GM, 1998, AM J EPIDEMIOL, V148, P30, DOI 10.1093/oxfordjournals.aje.a009555; Shaw GM, 2001, INT J EPIDEMIOL, V30, P60, DOI 10.1093/ije/30.1.60; Suarez L, 2000, AM J EPIDEMIOL, V152, P1017, DOI 10.1093/aje/152.11.1017; Thompson SJ, 2003, ANN EPIDEMIOL, V13, P412, DOI 10.1016/S1047-2797(02)00460-X; US Preventive Services Task Force, 2008, AHRQ PUBL; Vollset SE, 2005, EPIDEMIOLOGY, V16, P201, DOI 10.1097/01.ede.0000152914.84962.13; Wright J.D., 1998, VITAL HLTH STAT, V11, P1	30	124	132	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					632	U14		10.7326/0003-4819-150-9-200905050-00010	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414843				2022-12-28	WOS:000265903800008
J	Woloshin, S; Schwartz, LM; Casella, SL; Kennedy, AT; Larson, RJ				Woloshin, Steven; Schwartz, Lisa M.; Casella, Samuel L.; Kennedy, Abigail T.; Larson, Robin J.			Press Releases by Academic Medical Centers: Not So Academic?	ANNALS OF INTERNAL MEDICINE			English	Article							SCIENTIFIC MEETINGS; NEWS; COVERAGE; QUALITY; STORIES	Background: The news media are often criticized for exaggerated coverage of weak science. Press releases, a source of information for many journalists, might be a source of those exaggerations. Objective: To characterize research press releases from academic medical centers. Design: Content analysis. Setting: Press releases from 10 medical centers at each extreme of U. S. News & World Report's rankings for medical research. Measurements: Press release quality. Results: Academic medical centers issued a mean of 49 press releases annually. Among 200 randomly selected releases analyzed in detail, 87 (44%) promoted animal or laboratory research, of which 64 (74%) explicitly claimed relevance to human health. Among 95 releases about primary human research, 22 (23%) omitted study size and 32 (34%) failed to quantify results. Among all 113 releases about human research, few (17%) promoted studies with the strongest designs (randomized trials or meta-analyses). Forty percent reported on the most limited human studies-those with uncontrolled interventions, small samples (<30 participants), surrogate primary outcomes, or unpublished data-yet 58% lacked the relevant cautions. Limitation: The effects of press release quality on media coverage were not directly assessed. Conclusion: Press releases from academic medical centers often promote research that has uncertain relevance to human health and do not provide key facts or acknowledge important limitations. Primary Funding Source: National Cancer Institute.	Dept Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, White River Jct, VT USA; Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; Dartmouth Med Sch, White River Jct, VT USA	Dartmouth College; Dartmouth College	Schwartz, LM (corresponding author), Vet Affairs Med Ctr, Dept Vet Affairs, Vet Affairs Outcomes Grp 111B, White River Jct, VT 05009 USA.	lisa.schwartz@dartmouth.edu			National Cancer Institute [R01 CA104721]; Robert Wood Johnson Generalist Faculty Scholars Awards; NATIONAL CANCER INSTITUTE [R01CA104721] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert Wood Johnson Generalist Faculty Scholars Awards(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (grant R01 CA104721). Drs. Woloshin and Schwartz were also supported by Robert Wood Johnson Generalist Faculty Scholars Awards.	Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hoye Sigurd, 2002, Tidsskr Nor Laegeforen, V122, P1671; Kuriya B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002828; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; RUSSELL C, 2008, SCI REPORTING PRESS; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Schwartz LM, 2002, JAMA-J AM MED ASSOC, V287, P2859, DOI 10.1001/jama.287.21.2859; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Smith DE, 2005, MED J AUSTRALIA, V183, P190, DOI 10.5694/j.1326-5377.2005.tb06992.x; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; *US NEWS WORLD REP, 2005, AM BEST GRAD SCH PLU; WILKES MS, 1992, JAMA-J AM MED ASSOC, V268, P999, DOI 10.1001/jama.268.8.999; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; Woloshin S, 2006, MED J AUSTRALIA, V184, P576, DOI 10.5694/j.1326-5377.2006.tb00384.x	20	76	77	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					613	U8		10.7326/0003-4819-150-9-200905050-00007	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414840				2022-12-28	WOS:000265903800005
J	Pirker, R; Pereira, JR; Szczesna, A; von Pawel, J; Krzakowski, M; Ramlau, R; Vynnychenko, I; Park, K; Yu, CT; Ganul, V; Roh, JK; Bajetta, E; O'Byrne, K; de Marinis, F; Eberhardt, W; Goddemeier, T; Emig, M; Gatzemeier, U; Pirker, R; Thatcher, N; Armand, JP; Camus, P; Victor, N; Emig, M; Mueser, M; Pilz, K; Goddemeier, T; Montaner, I; Lachs, M; Hoang-Sayag, L; Alvarez, A; Coppola, F; Recondo, G; Richardet, E; Kirsten, F; Karapetis, C; Parente, P; Michael, M; White, S; Boyce, A; Lewis, C; Slancar, M; Pavlakis, N; Abdi, E; Underhill, C; Pittman, K; Burghuber, O; Pirker, R; Ruckser, R; Ulsperger, E; Kolb, R; Humblet, Y; Canon, JL; Bustin, F; Barrios, C; Gorini, C; Ferreira, CM; Pereira, J; Ivanova, N; Tomova, A; Tzekova, V; Chilingirov, P; Racheva, M; Gill, M; Orlandi, FJ; Reyes, J; Salman, P; Tomiskova, M; Roubec, J; Pesek, M; Musil, J; Zatloukal, P; Robinet, G; Riviere, A; Moro-Sibilot, D; Barlesi, F; Chouaid, C; Tourani, JM; Lena, H; Thiberville, L; Quoix, E; Schott, R; Lemarie, E; Schlimok, G; Loddenkemper, R; Eberhardt, W; Wilke, H; Martens, U; Waller, C; von Pawel, J; Griesinger, F; Gatzemeier, U; Schuette, W; Eschbach, C; Bischoff, H; Chemaissani, A; Wolf, J; Fischer, J; Bohnet, S; Klein, H; Kortsik, C; Peschel, C; Ittel, TH; Fett, W; Chua, D; Magyar, P; Ostoros, G; Somfay, A; Vinkler, I; Papai, Z; Szima, B; Mark, Z; Tehenes, S; O'Byrne, K; Brandes, A; Martoni, A; Marini, G; Artioli, F; Bajetta, E; Siena, S; de Marinis, F; Santoro, A; Barni, S; Berchem, G; Arrieta, O; Figueroa, J; Martinez, L; Llerena, E; Burgers, JA; Giaccone, G; Schramel, FMNH; Goey, SH; Stigt, JA; Jagiello, G; Jagiello-Gruszfeld, A; Szczesna, A; Ramlau, R; Krzakowski, M; Tomeczko, J; Teixeira, E; Parente, B; Kononova, G; Biakhov, M; Borisov, V; Gorbunova, V; Konev, A; Manzuk, L; Lukyanov, Y; Manikhas, G; Orlov, S; Heo, DS; Kim, SW; Park, K; Roh, JK; Choi, JH; Soo, R; Mazal, J; Kasan, P; Berzinec, P; Prochazka, M; Carrato, A; Pivlots, RB; Lianes, P; Villar, J; Paz-Ares, L; Cobo, M; Trigo, JM; Ayarra, AG; Constenla, M; Lario, AP; Brea, ML; Insa, A; Vivanco, GL; Brodin, O; Wagenius, G; Ochsenbein, A; Rauch, D; Knuth, A; Chang, GC; Perng, RP; Yang, CH; Yu, CT; Demirkazik, A; Demirelli, F; Nicolson, M; Falk, S; Price, A; Mulatero, C; Lee, SM; O'Brien, M; Gardiner, J; Laurence, V; Ferry, D; Paramonov, V; Bondarenko, I; Pylypenko, M; Ganul, V; Oliynichenko, P; Simonov, S; Shparyk, Y; Bashtan, V; Vynnychenko, I; Galaychuk, I; Hotko, Y				Pirker, Robert; Pereira, Jose R.; Szczesna, Aleksandra; von Pawel, Joachim; Krzakowski, Maciej; Ramlau, Rodryg; Vynnychenko, Ihor; Park, Keunchil; Yu, Chih-Teng; Ganul, Valentyn; Roh, Jae-Kyung; Bajetta, Emilio; O'Byrne, Kenneth; de Marinis, Filippo; Eberhardt, Wilfried; Goddemeier, Thomas; Emig, Michael; Gatzemeier, Ulrich; Pirker, R.; Thatcher, N.; Armand, J. P.; Camus, P.; Victor, N.; Emig, M.; Mueser, M.; Pilz, K.; Goddemeier, T.; Montaner, I.; Lachs, Martin; Hoang-Sayag, Loan; Alvarez, A.; Coppola, F.; Recondo, G.; Richardet, E.; Kirsten, F.; Karapetis, C.; Parente, P.; Michael, M.; White, S.; Boyce, A.; Lewis, C.; Slancar, M.; Pavlakis, N.; Abdi, E.; Underhill, C.; Pittman, K.; Burghuber, O.; Pirker, R.; Ruckser, R.; Ulsperger, E.; Kolb, R.; Humblet, Y.; Canon, J-L.; Bustin, F.; Barrios, C.; Gorini, C.; Ferreira, C. Moreira; Pereira, J.; Ivanova, N.; Tomova, A.; Tzekova, V.; Chilingirov, P.; Racheva, M.; Gill, M.; Orlandi, F. Javier; Reyes, J.; Salman, P.; Tomiskova, M.; Roubec, J.; Pesek, M.; Musil, J.; Zatloukal, P.; Robinet, G.; Riviere, A.; Moro-Sibilot, D.; Barlesi, F.; Chouaid, C.; Tourani, J-M.; Lena, H.; Thiberville, L.; Quoix, E.; Schott, R.; Lemarie, E.; Schlimok, G.; Loddenkemper, R.; Eberhardt, W.; Wilke, H.; Martens, U.; Waller, C.; von Pawel, J.; Griesinger, F.; Gatzemeier, U.; Schuette, W.; Eschbach, C.; Bischoff, H.; Chemaissani, A.; Wolf, J.; Fischer, J.; Bohnet, S.; Klein, H.; Kortsik, C.; Peschel, C.; Ittel, T. H.; Fett, W.; Chua, D.; Magyar, P.; Ostoros, G.; Somfay, A.; Vinkler, I.; Papai, Z.; Szima, B.; Mark, Z.; Tehenes, S.; O'Byrne, K.; Brandes, A.; Martoni, A.; Marini, G.; Artioli, F.; Bajetta, E.; Siena, S.; de Marinis, F.; Santoro, A.; Barni, S.; Berchem, G.; Arrieta, O.; Figueroa, J.; Martinez, L.; Llerena, E.; Burgers, J. A.; Giaccone, G.; Schramel, F. M. N. H.; Goey, S. H.; Stigt, J. A.; Jagiello, G.; Jagiello-Gruszfeld, A.; Szczesna, A.; Ramlau, R.; Krzakowski, M.; Tomeczko, J.; Teixeira, E.; Parente, B.; Kononova, G.; Biakhov, M.; Borisov, V.; Gorbunova, V.; Konev, A.; Manzuk, L.; Lukyanov, Y.; Manikhas, G.; Orlov, S.; Heo, D-S.; Kim, S-W.; Park, K.; Roh, J-K.; Choi, J-H.; Soo, R.; Mazal, J.; Kasan, P.; Berzinec, P.; Prochazka, M.; Carrato, A.; Pivlots, R. Bastus; Lianes, P.; Villar, J.; Paz-Ares, L.; Cobo, M.; Trigo, J. M.; Ayarra, A. Gurpide; Constenla, M.; Lario, A. Paredes; Brea, M. Lopez; Insa, A.; Vivanco, G. Lopez; Brodin, O.; Wagenius, G.; Ochsenbein, A.; Rauch, D.; Knuth, A.; Chang, G-C.; Perng, R. P.; Yang, C-H.; Yu, C-T.; Demirkazik, A.; Demirelli, F.; Nicolson, M.; Falk, S.; Price, A.; Mulatero, C.; Lee, S. M.; O'Brien, M.; Gardiner, J.; Laurence, V.; Ferry, D.; Paramonov, V.; Bondarenko, I.; Pylypenko, M.; Ganul, V.; Oliynichenko, P.; Simonov, S.; Shparyk, Y.; Bashtan, V.; Vynnychenko, I.; Galaychuk, I.; Hotko, Y.		FLEX Study Team	Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial	LANCET			English	Article							GROWTH-FACTOR RECEPTOR; 1ST-LINE TREATMENT; CARBOPLATIN; COMBINATION; CISPLATIN; GEMCITABINE; PACLITAXEL; GEFITINIB; ERLOTINIB; THERAPY	Background Use of cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has the potential to increase survival in patients with advanced non-small-cell lung cancer. We therefore compared chemotherapy plus cetuximab with chemotherapy alone in patients with advanced EGFR-positive non-small-cell lung cancer. Methods In a multinational, multicentre, open-label, phase III trial, chemotherapy-naive patients (>= 18 years) with advanced EGFR-expressing histologically or cytologically proven stage wet IIIB or stage IV non-small-cell lung cancer were randomly assigned in a 1:1 ratio to chemotherapy plus cetuximab or just chemotherapy. Chemotherapy was cisplatin 80 mg/m(2) intravenous infusion on day 1, and vinorelbine 25 mg/m(2) intravenous infusion on days 1 and 8 of every 3-week cycle) for up to six cycles. Cetuximab-at a starting dose of 400 mg/m(2) intravenous infusion over 2 h on day 1, and from day 8 onwards at 250 mg/m(2) over 1 h per week-was continued after the end of chemotherapy until disease progression or unacceptable toxicity had occurred. The primary endpoint was overall survival. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00148798. Findings Between October, 2004, and January, 2006, 1125 patients were randomly assigned to chemotherapy plus cetuximab (n=557) or chemotherapy alone (n=568). Patients given chemotherapy plus cetuximab survived longer than those in the chemotherapy-alone group (median 11.3 months vs 10.1 months; hazard ratio for death 0.871 [95% CI 0.762-0.996]; p=0.044). The main cetuximab-related adverse event was acne-like rash (57 [10%] of 548, grade 3). Interpretation Addition of cetuximab to platinum-based chemotherapy represents a new treatment option for patients with advanced non-small-cell lung cancer.	[Pirker, Robert] Med Univ Vienna, Dept Med 1, A-1090 Vienna, Austria; [Pereira, Jose R.] Inst Canc Amaldo Vieira Carvalho, Sao Paulo, Brazil; [Szczesna, Aleksandra] Mazowieckie Ctr Leczenia Chorob Pluc & Gruzlicy, Otwock, Poland; [von Pawel, Joachim] Asklepios Fachkliniken Muenchen Gauting, Gauting, Germany; [Krzakowski, Maciej] Maria Sklodowska Curie Mem Inst Oncol, Warsaw, Poland; [Ramlau, Rodryg] Wielkopolskie Ctr Chorob Pluc & Gruzlicy, Poznan, Poland; [Vynnychenko, Ihor] Sumy Reg Oncol Ctr, Sumy, Ukraine; [Park, Keunchil] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Yu, Chih-Teng] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Ganul, Valentyn] Ukraine Acad Med Sci, Inst Oncol, Kiev, Ukraine; [Roh, Jae-Kyung] Yonsei Univ, Coll Med, Seoul, South Korea; [Bajetta, Emilio] Natl Canc Inst, I-20133 Milan, Italy; [O'Byrne, Kenneth] St James Hosp, Dublin 8, Ireland; [de Marinis, Filippo] C Forlanini Hosp, Rome, Italy; [Eberhardt, Wilfried] Univ Duisburg Essen, Univ Hosp Essen, Essen, Germany; [Goddemeier, Thomas; Emig, Michael] Merck KGaA, Darmstadt, Germany; [Gatzemeier, Ulrich] Hosp Grosshansdorf, Grosshansdorf, Germany	Medical University of Vienna; Maria Sklodowska-Curie National Research Institute of Oncology; Ministry of Education & Science of Ukraine; Sumy State University; Sungkyunkwan University (SKKU); Samsung Medical Center; Chang Gung Memorial Hospital; Ministry of Health of Ukraine; National Cancer Institute; National Academy of Medical Sciences of Ukraine; Yonsei University; Yonsei University Health System; Fondazione IRCCS Istituto Nazionale Tumori Milan; Trinity College Dublin; Azienda Ospedaliera San Camillo-Forlanini; University of Duisburg Essen; Merck KGaA; Grosshansdorf Hospital	Pirker, R (corresponding author), Med Univ Vienna, Dept Med 1, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	robert.pirker@meduniwien.ac.at	de Marinis, Filippo/AAR-2826-2020; Hotko, Yevhen/F-9068-2019; Park, Keunchil/ABD-5852-2021; Paz-Ares, Luis/AAH-2750-2019; Vynnychenko, Ihor O/E-1684-2012; Demirelli, Fuat/AAD-2151-2021; christos, chouaid/R-4477-2018; SIENA, SALVATORE/AAC-5806-2019; Arrieta, Oscar/ABH-6022-2020; Bondarenko, Igor/W-9412-2019; Demirkazık, Ahmet/AAG-7699-2020; Berzinec, Peter/ABG-6237-2021; Recondo, Gonzalo/GNP-1009-2022; Berchem, Guy/C-9364-2014; Lopez, Guillermo/F-3435-2012; Underhill, Craig/ABB-8092-2020; Park, Keunchil/ABD-7072-2021; Bondarenko, Igor N/GQP-1497-2022; Martoni, Andrea/AAC-1707-2021; Jagiello-Gruszfeld, Agnieszka i/S-6924-2018	Hotko, Yevhen/0000-0002-4533-4210; Park, Keunchil/0000-0002-4846-7449; Vynnychenko, Ihor O/0000-0002-2339-6509; christos, chouaid/0000-0002-4290-5524; SIENA, SALVATORE/0000-0002-2681-2846; Bondarenko, Igor/0000-0002-7071-2471; Recondo, Gonzalo/0000-0002-4755-9325; Berchem, Guy/0000-0003-0157-2257; Underhill, Craig/0000-0001-9335-2678; Bondarenko, Igor N/0000-0002-7071-2471; Jagiello-Gruszfeld, Agnieszka i/0000-0002-2698-5499; Ostoros, Gyula/0000-0001-5339-7257; burghuber, otto/0000-0002-8419-621X; O'Byrne, Kenneth/0000-0002-6754-5633; Krzakowski, Maciej/0000-0003-3324-0900; MORO-SIBILOT, Denis/0000-0001-6776-8610; INSA, AMELIA/0000-0002-3438-6170; Waller, Cornelius/0000-0002-5777-0212; Ramlau, Rodryg/0000-0002-3199-2298; Schuette, Wolfgang/0000-0002-7516-5649; Karapetis, Christos/0000-0003-1741-996X; Arrieta, Oscar/0000-0002-1164-3779; Trigo, Jose/0000-0002-4489-2683; Eberhardt, Wilfried Ernst Erich/0000-0003-4284-3586; Ochsenbein, Adrian/0000-0003-1773-5436	Merck KGaA	Merck KGaA(Merck & Company)	Merck KGaA sponsored this study. We thank the participating patients and their families; Isil Montaner, Korinna Pilz, and Matthias Mueser for their contributions to the design and doing the trial; the study nurses, monitors, data managers, and support staff, Isabella Schmele for her support in the preparation of the report; and David Gandara for his critical review of the report.	Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Belani CP, 2008, CANCER-AM CANCER SOC, V113, P2512, DOI 10.1002/cncr.23902; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Butts CA, 2007, J CLIN ONCOL, V25, P5777, DOI 10.1200/JCO.2007.13.0856; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Eberhard DA, 2008, J CLIN ONCOL, V26, P983, DOI 10.1200/JCO.2007.12.9858; FAN Z, 1993, CANCER RES, V53, P4637; FAN Z, 1994, J BIOL CHEM, V269, P27595; GATZEMEIER U, 2008, J THORAC ONCOL, V3, pS265; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; KELLY K, 2006, J CLIN ONCOL S, V24; KHAMBATAFORD S, 2008, J THORAC ONCOL, V3, pS304; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Lynch TJ, 2007, J THORAC ONCOL, V2, pS340, DOI 10.1097/01.JTO.0000283155.03863.e7; Lynch TJ, 2008, J THORAC ONCOL, V3, pS107, DOI 10.1097/JTO.0b013e318174e9d3; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; NARAMURA M, 1993, CANCER IMMUNOL IMMUN, V37, P343, DOI 10.1007/BF01518458; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Robert F, 2005, J CLIN ONCOL, V23, P9089, DOI 10.1200/JCO.2004.00.1438; Rosell R, 2008, ANN ONCOL, V19, P362, DOI 10.1093/annonc/mdm474; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Thienelt CD, 2005, J CLIN ONCOL, V23, P8786, DOI 10.1200/jco.2005.03.1997; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656	28	1087	1142	1	89	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1525	1531		10.1016/S0140-6736(09)60569-9	http://dx.doi.org/10.1016/S0140-6736(09)60569-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440OT	19410716				2022-12-28	WOS:000265710300031
J	O'Sullivan, BP; Freedman, SD				O'Sullivan, Brian P.; Freedman, Steven D.			Cystic fibrosis	LANCET			English	Review							HIGH-DOSE IBUPROFEN; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY SURFACE DEHYDRATION; INHALED HYPERTONIC SALINE; PSEUDOMONAS-AERUGINOSA; LUNG-TRANSPLANTATION; ANTIBIOTIC-THERAPY; PULMONARY-FUNCTION; CONTROLLED-TRIAL	Cystic fibrosis is the most common lethal genetic disease in white populations. The outlook for patients with the disease has improved steadily over many years, largely as a result of earlier diagnosis, more aggressive therapy, and provision of care in specialised centres. Researchers now have a more complete understanding of the molecular-biological defect that underlies cystic fibrosis, which is leading to new approaches to treatment. One of these treatments, hypertonic saline, is already in use, whereas others are in advanced stages of development. We review clinical care for cystic fibrosis and discuss recent advances in the understanding of its pathogenesis, implementation of screening of neonates, and development of therapies aimed at treating the basic defect.	[O'Sullivan, Brian P.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; [Freedman, Steven D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	O'Sullivan, BP (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, 55 Lake Ave, Worcester, MA 01655 USA.	osullivb@ummhc.org	Zaky, Mohammad/I-3187-2017; Bell, Scott C/A-7241-2011; Connett, Gary/AAU-3686-2020; Glasscoe, Claire A/C-3561-2008; Briars, Graham Leslie/H-9713-2019	Zaky, Mohammad/0000-0003-3547-2588; Bell, Scott C/0000-0001-8651-7139; Connett, Gary/0000-0003-1310-3239; Briars, Graham Leslie/0000-0003-4798-3350				Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; [Anonymous], 2007, 2006 ANN DATA REPORT; Aris RM, 2005, J CLIN ENDOCR METAB, V90, P1888, DOI 10.1210/jc.2004-1629; Aurora P, 2008, AM J RESP CRIT CARE, V177, P935, DOI 10.1164/rccm.200801-019ED; Balfour-Lynn IM, 2006, AM J RESP CRIT CARE, V173, P1356, DOI 10.1164/rccm.200511-1808OC; Bell SC, 2007, THORAX, V62, P723, DOI 10.1136/thx.2006.060897; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; Block JK, 2006, THORAX, V61, P969, DOI 10.1136/thx.2006.061366; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bonfield TL, 1999, J ALLERGY CLIN IMMUN, V104, P72, DOI 10.1016/S0091-6749(99)70116-8; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; Borowitz D, 2007, J PEDIATR GASTR NUTR, V44, P219, DOI 10.1097/MPG.0b013e31802c41de; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Boyle MP, 2003, CURR OPIN PULM MED, V9, P498, DOI 10.1097/00063198-200311000-00009; Bradley J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002768.pub2; Bradley JM, 2006, RESP MED, V100, P191, DOI 10.1016/j.rmed.2005.11.028; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Button BM, 2003, PEDIATR PULM, V35, P208, DOI 10.1002/ppul.10227; CARLSTEDTDUKE J, 1986, P NATL ACAD SCI USA, V83, P9202, DOI 10.1073/pnas.83.23.9202; Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Carrabino S, 2006, J CYST FIBROS, V5, P113, DOI 10.1016/j.jcf.2005.12.003; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; CHATFIELD S, 1991, ARCH DIS CHILD-FETAL, V66, P29, DOI 10.1136/adc.66.1_Spec_No.29; CHERNICK WS, 1959, PEDIATRICS, V24, P739; Collaco JM, 2008, JAMA-J AM MED ASSOC, V299, P417, DOI 10.1001/jama.299.4.417; Colombo C, 2005, PEDIATR PULM, V40, P15, DOI 10.1002/ppul.20237; Comeau AM, 2007, PEDIATRICS, V119, pE495, DOI 10.1542/peds.2006-1993; Conway SP, 1997, THORAX, V52, P987, DOI 10.1136/thx.52.11.987; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; De Boeck K, 2006, THORAX, V61, P627, DOI 10.1136/thx.2005.043539; De Boeck K, 2004, EUR RESPIR J, V23, P851, DOI 10.1183/09031936.04.00118804; De Soyza A, 2004, AM J RESP CRIT CARE, V170, P70, DOI 10.1164/rccm.200304-592OC; Deterding RR, 2007, AM J RESP CRIT CARE, V176, P362, DOI 10.1164/rccm.200608-1238OC; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Egan TM, 2008, PEDIATR TRANSPLANT, V12, P125, DOI 10.1111/j.1399-3046.2008.00933.x; EIGEN H, 1995, J PEDIATR-US, V126, P515, DOI 10.1016/S0022-3476(95)70343-8; Elder DA, 2007, J PEDIATR-US, V151, P653, DOI 10.1016/j.jpeds.2007.05.012; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Equi A, 2002, LANCET, V360, P978, DOI 10.1016/S0140-6736(02)11081-6; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; Fennell PB, 2007, J CYST FIBROS, V6, P153, DOI 10.1016/j.jcf.2006.06.003; Flotte TR, 2005, HUM GENE THER, V16, P921, DOI 10.1089/hum.2005.16.921; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Goldberg HJ, 2007, CLIN CHEST MED, V28, P445, DOI 10.1016/j.ccm.2007.02.001; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Goss CH, 2004, THORAX, V59, P955, DOI 10.1136/thx.2003.017707; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Grasemann H, 2007, CHEST, V131, P1461, DOI 10.1378/chest.06-2085; Griesenbach U, 2006, GENE THER, V13, P1061, DOI 10.1038/sj.gt.3302809; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Hodson ME, 2002, EUR RESPIR J, V20, P658, DOI 10.1183/09031936.02.00248102; Hoiby N, 2005, J Cyst Fibros, V4 Suppl 2, P49, DOI 10.1016/j.jcf.2005.05.018; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; IMUNDO L, 1995, P NATL ACAD SCI USA, V92, P3019, DOI 10.1073/pnas.92.7.3019; JENSEN T, 1987, J ANTIMICROB CHEMOTH, V19, P831, DOI 10.1093/jac/19.6.831; Johnson C, 2003, CHEST, V123, P20, DOI 10.1378/chest.123.1.20; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Joseph PM, 2001, HUM GENE THER, V12, P1369, DOI 10.1089/104303401750298535; Kalish LA, 2006, AM J RESP CRIT CARE, V173, P421, DOI 10.1164/rccm.200503-344OC; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kohler T, 2007, ANTIMICROB AGENTS CH, V51, P4243, DOI 10.1128/AAC.00613-07; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; Konstan MW, 2003, J PEDIATR-US, V142, P624, DOI 10.1067/mpd.2003.152; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Koyama H, 1997, THORAX, V52, P915, DOI 10.1136/thx.52.10.915; KRAYNACK NC, 2007, PEDIAT PULMONOL S30, V42, P372; Lands LC, 2007, J PEDIATR-US, V151, P249, DOI 10.1016/j.jpeds.2007.04.009; Lao O, 2003, EUR J HUM GENET, V11, P385, DOI 10.1038/sj.ejhg.5200970; LeGrys VA, 2007, J PEDIATR-US, V151, P85, DOI 10.1016/j.jpeds.2007.03.002; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; Liou TG, 2007, NEW ENGL J MED, V357, P2143, DOI 10.1056/NEJMoa066359; Lubamba B, 2008, AM J RESP CRIT CARE, V177, P506, DOI 10.1164/rccm.200703-344OC; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Marshall BC, 2005, J PEDIATR-US, V146, P681, DOI 10.1016/j.jpeds.2004.12.039; Mastella G, 2000, EUR RESPIR J, V16, P464, DOI 10.1034/j.1399-3003.2000.016003464.x; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; McCool FD, 2006, CHEST, V129, p250S, DOI 10.1378/chest.129.1_suppl.250S; McKay KO, 2005, J PEDIATR-US, V147, pS47, DOI 10.1016/j.jpeds.2005.08.013; McMullen AH, 2006, CHEST, V129, P706, DOI 10.1378/chest.129.3.706; Mehta A, 2005, PEDIATR PULM, V39, P292, DOI 10.1002/ppul.20147; Milla CE, 2005, DIABETES CARE, V28, P2141, DOI 10.2337/diacare.28.9.2141; Mishra A, 2008, J PEDIATR-US, V153, P758, DOI 10.1016/j.jpeds.2008.04.067; Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022; Murray S, 2008, AM J RESP CRIT CARE, V178, P363, DOI 10.1164/rccm.200712-1834OC; Nazer D, 2006, PEDIATR PULM, V41, P744, DOI 10.1002/ppul.20433; NISSIMRAFINIA M, 2007, CYSTIC FIBROSIS, P54; O'Riordan SMP, 2008, PEDIATR DIABETES, V9, P338, DOI 10.1111/j.1399-5448.2008.00437.x; O'Sullivan BP, 2006, AM J RESP CRIT CARE, V173, P483, DOI 10.1164/rccm.200508-1243PP; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ordonez CL, 2001, PEDIATR PULM, V32, P29, DOI 10.1002/ppul.1085; Orozco L, 2000, HUM GENET, V106, P360, DOI 10.1007/s004390051051; Padman R, 2007, PEDIATRICS, V119, pE531, DOI 10.1542/peds.2006-1414; Pall H, 2007, J PEDIATR-US, V151, P255, DOI 10.1016/j.jpeds.2007.03.062; Parker EM, 2004, PEDIATR PULM, V37, P362, DOI 10.1002/ppul.10450; Peterson ML, 2003, PEDIATRICS, V112, P588, DOI 10.1542/peds.112.3.588; Pickles Raymond J, 2004, Proc Am Thorac Soc, V1, P302, DOI 10.1513/pats.200403-024MS; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; RATJEN E, 2006, J CYST FIBROS, V5, pS22; Ratjen F, 2006, NEW ENGL J MED, V354, P291, DOI 10.1056/NEJMe058293; REGELMANN WE, 1990, AM REV RESPIR DIS, V141, P914, DOI 10.1164/ajrccm/141.4_Pt_1.914; REISIN IL, 1994, J BIOL CHEM, V269, P20584; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rosenfeld M, 2003, CURR OPIN PULM MED, V9, P492, DOI 10.1097/00063198-200311000-00008; Rottner M, 2007, FASEB J, V21, P2939, DOI 10.1096/fj.06-7614com; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Schechter MS, 2008, J PEDIATR, V153, P733, DOI 10.1016/j.jpeds.2008.09.011; SCHIDLOW DV, 1994, PRACTICAL GUIDE PEDI; Schultz MJ, 2004, J ANTIMICROB CHEMOTH, V54, P21, DOI 10.1093/jac/dkh309; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Sims EJ, 2005, J PEDIATR-US, V147, pS42, DOI 10.1016/j.jpeds.2005.08.002; Sims EJ, 2007, LANCET, V369, P1187, DOI 10.1016/S0140-6736(07)60565-0; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Smyth A, 2008, THORAX, V63, P180, DOI 10.1136/thx.2006.060905; Smyth A, 2005, PEDIATR PULM, V40, P471, DOI 10.1002/ppul.20305; Steinkamp G, 2005, J Cyst Fibros, V4, P41, DOI 10.1016/j.jcf.2004.10.002; Stern M, 2008, EUR RESPIR J, V31, P29, DOI 10.1183/09031936.00056507; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Stutman HR, 2002, J PEDIATR-US, V140, P299, DOI 10.1067/mpd.2002.121930; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Subbarao P, 2007, PEDIATR PULM, V42, P471, DOI 10.1002/ppul.20603; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; SZAFF M, 1983, ACTA PAEDIATR SCAND, V72, P651, DOI 10.1111/j.1651-2227.1983.tb09789.x; Taccetti G, 2005, EUR RESPIR J, V26, P458, DOI 10.1183/09031936.05.00009605; Therrell BL, 2005, J PEDIATR-US, V147, pS6, DOI 10.1016/j.jpeds.2005.08.073; Thornton J, 2004, THORAX, V59, P242, DOI 10.1136/thx.2003.005876; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Tosi MF, 2004, GENE THER, V11, P1427, DOI 10.1038/sj.gt.3302290; Treggiari MM, 2007, PEDIATR PULM, V42, P751, DOI 10.1002/ppul.20665; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; van der Schans C, 2000, COCHRANE DB SYST REV, V2; Vankeerberghen Anne, 2002, J Cyst Fibros, V1, P13, DOI 10.1016/S1569-1993(01)00003-0; *VERT, VERT ANN POS 28 DAY; WALTERS S, 2007, CYSTIC FIBROSIS, P21; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WEAVER LT, 1994, ARCH DIS CHILD, V70, P84, DOI 10.1136/adc.70.2.84; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wilschanski M, 2007, GUT, V56, P1153, DOI 10.1136/gut.2004.062786; Wolter J, 2002, THORAX, V57, P212, DOI 10.1136/thorax.57.3.212; Wolter JM, 1997, EUR RESPIR J, V10, P896; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yamashiro Y, 1997, J PEDIATR GASTR NUTR, V24, P544, DOI 10.1097/00005176-199705000-00010; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S; Young AC, 2008, THORAX, V63, P72, DOI 10.1136/thx.2007.082602; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; Zaman MM, 2004, CLIN DIAGN LAB IMMUN, V11, P819, DOI 10.1128/CDLI.11.5.819-824.2004; Zeitlin PL, 2007, EXPERT OPIN EMERG DR, V12, P329, DOI 10.1517/14728214.12.2.329	170	918	944	4	292	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2009	373	9678					1891	1904		10.1016/S0140-6736(09)60327-5	http://dx.doi.org/10.1016/S0140-6736(09)60327-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19403164				2022-12-28	WOS:000266616400033
J	Goda, K; Tsia, KK; Jalali, B				Goda, K.; Tsia, K. K.; Jalali, B.			Serial time-encoded amplified imaging for real-time observation of fast dynamic phenomena	NATURE			English	Article							MICROSCOPY	Ultrafast real-time optical imaging is an indispensable tool for studying dynamical events such as shock waves(1,2), chemical dynamics in living cells(3,4), neural activity(5,6), laser surgery(7-9) and microfluidics(10,11). However, conventional CCDs (charge-coupled devices) and their complementary metal-oxide-semiconductor (CMOS) counterparts are incapable of capturing fast dynamical processes with high sensitivity and resolution. This is due in part to a technological limitation-it takes time to read out the data from sensor arrays. Also, there is the fundamental compromise between sensitivity and frame rate; at high frame rates, fewer photons are collected during each frame-a problem that affects nearly all optical imaging systems. Here we report an imaging method that overcomes these limitations and offers frame rates that are at least 1,000 times faster than those of conventional CCDs. Our technique maps a two-dimensional (2D) image into a serial time-domain data stream and simultaneously amplifies the image in the optical domain. We capture an entire 2D image using a single-pixel photodetector and achieve a net image amplification of 25 dB (a factor of 316). This overcomes the compromise between sensitivity and frame rate without resorting to cooling and high-intensity illumination. As a proof of concept, we perform continuous real-time imaging at a frame speed of 163 ns (a frame rate of 6.1 MHz) and a shutter speed of 440 ps. We also demonstrate real-time imaging of microfluidic flow and phase-explosion effects that occur during laser ablation.	[Goda, K.; Tsia, K. K.; Jalali, B.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Goda, K (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA.	goda@ee.ucla.edu	Tsia, Kevin Kin Man/E-9896-2010; jalali, bahram/AFK-2299-2022; GODA, KEISUKE/G-4997-2014	Tsia, Kevin Kin Man/0000-0002-6394-9657; Goda, Keisuke/0000-0001-6302-6038	US Defense Advanced Research Projects Agency; Center for Nanoscience Innovation for Defense	US Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Center for Nanoscience Innovation for Defense	This work was partially supported by the US Defense Advanced Research Projects Agency and the Center for Nanoscience Innovation for Defense. We are grateful to D. R. Solli, Y. Hoshino and T. Kodama for discussions. We also thank T. Lay for creating the animated film.	BARTELT HO, 1978, OPT COMMUN, V27, P365, DOI 10.1016/0030-4018(78)90400-5; Barty A, 2008, NAT PHOTONICS, V2, P415, DOI 10.1038/nphoton.2008.128; BUECHLER C, 2000, BIOPHYS J, V79, P536; Chou J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799741; Diddams SA, 2007, NATURE, V445, P627, DOI 10.1038/nature05524; Epstein I.R., 1998, INTRO NONLINEAR CHEM; Etoh T. G., 2007, PLASMA FUSION RES, V2, pS1021, DOI DOI 10.1585/PFR.2.S1021; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Goda K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2992064; Gridley T, 2007, NAT BIOTECHNOL, V25, P59, DOI 10.1038/nbt0107-59; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kodama R, 2001, NATURE, V412, P798, DOI 10.1038/35090525; Lynch TF, 2005, P SOC PHOTO-OPT INS, V5580, P790, DOI 10.1117/12.562303; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Petty HR, 2004, OPT PHOTONICS NEWS, V15, P40, DOI 10.1364/OPN.15.1.000040; Petty HR, 2006, BIOSYSTEMS, V83, P217, DOI 10.1016/j.biosystems.2005.05.018; Porneala C, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2393158; RIEHLE RA, 1987, PRINCIPLES EXTRACORP; Savage N., 2007, NATURE PHOTON, V1, P351; Slade S. G., 2002, COMPLETE BOOK LASER; Solli DR, 2008, NAT PHOTONICS, V2, P48, DOI 10.1038/nphoton.2007.253; Solli DR, 2007, NATURE, V450, P1054, DOI 10.1038/nature06402; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Tearney GJ, 2002, OPT LETT, V27, P412, DOI 10.1364/OL.27.000412; Watson J., 1991, FLUID FLOW DYNAMICS; Xiao SJ, 2004, OPT EXPRESS, V12, P2895, DOI 10.1364/OPEX.12.002895; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	28	528	566	13	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1145	U80		10.1038/nature07980	http://dx.doi.org/10.1038/nature07980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407796				2022-12-28	WOS:000265754600042
J	Keenan, K; Hayen, A; Neal, BC; Irwig, L				Keenan, Katherine; Hayen, Andrew; Neal, Bruce C.; Irwig, Les			Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VARIABILITY	Objective To determine the value of monitoring blood pressure by quantifying the probability that observed changes in blood pressure reflect true changes. Design Analysis of blood pressure measurements of patients in the perindopril protection against recurrent stroke study (PROGRESS). Setting Randomised placebo controlled trial carried out in 172 centres in Asia, Australasia, and Europe. Participants 1709 patients with history of stroke or transient ischaemic attack randomised to fixed doses of perindopril and indapamide. Measurements Mean of two blood pressure measurements in patients receiving treatment recorded to the nearest 2 mm Hg with a standard mercury sphygmomanometer at baseline and then at three months, six months, nine months, and 15 months and then every six months to 33 months. Results There was no change in the mean blood pressure of the cohort during the 33 month follow-up. Six months after blood pressure was stabilised on treatment, if systolic blood pressure was measured as having increased by > 10 mm Hg, six of those measurements would be false positives for every true increase of >= 10 mm Hg. The corresponding value for an increase of 20 mm Hg was over 200. Values for 5 mm Hg and 10 mm Hg increases in diastolic blood pressure were 3.5 and 39, respectively. The likelihood that observed increases in blood pressure reflected true increases rose with the time between measurements such that the ratio of true positives to false positives reached parity at 21 months. Conclusions Usual clinical approaches to the monitoring of patients taking drugs to lower blood pressure have a low probability of yielding reliable information about true changes in blood pressure. Evidence based guidelines for monitoring treatment response are urgently required to guide clinical practice.	[Keenan, Katherine; Hayen, Andrew; Irwig, Les] Univ Sydney, Sch Publ Hlth, STEP, Sydney, NSW 2006, Australia; [Neal, Bruce C.] Univ Sydney, Royal Prince Alfred Hosp, George Inst Int Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Hayen, A (corresponding author), Univ Sydney, Sch Publ Hlth, STEP, Bldg A27, Sydney, NSW 2006, Australia.	ahayen@health.usyd.edu.au		Hayen, Andrew/0000-0003-4046-8030; Neal, Bruce/0000-0002-0490-7465	Australian National Health and Medical Research Council Program [402764, 358395]; Servier; Health Research Council of New Zealand; National Health and Medical Research Council of Australia	Australian National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); Servier(Servier); Health Research Council of New Zealand(Health Research Council of New Zealand); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Australian National Health and Medical Research Council Program, grants 402764 and 358395. All of the researchers involved in this project are independent of the funding body (Australian National Health and Medical Research Council). PROGRESS was funded by grants from Servier, the Health Research Council of New Zealand, and the National Health and Medical Research Council of Australia. The study was designed, conducted, analysed, and interpreted by the investigators independently of all sponsors.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Britt H., 2007, GEN PRACTICE ACTIVIT; Chalmers J, 1999, J HYPERTENS, V17, P1647; Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644; Glasziou P, 2008, EVIDENCE BASED MED M; GOLDBERG AD, 1978, BRIT HEART J, V40, P656; GORDON T, 1976, INT J EPIDEMIOL, V5, P327, DOI 10.1093/ije/5.4.327; Harrison WN, 2008, J HUM HYPERTENS, V22, P163, DOI 10.1038/sj.jhh.1002312; Howard SC, 2003, J CLIN EPIDEMIOL, V56, P1084, DOI 10.1016/S0895-4356(03)00267-1; LANDAHL S, 1986, HYPERTENSION, V8, P1044, DOI 10.1161/01.HYP.8.11.1044; LASSEN JF, 1995, CLIN CHEM, V41, P1171; Macaskill P, 2008, EVIDENCE BASED MED M; MacLaughlin EJ, 2005, DRUG AGING, V22, P231, DOI 10.2165/00002512-200522030-00005; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MARSHALL T, 2005, BRAZILIAN J HYPERTEN, V12, P75; MCMANUS RJ, 2008, BMJ-BRIT MED J, pA2732; *NAT HEART FDN AUS, 2003, HYP MAN GUID DOCT 20; ROSNER B, 1979, J CHRON DIS, V32, P451, DOI 10.1016/0021-9681(79)90105-X; SHEPARD DS, 1981, J CHRON DIS, V34, P191, DOI 10.1016/0021-9681(81)90064-3; Turnbull F, 2003, LANCET, V362, P1527; WATSON RDS, 1980, HYPERTENSION, V2, P333, DOI 10.1161/01.HYP.2.3.333; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	24	49	49	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2009	338								b1492	10.1136/bmj.b1492	http://dx.doi.org/10.1136/bmj.b1492			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JY	19406886	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000265697800001
J	Glasziou, P; Rose, P; Heneghan, C; Balla, J				Glasziou, Paul; Rose, Peter; Heneghan, Carl; Balla, John			Diagnosis in General Practice Diagnosis using "test of treatment"	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE		[Glasziou, Paul; Rose, Peter] Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England	University of Oxford	Glasziou, P (corresponding author), Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England.	paul.glasziou@dphpc.ox.ac.uk	Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; Barraclough K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1218; Benatar M, 2006, NEUROMUSCULAR DISORD, V16, P459, DOI 10.1016/j.nmd.2006.05.006; Chun AA, 2004, AM J MED, V117, P334, DOI 10.1016/j.amjmed.2004.03.021; Dasgupta B, 2007, CLIN EXP RHEUMATOL, V25, pS130; Glasziou PP, 2001, DECISION MAKING HLTH; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; OSSERMAN KE, 1952, JAMA-J AM MED ASSOC, V150, P265, DOI 10.1001/jama.1952.03680040007002; PRATTER MR, 1993, ANN INTERN MED, V119, P977, DOI 10.7326/0003-4819-119-10-199311150-00003; Senn O, 2006, CHEST, V129, P67, DOI 10.1378/chest.129.1.67; Walker MB, 1934, LANCET, V1, P1200; WILLIAMS HC, 1991, ARCH DERMATOL, V127, P1023, DOI 10.1001/archderm.127.7.1023	12	17	17	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2009	338								b1312	10.1136/bmj.b1312	http://dx.doi.org/10.1136/bmj.b1312			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OR	19395419				2022-12-28	WOS:000265497300003
J	Kraemer, N; Krombach, GA				Kraemer, Nils; Krombach, Gabriele A.			Pulmonary Arteriovenous Fistula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kraemer, Nils; Krombach, Gabriele A.] Univ Aachen, D-52075 Aachen, Germany	RWTH Aachen University	Kraemer, N (corresponding author), Univ Aachen, D-52075 Aachen, Germany.	kraemer@rad.rwth-aachen.de	Jatene, Fabio B/D-1679-2012; Kraemer, Nils/ABD-9509-2020	Kraemer, Nils/0000-0001-5406-6396					0	7	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1769	1769		10.1056/NEJMicm0803889	http://dx.doi.org/10.1056/NEJMicm0803889			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19387018				2022-12-28	WOS:000265377800011
J	Khanna, R; Lakhanpaul, M; Burman-Roy, S; Murphy, MS				Khanna, Rajesh; Lakhanpaul, Monica; Burman-Roy, Shona; Murphy, M. Stephen		Guideline Dev Grp Tech Team	Guidelines Diarrhoea and vomiting caused by gastroenteritis in children under 5 years: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNITY; DISEASE		[Murphy, M. Stephen] Birmingham Childrens Hosp NHS Fdn Trust, Birmingham B4 6NH, W Midlands, England; [Murphy, M. Stephen] Univ Birmingham, Birmingham B4 6NH, W Midlands, England; [Lakhanpaul, Monica] Univ Leicester, Leicester LE1 9NH, Leics, England; [Lakhanpaul, Monica] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England	University of Birmingham; University of Birmingham; University of Leicester	Murphy, MS (corresponding author), Birmingham Childrens Hosp NHS Fdn Trust, Birmingham B4 6NH, W Midlands, England.	M.S.MURPHY@bham.ac.uk	Faust, Saul/J-9779-2014; Palanca, Ana/E-1541-2018	Faust, Saul/0000-0003-3410-7642; Palanca, Ana/0000-0003-3513-4458; Lakhanpaul, Monica/0000-0002-9855-2043				Armon K, 2001, ARCH DIS CHILD, V84, P390, DOI 10.1136/adc.84.5.390; Banyai K, 2006, EPIDEMIOL INFECT, V134, P908, DOI 10.1017/S0950268806006091; Fischer TK, 2007, J INFECT DIS, V195, P1117, DOI 10.1086/512863; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Lorgelly PK, 2008, EPIDEMIOL INFECT, V136, P34, DOI 10.1017/S0950268807008163; *NAT I HLTH CLIN E, 2009, CLIN GUID NICE, V84; Van Damme P, 2007, J INFECT DIS, V195, pS4, DOI 10.1086/516714; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	8	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2009	338								b1350	10.1136/bmj.b1350	http://dx.doi.org/10.1136/bmj.b1350			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437OP	19386673				2022-12-28	WOS:000265497100002
J	Feig, D				Feig, Denice			Oral drugs for gestational diabetes do not increase adverse maternal and neonatal outcomes more than insulin	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Toronto, ON, Canada	University of Toronto	Feig, D (corresponding author), Univ Toronto, Toronto, ON, Canada.		Feig, Denice/C-4606-2015						0	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-9	10.7326/0003-4819-150-8-200904210-02009	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391223				2022-12-28	WOS:000265457000024
J	Manns, B				Manns, Braden			Brand-name drugs are not more effective than generic versions for treating cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calgary, Calgary, AB, Canada	University of Calgary	Manns, B (corresponding author), Univ Calgary, Calgary, AB, Canada.		Manns, Braden J/I-8942-2012					Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-6	10.7326/0003-4819-150-8-200904210-02006	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391215				2022-12-28	WOS:000265457000021
J	Solomon, M; El-Khoury, T				Solomon, Michael; El-Khoury, Toufic			Review: Individual alarm features have moderate-to-high specificity and low sensitivity for diagnosing colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Solomon, Michael] Royal Prince Alfred Hosp, Surg Outcome Res Ctr, Sydney, NSW, Australia; Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Solomon, M (corresponding author), Royal Prince Alfred Hosp, Surg Outcome Res Ctr, Sydney, NSW, Australia.							Marderstein EL, 2008, DIS COLON RECTUM, V51, P202, DOI 10.1007/s10350-007-9123-1; National Institute of Clinical Excellence, 2004, GUID CANC SERV IMPR; Thompson MR, 2007, BRIT J SURG, V94, P1260, DOI 10.1002/bjs.5826	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-14	10.7326/0003-4819-150-8-200904210-02014	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391228				2022-12-28	WOS:000265457000029
J	Campbell, GK; Boyd, MM; Thomsen, JW; Martin, MJ; Blatt, S; Swallows, MD; Nicholson, TL; Fortier, T; Oates, CW; Diddams, SA; Lemke, ND; Naidon, P; Julienne, P; Ye, J; Ludlow, AD				Campbell, G. K.; Boyd, M. M.; Thomsen, J. W.; Martin, M. J.; Blatt, S.; Swallows, M. D.; Nicholson, T. L.; Fortier, T.; Oates, C. W.; Diddams, S. A.; Lemke, N. D.; Naidon, P.; Julienne, P.; Ye, Jun; Ludlow, A. D.			Probing Interactions Between Ultracold Fermions	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION; FREQUENCY-SHIFTS; NOBEL LECTURE; CLOCKS; ATOMS; LASER; COLLISIONS; WAVE; GAS	At ultracold temperatures, the Pauli exclusion principle suppresses collisions between identical fermions. This has motivated the development of atomic clocks with fermionic isotopes. However, by probing an optical clock transition with thousands of lattice-confined, ultracold fermionic strontium atoms, we observed density-dependent collisional frequency shifts. These collision effects were measured systematically and are supported by a theoretical description attributing them to inhomogeneities in the probe excitation process that render the atoms distinguishable. This work also yields insights for zeroing the clock density shift.	[Campbell, G. K.; Boyd, M. M.; Thomsen, J. W.; Martin, M. J.; Blatt, S.; Swallows, M. D.; Nicholson, T. L.; Ye, Jun; Ludlow, A. D.] Univ Colorado, Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA; [Campbell, G. K.; Boyd, M. M.; Thomsen, J. W.; Martin, M. J.; Blatt, S.; Swallows, M. D.; Nicholson, T. L.; Ye, Jun; Ludlow, A. D.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Fortier, T.; Oates, C. W.; Diddams, S. A.; Lemke, N. D.] NIST, Div Time & Frequency, Boulder, CO 80302 USA; [Naidon, P.; Julienne, P.] NIST, Atom Phys Div, Gaithersburg, MD 20899 USA; [Naidon, P.; Julienne, P.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA	Ye, J (corresponding author), Univ Colorado, Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA.	junye@jilau1.colorado.edu	Ye, Jun/C-3312-2011; Campbell, Gretchen K/E-8338-2010; Martin, Michael/AAV-6857-2021; Diddams, Scott A/L-2819-2013; Julienne, Paul S/E-9378-2012; Nicholson, Travis L/O-1573-2018; Blatt, Sebastian/F-8986-2012; Lemke, Nathan D/L-9059-2013; Thomsen, Jan W./M-9087-2016	Ye, Jun/0000-0003-0076-2112; Campbell, Gretchen K/0000-0003-2596-1919; Martin, Michael/0000-0002-6022-217X; Diddams, Scott A/0000-0002-2144-0764; Julienne, Paul S/0000-0002-5494-1442; Nicholson, Travis L/0000-0002-0503-7991; Blatt, Sebastian/0000-0003-2466-9967; Lemke, Nathan D/0000-0003-4165-0715; Thomsen, Jan W./0000-0003-3423-6989	NIST; NSF; Office of Naval Research; Defense Advanced Projects Research Agency; National Research Council postdoctoral fellowships	NIST(National Institute of Standards & Technology (NIST) - USA); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Defense Advanced Projects Research Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Research Council postdoctoral fellowships	We appreciate technical contributions of T. Zelevinsky and insightful discussions with K. Gibble, W. Ketterle, M. Zwierlein, E. Cornell, and S. Kokkelmans. We acknowledge funding support from NIST, NSF, Office of Naval Research, and Defense Advanced Projects Research Agency. G.K.C. and A.D.L. are supported by National Research Council postdoctoral fellowships. J.W.T. is a JILA visiting fellow, with a permanent address: The Niels Bohr Institute, Universitetsparken 5, 2100 Copenhagen, Denmark.	Boyd MM, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.022510; Cornell EA, 2002, REV MOD PHYS, V74, P875, DOI 10.1142/S0217979202014681; DeMarco B, 1999, PHYS REV LETT, V82, P4208, DOI 10.1103/PhysRevLett.82.4208; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Foreman SM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.153601; GIBBLE K, 1993, PHYS REV LETT, V70, P1771, DOI 10.1103/PhysRevLett.70.1771; GIBBLE K, 1995, PHYS REV A, V52, P3370, DOI 10.1103/PhysRevA.52.3370; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Harber DM, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.053616; Ketterle W, 2002, REV MOD PHYS, V74, P1131, DOI [10.1103/RevModPhys.74.1131, 10.1142/S0217979202014668]; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Leo PJ, 2001, PHYS REV LETT, V86, P3743, DOI 10.1103/PhysRevLett86.3743; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Ludlow AD, 2007, OPT LETT, V32, P641, DOI 10.1364/OL.32.000641; MARTIN PJ, 1988, PHYS REV LETT, V60, P515, DOI 10.1103/PhysRevLett.60.515; Porsev SG, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042506; Porsev SG, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.020701; Santra R, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042510; Sortais Y, 2001, PHYS SCRIPTA, VT95, P50, DOI 10.1238/Physica.Topical.095a00050; Ye J, 2008, SCIENCE, V320, P1734, DOI 10.1126/science.1148259; Zwierlein MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250404	23	89	90	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					360	363		10.1126/science.1169724	http://dx.doi.org/10.1126/science.1169724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372424	Green Submitted			2022-12-28	WOS:000265221600034
J	Cote, JF; Vuori, K				Cote, Jean-Francois; Vuori, Kristiina			Two Lipids That Give Direction	SCIENCE			English	Editorial Material							PROTEINS; CHEMOTAXIS; ACTIVATOR; MOTILITY; PRODUCTS; POLARITY; DOMAIN		[Cote, Jean-Francois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Vuori, Kristiina] Burnham Inst Med Res, La Jolla, CA 92037 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Sanford Burnham Prebys Medical Discovery Institute	Cote, JF (corresponding author), Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	jean-francois.cote@ircm.qc.ca; kvuori@burnham.org			CIHR [77591] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810	10	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	2009	324	5925					346	347		10.1126/science.1173646	http://dx.doi.org/10.1126/science.1173646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372420	Green Accepted			2022-12-28	WOS:000265221600029
J	Bauleo, PM; Martino, JR				Bauleo, Pablo M.; Martino, Julio Rodriguez			The dawn of the particle astronomy era in ultra-high-energy cosmic rays	NATURE			English	Review							NUCLEI; AGASA	Cosmic rays are charged particles arriving at the Earth from space. Those at the highest energies are particularly interesting because the physical processes that could create or accelerate them are at the limit of our present knowledge. They also open the window to particle astronomy, as the magnetic fields along their paths are not strong enough to deflect their trajectories much from a straight line. The Pierre Auger Observatory is the largest cosmic-ray detector on Earth, and as such is beginning to resolve past observational disagreements regarding the origin and propagation of these particles.	[Bauleo, Pablo M.] Colorado State Univ, Dept Phys, Ft Collins, CO 80523 USA; [Martino, Julio Rodriguez] Univ Catania, Dipartimento Fis & Astron, I-95123 Catania, Italy; [Martino, Julio Rodriguez] Ist Nazl Fis Nucl, Sez Catania, I-95123 Catania, Italy	Colorado State University; University of Catania; Istituto Nazionale di Fisica Nucleare (INFN)	Bauleo, PM (corresponding author), Colorado State Univ, Dept Phys, Ft Collins, CO 80523 USA.	bauleo@lamar.colostate.edu						Abbasi RU, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.101101; Abbasi RU, 2006, ASTROPHYS J, V636, P680, DOI 10.1086/498142; ABBASSI RU, 2008, SEARCH CORRELATIONS; Abraham J, 2008, ASTROPART PHYS, V29, P188, DOI 10.1016/j.astropartphys.2008.01.002; Abraham J, 2007, SCIENCE, V318, P938, DOI 10.1126/science.1151124; Abraham J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.061101; Abraham J, 2004, NUCL INSTRUM METH A, V523, P50, DOI 10.1016/j.nima.2003.12.012; Abu-Zayyad T, 2000, NUCL INSTRUM METH A, V450, P253, DOI 10.1016/S0168-9002(00)00307-7; Auger P, 1939, REV MOD PHYS, V11, P0288, DOI 10.1103/RevModPhys.11.288; Auger P, 1938, CR HEBD ACAD SCI, V207, P228; BELLIDO J, 2003, P 28 INT COSM RAY C, P425; Berezinsky V., 2006, Journal of Physics: Conference Series, V47, P142, DOI 10.1088/1742-6596/47/1/018; BIERMANN PL, 1995, PHYS REV D, V51, P3450, DOI 10.1103/PhysRevD.51.3450; Biermann PL, 2001, LECT NOTES PHYS, V576, P1; CHIBA N, 1992, NUCL INSTRUM METH A, V311, P338, DOI 10.1016/0168-9002(92)90882-5; De Marco D, 2003, ASTROPART PHYS, V20, P53, DOI 10.1016/S0927-6505(03)00148-8; Deligny O, 2004, ASTROPART PHYS, V21, P609, DOI 10.1016/j.astropartphys.2004.04.012; Ebisuzaki T, 2008, NUCL PHYS B-PROC SUP, V175, P237, DOI 10.1016/j.nuclphysbps.2007.11.005; Falcke H, 2005, NATURE, V435, P313, DOI 10.1038/nature03614; George MR, 2008, MON NOT R ASTRON SOC, V388, pL59, DOI 10.1111/j.1745-3933.2008.00499.x; GHISELLINI G, 2008, ULTRAHIGH ENERGY COS; Gibilisco M, 2001, NUCL PHYS B-PROC SUP, V100, P357, DOI 10.1016/S0920-5632(01)01472-4; GREISEN K, 1966, PHYS REV LETT, V16, P748, DOI 10.1103/PhysRevLett.16.748; Kachelriess M, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.043005; Kampert KH, 2008, J PHYS CONF SER, V120, DOI 10.1088/1742-6596/120/6/062002; Kawai H, 2008, NUCL PHYS B-PROC SUP, V175, P221, DOI 10.1016/j.nuclphysbps.2007.11.002; NEWTON D, 2007, P 30 INT COSM RAY C, P323; *OWL, 2004, ORB WID ANGL LIGHT C; PILKINGTON A, 2008, P 16 INT WORKSH DEEP, DOI DOI 10.3360/DIS.2008.50; SAKAKI N, 2001, P 27 INT COSM RAY C, P333; SOKOLSKY P, 2007, HIGHEST ENERGY COSMI; Sommerville K, 2005, AUSTRALAS I MIN MET, V2005, P7; Stanev T, 2007, NUCL PHYS B-PROC SUP, V168, P252, DOI 10.1016/j.nuclphysbps.2007.02.021; Takeda M, 2003, ASTROPART PHYS, V19, P447, DOI 10.1016/S0927-6505(02)00243-8; TESHIMA M, 2003, P 28 INT COSM RAY C, P437; Uchihori Y, 2000, ASTROPART PHYS, V13, P151, DOI 10.1016/S0927-6505(99)00119-X; Veron-Cetty MP, 2006, ASTRON ASTROPHYS, V455, P773, DOI 10.1051/0004-6361:20065177; Watson AA, 2008, NUCL INSTRUM METH A, V588, P221, DOI 10.1016/j.nima.2008.01.083	39	9	9	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					847	851		10.1038/nature07948	http://dx.doi.org/10.1038/nature07948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370026				2022-12-28	WOS:000265182500034
J	Saudek, CD				Saudek, Christopher D.			Can Diabetes Be Cured? Potential Biological and Mechanical Approaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ISLET TRANSPLANTATION; BETA-CELLS; MELLITUS; TRIAL; INSULIN		Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD 21287 USA	Johns Hopkins University	Saudek, CD (corresponding author), Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Osler 575,700 N Wolfe St, Baltimore, MD 21287 USA.	csaudek@jhu.edu						Bollyky J, 2008, MT SINAI J MED, V75, P385, DOI 10.1002/msj.20054; Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Couri CEB, 2009, JAMA-J AM MED ASSOC, V301, P1573, DOI 10.1001/jama.2009.470; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Mallett AG, 2009, TISSUE ENG PT A, V15, P1301, DOI 10.1089/ten.tea.2008.0118; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Saudek CD, 1996, JAMA-J AM MED ASSOC, V276, P1322, DOI 10.1001/jama.276.16.1322; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Waki Kayo, 2007, Clin Transpl, P9; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	15	17	17	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1588	1590		10.1001/jama.2009.508	http://dx.doi.org/10.1001/jama.2009.508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366779				2022-12-28	WOS:000265137900030
J	Chua, D; Ignaszewski, A				Chua, Doson; Ignaszewski, Andrew			Clopidogrel in acute coronary syndromes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ASSOCIATION TASK-FORCE; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; HEART-ASSOCIATION; AMERICAN-COLLEGE; CARDIOVASCULAR ANGIOGRAPHY; WRITING COMMITTEE; EUROPEAN-SOCIETY; ASPIRIN; INTERVENTION		[Chua, Doson; Ignaszewski, Andrew] St Pauls Hosp, Dept Pharm, Div Cardiol, Vancouver, BC V6Z 1Y6, Canada	St. Paul's Hospital; University of Saskatchewan	Chua, D (corresponding author), St Pauls Hosp, Dept Pharm, Div Cardiol, Vancouver, BC V6Z 1Y6, Canada.	dchua@providencehealth.bc.ca						Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Goodman SG, 2008, CHEST, V133, p708S, DOI 10.1378/chest.08-0665; Grech ED, 2003, BRIT MED J, V326, P1259, DOI 10.1136/bmj.326.7401.1259; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Harrington RA, 2004, CHEST, V126, p513S, DOI 10.1378/chest.126.3_suppl.513S; Harrington RA, 2008, CHEST, V133, p670S, DOI 10.1378/chest.08-0691; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002; Maisel WH, 2007, NEW ENGL J MED, V356, P981, DOI 10.1056/NEJMp068305; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Muller C, 2000, CIRCULATION, V101, P590, DOI 10.1161/01.CIR.101.6.590; Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Yusuf S, 2001, NEW ENGL J MED, V345, P494	25	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2009	338								b1180	10.1136/bmj.b1180	http://dx.doi.org/10.1136/bmj.b1180			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TI	19366756				2022-12-28	WOS:000265296600002
J	Das, P				Das, Pamela			Profile Bob Snow: championing malaria in Africa	LANCET			English	Biographical-Item												pamela.das@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1419	1419		10.1016/S0140-6736(09)60809-6	http://dx.doi.org/10.1016/S0140-6736(09)60809-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394522				2022-12-28	WOS:000265501900015
J	Pollock, JD; Koustova, E; Hoffman, A; Shurtleff, D; Volkow, ND				Pollock, Jonathan D.; Koustova, Elena; Hoffman, Allison; Shurtleff, David; Volkow, Nora D.			Treatments for nicotine addiction should be a top priority	LANCET			English	Editorial Material									[Pollock, Jonathan D.; Koustova, Elena; Hoffman, Allison; Shurtleff, David; Volkow, Nora D.] NIDA, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Pollock, JD (corresponding author), NIDA, NIH, US Dept HHS, Bethesda, MD 20892 USA.	jpollock@mail.nih.gov	Pollock, Jonathan D/B-1554-2009		Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; *CDCP, 1965, SMOK TOB US PERC AD; *INF HEALTHC, 2007, THER AN PHARM R D AN; Richard JBonnie, 2007, ENDING TOBACCO PROBL; SACHS DP, 2008, CHEST, V134; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V2; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975	8	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					513	514		10.1016/S0140-6736(09)60352-4	http://dx.doi.org/10.1016/S0140-6736(09)60352-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19394686	Green Accepted			2022-12-28	WOS:000269019400010
J	Lopez-Aviles, S; Kapuy, O; Novak, B; Uhlmann, F				Lopez-Aviles, Sandra; Kapuy, Orsolya; Novak, Bela; Uhlmann, Frank			Irreversibility of mitotic exit is the consequence of systems-level feedback	NATURE			English	Article							ANAPHASE PROMOTING COMPLEX; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PHOSPHATASE CDC14; PROTEIN-KINASE; PHOSPHORYLATION; APC; PROTEOLYSIS; INHIBITOR	The eukaryotic cell cycle comprises an ordered series of events, orchestrated by the activity of cyclin-dependent kinases (Cdks), leading from chromosome replication during S phase to their segregation in mitosis. The unidirectionality of cell-cycle transitions is fundamental for the successful completion of this cycle. It is thought that irrevocable proteolytic degradation of key cell-cycle regulators makes cell-cycle transitions irreversible, thereby enforcing directionality(1-3). Here we have experimentally examined the contribution of cyclin proteolysis to the irreversibility of mitotic exit, the transition from high mitotic Cdk activity back to low activity in G1. We show that forced cyclin destruction in mitotic budding yeast cells efficiently drives mitotic exit events. However, these remain reversible after termination of cyclin proteolysis, with recovery of the mitotic state and cyclin levels. Mitotic exit becomes irreversible only after longer periods of cyclin degradation, owing to activation of a double-negative feedback loop involving the Cdk inhibitor Sic1 (refs 4, 5). Quantitative modelling suggests that feedback is required to maintain low Cdk activity and to prevent cyclin resynthesis. Our findings demonstrate that the unidirectionality of mitotic exit is not the consequence of proteolysis but of systems-level feedback required to maintain the cell cycle in a new stable state.	[Lopez-Aviles, Sandra; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; [Kapuy, Orsolya; Novak, Bela] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Kapuy, Orsolya] Budapest Univ Technol & Econ, H-1521 Budapest, Hungary	Cancer Research UK; University of Oxford; Budapest University of Technology & Economics	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk	Novak, Bela/D-5365-2009	Novak, Bela/0000-0002-6961-1366; Uhlmann, Frank/0000-0002-3527-6619; Lopez-Aviles, Sandra/0000-0002-0498-1331	European Commission Marie Curie Individual Fellowship; BBSRC; EC FP7	European Commission Marie Curie Individual Fellowship(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC FP7(European Commission)	We thank C. Bouchoux, J. Kilmartin, E. Schwob and W. Zachariae for antibodies and constructs, and members of our laboratory for discussion and critical reading of the manuscript. This work was supported by a European Commission Marie Curie Individual Fellowship to S. L.-A., and the BBSRC and EC FP7 (O. K.).	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	30	75	75	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					592	595		10.1038/nature07984	http://dx.doi.org/10.1038/nature07984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387440	Green Accepted			2022-12-28	WOS:000266370500044
J	Steinbrook, R				Steinbrook, Robert			Controlling Conflict of Interest - Proposals from the Institute of Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Institute of Medicine, 2009, CONFL INT MED RES ED; Medicare Payment Advisory Commission, 2009, REP C MED PAYM POL; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Steinbrook R, 2008, JAMA-J AM MED ASSOC, V299, P1060, DOI 10.1001/jama.299.9.1060	4	92	93	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2160	2163		10.1056/NEJMp0810200	http://dx.doi.org/10.1056/NEJMp0810200			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19403898				2022-12-28	WOS:000266206000003
J	Kawamori, R; Tajima, N; Iwamoto, Y; Kashiwagi, A; Shimamoto, K; Koku, K				Kawamori, Ryuzo; Tajima, Naoko; Iwamoto, Yasuhiko; Kashiwagi, Atsunori; Shimamoto, Kazuaki; Koku, Kohei		Voglibose Ph 3 Study Grp	Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance	LANCET			English	Article							LIFE-STYLE; CARDIOVASCULAR-DISEASE; COMPETING RISKS; INHIBITORS; ACARBOSE; NIDDM; HYPERGLYCEMIA; IGT	Background The increased prevalence of type 2 diabetes mellitus is a major concern for health providers. We therefore assessed whether voglibose, an a-glucosidase inhibitor, could prevent the development of type 2 diabetes in high-risk Japanese individuals with impaired glucose tolerance. Methods 1780 eligible patients on a standard diet and taking regular exercise with impaired glucose tolerance were randomly assigned to oral voglibose 0.2 mg three times a day (n=897) or placebo (n=883) in a multicentre, double-blind, parallel group trial. Treatment was continued until participants developed type 2 diabetes (primary endpoint) or normoglycaemia (secondary endpoint), or for a minimum of 3 years, subject to the findings of an interim analysis. Analysis was by full analysis set. This trial is registered with the University Hospital Medical Information Network (UMIN) clinical trials registry, number UMIN 000001109. Findings In the interim analysis, voglibose was better than placebo (p=0.0026) in individuals treated for an average of 48.1 weeks (S D 36.3). Patients treated with voglibose had a lower risk of progression to type 2 diabetes than did those on placebo (50 of 897 vs 106 of 881; hazard ratio 0.595, 95% CI 0.433-0.818; p=0.0014). More people in the voglibose group achieved normoglycaemia than did those in the placebo group (599 of 897 vs 454 of 881; 1.539, 1.357-1.746; p<0.0001). 810 (90%) of 897 patients in the voglibose group had adverse events versus 750 (85%) of 881 in the placebo group. Serious adverse events (all one each) in the voglibose group were cholecystitis, colonic polyp, rectal neoplasm, inguinal hernia, liver dysfunction, and subarachnoid haemorrhage, and in the placebo group were cerebral infarction and cholecystitis. Interpretation Voglibose, in addition to lifestyle modification, can reduce the development of type 2 diabetes in high-risk Japanese individuals with impaired glucose tolerance.	[Kawamori, Ryuzo] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Bunkyo Ku, Tokyo 1138421, Japan; [Tajima, Naoko] Jikei Univ, Dept Internal Med, Sch Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Iwamoto, Yasuhiko] Tokyo Womens Med Univ, Dept Med, Ctr Diabet, Tokyo, Japan; [Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Shiga, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Dept Internal Med 2, Sapporo, Hokkaido, Japan; [Koku, Kohei] Kawasaki Med Sch, Dept Med, Diabet & Endocrine Div, Kurashiki, Okayama, Japan	Juntendo University; Jikei University; Tokyo Women's Medical University; Shiga University of Medical Science; Sapporo Medical University; Kawasaki Medical School	Kawamori, R (corresponding author), Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	kawamori@juntendo.ac.jp	Kashiwagi, Atsunori/H-8712-2019		Takeda; Steve Clissold	Takeda(Takeda Pharmaceutical Company Ltd); Steve Clissold	This study was funded by all unrestricted research grant from Takeda. We thank the sponsor for assistance with data monitoring and gathering, and for funding editorial support that was provided by Steve Clissold; and members of the Independent Data Monitoring Committee for their invaluable assistance in collating and analysing the data.	Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Alberti KGMM, 1996, DIABETIC MED, V13, P927, DOI 10.1002/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E; Borch-Johnsen K, 1999, LANCET, V354, P617; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fujisawa T, 2005, METABOLISM, V54, P387, DOI 10.1016/j.metabol.2004.10.004; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11; Heymsfield SB, 2000, ARCH INTERN MED, V160, P1321, DOI 10.1001/archinte.160.9.1321; International Diabetes Federation, DIAB FACTS FIG; *JAP DIAB SOC, 2007, DIAB MELL TREATM GUI, P257; *JAP HLTH SERV BUR, 2004, 2002 DIAB MELL SURV; *JAP MIN HLTH LAB, 1999, JAP NUTR REQ; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Matsumoto K, 1998, DIABETES CARE, V21, P256, DOI 10.2337/diacare.21.2.256; Matsumoto K, 2002, METABOLISM, V51, P1548, DOI 10.1053/meta.2002.36310; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; NIGEL JV, 1962, AM J HUM GENET, V14, P353; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Scheen AJ, 2003, DRUGS, V63, P933, DOI 10.2165/00003495-200363100-00002; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van de Laar FA, 2005, DIABETES CARE, V28, P154, DOI 10.2337/diacare.28.1.154	31	215	227	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2009	373	9675					1607	1614		10.1016/S0140-6736(09)60222-1	http://dx.doi.org/10.1016/S0140-6736(09)60222-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445QJ	19395079				2022-12-28	WOS:000266066300031
J	Guan, JS; Haggarty, SJ; Giacometti, E; Dannenberg, JH; Joseph, N; Gao, J; Nieland, TJF; Zhou, Y; Wang, XY; Mazitschek, R; Bradner, JE; DePinho, RA; Jaenisch, R; Tsai, LH				Guan, Ji-Song; Haggarty, Stephen J.; Giacometti, Emanuela; Dannenberg, Jan-Hermen; Joseph, Nadine; Gao, Jun; Nieland, Thomas J. F.; Zhou, Ying; Wang, Xinyu; Mazitschek, Ralph; Bradner, James E.; DePinho, Ronald A.; Jaenisch, Rudolf; Tsai, Li-Huei			HDAC2 negatively regulates memory formation and synaptic plasticity	NATURE			English	Article							HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION; MOUSE MODEL; HUNTINGTONS-DISEASE; CHROMATIN; ACETYLATION; MICE; MODULATION; RECEPTORS; MECHANISM	Chromatin modifications, especially histone-tail acetylation, have been implicated in memory formation. Increased histone-tail acetylation induced by inhibitors of histone deacetylases (HDACis) facilitates learning and memory in wild-type mice as well as in mouse models of neurodegeneration. Harnessing the therapeutic potential of HDACis requires knowledge of the specific HDAC family member(s) linked to cognitive enhancement. Here we show that neuron-specific overexpression of HDAC2, but not that of HDAC1, decreased dendritic spine density, synapse number, synaptic plasticity and memory formation. Conversely, Hdac2 deficiency resulted in increased synapse number and memory facilitation, similar to chronic treatment with HDACis in mice. Notably, reduced synapse number and learning impairment of HDAC2-overexpressing mice were ameliorated by chronic treatment with HDACis. Correspondingly, treatment with HDACis failed to further facilitate memory formation in Hdac2-deficient mice. Furthermore, analysis of promoter occupancy revealed an association of HDAC2 with the promoters of genes implicated in synaptic plasticity and memory formation. Taken together, our results suggest that HDAC2 functions in modulating synaptic plasticity and long-lasting changes of neural circuits, which in turn negatively regulates learning and memory. These observations encourage the development and testing of HDAC2-selective inhibitors for human diseases associated with memory impairment.	[Guan, Ji-Song; Joseph, Nadine; Gao, Jun; Zhou, Ying; Wang, Xinyu; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Guan, Ji-Song; Joseph, Nadine; Gao, Jun; Zhou, Ying; Wang, Xinyu; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Guan, Ji-Song; Haggarty, Stephen J.; Joseph, Nadine; Nieland, Thomas J. F.; Mazitschek, Ralph; Bradner, James E.; Tsai, Li-Huei] Harvard Univ, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Guan, Ji-Song; Haggarty, Stephen J.; Joseph, Nadine; Nieland, Thomas J. F.; Mazitschek, Ralph; Bradner, James E.; Tsai, Li-Huei] MIT, Cambridge, MA 02142 USA; [Haggarty, Stephen J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Cambridge, MA 02142 USA; [Giacometti, Emanuela; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Giacometti, Emanuela; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Dannenberg, Jan-Hermen; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [Dannenberg, Jan-Hermen; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Dannenberg, Jan-Hermen; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Dana Farber Canc Inst, Boston, MA 02115 USA; [Mazitschek, Ralph] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Haggarty, Stephen J/M-9495-2016; Mazitschek, Ralph/E-3741-2013	Haggarty, Stephen J/0000-0002-7872-168X; Mazitschek, Ralph/0000-0002-1105-689X; Guan, Ji-Song/0000-0001-5219-0289; DePinho, Ronald/0000-0002-5625-577X	National Institute of Neurological Disorders and Stroke [2 ROI NS051874]; Stanley Center for Psychiatric Research; National Alliance for Research on Schizophrenia and Depression Foundation; Damon-Runyon Cancer Research Foundation; Dutch Cancer Society; NIH [5-RO1-CA087869, 5-R37-CA084198, 5-RO1-HD0445022]; Robert A. and Renee E. Belfer Institute for Applied Cancer Science; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanley Center for Psychiatric Research; National Alliance for Research on Schizophrenia and Depression Foundation(NARSAD); Damon-Runyon Cancer Research Foundation; Dutch Cancer Society(KWF Kankerbestrijding); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Institute for Applied Cancer Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Scolnick, D. Fass, P. Sklar, T. Petryshen, B. A. Samuels, A. Fischer, C. Frank, D. Kim, S. Su and Y. Hayashi for advice and critical reading of the manuscript; T. Petryshen, A. Graybiel, J. Crittenden and M. C. Lewis for providing the T-maze behaviour model; R. Neve for providing tdTomato HSV. Funding was provided by a grant from the National Institute of Neurological Disorders and Stroke (2 ROI NS051874) to L.-H. T., by a research fund from the Stanley Center for Psychiatric Research to L.-H. T. and S. J. H., by the National Alliance for Research on Schizophrenia and Depression Foundation to S. J. H.; by a fellowship from the Damon-Runyon Cancer Research Foundation and The Dutch Cancer Society (KWF) to J. H. D. R. J. is supported by NIH grants (5-RO1-CA087869, 5-R37-CA084198, 5-RO1-HD0445022); R. A. D. is supported by the Robert A. and Renee E. Belfer Institute for Applied Cancer Science. L.-H. T. is an investigator of the Howard Hughes Medical Institute.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; BRESLOW R, 1993, Patent No. 1993007148; Bruserud O, 2007, CURR PHARM BIOTECHNO, V8, P388, DOI 10.2174/138920107783018417; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Radulovic J, 1999, J NEUROSCI, V19, P5016; RAMONMOLINIER E, 1970, CONT RES METHODS NEU; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Witter DJ, 2008, BIOORG MED CHEM LETT, V18, P726, DOI 10.1016/j.bmcl.2007.11.047	35	1174	1243	3	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					55	U58		10.1038/nature07925	http://dx.doi.org/10.1038/nature07925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424149	Green Accepted, Green Submitted			2022-12-28	WOS:000265801300027
J	Orentlicher, D				Orentlicher, David			Health Care Reform Beyond Ideology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSURANCE		Indiana Univ, Sch Law, Ctr Law & Hlth, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Orentlicher, D (corresponding author), Indiana Univ, Sch Law, Ctr Law & Hlth, 530 W New York St, Indianapolis, IN 46202 USA.	dorentli@iupui.edu						BILES R, 1990, HISTORIAN, V53, P33, DOI 10.1111/j.1540-6563.1990.tb00795.x; BILES R, 1990, HISTORIAN, V53, P39; Blanchard J, 2008, J HEALTH CARE POOR U, V19, P687, DOI 10.1353/hpu.0.0036; *CTR BUDG POL PRIO, INC THRESH PAR APPL; EISINGER PK, 1998, END HUNGER AM, P39; Elhauge Einer, 1994, Calif Law Rev, V82, P1449, DOI 10.2307/3480858; Emanuel EJ, 2005, NEW ENGL J MED, V352, P1255, DOI 10.1056/NEJMsb041704; GREENSTEIN R, 1991, URBAN UNDERCLASS, P447; Hays R. A., 1995, FEDERAL GOVT URBAN H, P91; Herszenhorn David M., 2009, NY TIMES, pA14; *KAIS COMM MED UN, 2008, UN PRIM; MARMOR T, 2000, POLITICS MEDICARE, P96; REYNOLDS G, FEDERAL HOUSING SUBS; Schoen C, 2008, HEALTH AFFAIR, V27, pW298, DOI 10.1377/hlthaff.27.4.w298; Sparer M, 2009, NEW ENGL J MED, V360, P323, DOI 10.1056/NEJMp0809878; WILSON WILLIAM JULIUS, 1987, TRULY DISADVANTAGED, P118	16	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1816	1818		10.1001/jama.2009.613	http://dx.doi.org/10.1001/jama.2009.613			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441AU	19417201				2022-12-28	WOS:000265742500034
J	Anderson, PW				Anderson, Philip W.			A Gross-Pitaevskii Treatment for Supersolid Helium	SCIENCE			English	Article							HE-4	Understanding the observations of nonlinear rotational susceptibility in samples of solid helium below temperatures of 1 to 200 millikelvin (mK) has been a subject of some controversy. Here, the observations are conjectured to be describable in terms of a rarified Gross-Pitaevskii superfluid of vacancies, with a transition temperature of about 50 mK, whose density is locally enhanced by crystal imperfections. The observations can be greatly affected by this density enhancement. I argue that every pure Bose solid's ground state is a supersolid.	Princeton Univ, Dept Phys, Princeton, NJ 08525 USA	Princeton University	Anderson, PW (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08525 USA.							Anderson PW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.215301; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Aoki Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.015301; Ceperley DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.155303; GROSS EP, 1957, PHYS REV, V106, P161, DOI 10.1103/PhysRev.106.161; Kim E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.115302; Penzev A, 2007, J LOW TEMP PHYS, V148, P677, DOI 10.1007/s10909-007-9452-4; PITAEVSKII LP, 1957, SOV PHYS JETP-USSR, V4, P439; Pollet L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.097202; Prokof'ev N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.155302; REATTO L, 1967, PHYS REV, V155, P88, DOI 10.1103/PhysRev.155.88; REATTO L, 1969, PHYS REV, V183, P334, DOI 10.1103/PhysRev.183.334; Rittner ASC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175302; Rittner ASC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.165301; Rossi M, 2008, J LOW TEMP PHYS, V153, P250, DOI 10.1007/s10909-008-9830-6	15	59	59	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					631	632		10.1126/science.1169456	http://dx.doi.org/10.1126/science.1169456			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407200	Green Submitted			2022-12-28	WOS:000265608800040
J	Li, CJ; Vagin, VV; Lee, SH; Xu, J; Ma, SM; Xi, HL; Seitz, H; Horwich, MD; Syrzycka, M; Honda, BM; Kittler, ELW; Zapp, ML; Klattenhoff, C; Schulz, N; Theurkauf, WE; Weng, ZP; Zamore, PD				Li, Chengjian; Vagin, Vasily V.; Lee, Soohyun; Xu, Jia; Ma, Shengmei; Xi, Hualin; Seitz, Herve; Horwich, Michael D.; Syrzycka, Monika; Honda, Barry M.; Kittler, Ellen L. W.; Zapp, Maria L.; Klattenhoff, Carla; Schulz, Nadine; Theurkauf, William E.; Weng, Zhiping; Zamore, Phillip D.			Collapse of Germline piRNAs in the Absence of Argonaute3 Reveals Somatic piRNAs in Flies	CELL			English	Article							EMBRYONIC AXIS SPECIFICATION; SELFISH GENETIC ELEMENTS; DROSOPHILA-MELANOGASTER; FLAMENCO GENE; PIWI; PATHWAY; AUBERGINE; PROTEIN; GYPSY; ENCODES	Piwi-interacting RNAs (piRNAs) silence transposons in animal germ cells. piRNAs are thought to derive from long transcripts spanning transposon-rich genomic loci and to direct an autoamplification loop in which an antisense piRNA, bound to Aubergine or Piwi protein, triggers production of a sense piRNA bound to the PIWI protein Argonaute3 (Ago3). In turn, the new piRNA is envisioned to produce a second antisense piRNA. Here, we describe strong loss-of-function mutations in ago3, allowing a direct genetic test of this model. We find that Ago3 acts to amplify piRNA pools and to enforce on them an antisense bias, increasing the number of piRNAs that can act to silence transposons. We also detect a second, Ago3-independent piRNA pathway centered on Piwi. Transposons targeted by this second pathway often reside in the flamenco locus, which is expressed in somatic ovarian follicle cells, suggesting a role for piRNAs beyond the germline.	[Lee, Soohyun; Xu, Jia; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Li, Chengjian; Vagin, Vasily V.; Ma, Shengmei; Seitz, Herve; Horwich, Michael D.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Li, Chengjian; Vagin, Vasily V.; Ma, Shengmei; Seitz, Herve; Horwich, Michael D.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Kittler, Ellen L. W.; Zapp, Maria L.; Klattenhoff, Carla; Schulz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kittler, Ellen L. W.; Zapp, Maria L.] Univ Massachusetts, Sch Med, Ctr AIDS Res, Worcester, MA 01605 USA; [Lee, Soohyun; Xi, Hualin] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xi, Hualin] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA 02139 USA; [Syrzycka, Monika; Honda, Barry M.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Pfizer; Simon Fraser University	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.	zhiping.weng@umassmed.edu; phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Seitz, Hervé/AAE-6487-2019; Xu, Jia/F-7750-2012	Seitz, Hervé/0000-0001-8172-5393; Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912; Lee, Soohyun/0000-0002-3594-6213; Xu, Jia/0000-0003-3921-018X	National Institutes of Health [GM62862, GM65236]; Natural Sciences and Engineering Research Council of Canada [GM050898, HD049116]; Canadian Institutes of Health Research; Pfizer, Inc; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050898, R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer, Inc(Pfizer); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mikiko and Haruhiko Siomi and Greg Hannon for antibodies, Erica Selva for flies expressing nanos-Gal4 from a transgene on the second chromosome, Paul Lasko for GFP-Vasa flies, Bradley Till for assistance with tilling primer design, Alicia Boucher for assistance with fly husbandry, Gwen Farley for technical assistance, and members of the Zamore and Weng laboratories for advice, suggestions, and critical comments on the text. This work was supported in part by grants from the National Institutes of Health to P.D.Z. (GM62862 and GM65236) and W.E.T. (GM050898 and HD049116) and from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research to B.M.H. H.X. was supported in part by Pfizer, Inc.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; BALAKIREVA MD, 1992, NUCLEIC ACIDS RES, V20, P3731, DOI 10.1093/nar/20.14.3731; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Fuller Margaret T., 1993, P71; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; LIVAK KJ, 1990, GENETICS, V124, P303; LIVAK KJ, 1984, GENETICS, V107, P611; MALONE CD, 2009, CELL IN PRESS, V137, DOI DOI 10.1016/J.CELL.2009.03.040; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; PALUMBO G, 1994, GENETICS, V138, P1181; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; PIMPINELLI S, 1985, GENETICS, V109, P701; PRUDHOMME N, 1995, GENETICS, V139, P697; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schmidt A, 1999, GENETICS, V151, P749; SCHUPBACH T, 1991, GENETICS, V129, P1119; Specchia V, 2008, GENETICS, V178, P1271, DOI 10.1534/genetics.107.078626; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	54	390	402	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					509	521		10.1016/j.cell.2009.04.027	http://dx.doi.org/10.1016/j.cell.2009.04.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19395009	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000265677200020
J	Allen, MR; Frame, DJ; Huntingford, C; Jones, CD; Lowe, JA; Meinshausen, M; Meinshausen, N				Allen, Myles R.; Frame, David J.; Huntingford, Chris; Jones, Chris D.; Lowe, Jason A.; Meinshausen, Malte; Meinshausen, Nicolai			Warming caused by cumulative carbon emissions towards the trillionth tonne	NATURE			English	Article							CLIMATE-CHANGE; STABILIZATION; TEMPERATURE; UNCERTAINTY; FEEDBACK	Global efforts to mitigate climate change are guided by projections of future temperatures(1). But the eventual equilibrium global mean temperature associated with a given stabilization level of atmospheric greenhouse gas concentrations remains uncertain(1-3), complicating the setting of stabilization targets to avoid potentially dangerous levels of global warming(4-8). Similar problems apply to the carbon cycle: observations currently provide only a weak constraint on the response to future emissions(9-11). Here we use ensemble simulations of simple climate-carbon-cycle models constrained by observations and projections from more comprehensive models to simulate the temperature response to a broad range of carbon dioxide emission pathways. We find that the peak warming caused by a given cumulative carbon dioxide emission is better constrained than the warming response to a stabilization scenario. Furthermore, the relationship between cumulative emissions and peak warming is remarkably insensitive to the emission pathway (timing of emissions or peak emission rate). Hence policy targets based on limiting cumulative emissions of carbon dioxide are likely to be more robust to scientific uncertainty than emission-rate or concentration targets. Total anthropogenic emissions of one trillion tonnes of carbon (3.67 trillion tonnes of CO2), about half of which has already been emitted since industrialization began, results in a most likely peak carbon-dioxide-induced warming of 2 degrees C above pre-industrial temperatures, with a 5-95% confidence interval of 1.3-3.9 degrees C.	[Allen, Myles R.; Frame, David J.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Frame, David J.] Univ Oxford, Smith Sch Enterprise & Environm, Oxford OX1 2BQ, England; [Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Jones, Chris D.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Lowe, Jason A.] Univ Reading, Dept Meteorol, Met Off Hadley Ctr, Reading Unit, Reading RG6 6BB, Berks, England; [Meinshausen, Malte] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Meinshausen, Nicolai] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; University of Oxford; UK Centre for Ecology & Hydrology (UKCEH); Met Office - UK; Hadley Centre; Met Office - UK; Hadley Centre; University of Reading; Potsdam Institut fur Klimafolgenforschung; University of Oxford	Allen, MR (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.	myles.allen@physics.ox.ac.uk	Frame, Dave/R-6169-2016; Allen, Myles R/A-5172-2012; Meinshausen, Malte/AAG-6505-2019; Huntingford, Christopher/A-4307-2008; Frame, Dave/A-8918-2014; Lowe, Jason/GQI-4036-2022; Meinshausen, Malte/A-7037-2011; Jones, Chris/I-2983-2014	Frame, Dave/0000-0002-0949-3994; Meinshausen, Malte/0000-0003-4048-3521; Huntingford, Christopher/0000-0002-5941-7770; Meinshausen, Malte/0000-0003-4048-3521; Jones, Chris/0000-0002-7141-9285	DOE Office of Science; Office of Biological and Environmental Research; NOAA Climate Program Office; British Council; CEH Science Budget Fund; Joint DECC; Defra and MoD Integrated Climate Programme [GA01101]; MoD [CBC/2B/0417_Annex C5]; Natural Environment Research Council [NE/C515747/1, ceh010023] Funding Source: researchfish	DOE Office of Science(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NOAA Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); British Council(The British Council in India); CEH Science Budget Fund; Joint DECC; Defra and MoD Integrated Climate Programme; MoD; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank N. Gillett, K. Shine and T. Stocker for suggestions, P. Stott for estimates of twentieth-century-attributable warming, J. Welby for help calibrating the simple climate model. P. Friedlingstein and the C 4 MIP modelling community for model output and I. Tracey for help with the manuscript. M. R. A. and D. J. F. acknowledge support from NERC and the FP6 ENSEMBLES project. M. R. A. received additional support from the International Detection and Attribution Working Group (IDAG), supported by the DOE Office of Science, Office of Biological and Environmental Research and NOAA Climate Program Office, and from the British Council. C. H. acknowledges the CEH Science Budget Fund. C. D. J. and J. A. L. were supported by the Joint DECC, Defra and MoD Integrated Climate Programme (DECC/Defra GA01101; MoD CBC/2B/0417_Annex C5).	Broecker WS, 2007, SCIENCE, V315, P1371, DOI 10.1126/science.1139585; den Elzen MGJ, 2007, P NATL ACAD SCI USA, V104, P17931, DOI 10.1073/pnas.0701598104; Frame DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025801; Frame DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022241; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2005, P NATL ACAD SCI USA, V102, P10832, DOI 10.1073/pnas.0504755102; Friedlingstein P, 2003, TELLUS B, V55, P692, DOI 10.1034/j.1600-0889.2003.01461.x; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Harvey LDD, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014001; Huntingford C, 2009, TELLUS B, V61, P355, DOI 10.1111/j.1600-0889.2009.00414.x; Huntingford C, 2007, SCIENCE, V316, P829; Jones CD, 2006, TELLUS B, V58, P603, DOI 10.1111/j.1600-0889.2006.00215.x; Keeling C.D., 2005, TRENDS COMPENDIUM DA; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Lowe JA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014012; Matthews HD, 2007, GLOBAL CHANGE BIOL, V13, P1068, DOI 10.1111/j.1365-2486.2007.01343.x; Matthews HD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037488; MATTHEWS HD, NATURE IN PRESS, DOI DOI 10.1038/NATURE08047; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MEINSHAUSEN M, 2006, AVOIDING DANGEROUS C, pCH28; PAWITAN Y, 2001, ALL LIKEHOOD STAT MO; Plattner GK, 2008, J CLIMATE, V21, P2721, DOI 10.1175/2007JCLI1905.1; Schneider SH, 2005, P NATL ACAD SCI USA, V102, P15728, DOI 10.1073/pnas.0506356102; Schneider SH, 2004, GLOBAL ENVIRON CHANG, V14, P245, DOI 10.1016/j.gloenvcha.2004.04.008; Shine KP, 2007, PHILOS T R SOC A, V365, P1903, DOI 10.1098/rsta.2007.2050; Shine KP, 2005, CLIMATIC CHANGE, V68, P281, DOI 10.1007/s10584-005-1146-9; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stott PA, 2006, J CLIMATE, V19, P3055, DOI 10.1175/JCLI3802.1; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Wigley TML, 2007, SCIENCE, V316, P829	30	881	907	35	437	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1163	1166		10.1038/nature08019	http://dx.doi.org/10.1038/nature08019			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407800				2022-12-28	WOS:000265754600046
J	Pope, KS; Gutheil, TG				Pope, Kenneth S.; Gutheil, Thomas G.			Contrasting ethical policies of physicians and psychologists concerning interrogation of detainees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gutheil, Thomas G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Brookline, MA 02446 USA	Harvard University; Beth Israel Deaconess Medical Center	Pope, KS (corresponding author), POB 777, Norwalk, CT 06856 USA.	kspope@mac.com						*AM CIV LIB UN, 2009, REL BUSH ADM SECR LE; *AM PSYCH ASS, 1992, AM PSYCH, V0047, P01597, DOI DOI 10.1037/0003-066X.47.12.1597; *AM PSYCH ASS, 2008, PET PSYCH WORK SETT; *AM PSYCH ASS, 2005, REP AM PSYCH ASS PRE; *AM PSYCH ASS, 2007, STAT AM PSYCH UNPUB; American Psychological Association, 2002, AM PSYCHOL, V57, P1060, DOI 10.1037/0003-066X.57.12.1060; BEHNKE S, 2006, MONITOR PSYCHOL, V37, P66, DOI DOI 10.1037/E532252006-041; BREHM S, 2007, COMMUNICATION   0109; DALY R, 2006, PSYCHIAT NEWS, V42, P9; Eban K., 2007, VANITY FAIR; FALHERTY A, 2008, USA TODAY       0617; LEWIS A, 2006, NY TIMES        0607; MAYER J, 2008, DARK SIDE; MORAN M, 2006, PSYCHIAT NEWS, V41, P1; Pope K. S., 2021, ETHICS PSYCHOTHERAPY, V6th; *PSYCH TORT, BOST GLOB 2008 AUG 3; ROMERO AD, 2008, COMMUNICATION   0618; SALAMEH WA, 1984, APA MONITOR, V15, P4; Samelson F., 1992, 100 YEARS AM PSYCHOL, P119; 1983, APA MONITOR, V14, P2; 2008, PSYCHOL PHYS INVOLVE	21	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2009	338								b1653	10.1136/bmj.b1653	http://dx.doi.org/10.1136/bmj.b1653			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JY	19406892				2022-12-28	WOS:000265697800003
J	Gupta, A; Urquhart, DS; Donovan, S; Bush, A				Gupta, Atul; Urquhart, Donald S.; Donovan, Sarah; Bush, Andrew			Picture quiz A 4 year old boy with recurrent wheeze and chest infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NORTH-AMERICAN-SOCIETY; GASTROESOPHAGEAL-REFLUX; PEDIATRIC-GASTROENTEROLOGY; INFANTS; CHILDREN; PREVALENCE; DIAGNOSIS; ASTHMA		[Gupta, Atul; Urquhart, Donald S.; Donovan, Sarah; Bush, Andrew] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England	Royal Brompton Hospital	Gupta, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England.	atulgupta@doctors.org.uk			Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 1992, J PEDIAT GASTROENTER, V14, P467; BLACK DD, 1990, GASTROENTEROLOGY, V98, P1408, DOI 10.1016/0016-5085(90)91069-I; BUTS JP, 1986, EUR J PEDIATR, V145, P396, DOI 10.1007/BF00439246; Chang AB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004823.pub3; CHEN PH, 1991, J PEDIATR GASTR NUTR, V13, P16, DOI 10.1097/00005176-199107000-00003; Chernick V, 2006, KENDIGS DISORDERS RE; COLLETTI RB, 1995, J PEDIATR GASTR NUTR, V21, P253, DOI 10.1097/00005176-199510000-00002; CUCCHIARA S, 1990, GUT, V31, P129, DOI 10.1136/gut.31.2.129; Dhillon AS, 2004, ACTA PAEDIATR, V93, P88, DOI 10.1080/08035250310007934; EKSTROM T, 1989, THORAX, V44, P19, DOI 10.1136/thx.44.1.19; EULER AR, 1981, GASTROENTEROLOGY, V80, P957; Gibson PG, 2003, COCHRANE DATABASE SY, pCD001496, DOI DOI 10.1002/14651858.CD001496; Keady S, 2007, ARCH DIS CHILDHOOD-E, V92, pEP114, DOI 10.1136/adc.2006.106328; Little JP, 1997, ANN OTO RHINOL LARYN, V106, P1; Lopez-Alonso M, 2006, PEDIATRICS, V118, pE299, DOI 10.1542/peds.2005-3140; Mahajan L, 1998, PEDIATRICS, V101, P260, DOI 10.1542/peds.101.2.260; MALFROOT A, 1987, PEDIATR PULM, V3, P208, DOI 10.1002/ppul.1950030403; Mattioli G, 2006, DIGEST DIS SCI, V51, P2341, DOI 10.1007/s10620-006-9374-z; McGovern MC, 2004, ARCH DIS CHILD, V89, P1043, DOI 10.1136/adc.2003.031740; Rudolph CD, 2001, J PEDIATR GASTR NUTR, V32, pS1, DOI 10.1097/00005176-200100002-00001; Sifrim D, 2008, DIGEST LIVER DIS, V40, P161, DOI 10.1016/j.dld.2007.10.023; Tighe MP, 2009, ARCH DIS CHILDHOOD-E, V94, P18, DOI 10.1136/adc.2008.145169; TOLIA V, 1990, J PEDIATR GASTR NUTR, V10, P426, DOI 10.1097/00005176-199005000-00002; TUCCI F, 1993, J PEDIATR GASTR NUTR, V17, P265, DOI 10.1097/00005176-199310000-00006; Washington N, 1999, ARCH DIS CHILD, V81, P309, DOI 10.1136/adc.81.4.309	25	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2009	338								b1255	10.1136/bmj.b1255	http://dx.doi.org/10.1136/bmj.b1255			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JW	19403569				2022-12-28	WOS:000265697600002
J	Bowman, DMJS; Balch, JK; Artaxo, P; Bond, WJ; Carlson, JM; Cochrane, MA; D'Antonio, CM; DeFries, RS; Doyle, JC; Harrison, SP; Johnston, FH; Keeley, JE; Krawchuk, MA; Kull, CA; Marston, JB; Moritz, MA; Prentice, IC; Roos, CI; Scott, AC; Swetnam, TW; van der Werf, GR; Pyne, SJ				Bowman, David M. J. S.; Balch, Jennifer K.; Artaxo, Paulo; Bond, William J.; Carlson, Jean M.; Cochrane, Mark A.; D'Antonio, Carla M.; DeFries, Ruth S.; Doyle, John C.; Harrison, Sandy P.; Johnston, Fay H.; Keeley, Jon E.; Krawchuk, Meg A.; Kull, Christian A.; Marston, J. Brad; Moritz, Max A.; Prentice, I. Colin; Roos, Christopher I.; Scott, Andrew C.; Swetnam, Thomas W.; van der Werf, Guido R.; Pyne, Stephen J.			Fire in the Earth System	SCIENCE			English	Review							FOREST-FIRES; CLIMATE; EXPANSION; HISTORY; ECOSYSTEMS; EVOLUTION; SYNCHRONY; EMISSIONS; ECOLOGY; CYCLE	Fire is a worldwide phenomenon that appears in the geological record soon after the appearance of terrestrial plants. Fire influences global ecosystem patterns and processes, including vegetation distribution and structure, the carbon cycle, and climate. Although humans and fire have always coexisted, our capacity to manage fire remains imperfect and may become more difficult in the future as climate change alters fire regimes. This risk is difficult to assess, however, because fires are still poorly represented in global models. Here, we discuss some of the most important issues involved in developing a better understanding of the role of fire in the Earth system.	[Balch, Jennifer K.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Johnston, Fay H.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7001, Australia; [Balch, Jennifer K.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Balch, Jennifer K.] Woods Hole Res Ctr, Woods Hole, MA 02543 USA; [Artaxo, Paulo] Univ Sao Paulo, Inst Fis, BR-05508900 Sao Paulo, Brazil; [Bond, William J.] Univ Cape Town, Dept Bot, ZA-7925 Cape Town, South Africa; [Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Cochrane, Mark A.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Environm Studies Program, Santa Barbara, CA 93106 USA; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [DeFries, Ruth S.] Columbia Univ, New York, NY 10027 USA; [Doyle, John C.] CALTECH, Dept Control & Dynam Syst, Pasadena, CA 91125 USA; [Harrison, Sandy P.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Keeley, Jon E.] US Geol Survey, Western Ecol Res Ctr, Sequoia Kings Canyon Field Stn, Three Rivers, CA 93271 USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Krawchuk, Meg A.; Moritz, Max A.] Univ Calif Berkeley, Ecosyst Sci Div, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kull, Christian A.] Monash Univ, Sch Geog & Environm Sci, Melbourne, Vic 3800, Australia; [Marston, J. Brad] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Prentice, I. Colin] Univ Bristol, QUEST, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Roos, Christopher I.] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Scott, Andrew C.] Royal Holloway Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Swetnam, Thomas W.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [van der Werf, Guido R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hydrol & Geoenvironm Sci, NL-1081 HV Amsterdam, Netherlands; [Pyne, Stephen J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	National Center for Ecological Analysis & Synthesis; University of Tasmania; Menzies Institute for Medical Research; Yale University; Woods Hole Research Center; Universidade de Sao Paulo; University of Cape Town; University of California System; University of California Santa Barbara; South Dakota State University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Columbia University; California Institute of Technology; University of Bristol; United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Monash University; Brown University; University of Bristol; University System of Ohio; Ohio State University; University of London; Royal Holloway University London; University of Arizona; Vrije Universiteit Amsterdam; Arizona State University; Arizona State University-Tempe	Balch, JK (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	balch@nceas.ucsb.edu	Scott, Andrew C/C-6661-2008; Roos, Christopher/F-3379-2011; van der Werf, Guido/M-8260-2016; Artaxo, Paulo/E-8874-2010; Swetnam, Thomas/A-6052-2008; Marston, Brad/B-3144-2012; Bowman, David M.J.S./A-2930-2011; Bond, William/AAY-7631-2020; Cochrane, Mark A/A-1735-2018; Nahas, Alberth/C-8379-2013; Kull, Christian A/C-5806-2015	Scott, Andrew C/0000-0002-1998-3508; van der Werf, Guido/0000-0001-9042-8630; Artaxo, Paulo/0000-0001-7754-3036; Swetnam, Thomas/0000-0001-7268-2184; Bowman, David M.J.S./0000-0001-8075-124X; Cochrane, Mark A/0000-0002-4573-568X; Harrison, Sandy/0000-0001-5687-1903; Roos, Christopher/0000-0001-8754-7655; Kull, Christian/0000-0002-7516-7898; Johnston, Fay Helena/0000-0002-5150-8678; Bond, William/0000-0002-3441-2084	Kavli Institute for Theoretical Physics (KITP); National Center for Ecological Analysis and Synthesis (NCEAS); NSF [PHY05-51164, DEB-0553768]; University of California, Santa Barbara; State of California; Instituto do Milenio Program; U.S. Geological Survey; Natural Environment Research Council [NE/E007600/1, quest010001, NE/E006183/1] Funding Source: researchfish; NERC [quest010001, NE/E006183/1, NE/E007600/1] Funding Source: UKRI	Kavli Institute for Theoretical Physics (KITP); National Center for Ecological Analysis and Synthesis (NCEAS); NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Instituto do Milenio Program; U.S. Geological Survey(United States Geological Survey); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank L. Curran, M. Einhorn, D. Gross, S. Hampton, D. Nepstad, and R. Whittaker for encouraging this synthesis, and G. Williamson for assistance with Fig. 2. This work was conducted as part of the Pyrogeography and Climate Change Working Group supported by the Kavli Institute for Theoretical Physics (KITP) and the National Center for Ecological Analysis and Synthesis (NCEAS), funded by NSF grants PHY05-51164 and DEB-0553768, respectively; the University of California, Santa Barbara; and the State of California. Additional support was provided by NCEAS (to J.K.B., the Postdoctoral Associate in the Group); CNPq/MCT Instituto do Milenio Program (to P.A.); and the U.S. Geological Survey (to J.E.K.). Contributions: D.M.J.S.B. conceived of the original idea; J.K.B. and D.M.J.S.B. co-organized the KITP/NCEAS workshop and assumed editorial responsibility; all authors participated in the workshop and/or contributed to manuscript writing; G.R.W., P.A., and I.C.P. developed the radiative forcing figure; C.A.K., C.I.R., and A.C.S. designed the timeline diagram.	Alencar A, 2006, EARTH INTERACT, V10; Allen CD, 2002, ECOL APPL, V12, P1418; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; ARINO O, 1999, EARTH OBS Q, V64, P1; Arora VK, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000042; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman D.M., 2000, AUSTR RAINFORESTS IS; Cochrane M. A, 2002, SPREAD LIK WILDF TRO; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Forsyth Greg G., 2008, Koedoe, V50, P3; Giglio L, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000142; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Keeley JE, 2005, ECOL LETT, V8, P683, DOI 10.1111/j.1461-0248.2005.00767.x; Kitzberger T, 2001, GLOBAL ECOL BIOGEOGR, V10, P315, DOI 10.1046/j.1466-822X.2001.00234.x; Kitzberger T, 2007, P NATL ACAD SCI USA, V104, P543, DOI 10.1073/pnas.0606078104; Langenfelds RL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001466; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Lenton TM, 2001, GLOBAL CHANGE BIOL, V7, P613, DOI 10.1046/j.1354-1013.2001.00429.x; Lohman DJ, 2007, SCIENCE, V316, P376, DOI 10.1126/science.1140278; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; MARSTON JB, 1991, NATURE, V349, P573, DOI 10.1038/349573b0; McGlone MS, 1999, J QUATERNARY SCI, V14, P239, DOI 10.1002/(SICI)1099-1417(199905)14:3<239::AID-JQS438>3.0.CO;2-9; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Platek SM, 2002, MED HYPOTHESES, V58, P1, DOI 10.1054/mehy.2001.1385; Power MJ, 2008, CLIM DYNAM, V30, P887, DOI 10.1007/s00382-007-0334-x; Pyne Stephen, 2001, FIRE BRIEF HIST; Pyne SJ, 2007, INT J WILDLAND FIRE, V16, P271, DOI 10.1071/WF06041; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; SCHWEITHELM J, 1999, INDONESIAS FIRE HAZE; Schwilk DW, 2002, OIKOS, V99, P431, DOI 10.1034/j.1600-0706.2002.11730.x; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Tansey K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031567; Theobald DM, 2007, LANDSCAPE URBAN PLAN, V83, P340, DOI 10.1016/j.landurbplan.2007.06.002; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083	48	1794	1865	57	1001	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					481	484		10.1126/science.1163886	http://dx.doi.org/10.1126/science.1163886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390038				2022-12-28	WOS:000265411200037
J	Elsik, CG; Tellam, RL; Worley, KC; Gibbs, RA; Abatepaulo, ARR; Abbey, CA; Adelson, DL; Aerts, J; Ahola, V; Alexander, L; Alioto, T; Almeida, IG; Amadio, AF; Anatriello, E; Antonarakis, SE; Anzola, JM; Astashyn, A; Bahadue, SM; Baldwin, CL; Barris, W; Baxter, R; Bell, SN; Bennett, AK; Bennett, GL; Biase, FH; Boldt, CR; Bradley, DG; Brinkman, FSL; Brinkmeyer-Langford, CL; Brown, WC; Brownstein, MJ; Buhay, C; Caetano, AR; Camara, F; Carroll, JA; Carvalho, WA; Casey, T; Cervelatti, EP; Chack, J; Chacko, E; Chandrabose, MM; Chapin, JE; Chapple, CE; Chen, HC; Chen, L; Cheng, Y; Cheng, Z; Childers, CP; Chitko-McKown, CG; Chiu, R; Choi, JW; Chrast, J; Colley, AJ; Connelley, T; Cree, A; Curry, S; Dalrymple, B; Diep Dao, M; Davis, C; de Oliveira, CJF; de Miranda Santos, IKF; de Campos, TA; Deobald, H; Devinoy, E; Dickens, CM; Ding, Y; Dinh, HH; De Donato, M; Donohue, KE; Donthu, R; Dovc, P; Dugan-Rocha, S; Durbin, KJ; Eberlein, A; Edgar, RC; Egan, A; Eggen, A; Eichler, EE; Elhaik, E; Ellis, SA; Elnitski, L; Ermolaeva, O; Eyras, E; Fitzsimmons, CJ; Fowler, GR; Franzin, AM; Fritz, K; Gabisi, RA; Garcia, GR; Garcia, JF; Genini, S; Gerlach, D; German, JB; Gilbert, JGR; Gill, CA; Gladney, CJ; Glass, EJ; Goodell, J; Grant, JR; Graur, D; Greaser, ML; Green, JA; Green, RD; Guan, L; Guigo, R; Hadsell, DL; Hagen, DE; Hakimov, HA; Halgren, R; Hamernik, DL; Hamilton, C; Harhay, GP; Harrow, JL; Hart, EA; Hastings, N; Havlak, P; Henrichsen, CN; Hernandez, J; Hernandez, M; Herzig, CTA; Hiendleder, SG; Hines, S; Hitchens, ME; Hlavina, W; Hobbs, M; Holder, M; Holt, RA; Hu, ZL; Hume, J; Iivanainen, A; Ingham, A; Iso-Touru, T; Jamis, C; Jann, O; Jensen, K; Jhangiani, SN; Jiang, HY; Johnson, AJ; Jones, SJM; Joshi, V; Junier, T; Kapetis, D; Kappes, SM; Kapustin, Y; Keele, JW; Kent, MP; Kerr, T; Khalil, SS; Khatib, H; Kiryutin, B; Kitts, P; Kokocinski, F; Kolbehdari, D; Kovar, CL; Kriventseva, EV; Kumar, CG; Kumar, D; Lahmers, KK; Landrum, M; Larkin, DM; Lau, LPL; Leach, R; Lee, JCM; Lee, S; Lemay, DG; Lewin, HA; Lewis, LR; Li, CX; Lien, S; Liu, GE; Liu, YS; Liu, Y; Logan, KM; Lopez, J; Lozado, RJ; Lutzow, YS; Lynn, DJ; MacNeil, MD; Maglott, D; Malinverni, R; Maqbool, NJ; Marques, E; Marra, MA; Martin, WF; Martins, NF; Maruyama, SR; Matukumalli, LK; Mazza, R; McEwan, JC; McKay, SD; McLean, KL; McWilliam, S; Medrano, JF; Memili, E; Moen, C; Molenaar, AL; Moore, SS; Moore, R; More, DD; Moreno, BT; Morgan, MB; Muntean, CT; Muzny, DM; Nandakumar, HP; Nazareth, LV; Nguyen, NB; Nicholas, FW; Nogueira, MFG; Okwuonu, GO; Olsaker, I; Pant, SD; Panzitta, F; Pastor, RCP; Patel, BM; Payne, GM; Plass, M; Poli, MA; Poslusny, N; Pruitt, K; Pu, LL; Qin, X; Rachagani, S; Raison, JM; Ranganathan, S; Ratnakumar, A; Razpet, A; Reecy, J; Reese, JT; Ren, Y; Reymond, A; Riggs, PK; Rijnkels, M; Rincon, G; Roberts, A; Rodriguez-Osorio, N; Rodriguez-Zas, SL; Romero, NE; Rosenwald, A; Ruiz, SJ; Sabo, A; Salih, H; Sando, L; Santibanez, J; Sapojnikov, V; Schein, JE; Schmutz, SM; Schnabel, RD; Schook, L; Searle, SM; Seo, SW; Shen, YF; Shen, LB; Sherman, L; Skow, LC; Smith, T; Snelling, WM; Sodergren, E; Solovyev, V; Song, H; Song, JZ; Sonstegard, TS; Southey, BR; Souvorov, A; Spurlock, D; Steffen, D; Stone, RT; Stothard, P; Sugimoto, Y; Sweedler, JV; Takasuga, A; Tammen, I; Taniguchi, M; Taylor, JF; Telugu, BPVL; Ucla, C; Urbanski, JM; Utsunomiya, YT; Van, CP; Vattathil, S; Verschoor, CP; Waardenberg, AJ; Walker, A; Wang, ZQ; Ward, R; Warren, JT; Waterman, RC; Weikard, R; Weinstock, GM; Welsh, TH; Wheeler, DA; Wheeler, TT; White, SN; Whitside, MD; Wilczek-Boney, K; Williams, JL; Williams, RL; Wilming, LG; Womack, J; Wright, RA; Wunderlich, KR; Wyss, C; Yang, MQ; Yang, JQ; Zdobnov, EM; Zhang, JK; Zhao, FQ; Zhu, B				Elsik, Christine G.; Tellam, Ross L.; Worley, Kim C.; Gibbs, Richard A.; Abatepaulo, Antonio R. R.; Abbey, Colette A.; Adelson, David L.; Aerts, Jan; Ahola, Virpi; Alexander, Lee; Alioto, Tyler; Almeida, Iassudara G.; Amadio, Ariel F.; Anatriello, Elen; Antonarakis, Stylianos E.; Anzola, Juan M.; Astashyn, Alex; Bahadue, Suria M.; Baldwin, Cynthia L.; Barris, Wes; Baxter, Rebecca; Bell, Stephanie Nicole; Bennett, Anna K.; Bennett, Gary L.; Biase, Fernando H.; Boldt, Clayton R.; Bradley, Daniel G.; Brinkman, Fiona S. L.; Brinkmeyer-Langford, Candice L.; Brown, Wendy C.; Brownstein, Michael J.; Buhay, Christian; Caetano, Alexandre R.; Camara, Francisco; Carroll, Jeffrey A.; Carvalho, Wanessa A.; Casey, Theresa; Cervelatti, Elaine P.; Chack, Joseph; Chacko, Elsa; Chandrabose, Mimi M.; Chapin, Jennifer E.; Chapple, Charles E.; Chen, Hsiu-Chuan; Chen, Lin; Cheng, Ye; Cheng, Ze; Childers, Christopher P.; Chitko-McKown, Carol G.; Chiu, Readman; Choi, Jungwoo; Chrast, Jacqueline; Colley, Adam J.; Connelley, Tomothy; Cree, Andy; Curry, Stacey; Dalrymple, Brian; Diep Dao, Marvin; Davis, Clay; de Oliveira, Carlo J. F.; de Miranda Santos, Isabel K. F.; de Campos, Tatiana A.; Deobald, Heather; Devinoy, Eve; Dickins, C. Michael; Yan, Ding; Dinh, Huyen H.; De Donato, Marcos; Donohue, Kaitlin E.; Donthu, Ravikiran; Dovc, Peter; Dugan-Rocha, Shannon; Durbin, K. James; Eberlein, Annett; Edgar, Robert C.; Egan, Amy; Eggen, Andre; Eichler, Evan E.; Elhaik, Eran; Ellis, Shirley A.; Elnitski, Laura; Ermolaeva, Olga; Eyras, Eduardo; Fitzsimmons, Carolyn J.; Fowler, Gerald R.; Franzin, Alessandra M.; Fritz, Krista; Gabisi, Ramatu Ayiesha; Garcia, Gustavo R.; Garcia, Jose Fernando; Genini, Sem; Gerlach, Daniel; German, J. Bruce; Gilbert, James G. R.; Gill, Clare A.; Gladney, Cody J.; Glass, Elizabeth J.; Goodell, Jason; Grant, Jason R.; Graur, Dan; Greaser, Marion L.; Green, Jonathan A.; Green, Ronnie D.; Guan, Leluo; Guigo, Roderic; Hadsell, Darryl L.; Hagen, Darren E.; Hakimov, Hatam A.; Halgren, Rob; Hamernik, Debora L.; Hamilton, Cerissa; Harhay, Gregory P.; Harrow, Jennifer L.; Hart, Elizabeth A.; Hastings, Nicola; Havlak, Paul; Henrichsen, Charlotte N.; Hernandez, Judith; Hernandez, Marta; Herzig, Carolyn T. A.; Hiendleder, Stefan G.; Hines, Sandra; Hitchens, Matthew Edward; Hlavina, Wratko; Hobbs, Matthew; Holder, Michael; Holt, Robert A.; Hu, Zhi-Liang; Hume, Jennifer; Iivanainen, Antti; Ingham, Aaron; Iso-Touru, Terhi; Jamis, Catherine; Jann, Oliver; Jensen, Kirsty; Jhangiani, Shalini N.; Jiang, Huaiyang; Johnson, Angela Jolivet; Jones, Steven J. M.; Joshi, Vandita; Junier, Thomas; Kapetis, Dimos; Kappes, Steve M.; Kapustin, Yuri; Keele, John W.; Kent, Matthew P.; Kerr, Tovah; Khalil, Sari S.; Khatib, Hasan; Kiryutin, Boris; Kitts, Paul; Kokocinski, Felix; Kolbehdari, Davood; Kovar, Christie L.; Kriventseva, Evgenia V.; Kumar, Charu G.; Kumar, Dinesh; Lahmers, Kevin K.; Landrum, Melissa; Larkin, Denis M.; Lau, Lilian P. L.; Leach, Richard; Lee, Justin C. M.; Lee, Sandra; Lemay, Danielle G.; Lewin, Harris A.; Lewis, Lora R.; Li, Changxi; Lien, Sigbjorn; Liu, George E.; Liu, Yih-shin; Liu, Yue; Logan, Krystin M.; Lopez, John; Lozado, Ryan J.; Lutzow, Ylva Strandberg; Lynn, David J.; MacNeil, Michael D.; Maglott, Donna; Malinverni, Roberto; Maqbool, Nauman J.; Marques, Elisa; Marra, Marco A.; Martin, William F.; Martins, Natalia F.; Maruyama, Sandra R.; Matukumalli, Lakshmi K.; Mazza, Raffaele; McEwan, John C.; McKay, Stephanie D.; McLean, Kim L.; McWilliam, Sean; Medrano, Juan F.; Memili, Erdogan; Moen, Charles; Molenaar, Adrian J.; Moore, Stephen S.; Moore, Richard; More, Daniela D.; Moreno, Barbara T.; Morgan, Margaret B.; Muntean, Carl T.; Muzny, Donna M.; Nandakumar, Hari P.; Nazareth, Lynne V.; Nguyen, Ngoc Bich; Nicholas, Frank W.; Nogueira, Marcelo F. G.; Okwuonu, Geoffrey O.; Olsaker, Ingrid; Pant, Sameer D.; Panzitta, Francesca; Pastor, Rosemeire C. P.; Patel, Bella Mayurkumar; Payne, Gemma M.; Plass, Mireya; Poli, Mario A.; Poslusny, Nathan; Pruitt, Kim; Pu, Ling-Ling; Qin, Xiang; Rachagani, Satyanarayana; Raison, Joy M.; Ranganathan, Shoba; Ratnakumar, Abhirami; Razpet, Andrej; Reecy, James; Reese, Justin T.; Ren, Yanru; Reymond, Alexandre; Riggs, Penny K.; Rijnkels, Monique; Rincon, Gonzalo; Roberts, Andy; Rodriguez-Osorio, Nelida; Rodriguez-Zas, Sandra L.; Romero, Natasha E.; Rosenwald, Anne; Ruiz, San Juana; Sabo, Aniko; Salih, Hanni; Sando, Lillian; Santibanez, Jireh; Sapojnikov, Victor; Schein, Jacqueline E.; Schmutz, Sheila M.; Schnabel, Robert D.; Schook, Lawrence; Searle, Stephen M.; Seo, Seongwon; Shen, Yufeng; Shen, Libing; Sherman, Laura; Skow, Loren C.; Smith, Timothy; Snelling, Warren M.; Sodergren, Erica; Solovyev, Victor; Song, Henry; Song, Jiuzhou; Sonstegard, Tad S.; Southey, Bruce R.; Souvorov, Alexandre; Spurlock, Diane; Steffen, David; Stone, Roger T.; Stothard, Paul; Sugimoto, Yoshikazu; Sweedler, Jonathan V.; Takasuga, Akiko; Tammen, Imke; Taniguchi, Masaaki; Taylor, Jeremy F.; Telugu, Bhanu Prakash V. L.; Ucla, Catherine; Urbanski, Jennifer M.; Utsunomiya, Yuri T.; Van, Curtis P.; Vattathil, Selina; Verschoor, Chris P.; Waardenberg, Ashley J.; Walker, Angela; Wang, Zhiquan; Ward, Robert; Warren, James T.; Waterman, Richard C.; Weikard, Rosemarie; Weinstock, George M.; Welsh, Thomas H., Jr.; Wheeler, David A.; Wheeler, Thomas T.; White, Stephen N.; Whiteside, Matthew D.; Wilczek-Boney, Katarzyna; Williams, John L.; Williams, Rex Lee, Jr.; Wilming, Laurens G.; Womack, James; Wright, Rita A.; Wunderlich, Kris R.; Wyss, Carine; Yang, Mary Q.; Yang, Jianqi; Zdobnov, Evgeny M.; Zhang, Jingkun; Zhao, Feng-Qi; Zhu, Bin		Bovine Genome Sequencing & Analysi	The Genome Sequence of Taurine Cattle: A Window to Ruminant Biology and Evolution	SCIENCE			English	Article							NEONATAL FC-RECEPTOR; GENE-EXPRESSION; BOVINE; ORGANIZATION; INTERFERON; FAMILY; ROLES; MAP	To understand the biology and evolution of ruminants, the cattle genome was sequenced to about sevenfold coverage. The cattle genome contains a minimum of 22,000 genes, with a core set of 14,345 orthologs shared among seven mammalian species of which 1217 are absent or undetected in noneutherian (marsupial or monotreme) genomes. Cattle-specific evolutionary breakpoint regions in chromosomes have a higher density of segmental duplications, enrichment of repetitive elements, and species-specific variations in genes associated with lactation and immune responsiveness. Genes involved in metabolism are generally highly conserved, although five metabolic genes are deleted or extensively diverged from their human orthologs. The cattle genome sequence thus provides a resource for understanding mammalian evolution and accelerating livestock genetic improvement for milk and meat production.	[Elsik, Christine G.] Georgetown Univ, Dept Biol, 406 Reiss,37th & O St NW, Washington, DC 20057 USA; [Tellam, Ross L.] CSIRO Livestock Ind, St Lucia, Qld 4067, Australia; [Worley, Kim C.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; Univ Adelaide, Sch Mol Biomed & Sci, Sch Agr Food & Wine, Adelaide, SA 5005, Australia; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Howard Hughes Med Inst, Seattle, WA 98195 USA; Natl Human Genome Res Inst, Natl Inst Hlth, Rockville, MD 20878 USA; Univ Pompeu Fabra, Ctr Genomic Regulation, Grp Recerca Informatica Biomed, Inst Municipal Invest Med, E-08003 Barcelona, Spain; USDA, Cooperative State Res Educ & Extension Serv, Washington, DC 20250 USA; USDA Agr Res Serv, Natl Program Staff, Beltsville, MD 20705 USA; Univ Illinois Urban Champaign, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois Urban Champaign, Inst Genomic Biol, Urbana, IL 61801 USA; Simon Fraser Univ, Dept Mol Biol Biochem, Burnaby, BC V5A 1S6, Canada; Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; Univ Lausanne, Ctr Integrative Genomics, CH-1015 Lausanne, Switzerland; Baylor Coll Med, Dept Pediat Nutr, USDA Agr Res Serv, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Texas A&M Univ, Dept Vet Integrative Biosci, College Stn, TX 77843 USA; Univ Geneva Med Sch, Dept Genetic Med & Dev, CH-1211 Geneva, Switzerland; Swiss Inst Bioinformatics, CH-1211 Geneva, Switzerland; Imperial Coll, S Kensington Campus, Div Mol Biosci, London SW7 2AZ, England; Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; Natl Inst Hlth, Natl Lib Med, Natl Ctr Biotech Information, Bethesda, MD 20892 USA; Wellcome Trust Sanger Inst Hinxton, Informatics Dept, Cambridge CB10 1HH, England; Univ London, Royal Holloway Egham, Dept Comp Sci, Surrey TW20 0EX, England; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Johns Hopkins Univ Sch Med, McKusick Nathans Inst Genetic Med, Baltimore, MD 21205 USA; 45 Monterey Dr, Tiburon, CA 94920 USA; AgResearch, Anim Genomics, Mosgiel 9053, New Zealand; Univ Adelaide N Terrace, eRes SA, Adelaide, SA 5005, Australia; Univ Geneva Med Sch, Dept Struct Biol Bioinformatics, CH-1211 Geneva, Switzerland; Catalan Inst Res & Adv Studies, E-08010 Barcelona, Spain; Univ Pompeu Fabra, Comp Genomics, E-08003 Barcelona, Spain; Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; USDA Agr Res Serv, Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; Bovine Functional Genomics Lab, USDA Agr Res Serv, BARC E, Beltsville, MD 20705 USA; George Mason Univ, Dept Bioinformatics & Computational Biol, Manassas, VA 20110 USA; Univ Maryland, Dept Bioengineering, College Pk, MD 20742 USA; Trinity Coll Dublin, Smurfit Inst Genetics, Dublin 2, Ireland; Univ Missouri, Dept Vet Pathobiology, Columbia, MO 65211 USA; Daily Sci & Tech Section, AgRes, Ruakura Res Ctr, Hamilton 3240, New Zealand; Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; Nestle Res Ctr, CH-1000 Lausanne, Switzerland; Univ Calif Davis, Dept Food Sci & Tech, Davis, CA 95616 USA; Bioinformatics Mathematics Stat, AgRes, Ruakura Res Ctr, Hamilton 3240, New Zealand; Chungnam Natl Univ, Div Anim Sci & Resource, Daejeon 305764, South Korea; Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; Univ Edinburgh, Roslin Inst & Royal Dick Sch Vet Studies, Midlothian EH25 9PS, Scotland; Washington State Univ, Dept Vet Microbiol & Pathology, Pullman, WA 99164 USA; Univ Edinburgh, Roslin Inst & Royal Dick Sch Vet Sci, Div Infect & Immunity, Midlothian EH25 9RG, Scotland; Inst Anim Hlth, Immunol Div, Compton RG20 7NN, England; Univ Helsinki, Dept Basic Vet Sci, FIN-00014 Helsinki, Finland; Wellcome Trust Sanger Inst, Genome Dynamics & Evolution, Cambridge CB10 1SA, England; Embrapa Recursos Geneticos Biotech, BR-70770900 Brasilia, DF, Brazil; UNESP Sao Paulo State Univ, Anim Prod & Hlth Dept, BR-16050680 Aracatuba, SP, Brazil; Texas AgriLife Res, College Stn, TX 77843 USA; Univ Adelaide, Sch Agr Food & Wine & Res Ctr Reprod Hlth, JS Davies Epigenetics & Genetics Grp, Roseworthy, SA 5371, Australia; Mississippi State Univ, Mississippi Agr & Forestry Expt Stn, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; Polo Univ, Parco Tecnol Padano, Via Einstein, I-26900 Lodi, Italy; USDA Agr Res Serv, Fort Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA; NIH, Natl Inst Mental Hlth, Lab Genetics, Bethesda, MD 20892 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; Natl Inst Agrobiol Sci, Div of Anim Sci, Tsukuba, Ibaraki 3058602, Japan; Baylor Coll Med, Bioinfo Res Ctr, Houston, TX 77030 USA; Univ California Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; Columbia Univ, Dept Comp Sci & Ctr Comp Biol & Bioinfo, New York, NY 10032 USA; INRA, Anim Genetics & Integrative Biol, Bovine Genetics & Genomics, F-78350 Jouy En Josas, France; Pfizer Anim Hlth, Pfizer Anim Genetics, New York, NY 10017 USA; Univ Sydney, Fac Vet Sci, Camden, NSW 2570, Australia; Norwegian Univ Life Sci, Ctr Integrative Genetics, Dept Anim & Aquacultural Sci, N-1432 As, Norway; Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; Shirakawa Inst Anim Genetics, Nishigo, Fukushima 9618061, Japan; Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil; MTT Agrifood Res Finland, Biotech & Food Res, FIN-31600 Jokioinen, Finland; INTA, EEA Rafaela, RA-3080 Rafaela, Argentina; USDA Agr Res Serv, Livestock Issues Res Unit, Lubbock, TX 79403 USA; Macquarie Univ, Dept Chem & Biomol Sci, ARC Ctr Excellence Bioinfo, Sydney, NSW 2109, Australia; Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; Univ Oriente, Inst Invest Biomed & Ciencias Aplicadas, Cumana 6101, Sucre, Venezuela; Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 5A8, Canada; INRA UR1196, Genomique Phys Lactation, F-78352 Jouy En Josas, France; Univ Ljubljana, Dept Anim Sci, SI-1230 Domzale, Slovenia; Res Inst Biol Farm Anim FBN, Res Unit Mol Biol, D-18196 Dummerstorf, Germany; Univ Wisconsin Madison, Dept Anim Sci, Madison, WI 53706 USA; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; EMBL Heidelberg, Cell Biol & Biophys, Heidelberg, Germany; ITACyL, Lab Mol Biol, E-47071 Valladolid, Spain; Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; Monsanto Co, Ankeny, IA 50021 USA; Natl Bur Anim Genetic Res, Genes & Genetic Res Mol Anal Lab, Karnal 132001, Haryana, India; Agr & Agri-Food Canada, Lacombe Res Ctr, Lacombe, AB T4L 1W1, Canada; Univ Guelph, Biomed Sci, Guelph, ON N1G 2W6, Canada; Univ Cattolica Sacro Cuore, Zootechnics Inst, I-29100 Piacenza, Italy; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; UNESP Sao Paulo State Univ, Dept Ciencias Biol, Fac Ciencias Letras, BR-19806900 Assis, SP, Brazil; Norwegian Sch Vet Sci, Dept Basic Sci & Aquatic Med, N-0033 Oslo, Norway; INTA, Inst Genetica Ewald Favret, RA-B1712WAA Buenos Aires, Argentina; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; Univ Antioquia, Grp CENTAURO, Medellin, Colombia; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, QLD 4111, Australia; Utah State Univ, Nutr & Food Sci, Logan, UT 84322 USA; USDA Agr Res Serv, Anim Dis Res Unit, Pullman, WA 99164 USA; Univ Iowa, Dept Pharm 2 344 BSB, Iowa City, IA 52242 USA; Univ Vermont, Dept Anim Sci 211 Terrill, Burlington, VT 05405 USA	Georgetown University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Baylor College of Medicine; Washington University (WUSTL); Texas A&M University System; Texas A&M University College Station; University of Adelaide; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Simon Fraser University; University of Sydney; University of Lausanne; Baylor College of Medicine; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; University of Geneva; Swiss Institute of Bioinformatics; Imperial College London; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Wellcome Trust Sanger Institute; University of London; Royal Holloway University London; University of Houston System; University of Houston; Johns Hopkins University; AgResearch - New Zealand; University of Adelaide; University of Geneva; ICREA; Pompeu Fabra University; Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); George Mason University; University System of Maryland; University of Maryland College Park; Trinity College Dublin; University of Missouri System; University of Missouri Columbia; AgResearch - New Zealand; Michigan State University; Nestle SA; University of California System; University of California Davis; AgResearch - New Zealand; Chungnam National University; University of Alberta; University of Massachusetts System; University of Massachusetts Amherst; University of Edinburgh; Washington State University; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Helsinki; Wellcome Trust Sanger Institute; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Adelaide; Mississippi State University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); British Columbia Cancer Agency; National Institute of Agrobiological Sciences - Japan; Baylor College of Medicine; University of California System; University of California Santa Cruz; University of Houston System; University of Houston; Columbia University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Pfizer; University of Sydney; Norwegian University of Life Sciences; University of Missouri System; University of Missouri Columbia; Uppsala University; Universidade de Sao Paulo; Natural Resources Institute Finland (Luke); Instituto Nacional de Tecnologia Agropecuaria (INTA); United States Department of Agriculture (USDA); Macquarie University; University of Guelph; University of Saskatchewan; INRAE; University of Ljubljana; Forschungsinstitut fur Nutztierbiologie (FBN); University of Wisconsin System; University of Wisconsin Madison; University of Guelph; European Molecular Biology Laboratory (EMBL); University of Wisconsin System; University of Wisconsin Madison; Monsanto; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Agriculture & Agri Food Canada; University of Guelph; Catholic University of the Sacred Heart; University of California System; University of California Davis; Universidade Estadual Paulista; Norwegian University of Life Sciences; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Singapore; Universidad de Antioquia; University of Illinois System; University of Illinois Urbana-Champaign; Griffith University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); University of Iowa; University of Vermont	Elsik, CG (corresponding author), Georgetown Univ, Dept Biol, 406 Reiss,37th & O St NW, Washington, DC 20057 USA.	ce75@georgetown.edu; ross.tellam@csiro.au; kworley@bcm.edu	KUMAR, DINESH/GRJ-5448-2022; Garcia, Gustavo/E-5182-2013; de Miranda Santos, Isabel K. F./D-5261-2016; Adelson, David L/E-5506-2011; Nicholas, Frank/AGY-8318-2022; McEwan, John/A-1143-2008; Elsik, Christine G/C-4120-2017; Hernandez, Marta/I-3276-2016; Junier, Thomas/A-6748-2011; Song, Jiuzhou/AAD-6440-2020; Rodriguez-Osorio, Nelida/AAT-1650-2020; Maruyama, Sandra R/G-1171-2012; Malinverni, Roberto/ABF-9644-2021; Driemeier, David/H-3461-2012; Weinstock, George M/C-6314-2013; Lahmers, Kevin/E-8272-2017; Hor, Charlotte/H-5908-2015; Kutalik, Zoltan/HHZ-5697-2022; Khaleel, Sari/ABH-2168-2021; Van Tassell, Curtis P./O-4247-2019; Keele, John W/A-5846-2009; de Miranda Santos, Isabel KF/B-7597-2012; Hor, Charlotte/AAB-4850-2020; martins, natalia florencio/AAE-7875-2019; Caetano, Alexandre Rodrigues/B-5227-2017; Sweedler, Jonathan V/A-9405-2009; Moore, Stephen S/F-5285-2013; Greaser, Marion L/C-6147-2012; Zhu, Bin/E-4911-2010; Ferreira, Francisco Câmara/G-9841-2015; plass, mireya/AAB-7483-2019; Utsunomiya, Yuri Tani T/K-5214-2013; Aerts, Jan/AAQ-6949-2020; Casey, Theresa Marie/F-1171-2015; Tammen, Imke/AFF-7998-2022; Hadsell, Darryl/GPF-9037-2022; Plass, Mireya/B-4240-2010; LEWIN, HARRIS/HGC-6543-2022; Khatib, Hasan/AAA-2693-2021; Liu, George/K-3371-2019; Marra, Marco A/B-5987-2008; Eyras, Eduardo/A-1560-2010; Harhay, Gregory/AAC-5411-2022; Tellam, Ross/T-2423-2019; Glass, Elizabeth J/L-4612-2016; Nogueira, Marcelo Fábio Gouveia/D-9801-2012; Tellam, Ross/H-2798-2013; Kumar, Charu/A-1582-2013; Wheeler, David A/M-9740-2018; Larkin, Denis/AAB-2249-2022; Anatriello, Elen/N-1429-2015; Ward, Robert E/E-1250-2011; Alioto, Tyler/AAF-6342-2020; BIASE, FERNANDO/A-3994-2010; Elnitski, Laura/AAD-3595-2021; Nicholas, Frank William/AAE-5566-2022; Franzin, Alessandra/D-4545-2013; Eyras, Eduardo/ABG-7144-2020; TANIGUCHI, Masaaki/I-2564-2019; Memili, Erdogan/AAY-8726-2020; Larkin, Denis/AAB-1633-2022; Riggs, Penny/AAE-8398-2020; Elhaik, Eran/H-6838-2019; Bradley, Daniel G/A-3240-2012; Malinverni, Roberto/K-2559-2017; Schein, Jacquie E/G-3674-2015; Zdobnov, Evgeny M/K-1133-2012; Solovyev, Victor/C-4614-2013; Riggs, Penny K/A-8192-2008; Seo, Seongwon/E-9687-2013; Holt, Robert A/C-3303-2009; Guigo, Roderic/D-1303-2010; Eduardo, Eyras/L-1053-2014; MacNeil, Michael D/A-6772-2009; Alioto, Tyler/K-7267-2015; Dalrymple, Brian P/F-8721-2010; Brinkman, Fiona/N-3195-2013; Antonarakis, Stylianos E/N-8866-2014; Pant, Sameer Dinkar/D-1448-2017; De Donato, Marcos/I-5307-2012; Zdobnov, Evgeny/AAB-2745-2022; Waardenberg, Ashley/D-2595-2012; Biase, Fernando/AAB-5132-2020; Gill, Clare/R-3677-2019; Jones, Steven J/C-3621-2009; Nguyen, Ngoc/HHZ-0886-2022; Ingham, Aaron/C-1166-2008; Bennett, Gary L/C-1124-2012; Gasull, Martina/J-4076-2019; McWilliam, Sean M/H-8978-2013	KUMAR, DINESH/0000-0002-9641-6662; Adelson, David L/0000-0003-2404-5636; Nicholas, Frank/0000-0002-9178-3965; McEwan, John/0000-0003-4801-6207; Elsik, Christine G/0000-0002-4248-7713; Hernandez, Marta/0000-0001-6914-9987; Rodriguez-Osorio, Nelida/0000-0002-2235-979X; Malinverni, Roberto/0000-0002-0113-3417; Driemeier, David/0000-0003-3766-0654; Weinstock, George M/0000-0002-2997-4592; Hor, Charlotte/0000-0002-5361-2372; Kutalik, Zoltan/0000-0001-8285-7523; Khaleel, Sari/0000-0002-0886-0860; Van Tassell, Curtis P./0000-0002-8416-2087; Hor, Charlotte/0000-0002-5361-2372; Caetano, Alexandre Rodrigues/0000-0002-3419-7337; Sweedler, Jonathan V/0000-0003-3107-9922; Greaser, Marion L/0000-0002-6583-9566; Ferreira, Francisco Câmara/0000-0002-1971-5466; plass, mireya/0000-0002-9891-2723; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Aerts, Jan/0000-0002-6416-2717; Casey, Theresa Marie/0000-0002-8835-3550; Tammen, Imke/0000-0002-5520-6597; Plass, Mireya/0000-0002-9891-2723; LEWIN, HARRIS/0000-0002-1043-7287; Liu, George/0000-0003-0192-6705; Marra, Marco A/0000-0001-7146-7175; Harhay, Gregory/0000-0002-0129-6822; Glass, Elizabeth J/0000-0002-6183-0185; Nogueira, Marcelo Fábio Gouveia/0000-0002-2239-9652; Tellam, Ross/0000-0003-2353-1640; Wheeler, David A/0000-0002-9056-6299; Ward, Robert E/0000-0002-6981-4040; Alioto, Tyler/0000-0002-2960-5420; Nicholas, Frank William/0000-0002-9178-3965; Eyras, Eduardo/0000-0003-0793-6218; TANIGUCHI, Masaaki/0000-0001-8194-3577; Memili, Erdogan/0000-0002-8335-5645; Larkin, Denis/0000-0001-7859-6201; Riggs, Penny/0000-0003-3296-320X; Elhaik, Eran/0000-0003-4795-1084; Malinverni, Roberto/0000-0002-0113-3417; Solovyev, Victor/0000-0001-8885-493X; Riggs, Penny K/0000-0003-3296-320X; Holt, Robert A/0000-0002-7259-1247; Guigo, Roderic/0000-0002-5738-4477; Eduardo, Eyras/0000-0003-0793-6218; Alioto, Tyler/0000-0002-2960-5420; Dalrymple, Brian P/0000-0003-3891-5233; Brinkman, Fiona/0000-0002-0584-4099; Antonarakis, Stylianos E/0000-0001-8907-5823; Pant, Sameer Dinkar/0000-0002-0672-4478; De Donato, Marcos/0000-0001-8860-6020; Zdobnov, Evgeny/0000-0002-5178-1498; Gill, Clare/0000-0003-2640-1825; Jones, Steven J/0000-0003-3394-2208; Ingham, Aaron/0000-0001-8006-9443; Bennett, Gary L/0000-0001-7649-018X; McWilliam, Sean M/0000-0002-3148-0428; Williams, John/0000-0001-5188-7957; Harrow, Jennifer/0000-0003-0338-3070; Molenaar, Adrian J./0000-0001-7347-0714; McKay, Stephanie/0000-0003-1434-3111; Moore, Stephen/0000-0002-9758-166X; White, Stephen N./0000-0001-9255-6054; Worley, Kim/0000-0002-0282-1000; Kokocinski, Felix/0000-0002-8472-9207; Southey, Bruce/0000-0002-8959-7709; Elnitski, Laura/0000-0003-1065-019X; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Schnabel, Robert/0000-0001-5018-7641; Seo, Seongwon/0000-0002-4131-0545; Kinney Ferreira de Miranda Santos, Isabel/0000-0002-0438-4430; Anzola, Juan/0000-0003-2677-6731; Hobbs, Matthew/0000-0002-6879-1369; Lynn, David/0000-0003-4664-1404; Childers, Chris/0000-0002-1253-5550; Jensen, Kirsty/0000-0002-0005-6931; Rincon, Gonzalo/0000-0002-6149-9103; Roberts, Andrew/0000-0001-8720-322X; Waardenberg, Ashley/0000-0002-9382-7490; carvalho, wanessa/0000-0002-1346-5240; Gilbert, James/0000-0001-8079-3159; Carroll, Jeffery/0000-0002-0202-4888; /0000-0001-6807-1452; Ranganathan, Shoba/0000-0002-8290-813X; Wilming, Laurens/0000-0002-4154-7358; Childers, Anna/0000-0002-0747-8539; Skow, Loren/0000-0001-8998-359X; Ternus, Krista/0000-0003-1138-5308; Bradley, Daniel G/0000-0001-7335-7092; Maqbool, Nauman/0000-0002-9404-3647; Reymond, Alexandre/0000-0003-1030-8327; Amadio, Ariel Fernando/0000-0002-1147-4485; Hagen, Darren/0000-0001-8295-020X; Pruitt, Kim/0000-0001-7950-1374; Reecy, James/0000-0003-4602-0990; Lahmers, Kevin/0000-0002-5290-3426; Gerlach, Daniel/0000-0001-9338-3765; martins, natalia florencio/0000-0002-8816-4258; Green, Jonathan/0000-0003-4968-8187; Lemay, Danielle/0000-0003-3318-0485; Schook, Lawrence/0000-0002-6580-8364; Iso-Touru, Terhi/0000-0001-8258-9047	National Human Genome Research Institute [U54 HG003273]; U.S. Department of Agriculture's Agricultural Research Service [59-0790-3-196]; Cooperative State Research, Education, and Extension Service National Research Initiative [2004-35216-14163]; the state of Texas; Genome British Columbia; Alberta Science and Research Authority; Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO); Agritech Investments Ltd; Dairy Insight, Inc; AgResearch Ltd.; Research Council of Norway; Kleberg Foundation; National, Texas, and South Dakota Beef Check-off Funds; BBSRC [BB/D524040/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/13438, BB/D524040/2, BBS/B/13446] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, ZIAHG200323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); U.S. Department of Agriculture's Agricultural Research Service; Cooperative State Research, Education, and Extension Service National Research Initiative; the state of Texas; Genome British Columbia; Alberta Science and Research Authority; Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Agritech Investments Ltd; Dairy Insight, Inc; AgResearch Ltd.; Research Council of Norway(Research Council of Norway); Kleberg Foundation; National, Texas, and South Dakota Beef Check-off Funds; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ICREA(ICREA)	Funded by the National Human Genome Research Institute (NHGRI U54 HG003273); the U.S. Department of Agriculture's Agricultural Research Service (USDA-ARS agreement no. 59-0790-3-196) and Cooperative State Research, Education, and Extension Service National Research Initiative (grant no. 2004-35216-14163); the state of Texas; Genome Canada through Genome British Columbia; the Alberta Science and Research Authority; the Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO); Agritech Investments Ltd., Dairy Insight, Inc., and AgResearch Ltd., all of New Zealand; the Research Council of Norway; the Kleberg Foundation; and the National, Texas, and South Dakota Beef Check-off Funds. The master accession for this WGS sequencing project is AAFC03000000. The individual WGS sequences are AAFC03000001 to AAFC03131728, and the scaffold records are CM000177 to CM000206 (chromosomes) and DS490632 to DS495890 (unplaced scaffolds).	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Clawson ML, 2004, MAMM GENOME, V15, P227, DOI 10.1007/s00335-003-2320-x; Everts-van der Wind A, 2005, P NATL ACAD SCI USA, V102, P18526, DOI 10.1073/pnas.0509285102; Hashizume K, 2007, REPROD FERT DEVELOP, V19, P79, DOI 10.1071/RD06118; IRWIN DM, 1995, J MOL EVOL, V41, P299, DOI 10.1007/BF01215177; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kordis D, 1999, GENE, V238, P171, DOI 10.1016/S0378-1119(99)00260-7; Larson JH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-227; Larson JH, 2006, PHYSIOL GENOMICS, V25, P405, DOI 10.1152/physiolgenomics.00307.2005; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Malik HS, 1998, MOL BIOL EVOL, V15, P1123, DOI 10.1093/oxfordjournals.molbev.a026020; Mayer B, 2005, J DAIRY RES, V72, P107, DOI 10.1017/S0022029905001135; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; NEWBY TJ, 1982, VET IMMUNOL IMMUNOP, V3, P67, DOI 10.1016/0165-2427(82)90032-0; Nilsen H, 2008, ANIM GENET, V39, P97, DOI 10.1111/j.1365-2052.2007.01686.x; Prasad A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-310; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; Roberts RM, 2008, SEMIN CELL DEV BIOL, V19, P170, DOI 10.1016/j.semcdb.2007.10.007; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SCHMIDHAUSER C, 1992, MOL BIOL CELL, V3, P699, DOI 10.1091/mbc.3.6.699; Scocchi M, 1997, FEBS LETT, V417, P311, DOI 10.1016/S0014-5793(97)01310-0; Shimamura M, 1999, MOL BIOL EVOL, V16, P1046, DOI 10.1093/oxfordjournals.molbev.a026194; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; WILLHAM RL, 1986, J ANIM SCI, V62, P1742, DOI 10.2527/jas1986.6261742x; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	28	854	1042	6	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					522	528		10.1126/science.1169588	http://dx.doi.org/10.1126/science.1169588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390049	Green Accepted			2022-12-28	WOS:000265411200050
J	Lipscombe, L				Lipscombe, Lorraine			Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR EVENTS; ROSIGLITAZONE; MELLITUS		Univ Toronto, Toronto, ON, Canada	University of Toronto	Lipscombe, L (corresponding author), Univ Toronto, Toronto, ON, Canada.							Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-8	10.7326/0003-4819-150-8-200904210-02008	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391221				2022-12-28	WOS:000265457000023
J	Lee, JD				Lee, John D.			Can Technology Get Your Eyes Back on the Road?	SCIENCE			English	Editorial Material							DRIVER DISTRACTION		Univ Iowa, Dept Mech & Ind Engn, Iowa City, IA 52242 USA	University of Iowa	Lee, JD (corresponding author), Univ Iowa, Dept Mech & Ind Engn, Iowa City, IA 52242 USA.	jdlee@engineering.uiowa.edu	Lee, John/E-9987-2010	Lee, John/0000-0001-9808-2160				Dingus T.A., 2006, 810593 DOT HS VIRG T; Donmez B, 2008, ACCIDENT ANAL PREV, V40, P776, DOI 10.1016/j.aap.2007.09.023; Evans L., 2004, TRAFFIC SAFETY; Horrey WJ, 2008, ACCIDENT ANAL PREV, V40, P675, DOI 10.1016/j.aap.2007.09.004; Klauer S.G, 2006, IMPACT DRIVER INATTE; Lee JD, 2002, HUM FACTORS, V44, P314, DOI 10.1518/0018720024497844; McCarley JS, 2004, HUM FACTORS, V46, P424, DOI 10.1518/hfes.46.3.424.50394; McGehee DV, 2007, J SAFETY RES, V38, P215, DOI 10.1016/j.jsr.2007.02.009; Rajalin S, 1997, ACCIDENT ANAL PREV, V29, P277, DOI 10.1016/S0001-4575(96)00081-4; Recarte MA, 2003, J EXP PSYCHOL-APPL, V9, P119, DOI 10.1037/1076-898X.9.2.119; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Toledo T, 2006, TRANSPORT RES REC, P112, DOI 10.3141/1953-13; Victor TW, 2005, TRANSPORT RES F-TRAF, V8, P167, DOI 10.1016/j.trf.2005.04.014; Waylen AE, 2004, TRANSPORT RES F-TRAF, V7, P323, DOI 10.1016/j.trf.2004.09.009; White MP, 2004, RISK ANAL, V24, P323, DOI 10.1111/j.0272-4332.2004.00434.x	15	25	25	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					344	346		10.1126/science.1168085	http://dx.doi.org/10.1126/science.1168085			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	433QT	19372419				2022-12-28	WOS:000265221600028
J	Disertori, M; Latini, R; Barlera, S; Franzosi, MG; Staszewsky, L; Maggioni, AP; Lucci, D; Di Pasquale, G; Tognoni, G				Disertori, Marcello; Latini, Roberto; Barlera, Simona; Franzosi, Maria Grazia; Staszewsky, Lidia; Maggioni, Aldo Pietro; Lucci, Donata; Di Pasquale, Giuseppe; Tognoni, Gianni		GISSI AF Investigators	Valsartan for Prevention of Recurrent Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; II RECEPTOR BLOCKADE; ANGIOTENSIN-II; SINUS RHYTHM; PROGNOSTIC-SIGNIFICANCE; SOLVD TRIALS; STROKE; METAANALYSIS	BACKGROUND Atrial fibrillation is the most common cardiac arrhythmia, and no current therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II-receptor blockers (ARBs) can influence atrial remodeling, and some clinical studies suggest that they may prevent atrial fibrillation. METHODS We conducted a large, randomized, prospective, placebo-controlled, multicenter trial to test whether the ARB valsartan could reduce the recurrence of atrial fibrillation. We enrolled patients who were in sinus rhythm but had had either two or more documented episodes of atrial fibrillation in the previous 6 months or successful cardioversion for atrial fibrillation in the previous 2 weeks. To be eligible, patients also had to have underlying cardiovascular disease, diabetes, or left atrial enlargement. Patients were randomly assigned to receive valsartan or placebo. The two primary end points were the time to a first recurrence of atrial fibrillation and the proportion of patients who had more than one recurrence of atrial fibrillation over the course of 1 year. RESULTS A total of 1442 patients were enrolled in the study. Atrial fibrillation recurred in 371 of the 722 patients (51.4%) in the valsartan group, as compared with 375 of 720 (52.1%) in the placebo group (adjusted hazard ratio, 0.97; 96% confidence interval [CI], 0.83 to 1.14; P = 0.73). More than one episode of atrial fibrillation occurred in 194 of 722 patients (26.9%) in the valsartan group and in 201 of 720 (27.9%) in the placebo group (adjusted odds ratio, 0.89; 99% CI, 0.64 to 1.23; P = 0.34). The results were similar in all predefined subgroups of patients, including those who were not receiving angiotensin-converting-enzyme inhibitors. CONCLUSIONS Treatment with valsartan was not associated with a reduction in the incidence of recurrent atrial fibrillation. (ClinicalTrials.gov number, NCT00376272.)	[Maggioni, Aldo Pietro] ANMCO Res Ctr, GISSI AF Coordinating Ctr, I-50121 Florence, Italy; [Disertori, Marcello] Santa Chiara Hosp, Dept Cardiol, Trento, Italy; [Latini, Roberto; Barlera, Simona; Franzosi, Maria Grazia; Staszewsky, Lidia] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Di Pasquale, Giuseppe] Maggiore Hosp, Cardiol Unit, Bologna, Italy; [Tognoni, Gianni] Consorzio Mario Negri Sud, Chieti, Italy	Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Santa Chiara Hospital; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; AUSL di Bologna; Consorzio Mario Negri Sud	Maggioni, AP (corresponding author), ANMCO Res Ctr, GISSI AF Coordinating Ctr, Via Marmora 34, I-50121 Florence, Italy.	gissiaf@anmco.it	sinagra, gianfranco gs/P-7643-2014; Latini, Roberto/AAB-1410-2020; Sciarra, Luigi/Y-8105-2018; Nicolis, Enrico Bjørn/ABG-8467-2020; Muscella, Antonella/B-2630-2013; Bertaglia, Emanuele/Y-8138-2019; Donatelli, Francesco/G-9311-2012; Maggioni, Aldo Pietro/AAL-5334-2020; Baviera, Marta/AAB-4299-2020; Gualco, Alessandra/AAI-2077-2020; Modena, Maria Grazia/N-2442-2015	Latini, Roberto/0000-0002-3729-4650; Sciarra, Luigi/0000-0002-9669-1330; Nicolis, Enrico Bjørn/0000-0001-9246-2533; Bertaglia, Emanuele/0000-0002-3878-2904; Donatelli, Francesco/0000-0003-2839-0373; Maggioni, Aldo Pietro/0000-0003-2764-6779; Baviera, Marta/0000-0002-0264-151X; Gualco, Alessandra/0000-0002-6075-9209; Volpe, Massimo/0000-0002-9642-8380; Modena, Maria Grazia/0000-0002-4704-4663; Gulizia, Michele Massimo/0000-0003-1513-7125; , Antonio/0000-0002-8739-5572; Staszewsky, Lidia/0000-0002-3702-1038; Zoppo, Franco/0000-0001-5480-6550; Aleksova, Aneta/0000-0001-7711-9905	Associazione Nazionale Medici Cardiologi Ospedalieri; Istituto di Ricerche Farmacologiche Mario Negri	Associazione Nazionale Medici Cardiologi Ospedalieri; Istituto di Ricerche Farmacologiche Mario Negri	The GISSI Studies are supported by Associazione Nazionale Medici Cardiologi Ospedalieri and by Istituto di Ricerche Farmacologiche Mario Negri.	Anand K, 2006, AM HEART J, V152, P217, DOI 10.1016/j.ahj.2006.01.007; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Chen YJ, 2006, BRIT J PHARMACOL, V147, P12, DOI 10.1038/sj.bjp.0706445; Daoud EG, 1999, CIRCULATION, V99, P3024, DOI 10.1161/01.CIR.99.23.3024; Disertori M, 2006, J CARDIOVASC MED, V7, P29, DOI 10.2459/01.JCM.0000199778.85343.08; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Ducharme A, 2006, AM HEART J, V152, P86, DOI 10.1016/j.ahj.2005.06.036; Fogari R, 2006, J CARDIOVASC PHARM, V47, P46, DOI 10.1097/01.fjc.0000193808.99773.28; Fuster V, 2007, EUR HEART J, V28, P2046, DOI 10.1093/eurheartj/ehm315; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Lafuente-Lafuente C, 2006, ARCH INTERN MED, V166, P719, DOI 10.1001/archinte.166.7.719; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Madrid AH, 2002, CIRCULATION, V106, P331, DOI 10.1161/01.CIR.0000022665.18619.83; Maggioni AP, 2005, AM HEART J, V149, P548, DOI 10.1016/j.ahj.2004.09.033; Mathew J, 2000, CHEST, V118, P914, DOI 10.1378/chest.118.4.914; Nattel S, 2000, CIRC RES, V87, P440; Pedersen OD, 1999, CIRCULATION, V100, P376, DOI 10.1161/01.CIR.100.4.376; Pizzetti F, 2001, HEART, V86, P527, DOI 10.1136/heart.86.5.527; Pozzoli M, 1998, J AM COLL CARDIOL, V32, P197, DOI 10.1016/S0735-1097(98)00221-6; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Schmieder RE, 2008, J HYPERTENS, V26, P403, DOI 10.1097/HJH.0b013e3282f35c67; Shi YF, 2002, CARDIOVASC RES, V54, P456, DOI 10.1016/S0008-6363(02)00243-2; Tieleman RG, 1998, J AM COLL CARDIOL, V31, P167, DOI 10.1016/S0735-1097(97)00455-5; Tveit A, 2007, INT J CARDIOL, V120, P85, DOI 10.1016/j.ijcard.2006.08.086; Vermes E, 2003, CIRCULATION, V107, P2926, DOI 10.1161/01.CIR.0000072793.81076.D4; Wachtell K, 2005, J AM COLL CARDIOL, V45, P712, DOI 10.1016/j.jacc.2004.10.068; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yin YH, 2006, EUR HEART J, V27, P1841, DOI 10.1093/eurheartj/ehl135	35	335	350	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1606	1617		10.1056/nejmoa0805710	http://dx.doi.org/10.1056/nejmoa0805710			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369667				2022-12-28	WOS:000265178000005
J	Knops, A; Thirion, B; Hubbard, EM; Michel, V; Dehaene, S				Knops, Andre; Thirion, Bertrand; Hubbard, Edward M.; Michel, Vincent; Dehaene, Stanislas			Recruitment of an Area Involved in Eye Movements During Mental Arithmetic	SCIENCE			English	Article							HUMAN BRAIN ACTIVITY; PARIETAL CORTEX; NUMBER LINE; SPACE; REPRESENTATION; PERCEPTION; ATTENTION; PATTERNS; IMAGES	Throughout the history of mathematics, concepts of number and space have been tightly intertwined. We tested the hypothesis that cortical circuits for spatial attention contribute to mental arithmetic in humans. We trained a multivariate classifier algorithm to infer the direction of an eye movement, left or right, from the brain activation measured in the posterior parietal cortex. Without further training, the classifier then generalized to an arithmetic task. Its left versus right classification could be used to sort out subtraction versus addition trials, whether performed with symbols or with sets of dots. These findings are consistent with the suggestion that mental arithmetic co-opts parietal circuitry associated with spatial coding.	[Knops, Andre; Hubbard, Edward M.; Dehaene, Stanislas] INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Knops, Andre; Thirion, Bertrand; Hubbard, Edward M.; Michel, Vincent; Dehaene, Stanislas] CEA, I2BM, F-91191 Gif Sur Yvette, France; [Knops, Andre; Hubbard, Edward M.; Michel, Vincent; Dehaene, Stanislas] Univ Paris 11, F-91405 Orsay, France; [Thirion, Bertrand; Michel, Vincent] Inst Natl Rech Informat & Automat Saclay Ile Fran, Orsay, France; [Dehaene, Stanislas] Coll France, F-75231 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	Knops, A (corresponding author), INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France.	knops.andre@gmail.com	Hubbard, Edward/N-2931-2019; Knops, André/D-5457-2013; Jovicich, Jorge/D-2293-2010; Hubbard, Edward/C-1770-2012	Hubbard, Edward/0000-0002-2701-415X; Knops, André/0000-0001-6357-9951; 	INSERM; CEA; McDonnell Foundation centennial fellowship; Volkswagen Foundation	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); McDonnell Foundation centennial fellowship; Volkswagen Foundation(Volkswagen)	The fMRI experiment was part of a general research program on functional neuroimaging of the human brain that was sponsored by the Atomic Energy Commission (D. Le Bihan). We thank L. Hertz-Pannier, A. Jobert, and the NeuroSpin staff for their help. Supported by INSERM, CEA, a McDonnell Foundation centennial fellowship (S.D.), and a Volkswagen Foundation grant (S.D. and A.K.).	Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Changizi MA, 2006, AM NAT, V167, pE117, DOI 10.1086/502806; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S., 2011, NUMBER SENSE MIND CR; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eger E, 2008, J COGNITIVE NEUROSCI, V20, P356, DOI 10.1162/jocn.2008.20019; Fischer MH, 2004, EXP PSYCHOL, V51, P91, DOI 10.1027/1618-3169.51.2.91; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Gallistel C. R., 1990, ORG LEARNING; Gobel SM, 2006, CORTEX, V42, P774, DOI 10.1016/S0010-9452(08)70416-7; Goldstone RL, 1998, COGNITION, V65, P231, DOI 10.1016/S0010-0277(97)00047-4; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Lakoff G., 2000, MATH COMES EMBODIED; McCrink K, 2004, PSYCHOL SCI, V15, P776, DOI 10.1111/j.0956-7976.2004.00755.x; McCrink K, 2007, PERCEPT PSYCHOPHYS, V69, P1324, DOI 10.3758/BF03192949; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	31	267	269	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1583	1585		10.1126/science.1171599	http://dx.doi.org/10.1126/science.1171599			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19423779	Green Submitted			2022-12-28	WOS:000267130600050
J	Compagno, M; Lim, WK; Grunn, A; Nandula, SV; Brahmachary, M; Shen, Q; Bertoni, F; Ponzoni, M; Scandurra, M; Califano, A; Bhagat, G; Chadburn, A; Dalla-Favera, R; Pasqualucci, L				Compagno, Mara; Lim, Wei Keat; Grunn, Adina; Nandula, Subhadra V.; Brahmachary, Manisha; Shen, Qiong; Bertoni, Francesco; Ponzoni, Maurilio; Scandurra, Marta; Califano, Andrea; Bhagat, Govind; Chadburn, Amy; Dalla-Favera, Riccardo; Pasqualucci, Laura			Mutations of multiple genes cause deregulation of NF-kappa B in diffuse large B-cell lymphoma	NATURE			English	Article							HODGKIN LYMPHOMA; EXPRESSION; RECEPTOR; CD40; TRANSDUCTION; RESPONSES; FAMILY; CANCER; BCL6; A20	Diffuse large B-cell lymphoma (DLBCL), the most common form of lymphoma in adulthood, comprises multiple biologically and clinically distinct subtypes including germinal centre B-cell-like (GCB) and activated B-cell-like (ABC) DLBCL1. Gene expression profile studies have shown that its most aggressive subtype, ABC-DLBCL, is associated with constitutive activation of the NF-kappa B transcription complex(2). However, except for a small fraction of cases(3), it remains unclear whether NF-kappa B activation in these tumours represents an intrinsic program of the tumour cell of origin or a pathogenetic event. Here we show that >50% of ABC-DLBCL and a smaller fraction of GCB- DLBCL carry somatic mutations in multiple genes, including negative (TNFAIP3, also called A20) and positive (CARD11, TRAF2, TRAF5, MAP3K7 (TAK1) and TNFRSF11A ( RANK)) regulators of NF-kappa B. Of these, the A20 gene, which encodes a ubiquitin-modifying enzyme involved in termination of NF-kappa B responses, is most commonly affected, with similar to 30% of patients displaying biallelic inactivation by mutations and/or deletions. When reintroduced in cell lines carrying biallelic inactivation of the gene, A20 induced apoptosis and cell growth arrest, indicating a tumour suppressor role. Less frequently, missense mutations of TRAF2 and CARD11 produce molecules with significantly enhanced ability to activate NF-kappa B. Thus, our results demonstrate that NF-kappa B activation in DLBCL is caused by genetic lesions affecting multiple genes, the loss or activation of which may promote lymphomagenesis by leading to abnormally prolonged NF-kappa B responses.	[Compagno, Mara; Grunn, Adina; Nandula, Subhadra V.; Brahmachary, Manisha; Shen, Qiong; Califano, Andrea; Bhagat, Govind; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Compagno, Mara; Grunn, Adina; Nandula, Subhadra V.; Brahmachary, Manisha; Shen, Qiong; Califano, Andrea; Bhagat, Govind; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Lim, Wei Keat; Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY 10032 USA; [Nandula, Subhadra V.; Bhagat, Govind; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bertoni, Francesco; Scandurra, Marta] Oncol Inst So Switzerland IOSI, Expt Oncol Lab, CH-6500 Bellinzona, Switzerland; [Bertoni, Francesco; Scandurra, Marta] Oncol Inst So Switzerland IOSI, Lymphoma Unit, CH-6500 Bellinzona, Switzerland; [Ponzoni, Maurilio] Ist Sci San Raffaele, Unit Lymphoid Malignancies, Pathol Unit, I-20132 Milan, Italy; [Chadburn, Amy] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Institute of Oncology Research (IOR); Institute of Oncology Research (IOR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Cornell University; Columbia University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	lp171@columbia.edu	Bertoni, Francesco/G-6922-2014; Bhagat, Govind/AAE-9493-2021	Bertoni, Francesco/0000-0001-5637-8983; Bhagat, Govind/0000-0001-6250-048X; Califano, Andrea/0000-0003-4742-3679	NIH [P01 CA92625-07]; NIAID [R01AI066116]; National Centers for Biomedical Computing NIH Roadmap [U54CA121852]; Leukemia and Lymphoma Society SCOR; NATIONAL CANCER INSTITUTE [U54CA121852, P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Centers for Biomedical Computing NIH Roadmap; Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Smith, P. Chadwick and the Molecular Pathology Facility of the Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center for histology service; V. V. V. Murty and the HICCC Molecular Cytogenetics Service for assistance on the FISH analysis; the HICCC Flow Cytometry Facility for fluorescence-activated cell sorting; V. Miljkovic and J. Pack for help with the Affymetrix gene expression hybridization; U. Klein and D. Dominguez-Sola for suggestions; L. Menard for help with the mutation analysis; and G. Inghirami for the pWPI lentiviral vector. Automated DNA sequencing was performed at Genewiz Inc. L. P. is on leave from the Institute of Hematology, University of Perugia Medical School, Perugia, Italy. This work was supported by NIH grants P01 CA92625-07 (R. D.-F.), NIAID R01AI066116, the National Centers for Biomedical Computing NIH Roadmap initiative U54CA121852 (A. Ca.), and a Leukemia and Lymphoma Society SCOR grant (R. D.- F.). L. P. would like to dedicate this work to the memory of Enrico Pasqualucci.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; GAIDANO G, 1992, BLOOD, V80, P1781, DOI 10.1182/blood.V80.7.1781.bloodjournal8071781; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; SCHMITZ R, J EXP MED IN PRESS; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	35	778	809	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					717	U124		10.1038/nature07968	http://dx.doi.org/10.1038/nature07968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19412164	Green Accepted			2022-12-28	WOS:000266608600047
J	Mueller, M; Grauschopf, U; Maier, T; Glockshuber, R; Ban, N				Mueller, Marcus; Grauschopf, Ulla; Maier, Timm; Glockshuber, Rudi; Ban, Nenad			The structure of a cytolytic alpha-helical toxin pore reveals its assembly mechanism	NATURE			English	Article							HEMOLYSIN-E HLYE; ESCHERICHIA-COLI; MOLECULAR ANALYSIS; CRYSTAL-STRUCTURE; BACTERIAL TOXIN; CLYA; PROTEIN; SHEA; SOFTWARE; REFINEMENT	Pore-forming toxins (PFTs) are a class of potent virulence factors that convert from a soluble form to a membrane-integrated pore(1). They exhibit their toxic effect either by destruction of the membrane permeability barrier or by delivery of toxic components through the pores. Among the group of bacterial PFTs are some of the most dangerous toxins, such as diphtheria and anthrax toxin. Examples of eukaryotic PFTs are perforin and the membrane-attack complex, proteins of the immune system(2). PFTs can be subdivided into two classes, alpha-PFTs and beta-PFTs, depending on the suspected mode of membrane integration, either by alpha-helical or beta-sheet elements(3). The only high-resolution structure of a transmembrane PFT pore is available for a beta-PFT-alpha-haemolysin from Staphylococcus aureus 4. Cytolysin A (ClyA, also known as HlyE), an alpha-PFT, is a cytolytic alpha-helical toxin responsible for the haemolytic phenotype of several Escherichia coli and Salmonella enterica strains(5-8). ClyA is cytotoxic towards cultured mammalian cells, induces apoptosis of macrophages and promotes tissue pervasion(9-11). Electron microscopic reconstructions demonstrated that the soluble monomer of ClyA(12) must undergo large conformational changes to form the transmembrane pore(13,14). Here we report the 3.3 angstrom crystal structure of the 400 kDa dodecameric transmembrane pore formed by ClyA. The tertiary structure of ClyA protomers in the pore is substantially different from that in the soluble monomer. The conversion involves more than half of all residues. It results in large rearrangements, up to 140 angstrom, of parts of the monomer, reorganization of the hydrophobic core, and transitions of beta-sheets and loop regions to alpha-helices. The large extent of interdependent conformational changes indicates a sequential mechanism for membrane insertion and pore formation.	[Mueller, Marcus; Grauschopf, Ulla; Maier, Timm; Glockshuber, Rudi; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR); Structural Biology program of the SNSF	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Structural Biology program of the SNSF	We thank B. Blattmann for help with initial screening, N. Eifler and A. Engel for providing electron microscopy maps, D. Boehringer for sample characterization, and H. Fah-Rechsteiner for technical assistance. We also acknowledge the staff of X06SA at the Swiss Light Source for developing an excellent beamline and support with data collection, T. C. Terwilliger for his support using RESOLVE, and M. Leibundgut and D. Boehringer for critically reading the manuscript. This work was supported by the Swiss National Science Foundation (SNSF) and the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkins A, 2000, J BIOL CHEM, V275, P41150, DOI 10.1074/jbc.M005420200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL., 2020, PYMOL MOL GRAPHICS S; delCastillo FJ, 1997, MOL MICROBIOL, V25, P107, DOI 10.1046/j.1365-2958.1997.4391813.x; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Evans W, 1997, CHEM BRIT, V33, P22; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Fuentes JA, 2008, RES MICROBIOL, V159, P279, DOI 10.1016/j.resmic.2008.02.006; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; Hunt S, 2008, MICROBIOL-SGM, V154, P633, DOI 10.1099/mic.0.2007/011700-0; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawate T, 2003, PROTEIN SCI, V12, P997, DOI 10.1110/ps.0231203; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai XH, 2000, INFECT IMMUN, V68, P4363, DOI 10.1128/IAI.68.7.4363-4367.2000; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Ludwig A, 2004, J BACTERIOL, V186, P5311, DOI 10.1128/JB.186.16.5311-5320.2004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Oscarsson J, 2002, INFECT IMMUN, V70, P5759, DOI 10.1128/IAI.70.10.5759-5769.2002; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Tzokov SB, 2006, J BIOL CHEM, V281, P23042, DOI 10.1074/jbc.M602421200; von Rhein C, 2009, INT J MED MICROBIOL, V299, P21, DOI 10.1016/j.ijmm.2008.06.004; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Wyborn NR, 2004, MICROBIOL-SGM, V150, P1495, DOI 10.1099/mic.0.26877-0	47	247	257	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					726	U135		10.1038/nature08026	http://dx.doi.org/10.1038/nature08026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19421192				2022-12-28	WOS:000266608600049
J	Semmelhack, JL; Wang, JW				Semmelhack, Julia L.; Wang, Jing W.			Select Drosophila glomeruli mediate innate olfactory attraction and aversion	NATURE			English	Article							ANTENNAL LOBE; BEHAVIORAL-RESPONSES; FLY BRAIN; NEURONS; RECEPTORS; MAP; MELANOGASTER; REPRESENTATION; INFORMATION; CHANNELS	Fruitflies show robust attraction to food odours, which usually excite several glomeruli. To understand how the representation of such odours leads to behaviour, we used genetic tools to dissect the contribution of each activated glomerulus. Apple cider vinegar triggers robust innate attraction at a relatively low concentration, which activates six glomeruli. By silencing individual glomeruli, here we show that the absence of activity in two glomeruli, DM1 and VA2, markedly reduces attraction. Conversely, when each of these two glomeruli was selectively activated, flies showed as robust an attraction to vinegar as wild-type flies. Notably, a higher concentration of vinegar excites an additional glomerulus and is less attractive to flies. We show that activation of the extra glomerulus is necessary and sufficient to mediate the behavioural switch. Together, these results indicate that individual glomeruli, rather than the entire pattern of active glomeruli, mediate innate behavioural output.	[Semmelhack, Julia L.; Wang, Jing W.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JW (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	jw800@ucsd.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Semmelhack, Julie/0000-0002-8154-264X	Whitehall Foundation; National Institute of Deafness and other Communication Disorders [R01DC009597]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009597] Funding Source: NIH RePORTER	Whitehall Foundation; National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank D. Anderson, R. Axel, C. Zuker and M. Gallio for comments on the manuscript. We thank M. Hilker for help with the design of the four- field olfactometer. We thank C. Root for generating the data presented in Supplementary Fig. 4. We thank L. Vosshall, B. Dickson and T. Lee for providing fly stocks. This work was partially supported by a research grant from the Whitehall Foundation to J. W. W. and a grant from the National Institute of Deafness and other Communication Disorders to J. W. W. (R01DC009597). J. W. W. is a Beckman Young Investigator, a Hellman Faculty scholar, and a Searle scholar.	Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; AURAND LW, 1966, J FOOD SCI, V31, P172, DOI 10.1111/j.1365-2621.1966.tb00474.x; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; LAING DG, 1978, CHEM SENS FLAV, V3, P149, DOI 10.1093/chemse/3.2.149; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	47	219	221	2	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					218	U100		10.1038/nature07983	http://dx.doi.org/10.1038/nature07983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19396157	Green Accepted			2022-12-28	WOS:000266036100033
J	Odd, DE; Lewis, G; Whitelaw, A; Gunnell, D				Odd, David E.; Lewis, Glyn; Whitelaw, Andrew; Gunnell, David			Resuscitation at birth and cognition at 8 years of age: a cohort study	LANCET			English	Article							RISK-FACTORS; NEWBORN ENCEPHALOPATHY; APGAR-SCORE; CHILDREN; INFANTS; TERM	Background Mild cerebral injury might cause subtle defects in cognitive function that are only detectable as the child grows older. Our aim was to determine whether infants receiving resuscitation after birth, but with no symptoms of encephalopathy, have reduced intelligence quotient (IQ) scores in childhood. Methods Three groups of infants were selected from the Avon Longitudinal Study of Parents and Children: infants who were resuscitated at birth but were asymptomatic for encephalopathy and had no further neonatal care (n=815), those who were resuscitated and had neonatal care for symptoms of encephalopathy (n=58), and the reference group who were not resuscitated, were asymptomatic for encephalopathy, and had no further neonatal care (n=10609). Cognitive function was assessed at a mean age of 8.6 years (SD 0.33); a low IQ score was defined as less than 80. IQ scores were obtained for 5953 children with a shortened version of the Weschler intelligence scale for children (WISC-III), the remaining 5529 were non-responders. All children did not complete all parts of the test, and therefore multiplied IQ values comparable to the full-scale test were only available for 5887 children. Results were adjusted for clinical and social covariates. Chained equations were used to impute missing values of covariates. Findings In the main analysis at 8 years of age (n=5887), increased risk of a low IQ score was recorded in both resuscitated infants asymptomatic for encephalopathy (odds ratio 1.65 [95% Cl 1.13-2.43]) and those with symptoms of encephalopathy (6.22 [1.57-24.65]). However, the population of asymptomatic infants was larger than that of infants with encephalopathy, and therefore the population attributable risk fraction for an IQ score that might be attributable to the need for resuscitation at birth was 3.4% (95% CI 0.5-6.3) for asymptomatic infants and 1.2% (0.2-2.2) for those who developed encephalopathy. Interpretation Infants who were resuscitated had increased risk of a low IQ score, even if they remained healthy during the neonatal period. Resuscitated infants asymptomatic for encephalopathy might result in a larger proportion of adults with low IQs than do those who develop neurological symptoms consistent with encephalopathy.	[Lewis, Glyn] Univ Bristol, Dept Community Based Med, Bristol, Avon, England; [Gunnell, David] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Bristol; University of Bristol	Odd, DE (corresponding author), Southmead Hosp, Neonatal Intens Care Unit, Bristol BS10 5NB, Avon, England.	david.odd@nbt.nhs.uk	Lewis, Glyn/E-9944-2012; Gunnell, David/ABE-6653-2020; Odd, David/G-8418-2016	Lewis, Glyn/0000-0001-5205-8245; Gunnell, David/0000-0002-0829-6470; Odd, David/0000-0002-6416-4966	Wellcome Trust [077036]; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G9815508] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. This research was funded by a fellowship award (077036) to DO from the Wellcome Trust. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC.	*AM AC PED COMM OB, 1996, OBSTET GYNECOL, V107, P1209; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Baskett TF, 2006, BJOG-INT J OBSTET GY, V113, P769, DOI 10.1111/j.1471-0528.2006.00987.x; Blackman J A, 1988, J Perinatol, V8, P206; Draycott T, 2006, BJOG-INT J OBSTET GY, V113, P177, DOI 10.1111/j.1471-0528.2006.00800.x; Dutton G N, 2001, Semin Neonatol, V6, P477, DOI 10.1053/siny.2001.0078; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Kaufman A.S., 1994, INTELLIGENT TESTING; KROLL L, 1994, EUR J OBSTET GYN R B, V55, P175, DOI 10.1016/0028-2243(94)90034-5; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; MYERS RE, 1972, AM J OBSTET GYNECOL, V112, P246, DOI 10.1016/0002-9378(72)90124-X; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V1-3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V2; PALMEKILANDER C, 1992, ACTA PAEDIATR, V81, P739, DOI 10.1111/j.1651-2227.1992.tb12094.x; PASAMANICK B, 1956, AM J PSYCHIAT, V112, P613, DOI 10.1176/ajp.112.8.613; PASQUIER F, 1995, J NEUROL NEUROSUR PS, V58, P81, DOI 10.1136/jnnp.58.1.81; PETERS TJ, 1984, EARLY HUM DEV, V9, P225, DOI 10.1016/0378-3782(84)90033-1; *RES COUNC UK, 2001, RES BIRTH NEWB LIF S; ROYSTON P, 2005, STATA J, V5, P681; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Saugstad OD, 2007, ACTA PAEDIATR, V96, P798, DOI 10.1111/j.1651-2227.2006.00348.x; Tan A, 2005, COCHRANE DB SYST REV, V2; Veltman DJ, 2005, PSYCHOL MED, V35, P175, DOI 10.1017/S0033291704002971; Viggedal G, 2002, ACTA PAEDIATR, V91, P1218, DOI 10.1080/080352502320777469; VILLAR J, 1990, AM J OBSTET GYNECOL, V163, P151, DOI 10.1016/S0002-9378(11)90690-5; Wechsler D., 1991, MANUAL WECHSLER INTE; WECHSLER D, 2004, WECHSLER INTELIGENCE	32	91	94	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1615	1622		10.1016/S0140-6736(09)60244-0	http://dx.doi.org/10.1016/S0140-6736(09)60244-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445QJ	19386357	Green Published, Bronze			2022-12-28	WOS:000266066300032
J	Koeller, P; Fuentes-Yaco, C; Platt, T; Sathyendranath, S; Richards, A; Ouellet, P; Orr, D; Skuladottir, U; Wieland, K; Savard, L; Aschan, M				Koeller, P.; Fuentes-Yaco, C.; Platt, T.; Sathyendranath, S.; Richards, A.; Ouellet, P.; Orr, D.; Skuladottir, U.; Wieland, K.; Savard, L.; Aschan, M.			Basin-Scale Coherence in Phenology of Shrimps and Phytoplankton in the North Atlantic Ocean	SCIENCE			English	Article							PANDALUS-BOREALIS; RECRUITMENT; BLOOM; SEA	Climate change could lead to mismatches between the reproductive cycles of marine organisms and their planktonic food. We tested this hypothesis by comparing shrimp (Pandalus borealis) egg hatching times and satellite-derived phytoplankton bloom dynamics throughout the North Atlantic. At large spatial and long temporal (10 years or longer) scales, hatching was correlated with the timing of the spring phytoplankton bloom. Annual egg development and hatching times were determined locally by bottom water temperature. We conclude that different populations of P. borealis have adapted to local temperatures and bloom timing, matching egg hatching to food availability under average conditions. This strategy is vulnerable to interannual oceanographic variability and long-term climatic changes.	[Koeller, P.; Fuentes-Yaco, C.; Platt, T.; Sathyendranath, S.] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS B2Y 4A2, Canada; [Fuentes-Yaco, C.; Sathyendranath, S.] Dalhousie Univ, Halifax, NS B3H 4R2, Canada; [Platt, T.; Sathyendranath, S.] Plymouth Marine Lab, Plymouth PL1 3, Devon, England; [Richards, A.] Natl Marine Fisheries Serv, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA; [Ouellet, P.; Savard, L.] Fisheries & Oceans Canada, Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada; [Orr, D.] Fisheries & Oceans Canada, Dept Fisheries & Oceans, St John, NF A1C 5X1, Canada; [Skuladottir, U.] Marine Res Inst, IS-121 Reykjavik, Iceland; [Wieland, K.] Tech Univ Denmark, Natl Inst Aquat Resources, DK-9850 Hirtshals, Denmark; [Aschan, M.] Univ Tromso, Norwegian Coll Fisheries Sci, N-9037 Tromso, Norway	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University; Plymouth Marine Laboratory; National Oceanic Atmospheric Admin (NOAA) - USA; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Marine & Freshwater Research Institute (MFRI); Technical University of Denmark; UiT The Arctic University of Tromso	Koeller, P (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	koellerp@mar.dfo-mpo.gc.ca		Wieland, Kai/0000-0003-1481-7743; Aschan, Michaela/0000-0002-9276-9321	Government Related Initiatives Program; Natural Sciences and Engineering Research Council of Canada; National Centre for Earth Observation; Natural Environment Research Council of the UK; NERC [earth010003, pml010007] Funding Source: UKRI; Natural Environment Research Council [earth010003, pml010007] Funding Source: researchfish	Government Related Initiatives Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Centre for Earth Observation; Natural Environment Research Council of the UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This analysis was made possible by the satellite data provided by NASA and the efforts of the technical personnel in six countries whose efforts at sea and in the laboratory provided the biological and physical oceanographic data. We also thank G. White III for extensive data preparation. This work was supported by the Canadian Space Agency through the Government Related Initiatives Program and by the Natural Sciences and Engineering Research Council of Canada through research grants to T.P. and S.S. This work is a contribution to the National Centre for Earth Observation and the Oceans 2025 programs of the Natural Environment Research Council of the UK.	BERGSTROM B I, 1991, Journal of Shellfish Research, V10, P327; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; Clark Stephen H., 2000, Journal of Northwest Atlantic Fishery Science, V27, P193, DOI 10.2960/J.v27.a18; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Koeller P.A., 2000, Journal of Northwest Atlantic Fishery Science, V27, P21, DOI 10.2960/J.v27.a3; Lilly G.R., 2000, Journal of Northwest Atlantic Fishery Science, V27, P45, DOI 10.2960/J.v27.a5; Ouellet P, 2007, MAR ECOL PROG SER, V339, P229, DOI 10.3354/meps339229; Parsons D.G., 1998, Journal of Northwest Atlantic Fishery Science, V24, P1, DOI 10.2960/J.v24.a1; Parsons D.G., 2000, Journal of Northwest Atlantic Fishery Science, V27, P11, DOI 10.2960/J.v27.a2; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Platt T, 2007, ICES J MAR SCI, V64, P863, DOI 10.1093/icesjms/fsm072; Platt T, 2009, ECOL MODEL, V220, P3057, DOI 10.1016/j.ecolmodel.2008.11.022; SHUMWAY SE, 1985, FAO FISH SYNOP, V144, P57; Sverdrup H.U., 1953, J CONSEILCONSEIL PER, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Wieland K, 2005, ICES J MAR SCI, V62, P1454, DOI 10.1016/j.icesjms.2005.02.012; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Wu YS, 2008, MAR ECOL PROG SER, V355, P9, DOI 10.3354/meps07233	20	149	156	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					791	793		10.1126/science.1170987	http://dx.doi.org/10.1126/science.1170987			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423827				2022-12-28	WOS:000265832400048
J	McKinstry, B; Padfield, P				McKinstry, Brian; Padfield, Paul			Endgames Case report A man with high blood pressure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERTENSION; PREVALENCE		[McKinstry, Brian] Univ Edinburgh, Gen Practice Sect, Ctr Populat Hlth Sci, Edinburgh EH8 9DR, Midlothian, Scotland; [Padfield, Paul] Western Gen Hosp, Dept Med Sci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	McKinstry, B (corresponding author), Univ Edinburgh, Gen Practice Sect, Ctr Populat Hlth Sci, Edinburgh EH8 9DR, Midlothian, Scotland.	brian.mckinstry@ed.ac.uk		McKinstry, Brian/0000-0001-9581-0468				BERGLUND G, 1976, BRIT MED J, V2, P554, DOI 10.1136/bmj.2.6035.554; Brecklin CS, 1998, AM J HYPERTENS, V11, P1279, DOI 10.1016/S0895-7061(98)00135-6; Frishman William H, 2003, Heart Dis, V5, P253, DOI 10.1097/01.hdx.0000080713.09303.a6; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Padfield P, 2007, NAT CLIN PRACT NEPHR, V3, P580, DOI 10.1038/ncpneph0625; Plouin PF, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-28; Tiu SC, 2005, J CLIN ENDOCR METAB, V90, P72, DOI 10.1210/jc.2004-1149; UMURA M, 2004, HYPERTENS RES, V27, P193; Vasbinder GBC, 2004, ANN INTERN MED, V141, P674, DOI 10.7326/0003-4819-141-9-200411020-00007; Verdecchia P, 2005, HYPERTENSION, V45, P203, DOI 10.1161/01.HYP.0000151623.49780.89; White WB, 2007, HYPERTENSION, V49, P408, DOI 10.1161/01.HYP.0000258106.74139.25; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Yap YG, 2007, J HYPERTENS, V25, P307, DOI 10.1097/HJH.0b013e3280115bae	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2009	338								b1550	10.1136/bmj.b1550	http://dx.doi.org/10.1136/bmj.b1550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GV	19420021				2022-12-28	WOS:000265969600001
J	Leng, GC				Leng, Gillian C.			NHS Evidence: better and faster access to information	LANCET			English	Editorial Material							SEEKING BEHAVIOR		Natl Inst Hlth & Clin Excellence, NHS Evidence, London WC1V 6NA, England	National Institute for Health & Care Excellence	Leng, GC (corresponding author), Natl Inst Hlth & Clin Excellence, NHS Evidence, London WC1V 6NA, England.	Gillian.Leng@nice.org.uk						Davies K, 2007, HEALTH INFO LIBR J, V24, P78, DOI 10.1111/j.1471-1842.2007.00713.x; Dawes M, 2003, INT J MED INFORM, V71, P9, DOI 10.1016/S1386-5056(03)00023-6; Masters K, 2008, INT J MED INFORM, V77, P4, DOI 10.1016/j.ijmedinf.2006.10.002; Rawlins MD, 2009, LANCET, V374, P351, DOI 10.1016/S0140-6736(09)60616-4; The AGREE Collaboration, 2001, APPR GUID RES EV AGR; Wyatt JC, 2005, BRIT MED J, V331, P1129, DOI 10.1136/bmj.331.7525.1129	6	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1502	1504		10.1016/S0140-6736(09)60786-8	http://dx.doi.org/10.1016/S0140-6736(09)60786-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19409609				2022-12-28	WOS:000265710300006
J	Hautier, Y; Niklaus, PA; Hector, A				Hautier, Yann; Niklaus, Pascal A.; Hector, Andy			Competition for Light Causes Plant Biodiversity Loss After Eutrophication	SCIENCE			English	Article							SPECIES RICHNESS; GRASSLAND; PRODUCTIVITY; DIVERSITY; RESOURCES	Human activities have increased the availability of nutrients in terrestrial and aquatic ecosystems. In grasslands, this eutrophication causes loss of plant species diversity, but the mechanism of this loss has been difficult to determine. Using experimental grassland plant communities, we found that addition of light to the grassland understory prevented the loss of biodiversity caused by eutrophication. There was no detectable role for competition for soil resources in diversity loss. Thus, competition for light is a major mechanism of plant diversity loss after eutrophication and explains the particular threat of eutrophication to plant diversity. Our conclusions have implications for grassland management and conservation policy and underscore the need to control nutrient enrichment if plant diversity is to be preserved.	[Hautier, Yann; Niklaus, Pascal A.; Hector, Andy] Univ Zurich, Inst Environm Sci, CH-8057 Zurich, Switzerland; [Niklaus, Pascal A.] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hautier, Y (corresponding author), Univ Zurich, Inst Environm Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	yhautier@uwinst.uzh.ch	Carneiro, Fernanda/E-9513-2013; Hautier, Yann/I-2526-2019; Hector, Andrew/H-4199-2011; Niklaus, Pascal A/G-5786-2010; Hautier, Yann/D-5426-2015	Carneiro, Fernanda/0000-0001-6389-4564; Hautier, Yann/0000-0003-4347-7741; Hector, Andrew/0000-0002-1309-7716; Niklaus, Pascal A/0000-0002-2360-1357; Hautier, Yann/0000-0003-4347-7741	Swiss National Foundation [3100A0-107572]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	We thank E.D. Schulze and C. Korner for discussion of light manipulation, B. Schmid and L. Turnbull for comments on the manuscript, and L. Wacker, E. Vojtech, G. Feichtinger, and T. Zwimpfer for helpful suggestions and field work assistance. Y.H. is funded by Swiss National Foundation grant 3100A0-107572 to A.H. The project was conceived by A.H., designed by A.H., P.A.N., and Y.H., conducted by Y.H., analyzed by Y.H. and A.H., and written up by Y.H. and A.H. with input from P.A.N.	Berendse F, 1999, TRENDS ECOL EVOL, V14, P4, DOI 10.1016/S0169-5347(98)01451-7; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Emery NC, 2001, ECOLOGY, V82, P2471, DOI 10.1890/0012-9658(2001)082[2471:CASMPZ]2.0.CO;2; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Grime J.P., 2002, PLANT STRATEGIES VEG; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.1890/0012-9658(1999)080[0211:CFLBPS]2.0.CO;2; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; Rajaniemi TK, 2003, OIKOS, V101, P449, DOI 10.1034/j.1600-0706.2003.12128.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevens MHH, 2004, J ECOL, V92, P339, DOI 10.1111/j.0022-0477.2004.00866.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; Wacker L, 2008, BASIC APPL ECOL, V9, P467, DOI 10.1016/j.baae.2007.08.003; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950	26	845	916	52	833	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					636	638		10.1126/science.1169640	http://dx.doi.org/10.1126/science.1169640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407202	Green Accepted			2022-12-28	WOS:000265608800042
J	McClintock, WE; Vervack, RJ; Bradley, ET; Killen, RM; Mouawad, N; Sprague, AL; Burger, MH; Solomon, SC; Izenberg, NR				McClintock, William E.; Vervack, Ronald J., Jr.; Bradley, E. Todd; Killen, Rosemary M.; Mouawad, Nelly; Sprague, Ann L.; Burger, Matthew H.; Solomon, Sean C.; Izenberg, Noam R.			MESSENGER Observations of Mercury's Exosphere: Detection of Magnesium and Distribution of Constituents	SCIENCE			English	Article							SODIUM TAIL; ATMOSPHERE; DISCOVERY; POTASSIUM; EMISSION; MISSION; CALCIUM; FLYBY; RATES; NA	Mercury is surrounded by a tenuous exosphere that is supplied primarily by the planet's surface materials and is known to contain sodium, potassium, and calcium. Observations by the Mercury Atmospheric and Surface Composition Spectrometer during MESSENGER's second Mercury flyby revealed the presence of neutral magnesium in the tail (anti-sunward) region of the exosphere, as well as differing spatial distributions of magnesium, calcium, and sodium atoms in both the tail and the nightside, near-planet exosphere. Analysis of these observations, supplemented by observations during the first Mercury flyby, as well as those by other MESSENGER instruments, suggests that the distinct spatial distributions arise from a combination of differences in source, transfer, and loss processes.	[McClintock, William E.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Vervack, Ronald J., Jr.; Izenberg, Noam R.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Bradley, E. Todd] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Killen, Rosemary M.; Mouawad, Nelly; Burger, Matthew H.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Sprague, Ann L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; State University System of Florida; University of Central Florida; University System of Maryland; University of Maryland College Park; University of Arizona; Carnegie Institution for Science	McClintock, WE (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA.	william.mcclintock@colorado.edu	Izenberg, Noam R/F-3952-2015; Killen, Rosemary M/E-7127-2012; Vervack, Ronald J/C-2702-2016; Mouawad, Nelly/AAH-5398-2020	Izenberg, Noam R/0000-0003-1629-6478; Vervack, Ronald J/0000-0002-8227-9564; Mouawad, Nelly/0000-0003-1609-5625	Johns Hopkins University Applied Physics Laboratory [NAS5-97271]; Carnegie Institution of Washington [NASW-00002]	Johns Hopkins University Applied Physics Laboratory(Johns Hopkins University); Carnegie Institution of Washington	We thank M. Lankton and M. Kochte for their important contributions to the acquisition and analysis of the data reported here. The MESSENGER project is supported by the NASA Discovery Program under contracts NAS5-97271 to Johns Hopkins University Applied Physics Laboratory and NASW-00002 to Carnegie Institution of Washington. R.J.V., R.M.K., and A.L.S. are supported by the MESSENGER Participating Scientist Program.	ANDERSON BJ, 2008, EOS T AGU S, V89; Baumgardner J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032337; Bida TA, 2000, NATURE, V404, P159, DOI 10.1038/35004521; BROADFOOT AL, 1974, SCIENCE, V185, P166, DOI 10.1126/science.185.4146.166; Denevi BW, 2009, SCIENCE, V324, P613, DOI 10.1126/science.1172226; Fulle M, 2007, ASTROPHYS J, V661, pL93, DOI 10.1086/518719; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Killen R, 2009, ASTROPHYS J SUPPL S, V181, P351, DOI 10.1088/0067-0049/181/2/351; Killen RM, 2005, ICARUS, V173, P300, DOI 10.1016/j.icarus.2004.08.022; Killen RM, 2004, ICARUS, V171, P1, DOI 10.1016/j.icarus.2004.04.007; Killen RM, 2001, J GEOPHYS RES-PLANET, V106, P20509, DOI 10.1029/2000JE001401; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Leblanc F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035322; McClintock WE, 2008, SCIENCE, V321, P62, DOI 10.1126/science.1159933; McClintock WE, 2007, SPACE SCI REV, V131, P481, DOI 10.1007/s11214-007-9264-5; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; Potter AE, 2008, ICARUS, V194, P1, DOI 10.1016/j.icarus.2007.09.023; Potter AE, 2007, ICARUS, V186, P571, DOI 10.1016/j.icarus.2006.09.025; POTTER AE, 1986, ICARUS, V67, P336, DOI 10.1016/0019-1035(86)90113-2; Potter AE, 2002, METEORIT PLANET SCI, V37, P1165, DOI 10.1111/j.1945-5100.2002.tb00886.x; Sarantos M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036207; SHEMANSKY DE, 1977, REV GEOPHYS, V15, P491, DOI 10.1029/RG015i004p00491; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; SMYTH WH, 1995, ASTROPHYS J, V441, P839, DOI 10.1086/175407; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; Sprague AL, 2009, PLANET SPACE SCI, V57, P364, DOI 10.1016/j.pss.2009.01.006; Sprague AL, 1997, ICARUS, V129, P506, DOI 10.1006/icar.1997.5784; Zurbuchen TH, 2008, SCIENCE, V321, P90, DOI 10.1126/science.1159314	29	75	75	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					610	613		10.1126/science.1172525	http://dx.doi.org/10.1126/science.1172525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407195				2022-12-28	WOS:000265608800035
J	Brice, R				Brice, Richard			Case report A taxi driver with type 2 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PEPTIDASE-4 INHIBITOR SITAGLIPTIN; GLYCEMIC CONTROL; ROSIGLITAZONE; THERAPY; PIOGLITAZONE; MONOTHERAPY; MANAGEMENT; METFORMIN; EFFICACY; EVENTS					richard.brice@gp-g82071.nhs.uk						Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Bakris GL, 2006, J HYPERTENS, V24, P2047, DOI 10.1097/01.hjh.0000244955.39491.88; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; *DEP HLTH, 2008, PROP CHANG QUAL OUTC; Department of Health, 2004, QUAL OUTC FRAM; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *DRIV MED GROUP, 2008, GLANC GUID CURR MED; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; *NAT I HLTH CLIN E, 2008, TYP 2 DIAB IN PRESS; *NAT I HLTH CLIN E, 2008, MAN TYP 2 DIAB UPD; Nathan DM, 2006, DIABETOLOGIA, V49, P1711, DOI 10.1007/s00125-006-0316-2; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pratley RE, 2007, DIABETES CARE, V30, P3017, DOI 10.2337/dc07-1188; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Rosenstock J, 2006, DIABETES CARE, V29, P554, DOI 10.2337/diacare.29.03.06.dc05-0695; Sutton MS, 2002, DIABETES CARE, V25, P2058, DOI 10.2337/diacare.25.11.2058; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	28	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2009	338								b1369	10.1136/bmj.b1369	http://dx.doi.org/10.1136/bmj.b1369			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JW	19403570				2022-12-28	WOS:000265697600003
J	Lee, R; Martin, R; D'Cruz, D				Lee, Richard; Martin, Rhodri; D'Cruz, David			Picture quiz A man with Wegener's granulomatosis and haemoptysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIBODY-ASSOCIATED VASCULITIS; DIFFUSE ALVEOLAR HEMORRHAGE; SMALL-VESSEL VASCULITIS; ANTINEUTROPHIL; THERAPY		[Martin, Rhodri; D'Cruz, David] St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	D'Cruz, D (corresponding author), St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England.	david.d'cruz@kcl.ac.uk						Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Bosch X, 2007, JAMA-J AM MED ASSOC, V298, P655, DOI 10.1001/jama.298.6.655; Falk RJ, 1997, J AM SOC NEPHROL, V8, P314; Fuiano G, 2000, AM J KIDNEY DIS, V35, P448, DOI 10.1016/S0272-6386(00)70197-1; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Lee RW, 2008, DRUGS, V68, P747, DOI 10.2165/00003495-200868060-00003; Liapis H, 2007, INT UROL NEPHROL, V39, P223, DOI 10.1007/s11255-006-9170-x; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; Schwarz MI, 2000, THORAX, V55, P502, DOI 10.1136/thorax.55.6.502; Specks U, 2001, CURR OPIN RHEUMATOL, V13, P12, DOI 10.1097/00002281-200101000-00003; Stone JH, 2005, NEW ENGL J MED, V352, P351; Wiik A, 2008, CURR OPIN RHEUMATOL, V20, P35, DOI 10.1097/BOR.0b013e3282f1331f; Zamora MR, 1997, MEDICINE, V76, P192, DOI 10.1097/00005792-199705000-00005	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2009	338								b1461	10.1136/bmj.b1461	http://dx.doi.org/10.1136/bmj.b1461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OP	19386669				2022-12-28	WOS:000265497100003
J	Bakker, M; Boon, D				Bakker, Martijn; Boon, Diederik			Practice 10-Minute Consultation Haematuria	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bakker, Martijn] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, NL-1007 MB Amsterdam, Netherlands; [Boon, Diederik] Dept Nephrol, NL-1620 AR Hoorn, Netherlands	Vrije Universiteit Amsterdam	Bakker, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Postbus 7057, NL-1007 MB Amsterdam, Netherlands.	mbakker72@gmail.com							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2009	338								b1324	10.1136/bmj.b1324	http://dx.doi.org/10.1136/bmj.b1324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TL	19376797				2022-12-28	WOS:000265296900001
J	Deneault, E; Cellot, S; Faubert, A; Laverdure, JP; Frechette, M; Chagraoui, J; Mayotte, N; Sauvageau, M; Ting, SB; Sauvageau, G				Deneault, Eric; Cellot, Sonia; Faubert, Amelie; Laverdure, Jean-Philippe; Frechette, Melanie; Chagraoui, Jalila; Mayotte, Nadine; Sauvageau, Martin; Ting, Stephen B.; Sauvageau, Guy			A Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity	CELL			English	Article							IN-VITRO; SELF-RENEWAL; EXPANSION; OVEREXPRESSION; VIVO; HOXB4; GENE; HSC	Despite tremendous progress made toward the identification of the molecular circuitry that governs cell fate in embryonic stem cells, genes controlling this process in the adult hematopoietic stem cell have proven to be more difficult to unmask. We now report the results of a novel gain-of-function screening approach, which identified a series of 18 nuclear factors that affect hematopoietic stem cell activity. Overexpression of ten of these factors resulted in an increased repopulating activity compared to unmanipulated cells. Interestingly, at least four of the 18 factors, Fos, Tcfec, Hmgb1, and Sfpi1, show non-cell-autonomous functions. The utilization of this screening method together with the creation of a database enriched for potential determinants of hematopoietic stem cell self-renewal will serve as a resource to uncover regulatory networks in these cells.	[Deneault, Eric; Cellot, Sonia; Faubert, Amelie; Laverdure, Jean-Philippe; Frechette, Melanie; Chagraoui, Jalila; Mayotte, Nadine; Sauvageau, Martin; Ting, Stephen B.; Sauvageau, Guy] Univ Montreal, Mol Genet Stem Cells Lab, IRIC, Montreal, PQ H3C 3J7, Canada; [Sauvageau, Guy] Hop Maison Neuve Rosemont, Div Hematol & Leukemia Cell Bank Quebec BCLQ, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Univ Montreal, Mol Genet Stem Cells Lab, IRIC, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca	Sauvageau, Martin/A-8967-2013	Sauvageau, Martin/0000-0001-9487-5016; Sauvageau, Guy/0000-0002-4333-7266	Canadian Institute of Health Research (CIHR) [154290, 2006-2011]; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI); Fonds de Recherche en Sante du Quebec (FRSQ)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	The authors thank J. Krosl, R. Bisaillon and B. T. Wilhelm for technical help, C. Charbonneau from IRIC imagery platform, D. Gagne from IRIC flow cytometry platform, and P. Chagnon and R. Lambert from IRIC genomic platform for their expertise with quantitative RT-PCR. We also want to acknowledge C. Perreault, M. Therrien, K. J. Hope, and R. K. Humphries for discussions and critical comments about the manuscript. This work was supported by the Canadian Institute of Health Research (CIHR) Team Grant in Hematopoietic Stem Cell Self-Renewal: From Genes to Bedside (Grant number 154290, 2006-2011). G. S. holds a Canada Research Chair on molecular genetics of stem cells; E. D. and S. C. are recipients of a CIHR studentship and Clinician Scientist award, respectively; J. C. holds an American Society of Hematology fellowship; M. S. holds a National Canadian Institute of Cancer studentship; and S. B. T. is the recipient of National Health Medical Research Council and a Royal Australian College of Physicians fellowships. IRIC is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canada Foundation for Innovation (CFI), and the Fonds de Recherche en Sante du Quebec (FRSQ).	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Cellot S, 2007, EXP HEMATOL, V35, P802, DOI 10.1016/j.exphem.2007.02.013; Cellot S, 2007, CELL, V129, P239, DOI 10.1016/j.cell.2007.04.002; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Hai-Jiang W, 2008, AM J HEMATOL, V83, P922, DOI 10.1002/ajh.21262; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Ohta H, 2007, EXP HEMATOL, V35, P817, DOI 10.1016/j.exphem.2007.02.012; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Uchida N, 2004, BLOOD, V103, P4487, DOI 10.1182/blood-2003-11-3989	23	100	102	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					369	379		10.1016/j.cell.2009.03.026	http://dx.doi.org/10.1016/j.cell.2009.03.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379700	Green Accepted, Bronze			2022-12-28	WOS:000265456800028
J	Steemans, P; Le Herisse, A; Melvin, J; Miller, MA; Paris, F; Verniers, J; Wellman, CH				Steemans, Philippe; Le Herisse, Alain; Melvin, John; Miller, Merrell A.; Paris, Florentin; Verniers, Jacques; Wellman, Charles H.			Origin and Radiation of the Earliest Vascular Land Plants	SCIENCE			English	Article									[Wellman, Charles H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Steemans, Philippe] Univ Liege, B-4000 Liege, Belgium; [Le Herisse, Alain] Univ Brest, UMR 6538, CNRS, Inst Univ Europeen Mer, F-29238 Brest 3, France; [Melvin, John; Miller, Merrell A.] Saudi Aramco, Dhahran 31311, Saudi Arabia; [Paris, Florentin] Univ Rennes 1, CNRS, UMR 6118, F-35042 Rennes, France; [Verniers, Jacques] Univ Ghent, Res Unit Palaentol, B-9000 Ghent, Belgium	University of Sheffield; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Ghent University	Wellman, CH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	c.wellman@sheffield.ac.uk	Verniers, Jacques/B-8024-2009; Paris, francois E/L-4915-2015	Verniers, Jacques/0000-0002-2939-7684; Paris, francois E/0000-0002-0176-7348; Steemans, Philippe/0000-0003-1183-6324	NERC [NE/E006612/1] Funding Source: UKRI; Natural Environment Research Council [NE/E006612/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		EDWARDS D, 2001, PLANTS INVADE LAND, pCH2; GRAY J, 1985, PHILOS T ROY SOC B, V309, P167, DOI 10.1098/rstb.1985.0077; RICHARDSON JB, 1996, PALYNOLOGY PRINCIPLE, V2, pCHA18; Steemans P, 2000, REV PALAEOBOT PALYNO, V113, P189, DOI 10.1016/S0034-6667(00)00059-2; Strother P.K., 2000, PHANEROZOIC TERRESTR, P3; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884	6	189	202	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					353	353		10.1126/science.1169659	http://dx.doi.org/10.1126/science.1169659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372423	Green Published			2022-12-28	WOS:000265221600032
J	Brass, SD; Smith, EE; Arboleda-Velasquez, JF; Copen, WA; Frosch, MP				Brass, Steven D.; Smith, Eric E.; Arboleda-Velasquez, Joseph F.; Copen, William A.; Frosch, Matthew P.			A Man with Migraine, Aphasia, and Hemiparesis and Similarly Affected Family Members Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMALL-VESSEL DISEASE; NOTCH3 MUTATIONS; MULTIPLE-SCLEROSIS; DIFFERENTIAL-DIAGNOSIS; HEREDITARY; SPECTRUM; BINDING; MUSCLE; ONSET		[Brass, Steven D.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Copen, William A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Smith, Eric E.] Foothills Prov Gen Hosp, Dept Neurol, Calgary, AB T2N 2T9, Canada; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brass, Steven D.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Arboleda-Velasquez, Joseph F.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Copen, William A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Calgary; University of Calgary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Brass, SD (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Smith, Eric E/C-5443-2012; Frosch, Matthew P/ABD-7456-2021	Smith, Eric E/0000-0003-3956-1668; Frosch, Matthew P/0000-0002-3940-9861				Arboleda-Velasquez JF, 2005, HUM MOL GENET, V14, P1631, DOI 10.1093/hmg/ddi171; Arboleda-Velasquez JF, 2002, NEUROLOGY, V59, P277, DOI 10.1212/WNL.59.2.277; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Carmosino MJ, 2005, ARCH NEUROL-CHICAGO, V62, P585, DOI 10.1001/archneur.62.4.585; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Charil A, 2006, LANCET NEUROL, V5, P841, DOI 10.1016/S1474-4422(06)70572-5; Cohen JA, 2000, MULTIPLE SCLEROSIS: DIAGNOSIS, MEDICAL MANAGEMENT, AND REHABILITATION, P127; Dichgans M, 2000, EUR J HUM GENET, V8, P280, DOI 10.1038/sj.ejhg.5200460; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Fellgiebel A, 2006, LANCET NEUROL, V5, P791, DOI 10.1016/S1474-4422(06)70548-8; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Kim Y, 2006, NEUROLOGY, V66, P1511, DOI 10.1212/01.wnl.0000216259.99811.50; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Louvi A, 2006, DEV NEUROSCI-BASEL, V28, P5, DOI 10.1159/000090748; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Low WC, 2007, BRAIN, V130, P357, DOI 10.1093/brain/awl360; Mayer M, 1999, J NEUROL, V246, P526, DOI 10.1007/s004150050398; Mazzei R, 2004, NEUROLOGY, V63, P561, DOI 10.1212/01.WNL.0000133399.37716.84; MILLER D, 2005, MCALPINES MULTIPLE S, P389; Olek MJ, 2005, CUR CLIN NEUROL, P15; Peters N, 2004, EXP CELL RES, V299, P454, DOI 10.1016/j.yexcr.2004.06.004; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rolak LA, 2007, NEUROLOGIST, V13, P57, DOI 10.1097/01.nrl.0000254705.39956.34; Santa Y, 2003, J NEUROL SCI, V212, P79, DOI 10.1016/S0022-510X(03)00109-6; Scheid R, 2008, NEUROLOGY, V71, P774, DOI 10.1212/01.wnl.0000324928.44694.f7; Scolding N, 2001, J NEUROL NEUROSUR S2, V71, pii9; SCOTT TF, 1991, POSTGRAD MED, V89, P187; Smith Eric E, 2003, Curr Atheroscler Rep, V5, P260, DOI 10.1007/s11883-003-0048-4; Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003; Trojano M, 2001, NEUROL SCI, V22, pS98, DOI 10.1007/s100720100044; Uchino M, 2002, ANN NY ACAD SCI, V977, P273, DOI 10.1111/j.1749-6632.2002.tb04826.x; van den Boom R, 2003, RADIOLOGY, V229, P683, DOI 10.1148/radiol.2293021354; Verreault S, 2006, ANN NEUROL, V59, P353, DOI 10.1002/ana.20775; Yap S, 2003, J INHERIT METAB DIS, V26, P259, DOI 10.1023/A:1024497419821; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	40	17	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1656	1665		10.1056/NEJMcpc0810839	http://dx.doi.org/10.1056/NEJMcpc0810839			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369672				2022-12-28	WOS:000265178000012
J	Fanestil, BD				Fanestil, Bradley D.			The Tyranny of the Measuring Cup	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bfanestil@gmail.com						Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Heng HHQ, 2008, JAMA-J AM MED ASSOC, V300, P1580, DOI 10.1001/jama.300.13.1580	2	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1515	1516		10.1001/jama.2009.137	http://dx.doi.org/10.1001/jama.2009.137			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366762				2022-12-28	WOS:000265137900001
J	Feher, O; Wang, HB; Saar, S; Mitra, PP; Tchernichovski, O				Feher, Olga; Wang, Haibin; Saar, Sigal; Mitra, Partha P.; Tchernichovski, Ofer			De novo establishment of wild-type song culture in the zebra finch	NATURE			English	Article							WHITE-CROWNED SPARROW; TAENIOPYGIA-GUTTATA; CONSPECIFIC SONG; UNTUTORED SONG; BIRD SONG; EVOLUTION; BEHAVIOR; SELECTIVITY; LANGUAGE; RULES	Culture is typically viewed as consisting of traits inherited epigenetically, through social learning. However, cultural diversity has species-typical constraints(1), presumably of genetic origin. A celebrated, if contentious, example is whether a universal grammar constrains syntactic diversity in human languages(2). Oscine songbirds exhibit song learning and provide biologically tractable models of culture: members of a species show individual variation in song(3) and geographically separated groups have local song dialects(4,5). Different species exhibit distinct song cultures(6,7), suggestive of genetic constraints(8,9). Without such constraints, innovations and copying errors should cause unbounded variation over multiple generations or geographical distance, contrary to observations(9). Here we report an experiment designed to determine whether wild-type song culture might emerge over multiple generations in an isolated colony founded by isolates, and, if so, how this might happen and what type of social environment is required(10). Zebra finch isolates, unexposed to singing males during development, produce song with characteristics that differ from the wild-type song found in laboratory(11) or natural colonies. In tutoring lineages starting from isolate founders, we quantified alterations in song across tutoring generations in two social environments: tutor-pupil pairs in sound-isolated chambers and an isolated semi-natural colony. In both settings, juveniles imitated the isolate tutors but changed certain characteristics of the songs. These alterations accumulated over learning generations. Consequently, songs evolved towards the wild-type in three to four generations. Thus, species-typical song culture can appear de novo. Our study has parallels with language change and evolution(12-14). In analogy to models in quantitative genetics(15,16), we model song culture as a multigenerational phenotype partly encoded genetically in an isolate founding population, influenced by environmental variables and taking multiple generations to emerge.	[Feher, Olga; Saar, Sigal; Tchernichovski, Ofer] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Wang, Haibin; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	City University of New York (CUNY) System; City College of New York (CUNY); Cold Spring Harbor Laboratory	Feher, O (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	olcifeher@gmail.com	Tchernichovski, Ofer/AAC-5678-2019	Tchernichovski, Ofer/0000-0001-6788-614X; Mitra, Partha/0000-0001-8818-6804	US National Institutes of Health (NIH); NIH Research Centers in Minority Institutions; Crick-Clay Professorship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Crick-Clay Professorship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Wallman and H. Williams for critical reading of the manuscript and consultation and F. Nottebohm, C. Harding and N. Leader for recordings of WT songs. The study was supported by US National Institutes of Health (NIH) grants to O. T. and P. P. M., by a NIH Research Centers in Minority Institutions grant to City College, City University of New York, and by the Crick-Clay Professorship to P. P. M.	Adret P, 2004, ANN NY ACAD SCI, V1016, P303, DOI 10.1196/annals.1298.005; Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; BOAKE CRB, 1994, QUANTITATIVE GENETIC, P94; BOHNER J, 1983, ANIM BEHAV, V31, P231, DOI 10.1016/S0003-3472(83)80193-6; Boyd R., 1985, CULTURE EVOLUTIONARY; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; Cheverud JM, 2003, P NATL ACAD SCI USA, V100, P4357, DOI 10.1073/pnas.0931311100; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; DICKERSON GE, 1947, IOWA AGR EXPT STATIO, V354, P489; Falconer DS, 1996, INTRO QUANTITATIVE G; Gardner TJ, 2005, SCIENCE, V308, P1046, DOI 10.1126/science.1108214; Jones AE, 1996, J COMP PSYCHOL, V110, P354; KEGL J, 2002, LANG ACQUIS, P207; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1985, ANIM BEHAV, V33, P57, DOI 10.1016/S0003-3472(85)80120-2; Mundinger PC, 1995, ANIM BEHAV, V50, P1491, DOI 10.1016/0003-3472(95)80006-9; NELSON DA, 1994, P NATL ACAD SCI USA, V91, P10498, DOI 10.1073/pnas.91.22.10498; Niyogi P, 2006, CURR STUD LINGUIST, V43, P1; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Olofsson H, 2008, BEHAV ECOL, V19, P594, DOI 10.1093/beheco/arn002; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; Saar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001461; Soha JA, 2000, ANIM BEHAV, V60, P297, DOI 10.1006/anbe.2000.1499; Soha JA, 2001, ETHOLOGY, V107, P813, DOI 10.1046/j.1439-0310.2001.00713.x; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 1999, P NATL ACAD SCI USA, V96, P12901, DOI 10.1073/pnas.96.22.12901; VOLMAN SF, 1995, J COMP PSYCHOL, V109, P211, DOI 10.1037/0735-7036.109.3.211; West M.J., 1985, P245; WILLHAM RL, 1963, BIOMETRICS, V19, P18, DOI 10.2307/2527570; WILLIAMS H, 1993, ANIM BEHAV, V45, P695, DOI 10.1006/anbe.1993.1084	32	204	207	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					564	U94		10.1038/nature07994	http://dx.doi.org/10.1038/nature07994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	449ZS	19412161	Green Accepted, Green Submitted			2022-12-28	WOS:000266370500038
J	Nobleft, SE; Welfare, M; Seymour, K				Nobleft, S. E.; Welfare, M.; Seymour, K.			The role of surgery in Clostridium difficile colitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DIARRHEA; DISEASE; RISK		[Nobleft, S. E.; Seymour, K.] N Tyneside Gen Hosp, Dept Surg, N Shields NE29 8NH, Tyne & Wear, England; [Welfare, M.] N Tyneside Gen Hosp, Dept Gastroenterol, N Shields NE29 8NH, Tyne & Wear, England		Seymour, K (corresponding author), N Tyneside Gen Hosp, Dept Surg, N Shields NE29 8NH, Tyne & Wear, England.	keith.seymour@northumbria-healthcare.nhs.uk		Seymour, Keith/0000-0003-0850-2745				Adams SD, 2007, CURR OPIN CRIT CARE, V13, P450, DOI 10.1097/MCC.0b013e3282638879; Ali SO, 2008, AM SURGEON, V74, P20; Barbut F, 2001, CLIN MICROBIOL INFEC, V7, P405, DOI 10.1046/j.1198-743x.2001.00289.x; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; BARTRAM CI, 1976, P ROY SOC MED, V69, P617, DOI 10.1177/003591577606900834; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Greenstein AJ, 2008, SURGERY, V143, P623, DOI 10.1016/j.surg.2007.12.008; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Juang P, 2007, AM J INFECT CONTROL, V35, P131, DOI 10.1016/j.ajic.2006.06.007; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; Lamontagne F, 2007, ANN SURG, V245, P267, DOI 10.1097/01.sla.0000236628.79550.e5; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Nelson R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004610.pub3; Paltansing S, 2007, CLIN MICROBIOL INFEC, V13, P1058, DOI 10.1111/j.1469-0691.2007.01793.x; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Pillai A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004611.pub2; Ros PR, 1996, RADIOLOGY, V198, P1; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Steering Group on Healthcare Associated Infections, 2008, CLOSTR DIFF INF DEAL; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163	25	18	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2009	338								b1563	10.1136/bmj.b1563	http://dx.doi.org/10.1136/bmj.b1563			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GV	19420031				2022-12-28	WOS:000265969600002
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, AJ; Gregory, KD; Grossman, D; Isham, G; LeFevre, ML; Leipzig, RM; Marion, LN; Melnyk, B; Moyer, VA; Ockene, JK; Sawaya, GF; Schwartz, JS; Wilt, T				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen J.; Gregory, Kimberly D.; Grossman, David; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne M.; Marion, Lucy N.; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Schwartz, J. Sanford; Wilt, Timothy		US Preventive Serv Task Force	Folic Acid for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							DIETARY-FOLATE; UNITED-STATES; HEALTH; FORTIFICATION; WOMEN; AGE	Description: In 1996, the U. S. Preventive Services Task Force (USPSTF) recommended that all women planning or capable of pregnancy take a multivitamin supplement containing folic acid for the prevention of neural tube defects. This recommendation is an update of the 1996 USPSTF recommendation. Methods: The USPSTF reviewed the evidence on folic acid supplementation in women of childbearing age published since the 1996 USPSTF recommendation. The USPSTF did not review the evidence on folic acid food fortification, counseling to increase dietary intake, or screening for neural tube defects. Recommendation: The USPSTF recommends that all women planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mu g) of folic acid. (Grade A recommendation).	[Calonge, Ned] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA; [Calonge, Ned] USPSTF, Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Petitti, Diana B.] Arizona State Univ, USPSTF, Phoenix, AZ USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Grossman, David] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Isham, George] HealthPartners Inc, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne M.] Mt Sinai Sch Med, New York, NY USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Melnyk, Bernadette] Arizona State Univ, Coll Nursing & Healthcare Innovat, Phoenix, AZ USA; [Moyer, Virginia A.] Baylor Coll Med, Houston, TX 77030 USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Schwartz, J. Sanford] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Wilt, Timothy] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA	Agency for Healthcare Research & Quality; Colorado Department of Public Health & Environment; Arizona State University; Arizona State University-Downtown Phoenix; Cincinnati Children's Hospital Medical Center; Dartmouth College; Cedars Sinai Medical Center; Group Health Cooperative; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University System of Georgia; Augusta University; Arizona State University; Arizona State University-Downtown Phoenix; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Calonge, N (corresponding author), US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA.		Melnyk, Bernadette J/E-9868-2013		USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	ACOG Committee on Practice Bulletins, 2003, Obstet Gynecol, V102, P203; *AM AC FAM PHYS, 2008, SUMM REC CLIN PREV S; [Anonymous], 1998, Epilepsia, V39, P1226; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Bentley TGK, 2006, AM J PUBLIC HEALTH, V96, P2040, DOI 10.2105/AJPH.2005.067371; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Cornel MC, 2005, REPROD TOXICOL, V20, P411, DOI 10.1016/j.reprotox.2005.03.015; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Desposito F, 1999, PEDIATRICS, V104, P325; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; Klein JD, 2005, PEDIATRICS, V116, P281, DOI 10.1542/peds.2005-0999; Mathews T, 2007, TRENDS SPINA BIFIDA; Mills JL, 2003, AM J CLIN NUTR, V77, P1474, DOI 10.1093/ajcn/77.6.1474; Petrini J. R., 2008, Morbidity and Mortality Weekly Report, V57, P5; [Preventive Services Task Force US US Preventive Services Task Force], 1996, GUID CLIN PREV SERV, P467; Quinlivan EP, 2007, AM J CLIN NUTR, V86, P1773; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Thompson SJ, 2003, ANN EPIDEMIOL, V13, P412, DOI 10.1016/S1047-2797(02)00460-X; Vollset SE, 2005, EPIDEMIOLOGY, V16, P201, DOI 10.1097/01.ede.0000152914.84962.13; Wright JD, 1998, VITAL HLTH STAT, V11, P1; Yang QH, 2007, AM J CLIN NUTR, V85, P1409, DOI 10.1093/ajcn/85.5.1409; Yerby MS, 2003, NEUROLOGY, V61, pS23, DOI 10.1212/WNL.61.6_suppl_2.S23	22	158	169	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					626	U10		10.7326/0003-4819-150-9-200905050-00009	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414842				2022-12-28	WOS:000265903800007
J	Wright, A; Zignol, M; Van Deun, A; Falzon, D; Gerdes, SR; Feldman, K; Hoffner, S; Drobniewski, F; Barrera, L; van Soolingen, D; Boulabhal, F; Paramasivan, CN; Kam, KM; Mitarai, S; Nunn, P; Raviglione, M				Wright, Abigail; Zignol, Matteo; Van Deun, Armand; Falzon, Dennis; Gerdes, Sabine Ruesch; Feldman, Knut; Hoffner, Sven; Drobniewski, Francis; Barrera, Lucia; van Soolingen, Dick; Boulabhal, Fadila; Paramasivan, C. N.; Kam, Kai Man; Mitarai, Satoshi; Nunn, Paul; Raviglione, Mario		Global Project Anti TB Drug Resist	Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance	LANCET			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SENSITIVITY	Background The Global Project on Anti-Tuberculosis Drug Resistance has been gathering data since 1994. This study provides the latest data on the extent of drug resistance worldwide. Methods Data for drug susceptibility were gathered from 90 726 patients in 83 countries and territories between 2002 and 2007. Standardised collection of results enabled comparison both between and within countries. Where possible, data for HIV status and resistance to second-line drugs were also obtained. Laboratory data were quality assured by the Supranational Tuberculosis Reference Laboratory Network. Findings The median prevalence of resistance to any drug in new cases of tuberculosis was 11.1% (IQR 7.0-22.3). The prevalence of multidrug resistance in new tuberculosis cases ranged from 0% in eight countries to 7% in two provinces in China, 11.1% in Northern Mariana Islands (although reporting only two cases), and between 6.8% and 22.3% in nine countries of the former Soviet Union, including 19.4% in Moldova and 22.3% in Baku, Azerbaijan (median for countries surveyed 1.6%, IQR 0.6-3.9). Trend analysis showed that between 1994 and 2007, the prevalence of multidrug-resistant (MDR) tuberculosis in new cases increased substantially in South Korea and in Tomsk Oblast and Orel Oblast, Russia, but was stable in Estonia and Latvia. The prevalence of MDR tuberculosis in all tuberculosis cases decreased in Hong Kong and the USA. 37 countries and territories reported representative data on extensively drug-resistant (XDR) tuberculosis. Five countries, all from the former Soviet Union, reported 25 cases or more of XDR tuberculosis each, with prevalence among MDR-tuberculosis cases ranging between 6.6% and 23.7%. Interpretation MDR tuberculosis remains a threat to tuberculosis control in provinces in China and countries of the former Soviet Union. Data on drug resistance are unavailable in many countries, especially in Africa, emphasising the need to develop easier methods for surveillance of resistance in tuberculosis. Funding Global Project: United States Agency for International Development and Eli Lilly and Company. Drug resistance surveys: national tuberculosis programmes, the Government of the Netherlands, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Japan International Cooperation Agency, and Kreditanstalt fur Wiederaufbau.	[Van Deun, Armand] Int Union TB & Lung Dis, Paris, France; [Wright, Abigail; Zignol, Matteo; Nunn, Paul; Raviglione, Mario] WHO, StopTB Dept, CH-1211 Geneva, Switzerland; [Van Deun, Armand] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Falzon, Dennis] Inst Veille Sanit, EuroTB, St Maurice, France; [Gerdes, Sabine Ruesch] Natl Ref Ctr Mycobacteria, Borstel, Germany; [Feldman, Knut] Asklepios Fachkliniken Munich Gauting, Inst Microbiol & Lab Med, Munich, Germany; [Hoffner, Sven] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Drobniewski, Francis] Dept Infect Dis, Natl Mycobacterium Reference Unit, Hlth Protect Agcy, London, England; [Barrera, Lucia] Natl Inst Infect Dis, Mycobacteria Lab, Buenos Aires, DF, Argentina; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Boulabhal, Fadila] Inst Pasteur, Lab TB, Algiers, Algeria; [Paramasivan, C. N.] Indian Council Med Res, TB Res Ctr, Madras, Tamil Nadu, India; [Kam, Kai Man] Dept Hlth, TB Reference Lab, Hong Kong, Hong Kong, Peoples R China; [Mitarai, Satoshi] Anti TB Assoc, Tokyo, Japan	World Health Organization; Institute of Tropical Medicine (ITM); Institute of Public Health Surveillance; Swedish Institute for Infectious Disease Control; Health Protection Agency; Netherlands National Institute for Public Health & the Environment; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Wright, A (corresponding author), WHO, StopTB Dept, 20 Ave Appia, CH-1211 Geneva, Switzerland.	wrighta@who.int	KAM, Kai Man/K-4546-2012	KAM, Kai Man/0000-0003-0579-0307; RAVIGLIONE, Mario/0000-0002-9331-2067	United States Agency for International Development (USAID); Eli Lilly and Company; national tuberculosis programmes; Government of the Netherlands; Global Fund to Fight AIDS; Tuberculosis and Malaria; Japan International Cooperation Agency; Kreditanstalt fur Wiederaufbau (KfW Entwicklungsbank)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Eli Lilly and Company(Eli Lilly); national tuberculosis programmes; Government of the Netherlands(Netherlands Government); Global Fund to Fight AIDS; Tuberculosis and Malaria; Japan International Cooperation Agency; Kreditanstalt fur Wiederaufbau (KfW Entwicklungsbank)	We thank Brian Williams for reviewing the manuscript. The Global Project on Anti-Tuberculosis Drug Resistance is carried out with funding from United States Agency for International Development (USAID) and Eli Lilly and Company as part of the Lilly MDR-TB Partnership. Drug resistance surveys were supported financially by national tuberculosis programmes, the Government of the Netherlands, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Japan International Cooperation Agency, and Kreditanstalt fur Wiederaufbau (KfW Entwicklungsbank). The laboratories that form the Network of Supranational TB Reference Laboratories are funded principally by their host institutions. AW, MZ, PN, MR are staff members of WHO. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of WHO. The Lancet takes responsibility for all country names used in the manuscript.	Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; CDC, 2006, MMWR-MORBID MORTAL W, V55, P301, DOI DOI 10.1038/NBT1273; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P1176; Cohen T, 2008, AM J RESP CRIT CARE, V177, P1302, DOI 10.1164/rccm.200801-175PP; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; Maher D, 2006, INT J TUBERC LUNG D, V10, P240; *MIN HLTH SOC DEV, 2007, TUB RUSS FED 2006 AN, P126; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Siddiqi S. H., 1996, BACTEC 460TB SYSTEM; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2008, GLOBAL TUBERCULOSIS; *WHO, 2007, WHOHTMTB2007385; *WHO, 2008, WHOHTMTB2008394; WHO, 2017, EST TB MDR TB BEL; World Health Organization, 2008, WHOHTMTB2008392; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	20	295	313	2	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2009	373	9678					1861	1873		10.1016/S0140-6736(09)60331-7	http://dx.doi.org/10.1016/S0140-6736(09)60331-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453ND	19375159				2022-12-28	WOS:000266616400029
J	Skotheim, JM				Skotheim, Jan M.			To Divide or Not to Divide	SCIENCE			English	Editorial Material							CELL-CYCLE; POSITIVE-FEEDBACK; KINASE; YEAST; FAR1; PHOSPHORYLATION; INHIBITION		Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Skotheim, JM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	skotheim@stanford.edu	Skotheim, Jan/C-3238-2015	Skotheim, Jan/0000-0001-8420-6820				Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Justman QA, 2009, SCIENCE, V324, P509, DOI 10.1126/science.1169498; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; MCKINNEY JD, 1993, GENE DEV, V7, P833, DOI 10.1101/gad.7.5.833; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	9	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					476	477		10.1126/science.1173769	http://dx.doi.org/10.1126/science.1173769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390035				2022-12-28	WOS:000265411200034
J	Kringelbach, ML; Aziz, TZ				Kringelbach, Morten L.; Aziz, Tipu Z.			Deep Brain Stimulation Avoiding the Errors of Psychosurgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PARKINSONISM; NUCLEUS; DISEASE; PAIN		[Kringelbach, Morten L.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Kringelbach, Morten L.] Univ Aarhus, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Kringelbach, Morten L.; Aziz, Tipu Z.] John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England	University of Oxford; Aarhus University; University of Oxford	Kringelbach, ML (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	morten.kringelbach@psych.ox.ac.uk	Kringelbach, Morten/AAW-5847-2021; Kringelbach, Morten L/AAF-5508-2020	Kringelbach, Morten/0000-0002-3908-6898; 				[Anonymous], 2002, NEUROSURGERY, V51, P519, DOI 10.1227/01.NEU.0000023150.01402.18; AZIZ TZ, 1991, MOVEMENT DISORD, V6, P288, DOI 10.1002/mds.870060404; Bittar RG, 2005, J CLIN NEUROSCI, V12, P457, DOI 10.1016/j.jocn.2004.09.001; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Franzini A, 2003, NEUROSURGERY, V52, P1095, DOI 10.1227/01.NEU.0000057698.29634.D6; Jenkinson N, 2004, NEUROREPORT, V15, P2621, DOI 10.1097/00001756-200412030-00012; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kringelbach ML, 2007, NEUROREPORT, V18, P223, DOI 10.1097/WNR.0b013e328010dc3d; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Sydow O, 2003, J NEUROL NEUROSUR PS, V74, P1387, DOI 10.1136/jnnp.74.10.1387; Valenstein E.S., 1973, BRAIN CONTROL CRITIC; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; ZAMINSKA N, 2008, WALL STREET J   0428, pA11	15	26	26	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1705	1707		10.1001/jama.2009.551	http://dx.doi.org/10.1001/jama.2009.551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435NN	19383961				2022-12-28	WOS:000265350700026
J	Cave, J				Cave, James			This House believes doctors are neglecting their duty to lead health service change: Opposer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drjcave@btinternet.com		Cave, James/0000-0003-0721-9534				Darzi A., 2008, HIGH QUALITY CARE AL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2009	338								b1577	10.1136/bmj.b1577	http://dx.doi.org/10.1136/bmj.b1577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OO	19383754				2022-12-28	WOS:000265497000005
J	Hirano, M; DiMauro, S				Hirano, Michio; DiMauro, Salvatore			VMA21 Deficiency: A Case of Myocyte Indigestion	CELL			English	Editorial Material							SUBUNIT; DISEASE; AUTOPHAGY; MUTATIONS; MYOPATHY	The Vma21p protein in yeast is an essential assembly chaperone for the vacuolar ATPase, the major proton pump of cellular membranes. In this issue, Ramachandran et al. ( 2009) report that mutations in the gene encoding the human homolog VMA21 cause the disease X-linked myopathy with excessive autophagy through an unexpected mechanism.	[Hirano, Michio; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA	Columbia University	Hirano, M (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.	mh29@columbia.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062, R01HD057543] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD32062, P01 HD032062, R01 HD057543, R01 HD057543-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; KALIMO H, 1988, ANN NEUROL, V23, P258, DOI 10.1002/ana.410230308; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408	8	4	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					213	215		10.1016/j.cell.2009.04.005	http://dx.doi.org/10.1016/j.cell.2009.04.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379689	Green Accepted, Bronze			2022-12-28	WOS:000265456800015
J	Li, X; Cassidy, JJ; Reinke, CA; Fischboeck, S; Carthew, RW				Li, Xin; Cassidy, Justin J.; Reinke, Catherine A.; Fischboeck, Stephen; Carthew, Richard W.			A MicroRNA Imparts Robustness against Environmental Fluctuation during Development	CELL			English	Article							TRANSCRIPTIONAL REPRESSOR; SIGNAL INTEGRATION; NETWORK MOTIFS; TARGET GENES; NOTCH; CANALIZATION; EXPRESSION; FEEDBACK; RECEPTOR; DIFFERENTIATION	The microRNA miR-7 is perfectly conserved from annelids to humans, and yet some of the genes that it regulates in Drosophila are not regulated in mammals. We have explored the role of lineage restricted targets, using Drosophila, in order to better understand the evolutionary significance of microRNA-target relationships. From studies of two well characterized developmental regulatory networks, we find that miR-7 functions in several interlocking feedback and feedforward loops, and propose that its role in these networks is to buffer them against perturbation. To directly demonstrate this function for miR-7, we subjected the networks to temperature fluctuation and found that miR-7 is essential for the maintenance of regulatory stability under conditions of environmental flux. We suggest that some conserved microRNAs like miR-7 may enter into novel genetic relationships to buffer developmental programs against variation and impart robustness to diverse regulatory networks.	[Li, Xin; Cassidy, Justin J.; Reinke, Catherine A.; Fischboeck, Stephen; Carthew, Richard W.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	r-carthew@northwestern.edu	Li, Xin/D-3421-2013	Li, Xin/0000-0002-3428-3569	Chicago Biomedical Consortium; Chicago Community Trust; NIH [GM077581]; Northwestern Vision Training Grant; CMDB Training; Malkin Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Chicago Community Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern Vision Training Grant; CMDB Training; Malkin Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bellen, S. Bray, C. Delidakis, S. Cohen, T. Hayashi, G. Mardon, and the Bloomington stock center for fly strains; N. Baker, H. Bellen, T. Hayashi, Z.C. Lai, and the Developmental Studies Hybridoma Bank for antibodies; T. Hayashi for sharing unpublished data; R. Gejman for advice and help with all stages of the informatic analysis; Carthew lab members and C. Labonne for discussions; the Biology Imaging Facility at Northwestern University for imaging. This work was supported by the by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust, the NIH (GM077581), the Northwestern Vision Training Grant (C.A.R.), the CMDB Training Grant (J.J.C.), and the Malkin Scholars program.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cave JW, 2005, CURR BIOL, V15, P94, DOI 10.1016/j.cub.2004.12.070; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gibson G, 1996, SCIENCE, V271, P200, DOI 10.1126/science.271.5246.200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Jander U, 2002, ARTHROPOD STRUCT DEV, V30, P179, DOI 10.1016/S1467-8039(01)00035-4; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakahara K, 2005, P NATL ACAD SCI USA, V102, P12023, DOI 10.1073/pnas.0500053102; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Powell LM, 2004, MOL CELL BIOL, V24, P9517, DOI 10.1128/MCB.24.21.9517-9526.2004; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; RENDEL J. M., 1960, AUSTRALIAN JOUR BIOL SCI, V13, P36; RENDEL JM, 1959, EVOLUTION, V13, P425, DOI 10.1111/j.1558-5646.1959.tb03033.x; Rohrbaugh M, 2002, CURR BIOL, V12, P576, DOI 10.1016/S0960-9822(02)00743-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Strausfeld N. J., 1981, HDB SENSORY PHYSL, VVII, P1; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0	60	349	364	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					273	282		10.1016/j.cell.2009.01.058	http://dx.doi.org/10.1016/j.cell.2009.01.058			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379693	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000265456800020
J	Armstrong, N; Vale, L; Deverill, M; Nabi, G; McClinton, S; N'Dow, J; Pickard, R				Armstrong, Nigel; Vale, Luke; Deverill, Mark; Nabi, Ghulam; McClinton, Samuel; N'Dow, James; Pickard, Robert		BPE Study Grp	Surgical treatments for men with benign prostatic enlargement: cost effectiveness study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSURETHRAL MICROWAVE THERMOTHERAPY; URINARY-TRACT SYMPTOMS; PHOTOSELECTIVE VAPORIZATION; RANDOMIZED-TRIAL; HYPERPLASIA; PROSTATECTOMY; RESECTION; MORTALITY	Objective To determine which surgical treatment for lower urinary tract symptoms suggestive of benign prostate enlargement is cost effective. Design Care pathways describing credible treatment strategies were decided by consensus. Cost-utility analysis used Markov modelling and Monte Carlo simulation. Data sources Clinical effectiveness data came from a systematic review and an individual level dataset. Utility values came from previous economic evaluations. Costs were calculated from National Health Service (NHS) and commercial sources. Methods The Markov model included parameters with associated measures of uncertainty describing health states between which individuals might move at three monthly intervals over 10 years. Successive annual cohorts of 25 000 men were entered into the model and the probability that treatment strategies were cost effective was assessed with Monte Carlo simulation with 10 000 iterations. Results A treatment strategy of initial diathermy vaporisation of the prostate followed by endoscopic holmium laser enucleation of the prostate in case of failure to benefit or subsequent relapse had an 85% probability of being cost effective at a willingness to pay value of 20 pound 000 ((sic)21 595, $28 686)/quality adjusted life year (QALY) gained. Other strategies with diathermy vaporisation as the initial treatment were generally cheaper and more effective than the current standard of transurethral resection repeated once if necessary. The use of potassium titanyl phosphate laser vaporisation incurred higher costs and was less effective than transurethral resection, and strategies involving initial minimally invasive treatment with microwave thermotherapy were not cost effective. Findings were unchanged by wide ranging sensitivity analyses. Conclusion The outcome of this economic model should be interpreted cautiously because of the limitations of the data used. The finding that initial vaporisation followed by holmium laser enucleation for failure or relapse might be advantageous both to men with lower urinary tract symptoms and to healthcare providers requires confirmation in a good quality prospective clinical trial before any change in current practice. Potassium titanyl phosphate laser vaporisation was unlikely to be cost effective in our model, which argues against its unrestricted use until further evidence of effectiveness and cost reduction is obtained.	[Pickard, Robert] Univ Newcastle, Inst Cellular Med, Urol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Armstrong, Nigel] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Vale, Luke] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland; [Vale, Luke] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Nabi, Ghulam; McClinton, Samuel; N'Dow, James] Univ Aberdeen, Inst Appl Hlth Sci, Acad Urol Unit, Aberdeen AB25 2ZD, Scotland	Newcastle University - UK; Newcastle University - UK; University of Aberdeen; University of Aberdeen; University of Aberdeen	Pickard, R (corresponding author), Univ Newcastle, Inst Cellular Med, Urol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.s.pickard@ncl.ac.uk		Nabi, Ghulam/0000-0002-4864-9445; Vale, Luke/0000-0001-8574-8429	Health Technology Assessment Programme [04/38/03]; National Institute for Health Research [04/38/03] Funding Source: researchfish; Chief Scientist Office [HERU2, HSRU1, HERU1] Funding Source: researchfish	Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	This study was funded by the Health Technology Assessment Programme (project No 04/38/03). The views expressed in this paper are those of the authors not the institutions providing funding. An extensive monograph describing the whole project of which this analysis is a part is available for open access (Lourenco T, Armstrong N, N'Dow J, Nabi G, Deverill M, Pickard R, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 2008; 12: 1516).	Ackerman SJ, 2000, UROLOGY, V56, P972, DOI 10.1016/S0090-4295(00)00828-1; Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; *AM UR ASS, 2003, GUID MAN BEN PROST H; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Blute M, 2000, UROLOGY, V56, P981, DOI 10.1016/S0090-4295(00)00829-3; Boyle P, 2003, BJU INT, V92, P409, DOI 10.1046/j.1464-410X.2003.04369.x; Briggs A., 2001, EC EVALUATION HLTH C; *DEP HLTH, 2005, NHS REF COSTS NHS TR; DiSantostefano RL, 2006, PHARMACOECONOMICS, V24, P171, DOI 10.2165/00019053-200624020-00006; Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3; Francisca EAE, 1999, J UROLOGY, V161, P486, DOI 10.1016/S0022-5347(01)61930-X; Harding C, 2007, EUR UROL, V52, P186, DOI 10.1016/j.eururo.2006.11.009; Horasanli K, 2008, UROLOGY, V71, P247, DOI 10.1016/j.urology.2007.09.017; HOWARD K, 2002, MSAC APPL, V1014; Kok ET, 2002, EUR UROL, V42, P491, DOI 10.1016/S0302-2838(02)00403-7; Lourenco T, 2008, HEALTH TECHNOL ASSES, V12, P1; Lourenco Tania, 2008, BMJ, V337, pa449, DOI 10.1136/bmj.39575.517674.BE; Lourenco T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1662; Madersbacher S, 2005, EUR UROL, V47, P499, DOI 10.1016/j.eururo.2004.12.010; MEBUST WK, 1989, J UROLOGY, V141, P243, DOI 10.1016/S0022-5347(17)40731-2; *NIH CLIN EXC, GUID MAN 2007; Noble SM, 2002, J UROLOGY, V168, P2476, DOI 10.1016/S0022-5347(05)64172-9; Norby B, 2002, SCAND J UROL NEPHROL, V36, P286, DOI 10.1080/003655902320248263; SEAGROATT V, 1995, LANCET, V346, P1521, DOI 10.1016/S0140-6736(95)92052-8; Stafinski T, 2008, CUAJ-CAN UROL ASSOC, V2, P124; Stovsky MD, 2006, J UROLOGY, V176, P1500, DOI 10.1016/j.juro.2006.06.064; Tooher R, 2004, J UROLOGY, V171, P1773, DOI 10.1097/01.ju.0000113494.03668.6d; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; Watson V, 2004, J UROLOGY, V172, P2321, DOI 10.1097/01.ju.0000140957.31325.7f	29	16	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2009	338								b1288	10.1136/bmj.b1288	http://dx.doi.org/10.1136/bmj.b1288			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TK	19372131	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000265296800003
J	Christoffels, VM; Grieskamp, T; Norden, J; Mommersteeg, MTM; Rudat, C; Kispert, A				Christoffels, Vincent M.; Grieskamp, Thomas; Norden, Julia; Mommersteeg, Mathilda T. M.; Rudat, Carsten; Kispert, Andreas			Tbx18 and the fate of epicardial progenitors	NATURE			English	Letter							CELLS; HEART; LINEAGE; EXPRESSION		[Christoffels, Vincent M.; Mommersteeg, Mathilda T. M.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat & Embryol, NL-1105 AZ Amsterdam, Netherlands; [Grieskamp, Thomas; Norden, Julia; Rudat, Carsten; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, OE5250, D-30625 Hannover, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Hannover Medical School	Christoffels, VM (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat & Embryol, Meibergdreef 15 L2-108, NL-1105 AZ Amsterdam, Netherlands.	kispert.andreas@mh-hannover.de		Mommersteeg, Mathilda/0000-0001-6624-3038				Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Franco D, 2006, DEV BIOL, V294, P366, DOI 10.1016/j.ydbio.2006.02.045; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; Moore AW, 1999, DEVELOPMENT, V126, P1845; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	15	208	217	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					E8	E9		10.1038/nature07916	http://dx.doi.org/10.1038/nature07916			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19369973				2022-12-28	WOS:000265182500032
J	Hoge, CW; Goldberg, HM; Castro, CA				Hoge, Charles W.; Goldberg, Herb M.; Castro, Carl A.			Care of War Veterans with Mild Traumatic Brain Injury - Flawed Perspectives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hoge, Charles W.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD USA; [Goldberg, Herb M.] Walter Reed Army Inst Res, Battlemind Training Off, Silver Spring, MD USA; [Castro, Carl A.] USA, Med Res & Mat Command, Mil Operat Med Res Program, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Hoge, CW (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD USA.							Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; McCrea M., 2008, MILD TRAUMATIC BRAIN; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	5	200	202	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1588	1591		10.1056/NEJMp0810606	http://dx.doi.org/10.1056/NEJMp0810606			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433BH	19369664				2022-12-28	WOS:000265178000002
J	Elsaesser, H; Sauer, K; Brooks, DG				Elsaesser, Heidi; Sauer, Karsten; Brooks, David G.			IL-21 Is Required to Control Chronic Viral Infection	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ACUTE HEPATITIS-C; T-CELL RESPONSES; IMMUNE EVASION; PERSISTENCE; CD8; INTERLEUKIN-21; EXHAUSTION; CLEARANCE; RECEPTOR	CD4(+) and CD8(+) T cell functions are rapidly aborted during chronic infection, preventing viral clearance. CD4(+) T cell help is required throughout chronic infection so as to sustain CD8(+) T cell responses; however, the necessary factor(s) provided by CD4(+) T cells are currently unknown. Using a mouse model of chronic viral infection, we demonstrated that interleukin-21 (IL-21) is an essential component of CD4(+) T cell help. In the absence of IL-21 signaling, despite elevated CD4(+) T cell responses, CD8(+) T cell responses are severely impaired. CD8(+) T cells directly require IL-21 to avoid deletion, maintain immunity, and resolve persistent infection. Thus, IL-21 specifically sustains CD8(+) T cell effector activity and provides a mechanism of CD4(+) T cell help during chronic viral infection.	[Elsaesser, Heidi; Brooks, David G.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Elsaesser, Heidi; Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Scripps Research Institute	Brooks, DG (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	dbrooks@em.ucla.edu		Brooks, David/0000-0001-7763-8764	M. Oldstone [AI09484]; UCLA Center for AIDS Research; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NIH [AI077012, AI082975, AI070845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082975, R01AI085043, R21AI077012, R01AI070845] Funding Source: NIH RePORTER	M. Oldstone; UCLA Center for AIDS Research; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Oldstone for his generous support (AI09484). Our work was supported by the UCLA Center for AIDS Research, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, and NIH grants AI077012, AI082975 (to D.G.B.), and AI070845 (to K.S.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Holm C, 2006, CYTOKINE, V33, P41, DOI 10.1016/j.cyto.2005.11.014; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Smyk-Pearson S, 2008, J VIROL, V82, P1827, DOI 10.1128/JVI.01581-07; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	21	411	425	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1569	1572		10.1126/science.1174182	http://dx.doi.org/10.1126/science.1174182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19423777	Green Accepted			2022-12-28	WOS:000267130600046
J	Cripe, LD				Cripe, Larry D.			Giving Up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lcripe@iupui.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1747	1748		10.1001/jama.2009.550	http://dx.doi.org/10.1001/jama.2009.550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19417181				2022-12-28	WOS:000265742500001
J	Mahmoodi, BK; Gansevoort, RT; Veeger, NJGM; Matthews, AG; Navis, G; Hillege, HL; van der Meer, J				Mahmoodi, Bakhtawar K.; Gansevoort, Ron T.; Veeger, Nic J. G. M.; Matthews, Abigail G.; Navis, Gerjan; Hillege, Hans L.; van der Meer, Jan		PREVEND Study Grp	Microalbuminuria and Risk of Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							URINARY ALBUMIN EXCRETION; HEMOSTATIC FACTORS; CARDIOVASCULAR EVENTS; THROMBOSIS; POPULATION; ARTERIAL; INFLAMMATION; ASSOCIATION; PREDICTOR; DAMAGE	Context Microalbuminuria (albuminuria 30-300 mg per 24-hour urine collection) is a well-known risk marker for arterial thromboembolism. It is assumed that microalbuminuria reflects generalized endothelial dysfunction. Hence, microalbuminuria may also predispose for venous thromboembolism (VTE). Objective To assess whether microalbuminuria is associated with VTE. Design, Setting, and Participants Prevention of Renal and Vascular End-stage Disease (PREVEND) study, an ongoing community-based prospective cohort study initiated in 1997. All inhabitants of Groningen, the Netherlands, aged 28 through 75 years (n=85 421) were sent a postal questionnaire and a vial to collect a first morning urine sample for measurement of urinary albumin concentration. Of those who responded (40 856), a cohort (8592 participants) including more participants with higher levels of urinary albumin concentration completed screening at an outpatient clinic. Screening data were collected on urinary albumin excretion (UAE) and risk factors for cardiovascular and renal disease. Main Outcome Measure Symptomatic and objectively verified VTE (ie, deep vein thrombosis, pulmonary embolism, or both) between study initiation and June 1, 2007. Results Of 8574 evaluable participants (mean [SD] age, 49 [13] years; 50% men), 129 experienced VTE during a mean (SD) follow-up period of 8.6 (1.8) years, corresponding to overall annual incidence of 0.14% (95% confidence interval [CI], 0.11%-0.19%). Annual incidences were 0.12%, 0.20%, 0.40%, and 0.56% in participants with UAE of less than 15 (n=6013), 15-29 (n=1283), 30-300 (n=1144), and greater than 300 (n=134) mg per 24-hour urine collection, respectively (P for trend <.001). When adjusted for age, cancer, use of oral contraceptives, and atherosclerosis risk factors, hazard ratios associated with UAE levels of 15-29, 30-300, and greater than 300 mg/24 h were 1.40 (95% CI, 0.86-2.35), 2.20 (95% CI, 1.44-3.36), and 2.82 (95% CI, 1.21-6.61), respectively, compared with participants with UAE of less than 15 mg/24 h (global P=.001). Adjusted hazard ratio for microalbuminuria vs normoalbuminuria (UAE<30 mg/24 h) was 2.00 (95% CI, 1.34-2.98; P<.001). Microalbuminuria-related number needed to harm was 388 per year. Conclusion Microalbuminuria is independently associated with an increased risk for VTE.	[Mahmoodi, Bakhtawar K.; Veeger, Nic J. G. M.; van der Meer, Jan] Univ Groningen, Univ Med Ctr Groningen, Div Hemostasis Thrombosis & Rheol, Dept Hematol, NL-9713 GZ Groningen, Netherlands; [Gansevoort, Ron T.; Navis, Gerjan] Univ Med Ctr Groningen, Dept Nephrol, NL-9713 GZ Groningen, Netherlands; [Veeger, Nic J. G. M.; Hillege, Hans L.] Univ Med Ctr Groningen, Trial Coordinat Ctr, Dept Epidemiol, NL-9713 GZ Groningen, Netherlands; [Matthews, Abigail G.] Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	University of Groningen; University of Groningen; University of Groningen; Rockefeller University	Mahmoodi, BK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Hemostasis Thrombosis & Rheol, Dept Hematol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	b.k.mahmoodi@int.umcg.nl	Veeger, Nic JGM/F-2966-2013; Mahmoodi, Bakhtawar/ABA-7050-2020	Veeger, Nic JGM/0000-0002-1492-7937; 	Dutch Kidney Foundation	Dutch Kidney Foundation	The PREVEND Study has been made possible by grants from the Dutch Kidney Foundation.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; AGEWALL S, 1995, J INTERN MED, V237, P195, DOI 10.1111/j.1365-2796.1995.tb01161.x; Agewall S, 2001, ATHEROSCLEROSIS, V157, P197, DOI 10.1016/S0021-9150(00)00706-1; [Anonymous], 2007, SURVEY DATA REFERENC; [Anonymous], 2007, SURVIVAL ANAL EPIDEM; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Borch-Johnsen K, 1999, ARTERIOSCL THROM VAS, V19, P1992, DOI 10.1161/01.ATV.19.8.1992; Clausen P, 1999, CLIN SCI, V97, P37, DOI 10.1042/CS19990002; COLLIER A, 1992, DIABETES, V41, P909, DOI 10.2337/diabetes.41.8.909; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Deguchi H, 2005, CIRCULATION, V112, P893, DOI 10.1161/CIRCULATIONAHA.104.521344; Festa A, 2000, KIDNEY INT, V58, P1703, DOI 10.1046/j.1523-1755.2000.00331.x; Franchini M, 2008, THROMB RES, V122, P727, DOI 10.1016/j.thromres.2007.09.010; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; GRUDEN G, 1994, DIABETES, V43, P426, DOI 10.2337/diabetes.43.3.426; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hansson PO, 1999, ARCH INTERN MED, V159, P1886, DOI 10.1001/archinte.159.16.1886; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Kario K, 1996, ARTERIOSCL THROM VAS, V16, P455, DOI 10.1161/01.ATV.16.3.455; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mahmoodi BK, 2008, CIRCULATION, V117, P224, DOI 10.1161/CIRCULATIONAHA.107.716951; Migliacci R, 2007, HAEMATOLOGICA, V92, P812, DOI 10.3324/haematol.10872; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Petrauskiene V, 2005, DIABETOLOGIA, V48, P1017, DOI 10.1007/s00125-005-1715-5; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Ray JG, 2007, QJM-INT J MED, V100, P679, DOI 10.1093/qjmed/hcm083; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Virchow RLK., 1856, GESAMMELTE ABH; Yuyun MF, 2004, J INTERN MED, V255, P247, DOI 10.1046/j.1365-2796.2003.01264.x	39	148	152	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1790	1797		10.1001/jama.2009.565	http://dx.doi.org/10.1001/jama.2009.565			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19417196	Bronze			2022-12-28	WOS:000265742500028
J	Sessions, SY; Detsky, AS				Sessions, Samuel Y.; Detsky, Allan S.			Employment and US Health Care Reform Saving Jobs While Cutting Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Sessions, Samuel Y.] Harbor UCLA Med Ctr, Dept Psychiat & Biobehav Sci, Torrance, CA 90509 USA; [Sessions, Samuel Y.] Harbor UCLA Med Ctr, LABiomed, Torrance, CA 90509 USA; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Toronto; University of Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 427-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Aaron HJ, 2008, NEW ENGL J MED, V359, P1865, DOI 10.1056/NEJMp0807204; AMBINDER M, 2009, ATLANTIC        0205; [Anonymous], 2009, ECONOMIST       0312; Bodenheimer T, 2005, ANN INTERN MED, V142, P996, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00009; *BUR LAB STAT, EMPL SIT FEBR 2009; Congressional Budget Office, 2007, LONG TERM BUDG OUTL; Fuchs VR, 2008, NEW ENGL J MED, V359, P1749, DOI 10.1056/NEJMp0807432; Fuchs VR, 2009, JAMA-J AM MED ASSOC, V301, P963, DOI 10.1001/jama.2009.248; GLIED S, 2008, 10029 NAT BUR EC RES; Gordon C, 2003, POLIT SOC TWENTIETH, P1; Iglehart JK, 2009, NEW ENGL J MED, V360, P1381, DOI 10.1056/NEJMp0901927; PEAR R, 2009, NY TIMES        0305; RELMAN AS, 2007, 2 OPINION RESCUING A, P53; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	14	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1811	1813		10.1001/jama.2009.571	http://dx.doi.org/10.1001/jama.2009.571			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19417199				2022-12-28	WOS:000265742500032
J	Vousden, KH; Prives, C				Vousden, Karen H.; Prives, Carol			Blinded by the Light: The Growing Complexity of p53	CELL			English	Review							TUMOR-SUPPRESSOR P53; CELL-CYCLE ARREST; INTERACTING PROTEIN KINASE-2; CAENORHABDITIS-ELEGANS P53; FACTOR-BINDING-SITES; DNA-DAMAGE; IN-VIVO; GENE-EXPRESSION; P53-MEDIATED APOPTOSIS; POSTTRANSLATIONAL MODIFICATIONS	While the tumor suppressor functions of p53 have long been recognized, the contribution of p53 to numerous other aspects of disease and normal life is only now being appreciated. This burgeoning range of responses to p53 is reflected by an increasing variety of mechanisms through which p53 can function, although the ability to activate transcription remains key to p53's modus operandi. Control of p53's transcriptional activity is crucial for determining which p53 response is activated, a decision we must understand if we are to exploit efficiently the next generation of drugs that selectively activate or inhibit p53.	[Vousden, Karen H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Beatson Institute; Columbia University	Vousden, KH (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk; clp3@columbia.edu			Cancer Research UK; NCI [CA77742]; NATIONAL CANCER INSTITUTE [R01CA077742] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Ryan and E. Gottlieb for helpful suggestions and acknowledge funding support from Cancer Research UK (K. H. V.) and NCI grant number CA77742 (C. P.).	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Aranda-Anzaldo A, 2007, MECH AGEING DEV, V128, P293, DOI 10.1016/j.mad.2007.01.001; Arum O, 2007, J GERONTOL A-BIOL, V62, P951, DOI 10.1093/gerona/62.9.951; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Augustyn KE, 2007, P NATL ACAD SCI USA, V104, P18907, DOI 10.1073/pnas.0709326104; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Baptiste-Okoh N, 2008, CELL CYCLE, V7, P1133, DOI 10.4161/cc.7.9.5805; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Berns A, 2006, NATURE, V443, P153, DOI 10.1038/443153a; Bertheau P, 2008, PATHOBIOLOGY, V75, P132, DOI 10.1159/000123851; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Bruins W, 2007, CARCINOGENESIS, V28, P1814, DOI 10.1093/carcin/bgm041; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budhram-Mahadeo VS, 2006, NUCLEIC ACIDS RES, V34, P6640, DOI 10.1093/nar/gkl878; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cecchinelli B, 2006, CELL DEATH DIFFER, V13, P1994, DOI 10.1038/sj.cdd.4401933; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Culmsee Carsten, 2006, Current Alzheimer Research, V3, P269, DOI 10.2174/156720506778249461; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Ding K, 2005, J AM CHEM SOC, V127, P10130, DOI 10.1021/ja051147z; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Esteve PO, 2007, J BIOL CHEM, V282, P2615, DOI 10.1074/jbc.M606203200; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Fogal V, 2005, EMBO J, V24, P2768, DOI 10.1038/sj.emboj.7600735; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hearnes JM, 2005, MOL CELL BIOL, V25, P10148, DOI 10.1128/MCB.25.22.10148-10158.2005; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Hudson CD, 2005, J BIOL CHEM, V280, P11851, DOI 10.1074/jbc.M408679200; Iizuka M, 2008, MOL CELL BIOL, V28, P140, DOI 10.1128/MCB.00662-07; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kondoh H, 2005, CANCER RES, V65, P177; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kranz D, 2006, CANCER RES, V66, P10274, DOI 10.1158/0008-5472.CAN-06-1527; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lanni C, 2007, J ALZHEIMERS DIS, V12, P93; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Liu PT, 2006, SHOCK, V26, P608, DOI 10.1097/01.shk.0000232273.11225.af; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matsui T, 2004, J BIOL CHEM, V279, P25093, DOI 10.1074/jbc.M403232200; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; McLure KG, 2004, MOL CELL BIOL, V24, P9958, DOI 10.1128/MCB.24.22.9958-9967.2004; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Miled C, 2005, CANCER RES, V65, P5096, DOI 10.1158/0008-5472.CAN-04-4232; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Morselli E, 2008, CELL CYCLE, V7, P3056, DOI 10.4161/cc.7.19.6751; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pan YP, 2008, J PHYS CHEM B, V112, P6716, DOI 10.1021/jp800680w; Paris R, 2008, CELL CYCLE, V7, P2427, DOI 10.4161/cc.6420; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Piccolo S, 2008, CELL, V133, P767, DOI 10.1016/j.cell.2008.05.013; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Poyurovsky MV, 2006, GENE DEV, V20, P125, DOI 10.1101/gad.1397506; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Rother K, 2007, CELL CYCLE, V6, P853, DOI 10.4161/cc.6.7.4017; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sbisa E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S20; Schuler M, 2005, TRENDS GENET, V21, P182, DOI 10.1016/j.tig.2005.01.001; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Sengupta S, 2005, ONCOGENE, V24, P1738, DOI 10.1038/sj.onc.1208380; Senzer N, 2009, CURR OPIN MOL THER, V11, P54; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shmueli A, 2007, MOL CELL, V25, P794, DOI 10.1016/j.molcel.2007.03.006; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; St Clair S, 2004, MOL CELL, V16, P725; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Sutcliffe JE, 2004, FEBS LETT, V567, P86, DOI 10.1016/j.febslet.2004.03.122; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Van Nguyen T, 2007, J EXP MED, V204, P1453, DOI 10.1084/jem.20062453; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wei G, 2005, J BIOL CHEM, V280, P12271, DOI 10.1074/jbc.M409522200; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; Wilkinson DS, 2008, MOL CELL BIOL, V28, P1988, DOI 10.1128/MCB.01442-07; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6; Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173; Zhan MC, 2005, J BIOL CHEM, V280, P4825, DOI 10.1074/jbc.M407450200; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zupnick A, 2006, J BIOL CHEM, V281, P20464, DOI 10.1074/jbc.M603387200	228	2209	2290	7	331	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					413	431		10.1016/j.cell.2009.04.037	http://dx.doi.org/10.1016/j.cell.2009.04.037			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410540	Bronze			2022-12-28	WOS:000265677200013
J	McHutchison, JG; Everson, GT; Gordon, SC; Jacobson, IM; Sulkowski, M; Kauffman, R; McNair, L; Alam, J; Muir, AJ				McHutchison, John G.; Everson, Gregory T.; Gordon, Stuart C.; Jacobson, Ira M.; Sulkowski, Mark; Kauffman, Robert; McNair, Lindsay; Alam, John; Muir, Andrew J.		PROVE1 Study Team	Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; PLUS RIBAVIRIN; ALPHA-2B; VX-950; INHIBITOR	BACKGROUND Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of patients infected with HCV genotype 1. Telaprevir, a protease inhibitor specific to the HCV nonstructural 3/4A serine protease, rapidly reduced HCV RNA levels in early studies. METHODS We randomly assigned patients infected with HCV genotype 1 to one of three telaprevir groups or to the control group. The control group (called the PR48 group) received peginterferon alfa-2a (180 mu g per week) and ribavirin (1000 or 1200 mg per day, according to body weight) for 48 weeks, plus telaprevir-matched placebo for the first 12 weeks (75 patients). The telaprevir groups received telaprevir (1250 mg on day 1 and 750 mg every 8 hours thereafter) for 12 weeks, as well as peginterferon alfa-2a and ribavirin (at the same doses as in the PR48 group) for the same 12 weeks (the T12PR12 group, 17 patients) or for a total of 24 weeks (the T12PR24 group, 79 patients) or 48 weeks (the T12PR48 group, 79 patients). The primary outcome was a sustained virologic response (an undetectable HCV RNA level 24 weeks after the end of therapy). RESULTS The rate of sustained virologic response was 41% (31 of 75 patients) in the PR48 group, as compared with 61% (48 of 79 patients) in the T12PR24 group (P = 0.02), 67% (53 of 79 patients) in the T12PR48 group (P = 0.002), and 35% (6 of 17 patients) in the T12PR12 group (this group was exploratory and not compared with the control group). Viral breakthrough occurred in 7% of patients receiving telaprevir. The rate of discontinuation because of adverse events was higher in the three telaprevir-based groups (21%, vs. 11% in the PR48 group), with rash the most common reason for discontinuation. CONCLUSIONS Treatment with a telaprevir-based regimen significantly improved sustained virologic response rates in patients with genotype 1 HCV, albeit with higher rates of discontinuation because of adverse events. (ClinicalTrials.gov number, NCT00336479.)	[McHutchison, John G.; Muir, Andrew J.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; [Everson, Gregory T.] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol & Hepatol, Denver, CO USA; [Gordon, Stuart C.] Henry Ford Hosp, Div Hepatol, Detroit, MI 48202 USA; [Jacobson, Ira M.] Weill Cornell Med Coll, Div Gastroenterol & Hepatol, New York, NY USA; [Sulkowski, Mark] Johns Hopkins Univ, Baltimore, MD USA; [Kauffman, Robert; McNair, Lindsay; Alam, John] Vertex Pharmaceut, Cambridge, MA USA	Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Henry Ford Health System; Henry Ford Hospital; Cornell University; Johns Hopkins University; Vertex Pharmaceuticals	McHutchison, JG (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	mchut001@mc.duke.edu	Vargas, Hugo E./K-1562-2019; Yang, Chen/G-1379-2010	Vargas, Hugo E./0000-0002-7802-688X; Afdhal, Nezam/0000-0002-7342-6593; Dienstag, Jules/0000-0001-7024-0980; McNair, Lindsay/0000-0003-2458-8550	Vertex Pharmaceuticals	Vertex Pharmaceuticals(Vertex Pharmaceuticals)	Supported by Vertex Pharmaceuticals.	[Anonymous], HEP C; Di Bisceglie AM, 2003, AM J GASTROENTEROL, V98, P2060, DOI 10.1111/j.1572-0241.2003.t01-1-07641.x; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; Forestier N, 2007, HEPATOLOGY, V46, P640, DOI 10.1002/hep.21774; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lawitz E, 2008, J HEPATOL, V49, P163, DOI 10.1016/j.jhep.2008.03.027; Lin C., 2006, Infectious Disorders - Drug Targets, V6, P3, DOI 10.2174/187152606776056706; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MANNS MP, 2008, NAT REV DRUG DISCOV, V7, P458; MANNS MP, 2008, NAT REV DRUG DISCOV, V7, P102; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Muir AJ, 2004, NEW ENGL J MED, V351, P1268; Organ Procurement and Transplantation Network, 2008, US LIV TRANSPL PERF; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; SULKOWSKI M, 2008, 43 ANN M EUR ASS STU; Zhou Y, 2006, 13 INT S HEP C VIR R	24	874	917	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1827	1838		10.1056/NEJMoa0806104	http://dx.doi.org/10.1056/NEJMoa0806104			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403902	Green Published			2022-12-28	WOS:000265560300005
J	Meinshausen, M; Meinshausen, N; Hare, W; Raper, SCB; Frieler, K; Knutti, R; Frame, DJ; Allen, MR				Meinshausen, Malte; Meinshausen, Nicolai; Hare, William; Raper, Sarah C. B.; Frieler, Katja; Knutti, Reto; Frame, David J.; Allen, Myles R.			Greenhouse-gas emission targets for limiting global warming to 2 degrees C	NATURE			English	Article							CLIMATE SENSITIVITY; TEMPERATURE; UNCERTAINTIES; PROJECTIONS; INCREASE; CYCLE	More than 100 countries have adopted a global warming limit of 2 degrees C or below ( relative to pre-industrial levels) as a guiding principle for mitigation efforts to reduce climate change risks, impacts and damages(1,2). However, the greenhouse gas (GHG) emissions corresponding to a specified maximum warming are poorly known owing to uncertainties in the carbon cycle and the climate response. Here we provide a comprehensive probabilistic analysis aimed at quantifying GHG emission budgets for the 2000-50 period that would limit warming throughout the twenty-first century to below 2 degrees C, based on a combination of published distributions of climate system properties and observational constraints. We show that, for the chosen class of emission scenarios, both cumulative emissions up to 2050 and emission levels in 2050 are robust indicators of the probability that twenty-first century warming will not exceed 2 degrees C relative to pre-industrial temperatures. Limiting cumulative CO2 emissions over 2000-50 to 1,000 Gt CO2 yields a 25% probability of warming exceeding 2 degrees C-and a limit of 1,440 Gt CO2 yields a 50% probability - given a representative estimate of the distribution of climate system properties. As known 2000-06 CO2 emissions(3) were similar to 234 Gt CO2, less than half the proven economically recoverable oil, gas and coal reserves(4-6) can still be emitted up to 2050 to achieve such a goal. Recent G8 Communiques(7) envisage halved global GHG emissions by 2050, for which we estimate a 12-45% probability of exceeding 2 degrees C-assuming 1990 as emission base year and a range of published climate sensitivity distributions. Emissions levels in 2020 are a less robust indicator, but for the scenarios considered, the probability of exceeding 2 degrees C rises to 53-87% if global GHG emissions are still more than 25% above 2000 levels in 2020.	[Meinshausen, Malte; Hare, William; Frieler, Katja] Telegraphenberg, Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Meinshausen, Nicolai] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Hare, William] Telegraphenberg, Climate Analyt, D-14412 Potsdam, Germany; [Raper, Sarah C. B.] Manchester Metropolitan Univ, Ctr Air Transport & Environm, Manchester M1 5GD, Lancs, England; [Knutti, Reto] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Frame, David J.] Univ Oxford, Smith Sch Enterprise & Environm, Oxford OX1 2BQ, England; [Frame, David J.; Allen, Myles R.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England	Potsdam Institut fur Klimafolgenforschung; University of Oxford; Manchester Metropolitan University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; University of Oxford	Meinshausen, M (corresponding author), Telegraphenberg, Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany.	malte.meinshausen@pik-potsdam.de	Knutti, Reto/B-8763-2008; Hare, Bill/A-8527-2013; Frame, Dave/R-6169-2016; Meinshausen, Malte/AAG-6505-2019; Allen, Myles R/A-5172-2012; Meinshausen, Malte/A-7037-2011; Frame, Dave/A-8918-2014	Knutti, Reto/0000-0001-8303-6700; Hare, Bill/0000-0003-1242-8250; Frame, Dave/0000-0002-0949-3994; Meinshausen, Malte/0000-0003-4048-3521; Meinshausen, Malte/0000-0003-4048-3521; Frieler, Katja/0000-0003-4869-3013	DAAD; German Ministry of Environment; Natural Environment Research Council [NE/C515747/1] Funding Source: researchfish	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); German Ministry of Environment; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank T. Wigley, M. Schaeffer, K. Briffa, R. Schofield, T. S., von Deimling, J. Nabel, J. Rogelj, V. Huber and A. Fischlin for discussions and comments on earlier manuscripts and our code, J. Gregory for AOGCM diagnostics, D. Giebitz-Rheinbay and B. Kriemann for IT support and the EMF- 21 modelling groups for providing their emission scenarios. M. M. thanks DAAD and the German Ministry of Environment for financial support. We acknowledge the modelling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI) and the WCRP's Working Group on Coupled Modelling (WGCM) for their roles in making available the WCRP CMIP3 multi-model data set. Support of this data set is provided by the Office of Science, US Department of Energy.	ABRAHAM K, 2007, WORLD OIL, V228; Andronova NG, 2001, J GEOPHYS RES-ATMOS, V106, P22605, DOI 10.1029/2000JD000259; Annan JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025259; BP, 2008, BP STAT REV WORLD EN; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; CLARKE AW, 2007, SURVEY ENERGY RESOUR; CLARKE AW, 2007, 2007 SURVEY ENERGY R; Council of the European Union, 2005, PRES CONCL BRUSS 22; den Elzen M, 2006, CLIM POLICY, V6, P545; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; EGGELSTON HS, 2006, 2006 GUIDELINES NATL; ENTING IG, 1994, 31 CSIRO DIV ATM RES; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Forest CE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL023977; FORSTER P, 2007, IPCC CLIMATE CHANGE, P129; Frame DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025801; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; *G8, 2008, HOKK TOY SUMM LEAD D; Gregory JM, 2002, J CLIMATE, V15, P3117, DOI [10.1175/1520-0442(2002)015<3117:AOBEOT>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3117:AOBEOT&gt;2.0.CO;2]; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; HOUGHTON JT, 1996, IPPC CLIMATE CHANGE; Knutti R, 2003, CLIM DYNAM, V21, P257, DOI 10.1007/s00382-003-0345-1; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; Knutti R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032904; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Knutti R, 2006, J CLIMATE, V19, P4224, DOI 10.1175/JCLI3865.1; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Meinshausen M., 2008, ATMOS CHEM PHYS DISC, V8, P6153, DOI DOI 10.5194/ACPD-8-6153-2008; Meinshausen M, 2006, CLIMATIC CHANGE, V75, P151, DOI 10.1007/s10584-005-9013-2; Metz B., 2007, IPCC CLIMATE CHANGE; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Piani C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024452; Radler M, 2006, OIL GAS J, V104, P20; REMPE H, 2007, RESERVES RESOURCES A; SCHELLNHUBER JS, 2006, AVOIDING DANGEROUS C; Solomon S., 2007, CONTRIBUTION WORKING, P996; Van Vuuren DP, 2008, P NATL ACAD SCI USA, V105, P15258, DOI 10.1073/pnas.0711129105; WATKINS K, 2007, FIGHTING CLIMATE CHA; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	44	1668	1726	37	3670	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1158	U96		10.1038/nature08017	http://dx.doi.org/10.1038/nature08017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407799				2022-12-28	WOS:000265754600045
J	Sokol, DK				Sokol, Daniel K.			Observations Ethics Man The death of DNR	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOW NATURAL DEATH; CARDIOPULMONARY-RESUSCITATION		Univ London, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, London WC1E 7HU, England.	daniel.sokol@talk21.com						Adams DH, 2006, J AM OSTEOPATH ASSOC, V106, P402; Chen YY, 2008, J MED ETHICS, V34, P887, DOI 10.1136/jme.2008.024570; Chessa F, 2004, HASTINGS CENT REP, V34, P4, DOI 10.2307/3527579; Cohen RW, 2004, HASTINGS CENT REP, V34, P4; Conroy SP, 2006, BRIT MED J, V332, P479, DOI 10.1136/bmj.332.7539.479; Jones GK, 2000, ACAD EMERG MED, V7, P48, DOI 10.1111/j.1553-2712.2000.tb01891.x; Jonsen AR, 2006, CLIN ETHICS; Venneman SS, 2008, J MED ETHICS, V34, P2, DOI 10.1136/jme.2006.018317	8	9	9	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2009	338								b1723	10.1136/bmj.b1723	http://dx.doi.org/10.1136/bmj.b1723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JY	19406889				2022-12-28	WOS:000265697800010
J	Iversen, A; Rushforth, B; Forrest, K				Iversen, Amy; Rushforth, Bruno; Forrest, Kirsty			Practice The Competent Novice How to handle stress and look after your mental health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITAL CONSULTANTS; DOCTORS; BURNOUT; PRACTITIONERS; SATISFACTION; DEPRESSION; DISTRESS; GENDER; RISK		[Iversen, Amy] Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England; [Rushforth, Bruno] Dewsbury & Dist Hosp, Dewsbury WF13 4HS, England; [Forrest, Kirsty] Leeds Gen Infirm, Leeds Teaching Hosp NHS Trust, Leeds LS1 3EX, W Yorkshire, England	University of London; King's College London; Leeds General Infirmary; University of Leeds	Iversen, A (corresponding author), Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England.	a.iversen@iop.kcl.ac.uk	Iversen, Amy/D-1112-2011					Churchill R, 2001, HEALTH TECHNOL ASSES, V5, P1, DOI DOI 10.3310/HTA5350; Davidson SK, 2003, MED J AUSTRALIA, V179, P302, DOI 10.5694/j.1326-5377.2003.tb05552.x; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Firth-Cozens J, 2003, BRIT MED J, V326, P670, DOI 10.1136/bmj.326.7391.670; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; Firth-Cozens J., 1999, STRESS HLTH PROFESSI; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; Forsythe M, 1999, BRIT MED J, V319, P605, DOI 10.1136/bmj.319.7210.605; General Medical Council, 2006, GOOD MED PRACT; GHODSE H, 2000, DOCTORS THEIR HLTH; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; JONES JW, 1988, J APPL PSYCHOL, V73, P727, DOI 10.1037/0021-9010.73.4.727; JONES P, 2005, DOCTORS PATIENTS; Kjeldmand D, 2008, ANN FAM MED, V6, P138, DOI 10.1370/afm.813; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lazarus R., 1987, STRESS APPRAISAL COP, V1, P141, DOI https://doi.org/10.1002/per.2410010304; Leichsenring F, 2008, JAMA-J AM MED ASSOC, V300, P1551, DOI 10.1001/jama.300.13.1551; MANN MP, 1992, MED TEACH, V14, P311, DOI 10.3109/01421599209018849; McCray LW, 2008, FAM MED, V40, P626; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; *NAT I HLTH CLIN E, 2007, CLIN GUID NAT I HLTH, V23; Ospina-Kammerer Veronika, 2003, Int J Emerg Ment Health, V5, P29; Paice E, 2002, MED EDUC, V36, P56, DOI 10.1046/j.1365-2923.2002.01101.x; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Rosenzweig S, 2003, TEACH LEARN MED, V15, P88, DOI 10.1207/S15328015TLM1502_03; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; Taylor C, 2007, BRIT J PSYCHIAT, V190, P268, DOI 10.1192/bjp.bp.106.023234; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; Whelan P, 2008, J ROY SOC MED, V101, P313, DOI 10.1258/jrsm.2008.070449	33	10	10	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2009	338								b1368	10.1136/bmj.b1368	http://dx.doi.org/10.1136/bmj.b1368			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JR	19398476				2022-12-28	WOS:000265697100009
J	Chen, L; Horton, R; Summerskill, W				Chen, Lincoln; Horton, Richard; Summerskill, William			A call for research papers from China	LANCET			English	Editorial Material							HEALTH		[Chen, Lincoln] China Med Board, Cambridge, MA USA; [Horton, Richard; Summerskill, William] The Lancet, London NW1 7BY, England		Chen, L (corresponding author), China Med Board, Cambridge, MA USA.							Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Han QD, 2008, LANCET, V372, P1439, DOI 10.1016/S0140-6736(08)61350-1; Wilsdon J., 2007, CHINA NEXT SCI SUPER; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; 2008, LANCET, V372, P1608	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 18	2009	373	9672					1324	1324		10.1016/S0140-6736(09)60754-6	http://dx.doi.org/10.1016/S0140-6736(09)60754-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434UR	19376437				2022-12-28	WOS:000265300100011
J	Meijsing, SH; Pufall, MA; So, AY; Bates, DL; Chen, L; Yamamoto, KR				Meijsing, Sebastiaan H.; Pufall, Miles A.; So, Alex Y.; Bates, Darren L.; Chen, Lin; Yamamoto, Keith R.			DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity	SCIENCE			English	Article							RESPONSE ELEMENTS; NUCLEAR RECEPTOR; GENE; EXPRESSION; REPRESSION; MOTIF	Genes are not simply turned on or off, but instead their expression is fine-tuned to meet the needs of a cell. How genes are modulated so precisely is not well understood. The glucocorticoid receptor (GR) regulates target genes by associating with specific DNA binding sites, the sequences of which differ between genes. Traditionally, these binding sites have been viewed only as docking sites. Using structural, biochemical, and cell-based assays, we show that GR binding sequences, differing by as little as a single base pair, differentially affect GR conformation and regulatory activity. We therefore propose that DNA is a sequence-specific allosteric ligand of GR that tailors the activity of the receptor toward specific target genes.	[Meijsing, Sebastiaan H.; Pufall, Miles A.; So, Alex Y.; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [So, Alex Y.; Yamamoto, Keith R.] Univ Calif San Francisco, Chem & Chem Biol Program, San Francisco, CA 94107 USA; [Bates, Darren L.; Chen, Lin] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California	Yamamoto, KR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	yamamoto@cmp.ucsf.edu	chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199; Pufall, Miles/0000-0002-7022-6916	NIH [GM08537]; NATIONAL CANCER INSTITUTE [R01CA020535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642, T32GM008537, R01GM077320] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E.C. Bolton, A. Kroch, J. J. Miranda, and A. Frankel for reviewing the manuscript. Work by M.A.P. was performed under NIH grant GM08537 and by M.A.P. and S.H.M. as fellows of the Leukemia and Lymphoma Society. We received research support from NIH grants (to K.R.Y., D.L.B., and L.C.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3FYL, 3G6P, 3G6Q, 3G6R, 3G6T, 3G6U, 3G8U, 3G97, 3G8X, 3G99, 3G9I, 3G9J, 3G9M, 3G9O, and 3G9P. K.R.Y. is a paid consultant with Merck and Company.	GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; KASAI Y, 1990, FEBS LETT, V274, P99, DOI 10.1016/0014-5793(90)81339-P; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; LABAER J, 1994, J MOL BIOL, V239, P664, DOI 10.1006/jmbi.1994.1405; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Meyer T, 1997, DNA CELL BIOL, V16, P919, DOI 10.1089/dna.1997.16.919; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101	23	502	517	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					407	410		10.1126/science.1164265	http://dx.doi.org/10.1126/science.1164265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372434	Green Accepted			2022-12-28	WOS:000265221600048
J	Cardin, JA; Carlen, M; Meletis, K; Knoblich, U; Zhang, F; Deisseroth, K; Tsai, LH; Moore, CI				Cardin, Jessica A.; Carlen, Marie; Meletis, Konstantinos; Knoblich, Ulf; Zhang, Feng; Deisseroth, Karl; Tsai, Li-Huei; Moore, Christopher I.			Driving fast-spiking cells induces gamma rhythm and controls sensory responses	NATURE			English	Article							NEURONAL SYNCHRONIZATION; ELECTRICAL SYNAPSES; CORTICAL NETWORKS; FAST OSCILLATIONS; CORTEX; INTERNEURONS; BRAIN; SCHIZOPHRENIA; GENERATION; ATTENTION	Cortical gamma oscillations (20-80 Hz) predict increases in focused attention, and failure in gamma regulation is a hallmark of neurological and psychiatric disease. Current theory predicts that gamma oscillations are generated by synchronous activity of fast-spiking inhibitory interneurons, with the resulting rhythmic inhibition producing neural ensemble synchrony by generating a narrow window for effective excitation. We causally tested these hypotheses in barrel cortex in vivo by targeting optogenetic manipulation selectively to fast-spiking interneurons. Here we show that light-driven activation of fast-spiking interneurons at varied frequencies (8-200 Hz) selectively amplifies gamma oscillations. In contrast, pyramidal neuron activation amplifies only lower frequency oscillations, a cell-type-specific double dissociation. We found that the timing of a sensory input relative to a gamma cycle determined the amplitude and precision of evoked responses. Our data directly support the fast-spiking-gamma hypothesis and provide the first causal evidence that distinct network activity states can be induced in vivo by cell-type-specific activation.	[Cardin, Jessica A.; Knoblich, Ulf; Moore, Christopher I.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cardin, Jessica A.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Carlen, Marie; Meletis, Konstantinos; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Carlen, Marie; Meletis, Konstantinos; Tsai, Li-Huei] Broad Inst Harvard & Massachusetts Inst Technol, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tsai, Li-Huei] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Howard Hughes Medical Institute	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	deissero@stanford.edu; lhtsai@mit.edu; cim@mit.edu	Macrae, Rhiannon/AAX-1536-2020; Moore, Christopher/C-5588-2009; Meletis, Konstantinos/ABE-6777-2020; Carlen, Marie Carlen/C-9112-2014; Knoblich, Ulf/A-1762-2010	Carlen, Marie Carlen/0000-0003-1658-1631; Knoblich, Ulf/0000-0002-0756-5587; Meletis, Konstantinos/0000-0001-5665-4781; Moore, Christopher/0000-0003-4534-1602	NIH/NEI; Knut och Alice Wallenberg Foundation; NARSAD Young Investigator Award; NIH NRSA; Tom F. Petersen; NIH; NSF; Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NARSAD Young Investigator Award(NARSAD); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom F. Petersen; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to S. Arber for the PV-Cre mice, S. Tonegawa for the CW2 mice, and A. Bradshaw, C. Ruehlmann and S. Su for technical assistance. We thank members of the Boyden laboratory and J. Bernstein for help in setting up optical techniques. We thank members of the Tsai and Moore laboratories, D. Vierling-Claassen and M. J. Higley for discussions and comments on the paper. This study was supported by grants from Tom F. Petersen, the NIH and the NSF to C. I. M. and by the Simons Foundation Autism Research Initiative to L.-H. T. K. D. is supported by the NIH Pioneer Program. L.-H. T. is an investigator of the Howard Hughes Medical Institute. J. A. C. is supported by a K99 from the NIH/NEI, M. C. and K. M. by postdoctoral fellowships from the Knut och Alice Wallenberg Foundation, M. C. by a NARSAD Young Investigator Award, and F. Z. by an NIH NRSA.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Berger H, 1969, ELECTROENCEPHALOGR S, P37; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burchell TR, 1998, NEUROSCI LETT, V255, P151, DOI 10.1016/S0304-3940(98)00676-4; Cauli B, 1997, J NEUROSCI, V17, P3894; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hubbard JI., 1969, ELECTROPHYSIOLOGICAL; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; REN JQ, 1992, EXP BRAIN RES, V92, P1; Spencer KM, 2008, BIOL PSYCHIAT, V63, P744, DOI 10.1016/j.biopsych.2007.10.017; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Wang XJ, 1996, J NEUROSCI, V16, P6402; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; Whittington MA, 2000, PHARMACOL THERAPEUT, V86, P171, DOI 10.1016/S0163-7258(00)00038-3; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	33	1678	1735	8	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					663	U63		10.1038/nature08002	http://dx.doi.org/10.1038/nature08002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396156	Green Accepted			2022-12-28	WOS:000266608600035
J	Scheen, AJ				Scheen, Andre J.			Voglibose for prevention of type 2 diabetes mellitus	LANCET			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; FOLLOW-UP; TRIAL; ACARBOSE; REDUCTION; METFORMIN; EFFICACY; THERAPY; DESIGN		Univ Liege, CHU Sart Tilman, Dept Med, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium	University of Liege	Scheen, AJ (corresponding author), Univ Liege, CHU Sart Tilman, Dept Med, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium.	andre.scheen@chu.ulg.ac.be						Bassler D, 2008, J CLIN EPIDEMIOL, V61, P241, DOI 10.1016/j.jclinepi.2007.07.016; BEALS JK, PIOGLITAZONE REDUCES; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Califf RM, 2008, AM HEART J, V156, P623, DOI 10.1016/j.ahj.2008.05.017; Chan JCN, 1998, DIABETES CARE, V21, P1058, DOI 10.2337/diacare.21.7.1058; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Nijpels G, 2008, DIABETES-METAB RES, V24, P611, DOI 10.1002/dmrr.839; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Scheen AJ, 2007, DIABETES METAB, V33, P3, DOI 10.1016/j.diabet.2006.11.005; Scheen AJ, 2003, DRUGS, V63, P933, DOI 10.2165/00003495-200363100-00002; SCHEEN AJ, 2008, EPIDEMIOLOGY DIABETE, P449; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; *TROGL DIAB PREV P, 2005, DIABETES, V54, P1150; Zinman B, 2006, DIABETES OBES METAB, V8, P531, DOI 10.1111/j.1463-1326.2005.00540.x; 2006, ACTOS NOW PREVENTION	21	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1579	1580		10.1016/S0140-6736(09)60575-4	http://dx.doi.org/10.1016/S0140-6736(09)60575-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19395080	Green Submitted			2022-12-28	WOS:000266066300004
J	Fazel, R; Dhaliwal, G; Saint, S; Nallamothu, BK				Fazel, Reza; Dhaliwal, Gurpreet; Saint, Sanjay; Nallamothu, Brahmajee K.			A Red Flag.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; EOSINOPHILIA		[Fazel, Reza] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30306 USA; [Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, San Francisco, CA USA; [Saint, Sanjay; Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; [Saint, Sanjay; Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Emory University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Fazel, R (corresponding author), Emory Univ, Sch Med, Div Cardiol, Bldg A,Suite 1-N,1256 Briarcliff Rd NE, Atlanta, GA 30306 USA.	rfazel@emory.edu	Saint, Sanjay/AAF-5126-2019	Fazel, Reza/0000-0002-9102-6155				Brito-Babapulle F, 2003, BRIT J HAEMATOL, V121, P203, DOI 10.1046/j.1365-2141.2003.04195.x; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78; Fletcher S, 2007, CURR OPIN HEMATOL, V14, P37, DOI 10.1097/00062752-200701000-00008; Gleich GJ, 2002, LANCET, V359, P1577, DOI 10.1016/S0140-6736(02)08505-7; Klion AD, 2006, J ALLERGY CLIN IMMUN, V117, P1292, DOI 10.1016/j.jaci.2006.02.042; Leiferman KM, 2004, J ALLERGY CLIN IMMUN, V113, P50, DOI 10.1016/j.jaci.2003.10.051; PARRILLO JE, 1979, AM J MED, V67, P572, DOI 10.1016/0002-9343(79)90227-4; PARRILLO JE, 1978, ANN INTERN MED, V89, P167, DOI 10.7326/0003-4819-89-2-167; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Simon HU, 1999, NEW ENGL J MED, V341, P1112, DOI 10.1056/NEJM199910073411503	11	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					2005	2010		10.1056/NEJMcps0802754	http://dx.doi.org/10.1056/NEJMcps0802754			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420370				2022-12-28	WOS:000265784400012
J	Brennan, TA; Mello, MM				Brennan, Troyen A.; Mello, Michelle M.			Incremental Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COVERAGE; STATES		[Brennan, Troyen A.] CVS Caremark, Woonsocket, RI 02895 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Brennan, TA (corresponding author), CVS Caremark, 1 CVS Dr, Woonsocket, RI 02895 USA.	tabrennan@cvs.com						Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; *COMM CONN, HLTH CAR REF OV; DASCHLE T, 2008, CRITICAL WHAT WE CAN; Emanuel E, 2008, JAMA-J AM MED ASSOC, V300, P1931, DOI 10.1001/jama.2008.536; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Gabel JR, 2008, HEALTH AFFAIR, V27, pW566, DOI 10.1377/hlthaff.27.6.w566; Galvin RS, 2008, NEW ENGL J MED, V359, P1421, DOI 10.1056/NEJMp0805021; Glendinning D., AM MED NEWS; Hacker JS, 2007, NEW ENGL J MED, V357, P733, DOI 10.1056/NEJMp078143; KRASNER J, 2009, BOSTON GLOBE    0101, pA1; LONG SK, HLTH INSURANCE COVER; McDonough JE, 2006, HEALTH AFFAIR, V25, pW420, DOI 10.1377/hlthaff.25.w420; *ORG EC COOP DEV, OECD HLTH DAT 2008 S; Pear Robert, 2009, NY TIMES, pA12; Swartz K, 2007, INQUIRY-J HEALTH CAR, V44, P5, DOI 10.5034/inquiryjrnl_44.1.5	15	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1814	1816		10.1001/jama.2009.610	http://dx.doi.org/10.1001/jama.2009.610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19417200				2022-12-28	WOS:000265742500033
J	Glassmeier, KH				Glassmeier, Karl-Heinz			Magnetic Twisters on Mercury	SCIENCE			English	Editorial Material							MAGNETOSPHERE; RECONNECTION		[Glassmeier, Karl-Heinz] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, Braunschweig, Germany; [Glassmeier, Karl-Heinz] Max Planck Inst Solar Syst Res, Katlenburg Lindau, Germany	Braunschweig University of Technology; Max Planck Society	Glassmeier, KH (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, Braunschweig, Germany.	kh.glassmeier@tu-bs.de						Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; Glassmeier KH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031662; HAERENDEL G, 1978, J GEOPHYS RES-SPACE, V83, P3195, DOI 10.1029/JA083iA07p03195; McClintock WE, 2009, SCIENCE, V324, P610, DOI 10.1126/science.1172525; Milillo A, 2010, PLANET SPACE SCI, V58, P40, DOI 10.1016/j.pss.2008.06.005; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; Orsini S, 2007, SPACE SCI REV, V132, P551, DOI 10.1007/s11214-007-9222-2; RUSSELL CT, 1978, SPACE SCI REV, V22, P681, DOI 10.1007/BF00212619; Sandholt PE, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011952; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; Szego K, 2000, SPACE SCI REV, V94, P429, DOI 10.1023/A:1026568530975	12	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					597	598		10.1126/science.1173770	http://dx.doi.org/10.1126/science.1173770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407187				2022-12-28	WOS:000265608800027
J	Schaefer, JM; Denton, GH; Kaplan, MR; Putnam, A; Finkel, RC; Barrell, DJA; Andersen, BG; Schwartz, R; Mackintosh, A; Chinn, T; Schluchter, C				Schaefer, Joerg M.; Denton, George H.; Kaplan, Michael R.; Putnam, Aaron; Finkel, Robert C.; Barrell, David J. A.; Andersen, Bjorn G.; Schwartz, Roseanne; Mackintosh, Andrew; Chinn, Trevor; Schluechter, Christian			High-Frequency Holocene Glacier Fluctuations in New Zealand Differ from the Northern Signature	SCIENCE			English	Article							WEATHERING-RIND THICKNESS; MEDIEVAL WARM PERIOD; COOK-NATIONAL-PARK; ICE-AGE; SOUTHERN ALPS; CLIMATE; TEMPERATURE; CIRCULATION; PATTERNS; MORAINES	Understanding the timings of interhemispheric climate changes during the Holocene, along with their causes, remains a major problem of climate science. Here, we present a high-resolution (10)Be chronology of glacier fluctuations in New Zealand's Southern Alps over the past 7000 years, including at least five events during the last millennium. The extents of glacier advances decreased from the middle to the late Holocene, in contrast with the Northern Hemisphere pattern. Several glacier advances occurred in New Zealand during classic northern warm periods. These findings point to the importance of regional driving and/ or amplifying mechanisms. We suggest that atmospheric circulation changes in the southwest Pacific were one important factor in forcing high-frequency Holocene glacier fluctuations in New Zealand.	[Schaefer, Joerg M.; Kaplan, Michael R.; Schwartz, Roseanne] LDEO, Palisades, NY 10964 USA; [Denton, George H.; Putnam, Aaron] Univ Maine, Dept Earth Sci, Orono, ME 04469 USA; [Denton, George H.; Putnam, Aaron] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Finkel, Robert C.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 95064 USA; [Finkel, Robert C.] CEREGE, F-13545 Aix En Provence 4, France; [Barrell, David J. A.] GNS Sci, Dunedin 9054, New Zealand; [Andersen, Bjorn G.] Univ Oslo, Dept Geol, N-0316 Oslo, Norway; [Mackintosh, Andrew] Victoria Univ Wellington, Wellington 6140, New Zealand; [Chinn, Trevor] Alpine & Polar Proc Consultancy, Lake Hawea 9382, Otago, New Zealand; [Schluechter, Christian] Univ Bern, Inst Geol, CH-3012 Bern, Switzerland	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of California System; University of California Berkeley; UDICE-French Research Universities; Aix-Marseille Universite; GNS Science - New Zealand; University of Oslo; Victoria University Wellington; University of Bern	Schaefer, JM (corresponding author), LDEO, Palisades, NY 10964 USA.	schaefer@ldeo.columbia.edu	Kaplan, Michael R/D-4720-2011	Mackintosh, Andrew/0000-0002-6430-4711; Putnam, Aaron/0000-0002-5358-1473	NSF [EAR-0823521, EAR-0345835]; Comer Science and Educational Foundation; New Zealand Foundation for Research, Science, and Technology [C05X0701]; Department of Conservation (DOC); National Oceanic and Atmospheric Administration (NOAA); Mardsen Fund [VUW0611]; Swiss National Fond [200020-105220/1]; LDEO [7243]	NSF(National Science Foundation (NSF)); Comer Science and Educational Foundation; New Zealand Foundation for Research, Science, and Technology(New Zealand Foundation for Research, Science and Technology); Department of Conservation (DOC); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Mardsen Fund; Swiss National Fond(Swiss National Science Foundation (SNSF)); LDEO	J.M.S. acknowledges NSF support of this study (grants EAR-0823521 and EAR-0345835). The Comer Science and Educational Foundation supported J.M.S., M.K., and A.P. The New Zealand Foundation for Research, Science, and Technology (contract C05X0701) provided support for the glacial geomorphic mapping and the participation of D.J.A.B. We thank the Department of Conservation (DOC), R. Bellringer of the Mount Cook DOC, and Te Runanga o Ngai Tahu for permission to work in Mount Cook National Park. National Oceanic and Atmospheric Administration (NOAA) supported the participation of G.H.D., D.J.A.B., T.C., A.P., and B.G.A. A.M. acknowledges support by Mardsen Fund contract VUW0611. C.S. was supported by the Swiss National Fond, proposal no. 200020-105220/1. We thank the staff of the Center for Accelerator Mass Spectrometry (AMS) at Lawrence Livermore National Laboratory for their tireless support throughout the AMS measurements and S. Travis and A. Doughty for help during field work. This is LDEO contribution number 7243.	Balco G, 2009, QUAT GEOCHRONOL, V4, P93, DOI 10.1016/j.quageo.2008.09.001; Bard E, 2000, TELLUS B, V52, P985, DOI 10.1034/j.1600-0889.2000.d01-7.x; Barrows TT, 2007, SCIENCE, V318, P86, DOI 10.1126/science.1145873; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Broecker WS, 2001, SCIENCE, V291, P1497, DOI 10.1126/science.291.5508.1497; Burrows C. J., 2005, J HAAST SO ALPS; BURROWS CJ, 1973, NEW ZEAL J GEOL GEOP, V16, P831, DOI 10.1080/00288306.1973.10555228; Burrows CJ., 1990, PROCESSES VEGETATION, DOI [10.1007/978-94-011-3058-5_11, DOI 10.1007/978-94-011-3058-5_11]; BURROWS CJ, 1989, NZ J GEOL GEOPHYS, V39, P205; CHINN TJH, 1981, ARCTIC ALPINE RES, V13, P33, DOI 10.2307/1550624; Cook ER, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014580; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Dahl SO, 1996, HOLOCENE, V6, P381, DOI 10.1177/095968369600600401; Das SB, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008790; Denton GH, 2008, QUATERNARY SCI REV, V27, P1939, DOI 10.1016/j.quascirev.2008.08.008; Fitzharris BB, 1997, INT J CLIMATOL, V17, P745, DOI 10.1002/(SICI)1097-0088(19970615)17:7<745::AID-JOC160>3.0.CO;2-Y; GELLATLY AF, 1984, ARCTIC ALPINE RES, V16, P225, DOI 10.2307/1551074; Grove J.M., 2004, LITTLE ICE AGES; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Holzhauser H, 2005, HOLOCENE, V15, P789, DOI 10.1191/0959683605hl853ra; Joerin UE, 2008, QUATERNARY SCI REV, V27, P337, DOI 10.1016/j.quascirev.2007.10.016; Lawrence D. B., 1965, MAZAMA, V47, P17, DOI [10.1016/j.epsl.2013.10.052, DOI 10.1016/J.EPSL.2013.10.052]; Luckman BH, 2000, GEOMORPHOLOGY, V32, P357, DOI 10.1016/S0169-555X(99)00104-X; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; McKinzey KM, 2004, J ROY SOC NEW ZEAL, V34, P381, DOI 10.1080/03014223.2004.9517774; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; WARDLE P, 1973, New Zealand Journal of Botany, V11, P349; Wiles GC, 2008, GLOBAL PLANET CHANGE, V60, P115, DOI 10.1016/j.gloplacha.2006.07.036; Winkler S, 2004, HOLOCENE, V14, P911, DOI 10.1191/0959683604hl767rp; *WORLD GLAC MON SE, 2007, GLOB GLAC CHANG FACT	31	268	271	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					622	625		10.1126/science.1169312	http://dx.doi.org/10.1126/science.1169312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407198				2022-12-28	WOS:000265608800038
J	Calvo, MR; Fernandez-Rossier, J; Palacios, JJ; Jacob, D; Natelson, D; Untiedt, C				Reyes Calvo, M.; Fernandez-Rossier, Joaquin; Jose Palacios, Juan; Jacob, David; Natelson, Douglas; Untiedt, Carlos			The Kondo effect in ferromagnetic atomic contacts	NATURE			English	Article								Iron, cobalt and nickel are archetypal ferromagnetic metals. In bulk, electronic conduction in these materials takes place mainly through the s and p electrons, whereas the magnetic moments are mostly in the narrow d-electron bands, where they tend to align. This general picture may change at the nanoscale because electrons at the surfaces of materials experience interactions that differ from those in the bulk. Here we show direct evidence for such changes: electronic transport in atomic-scale contacts of pure ferromagnets ( iron, cobalt and nickel), despite their strong bulk ferromagnetism, unexpectedly reveal Kondo physics, that is, the screening of local magnetic moments by the conduction electrons below a characteristic temperature(1). The Kondo effect creates a sharp resonance at the Fermi energy, affecting the electrical properties of the system; this appears as a Fano-Kondo resonance(2) in the conductance characteristics as observed in other artificial nanostructures(3-11). The study of hundreds of contacts shows material-dependent log-normal distributions of the resonance width that arise naturally from Kondo theory(12). These resonances broaden and disappear with increasing temperature, also as in standard Kondo systems(4-7). Our observations, supported by calculations, imply that coordination changes can significantly modify magnetism at the nanoscale. Therefore, in addition to standard micromagnetic physics, strong electronic correlations along with atomic-scale geometry need to be considered when investigating the magnetic properties of magnetic nanostructures.	[Reyes Calvo, M.; Fernandez-Rossier, Joaquin; Jose Palacios, Juan; Untiedt, Carlos] Univ Alicante, Fac Ciencias, Dept Fis Aplicada, E-03790 Alicante, Spain; [Jacob, David] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Natelson, Douglas] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Universitat d'Alacant; Rutgers State University New Brunswick; Rice University	Untiedt, C (corresponding author), Univ Alicante, Fac Ciencias, Dept Fis Aplicada, E-03790 Alicante, Spain.	untiedt@ua.es	Untiedt, Carlos/C-6269-2011; Calvo, Reyes/L-8651-2014; fernandez-rossier, joaquin/C-3910-2009; Jacob, David/A-3922-2011; Palacios, Juan Jose/A-9872-2011	Untiedt, Carlos/0000-0003-4800-082X; Calvo, Reyes/0000-0001-5991-2619; fernandez-rossier, joaquin/0000-0003-2297-0289; Jacob, David/0000-0003-4434-844X; Palacios, Juan Jose/0000-0003-2378-0866; Natelson, Douglas/0000-0003-2370-9859	European Union through MolSpinQIP and Spanish MEC [MAT2007-65487, 31099-E, CSD2007-0010]; US National Science Foundation (NSF) [DMR-0528969]; NSF [DMR-0347253]; Lucille Packard Foundation; W. M. Keck Program in Quantum Materials	European Union through MolSpinQIP and Spanish MEC(European Commission); US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Lucille Packard Foundation; W. M. Keck Program in Quantum Materials(W.M. Keck Foundation)	We thank E. Tosatti, R. Aguado and J. Ferrer for discussions, G. Scott and G. Saenz-Arce for experimental support and V. Esteve for technical support. This work was partly supported by the European Union through MolSpinQIP and Spanish MEC ( grants MAT2007-65487, 31099-E and CONSOLIDER CSD2007-0010). D. J. acknowledges funding by the US National Science Foundation (NSF) under grant DMR-0528969. D. N. acknowledges the support of NSF grant DMR-0347253, the David and Lucille Packard Foundation and the W. M. Keck Program in Quantum Materials.	Agrait N, 2003, PHYS REP, V377, P81, DOI 10.1016/S0370-1573(02)00633-6; ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; Calvo AR, 2008, IEEE T NANOTECHNOL, V7, P165, DOI 10.1109/TNANO.2008.917847; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Hauptmann JR, 2008, NAT PHYS, V4, P373, DOI 10.1038/nphys931; Hewson A C, 1993, KONDO PROBLEM HEAVY; Jacob D, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.220403; Jamneala T, 2000, PHYS REV B, V61, P9990, DOI 10.1103/PhysRevB.61.9990; Keane ZK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172232; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Li JT, 1998, PHYS REV LETT, V80, P2893, DOI 10.1103/PhysRevLett.80.2893; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; MANDHAVAN V, 1998, SCIENCE, V280, P568; Martinek J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247202; Martinek J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.127203; MOOK HA, 1985, PHYS REV LETT, V54, P227, DOI 10.1103/PhysRevLett.54.227; Neel N, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.016801; Nygard J, 2000, NATURE, V408, P342, DOI 10.1038/35042545; Pajda M, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.174402; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Pasupathy AN, 2004, SCIENCE, V306, P86, DOI 10.1126/science.1102068; SCHRIEFFER JR, 1966, PHYS REV, V149, P491, DOI 10.1103/PhysRev.149.491; Untiedt C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.081401; van der Wiel WG, 2000, SCIENCE, V289, P2105, DOI 10.1126/science.289.5487.2105; Wierzbowska M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035439; Yu LH, 2004, NANO LETT, V4, P79, DOI 10.1021/nl034893f	29	119	120	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1150	U85		10.1038/nature07878	http://dx.doi.org/10.1038/nature07878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407797	Green Submitted			2022-12-28	WOS:000265754600043
J	Rebolj, M; van Ballegooijen, M; Lynge, E; Looman, C; Essink-Bot, ML; Boer, R; Habbema, D				Rebolj, Matejka; van Ballegooijen, Marjolein; Lynge, Elsebeth; Looman, Caspar; Essink-Bot, Marie-Louise; Boer, Rob; Habbema, Dik			Incidence of cervical cancer after several negative smear results by age 50: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-SITU; RISK; WOMEN; ABNORMALITIES; NETHERLANDS; CARCINOMA	Objective To determine the incidence of cervical cancer after several negative cervical smear tests at different ages. Design Prospective observational study of incidence of cervical cancer after the third consecutive negative result based on individual level data in a national registry of histopathology and cytopathology (PALGA). Setting Netherlands, national data. Population 218 847 women aged 45-54 and 445 382 aged 30-44 at the time of the third negative smear test. Main outcome measures 10 year cumulative incidence of interval cervical cancer. Results 105 women developed cervical cancer within 2 595 964 woman years at risk after the third negative result at age 30-44 and 42 within 1 278 532 woman years at risk after age 45-54. During follow-up, both age groups had similar levels of screening. After 10 years of follow-up, the cumulative incidence rate of cervical cancer was similar: 41/100 000 (95% confidence interval 33 to 51) in the younger group and 36/100 000 (24 to 52) in the older group (P=0.48). The cumulative incidence rate of cervical intraepithelial neoplasia grade I+ was twice as high in the younger than in the older group (P<0.001). Conclusions The risk for cervical cancer after several negative smear results by age 50 is similar to the risk at younger ages. Even after several negative smear results, age is not a good discriminative factor for early cessation of cervical cancer screening.	[Rebolj, Matejka; van Ballegooijen, Marjolein; Looman, Caspar; Essink-Bot, Marie-Louise; Boer, Rob; Habbema, Dik] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Lynge, Elsebeth] Univ Copenhagen, Inst Publ Hlth, DK-1014 Copenhagen K, Denmark	Erasmus University Rotterdam; Erasmus MC; University of Copenhagen	Rebolj, M (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.rebolj@pubhealth.ku.dk	Boer, Rob/E-6473-2015; Boer, Robert/AFM-0525-2022; Boer, Robert/AAH-2901-2022	Boer, Rob/0000-0003-0680-001X; Boer, Robert/0000-0003-0680-001X; Boer, Robert/0000-0003-0680-001X; Essink-Bot, Marie-Louise/0000-0002-4650-5886; Rebolj, Matejka/0000-0001-9597-645X; Lynge, Elsebeth/0000-0003-4785-5236	Dutch National Institute for Public Health and the Environment [3022/07DG MS/CvB/NvN]	Dutch National Institute for Public Health and the Environment	This study was financed by the Dutch National Institute for Public Health and the Environment (RIVM, grant No 3022/07DG MS/CvB/NvN). The authors wrote the manuscript independent of the funder. The RIVM had no role in the design of the study, data collection, analysis and interpretation of the data, and the decision to submit the manuscript for publication.	Akker-van Marle MEV, 2003, BRIT J CANCER, V88, P1054, DOI 10.1038/sj.bjc.6600843; Anttila A, 2004, BRIT J CANCER, V91, P935, DOI 10.1038/sj.bjc.6602069; Baay MFD, 2004, INT J CANCER, V108, P258, DOI 10.1002/ijc.11543; *CENTR BUR STAT, 2008, SURV TABL PER SEX AG; *CENTR BUR STAT, 2007, MORT CAUS DEATH EUTH; Coldman A, 2005, J MED SCREEN, V12, P7, DOI 10.1258/0969141053279103; COOK GA, 1984, BRIT J CANCER, V50, P367, DOI 10.1038/bjc.1984.185; Cruickshank ME, 1997, BRIT J OBSTET GYNAEC, V104, P586, DOI 10.1111/j.1471-0528.1997.tb11537.x; de Rijke JM, 2002, EUR J CANCER, V38, P2041, DOI 10.1016/S0959-8049(02)00315-5; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; *DUTCH COMPR CANC, CANC REG ONL COR IND; *DUTCH NETW NAT DA, 2007, RES RETR ACT CERV UT; Flannelly G, 2004, BJOG-INT J OBSTET GY, V111, P362, DOI 10.1111/j.1471-0528.2004.00085.x; Flannelly G, 2001, BRIT J OBSTET GYNAEC, V108, P1025; Grainge MJ, 2005, EMERG INFECT DIS, V11, P1680, DOI 10.3201/eid1111.050575; Gustafsson L, 1995, INT J CANCER, V63, P804, DOI 10.1002/ijc.2910630610; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hawkes AP, 1996, AM J PREV MED, V12, P342; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Mitchell H, 2002, INT J GYNECOL CANCER, V12, P728, DOI 10.1046/j.1525-1438.2002.01153.x; MOSCICKI AB, 1993, OBSTET GYNECOL, V82, P578; *NAT HLTH INS COUN, 1993, START POINTS RESTR O; Ogilvie D, 2001, J PUBLIC HEALTH MED, V23, P272, DOI 10.1093/pubmed/23.4.272; *PALGA, 2004, DESCR PALGA SYST COM; PETTERSSON F, 1989, RADIOTHER ONCOL, V16, P115, DOI 10.1016/0167-8140(89)90028-5; REBOLJ M, 2008, THESIS DEP PUBLIC HL; Rebolj M, 2007, INT J CANCER, V120, P806, DOI 10.1002/ijc.22167; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Sawaya GF, 2000, OBSTET GYNECOL, V96, P219, DOI 10.1016/S0029-7844(00)00882-6; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; Syrjanen S, 2005, INT J STD AIDS, V16, P217, DOI 10.1258/0956462053420211; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; U. S. Preventive Services Task Force, SCREEN CERV CANC REC; van der Aa MA, 2008, INT J CANCER, V123, P1403, DOI 10.1002/ijc.23652; VANBALLEGOOIJEN M, 1998, EFFECTS COSTS CERVIC; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; VANWIJNGAARDEN WJ, 1993, BRIT MED J, V306, P967, DOI 10.1136/bmj.306.6883.967; VANWIJNGAARDEN WJ, 1993, BRIT MED J, V306, P1409, DOI 10.1136/bmj.306.6889.1409-c; Yasmeen S, 2006, OBSTET GYNECOL, V108, P410, DOI 10.1097/01.AOG.0000225976.69396.fb	42	27	29	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2009	338								b1354	10.1136/bmj.b1354	http://dx.doi.org/10.1136/bmj.b1354			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OR	19395420	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000265497300004
J	Biercuk, MJ; Uys, H; VanDevender, AP; Shiga, N; Itano, WM; Bollinger, JJ				Biercuk, Michael J.; Uys, Hermann; VanDevender, Aaron P.; Shiga, Nobuyasu; Itano, Wayne M.; Bollinger, John J.			Optimized dynamical decoupling in a model quantum memory	NATURE			English	Article							CRYSTALLIZED ION PLASMAS; DECOHERENCE; SYSTEMS	Any quantum system, such as those used in quantum information or magnetic resonance, is subject to random phase errors that can dramatically affect the fidelity of a desired quantum operation or measurement(1). In the context of quantum information, quantum error correction techniques have been developed to correct these errors, but resource requirements are extraordinary. The realization of a physically tractable quantum information system will therefore be facilitated if qubit (quantum bit) error rates are far below the so-called fault-tolerance error threshold(1), predicted to be of the order of 10(-3)-10(-6). The need to realize such low error rates motivates a search for alternative strategies to suppress dephasing in quantum systems(2). Here we experimentally demonstrate massive suppression of qubit error rates by the application of optimized dynamical decoupling(3-8) pulse sequences, using a model quantum system capable of simulating a variety of qubit technologies. We demonstrate an analytically derived pulse sequence(9), UDD, and find novel sequences through active, real-time experimental feedback. The latter sequences are tailored to maximize error suppression without the need for a priori knowledge of the ambient noise environment, and are capable of suppressing errors by orders of magnitude compared to other existing sequences (including the benchmark multi-pulse spin echo(10,11)). Our work includes the extension of a treatment to predict qubit decoherence(12,13) under realistic conditions, yielding strong agreement between experimental data and theory for arbitrary pulse sequences incorporating nonidealized control pulses. These results demonstrate the robustness of qubit memory error suppression through dynamical decoupling techniques across a variety of qubit technologies(11,14-16).	[Biercuk, Michael J.; Uys, Hermann; VanDevender, Aaron P.; Shiga, Nobuyasu; Itano, Wayne M.; Bollinger, John J.] NIST, Div Time & Frequency, Boulder, CO 80305 USA; [Biercuk, Michael J.] Georgia Inst Technol, Atlanta, GA USA; [Uys, Hermann] CSIR, ZA-0001 Pretoria, South Africa	National Institute of Standards & Technology (NIST) - USA; University System of Georgia; Georgia Institute of Technology; Council for Scientific & Industrial Research (CSIR) - South Africa	Biercuk, MJ (corresponding author), NIST, Div Time & Frequency, Boulder, CO 80305 USA.	biercuk@boulder.nist.gov	Uys, Hermann/Q-2002-2019; Biercuk, Michael J/B-4768-2010; Itano, Wayne/AAV-8781-2020	Biercuk, Michael J/0000-0002-4371-2580; 	IARPA; NIST; Georgia Tech.; CSIR	IARPA; NIST(National Institute of Standards & Technology (NIST) - USA); Georgia Tech.; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	We thank L. Cywinski, S. Das Sarma, V. V. Dobrovitski, X. Hu, E. Knill, S. Lyon, G. Uhrig, and W. Witzel for discussions. We also thank D. Hanneke, C. Ospelkaus and D. J. Wineland for comments on the manuscript, and C. Nelson for technical assistance. We acknowledge research funding from IARPA and the NIST Quantum Information Program. M. J. B. acknowledges fellowship support from IARPA and Georgia Tech., and H. U. acknowledges support from CSIR. This manuscript is a contribution of the US NIST and is not subject to US copyright.	BREWER LR, 1988, PHYS REV A, V38, P859, DOI 10.1103/PhysRevA.38.859; Cywinski L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.174509; Faoro L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047001; Haeberlen  U., 1976, ADV MAGNETIC RESONAN; Huang XP, 1998, PHYS REV LETT, V80, P73, DOI 10.1103/PhysRevLett.80.73; ITANO WM, 1993, PHYS REV A, V47, P3554, DOI 10.1103/PhysRevA.47.3554; Itano WM, 1998, SCIENCE, V279, P686, DOI 10.1126/science.279.5351.686; Jensen MJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.025001; Khodjasteh K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.180501; Koch RH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.267003; Kuopanportti P, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.032334; Lee B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.160505; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; Mitchell TB, 1998, SCIENCE, V282, P1290, DOI 10.1126/science.282.5392.1290; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Pasini S, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.032315; Taylor JM, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.062331; Uhrig GS, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083024; Uhrig GS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.100504; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037; Viola L, 1998, PHYS REV A, V58, P2733, DOI 10.1103/PhysRevA.58.2733; Vitali D, 1999, PHYS REV A, V59, P4178, DOI 10.1103/PhysRevA.59.4178; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654; Witzel WM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077601; Yang W, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.180403; Zanardi P, 1999, PHYS LETT A, V258, P77, DOI 10.1016/S0375-9601(99)00365-5; Zhang WX, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125336; Zoller P, 2005, EUR PHYS J D, V36, P203, DOI 10.1140/epjd/e2005-00251-1	30	421	424	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					996	1000		10.1038/nature07951	http://dx.doi.org/10.1038/nature07951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396139	Green Submitted			2022-12-28	WOS:000265412900035
J	Hardy, J; Singleton, A				Hardy, John; Singleton, Andrew			CURRENT CONCEPTS Genomewide Association Studies and Human Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; GENE-EXPRESSION; PARKINSONS-DISEASE; WIDE ASSOCIATION; RISK; LOCUS; DROSOPHILA-PINK1; SUSCEPTIBILITY; CHOLESTEROL		[Hardy, John] UCL, Inst Neurol, London WC1N 3BG, England; [Singleton, Andrew] Neurogenet Lab, Bethesda, MD USA	University of London; University College London	Hardy, J (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	jhardy@ion.ucl.ac.uk	Singleton, Andrew B/C-3010-2009; Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423	National Institute on Aging of the National Institutes of Health [1-Z01-AG000949-02]; Medical Research Council; MRC [G0701075] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000949, ZIAAG000932, Z01AG000949] Funding Source: NIH RePORTER; Medical Research Council [G0701075] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	Supported in part by the Intramural Research Program of the National Institute on Aging of the National Institutes of Health ( project number, 1-Z01-AG000949-02) and by the Medical Research Council.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Brenner S, 2000, NAT BIOTECHNOL, V18, P1021; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hardy J, 2000, NEUROBIOL DIS, V7, P65, DOI 10.1006/nbdi.2000.0291; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Melquist S, 2007, AM J HUM GENET, V80, P769, DOI 10.1086/513320; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; *NIH RODAM MED RES, GEN TISS EXPR GTEX P; Olson M, 2007, NAT METHODS, V4, P891, DOI 10.1038/nmeth1107-891; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Venter JC, 2001, SCIENCE, V292, P1838; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; 1000 GENOMES DEEP CA	46	532	564	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1759	1768		10.1056/NEJMra0808700	http://dx.doi.org/10.1056/NEJMra0808700			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369657	Green Accepted			2022-12-28	WOS:000265377800010
J	Leopold, SS				Leopold, Seth S.			Minimally Invasive Total Knee Arthroplasty for Osteoarthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENOUS THROMBOEMBOLISM; STANDARD APPROACH; UNITED-STATES; RISK-FACTORS; TOTAL HIP; REPLACEMENT; OUTCOMES; INCISION; EXPERIENCE; IMPACT	A 65-year-old woman with osteoarthritis of her right knee is referred by her primary care physician for orthopedic consultation. She is healthy except for some well-controlled hypertension. She is 5 ft 5 in. tall (165 cm) and weighs 160 lb (73 kg), so her body-mass index (the weight in kilograms divided by the square of the height in meters) is 26.6. Her arthritis is not limited to one part of her knee but is diffuse and severe. She has minimal joint deformity and good bone quality. For several years, she was able to control the pain in her right knee with indomethacin, but recently this has been insufficient. An intraarticular corticosteroid injection was performed several months ago, with limited effect. The surgeon recommends total knee arthroplasty. The patient has a friend who has told her that his surgeon used a "minimally invasive" approach for his total knee replacement, and it went well. The patient has investigated this approach on the Internet, and she isn't sure what to do. She asks her primary care physician whether he recommends that she consider "minimally invasive" surgery.	Univ Washington, Sch Med, Dept Orthoped & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Leopold, SS (corresponding author), Univ Washington, Sch Med, Dept Orthoped & Sports Med, Box 356500, Seattle, WA 98195 USA.	leopold@u.washington.edu			Orthopedic Research and Education Foundation	Orthopedic Research and Education Foundation	Dr. Leopold reports receiving grant support from the Orthopedic Research and Education Foundation, which receives funding from several medical and surgical pharmaceutical and equipment manufacturers. No other potential conflict of interest relevant to this article was reported.	*AM AC ORTH SURG, CLIN PRACT GUID ADV; *AM ASS HIP KNEE S, PHYS ADV STAT MIN IN; American Academy of Orthopaedic Surgeons, CLIN GUID PREV PULM; Anderson JG, 1996, J ARTHROPLASTY, V11, P831, DOI 10.1016/S0883-5403(96)80183-5; Bal BS, 2005, J BONE JOINT SURG AM, V87A, P2432, DOI 10.2106/JBJS.D.02847; Bonutti PM, 2004, J BONE JOINT SURG AM, V86A, P26, DOI 10.2106/00004623-200412002-00005; Bozic KJ, 2008, J ARTHROPLASTY, V23, P133, DOI 10.1016/j.arth.2008.04.013; Bozic Kevin J, 2006, J Knee Surg, V19, P149; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, pS6, DOI 10.1097/01.blo.0000143938.30681.9d; Chin PL, 2007, J ARTHROPLASTY, V22, P800, DOI 10.1016/j.arth.2006.10.009; Dalury DF, 2005, CLIN ORTHOP RELAT R, P77, DOI 10.1097/01.blo.0000185757.17401.7b; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Douketis JD, 2002, ARCH INTERN MED, V162, P1465, DOI 10.1001/archinte.162.13.1465; Felson DT, 2004, CLIN ORTHOP RELAT R, pS16, DOI 10.1097/01.blo.0000144971.12731.a2; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Felson DT, 1995, OSTEOARTHRITIC DISOR, P13; Floren M, 2007, J ARTHROPLASTY, V22, P51, DOI 10.1016/j.arth.2007.05.008; Fukui N, 2001, Curr Rheumatol Rep, V3, P496, DOI 10.1007/s11926-001-0064-8; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Haas SB, 2004, CLIN ORTHOP RELAT R, P68, DOI 10.1097/01.blo.0000147649.82883.ca; Hervey SL, 2003, J BONE JOINT SURG AM, V85A, P1775, DOI 10.2106/00004623-200309000-00017; Huang HT, 2007, J ARTHROPLASTY, V22, P1007, DOI 10.1016/j.arth.2007.03.021; Jamsen E, 2009, J BONE JOINT SURG AM, V91A, P38, DOI 10.2106/JBJS.G.01686; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; King J, 2007, J BONE JOINT SURG AM, V89A, P1497, DOI 10.2106/JBJS.F.00867; Kolisek FR, 2007, J ARTHROPLASTY, V22, P8, DOI 10.1016/j.arth.2006.06.004; Laskin RS, 2004, CLIN ORTHOP RELAT R, P74, DOI 10.1097/01.blo.0000148582.86102.47; Lingard EA, 2006, J BONE JOINT SURG AM, V88A, P1201, DOI 10.2106/JBJS.E.00147; Lohmander LS, 2003, ARTHRITIS RHEUM, V48, P3130, DOI 10.1002/art.11326; Lombardi AV, 2006, CLIN ORTHOP RELAT R, P117, DOI 10.1097/01.blo.0000238824.56024.7a; Maloney WJ, 2002, J ARTHROPLASTY, V17, P71, DOI 10.1054/arth.2002.32450; McAllister CM, 2008, J ARTHROPLASTY, V23, P10, DOI 10.1016/j.arth.2007.01.011; Milne S, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004260; Pagnano MW, 2005, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000191275.80527.d6; Praemer A., 1992, MUSCULOSKELETAL COND, P143; Schinsky MF, 2001, J ARTHROPLASTY, V16, P1048, DOI 10.1054/arth.2001.26591; Seon JK, 2007, COMPUT AIDED SURG, V12, P189, DOI 10.1080/10929080701311861; Seon JK, 2006, J ARTHROPLASTY, V21, P777, DOI 10.1016/j.arth.2005.08.024; Song EK, 2006, ORTHOPEDICS, V29, pS145; Song EK, 2007, ORTHOPEDICS, V30, pS127; Tashiro Y, 2007, CLIN ORTHOP RELAT R, P144, DOI 10.1097/BLO.0b013e31814a5100; Tria AJ, 2003, CLIN ORTHOP RELAT R, P185, DOI 10.1097/01.blo.0000093030.56370.d9; Vessely MB, 2006, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000229356.81749.11; Walton NP, 2005, KNEE, V12, P103, DOI 10.1016/j.knee.2004.06.004; *WHO BON JOINT DEC, 2001, GLOB EC HEALTHC BURD	47	27	30	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1749	1758		10.1056/NEJMct0806027	http://dx.doi.org/10.1056/NEJMct0806027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19387017				2022-12-28	WOS:000265377800009
J	Imison, C; Giordano, RW				Imison, Candace; Giordano, Richard W.			Doctors as leaders	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												c.imison@kingsfund.org.uk						HALLIGAN A, 2008, HLTH SERVICES J 0607; Health Commission, 2009, INV MIDST NHS FDN TR; Levenson R., 2008, UNDERSTANDING DOCTOR; Smith R, 2003, BRIT MED J, V326, P610, DOI 10.1136/bmj.326.7390.610	4	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2009	338								b1555	10.1136/bmj.b1555	http://dx.doi.org/10.1136/bmj.b1555			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OO	19383750				2022-12-28	WOS:000265497000001
J	Thompson, MJ; Harnden, A; Del Mar, C				Thompson, Matthew J.; Harnden, Anthony; Del Mar, Chris			Diagnosis in General Practice Excluding serious illness in feverish children in primary care: restricted rule-out method for diagnosis	BRITISH MEDICAL JOURNAL			English	Article							RECOGNIZING MENINGOCOCCAL DISEASE; BACTERIAL-MENINGITIS; CLINICAL-FEATURES; SIGNS; INFECTIONS; SYMPTOMS; RASH		[Thompson, Matthew J.; Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England; [Del Mar, Chris] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia	University of Oxford; Bond University	Thompson, MJ (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England.	matthew.thompson@dphpc.ox.ac.uk	Del Mar, Chris/B-1136-2008	Del Mar, Chris/0000-0003-3821-8163				Attia J, 1999, JAMA-J AM MED ASSOC, V282, P175, DOI 10.1001/jama.282.2.175; Brogan PA, 2000, ARCH DIS CHILD, V83, P506, DOI 10.1136/adc.83.6.506; Granier S, 1998, BRIT MED J, V316, P276, DOI 10.1136/bmj.316.7127.276; Granier S, 1998, BRIT J GEN PRACT, V48, P1167; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; Inkelis SH, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e3; Kai J, 1996, BRIT MED J, V313, P983; Margolis P, 1998, JAMA-J AM MED ASSOC, V279, P308, DOI 10.1001/jama.279.4.308; MARZOUK O, 1991, ARCH DIS CHILD, V66, P485, DOI 10.1136/adc.66.4.485; Murtagh J, 1990, Aust Fam Physician, V19, P733; Nadel S, 1998, J ACCID EMERG MED, V15, P298; *SIGN, 2008, SIGN GUID, V102; SORENSEN HT, 1992, J CLIN EPIDEMIOL, V45, P1289; Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; VALMARI P, 1987, EUR J PEDIATR, V146, P515, DOI 10.1007/BF00441607; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; VOSS L, 1989, NEW ZEAL MED J, V102, P243	20	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 20	2009	338								b1187	10.1136/bmj.b1187	http://dx.doi.org/10.1136/bmj.b1187			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437ON	19380412				2022-12-28	WOS:000265496900001
J	Einarsdottir, AB; Stefansson, E				Einarsdottir, Ann B.; Stefansson, Einar			Prevention of diabetic retinopathy	LANCET			English	Editorial Material							VISUAL-ACUITY; MACULAR EDEMA; RUBOXISTAURIN; PROGRESSION; TRIAL		[Stefansson, Einar] Univ Iceland, IS-101 Reykjavik, Iceland; Natl Hosp, Landspitali, IS-101 Reykjavik, Iceland	University of Iceland	Stefansson, E (corresponding author), Univ Iceland, IS-101 Reykjavik, Iceland.	einarste@landspitali.is	Synek, Svatopluk/B-9815-2011					Aiello LP, 2007, ARCH OPHTHALMOL-CHIC, V125, P318; Bek T, 2009, ACTA OPHTHALMOL, V87, P270, DOI 10.1111/j.1755-3768.2008.01207.x; Chung SSM, 2005, CURR DRUG TARGETS, V6, P475, DOI 10.2174/1389450054021891; Davis MD, 2009, INVEST OPHTH VIS SCI, V50, P1, DOI 10.1167/iovs.08-2473; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Haritoglou C, 2009, LANCET, V373, P1364, DOI 10.1016/S0140-6736(09)60218-X; Olafsdottir E, 2007, ACTA OPHTHALMOL SCAN, V85, P40, DOI 10.1111/j.1600-0420.2006.00753.x; Pedersen DB, 2005, GRAEF ARCH CLIN EXP, V243, P163, DOI 10.1007/s00417-003-0817-3; Ribeiro ML, 2006, GRAEF ARCH CLIN EXP, V244, P1591, DOI 10.1007/s00417-006-0318-2; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Stefansson E, 2000, ACTA OPHTHALMOL SCAN, V78, P374, DOI 10.1034/j.1600-0420.2000.078004374.x; Stefansson E, 2001, INVEST OPHTH VIS SCI, V42, pS804; Zhang JZ, 2007, CURR EYE RES, V32, P883, DOI 10.1080/02713680701584123	13	10	12	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2009	373	9672					1316	1318		10.1016/S0140-6736(09)60750-9	http://dx.doi.org/10.1016/S0140-6736(09)60750-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434UR	19376433				2022-12-28	WOS:000265300100006
J	Concannon, P; Rich, SS; Nepom, GT				Concannon, Patrick; Rich, Stephen S.; Nepom, Gerald T.			Genetics of Type 1A Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENOME-WIDE ASSOCIATION; LYMPHOID TYROSINE PHOSPHATASE; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCUS; AUTOIMMUNE-DISEASE; MULTIPLEX FAMILIES; NONSYNONYMOUS SNPS; R620W POLYMORPHISM; MELLITUS; PTPN22		[Concannon, Patrick; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Concannon, Patrick] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Nepom, Gerald T.] Benaroya Res Inst, Diabet Res Program, Seattle, WA USA	University of Virginia; University of Virginia; University of Virginia; Benaroya Research Institute	Concannon, P (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA.	patcon@virginia.edu		Concannon, Patrick/0000-0002-5801-1859; Rich, Stephen/0000-0003-3872-7793; Nepom, Gerald/0000-0002-8063-1464	National Institutes of Health [DK062418, DK46635]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418, R01DK046635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (DK062418 and DK46635) from the National Institutes of Health and from the Juvenile Diabetes Research Foundation.	Aly TA, 2005, J AUTOIMMUN, V25, P40, DOI 10.1016/j.jaut.2005.09.002; Aly TA, 2006, P NATL ACAD SCI USA, V103, P14074, DOI 10.1073/pnas.0606349103; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; BOUGNERES PF, 1988, NEW ENGL J MED, V318, P663, DOI 10.1056/NEJM198803173181103; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; CLEMENTS GB, 1995, LANCET, V346, P221, DOI 10.1016/S0140-6736(95)91270-3; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cox NJ, 2001, AM J HUM GENET, V69, P820, DOI 10.1086/323501; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Eisenbarth GS, 2004, ADV EXP MED BIOL, V552, P268; Grant SFA, 2009, DIABETES, V58, P290, DOI 10.2337/db08-1022; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Holm P, 2001, AM J HUM GENET, V69, P1301; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Neel J. V, 1976, GENETICS DIABETES ME, P1; NERUP J, 1974, LANCET, V2, P864; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Redondo MJ, 2001, DIABETOLOGIA, V44, P927; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; SILVERSTEIN J, 1988, NEW ENGL J MED, V319, P599, DOI 10.1056/NEJM198809083191002; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361	55	346	357	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1646	1654		10.1056/NEJMra0808284	http://dx.doi.org/10.1056/NEJMra0808284			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369670				2022-12-28	WOS:000265178000009
J	Meador, KJ; Baker, GA; Browning, N; Clayton-Smith, J; Combs-Cantrell, DT; Cohen, M; Kalayjian, LA; Kanner, A; Liporace, JD; Pennell, PB; Privitera, M; Loring, DW				Meador, Kimford J.; Baker, Gus A.; Browning, Nancy; Clayton-Smith, Jill; Combs-Cantrell, Deborah T.; Cohen, Morris; Kalayjian, Laura A.; Kanner, Andres; Liporace, Joyce D.; Pennell, Page B.; Privitera, Michael; Loring, David W.		NEAD Study Grp	Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROPENSITY SCORE; MAJOR MALFORMATIONS; CHILDREN BORN; IN-UTERO; EPILEPSY; PREGNANCY; WOMEN; CARBAMAZEPINE; VALPROATE; REGISTER	BACKGROUND Fetal exposure of animals to antiepileptic drugs at doses lower than those required to produce congenital malformations can produce cognitive and behavioral abnormalities, but cognitive effects of fetal exposure of humans to antiepileptic drugs are uncertain. METHODS Between 1999 and 2004, we enrolled pregnant women with epilepsy who were taking a single antiepileptic agent (carbamazepine, lamotrigine, phenytoin, or valproate) in a prospective, observational, multicenter study in the United States and the United Kingdom. The primary analysis is a comparison of neurodevelopmental outcomes at the age of 6 years after exposure to different antiepileptic drugs in utero. This report focuses on a planned interim analysis of cognitive outcomes in 309 children at 3 years of age. RESULTS At 3 years of age, children who had been exposed to valproate in utero had significantly lower IQ scores than those who had been exposed to other antiepileptic drugs. After adjustment for maternal IQ, maternal age, antiepileptic-drug dose, gestational age at birth, and maternal preconception use of folate, the mean IQ was 101 for children exposed to lamotrigine, 99 for those exposed to phenytoin, 98 for those exposed to carbamazepine, and 92 for those exposed to valproate. On average, children exposed to valproate had an IQ score 9 points lower than the score of those exposed to lamotrigine (95% confidence interval [CI], 3.1 to 14.6; P = 0.009), 7 points lower than the score of those exposed to phenytoin (95% CI, 0.2 to 14.0; P = 0.04), and 6 points lower than the score of those exposed to carbamazepine (95% CI, 0.6 to 12.0; P = 0.04). The association between valproate use and IQ was dose dependent. Children's IQs were significantly related to maternal IQs among children exposed to carbamazepine, lamotrigine, or phenytoin but not among those exposed to valproate. CONCLUSIONS In utero exposure to valproate, as compared with other commonly used antiepileptic drugs, is associated with an increased risk of impaired cognitive function at 3 years of age. This finding supports a recommendation that valproate not be used as a first-choice drug in women of childbearing potential.	[Meador, Kimford J.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Baker, Gus A.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Browning, Nancy] EMMES Corp, Rockville, MD USA; [Clayton-Smith, Jill] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Combs-Cantrell, Deborah T.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Cohen, Morris] Med Coll Georgia, Augusta, GA 30912 USA; [Kalayjian, Laura A.] Univ So Calif, Los Angeles, CA USA; [Kanner, Andres] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Privitera, Michael] Univ Cincinnati, Cincinnati, OH USA	Emory University; University of Liverpool; Emmes Corporation; University of Manchester; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Georgia; Augusta University; University of Southern California; Rush University; University System of Ohio; University of Cincinnati	Meador, KJ (corresponding author), Emory Univ, Dept Neurol, Woodruff Mem Res Bldg,101 Woodruff Cir,Suite 6000, Atlanta, GA 30322 USA.	kimford.meador@emory.edu	Murray-Krezan, Cristina/O-3834-2016; Meador, Kimford/W-6167-2019	Murray-Krezan, Cristina/0000-0002-5488-1080; Liow, Kore/0000-0001-6452-9227; Meador, Kimford/0000-0002-7471-882X	National Institute of Neurological Disorders and Stroke [R01NS038455, R01NS050659]; United Kingdom Epilepsy Research Foundation [RB219738]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050659, R01NS038455] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United Kingdom Epilepsy Research Foundation(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Institute of Neurological Disorders and Stroke (R01NS038455 and R01NS050659) and the United Kingdom Epilepsy Research Foundation (RB219738).	Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; Adab N, 2001, J NEUROL NEUROSUR PS, V70, P15, DOI 10.1136/jnnp.70.1.15; Artama M, 2005, NEUROLOGY, V64, P1874, DOI 10.1212/01.WNL.0000163771.96962.1F; Bayley N, 1993, BAYLEY SCALES INFANT; Belsley D. A., 1991, CONDITIONING DIAGNOS; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brown L., 1996, TEST NONVERBAL INTEL; *COMM ED B AM COLL, 1997, INT J GYNECOL OBSTET, V56, P279; Cunnington M, 2005, NEUROLOGY, V64, P955, DOI 10.1212/01.WNL.0000154515.94346.89; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Elliott C. D., 1990, DIFFERENTIAL ABILITY; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finnell Richard H., 1995, P209; FISHER JE, 1992, PHARMACOL RES, V26, P207, DOI 10.1016/1043-6618(92)90210-3; Gaily E, 2004, NEUROLOGY, V62, P28, DOI 10.1212/WNL.62.1.28; Gaily E, 2007, EPILEPSY COMPREHENSI, P1225; Greenberg MK, 1998, NEUROLOGY, V51, P944; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; JANZ D, 1993, EPILEPSIA, V34, P588; Li KH, 1988, J STATISTICAL COMPUT, V30, P57, DOI DOI 10.1080/00949658808811085; Little R.J.A., 2002, STAT ANAL MISSING DA; Meador KJ, 2006, NEUROLOGY, V67, P407, DOI 10.1212/01.wnl.0000227919.81208.b2; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Nelson H., 1991, NATL ADULT READING T; Pennell PB, 2004, NEUROL CLIN, V22, P799, DOI 10.1016/j.ncl.2004.07.004; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sattler J., 1992, ASSESSMENT CHILDREN; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Vajda FJE, 2005, ACTA NEUROL SCAND, V112, P137, DOI 10.1111/j.1600-0404.2005.00458.x; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; Wyszynski DF, 2005, NEUROLOGY, V64, P961, DOI 10.1212/01.WNL.0000154516.43630.C5	35	493	507	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1597	1605		10.1056/NEJMoa0803531	http://dx.doi.org/10.1056/NEJMoa0803531			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369666	Green Accepted, Bronze			2022-12-28	WOS:000265178000004
J	Purnell, JQ; Flum, DR				Purnell, Jonathan Q.; Flum, David R.			Bariatric Surgery and Diabetes Who Should Be Offered the Option of Remission?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GASTRIC BYPASS		[Purnell, Jonathan Q.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Flum, David R.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Purnell, JQ (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Mailstop L481,3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.	purnellj@ohsu.edu	Flum, David/GPX-7976-2022		NIDDK NIH HHS [U01 DK066568] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066568] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; *DARTM HITCHC MED, WEIGHT MAN; *DEP HLTH HUM SERV, CMS PROGR INF; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Ferrannini E, 2009, DIABETES CARE, V32, P514, DOI 10.2337/dc08-1762; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Tarnoff M, 2009, SURG ENDOSC, V23, P650, DOI 10.1007/s00464-008-0125-4; Whitson BA, 2007, J SURG RES, V141, P31, DOI 10.1016/j.jss.2007.02.022	13	17	18	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1593	1595		10.1001/jama.2009.541	http://dx.doi.org/10.1001/jama.2009.541			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366781	Green Accepted			2022-12-28	WOS:000265137900032
J	Hirsh, J; Guyatt, G				Hirsh, Jack; Guyatt, Gordon			Clinical experts or methodologists to write clinical guidelines?	LANCET			English	Editorial Material							VENOUS THROMBOEMBOLISM; DARBEPOETIN; CANCER		[Hirsh, Jack] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; [Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	McMaster University	Hirsh, J (corresponding author), Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada.	jhirsh@thrombosis.hhscr.org						Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Corrigan Janet M, 2007, J Fam Pract, V56, p4A; Eikelboom J, 2008, LANCET, V371, P1559, DOI 10.1016/S0140-6736(08)60670-4; Eikelboom JW, 2009, CHEST, V135, P513, DOI 10.1378/chest.08-2655; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hirsh J, 2008, CHEST, V133, p110S, DOI 10.1378/chest.08-0652; Rawlins MD, 2009, LANCET, V374, P351, DOI 10.1016/S0140-6736(09)60616-4; Rizzo JD, 2008, BLOOD, V111, P25, DOI 10.1182/blood-2007-08-109488; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15	10	64	68	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					273	275		10.1016/S0140-6736(09)60787-X	http://dx.doi.org/10.1016/S0140-6736(09)60787-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19394076				2022-12-28	WOS:000268508200008
J	Pecho-Vrieseling, E; Sigrist, M; Yoshida, Y; Jessell, TM; Arber, S				Pecho-Vrieseling, Eline; Sigrist, Markus; Yoshida, Yutaka; Jessell, Thomas M.; Arber, Silvia			Specificity of sensory-motor connections encoded by Sema3e-Plxnd1 recognition	NATURE			English	Article							SYNAPTIC CONNECTIONS; SPINAL-CORD; MOTONEURONS; AFFERENTS; NEURONS; PROTEINS; AXONS; PEA3	Spinal reflexes are mediated by synaptic connections between sensory afferents and motor neurons(1-3). The organization of these circuits shows several levels of specificity. Only certain classes of proprioceptive sensory neurons make direct, monosynaptic connections with motor neurons(4). Those that do are bound by rules of motor pool specificity: they form strong connections with motor neurons supplying the same muscle, but avoid motor pools supplying antagonistic muscles(1,5-7). This pattern of connectivity is initially accurate and is maintained in the absence of activity(8), implying that wiring specificity relies on the matching of recognition molecules on the surface of sensory and motor neurons. However, determinants of fine synaptic specificity here, as in most regions of the central nervous system, have yet to be defined. To address the origins of synaptic specificity in these reflex circuits we have used molecular genetic methods to manipulate recognition proteins expressed by subsets of sensory and motor neurons. We show here that a recognition system involving expression of the class 3 semaphorin Sema3e by selected motor neuron pools, and its high-affinity receptor plexin D1 (Plxnd1) by proprioceptive sensory neurons, is a critical determinant of synaptic specificity in sensory-motor circuits in mice. Changing the profile of Sema3e-Plxnd1 signalling in sensory or motor neurons results in functional and anatomical rewiring of monosynaptic connections, but does not alter motor pool specificity. Our findings indicate that patterns of monosynaptic connectivity in this prototypic central nervous system circuit are constructed through a recognition program based on repellent signalling.	[Pecho-Vrieseling, Eline; Sigrist, Markus; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland; [Pecho-Vrieseling, Eline; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Yoshida, Yutaka; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, Kavli Inst Brain Sci, New York, NY 10032 USA; [Yoshida, Yutaka; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Kavli Inst Brain Sci, New York, NY 10032 USA; [Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	University of Basel; Friedrich Miescher Institute for Biomedical Research; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Cincinnati Children's Hospital Medical Center	Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.	tmj1@columbia.edu; silvia.arber@unibas.ch	Pecho-Vrieseling, Eline/AAP-7239-2020	Pecho-Vrieseling, Eline/0000-0001-6712-775X; Arber, Silvia/0000-0002-6261-250X	Swiss National Science Foundation; NCCR Frontiers in Genetics; Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation; NIH [RO1NS065048]; NINDS; Harold and Leila Mathers Foundation; Wellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Frontiers in Genetics(Swiss National Science Foundation (SNSF)); Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Harold and Leila Mathers Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ladle for help in analysis of electrophysiological data, J. Livet and C. Henderson for discussions, and P. Schwarb, A. Ponti and M. Stadler for help in image and statistical analysis. M. Mendelsohn, J. Kirkland and B. Han helped in the generation of Plxnd1<SUP>cond</SUP> mice and J. F. Spetz, P. Kopp and B. Kuchemann in the generation of Sema3e mutant and MN:: Sema3e mice. R. Axel, P. Caroni, E. Frank, A. Hantman, C. Henderson, D. Ladle and A. Luethi provided comments on the manuscript. E. P.-V., M. S. and S. A. are supported by the Swiss National Science Foundation, NCCR Frontiers in Genetics, the Kanton Basel-Stadt, EU Framework Program 7 and the Novartis Research Foundation. Y. Y. is supported by NIH grant RO1NS065048. T. M. J. is an HHMI Investigator, and is supported by grants from NINDS, EU Framework Program 7, Project ALS, The Harold and Leila Mathers Foundation, and The Wellcome Trust.	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BALDISSERA F, 1981, HDB PHYSL INTEGRATIO, V509; Brown AG, 1981, ORG SPINAL CORD; Burke RE, 1996, J COMP NEUROL, V372, P465; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; FRANK E, 1990, J NEUROSCI, V10, P2250; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HOLSTEGE G, 1987, EXP BRAIN RES, V67, P179, DOI 10.1007/BF00269465; Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105; Mears SC, 1997, J NEUROSCI, V17, P3128; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; THERIAULT E, 1988, J NEUROPHYSIOL, V60, P463, DOI 10.1152/jn.1988.60.2.463; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031	30	131	135	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					842	846		10.1038/nature08000	http://dx.doi.org/10.1038/nature08000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19421194	Green Accepted			2022-12-28	WOS:000267084500039
J	Xu, N; Papagiannakopoulos, T; Pan, GJ; Thomson, JA; Kosik, KS				Xu, Na; Papagiannakopoulos, Thales; Pan, Guangjin; Thomson, James A.; Kosik, Kenneth S.			MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells	CELL			English	Article							SELF-RENEWAL; MOUSE; DIFFERENTIATION; CIRCUITRY; EXPRESSION; GENES; NANOG; FIBROBLASTS; BIOGENESIS; LINEAGES	MicroRNAs (miRNAs) are posttranscriptional modulators of gene expression and play an important role in many developmental processes. We report here that expression of microRNA-145 (miR-145) is low in self-renewing human embryonic stem cells (hESCs) but highly upregulated during differentiation. We identify the pluripotency factors OCT4, SOX2, and KLF4 as direct targets of miR-145 and show that endogenous miR-145 represses the 3' untranslated regions of OCT4, SOX2, and KLF4. Increased miR-145 expression inhibits hESC self-renewal, represses expression of pluripotency genes, and induces lineage-restricted differentiation. Loss of miR-145 impairs differentiation and elevates OCT4, SOX2, and KLF4. Furthermore, we find that the miR-145 promoter is bound and repressed by OCT4 in hESCs. This work reveals a direct link between the core reprogramming factors and miR-145 and uncovers a double-negative feedback loop involving OCT4, SOX2, KLF4, and miR-145.	[Xu, Na; Papagiannakopoulos, Thales; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Pan, Guangjin; Thomson, James A.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of California System; University of California Santa Barbara; University of Wisconsin System; University of Wisconsin Madison	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu			W. M. Keck Foundation; California Institute for Regenerative Medicine (CIRM)	W. M. Keck Foundation(W.M. Keck Foundation); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by W. M. Keck Foundation. N. X. is funded by a Postdoctoral Fellowship from California Institute for Regenerative Medicine (CIRM). We thank Sherry Hikita for valuable discussions and Cecilia Conaco and MinJeong Kye for critical reviews of the manuscript. Kai Lao from Applied Biosystems provided the miRNA real-time RT-PCR detection reagents. J. A. T. is a founder of Cellular Dynamics International. He owns stock in the company and serves on its board of directors. K. S. K. owns stock in and serves on the board of Minerva Biotechnologies corporation.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998b; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gropp M, 2006, METHOD ENZYMOL, V420, P64, DOI 10.1016/S0076-6879(06)20005-3; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	48	885	950	3	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					647	658		10.1016/j.cell.2009.02.038	http://dx.doi.org/10.1016/j.cell.2009.02.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19409607	Bronze			2022-12-28	WOS:000266114100014
J	Grant, MR; Jones, JDG				Grant, Murray R.; Jones, Jonathan D. G.			Hormone (Dis)harmony Moulds Plant Health and Disease	SCIENCE			English	Editorial Material							PSEUDOMONAS-SYRINGAE; SALICYLIC-ACID; ABSCISIC-ACID; DEFENSE RESPONSES; ARABIDOPSIS-THALIANA; BOTRYTIS-CINEREA; SIGNALING PATHWAY; ESCHERICHIA-COLI; JASMONATE; AUXIN	Diseased plants often display phenotypes consistent with hormone perturbations. We review recent data that have revealed roles in plant-microbe interactions for cellular components and signaling molecules that previously were associated only with hormone signaling. A better understanding of cross-talk between hormonal and defense signaling pathways should reveal new potential targets for microbial effectors that attenuate host resistance mechanisms.	[Jones, Jonathan D. G.] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Grant, Murray R.] Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Exeter	Jones, JDG (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	jonathan.jones@tsl.ac.uk	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X	Biotechnology and Biological Sciences Research Council [BB/C514115/1, BB/E010334/1] Funding Source: Medline; BBSRC [BB/E010334/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABEL S, 1995, J BIOL CHEM, V270, P19093, DOI 10.1074/jbc.270.32.19093; Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Audenaert K, 2002, PLANT PHYSIOL, V128, P491, DOI 10.1104/pp.010605; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Chen ZY, 2007, P NATL ACAD SCI USA, V104, P20131, DOI 10.1073/pnas.0704901104; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Christmann A, 2005, PLANT PHYSIOL, V137, P209, DOI 10.1104/pp.104.053082; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Inomata M, 2004, PHYTOCHEMISTRY, V65, P2667, DOI 10.1016/j.phytochem.2004.08.025; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaliff M, 2007, MOL PLANT MICROBE IN, V20, P335, DOI 10.1094/MPMI-20-4-0335; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tiryaki I, 2002, PLANT PHYSIOL, V130, P887, DOI 10.1104/pp.005272; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021	50	306	320	7	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					750	752		10.1126/science.1173771	http://dx.doi.org/10.1126/science.1173771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423816				2022-12-28	WOS:000265832400035
J	Jacoby, CA; Frazer, TK				Jacoby, Charles A.; Frazer, Thomas K.			Eutrophication: Time to Adjust Expectations	SCIENCE			English	Letter									[Jacoby, Charles A.; Frazer, Thomas K.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32653 USA	State University System of Florida; University of Florida	Jacoby, CA (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32653 USA.	cajacoby@ufl.edu	Jacoby, Charles A/D-5608-2013	Jacoby, Charles A/0000-0002-5948-3241				CONLEY DJ, POLICY FORUM    0220, P1014; Duarte CM, 2009, ESTUAR COAST, V32, P29, DOI 10.1007/s12237-008-9111-2; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815	5	15	18	8	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					723	724		10.1126/science.324_723b	http://dx.doi.org/10.1126/science.324_723b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423801				2022-12-28	WOS:000265832400020
J	Bromm, V; Yoshida, N; Hernquist, L; Mckee, CF				Bromm, Volker; Yoshida, Naoki; Hernquist, Lars; McKee, Christopher F.			The formation of the first stars and galaxies	NATURE			English	Review							POPULATION-III STARS; INITIAL MASS FUNCTION; LARGE-SCALE STRUCTURE; GAMMA-RAY BURSTS; RADIATIVE FEEDBACK; SUPERNOVA EXPLOSIONS; STELLAR EVOLUTION; PRIMORDIAL STARS; METAL ENRICHMENT; HII REGION	Observations made using large ground-based and space-borne telescopes have probed cosmic history from the present day to a time when the Universe was less than one-tenth of its present age. Earlier still lies the remaining frontier, where the first stars, galaxies and massive black holes formed. They fundamentally transformed the early Universe by endowing it with the first sources of light and chemical elements beyond the primordial hydrogen and helium produced in the Big Bang. The interplay of theory and upcoming observations promises to answer the key open questions in this emerging field.	[Bromm, Volker] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Yoshida, Naoki] Univ Tokyo, Inst Phys & Math Universe, Chiba 2778568, Japan; [Hernquist, Lars] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [McKee, Christopher F.] Univ Calif Berkeley, Dept Phys & Astron, Berkeley, CA 94720 USA	University of Texas System; University of Texas Austin; University of Tokyo; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Berkeley	Bromm, V (corresponding author), Univ Texas Austin, Dept Astron, 2511 Speedway, Austin, TX 78712 USA.	vbromm@astro.as.utexas.edu	Yoshida, Naoki/A-4305-2011	Yoshida, Naoki/0000-0001-7925-238X	NSF; NASA	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	We are grateful for the hospitality of KITP, University of California Santa Barbara. This work was supported in part by NSF and NASA.	Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Abel T, 2007, ASTROPHYS J, V659, pL87, DOI 10.1086/516820; Ahn K, 2007, MON NOT R ASTRON SOC, V375, P881, DOI 10.1111/j.1365-2966.2006.11332.x; Alvarez MA, 2006, ASTROPHYS J, V639, P621, DOI 10.1086/499578; Barkana R, 2001, PHYS REP, V349, P126, DOI 10.1016/s0370-1573(01)00019-9; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; BLUMENTHAL GR, 1984, NATURE, V311, P517, DOI 10.1038/311517a0; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; Bromm V, 2006, ASTROPHYS J, V642, P382, DOI 10.1086/500799; Bromm V, 2004, ANNU REV ASTRON ASTR, V42, P79, DOI 10.1146/annurev.astro.42.053102.134034; Bromm V, 2003, NATURE, V425, P812, DOI 10.1038/nature02071; Bromm V, 2003, ASTROPHYS J, V596, pL135, DOI 10.1086/379359; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Bromm V, 2001, MON NOT R ASTRON SOC, V328, P969, DOI 10.1046/j.1365-8711.2001.04915.x; Bromm V, 2004, NEW ASTRON, V9, P353, DOI 10.1016/j.newast.2003.12.006; Cen R, 2008, ASTROPHYS J, V674, P644, DOI 10.1086/524724; Ciardi B, 2000, ASTROPHYS J, V533, P594, DOI 10.1086/308673; COUCHMAN HMP, 1986, MON NOT R ASTRON SOC, V221, P53, DOI 10.1093/mnras/221.1.53; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Fan XH, 2006, ANNU REV ASTRON ASTR, V44, P415, DOI 10.1146/annurev.astro.44.051905.092514; Ferrara A, 1998, ASTROPHYS J, V499, pL17, DOI 10.1086/311344; Frebel A, 2007, MON NOT R ASTRON SOC, V380, pL40, DOI 10.1111/j.1745-3933.2007.00344.x; Freese K, 2008, ASTROPHYS J LETT, V685, pL101, DOI 10.1086/592685; Furlanetto SR, 2006, PHYS REP, V433, P181, DOI 10.1016/j.physrep.2006.08.002; Galli D, 1998, ASTRON ASTROPHYS, V335, P403; Gao L, 2007, MON NOT R ASTRON SOC, V378, P449, DOI 10.1111/j.1365-2966.2007.11814.x; Gao L, 2007, SCIENCE, V317, P1527, DOI 10.1126/science.1146676; Gardner JP, 2006, SPACE SCI REV, V123, P485, DOI 10.1007/s11214-006-8315-7; Glover S, 2005, SPACE SCI REV, V117, P445, DOI 10.1007/s11214-005-5821-y; Greif TH, 2008, MON NOT R ASTRON SOC, V387, P1021, DOI 10.1111/j.1365-2966.2008.13326.x; Greif TH, 2007, ASTROPHYS J, V670, P1, DOI 10.1086/522028; Griest K, 2000, PHYS REP, V333, P167, DOI 10.1016/S0370-1573(00)00021-1; Haiman Z, 2000, ASTROPHYS J, V534, P11, DOI 10.1086/308723; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Holder GP, 2003, ASTROPHYS J, V595, P13, DOI 10.1086/377338; HOLLENBACH D, 1994, ASTROPHYS J, V428, P654, DOI 10.1086/174276; Iocco F, 2008, MON NOT R ASTRON SOC, V390, P1655, DOI 10.1111/j.1365-2966.2008.13853.x; Iwamoto N, 2005, SCIENCE, V309, P451, DOI 10.1126/science.1112997; JAPPSEN AK, 2007, ASTROPHYS J IN PRESS; Johnson JL, 2008, MON NOT R ASTRON SOC, V388, P26, DOI 10.1111/j.1365-2966.2008.13381.x; Johnson JL, 2007, ASTROPHYS J, V665, P85, DOI 10.1086/519212; Johnson JL, 2006, MON NOT R ASTRON SOC, V366, P247, DOI 10.1111/j.1365-2966.2005.09846.x; Karlsson T, 2008, ASTROPHYS J, V679, P6, DOI 10.1086/533520; Kashlinsky A, 2005, NATURE, V438, P45, DOI 10.1038/nature04143; Kitayama T, 2005, ASTROPHYS J, V630, P675, DOI 10.1086/432114; Kitayama T, 2004, ASTROPHYS J, V613, P631, DOI 10.1086/423313; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Loeb A., 2008, 1 LIGHT UNIVERSE; Mac Low MM, 2004, REV MOD PHYS, V76, P125, DOI 10.1103/RevModPhys.76.125; Machacek ME, 2001, ASTROPHYS J, V548, P509, DOI 10.1086/319014; Machida MN, 2008, ASTROPHYS J, V677, P813, DOI 10.1086/533434; Machida MN, 2005, ASTROPHYS J, V622, P39, DOI 10.1086/428030; Mackey J, 2003, ASTROPHYS J, V586, P1, DOI 10.1086/367613; Madau P, 1997, ASTROPHYS J, V475, P429, DOI 10.1086/303549; Maeder A, 2007, ASTR SOC P, V374, P13; McGreer ID, 2008, ASTROPHYS J, V685, P8, DOI 10.1086/590530; McKee CF, 2002, NATURE, V416, P59, DOI 10.1038/416059a; Mckee CF, 2008, ASTROPHYS J, V681, P771, DOI 10.1086/587434; Mckee CF, 2007, ANNU REV ASTRON ASTR, V45, P565, DOI 10.1146/annurev.astro.45.051806.110602; McQuinn M, 2007, MON NOT R ASTRON SOC, V377, P1043, DOI 10.1111/j.1365-2966.2007.11489.x; Miralda-Escude J, 2003, SCIENCE, V300, P1904, DOI 10.1126/science.1085325; Mori M, 2002, ASTROPHYS J, V571, P40, DOI 10.1086/339913; Nakamura F, 2002, ASTROPHYS J, V569, P549, DOI 10.1086/339392; Nomoto K., 2008, MASSIVE STARS COSMIC, P463; Oh SP, 2002, ASTROPHYS J, V569, P558, DOI 10.1086/339393; Omukai K, 1999, ASTROPHYS J, V518, P64, DOI 10.1086/307285; Omukai K, 2005, ASTROPHYS J, V626, P627, DOI 10.1086/429955; Ricotti M, 2001, ASTROPHYS J, V560, P580, DOI 10.1086/323051; Ryu D, 2008, SCIENCE, V320, P909, DOI 10.1126/science.1154923; Scannapieco E, 2005, ASTROPHYS J, V633, P1031, DOI 10.1086/444450; Schaerer D, 2002, ASTRON ASTROPHYS, V382, P28, DOI 10.1051/0004-6361:20011619; SILK J, 1983, MON NOT R ASTRON SOC, V205, P705, DOI 10.1093/mnras/205.3.705; Spolyar D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.051101; Stacy A, 2007, MON NOT R ASTRON SOC, V382, P229, DOI 10.1111/j.1365-2966.2007.12247.x; Susa H, 2006, ASTROPHYS J, V645, pL93, DOI 10.1086/506275; Tan JC, 2004, ASTROPHYS J, V603, P383, DOI 10.1086/381490; Tan JC, 2004, ASTROPHYS J, V603, P401, DOI 10.1086/381668; Tegmark M, 1997, ASTROPHYS J, V474, P1, DOI 10.1086/303434; Tornatore L, 2007, MON NOT R ASTRON SOC, V382, P945, DOI 10.1111/j.1365-2966.2007.12215.x; Totani T, 2006, PUBL ASTRON SOC JPN, V58, P485, DOI 10.1093/pasj/58.3.485; Tumlinson J, 2006, ASTROPHYS J, V641, P1, DOI 10.1086/500383; Whalen D, 2004, ASTROPHYS J, V610, P14, DOI 10.1086/421548; Whalen D, 2008, ASTROPHYS J, V682, P49, DOI 10.1086/589643; Whalen D, 2008, ASTROPHYS J, V679, P925, DOI 10.1086/587731; Wise JH, 2008, ASTROPHYS J, V685, P40, DOI 10.1086/590417; Wise JH, 2007, ASTROPHYS J, V665, P899, DOI 10.1086/520036; Woosley SE, 2006, ASTROPHYS J, V637, P914, DOI 10.1086/498500; Yoon SC, 2005, ASTRON ASTROPHYS, V443, P643, DOI 10.1051/0004-6361:20054030; Yoshida N, 2004, ASTROPHYS J, V605, P579, DOI 10.1086/382499; Yoshida N, 2003, ASTROPHYS J, V591, pL1, DOI 10.1086/376963; Yoshida N, 2003, ASTROPHYS J, V592, P645, DOI 10.1086/375810; Yoshida N, 2008, SCIENCE, V321, P669, DOI 10.1126/science.1160259; Yoshida N, 2007, ASTROPHYS J, V667, pL117, DOI 10.1086/522202; Yoshida N, 2007, ASTROPHYS J, V663, P687, DOI 10.1086/518227; Yoshida N, 2006, ASTROPHYS J, V652, P6, DOI 10.1086/507978	100	253	254	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					49	54		10.1038/nature07990	http://dx.doi.org/10.1038/nature07990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424148	Green Accepted, Green Submitted			2022-12-28	WOS:000265801300026
J	Herbst, RS; Hirsch, FR				Herbst, Roy S.; Hirsch, Fred R.			Patient selection criteria and the FLEX Study	LANCET			English	Editorial Material							CELL LUNG-CANCER; GROWTH-FACTOR-RECEPTOR; GENE COPY NUMBER; PHASE-III TRIAL; GEFITINIB; CHEMOTHERAPY; COMBINATION; CETUXIMAB; GEMCITABINE; CARBOPLATIN		[Herbst, Roy S.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Hirsch, Fred R.] Univ Colorado, Denver, CO 80202 USA	University of Texas System; UTMD Anderson Cancer Center; University of Colorado System; University of Colorado Denver	Herbst, RS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	rherbst@mdanderson.org						Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Hirsch FR, 2005, J CLIN ONCOL, V23, P6838, DOI 10.1200/JCO.2005.01.2823; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hirsch FR, 2008, J CLIN ONCOL, V26, P3351, DOI 10.1200/JCO.2007.14.0111; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Rosell R, 2008, ANN ONCOL, V19, P362, DOI 10.1093/annonc/mdm474; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 2	2009	373	9674					1497	1498		10.1016/S0140-6736(09)60834-5	http://dx.doi.org/10.1016/S0140-6736(09)60834-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440OT	19410696				2022-12-28	WOS:000265710300003
J	Watts, G				Watts, Geoff			Feature Surgical research Cutting truths	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS					geoff@scileg.freeserve.co.uk						Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; McCulloch P, 2005, BRIT J SURG, V92, P1293, DOI 10.1002/bjs.4930; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; McCulloch P, 2009, J ROY SOC MED, V102, P51, DOI 10.1258/jrsm.2008.080308; *U BRIST, PROTECT STUD PROST T	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2009	338								b1722	10.1136/bmj.b1722	http://dx.doi.org/10.1136/bmj.b1722			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JZ	19411399				2022-12-28	WOS:000265697900005
J	Pollock, AM; Kirkwood, G				Pollock, Allyson M.; Kirkwood, Graham			Independent sector treatment centres: learning from a Scottish case study	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pollock, Allyson M.] Univ Edinburgh, Ctr Int Publ Hlth Policy, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Pollock, AM (corresponding author), Univ Edinburgh, Ctr Int Publ Hlth Policy, Edinburgh EH8 9AG, Midlothian, Scotland.	allyson.pollock@ed.ac.uk		pollock, allyson/0000-0002-7388-3110				APPLEBY J, 2007, HLTH SERV J     1206; BRODIES LLP, 2006, SCOTTISH REGIONAL TR; Browne J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-78; Clamp JA, 2008, ANN ROY COLL SURG, V90, P492, DOI 10.1308/003588408X301073; *DEP HLTH, 2006, ISTC MAN FEB 2006; *DEP HLTH, 2008, MAPS TREATM CTR LOC; *DEP HLTH, 2008, IND SECT TREATM CTR; DOWIE M, 2007, PRESS J         0627; GAINSBURY S, 2008, HLTH SERVICE J  1218; Healthcare Commission, 2008, IND SECT TREATM CTR; Healthcare Commission, 2007, IND SECT TREATM CTR; *IND SECT TREATM C, 2006, 4 REP SESS 2005 06, V1; *INF SERV DIV NHS, 2008, DAT QUAL ASS; *INF SERV DIV NHS, 2008, MAN DAT QUAL SMR COM; *NHS TAYS DEL UN C, 2008, 162008 NHS TAYS DEL; Pollock AM, 2008, BMJ-BRIT MED J, V336, P421, DOI 10.1136/bmj.39470.505556.80; *PRICEWATERHOUSE C, 2008, STRAC REG TREATM CTR; SHARMAN L, 2001, HOLDING ACCOUNT; *TAYS NHS BOARD, 2007, 252007 TAYS NHS BOAR; WEST D, 2009, HLTH SERV J     0112	20	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 30	2009	338								b1421	10.1136/bmj.b1421	http://dx.doi.org/10.1136/bmj.b1421			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JY	19406891	Green Submitted			2022-12-28	WOS:000265697800007
J	Wilson, JF				Wilson, Jennifer Fisher			Cancer Care: A Microcosm of the Problems Facing All of Health Care	ANNALS OF INTERNAL MEDICINE			English	News Item							LIFE; END; CHEMOTHERAPY; DEATH					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Avorn J, 2009, ANN INTERN MED, V150, P563, DOI 10.7326/0003-4819-150-8-200904210-00012; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; *MED PAYM ADV COMM, 2003, REP C VAR INN MED JU; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Miksad RA, 2007, J CLIN ONCOL, V25, P4506, DOI 10.1200/JCO.2007.13.0401; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; OGLESBY P, 1991, CARING PHYS LIFE FRA; Pollak KI, 2007, J CLIN ONCOL, V25, P5748, DOI 10.1200/JCO.2007.12.4180; Schrag D, 2007, J CLIN ONCOL, V25, P233, DOI 10.1200/JCO.2006.09.2437; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	13	8	8	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					573	576		10.7326/0003-4819-150-8-200904210-00024	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380865				2022-12-28	WOS:000265457000017
J	Berkman, PA; Young, OR				Berkman, Paul Arthur; Young, Oran R.			Governance and Environmental Change in the Arctic Ocean	SCIENCE			English	Editorial Material									[Berkman, Paul Arthur] Univ Cambridge, Scott Polar Res Inst, Arctic Ocean Geopolit Programme, Cambridge CB2 1ER, England; [Berkman, Paul Arthur; Young, Oran R.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Governance Sustainable Dev Program, Santa Barbara, CA 93106 USA	University of Cambridge; University of California System; University of California Santa Barbara	Berkman, PA (corresponding author), Univ Cambridge, Scott Polar Res Inst, Arctic Ocean Geopolit Programme, Cambridge CB2 1ER, England.	pb426@cam.ac.uk						Arctic Climate Impact Assessment, 2004, IMP WARM ARCT ARCT C, DOI DOI 10.1371/journal.pone.0028900; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Holland MM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028024; *INT ARCT SCI COMM, 2009, IASC TRANS FAC NEW C; JENSEN O, 2007, IMO GUIDELINES SHIPS; Koivurova T., 2009, INT GOVERNANCE REGUL; Macnab R., 2007, MERIDIAN         FAL, P1; Molenaar Erik J., 2009, ARCTIC FISHERIES BAC; Proelss Alexander, 2008, HEIDELBERG J INT LAW, V68, P651; BASICS STATE POLICY; 2008, ARCT OC C IL GREENL	11	59	62	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					339	340		10.1126/science.1173200	http://dx.doi.org/10.1126/science.1173200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	433QT	19372415				2022-12-28	WOS:000265221600024
J	Blanchon, P; Eisenhauer, A; Fietzke, J; Liebetrau, V				Blanchon, Paul; Eisenhauer, Anton; Fietzke, Jan; Liebetrau, Volker			Rapid sea-level rise and reef back-stepping at the close of the last interglacial highstand	NATURE			English	Article							U-SERIES; CORAL-REEFS; PRECISE; EVENT; DURATION; SYSTEM; RECORD; RATES	Widespread evidence of a +4-6-m sea-level highstand during the last interglacial period (Marine Isotope Stage 5e) has led to warnings that modern ice sheets will deteriorate owing to global warming and initiate a rise of similar magnitude by AD 2100 (ref. 1). The rate of this projected rise is based on ice-sheet melting simulations and downplays discoveries of more rapid ice loss(2,3). Knowing the rate at which sea level reached its highstand during the last interglacial period is fundamental in assessing if such rapid ice-loss processes could lead to future catastrophic sea-level rise. The best direct record of sea level during this highstand comes from well-dated fossil reefs in stable areas(4-6). However, this record lacks both reef-crest development up to the full highstand elevation, as inferred(7) from widespread intertidal indicators at +6m, and a detailed chronology, owing to the difficulty of replicating U-series ages on submillennial timescales(8). Here we present a complete reef-crest sequence for the last interglacial highstand and its U-series chronology from the stable northeast Yucatan peninsula, Mexico. We find that reef development during the highstand was punctuated by reef-crest demise at +3m and back-stepping to +6m. The abrupt demise of the lower-reef crest, but continuous accretion between the lower-lagoonal unit and the upper-reef crest, allows us to infer that this back-stepping occurred on an ecological timescale and was triggered by a 2-3-m jump in sea level. Using strictly reliable Th-230 ages of corals from the upper-reef crest, and improved stratigraphic screening of coral ages from other stable sites, we constrain this jump to have occurred similar to 121 kyr ago and conclude that it supports an episode of ice-sheet instability during the terminal phase of the last interglacial period.	[Blanchon, Paul] Univ Nacl Autonoma Mexico, Inst Marine & Limnol Sci, Cancun, Quintana Roo, Mexico; [Eisenhauer, Anton; Fietzke, Jan; Liebetrau, Volker] IFM GEOMAR, Leibniz Inst Marine Sci, D-24148 Kiel, Germany	Universidad Nacional Autonoma de Mexico; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Blanchon, P (corresponding author), Univ Nacl Autonoma Mexico, Inst Marine & Limnol Sci, AP1152, Cancun, Quintana Roo, Mexico.	blanchon@icmyl.unam.mx	Eisenhauer, Anton/K-6454-2012; Liebetrau, Volker/AAF-9556-2021; Blanchon, Paul/B-7720-2009	Fietzke, Jan/0000-0002-5530-7208; Blanchon, Paul/0000-0002-7792-5808	DGAPA [IN218799]	DGAPA	We thank M. Sanchez, E. Rios and R. Raigoza for providing park access and hospitality; E. Jordan-Dahlgren for original descriptions of the aquarium trench; G. Jordan-Garza and I. Pino for field assistance; A. Kolevica and K. Fischer von Mollard for help with the <SUP>230</SUP>Th measurements; and C. Neumann, P. Hearty, C. Holmden, D. Hopley, A. Curran and W. C. Ward for discussions. Funding was provided by DGAPA grant IN218799.	[Anonymous], 2000, GEOFIS INT; Aronson RB, 2005, GEOLOGY, V33, P717, DOI 10.1130/G21640.1; Bamber JL, 2007, EARTH PLANET SC LETT, V257, P1, DOI 10.1016/j.epsl.2007.03.005; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Blanchon P, 2004, SEDIMENTOLOGY, V51, P53, DOI 10.1046/j.1365-3091.2003.00610.x; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Blanchon P, 2002, SEDIMENT GEOL, V147, P253, DOI 10.1016/S0037-0738(01)00143-9; Bruggemann JH, 2004, PALAEOGEOGR PALAEOCL, V203, P179, DOI 10.1016/S0031-0182(03)00659-X; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; Delanghe D, 2002, MAR CHEM, V80, P79, DOI 10.1016/S0304-4203(02)00100-7; Edinger EN, 2007, EARTH PLANET SC LETT, V253, P37, DOI 10.1016/j.epsl.2006.10.014; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fietzke J, 2005, J ANAL ATOM SPECTROM, V20, P395, DOI 10.1039/b415958f; Gonzalez-Herrera R, 2002, HYDROGEOL J, V10, P539, DOI 10.1007/s10040-002-0216-6; Henderson GM, 2002, EARTH PLANET SC LETT, V199, P97, DOI 10.1016/S0012-821X(02)00556-3; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Marquez-Azua B., 2004, GEOFIS INT, V43, P319; Neumann AC, 1996, GEOLOGY, V24, P775; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Potter EK, 2004, EARTH PLANET SC LETT, V217, P171, DOI 10.1016/S0012-821X(03)00587-9; Rohling EJ, 2008, NAT GEOSCI, V1, P38, DOI 10.1038/ngeo.2007.28; Scholz D, 2007, GEOCHIM COSMOCHIM AC, V71, P1935, DOI 10.1016/j.gca.2007.01.016; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; Steneck RS, 1997, CORAL REEFS, V16, P29, DOI 10.1007/s003380050056; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; STIRLING CH, 1995, EARTH PLANET SC LETT, V135, P115, DOI 10.1016/0012-821X(95)00152-3; SZABO BJ, 1978, GEOLOGY, V6, P713, DOI 10.1130/0091-7613(1978)6<713:AAMOTL>2.0.CO;2; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Thompson WG, 2005, SCIENCE, V308, P401, DOI 10.1126/science.1104035; Wilson HA, 1998, LETHAIA, V31, P241	32	154	155	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					881	U6		10.1038/nature07933	http://dx.doi.org/10.1038/nature07933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370032				2022-12-28	WOS:000265182500041
J	Koehn, EM; Fleischmann, T; Conrad, JA; Palfey, BA; Lesley, SA; Mathews, II; Kohen, A				Koehn, Eric M.; Fleischmann, Todd; Conrad, John A.; Palfey, Bruce A.; Lesley, Scott A.; Mathews, Irimpan I.; Kohen, Amnon			An unusual mechanism of thymidylate biosynthesis in organisms containing the thyX gene	NATURE			English	Article							CATALYTIC MECHANISM; ESCHERICHIA-COLI; ACTIVE-SITE; SYNTHASE-X; FLAVIN; ENZYME; DNA	Biosynthesis of the DNA base thymine depends on activity of the enzyme thymidylate synthase to catalyse the methylation of the uracil moiety of 2'-deoxyuridine-5'-monophosphate. All known thymidylate synthases rely on an active site residue of the enzyme to activate 2'-deoxyuridine-5'-monophosphate(1,2). This functionality has been demonstrated for classical thymidylate synthases, including human thymidylate synthase, and is instrumental in mechanism-based inhibition of these enzymes. Here we report an example of thymidylate biosynthesis that occurs without an enzymatic nucleophile. This unusual biosynthetic pathway occurs in organisms containing the thyX gene, which codes for a flavin-dependent thymidylate synthase (FDTS), and is present in several human pathogens(3-5). Our findings indicate that the putative active site nucleophile is not required for FDTS catalysis, and no alternative nucleophilic residues capable of serving this function can be identified. Instead, our findings suggest that a hydride equivalent (that is, a proton and two electrons) is transferred from the reduced flavin cofactor directly to the uracil ring, followed by an isomerization of the intermediate to form the product, 2'-deoxythymidine-5'-monophosphate. These observations indicate a very different chemical cascade than that of classical thymidylate synthases or any other known biological methylation. The findings and chemical mechanism proposed here, together with available structural data, suggest that selective inhibition of FDTSs, with little effect on human thymine biosynthesis, should be feasible. Because several human pathogens depend on FDTS for DNA biosynthesis, its unique mechanism makes it an attractive target for antibiotic drugs.	[Koehn, Eric M.; Fleischmann, Todd; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Conrad, John A.; Palfey, Bruce A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Joint Ctr Struct Genom, San Diego, CA 92121 USA; [Mathews, Irimpan I.] Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	University of Iowa; University of Michigan System; University of Michigan; Novartis; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	amnon-kohen@uiowa.edu		Palfey, Bruce/0000-0001-5098-259X; Koehn, Eric/0000-0001-8195-9595	NIH [R01 GM065368, R01 GM61087, GM08270]; NSF [CHE 0715448]; JCSG [U54GM074898]; DOE; OBER; NCRR; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270, R01GM061087, U54GM074898, R01GM065368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); JCSG; DOE(United States Department of Energy (DOE)); OBER; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 GM065368 and NSF CHE 0715448 to A. K., the Iowa Center for Biocatalysis and Bioprocessing to E. M. K., NIH R01 GM61087 to B. A. P., NIH training grant GM08270 to J.A.C., and JCSG grant U54GM074898 to S. A. L. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of DOE, OBER. The SSRL Structural Molecular Biology Program is supported by DOE, OBER and by NIH, NCRR, Biomedical Technology Program and NIGMS.	Agrawal N, 2004, BIOCHEMISTRY-US, V43, P10295, DOI 10.1021/bi0490439; Brown BJ, 1998, J BIOL CHEM, V273, P32753, DOI 10.1074/jbc.273.49.32753; Burdzy A, 2002, NUCLEIC ACIDS RES, V30, P4068, DOI 10.1093/nar/gkf520; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chernyshev A, 2007, APPL MICROBIOL BIOT, V74, P282, DOI 10.1007/s00253-006-0763-1; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Fagan RL, 2006, BIOCHEMISTRY-US, V45, P14926, DOI 10.1021/bi060919g; Finer-Moore JS, 2003, BIOCHEMISTRY-US, V42, P248, DOI 10.1021/bi020599a; Gattis SG, 2005, J AM CHEM SOC, V127, P832, DOI 10.1021/ja0432214; Graziani S, 2006, J BIOL CHEM, V281, P24048, DOI 10.1074/jbc.M600745200; Hong B, 2005, J LABELLED COMPD RAD, V48, P759, DOI 10.1002/jlcr.993; Hong BY, 2007, BIOCHEMISTRY-US, V46, P14188, DOI 10.1021/bi701363s; Hyatt DC, 1997, BIOCHEMISTRY-US, V36, P4585, DOI 10.1021/bi962936j; KLOTZER W, 1973, MONATSH CHEM, V104, P415, DOI 10.1007/BF00903105; Leduc D, 2004, BIOCHEM SOC T, V32, P231, DOI 10.1042/BST0320231; Leduc D, 2004, P NATL ACAD SCI USA, V101, P7252, DOI 10.1073/pnas.0401365101; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Mathews II, 2003, STRUCTURE, V11, P677, DOI 10.1016/S0969-2126(03)00097-2; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Myllykallio H, 2003, TRENDS MICROBIOL, V11, P220, DOI 10.1016/S0966-842X(03)00101-X; Sampathkumar P, 2005, J MOL BIOL, V352, P1091, DOI 10.1016/j.jmb.2005.07.071; Sundberg R, 2000, ADV ORGANIC CHEM; WALDMAN AS, 1983, J BIOL CHEM, V258, P1571; WATAYA Y, 1975, BIOCHEM BIOPH RES CO, V67, P818, DOI 10.1016/0006-291X(75)90886-4	24	65	66	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					919	U13		10.1038/nature07973	http://dx.doi.org/10.1038/nature07973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370033	Green Accepted			2022-12-28	WOS:000265182500049
J	Negi, SI; Krishnaswamy, G				Negi, Smita I.; Krishnaswamy, Guha			Keyhole Pupils	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Negi, Smita I.; Krishnaswamy, Guha] E Tennessee State Univ, Johnson City, TN 37604 USA	East Tennessee State University	Negi, SI (corresponding author), E Tennessee State Univ, Johnson City, TN 37604 USA.		Krishnaswamy, Guha/R-9076-2019; KRISHNASWAMY, GUHA/AAR-8844-2021	KRISHNASWAMY, GUHA/0000-0002-9848-6197					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1655	1655		10.1056/NEJMicm0707961	http://dx.doi.org/10.1056/NEJMicm0707961			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369671				2022-12-28	WOS:000265178000010
J	Sakuno, T; Tada, K; Watanabe, Y				Sakuno, Takeshi; Tada, Kenji; Watanabe, Yoshinori			Kinetochore geometry defined by cohesion within the centromere	NATURE			English	Article							REDUCTIONAL CHROMOSOME SEGREGATION; FISSION YEAST CENTROMERE; 1ST MEIOTIC DIVISION; MEIOSIS-I; MITOTIC SPINDLE; PRECOCIOUS SEPARATION; MONOPOLAR ATTACHMENT; SISTER KINETOCHORES; BI-ORIENTATION; BUDDING YEAST	During cell division microtubules capture chromosomes by binding to the kinetochore assembled in the centromeric region of chromosomes. In mitosis sister chromatids are captured by microtubules emanating from both spindle poles, a process called bipolar attachment, whereas in meiosis I sisters are attached to microtubules originating from one spindle pole, called monopolar attachment. For determining chromosome orientation, kinetochore geometry or structure might be an important target of regulation. However, the molecular basis of this regulation has remained elusive. Here we show the link between kinetochore orientation and cohesion within the centromere in fission yeast Schizosaccharomyces pombe by strategies developed to visualize the concealed cohesion within the centromere, and to introduce artificial tethers that can influence kinetochore geometry. Our data imply that cohesion at the core centromere induces the mono-orientation of kinetochores whereas cohesion at the peri-centromeric region promotes bi-orientation. Our study may reveal a general mechanism for the geometric regulation of kinetochores, which collaborates with previously defined tension-dependent reorientation machinery.	[Sakuno, Takeshi; Tada, Kenji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Tada, Kenji; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo GRAD SCH SC, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Sakuno, Takeshi/Y-9478-2019	Watanabe, Yoshinori/0000-0002-5488-4812	Special Coordination Funds for Promoting Science and Technology; MEXT, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript. We thank H. Matsuzaki, A. Yamamoto, R. Allshire, K. Nasmyth and the Yeast Genetic Resource Center (YGRC) for yeast strains. We also thank all the members of our laboratory for their support and discussion, especially S. Yokobayashi for materials and assistance in the initial stage of this project. This work was supported in part by Special Coordination Funds for Promoting Science and Technology (to T. S.), the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan, and a Grant- in- Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. W.).	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; ARAKI H, 1992, J MOL BIOL, V225, P25, DOI 10.1016/0022-2836(92)91023-I; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lee J, 2000, MOL REPROD DEV, V56, P51, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;51::AID-MRD7&gt;3.0.CO;2-N; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; OSTERGREN G, 1951, HEREDITAS, V37, P85; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2002, CURR OPIN CELL BIOL, V14, P365, DOI 10.1016/S0955-0674(02)00328-9; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yamamoto A, 2008, J CELL BIOL, V182, P277, DOI 10.1083/jcb.200802053; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	50	127	127	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					852	U1		10.1038/nature07876	http://dx.doi.org/10.1038/nature07876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370027				2022-12-28	WOS:000265182500035
J	Christakis, NA				Christakis, Nicholas A.			Observations Only Connect The anthroposphere is changing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, MA USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009						0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2009	338								b1534	10.1136/bmj.b1534	http://dx.doi.org/10.1136/bmj.b1534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TJ	19369280				2022-12-28	WOS:000265296700006
J	Frenk, J; Gomez-Dantes, O				Frenk, Julio; Gomez-Dantes, Octavio			Ideas and ideals: ethical basis of health reform in Mexico	LANCET			English	Editorial Material							SYSTEM REFORM		[Gomez-Dantes, Octavio] Inst Nacl Salud Publ, Cuernavaca 62100, Morelos, Mexico; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Instituto Nacional de Salud Publica; Harvard University; Harvard T.H. Chan School of Public Health	Gomez-Dantes, O (corresponding author), Inst Nacl Salud Publ, Cuernavaca 62100, Morelos, Mexico.	ocogomez@yahoo.com						Frenk J, 2006, CONSTRUCTIVE CONVERS, P165; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Marshall Thomas Humphrey, 1977, CLASS CITIZENSHIP SO; ODonnel G, 1991, TRANSICIONES DESDE G, P22; Roberts MJ., 2004, GETTING HLTH REFORM; Sen A, 2008, LANCET, V372, P2010, DOI 10.1016/S0140-6736(08)61784-5; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; 2009, POLITICO        0226	14	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1406	1408		10.1016/S0140-6736(09)60800-X	http://dx.doi.org/10.1016/S0140-6736(09)60800-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437QL	19394519				2022-12-28	WOS:000265501900007
J	Mironov, V; Kasyanov, V				Mironov, Vladimir; Kasyanov, Vladimir			Emergence of clinical vascular tissue engineering	LANCET			English	Editorial Material							BLOOD-VESSEL; IN-VITRO; COLLAGEN; CELLS		[Mironov, Vladimir] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Kasyanov, Vladimir] Riga Stradins Univ, Inst Anat & Anthropol, Riga, Latvia	Medical University of South Carolina; Riga Stradins University	Mironov, V (corresponding author), Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA.	mironovv@musc.edu	Kasyanov, Vladimir/V-2109-2019; Mironov, Vladimir/AAC-5926-2022					Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; Kasyanov VA, 2009, J MATER SCI-MATER M, V20, P329, DOI 10.1007/s10856-008-3590-3; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; Mironov V, 2008, TRENDS BIOTECHNOL, V26, P338, DOI 10.1016/j.tibtech.2008.03.001; Mironov V, 2008, EXPERT OPIN BIOL TH, V8, P143, DOI 10.1517/14712598.8.2.143 ; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816; Wilson G J, 1990, ASAIO Trans, V36, pM340	12	5	5	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1402	1404		10.1016/S0140-6736(09)60799-6	http://dx.doi.org/10.1016/S0140-6736(09)60799-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394518				2022-12-28	WOS:000265501900005
J	Boller, T; He, SY				Boller, Thomas; He, Sheng Yang			Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens	SCIENCE			English	Editorial Material							ARABIDOPSIS; KINASE; BAK1; PERCEPTION; COMPLEX; FLG22	For many years, research on a suite of plant defense responses that begin when plants are exposed to general microbial elicitors was underappreciated, for a good reason: There has been no critical experimental demonstration of their importance in mediating plant resistance during pathogen infection. Today, these microbial elicitors are named pathogen-or microbe-associated molecular patterns (PAMPs or MAMPs) and the plant responses are known as PAMP-triggered immunity (PTI). Recent studies provide an elegant explanation for the difficulty of demonstrating the role of PTI in plant disease resistance. It turns out that the important contribution of PTI to disease resistance is masked by pathogen virulence effectors that have evolved to suppress it.	[Boller, Thomas] Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, CH-4056 Basel, Switzerland; [He, Sheng Yang] Michigan State Univ, Dept Plant Biol, Dept Energy Plant Res Lab, E Lansing, MI 48824 USA	University of Basel; Michigan State University	Boller, T (corresponding author), Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	thomas.boller@unibas.ch; hes@msu.edu	poinssot, benoit/B-2569-2009; Boller, Thomas/G-3500-2012	poinssot, benoit/0000-0001-5890-4318; Boller, Thomas/0000-0001-6768-7503; He, Sheng Yang/0000-0003-1308-498X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060761] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060761, R01AI060761, R01 AI060761-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; *SWISS NAT SCI FDN, 31003A105852TB SWISS; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	23	644	712	15	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					742	744		10.1126/science.1171647	http://dx.doi.org/10.1126/science.1171647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423812	Green Accepted			2022-12-28	WOS:000265832400031
J	Andersen, ES; Dong, M; Nielsen, MM; Jahn, K; Subramani, R; Mamdouh, W; Golas, MM; Sander, B; Stark, H; Oliveira, CLP; Pedersen, JS; Birkedal, V; Besenbacher, F; Gothelf, KV; Kjems, J				Andersen, Ebbe S.; Dong, Mingdong; Nielsen, Morten M.; Jahn, Kasper; Subramani, Ramesh; Mamdouh, Wael; Golas, Monika M.; Sander, Bjoern; Stark, Holger; Oliveira, Cristiano L. P.; Pedersen, Jan Skov; Birkedal, Victoria; Besenbacher, Flemming; Gothelf, Kurt V.; Kjems, Jorgen			Self-assembly of a nanoscale DNA box with a controllable lid	NATURE			English	Article							SMALL-ANGLE SCATTERING; NANOSTRUCTURES; JUNCTIONS; ALIGNMENT	The unique structural motifs and self-recognition properties of DNA can be exploited to generate self-assembling DNA nanostructures of specific shapes using a 'bottom-up' approach(1). Several assembly strategies have been developed for building complex three-dimensional (3D) DNA nanostructures(2-8). Recently, the DNA 'origami' method was used to build two-dimensional addressable DNA structures of arbitrary shape(9) that can be used as platforms to arrange nanomaterials with high precision and specificity(9-13). A long-term goal of this field has been to construct fully addressable 3D DNA nanostructures(14,15). Here we extend the DNA origami method into three dimensions by creating an addressable DNA box 42 x 36 x 36 nm(3) in size that can be opened in the presence of externally supplied DNA 'keys'. We thoroughly characterize the structure of this DNA box using cryogenic transmission electron microscopy, small-angle X-ray scattering and atomic force microscopy, and use fluorescence resonance energy transfer to optically monitor the opening of the lid. Controlled access to the interior compartment of this DNA nanocontainer could yield several interesting applications, for example as a logic sensor for multiple-sequence signals or for the controlled release of nanocargos.	[Andersen, Ebbe S.; Dong, Mingdong; Nielsen, Morten M.; Jahn, Kasper; Subramani, Ramesh; Mamdouh, Wael; Besenbacher, Flemming; Gothelf, Kurt V.; Kjems, Jorgen] Aarhus Univ, Danish Natl Res Fdn, Ctr DNA Nanotechnol, DK-8000 Aarhus, Denmark; [Andersen, Ebbe S.; Dong, Mingdong; Nielsen, Morten M.; Jahn, Kasper; Subramani, Ramesh; Mamdouh, Wael; Oliveira, Cristiano L. P.; Pedersen, Jan Skov; Birkedal, Victoria; Besenbacher, Flemming; Gothelf, Kurt V.; Kjems, Jorgen] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Andersen, Ebbe S.; Nielsen, Morten M.; Jahn, Kasper; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Dong, Mingdong; Subramani, Ramesh; Mamdouh, Wael; Besenbacher, Flemming] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus, Denmark; [Golas, Monika M.] Aarhus Univ, Water & Salt Res Ctr, Inst Anat, DK-8000 Aarhus, Denmark; [Sander, Bjoern] Aarhus Univ, Stereol & EM Res Lab, DK-8000 Aarhus, Denmark; [Oliveira, Cristiano L. P.; Pedersen, Jan Skov; Gothelf, Kurt V.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Golas, Monika M.; Sander, Bjoern; Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Stark, Holger] Univ Gottingen, Gottingen Ctr Mol Biol, D-37077 Gottingen, Germany	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Max Planck Society; University of Gottingen	Gothelf, KV (corresponding author), Aarhus Univ, Danish Natl Res Fdn, Ctr DNA Nanotechnol, DK-8000 Aarhus, Denmark.	kvg@chem.au.dk; jk@mb.au.dk	Oliveira, Cristiano L P/B-4403-2008; Andersen, Ebbe S/O-3936-2014; dong, mingdong/AAK-9315-2020; Dong, Mingdong/B-3341-2010; Birkedal, Victoria/C-8899-2015; Dong, Mingdong/AAC-3023-2020; Besenbacher, Flemming/A-9623-2010; Kjems, Jorgen/I-3490-2016; Sander, Bjoern/AAO-9021-2021; Subramani, Ramesh/AAF-1337-2020; Subramani, Ramesh/A-9583-2010; Complexos, INCT Fluidos/H-9172-2013; Pedersen, Jan Skov/A-8346-2008	Oliveira, Cristiano L P/0000-0002-3426-6507; Andersen, Ebbe S/0000-0002-6236-8164; Dong, Mingdong/0000-0002-2025-2171; Birkedal, Victoria/0000-0002-1360-8870; Dong, Mingdong/0000-0002-2025-2171; Kjems, Jorgen/0000-0003-4128-9317; Sander, Bjoern/0000-0001-8495-2321; Subramani, Ramesh/0000-0002-2153-5595; Pedersen, Jan Skov/0000-0002-7768-0206; Mamdouh, Wael/0000-0003-0642-1992; Nielsen, Morten/0000-0002-8972-7577; Holger, Stark/0000-0002-6161-1118	Danish National Research Foundation; Federal Ministry of Education and Research, Germany [0311899]; European Union	Danish National Research Foundation(Danmarks Grundforskningsfond); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	We thank R. Rosendahl Hansen and J. Kristensen for technical assistance. This work was supported by grants from the Danish National Research Foundation to the Centre for DNA Nanotechnology and the Danish Research Agency through support to the Interdisciplinary Nanoscience Center, by the Federal Ministry of Education and Research, Germany (0311899), and by the Sixth Framework Program of the European Union through the Integrated Project '3D Repertoire' (H. S.).	Andersen ES, 2008, ACS NANO, V2, P1213, DOI 10.1021/nn800215j; Andersen FF, 2008, NUCLEIC ACIDS RES, V36, P1113, DOI 10.1093/nar/gkm1124; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Goodman RP, 2008, NAT NANOTECHNOL, V3, P93, DOI 10.1038/nnano.2008.3; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; PEDERSEN JS, 1990, J APPL CRYSTALLOGR, V23, P321, DOI 10.1107/S0021889890003946; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Pedersen JS, 1997, ADV COLLOID INTERFAC, V70, P171, DOI 10.1016/S0001-8686(97)00312-6; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI [10.1016/j.jsb.2005.04.004, 10.1016/j.jsb,2005.04.004]; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Simmel FC, 2008, ANGEW CHEM INT EDIT, V47, P5884, DOI 10.1002/anie.200801982; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Williams BAR, 2007, ANGEW CHEM INT EDIT, V46, P3051, DOI 10.1002/anie.200603919; Yang H, 2008, ANGEW CHEM INT EDIT, V47, P2443, DOI 10.1002/anie.200703741; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	30	1142	1190	33	1095	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					73	U75		10.1038/nature07971	http://dx.doi.org/10.1038/nature07971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424153	Green Published			2022-12-28	WOS:000265801300031
J	Prandoni, P; Prins, MH; Lensing, AWA; Ghirarduzzi, A; Ageno, W; Imberti, D; Scannapieco, G; Ambrosio, GB; Pesavento, R; Cuppini, S; Quintavalla, R; Agnelli, G				Prandoni, Paolo; Prins, Martin H.; Lensing, Anthonie W. A.; Ghirarduzzi, Angelo; Ageno, Walter; Imberti, Davide; Scannapieco, Gianluigi; Ambrosio, Giovanni B.; Pesavento, Raffaele; Cuppini, Stefano; Quintavalla, Roberto; Agnelli, Giancarlo		AESOPUS Investigators	Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSITY WARFARIN THERAPY; FATAL PULMONARY-EMBOLISM; COMPRESSION ULTRASONOGRAPHY; VEIN-THROMBOSIS; LONG-TERM; FIRST EPISODE; D-DIMER; RISK; THROMBOEMBOLISM; PREVENTION	Background: The optimal duration of oral anticoagulant therapy in patients with deep venous thrombosis (DVT) of the lower extremities remains uncertain. Objective: To assess whether tailoring the duration of anticoagulation on the basis of the persistence of residual thrombi on ultrasonography reduces the rate of recurrent venous thromboembolism (VTE) compared with the administration of conventional fixed-duration treatment in adults with proximal DVT. Design: Parallel, randomized trial from 1999 to 2006. Trained physicians who assessed outcomes were blinded to patient assignment status, but patients and providers were not. Setting: 9 university or hospital centers in Italy. Patients: 538 consecutive outpatients with a first episode of acute proximal DVT at completion of an uneventful 3-month period of anticoagulation. Intervention: Patients were randomly assigned (stratified by center and secondary vs. unprovoked DVT by using a computer-generated list that was accessible only to a trial nurse) to fixed-duration anticoagulation (no further anticoagulation for secondary thrombosis and an extra 3 months for unprovoked thrombosis) or flexible-duration, ultrasonography-guided anticoagulation (no further anticoagulation in patients with recanalized veins and continued anticoagulation in all other patients for up to 9 months for secondary DVT and up to 21 months for unprovoked thrombosis). For the primary outcome assessment, 530 patients completed the trial. Measurements: The rate of confirmed recurrent VTE during 33 months of follow-up. Results: Overall, 46 (17.2%) of 268 patients allocated to fixed-duration anticoagulation and 32 (11.9%) of 270 patients allocated to flexible-duration anticoagulation developed recurrent VTE (adjusted hazard ratio [HR], 0.64 [95% CI, 0.39 to 0.99]). For patients with unprovoked DVT, the adjusted HR was 0.61 (CI, 0.36 to 1.02) and 0.81 (CI, 0.32 to 2.06) for those with secondary DVT. Major bleeding occurred in 2 (0.7%) patients in the fixed-duration group and 4 (1.5%) patients in the flexible-duration group (P = 0.67). Limitations: The trial lacked a double-blind design. The sample size was not powered to detect differences in bleeding between groups and to detect effectiveness of the intervention in the subgroups of patients with unprovoked and secondary DVT. Patients with previous thromboembolism, permanent risk factors for thrombosis, and thrombophilic abnormalities other than factor V Leiden and prothrombin mutation were excluded. Conclusion: Tailoring the duration of anticoagulation on the basis of ultrasonography findings reduces the rate of recurrent VTE in adults with proximal DVT. Primary Funding Source: None.	[Prandoni, Paolo] Univ Padua, Dept Cardiothorac & Vasc Sci, Med Clin 2, Thromboembolism Unit, I-35128 Padua, Italy; Univ Maastricht, Maastricht, Netherlands; Univ Amsterdam, Amsterdam, Netherlands; Santa Maria Nuova Hosp, Reggio Emilia, Italy; Univ Insubria, Varese, Italy; Hosp Piacenza, Piacenza, Italy; Treviso Healthcare Trust, Treviso, Italy; Civ Hosp Venice, Venice, Italy; Civ Hosp, Castelfranco Veneto, Italy; Civ Hosp, Rovigo, Italy; Civ Hosp Parma, Parma, Italy; Univ Perugia, I-06100 Perugia, Italy	University of Padua; Maastricht University; University of Amsterdam; IRCCS Arcispedale S. Maria Nuova; University of Insubria; University of Parma; University Hospital of Parma; University of Perugia	Prandoni, P (corresponding author), Univ Padua, Dept Cardiothorac & Vasc Sci, Med Clin 2, Thromboembolism Unit, Via Giustiniani 2, I-35128 Padua, Italy.	paoloprandoni@tin.it	Imberti, Davide/AGB-5049-2022; Pesavento, Raffaele/E-1095-2012; Pesavento, Raffaele/J-1643-2014	Imberti, Davide/0000-0002-9284-6227; Pesavento, Raffaele/0000-0001-9578-3455; Pesavento, Raffaele/0000-0001-9578-3455; Giorgi-Pierfranceschi, Matteo/0000-0002-7988-9652; ageno, walter/0000-0002-1922-8879				Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Douketis JD, 2007, ANN INTERN MED, V147, P766, DOI 10.7326/0003-4819-147-11-200712040-00007; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Nicolaides AN, 2006, INT ANGIOL, V25, P101; Ost D, 2005, JAMA-J AM MED ASSOC, V294, P706, DOI 10.1001/jama.294.6.706; Palareti G, 2005, J THROMB HAEMOST, V3, P955, DOI 10.1111/j.1538-7836.2005.01330.x; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Pinede L, 2001, CIRCULATION, V103, P2453; Piovella F, 2002, HAEMATOLOGICA, V87, P515; Prandoni P, 2007, J THROMB HAEMOST, V5, P1076, DOI 10.1111/j.1538-7836.2007.02455.x; PRANDONI P, 1993, CIRCULATION, V88, P1730, DOI 10.1161/01.CIR.88.4.1730; Prandoni P, 2002, ANN INTERN MED, V137, P955, DOI 10.7326/0003-4819-137-12-200212170-00008; Prandoni P, 2002, THROMB HAEMOSTASIS, V88, P402; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Segal JB, 2007, ANN INTERN MED, V146, P211, DOI 10.7326/0003-4819-146-3-200702060-00150; Simioni P, 1999, BEST PRACT RES CL HA, V12, P479, DOI 10.1053/beha.1999.0037; Siragusa S, 2008, BLOOD, V112, P511, DOI 10.1182/blood-2008-01-131656; Stain M, 2005, J THROMB HAEMOST, V3, P2671, DOI 10.1111/j.1538-7836.2005.01648.x; Streiff MB, 2006, AM J HEMATOL, V81, P684, DOI 10.1002/ajh.20691; Young L, 2006, J THROMB HAEMOST, V4, P1919, DOI 10.1111/j.1538-7836.2006.02120.x	27	164	169	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					577	U1		10.7326/0003-4819-150-9-200905050-00003	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414836				2022-12-28	WOS:000265903800001
J	Thukral, A; Tripathi, K; Khan, I; Chaudhary, R				Thukral, Anubhav; Tripathi, Kamalakar; Khan, Imran; Chaudhary, Rahul			Fever, rash, and crusting ulcers	LANCET			English	Editorial Material							PITYRIASIS LICHENOIDES; DISORDER		[Thukral, Anubhav; Tripathi, Kamalakar] Banaras Hindu Univ, Dept Med, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Khan, Imran] Banaras Hindu Univ, Dept Anaesthesia, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Chaudhary, Rahul] Banaras Hindu Univ, Dept Skin & Venerol, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Thukral, A (corresponding author), Banaras Hindu Univ, Dept Med, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	anubhavthukral@rediffmail.com						Maekawa Yoshihiro, 1994, Journal of Dermatology (Tokyo), V21, P46; Magro C, 2002, HUM PATHOL, V33, P788, DOI 10.1053/hupa.2002.125381; Tomasini D, 2004, J CUTAN PATHOL, V31, P531, DOI 10.1111/j.0303-6987.2004.00186.x; Tsai KS, 2001, INT J DERMATOL, V40, P694, DOI 10.1046/j.1365-4362.2001.01301.x; Weinberg JM, 2002, ARCH DERMATOL, V138, P1063, DOI 10.1001/archderm.138.8.1063	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 2	2009	373	9674					1576	1576		10.1016/S0140-6736(09)60655-3	http://dx.doi.org/10.1016/S0140-6736(09)60655-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440OT	19410719				2022-12-28	WOS:000265710300037
J	Hallows, WC; Smith, BC; Lee, S; Denu, JM				Hallows, William C.; Smith, Brian C.; Lee, Susan; Denu, John M.			Ure(k)a! Sirtuins Regulate Mitochondria	CELL			English	Editorial Material							LYSINE ACETYLATION; SIRT3	Increasing evidence suggests that multiple metabolic pathways are regulated by sirtuin-dependent protein deacetylation in the mitochondria. In this issue, Nakagawa et al. (2009) show that the sirtuin SIRT5 deacetylates and activates a mitochondrial enzyme, carbamoyl phosphate synthetase 1, which mediates the first step in the urea cycle.	[Hallows, William C.; Smith, Brian C.; Lee, Susan; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	jmdenu@wisc.edu	Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768	NIGMS NIH HHS [R01 GM065386-07, R01 GM065386] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200	9	12	13	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					404	406		10.1016/j.cell.2009.04.036	http://dx.doi.org/10.1016/j.cell.2009.04.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410538	Green Accepted, Bronze			2022-12-28	WOS:000265677200011
J	He, XJ; Hsu, YF; Zhu, SH; Wierzbicki, AT; Pontes, O; Pikaard, CS; Liu, HL; Wang, CS; Jin, HL; Zhu, JK				He, Xin-Jian; Hsu, Yi-Feng; Zhu, Shihua; Wierzbicki, Andrzej T.; Pontes, Olga; Pikaard, Craig S.; Liu, Hai-Liang; Wang, Co-Shine; Jin, Hailing; Zhu, Jian-Kang			An Effector of RNA-Directed DNA Methylation in Arabidopsis Is an ARGONAUTE 4-and RNA-Binding Protein	CELL			English	Article							GLYCOSYLASE/LYASE ROS1; POLYMERASE-II; TRANSCRIPTION; HETEROCHROMATIN; ROLES; SPT5; IV; MAINTENANCE; SUBUNIT; RITS	DNA methylation is a conserved epigenetic mark in plants and mammals. In Arabidopsis, DNA methylation can be triggered by small interfering RNAs (siRNAs) through an RNA-directed DNA methylation (RdDM) pathway. Here, we report the identification of an RdDM effector, KTF1. Loss-of-function mutations in KTF1 reduce DNA methylation and release the silencing of RdDM target loci without abolishing the siRNA triggers. KTF1 has similarity to the transcription elongation factor SPT5 and contains a C-terminal extension rich in GW/WG repeats. KTF1 colocalizes with ARGONAUTE 4 (AGO4) in punctate nuclear foci and binds AGO4 and RNA transcripts. Our results suggest KTF1 as an adaptor protein that binds scaffold transcripts generated by Pol V and recruits AGO4 and AGO4-bound siRNAs to form an RdDM effector complex. The dual interaction of an effector protein with AGO and small RNA target transcripts may be a general feature of RNA-silencing effector complexes.	[He, Xin-Jian; Hsu, Yi-Feng; Zhu, Shihua; Liu, Hai-Liang; Jin, Hailing; Zhu, Jian-Kang] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [He, Xin-Jian; Hsu, Yi-Feng; Zhu, Shihua; Liu, Hai-Liang; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Jin, Hailing] Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; [Hsu, Yi-Feng; Wang, Co-Shine] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Zhu, Shihua] Ningbo Univ, Coll Sci & Technol, Ningbo 315211, Zhejiang, Peoples R China; [Wierzbicki, Andrzej T.; Pontes, Olga; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; National Chung Hsing University; Ningbo University; Washington University (WUSTL)	Zhu, JK (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Zhu, Jian-Kang/F-7658-2011; Pikaard, Craig S/K-8772-2012; Pontes, Olga MF/F-9768-2011; Jin, Hailing/Z-1168-2019; Hsu, Yi Feng/P-7737-2014; hsu, yifeng/GPW-9650-2022	Zhu, Jian-Kang/0000-0001-5134-731X; Pikaard, Craig S/0000-0001-8204-7459; Pontes, Olga MF/0000-0003-3316-1145; Jin, Hailing/0000-0001-5778-5193; hsu, yifeng/0000-0001-6070-9925; Zhu, Shihua/0000-0002-8046-6825; Wang, Co-Shine/0000-0002-1668-2750	National Institutes of Health [R01GM070795, R01GM059138, GM077590]; National Science Foundation [MCB-0642843]; Edward Mallinckrodt Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138, R01GM070795, R01GM077590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Edward Mallinckrodt Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xuemei Chen and Shou-Wei Ding for helpful discussion. This work was supported by National Institutes of Health grants R01GM070795 and R01GM059138 to J.-K.Z., GM077590 to C.S.P., and National Science Foundation grant MCB-0642843 to H.J.O.P. was supported by an Edward Mallinckrodt Foundation Award.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Huang LF, 2009, NAT STRUCT MOL BIOL, V16, P91, DOI 10.1038/nsmb.1539; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Partridge JF, 2007, MOL CELL, V26, P593, DOI 10.1016/j.molcel.2007.05.004; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Ream TS, 2009, MOL CELL, V33, P192, DOI 10.1016/j.molcel.2008.12.015; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Winston F, 2001, GENOME BIOL, V2; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	43	179	199	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					498	508		10.1016/j.cell.2009.04.028	http://dx.doi.org/10.1016/j.cell.2009.04.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410546	Green Accepted, Bronze			2022-12-28	WOS:000265677200019
J	Hothorn, M; Neumann, H; Lenherr, ED; Wehner, M; Rybin, V; Hassa, PO; Uttenweiler, A; Reinhardt, M; Schmidt, A; Seiler, J; Ladurner, AG; Herrmann, C; Scheffzek, K; Mayer, A				Hothorn, Michael; Neumann, Heinz; Lenherr, Esther D.; Wehner, Mark; Rybin, Vladimir; Hassa, Paul O.; Uttenweiler, Andreas; Reinhardt, Monique; Schmidt, Andrea; Seiler, Jeanette; Ladurner, Andreas G.; Herrmann, Christian; Scheffzek, Klaus; Mayer, Andreas			Catalytic Core of a Membrane-Associated Eukaryotic Polyphosphate Polymerase	SCIENCE			English	Article							INORGANIC POLYPHOSPHATE; MYCORRHIZAL SYMBIOSIS; VTC PROTEINS; V-ATPASE; POLY-P; YEAST; METABOLISM; PHOSPHATE; TRIPHOSPHATASE; INSIGHTS	Polyphosphate (polyP) occurs ubiquitously in cells, but its functions are poorly understood and its synthesis has only been characterized in bacteria. Using x-ray crystallography, we identified a eukaryotic polyphosphate polymerase within the membrane-integral vacuolar transporter chaperone (VTC) complex. A 2.6 angstrom crystal structure of the catalytic domain grown in the presence of adenosine triphosphate (ATP) reveals polyP winding through a tunnel-shaped pocket. Nucleotide-and phosphate-bound structures suggest that the enzyme functions by metal-assisted cleavage of the ATP gamma-phosphate, which is then in-line transferred to an acceptor phosphate to form polyP chains. Mutational analysis of the transmembrane domain indicates that VTC may integrate cytoplasmic polymer synthesis with polyP membrane translocation. Identification of the polyP-synthesizing enzyme opens the way to determine the functions of polyP in lower eukaryotes.	[Hothorn, Michael; Lenherr, Esther D.; Rybin, Vladimir; Hassa, Paul O.; Seiler, Jeanette; Ladurner, Andreas G.; Scheffzek, Klaus] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Hothorn, Michael] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Neumann, Heinz; Uttenweiler, Andreas; Reinhardt, Monique; Schmidt, Andrea; Mayer, Andreas] Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland; [Wehner, Mark; Herrmann, Christian] Ruhr Univ Bochum, D-44780 Bochum, Germany; [Mayer, Andreas] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	European Molecular Biology Laboratory (EMBL); Salk Institute; University of Lausanne; Ruhr University Bochum; Baylor College of Medicine	Scheffzek, K (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	scheffzek@embl.de	Neumann, Heinz/F-7875-2014; Hothorn, Michael/C-6807-2011; Neumann, Heinz/ABC-7323-2021; Mayer, Andreas/AAE-4315-2020	Neumann, Heinz/0000-0001-9657-1913; Mayer, Andreas/0000-0001-6131-313X; Ladurner, Andreas/0000-0003-3835-232X; Hothorn, Michael/0000-0002-3597-5698	Peter and Traudl Engelhorn Foundation (Penzberg, Germany); European Molecular Biology Organization long-term fellowship; Boehringer Ingelheim Fonds; German Science Foundation; Landesstiftung Baden-Wurttemberg; Swiss National Science Foundation; National Science Foundation [IOS-0649389]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Peter and Traudl Engelhorn Foundation (Penzberg, Germany); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); German Science Foundation(German Research Foundation (DFG)); Landesstiftung Baden-Wurttemberg; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	With the exception of the AppNHp-Mn2+ and PPi complexes (determined at the Salk Institute), all crystallographic work was carried out at the European Molecular Biology Laboratory. We thank J. Noel, T. Gibson, and T. A. Steitz for discussion and J. Chory for generous support. This work was funded by the Peter and Traudl Engelhorn Foundation (Penzberg, Germany) and a European Molecular Biology Organization long-term fellowship (M.H), the Boehringer Ingelheim Fonds (A.U.), the German Science Foundation and the Landesstiftung Baden-Wurttemberg (K.S.), the Swiss National Science Foundation (A.M, P.O.H), and the National Science Foundation (IOS-0649389 to J. Chory). We thank the staff at the European Synchrotron Radiation Facility, Grenoble, France, at the Deutsches Elektronen Synchrotron, Hamburg, Germany, and at the Advanced Light Source, Berkeley, for technical support; and C. Muller and S. Cusack for sharing beam time. Coordinates and structure factors for Vtc2p183-553 (PDB-ID 3g3o), Vtc4p*-polyP (3g3q), Vtc4p*-AppNHp-Mn2+ (3g3r), Vtc4p*-Pi (3g3t), and Vtc4p*- PPi (3g3u) have been deposited with the Protein DataBank (www.rcsb.org).	AHN KH, 1990, J BIOL CHEM, V265, P11734; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Murray JM, 2000, GENETICS, V154, P155; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Werner TP, 2007, FUNGAL GENET BIOL, V44, P845, DOI 10.1016/j.fgb.2007.01.008; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P2731, DOI 10.1073/pnas.0500023102	22	193	199	5	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					513	516		10.1126/science.1168120	http://dx.doi.org/10.1126/science.1168120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390046				2022-12-28	WOS:000265411200047
J	Lee, SM; Pippel, E; Gosele, U; Dresbach, C; Qin, Y; Chandran, CV; Brauniger, T; Hause, G; Knez, M				Lee, Seung-Mo; Pippel, Eckhard; Goesele, Ulrich; Dresbach, Christian; Qin, Yong; Chandran, C. Vinod; Braeuniger, Thomas; Hause, Gerd; Knez, Mato			Greatly Increased Toughness of Infiltrated Spider Silk	SCIENCE			English	Article							MECHANICAL-PROPERTIES; MOLECULAR-ORIENTATION; INSECT MANDIBLES; POLYCHAETE JAWS; ZINC; PROTEIN; METAL; MANGANESE; COMPLEX; DESIGN	In nature, tiny amounts of inorganic impurities, such as metals, are incorporated in the protein structures of some biomaterials and lead to unusual mechanical properties of those materials. A desire to produce these biomimicking new materials has stimulated materials scientists, and diverse approaches have been attempted. In contrast, research to improve the mechanical properties of biomaterials themselves by direct metal incorporation into inner protein structures has rarely been tried because of the difficulty of developing a method that can infiltrate metals into biomaterials, resulting in a metal-incorporated protein matrix. We demonstrated that metals can be intentionally infiltrated into inner protein structures of biomaterials through multiple pulsed vapor-phase infiltration performed with equipment conventionally used for atomic layer deposition (ALD). We infiltrated zinc (Zn), titanium (Ti), or aluminum (Al), combined with water from corresponding ALD precursors, into spider dragline silks and observed greatly improved toughness of the resulting silks. The presence of the infiltrated metals such as Al or Ti was verified by energy-dispersive x-ray (EDX) and nuclear magnetic resonance spectra measured inside the treated silks. This result of enhanced toughness of spider silk could potentially serve as a model for a more general approach to enhance the strength and toughness of other biomaterials.	[Lee, Seung-Mo; Pippel, Eckhard; Goesele, Ulrich; Qin, Yong; Knez, Mato] Max Planck Inst Microstruct Phys, D-06120 Halle, Germany; [Dresbach, Christian] Fraunhofer Inst Mech Mat, D-06120 Halle, Germany; [Chandran, C. Vinod; Braeuniger, Thomas] Univ Halle Wittenberg, Inst Phys, Nucl Magnet Resonance Grp, D-06108 Halle, Germany; [Hause, Gerd] Univ Halle Wittenberg, Microscopy Unit Bioctr, D-06120 Halle, Germany	Max Planck Society; Fraunhofer Gesellschaft; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Lee, SM (corresponding author), Max Planck Inst Microstruct Phys, Weinberg 2, D-06120 Halle, Germany.	smlee@mpi-halle.de; mknez@mpi-halle.de	Knez, Mato/F-9287-2014; Qin, Yong/D-9716-2011	Knez, Mato/0000-0002-9850-1035; Chandran, C. Vinod/0000-0003-4074-8833	Bundesministerium fur Bildung und Forschung [FKZ 03X5507]; Deutsche Forschungsgemeinschaft [BR 3370/3-1, Mi 390/17-1]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank W. Lee from the Korea Research Institute of Standards and Science in Daejeon, Korea; H. Han from the Department of Material Science and Engineering, Pohang University of Science and Technology in Pohang, Korea; and G.-M. Kim from the Department of Physics, Martin-Luther-University Halle-Wittenberg in Merseburg, Germany, for their helpful discussions on physical and chemical interpretations of mechanical properties, WAXS, NMR spectra, Raman spectra, energy-filtered TEM (EFTEM), and time-of-flight secondary ion mass spectroscopy (TOF-SIMS) data. We also thank J. Woltersdorf, M. Becker, and J. Liu from the Max Planck Institute of Microstructure Physics in Halle, Germany, for EFTEM and Raman measurements. We appreciate TOF-SIMS measurement by M. Krause and help and support in arranging the mechanical properties measurements and TOF-SIMS measurement by M. Petzold from the Fraunhofer Institute for Mechanics of Materials in Halle, Germany. This work has received financial support from the Bundesministerium fur Bildung und Forschung (grant FKZ 03X5507) and Deutsche Forschungsgemeinschaft (grants BR 3370/3-1 and Mi 390/17-1).	ARNOLD FH, 1991, SCIENCE, V252, P1796, DOI 10.1126/science.1648261; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; BRYAN GW, 1979, J MAR BIOL ASSOC UK, V59, P969, DOI 10.1017/S0025315400036961; Chang CY, 2008, ORG ELECTRON, V9, P667, DOI 10.1016/j.orgel.2008.04.009; Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P17, DOI 10.1007/s00114-007-0288-1; Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144; Edwards Ashley J., 1993, Cell Biology International, V17, P697, DOI 10.1006/cbir.1993.1125; Fernandez A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.018102; FORNES RE, 1983, J POLYM SCI POL PHYS, V21, P1163, DOI 10.1002/pol.1983.180210715; GIBBS PE, 1980, J MAR BIOL ASSOC UK, V60, P205, DOI 10.1017/S0025315400024267; Gosline JM, 1999, J EXP BIOL, V202, P3295; GROSSKREUTZ JC, 1969, J ELECTROCHEM SOC, V116, P1232, DOI 10.1149/1.2412286; Guinea GV, 2005, J EXP BIOL, V208, P25, DOI 10.1242/jeb.01344; GURD FRN, 1956, ADV PROTEIN CHEM, V11, P311, DOI 10.1016/S0065-3233(08)60424-6; GUSTAVSON KH, 1958, NATURE, V182, P1125, DOI 10.1038/1821125a0; HANDEL T, 1990, J AM CHEM SOC, V112, P6710, DOI 10.1021/ja00174a039; HILLERTON JE, 1982, J EXP BIOL, V101, P333; HILLERTON JE, 1984, J STORED PROD RES, V20, P133, DOI 10.1016/0022-474X(84)90020-1; KELLIS JT, 1991, BIO-TECHNOL, V9, P994, DOI 10.1038/nbt1091-994; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339; Let AL, 2008, J NON-CRYST SOLIDS, V354, P1801, DOI 10.1016/j.jnoncrysol.2007.09.005; Lichtenegger HC, 2002, SCIENCE, V298, P389, DOI 10.1126/science.1075433; Lichtenegger HC, 2003, P NATL ACAD SCI USA, V100, P9144, DOI 10.1073/pnas.1632658100; Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmat1534; Morgan TD, 2003, J STORED PROD RES, V39, P65, DOI 10.1016/S0022-474X(02)00019-X; Pontin MG, 2007, P NATL ACAD SCI USA, V104, P13559, DOI 10.1073/pnas.0702034104; Quicke DLJ, 1998, ZOOL J LINN SOC-LOND, V124, P387, DOI 10.1006/zjls.1997.0146; RAO KSJ, 1994, MOL CELL BIOCHEM, V137, P61; SCHOFIELD R, 1989, J EXP BIOL, V144, P577; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sun HZ, 1998, ANGEW CHEM INT EDIT, V37, P1577, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1577::AID-ANIE1577>3.0.CO;2-M; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wilson CA, 2005, CHEM MATER, V17, P5625, DOI 10.1021/cm050704d	39	288	291	12	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					488	492		10.1126/science.1168162	http://dx.doi.org/10.1126/science.1168162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390040				2022-12-28	WOS:000265411200040
J	Ikram, MA; Seshadri, S; Bis, JC; Fornage, M; DeStefano, AL; Aulchenko, YS; Debette, S; Lumley, T; Folsom, AR; van den Herik, EG; Bos, MJ; Beiser, A; Cushman, M; Launer, LJ; Shahar, E; Struchalin, M; Du, YC; Glazer, NL; Rosamond, WD; Rivadeneira, F; Kelly-Hayes, M; Lopez, OL; Coresh, J; Hofman, A; DeCarli, C; Heckbert, SR; Koudstaal, PJ; Yang, Q; Smith, NL; Kase, CS; Rice, K; Haritunians, T; Roks, G; de Kort, PLM; Taylor, KD; de Lau, LM; Oostra, BA; Uitterlinden, AG; Rotter, JI; Boerwinkle, E; Psaty, BM; Mosley, TH; van Duijn, CM; Breteler, MMB; Longstreth, WT; Wolf, PA				Ikram, M. Arfan; Seshadri, Sudha; Bis, Joshua C.; Fornage, Myriam; DeStefano, Anita L.; Aulchenko, Yurii S.; Debette, Stephanie; Lumley, Thomas; Folsom, Aaron R.; van den Herik, Evita G.; Bos, Michiel J.; Beiser, Alexa; Cushman, Mary; Launer, Lenore J.; Shahar, Eyal; Struchalin, Maksim; Du, Yangchun; Glazer, Nicole L.; Rosamond, Wayne D.; Rivadeneira, Fernando; Kelly-Hayes, Margaret; Lopez, Oscar L.; Coresh, Josef; Hofman, Albert; DeCarli, Charles; Heckbert, Susan R.; Koudstaal, Peter J.; Yang, Qiong; Smith, Nicholas L.; Kase, Carlos S.; Rice, Kenneth; Haritunians, Talin; Roks, Gerwin; de Kort, Paul L. M.; Taylor, Kent D.; de Lau, Lonneke M.; Oostra, Ben A.; Uitterlinden, Andre G.; Rotter, Jerome I.; Boerwinkle, Eric; Psaty, Bruce M.; Mosley, Thomas H.; van Duijn, Cornelia M.; Breteler, Monique M. B.; Longstreth, W. T., Jr.; Wolf, Philip A.			Genomewide Association Studies of Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WNK1 GENE; FOLLOW-UP; WIDE ASSOCIATION; BLOOD-PRESSURE; LIFETIME RISK; FRAMINGHAM; HEART; POPULATION; DESIGN; EPIDEMIOLOGY	Background The genes underlying the risk of stroke in the general population remain undetermined. Methods We carried out an analysis of genomewide association data generated from four large cohorts composing the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium, including 19,602 white persons (mean [+/- SD] age, 63 +/- 8 years) in whom 1544 incident strokes (1164 ischemic strokes) developed over an average follow-up of 11 years. We tested the markers most strongly associated with stroke in a replication cohort of 2430 black persons with 215 incident strokes (191 ischemic strokes), another cohort of 574 black persons with 85 incident strokes (68 ischemic strokes), and 652 Dutch persons with ischemic stroke and 3613 unaffected persons. Results Two intergenic single-nucleotide polymorphisms on chromosome 12p13 and within 11 kb of the gene NINJ2 were associated with stroke (P<5x10(-8)). NINJ2 encodes an adhesion molecule expressed in glia and shows increased expression after nerve injury. Direct genotyping showed that rs12425791 was associated with an increased risk of total (i.e., all types) and ischemic stroke, with hazard ratios of 1.30 (95% confidence interval [CI], 1.19 to 1.42) and 1.33 (95% CI, 1.21 to 1.47), respectively, yielding population attributable risks of 11% and 12% in the discovery cohorts. Corresponding hazard ratios were 1.35 (95% CI, 1.01 to 1.79; P = 0.04) and 1.42 (95% CI, 1.06 to 1.91; P = 0.02) in the large cohort of black persons and 1.17 (95% CI, 1.01 to 1.37; P = 0.03) and 1.19 (95% CI, 1.01 to 1.41; P = 0.04) in the Dutch sample; the results of an underpowered analysis of the smaller black cohort were nonsignificant. Conclusions A genetic locus on chromosome 12p13 is associated with an increased risk of stroke.	[Ikram, M. Arfan; Aulchenko, Yurii S.; Bos, Michiel J.; Struchalin, Maksim; Hofman, Albert; Oostra, Ben A.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Breteler, Monique M. B.] Erasmus MC Univ, Med Ctr, Dept Epidemiol, Rotterdam Study, Rotterdam, Netherlands; [van den Herik, Evita G.; Bos, Michiel J.; Koudstaal, Peter J.; de Lau, Lonneke M.] Erasmus MC Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Struchalin, Maksim] Erasmus MC Univ, Med Ctr, Dept Forens Mol Biol, Rotterdam, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands; [Roks, Gerwin; de Kort, Paul L. M.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Roks, Gerwin; de Kort, Paul L. M.] TweeSteden Hosp, Dept Neurol, Tilburg, Netherlands; [Seshadri, Sudha; DeStefano, Anita L.; Debette, Stephanie; Beiser, Alexa; Du, Yangchun; Kelly-Hayes, Margaret; Kase, Carlos S.; Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Framingham Heart Study, Boston, MA 02118 USA; [DeStefano, Anita L.; Beiser, Alexa; Du, Yangchun; Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA; [Bis, Joshua C.; Glazer, Nicole L.; Psaty, Bruce M.; Longstreth, W. T., Jr.] Univ Washington, Dept Med, Cardiovasc Hlth Study, Seattle, WA 98195 USA; [Lumley, Thomas; Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Heckbert, Susan R.; Smith, Nicholas L.; Psaty, Bruce M.; Longstreth, W. T., Jr.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Heckbert, Susan R.; Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Smith, Nicholas L.] Seattle Epidemiol Res & Informat Ctr, Dept Vet Affairs Off, Res & Dev, Seattle, WA USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Atherosclerosis Risk Communities Study, Houston, TX USA; [Cushman, Mary] Univ Vermont, Dept Pathol & Med, Burlington, VT 05405 USA; [Lopez, Oscar L.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; [Haritunians, Talin; Taylor, Kent D.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Folsom, Aaron R.] Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA; [Folsom, Aaron R.] Univ Minnesota, Community Hlth Sch Publ Hlth, Minneapolis, MN 55455 USA; [Shahar, Eyal] Univ Arizona, Div Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Rosamond, Wayne D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Coresh, Josef] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent, Baltimore, MD USA; [Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Geriatr Med, Jackson, MS USA; [Launer, Lenore J.] NIA, Intramural Res Program, Aging Gene Environm Susceptibil Reykjavik Study, Washington, DC USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ); Boston University; Framingham Heart Study; Boston University; University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cedars Sinai Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Arizona; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Mississippi; University of Mississippi Medical Center	Seshadri, S (corresponding author), Boston Univ, Sch Med, Dept Neurol, Framingham Heart Study, 72 E Concord St, Boston, MA 02118 USA.	suseshad@bu.edu	Rice, Kenneth M/A-4150-2013; Ikram, M. Arfan/AAM-5225-2021; Launer, Lenore J/A-8218-2010; Debette, Stephanie/T-4946-2019; Breteler, Monique M.B./J-5058-2014; Yang, Qiong/G-5438-2014; Aulchenko, Yurii/M-8270-2013; Demchuk, Andrew M/E-1103-2012; Rotter, Jerome/AAY-6598-2021; DeCarli, Charles/B-5541-2009; Rivadeneira, Fernando/O-5385-2015	Rice, Kenneth M/0000-0001-5779-4495; Debette, Stephanie/0000-0001-8675-7968; Breteler, Monique M.B./0000-0002-0626-9305; Aulchenko, Yurii/0000-0002-7899-1575; Demchuk, Andrew M/0000-0002-4930-7789; Rivadeneira, Fernando/0000-0001-9435-9441; Kase, Carlos/0000-0002-3047-5010; Kelly-Hayes, Margaret/0000-0001-5938-8052; Glazer, Nicole/0000-0002-6397-609X; Ikram, Mohammad Arfan/0000-0003-0372-8585; DeStefano, Anita/0000-0002-9335-2819; Wolf, Philip/0000-0002-3628-301X; Ballantyne, Christie/0000-0002-6432-1730; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Van Duijn, Cornelia/0000-0002-2374-9204	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC55022, R01HL087641, R01HL59367, R01HL086694, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01HL080295, R01HL087652]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health (NIH) [HHSN268200625226C]; NIH Roadmap for Medical Research [UL1RR025005]; National Institute of Neurological Disorders and Stroke (NINDS); National Center for Research Resources [M01RR00069]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; Cardiovascular Health Study; grants from the National Heart, Lung, and Blood Institute [N01-HC-25195]; Affymetrix for genotyping services [N02-HL-6-4278]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center for the use of the Linux Cluster for Genetic Analysis; NINDS [NS17950]; National Institute of Aging [AG08122, AG16495, AG033193]; Framingham Heart Study), the Netherlands Organization of Scientific Research [175.010.2005.011]; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) Netherlands Consortium for Healthy Ageing [050-060-810]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly; Ministry of Education, Culture, and Science; Ministry for Health, Welfare, and Sports; European Commission; Municipality of Rotterdam to the Rotterdam Study; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085080, N01HC085082, N01HC075150, N01HC035129, N01HC055222, N01HC085081, N01HC055016, N01HC055020, N01HC085079, N01HC015103, N01HC085084, N01HC055021, N01HC055018, N01HC055022, N01HC085086, N01HC085085, N01HC055015, N01HC045133, N01HC025195, N01HC055019, N01HC085083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL059367, R01HL087641, R01HL087652, R01HL064278, R41HL055018, R41HL055019, U01HL080295, R42HL055018] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033193, P30AG010129, R01AG008122, ZIAAG007270, R01AG016495, ZIAAG006000] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cardiovascular Health Study; grants from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix for genotyping services; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center for the use of the Linux Cluster for Genetic Analysis; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Framingham Heart Study), the Netherlands Organization of Scientific Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) Netherlands Consortium for Healthy Ageing(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare, and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam to the Rotterdam Study; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants or contracts from the National Heart, Lung, and Blood Institute (N01-HC-55015, N01-HC-55016, N01HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC55022 R01HL087641, R01HL59367, and R01HL086694), the National Human Genome Research Institute (U01HG004402), and the National Institutes of Health (NIH) (HHSN268200625226C) and the NIH Roadmap for Medical Research (UL1RR025005) to the Atherosclerosis Risk in Communities study; grants from the National Heart, Lung, and Blood Institute (N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01HL080295, and R01HL087652), the National Institute of Neurological Disorders and Stroke (NINDS), the National Center for Research Resources (M01RR00069, to the Cedars-Sinai General Clinical Research Center Genotyping core), and the National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, to the Southern California Diabetes Endocrinology Research Center) to the Cardiovascular Health Study; grants from the National Heart, Lung, and Blood Institute (N01-HC-25195) and its contract with Affymetrix for genotyping services (N02-HL-6-4278), the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center for the use of the Linux Cluster for Genetic Analysis; and by grants from the NINDS (NS17950) and the National Institute of Aging (AG08122, AG16495, and AG033193 to the Framingham Heart Study), the Netherlands Organization of Scientific Research (175.010.2005.011), the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) Netherlands Consortium for Healthy Ageing (050-060-810), the Erasmus Medical Center and Erasmus University, Rotterdam, the Netherlands Organization for Health Research and Development, the Research Institute for Diseases in the Elderly, the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission, and the Municipality of Rotterdam to the Rotterdam Study.	Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619; Bots ML, 1996, STROKE, V27, P1499, DOI 10.1161/01.STR.27.9.1499; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Eladari D, 2007, J NEPHROL, V20, P260; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Jousilahti P, 1997, STROKE, V28, P1361, DOI 10.1161/01.STR.28.7.1361; Liao DP, 1997, STROKE, V28, P1908, DOI 10.1161/01.STR.28.10.1908; Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Newhouse SJ, 2005, HUM MOL GENET, V14, P1805, DOI 10.1093/hmg/ddi187; Price T R, 1993, Ann Epidemiol, V3, P504; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Stokes 3rd J, 1989, HYPERTENSION S1, V13, pI13; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wolf P A, 1978, Adv Neurol, V19, P107; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang S, 2006, GENE DEV, V20, P1899, DOI 10.1101/gad.1426906	38	362	393	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1718	1728		10.1056/NEJMoa0900094	http://dx.doi.org/10.1056/NEJMoa0900094			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369658	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000265377800006
J	Kraft, P; Hunter, DJ				Kraft, Peter; Hunter, David J.			Genetic Risk Prediction - Are We There Yet?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kraft, P (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.							Couzin J, 2008, SCIENCE, V322, P357, DOI 10.1126/science.322.5900.357; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Katsanis SH, 2008, SCIENCE, V320, P316; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407	5	307	317	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1701	1703		10.1056/NEJMp0810107	http://dx.doi.org/10.1056/NEJMp0810107			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435XY	19369656				2022-12-28	WOS:000265377800004
J	Simpkin, AL; Robertson, LC; Barber, VS; Young, JD				Simpkin, Arabella L.; Robertson, Laura C.; Barber, Vicki S.; Young, J. Duncan			Modifiable factors influencing relatives' decision to offer organ donation: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To identify modifiable factors that influence relatives' decision to allow organ donation. Design Systematic review. Data sources Medline, Embase, and CINAHL, without language restriction, searched to April 2008. Review methods Three authors independently assessed the eligibility of the identified studies. We excluded studies that examined only factors affecting consent that could not be altered, such as donor ethnicity. We extracted quantitative results to an electronic database. For data synthesis, we summarised the results of studies comparing similar themes. Results We included 20 observational studies and audits. There were no randomised controlled trials. The main factors associated with reduced rates of refusal were the provision of adequate information on the process of organ donation and its benefits; high quality of care of potential organ donors; ensuring relatives had a clear understanding of brain stem death; separating the request for organ donation from notification that the patient had died; making the request in a private setting; and using trained and experienced individuals to make the request. Conclusions Limited evidence suggests that there are modifiable factors in the process of requests for organ donation, in particular the skills of the individual making the request and the timing of this conversation, that might have a significant impact on rates of consent. Targeting these factors might have a greater and more immediate effect on the number of organs for donation than legislative or other long term strategies.	[Barber, Vicki S.; Young, J. Duncan] John Radcliffe Hosp, Kadoorie Ctr, Intens Care Soc Clin Trials Grp, Oxford OX3 9DU, England	University of Oxford	Young, JD (corresponding author), John Radcliffe Hosp, Kadoorie Ctr, Intens Care Soc Clin Trials Grp, Oxford OX3 9DU, England.	duncan.young@nda.ox.ac.uk	Young, John D/M-9756-2016; Barber, Vicki/G-7383-2019	Young, John Duncan/0000-0002-6838-4835; Simpkin, Arabella/0000-0001-6652-8789	University of Oxford; Oxford Radcliffe Hospitals NHS Trust	University of Oxford; Oxford Radcliffe Hospitals NHS Trust	This study was funded by the University of Oxford and the Oxford Radcliffe Hospitals NHS Trust.	[Anonymous], 2004, HUMAN TISSUE ACT 200; Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Department of Health, 2007, STAT PUBL HLTH ANN R; Gortmaker SL, 1996, CRIT CARE MED, V24, P432, DOI 10.1097/00003246-199603000-00012; Ptacek JT, 1996, JAMA-J AM MED ASSOC, V276, P496; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; *UK TRANSPL, 2001, TRANSPL ACT UK ANN R	7	176	182	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2009	338								b991	10.1136/bmj.b991	http://dx.doi.org/10.1136/bmj.b991			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OO	19383730	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000265497000026
J	Caggiano, V; Fogassi, L; Rizzolatti, G; Thier, P; Casile, A				Caggiano, Vittorio; Fogassi, Leonardo; Rizzolatti, Giacomo; Thier, Peter; Casile, Antonino			Mirror Neurons Differentially Encode the Peripersonal and Extrapersonal Space of Monkeys	SCIENCE			English	Article							PREMOTOR CORTEX; BODY SCHEMA; AREA-6	Actions performed by others may have different relevance for the observer, and thus lead to different behavioral responses, depending on the regions of space in which they are executed. We found that in rhesus monkeys, the premotor cortex neurons activated by both the execution and the observation of motor acts (mirror neurons) are differentially modulated by the location in space of the observed motor acts relative to the monkey, with about half of them preferring either the monkey's peripersonal or extrapersonal space. A portion of these spatially selective mirror neurons encode space according to a metric representation, whereas other neurons encode space in operational terms, changing their properties according to the possibility that the monkey will interact with the object. These results suggest that a set of mirror neurons encodes the observed motor acts not only for action understanding, but also to analyze such acts in terms of features that are relevant to generating appropriate behaviors.	[Caggiano, Vittorio; Thier, Peter; Casile, Antonino] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany; [Fogassi, Leonardo] Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy; [Fogassi, Leonardo; Rizzolatti, Giacomo] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Fogassi, Leonardo; Rizzolatti, Giacomo] Univ Parma, Ist Italiano Tecnol, I-43100 Parma, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Parma; University of Parma; Istituto Italiano di Tecnologia - IIT; University of Parma	Casile, A (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany.	antonino.casile@uni-tuebingen.de	Caggiano, Vittorio/E-5623-2012; FOGASSI, Leonardo/K-3541-2018	Caggiano, Vittorio/0000-0002-2186-1550; FOGASSI, Leonardo/0000-0003-3348-039X; Thier, Peter/0000-0001-5909-4222	Deutsche Forschungsgemeinschaft [SFB550-C10]; Hermann and Lilly Schilling Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hermann and Lilly Schilling Foundation	We thank P. Dicke for many decisive technical contributions, two anonymous reviewers for helpful comments, and M. Giese for stimulating discussions. Supported by Deutsche Forschungsgemeinschaft grant SFB550-C10 and by the Hermann and Lilly Schilling Foundation.	Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Iriki A, 1996, NEUROREPORT, V7, P2325; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1983, BRAIN, V106, P655, DOI 10.1093/brain/106.3.655; RIZZOLATTI G, 1996, BRAIN RES COGN BRAIN, V3, P131, DOI DOI 10.1016/0926-6410(95)00038-0	10	190	195	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					403	406		10.1126/science.1166818	http://dx.doi.org/10.1126/science.1166818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372433				2022-12-28	WOS:000265221600047
J	Crowder, CM				Crowder, C. Michael			Ceramides-Friend or Foe in Hypoxia?	SCIENCE			English	Editorial Material							C-ELEGANS; DEATH; SYNTHASE; YEAST; LAG1P; LAC1P; GENE		[Crowder, C. Michael] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Crowder, C. Michael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Crowder, CM (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	crowderm@morpheus.wustl.edu			NINDS NIH HHS [R01 NS045905] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Basnakian AG, 2005, AM J PHYSIOL-RENAL, V288, pF308, DOI 10.1152/ajprenal.00204.2004; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302	15	23	23	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					343	344		10.1126/science.1173278	http://dx.doi.org/10.1126/science.1173278			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372418	Green Accepted			2022-12-28	WOS:000265221600027
J	Solovei, I; Kreysing, M; Lanctot, C; Kosem, S; Peichl, L; Cremer, T; Guck, J; Joffe, B				Solovei, Irina; Kreysing, Moritz; Lanctot, Christian; Koesem, Sueleyman; Peichl, Leo; Cremer, Thomas; Guck, Jochen; Joffe, Boris			Nuclear Architecture of Rod Photoreceptor Cells Adapts to Vision in Mammalian Evolution	CELL			English	Article							CHROMOSOME TERRITORIES; GENE-EXPRESSION; MOUSE RETINA; INACTIVE-X; ORGANIZATION; GENOME; LOCUS; TRANSCRIPTION; REPRESSION; LAMINA	We show that the nuclear architecture of rod photoreceptor cells differs fundamentally in nocturnal and diurnal mammals. The rods of diurnal retinas possess the conventional architecture found in nearly all eukaryotic cells, with most heterochromatin situated at the nuclear periphery and euchromatin residing toward the nuclear interior. The rods of nocturnal retinas have a unique inverted pattern, where heterochromatin localizes in the nuclear center, whereas euchromatin, as well as nascent transcripts and splicing machinery, line the nuclear border. The inverted pattern forms by remodeling of the conventional one during terminal differentiation of rods. The inverted rod nuclei act as collecting lenses, and computer simulations indicate that columns of such nuclei channel light efficiently toward the light-sensing rod outer segments. Comparison of the two patterns suggests that the conventional architecture prevails in eukaryotic nuclei because it results in more flexible chromosome arrangements, facilitating positional regulation of nuclear functions.	[Kreysing, Moritz; Guck, Jochen] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England; [Solovei, Irina; Lanctot, Christian; Koesem, Sueleyman; Cremer, Thomas; Joffe, Boris] Univ Munich, Div Anthropol & Human Genet, Bioctr, D-82152 Planegg Martinsried, Germany; [Peichl, Leo] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; [Cremer, Thomas] CiPSM, D-81377 Munich, Germany	University of Cambridge; University of Munich; Max Planck Society	Guck, J (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	jg473@cam.ac.uk; boris.joffe@lrz.uni-muenchen.de	Kreysing, Moritz/B-3751-2017; Guck, Jochen/B-4412-2014; Cremer, Thomas/D-7979-2011; Solovei, Irina/K-1191-2014	Kreysing, Moritz/0000-0001-7432-3871; Guck, Jochen/0000-0002-1453-6119; Cremer, Thomas/0000-0002-1830-9589; Cremer, Thomas/0000-0001-7135-7216; Lanctot, Christian/0000-0003-3211-3061; Peichl, Leo/0000-0002-8141-0911; Solovei, Irina/0000-0002-6813-7279	Deutsche Forschungsgemeinschaft [Cr59/ 20]; Bundesministerium fur Bildung und Forschung NGFN II-EP [0213377A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung NGFN II-EP	We thank A. H. F. M. Peters (FMI for Biomedical Research, Basel) for antibodies against H3K9me3 and H4K20me3, M. Hess (University of Munich) for initial help with mouse retina, S. Heynck (MPI for Brain Research, Frankfurt) for perfect sectioning, all colleagues who kindly supplied us mammal retina material (see Table S2), S. Haverkamp (MPI for Brain Research) for a TEM image of mouse rod perykarion, B. Amos (MRC LMB, Cambridge, UK) for help with the Jamin-Lebedev microscope, and M. Gerard (Abattoir Haverhill) for the provision of pig eyes. We are grateful to D. Sheer (Queen Mary's School of Medicine and Dentistry, London), A. Reichenbach (University of Leipzig), W. Stephan (University of Munich), and T. D. Lamb (Australian National University, Canberra) for reading of the manuscript and/or critical comments. The study was supported by Deutsche Forschungsgemeinschaft grant Cr59/ 20 and Bundesministerium fur Bildung und Forschung NGFN II-EP grant 0213377A to T. C., fellowships from the Instituts de recherche en sante du Canada and the Humboldt Stiftung to C. L., and Engineering and Physical Sciences Research Council and Cambridge European Trust scholarships to M. K.	Acosta ML, 2008, J COMP NEUROL, V506, P506, DOI 10.1002/cne.21561; Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Cremer Marion, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4723; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Farjadpour A, 2006, OPT LETT, V31, P2972, DOI 10.1364/OL.31.002972; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Knabe W, 1997, VISION RES, V37, P267, DOI 10.1016/S0042-6989(96)00199-X; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Kupper K, 2007, CHROMOSOMA, V116, P285, DOI 10.1007/s00412-007-0098-4; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Postberg J, 2005, J CELL SCI, V118, P3973, DOI 10.1242/jcs.02497; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; REESE BE, 1995, P NATL ACAD SCI USA, V92, P2494, DOI 10.1073/pnas.92.7.2494; Ronneberger O, 2008, CHROMOSOME RES, V16, P523, DOI 10.1007/s10577-008-1236-4; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; SOLOVEI I, 2007, COLD SPRING HARBOR P, DOI DOI 10.1101/PDB.PR0T4729; Sterling P, 2003, VISUAL NEUROSCIENCES, V1, P234; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILLIAMS RW, 2003, VISUAL NEUROSCIENCES, P65; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	44	513	533	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					356	368		10.1016/j.cell.2009.01.052	http://dx.doi.org/10.1016/j.cell.2009.01.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379699	Bronze			2022-12-28	WOS:000265456800027
J	Di Sabatino, A; Corazza, GR				Di Sabatino, Antonio; Corazza, Gino Roberto			Coeliac disease	LANCET			English	Review							STEM-CELL TRANSPLANTATION; INTESTINAL T-CELLS; GLUTEN-FREE DIET; TERM-FOLLOW-UP; TISSUE TRANSGLUTAMINASE; VILLOUS ATROPHY; INTRAEPITHELIAL LYMPHOCYTES; CLINICAL PRESENTATION; SPLENIC HYPOFUNCTION; GLIADIN PEPTIDES	Coeliac disease is a chronic inflammatory disorder of the small bowel induced in genetically susceptible people by the irritant gluten and possibly other environmental cofactors. The disorder is characterised by a diverse clinical heterogeneity that ranges from asymptomatic to severely symptomatic, and it manifests with frank malabsorption, an increased morbidity attributable to the frequent association with autoimmune disorders and increased mortality resulting from the emergence of T-cell clonal proliferations that predispose the patient to enteropathy-type T-cell lymphoma. Our understanding of the molecular basis for this disorder has improved and enabled the identification of targets for new therapies, although a strict gluten-free diet remains the mainstay of safe and effective treatment. In this Seminar we critically reassess the clinical and diagnostic aspects of this disease and new perspectives in its pathogenesis and treatment.	[Corazza, Gino Roberto] Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Dept Med 1,Ctr Studio & Cura Malattia Celiaca, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia	Corazza, GR (corresponding author), Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Dept Med 1,Ctr Studio & Cura Malattia Celiaca, Piazzale Golgi 5, I-27100 Pavia, Italy.	gr.corazza@smatteo.pv.it	CORAZZA, GINO ROBERTO/K-8500-2016; Di Sabatino, Antonio/K-8015-2016	CORAZZA, GINO ROBERTO/0000-0001-9532-0573; Di Sabatino, Antonio/0000-0002-0302-8645				Al-Toma A, 2007, GUT, V56, P1373, DOI 10.1136/gut.2006.114512; Al-Toma A, 2007, BLOOD, V109, P2243, DOI 10.1182/blood-2006-08-042820; Al-Toma A, 2006, CLIN GASTROENTEROL H, V4, P1322, DOI 10.1016/j.cgh.2006.07.007; Arentz-Hansen H, 2004, PLOS MED, V1, P84, DOI 10.1371/journal.pmed.0010001; AshtonKey M, 1997, AM J PATHOL, V151, P493; Bardella MT, 2000, GASTROINTEST ENDOSC, V51, P714, DOI 10.1067/mge.2000.104653; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Benahmed M, 2007, GASTROENTEROLOGY, V132, P994, DOI 10.1053/j.gastro.2006.12.025; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001614; Bishton MJ, 2007, BRIT J HAEMATOL, V136, P111, DOI 10.1111/j.1365-2141.2006.06371.x; Bonamico M, 2008, J PEDIATR GASTR NUTR, V47, P618, DOI 10.1097/MPG.0b013e3181677d6e; Brar P, 2007, DIGEST LIVER DIS, V39, P26, DOI 10.1016/j.dld.2006.07.014; BROCCHI E, 1988, NEW ENGL J MED, V319, P741, DOI 10.1056/NEJM198809223191202; Brown I, 2006, ARCH PATHOL LAB MED, V130, P1020; Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018; Cammarota G, 2000, LANCET, V356, P1494, DOI 10.1016/S0140-6736(00)02880-4; Cammarota G, 2006, ALIMENT PHARM THER, V23, P61, DOI 10.1111/j.1365-2036.2006.02732.x; Carroccio A, 2002, CLIN CHEM, V48, P1546; Cataldo F, 2000, GUT, V47, P366, DOI 10.1136/gut.47.3.366; Catassi C, 1999, LANCET, V354, P647, DOI 10.1016/S0140-6736(99)02609-4; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Ciccocioppo R, 2006, AM J CLIN PATHOL, V125, P502, DOI 10.1309/DTYRA91G8R0KTM8M; Ciccocioppo R, 2005, LAB INVEST, V85, P397, DOI 10.1038/labinvest.3700225; COLLIN P, 1993, SCAND J GASTROENTERO, V28, P595, DOI 10.3109/00365529309096094; CORAZZA G, 1992, GASTROENTEROLOGY, V103, P1517, DOI 10.1016/0016-5085(92)91172-Z; Corazza GR, 2007, CLIN GASTROENTEROL H, V5, P838, DOI 10.1016/j.cgh.2007.03.019; Corazza GR, 1997, LANCET, V350, P106, DOI 10.1016/S0140-6736(97)01042-8; CORAZZA GR, 1993, J CLIN GASTROENTEROL, V16, P16, DOI 10.1097/00004836-199301000-00006; Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; CORAZZA GR, 1995, GASTROENTEROLOGY, V109, P122, DOI 10.1016/0016-5085(95)90276-7; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Dewar DH, 2006, EUR J GASTROEN HEPAT, V18, P483, DOI 10.1097/00042737-200605000-00005; Dewar DH, 2005, GASTROENTEROLOGY, V128, pS19, DOI 10.1053/j.gastro.2005.02.010; Di Cagno R, 2004, APPL ENVIRON MICROB, V70, P1088, DOI 10.1128/AEM.70.2.1088-1096.2004; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Di Sabatino A, 2006, CLIN GASTROENTEROL H, V4, P179, DOI 10.1016/S1542-3565(05)00982-1; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Di Sabatino A, 2007, J ALLERGY CLIN IMMUN, V120, P1461, DOI 10.1016/j.jaci.2007.07.054; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P1175, DOI 10.1053/j.gastro.2007.08.018; Dieterich W, 2006, GUT, V55, P478, DOI 10.1136/gut.2005.069385; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fabbro E, 2008, CLIN CHIM ACTA, V390, P134, DOI 10.1016/j.cca.2008.01.015; Fabiani E, 2000, J PEDIATR-US, V136, P841, DOI 10.1016/S0022-3476(00)35904-2; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; FERGUSON A, 1993, GUT, V34, P150, DOI 10.1136/gut.34.2.150; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Fine KD, 1997, GASTROENTEROLOGY, V112, P1830, DOI 10.1053/gast.1997.v112.pm9178673; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Gale J, 2000, J CLIN ONCOL, V18, P795, DOI 10.1200/JCO.2000.18.4.795; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Guidetti CS, 2001, GUT, V49, P502, DOI 10.1136/gut.49.4.502; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Hoffenberg EJ, 2003, J PEDIATR-US, V143, P308, DOI 10.1067/S0022-3476(03)00282-8; Holopainen P, 2004, TISSUE ANTIGENS, V63, P212, DOI 10.1111/j.1399-0039.2004.00189.x; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; JABBARI M, 1988, GASTROENTEROLOGY, V95, P1518, DOI 10.1016/S0016-5085(88)80071-4; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Jafri MR, 2008, DIGEST DIS SCI, V53, P964, DOI 10.1007/s10620-007-9976-0; Jantunen E, 2003, LEUKEMIA LYMPHOMA, V44, P2163, DOI 10.1080/1042819031000123456; Johnston SD, 1998, QJM-MON J ASSOC PHYS, V91, P853, DOI 10.1093/qjmed/91.12.853; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kaukinen K, 2007, SCAND J GASTROENTERO, V42, P1428, DOI 10.1080/00365520701452217; Kemppainen T, 1999, BONE, V24, P249, DOI 10.1016/S8756-3282(98)00178-1; Kemppainen T, 2007, SCAND J GASTROENTERO, V42, P54, DOI 10.1080/00365520600842245; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kiraly R, 2006, J AUTOIMMUN, V26, P278, DOI 10.1016/j.jaut.2006.03.002; Korponay-Szabo IR, 2007, BMJ-BRIT MED J, V335, P1244, DOI 10.1136/bmj.39405.472975.80; KUMAR PJ, 1988, ARCH DIS CHILD, V63, P916, DOI 10.1136/adc.63.8.916; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lee A, 2003, J AM DIET ASSOC, V103, P1533, DOI 10.1016/j.jada.2003.08.027; Lewis NR, 2008, ALIMENT PHARM THER, V27, P1140, DOI 10.1111/j.1365-2036.2008.03660.x; Lewis NR, 2005, EUR J GASTROEN HEPAT, V17, P1065, DOI 10.1097/00042737-200510000-00009; Losowsky MS, 2008, DIGEST DIS, V26, P112, DOI 10.1159/000116768; Ludvigsson JF, 2008, GUT, V57, P1074, DOI 10.1136/gut.2007.133868; Ludvigsson JF, 2007, ALIMENT PHARM THER, V25, P273, DOI 10.1111/j.1365-2036.2006.03203.x; Lundin KEA, 2003, GUT, V52, P1649, DOI 10.1136/gut.52.11.1649; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MAKI M, 1990, ARCH DIS CHILD, V65, P1137, DOI 10.1136/adc.65.10.1137; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; MANN NS, 2006, INTERN MED J, V13, P3; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Matysiak-Budnik T, 2007, GUT, V56, P1379, DOI 10.1136/gut.2006.100511; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Molberg O, 2003, GASTROENTEROLOGY, V125, P337, DOI 10.1016/S0016-5085(03)00890-4; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Monteleone G, 2001, EUR J IMMUNOL, V31, P2247, DOI 10.1002/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO;2-4; Monteleone I, 2004, GUT, V53, P1090, DOI 10.1136/gut.2003.030551; Mora S, 2001, J PEDIATR-US, V139, P516, DOI 10.1067/mpd.2001.116298; MORTIMER PE, 1968, BRIT MED J, V3, P7, DOI 10.1136/bmj.3.5609.7; Mulder CJJ, 2005, BEST PRACT RES CL GA, V19, P479, DOI 10.1016/j.bpg.2005.01.007; Murray JA, 2008, CLIN GASTROENTEROL H, V6, P186, DOI 10.1016/j.cgh.2007.10.012; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; O'Leary C, 2004, AM J GASTROENTEROL, V99, P2437, DOI 10.1111/j.1572-0241.2004.40182.x; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Obermann EC, 2004, J PATHOL, V202, P252, DOI 10.1002/path.1506; Pais WP, 2008, GASTROINTEST ENDOSC, V67, P1082, DOI 10.1016/j.gie.2007.10.015; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Pietzak MM, 2005, GASTROENTEROLOGY, V128, pS135, DOI 10.1053/j.gastro.2005.02.025; PRZEMIOSLO RT, 1994, GUT, V35, P1398, DOI 10.1136/gut.35.10.1398; Pyle GG, 2005, CLIN GASTROENTEROL H, V3, P687, DOI 10.1016/S1542-3565(05)00366-6; Qiao SW, 2005, J IMMUNOL, V174, P1657, DOI 10.4049/jimmunol.174.3.1657; Qiao SW, 2004, J IMMUNOL, V173, P1757, DOI 10.4049/jimmunol.173.3.1757; Rashtak S, 2007, ANN INTERN MED, V147, P339, DOI 10.7326/0003-4819-147-5-200709040-00009; Rostami K, 2001, EUR J OBSTET GYN R B, V96, P146, DOI 10.1016/S0301-2115(00)00457-7; Rubio-Tapia A, 2007, HEPATOLOGY, V46, P1650, DOI 10.1002/hep.21949; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V136, P99, DOI 10.1053/j.gastro.2008.10.013; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; SategnaGuidetti C, 1996, J CLIN GASTROENTEROL, V23, P101, DOI 10.1097/00004836-199609000-00006; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Shah VH, 2000, GASTROINTEST ENDOSC, V51, P717, DOI 10.1067/mge.2000.104977; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Solaymani-Dodaran M, 2007, AM J GASTROENTEROL, V102, P864, DOI 10.1111/j.1572-0241.2007.01111.x; Sollid LM, 2005, CLIN GASTROENTEROL H, V3, P843, DOI 10.1016/S1542-3565(05)00532-X; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; Thomas HJ, 2008, EUR J GASTROEN HEPAT, V20, P624, DOI 10.1097/MEG.0b013e3282f45764; Tommasini A, 2004, ARCH DIS CHILD, V89, P512, DOI 10.1136/adc.2003.029603; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI [10.1016/S0002-9270(02)06006-9, 10.1111/j.1572-0241.2003.07284.x]; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Verkarre V, 2003, GASTROENTEROLOGY, V125, P40, DOI 10.1016/S0016-5085(03)00692-9; Vivas S, 2006, NEW ENGL J MED, V354, P2514, DOI 10.1056/NEJMc053129; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; WIESER H, 1995, BAILLIERE CLIN GASTR, V9, P191, DOI 10.1016/0950-3528(95)90027-6; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; Wolters VM, 2008, AM J GASTROENTEROL, V103, P190, DOI 10.1111/j.1572-0241.2007.01471.x; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	155	464	492	1	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1480	1493		10.1016/S0140-6736(09)60254-3	http://dx.doi.org/10.1016/S0140-6736(09)60254-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394538				2022-12-28	WOS:000265501900037
J	Gilman, M; Gilman, SL; Johns, MM				Gilman, Marina; Gilman, Sander L.; Johns, Michael M., III			The art of medicine Human papillomavirus, abstinence, and the other risks	LANCET			English	Editorial Material									[Gilman, Sander L.] Emory Univ, Grad Inst Liberal Arts, Atlanta, GA 30322 USA; [Gilman, Sander L.] Emory Univ, Dept Psychiat, Atlanta, GA 30322 USA; [Gilman, Marina; Johns, Michael M., III] Emory Univ, Emory Voice Clin, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Gilman, SL (corresponding author), Emory Univ, Grad Inst Liberal Arts, Atlanta, GA 30322 USA.	sander.gilman@emory.edu	Gilman, Marina/AAI-8144-2021					[Anonymous], 2006, Lancet, V368, P1212; Chan JK, 2007, J CLIN ONCOL, V25, P2975, DOI 10.1200/JCO.2007.10.8662; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Trenholm C, 2008, J POLICY ANAL MANAG, V27, P255, DOI 10.1002/pam.20324; Winer RL, 2008, J INFECT DIS, V197, P279, DOI 10.1086/524875	5	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1420	1421		10.1016/S0140-6736(09)60810-2	http://dx.doi.org/10.1016/S0140-6736(09)60810-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437QL	19400001				2022-12-28	WOS:000265501900016
J	Roelofs, J; Park, S; Haas, W; Tian, G; McAllister, FE; Huo, Y; Lee, BH; Zhang, F; Shi, YG; Gygi, SP; Finley, D				Roelofs, Jeroen; Park, Soyeon; Haas, Wilhelm; Tian, Geng; McAllister, Fiona E.; Huo, Ying; Lee, Byung-Hoon; Zhang, Fan; Shi, Yigong; Gygi, Steven P.; Finley, Daniel			Chaperone-mediated pathway of proteasome regulatory particle assembly	NATURE			English	Article							YEAST 26S PROTEASOME; 20S PROTEASOMES; S PROTEASOME; COMPLEX; PROTEINS; SUBUNITS; ATPASE; TRANSCRIPTION; ONCOPROTEIN; SUBSTRATE	The proteasome is a protease that controls diverse processes in eukaryotic cells. Its regulatory particle (RP) initiates the degradation of ubiquitin-protein conjugates by unfolding the substrate and translocating it into the proteasome core particle (CP) to be degraded(1). The RP has 19 subunits, and their pathway of assembly is not understood. Here we show that in the yeast Saccharomyces cerevisiae three proteins are found associated with RP but not with the RP-CP holoenzyme: Nas6, Rpn14 and Hsm3. Mutations in the corresponding genes confer proteasome loss-of-function phenotypes, despite their virtual absence from the holoenzyme. These effects result from deficient RP assembly. Thus, Nas6, Rpn14 and Hsm3 are RP chaperones. The RP contains six ATPases-the Rpt proteins-and each RP chaperone binds to the carboxy-terminal domain of a specific Rpt. We show in an accompanying study(2) that RP assembly is templated through the Rpt C termini, apparently by their insertion into binding pockets in the CP. Thus, RP chaperones may regulate proteasome assembly by directly restricting the accessibility of Rpt C termini to the CP. In addition, competition between the RP chaperones and the CP for Rpt engagement may explain the release of RP chaperones as proteasomes mature.	[Roelofs, Jeroen; Park, Soyeon; Haas, Wilhelm; Tian, Geng; McAllister, Fiona E.; Huo, Ying; Lee, Byung-Hoon; Gygi, Steven P.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhang, Fan; Shi, Yigong] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	Harvard University; Harvard Medical School; Princeton University	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu	Tian, Geng/G-7374-2011; Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465; Shi, Yigong/0000-0003-2030-168X; Lee, Byung-Hoon/0000-0002-7101-0471	NIH [GM043601, GM67945]; NIH NRSA [5F32GM75737-2]; EMBO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601, R01GM067945, F32GM075737, R37GM043601] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Mann for Rpt1 (also known as Cim5) and Rpt6 (Cim3) antibodies, K. Kubota for preparing HeLa lysates and especially L. Huang for the human Rpn112HTBH-expressing cell line. We also thank J. Hanna, M. Schmidt and members of the Finley laboratory, in particular S. Elsasser, for critically reading the manuscript. This work was supported by the NIH (GM043601 to D. F. and GM67945 to S. P. G.), a NIH NRSA postdoctoral fellowship (5F32GM75737-2 to S. P.) and an EMBO long-term fellowship (to J. R.).	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; ZHANG F, MOL CELL IN PRESS	29	133	145	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					861	865		10.1038/nature08063	http://dx.doi.org/10.1038/nature08063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19412159	Green Accepted			2022-12-28	WOS:000267084500043
J	Fujiki, R; Chikanishi, T; Hashiba, W; Ito, H; Takada, I; Roeder, RG; Kitagawa, H; Kato, S				Fujiki, Ryoji; Chikanishi, Toshihiro; Hashiba, Waka; Ito, Hiroaki; Takada, Ichiro; Roeder, Robert G.; Kitagawa, Hirochika; Kato, Shigeaki			GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis	NATURE			English	Article							O-GLCNAC TRANSFERASE; TRANSCRIPTIONAL REGULATION; N-ACETYLGLUCOSAMINE; MYELOID-LEUKEMIA; CHROMATIN; COMPLEX; PROTEINS; RECEPTOR; CELLS; GLYCOSYLATION	The post-translational modifications of histone tails generate a 'histone code' that defines local and global chromatin states(1). The resultant regulation of gene function is thought to govern cell fate, proliferation and differentiation(2). Reversible histone modifications such as methylation are under mutual controls to organize chromosomal events(3,4). Among the histone modifications, methylation of specific lysine and arginine residues seems to be critical for chromatin configuration and control of gene expression(5). Methylation of histone H3 lysine 4 (H3K4) changes chromatin into a transcriptionally active state(6). Reversible modification of proteins by beta-N-acetylglucosamine (O-GlcNAc) in response to serum glucose levels regulates diverse cellular processes(7,8,9). However, the epigenetic impact of protein GlcNAcylation is unknown. Here we report that nuclear GlcNAcylation of a histone lysine methyltransferase (HKMT), MLL5, by O-GlcNAc transferase facilitates retinoic-acid-induced granulopoiesis in human HL60 promyelocytes through methylation of H3K4. MLL5 is biochemically identified in a GlcNAcylation-dependent multi-subunit complex associating with nuclear retinoic acid receptor RAR alpha (also known as RARA), serving as a mono-and di-methyl transferase to H3K4. GlcNAcylation at Thr 440 in the MLL5 SET domain evokes its H3K4 HKMT activity and co-activates RARa in target gene promoters. Increased nuclear GlcNAcylation by means of O-GlcNAc transferase potentiates retinoic-acid-induced HL60 granulopoiesis and restores the retinoic acid response in the retinoic-acid-resistant HL60-R2 cell line. Thus, nuclear MLL5 GlcNAcylation triggers cell lineage determination of HL60 through activation of its HKMT activity.	[Fujiki, Ryoji; Chikanishi, Toshihiro; Hashiba, Waka; Ito, Hiroaki; Takada, Ichiro; Kitagawa, Hirochika; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Fujiki, Ryoji; Chikanishi, Toshihiro; Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama 3320012, Japan; [Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	University of Tokyo; Japan Science & Technology Agency (JST); Rockefeller University	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Miyajima and S. Saito for cell lines, P. Chambon, T. Kitamura and S. Suzuki for experimental materials, H. Akaishi for technical support, and M. Yamaki for manuscript preparation. This work was supported in part by priority areas from the Ministry of Education, Culture, Sports, Science and Technology (to H. K. and S. K.).	Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mori J, 1999, JPN J CANCER RES, V90, P660, DOI 10.1111/j.1349-7006.1999.tb00798.x; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Si JT, 2007, J CLIN INVEST, V117, P1412, DOI 10.1172/JCI30779; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	27	135	151	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					455	U179		10.1038/nature07954	http://dx.doi.org/10.1038/nature07954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19377461				2022-12-28	WOS:000266243700052
J	Korb, J; Weil, T; Hoffmann, K; Foster, KR; Rehli, M				Korb, Judith; Weil, Tobias; Hoffmann, Katharina; Foster, Kevin R.; Rehli, Michael			A Gene Necessary for Reproductive Suppression in Termites	SCIENCE			English	Article							DIVISION-OF-LABOR		[Korb, Judith; Hoffmann, Katharina] Univ Osnabruck, D-49076 Osnabruck, Germany; [Korb, Judith; Weil, Tobias] Univ Regensburg, D-93040 Regensburg, Germany; [Weil, Tobias; Rehli, Michael] Univ Hosp Regensburg, Dept Hematol, D-93042 Regensburg, Germany; [Foster, Kevin R.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA	University Osnabruck; University of Regensburg; University of Regensburg; Harvard University	Korb, J (corresponding author), Univ Osnabruck, Barbarastr 11, D-49076 Osnabruck, Germany.	judith.korb@biologie.uni-osnabrueck.de; weil.tobias@web.de	Rehli, Michael/E-9093-2011	Rehli, Michael/0000-0003-3992-932X; Foster, Kevin/0000-0003-4687-6633	Deutsche Forschungsgemeinschaft (DFG) [KO1895/6]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank S. Schneuwly and J. Landskron for micromanipulator help and K. Merches and K. Borner for laboratory support. Supported by a Deutsche Forschungsgemeinschaft (DFG) grant to J.K. and M.R. (KO1895/6).	Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Cornette R, 2003, BIOCHEM J, V372, P535, DOI 10.1042/BJ20030025; Matsuura K, 2009, CURR BIOL, V19, P30, DOI 10.1016/j.cub.2008.11.030; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; Plettner E, 1996, SCIENCE, V271, P1851, DOI 10.1126/science.271.5257.1851; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Terra W. R., 1996, P153; Weil T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-198	8	82	83	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					758	758		10.1126/science.1170660	http://dx.doi.org/10.1126/science.1170660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423819				2022-12-28	WOS:000265832400038
J	Garber, AM; Tunis, SR				Garber, Alan M.; Tunis, Sean R.			Does Comparative-Effectiveness Research Threaten Personalized Medicine?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garber, Alan M.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Garber, Alan M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Garber, Alan M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Tunis, Sean R.] Ctr Med Technol Policy, Baltimore, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Garber, AM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.		Garber, Alan M/F-1476-2010					Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; *PARTN IMPR PAT CA, 2009, IND PAT PERS CAR; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Shurin SB, 2008, NEW ENGL J MED, V358, P1061, DOI 10.1056/NEJMe0800801	5	158	163	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1925	1927		10.1056/NEJMp0901355	http://dx.doi.org/10.1056/NEJMp0901355			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441QN	19420360	Green Published, Green Submitted			2022-12-28	WOS:000265784400001
J	Liman, AK; Zbytek, B				Liman, Agnes K.; Zbytek, Blazej			Fecaliths in Crohn's Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liman, Agnes K.; Zbytek, Blazej] Vet Adm Med Ctr, Memphis, TN 38104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Liman, AK (corresponding author), Vet Adm Med Ctr, Memphis, TN 38104 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					E25	E25		10.1056/NEJMicm0800214	http://dx.doi.org/10.1056/NEJMicm0800214			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420359				2022-12-28	WOS:000265784400011
J	Lehman, R; Pinder, S				Lehman, Richard; Pinder, Sarah			Easily Missed? Streptococcal perianal infection in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lehman, Richard; Pinder, Sarah] Hightown Surg, Banbury OX16 9DB, England		Lehman, R (corresponding author), Hightown Surg, Banbury OX16 9DB, England.	richard.lehman@nhs.net						AMREN DP, 1966, AM J DIS CHILD, V112, P546, DOI 10.1001/archpedi.1966.02090150090007; ECHEVERRIA FM, 2006, AN PEDIAT BARC, V64, P153; Gulla K, 2007, CHILD ABUSE NEGLECT, V31, P885, DOI 10.1016/j.chiabu.2007.03.017; KOKX NP, 1987, PEDIATRICS, V80, P659; KYRIAZI NC, 1991, PEDIATRICS, V88, P154; Landolt M, 2005, Praxis (Bern 1994), V94, P1467; MCCANN J, 1989, CHILD ABUSE NEGLECT, V13, P179, DOI 10.1016/0145-2134(89)90005-7; Mogielnicki NP, 2000, PEDIATRICS, V106, P276, DOI 10.1542/peds.106.2.276; Petersen JP, 2003, PEDIATR INFECT DIS J, V22, P105; WRIGHT JE, 1994, ARCH DIS CHILD, V70, P145, DOI 10.1136/adc.70.2.145	10	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2009	338								b1517	10.1136/bmj.b1517	http://dx.doi.org/10.1136/bmj.b1517			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GT	19416994				2022-12-28	WOS:000265969400002
J	Hartley, PD; Madhani, HD				Hartley, Paul D.; Madhani, Hiten D.			Mechanisms that Specify Promoter Nucleosome Location and Identity	CELL			English	Article							BINDING-SITES; HISTONE H2A.Z; CHROMATIN; YEAST; VARIANT; RSC; OCCUPANCY; SEQUENCE; PROTEIN; REGION	The chromatin architecture of eukaryotic gene promoters is generally characterized by a nucleosome-free region (NFR) flanked by at least one H2A.Z variant nucleosome. Computational predictions of nucleosome positions based on thermodynamic properties of DNA-histone interactions have met with limited success. Here we show that the action of the essential RSC remodeling complex in S. cerevisiae helps explain the discrepancy between theory and experiment. In RSC-depleted cells, NFRs shrink such that the average positions of flanking nucleosomes move toward predicted sites. Nucleosome positioning at distinct subsets of promoters additionally requires the essential Myb family proteins Abf1 and Reb1, whose binding sites are enriched in NFRs. In contrast, H2A.Z deposition is dispensable for nucleosome positioning. By regulating H2A.Z deposition using a steroid-inducible protein splicing strategy, we show that NFR establishment is necessary for H2A.Z deposition. These studies suggest an ordered pathway for the assembly of promoter chromatin architecture.	[Hartley, Paul D.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,MC2200, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Madhani, Hiten/0000-0001-7400-6657	National Institutes of Health Kirschstein [1F31GM083619, 5R01GM071801]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801, F31GM083619] Funding Source: NIH RePORTER	National Institutes of Health Kirschstein(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank past and present members of our laboratory for discussions and advice over the course of this research. We thank Leslie Chu and Joachim Li for the pMET3 degron construct. We are especially grateful to Allen Buskirk and David Liu for providing the 4-hydroxytamoxifen-regulated intein construct. This work was supported by a National Institutes of Health Kirschstein predoctoral fellowship (1F31GM083619) to P. D. H. and NIH grant 5R01GM071801 to H. D. M. H. D. M. is a scholar of the Leukemia and Lymphoma Society.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Angermayr M, 2003, J BIOL CHEM, V278, P17918, DOI 10.1074/jbc.M301806200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beinoraviciute-Kellner R, 2005, FEBS LETT, V579, P4535, DOI 10.1016/j.febslet.2005.07.009; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; DEWINDE JH, 1993, YEAST, V9, P847, DOI 10.1002/yea.320090805; Dohmen RJ, 2005, METHOD ENZYMOL, V399, P799, DOI 10.1016/S0076-6879(05)99052-6; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; HARBISON CT, 2004, NAT GENET, V38, P1210; JAKOBOVITS EB, 1980, NATURE, V285, P263, DOI 10.1038/285263a0; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; LIAW PCY, 1994, YEAST, V10, P771, DOI 10.1002/yea.320100608; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; SARAGOSTI S, 1980, CELL, V20, P65, DOI 10.1016/0092-8674(80)90235-4; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal MR, 2008, STAT APPL GENET MOL, V7; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	45	286	289	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					445	458		10.1016/j.cell.2009.02.043	http://dx.doi.org/10.1016/j.cell.2009.02.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410542	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000265677200015
J	Chessa, B; Pereira, F; Arnaud, F; Amorim, A; Goyache, F; Mainland, I; Kao, RR; Pemberton, JM; Beraldi, D; Stear, MJ; Alberti, A; Pittau, M; Iannuzzi, L; Banabazi, MH; Kazwala, RR; Zhang, YP; Arranz, JJ; Ali, BA; Wang, ZL; Uzun, M; Dione, MM; Olsaker, I; Holm, LE; Saarma, U; Ahmad, S; Marzanov, N; Eythorsdottir, E; Holland, MJ; Ajmone-Marsan, P; Bruford, MW; Kantanen, J; Spencer, TE; Palmarini, M				Chessa, Bernardo; Pereira, Filipe; Arnaud, Frederick; Amorim, Antonio; Goyache, Felix; Mainland, Ingrid; Kao, Rowland R.; Pemberton, Josephine M.; Beraldi, Dario; Stear, Michael J.; Alberti, Alberto; Pittau, Marco; Iannuzzi, Leopoldo; Banabazi, Mohammad H.; Kazwala, Rudovick R.; Zhang, Ya-ping; Arranz, Juan J.; Ali, Bahy A.; Wang, Zhiliang; Uzun, Metehan; Dione, Michel M.; Olsaker, Ingrid; Holm, Lars-Erik; Saarma, Urmas; Ahmad, Sohail; Marzanov, Nurbiy; Eythorsdottir, Emma; Holland, Martin J.; Ajmone-Marsan, Paolo; Bruford, Michael W.; Kantanen, Juha; Spencer, Thomas E.; Palmarini, Massimo			Revealing the History of Sheep Domestication Using Retrovirus Integrations	SCIENCE			English	Article							NEAR-EAST; MITOCHONDRIAL; LINEAGES; ORIGIN; WILD	The domestication of livestock represented a crucial step in human history. By using endogenous retroviruses as genetic markers, we found that sheep differentiated on the basis of their "retrotype" and morphological traits dispersed across Eurasia and Africa via separate migratory episodes. Relicts of the first migrations include the Mouflon, as well as breeds previously recognized as "primitive" on the basis of their morphology, such as the Orkney, Soay, and the Nordic short-tailed sheep now confined to the periphery of northwest Europe. A later migratory episode, involving sheep with improved production traits, shaped the great majority of present-day breeds. The ability to differentiate genetically primitive sheep from more modern breeds provides valuable insights into the history of sheep domestication.	[Chessa, Bernardo; Arnaud, Frederick; Kao, Rowland R.; Stear, Michael J.; Palmarini, Massimo] Univ Glasgow, Fac Vet Med, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland; [Chessa, Bernardo; Alberti, Alberto; Pittau, Marco] Univ Sassari, Dipartimento Patol & Clin Vet, I-07100 Sassari, Italy; [Pereira, Filipe; Amorim, Antonio] Univ Porto, Inst Patol & Imunol Mol, Fac Ciencias, P-4200465 Oporto, Portugal; [Goyache, Felix] SERIDA Somio, Area Genet & Reprod Anim, E-33203 Gijon, Spain; [Mainland, Ingrid] Univ Bradford, Div Archael Geog & Environm Sci, Bradford BD7 1DP, W Yorkshire, England; [Pemberton, Josephine M.; Beraldi, Dario] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Iannuzzi, Leopoldo] ISPAAM, CNR, Natl Res Council, I-80147 Naples, Italy; [Banabazi, Mohammad H.] Anim Sci Res Inst Iran, Dept Biotechnol, Karaj 3146618361, Iran; [Kazwala, Rudovick R.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Zhang, Ya-ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Arranz, Juan J.] Univ Leon, Fac Vet, Dept Anim Prod, E-24071 Leon, Spain; [Ali, Bahy A.] Mubarak City Sci Res & Technol Applicat, Genet Engn & Biotechnol Res Inst, Alexandria 21934, Egypt; [Wang, Zhiliang] China Anim Hlth & Epidemiol Ctr, Natl Diagnost Ctr Exot Anim Dis, Qingdao 266032, Peoples R China; [Uzun, Metehan] Canakkale Onsekiz Mart Univ, Sch Hlth Sci, TR-17100 Canakkale, Turkey; [Dione, Michel M.] Int Trypanotolerance Ctr, Banjul, Gambia; [Olsaker, Ingrid] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, N-0033 Oslo, Norway; [Holm, Lars-Erik] Univ Aarhus, Fac Agr Sci, Dept Genet & Biotechnol, DK-8830 Tjele, Denmark; [Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-51014 Tartu, Estonia; [Ahmad, Sohail] NW Frontier Prov Agr Univ, Peshwar, Pakistan; [Marzanov, Nurbiy] Russian Acad Agr Sci, All Russian Res Inst Anim Husbandry, Dubrovitsy 142132, Russia; [Eythorsdottir, Emma] Agr Univ Iceland, IS-311 Hvanneyri, Borgarnes, Iceland; [Holland, Martin J.] MRC Labs, Banjul, Gambia; [Holland, Martin J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ist Zootecn, I-29100 Piacenza, Italy; [Bruford, Michael W.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Kantanen, Juha] MTT Agrifood Res Finland, Biotechnol & Food Res, Jokioinen 31600, Finland; [Spencer, Thomas E.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX 77843 USA	University of Glasgow; University of Sassari; Universidade do Porto; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; University of Bradford; University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); Sokoine University of Agriculture; Chinese Academy of Sciences; Kunming Institute of Zoology; Universidad de Leon; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City); China Animal Health & Epidemiology Center; Canakkale Onsekiz Mart University; Norwegian University of Life Sciences; Aarhus University; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Agricultural University Peshawar; L.K. Ernst Federal Science Center for Animal Husbandry; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; Catholic University of the Sacred Heart; Cardiff University; Natural Resources Institute Finland (Luke); Texas A&M University System; Texas A&M University College Station	Palmarini, M (corresponding author), Univ Glasgow, Fac Vet Med, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland.	m.palmarini@vet.gla.ac.uk	Bruford, Michael W/D-3750-2009; Holland, Martin J/K-6502-2012; Banabazi, Mohammad Hossein/AAV-4375-2021; Holm, Lars-Erik/A-4678-2013; Kantanen, Juha/AAA-4333-2022; Stear, Michael/AAG-6329-2020; Spencer, Thomas/AAD-6434-2020; Goyache, Felix/B-7764-2009; Pereira, Filipe/F-6391-2010; Banabazi, Mohammad Hossein/S-2335-2016; Saarma, Urmas/J-6448-2015; Palmarini, Massimo/H-5982-2011; Pemberton, Josephine M/F-3100-2010; Arranz, Juan-Jose/H-1225-2015; Bruford, Michael/Y-7463-2019; Saarma, Urmas/AAC-9813-2019; Amorim, Antonio/A-7938-2008; Arnaud, Frédérick/F-4892-2019; AJMONE MARSAN, Paolo/M-2466-2018	Bruford, Michael W/0000-0001-6357-6080; Holland, Martin J/0000-0002-5828-6318; Holm, Lars-Erik/0000-0002-5312-3579; Stear, Michael/0000-0001-5054-1348; Goyache, Felix/0000-0002-6872-1045; Pereira, Filipe/0000-0001-8950-1036; Saarma, Urmas/0000-0002-3222-571X; Arranz, Juan-Jose/0000-0001-9058-131X; Bruford, Michael/0000-0001-6357-6080; Saarma, Urmas/0000-0002-3222-571X; Amorim, Antonio/0000-0002-7518-6247; Arnaud, Frédérick/0000-0001-6893-9848; Spencer, Thomas/0000-0003-2815-766X; Marzanov, Nurbi/0000-0003-0708-6196; Alberti, Alberto/0000-0002-1708-9473; Kao, Rowland/0000-0003-0919-6401; Beraldi, Dario/0000-0003-1504-5212; Banabazi, Mohammad Hossein/0000-0002-7873-8123; PITTAU, Marco/0000-0001-9222-8835; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Dione, Michel/0000-0001-7812-5776; Iannuzzi, Leopoldo/0000-0002-5445-883X; Palmarini, Massimo/0000-0001-7007-4070	Natural Environment Research Council [NER/A/S/2003/00461] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F014643/1] Funding Source: Medline; NICHD NIH HHS [HD05274, R01 HD052745] Funding Source: Medline; Wellcome Trust [076522, 081696] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052745] Funding Source: NIH RePORTER; BBSRC [BB/F014643/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arnaud F, 2008, CELL MOL LIFE SCI, V65, P3422, DOI 10.1007/s00018-008-8500-9; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Barker G., 2002, EXAMINING FARMING LA, P151; Boeke J. D., 1997, P343; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CLUTTONBROCK J, 1999, NATURAL HIST DOMESTR; Colledge S., 2005, EUR J ARCHAEOL, V8, P137, DOI [10.1177/1461957105066937, DOI 10.1177/1461957105066937]; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Harris D. R., 1996, ORIGINS SPREAD AGR P, P370; Helmer Daniel, 2007, Anthropozoologica, V42, P41; Hernandez S, 2005, WIT TRANS BUILT ENV, V80, P269; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; MCGOVERN TH, 1990, ANNU REV ANTHROPOL, V19, P331, DOI 10.1146/annurev.an.19.100190.001555; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pedrosa S, 2007, GENET SEL EVOL, V39, P91, DOI 10.1051/gse:2006034; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; POPLIN F, 1979, ANN GENET SEL ANIM, V11, P133, DOI 10.1186/1297-9686-11-2-133; Price TD, 2000, EUROPES 1 FARMERS; Ryder M. L., 1983, SHEEP AND MAN; Sherratt A. G., 1981, PATTERN OF THE PAST, P261; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Vigne Jean-Denis, 1999, P295; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zohary D, 1998, J ZOOL, V245, P129, DOI 10.1111/j.1469-7998.1998.tb00082.x	27	270	289	4	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					532	536		10.1126/science.1170587	http://dx.doi.org/10.1126/science.1170587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390051	Green Accepted, Green Submitted			2022-12-28	WOS:000265411200052
J	Kawakatsu, H; Kumar, P; Takei, Y; Shinohara, M; Kanazawa, T; Araki, E; Suyehiro, K				Kawakatsu, Hitoshi; Kumar, Prakash; Takei, Yasuko; Shinohara, Masanao; Kanazawa, Toshihiko; Araki, Eiichiro; Suyehiro, Kiyoshi			Seismic Evidence for Sharp Lithosphere-Asthenosphere Boundaries of Oceanic Plates	SCIENCE			English	Article							UPPER-MANTLE; ANISOTROPY; WATER; PACIFIC; MELT; BENEATH; ORIGIN	The mobility of the lithosphere over a weaker asthenosphere constitutes the essential element of plate tectonics, and thus the understanding of the processes at the lithosphere-asthenosphere boundary (LAB) is fundamental to understand how our planet works. It is especially so for oceanic plates because their relatively simple creation and evolution should enable easy elucidation of the LAB. Data from borehole broadband ocean bottom seismometers show that the LAB beneath the Pacific and Philippine Sea plates is sharp and age-dependent. The observed large shear wave velocity reduction at the LAB requires a partially molten asthenosphere consisting of horizontal melt-rich layers embedded in meltless mantle, which accounts for the large viscosity contrast at the LAB that facilitates horizontal plate motions.	[Kawakatsu, Hitoshi; Kumar, Prakash; Takei, Yasuko; Shinohara, Masanao; Kanazawa, Toshihiko] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Araki, Eiichiro; Suyehiro, Kiyoshi] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Kawakatsu, H (corresponding author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	hitosi@eri.u-tokyo.ac.jp			Japan Society for the Promotion of Science fellowship; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	B. Holtzman's drawing [figure 12 of (25)] was the inspiration for the proposed model of the melt-segregated shear zone in the asthenosphere. We thank S. Honda for the computer code to calculate the thermal structure and T. Inoue and K. Mibe for discussions. P.K. is supported by the JSPS fellowship provided by the Japan Society for the Promotion of Science. OHP was funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; BACKUS GE, 1962, J GEOPHYS RES, V67, P4427, DOI 10.1029/JZ067i011p04427; Ekstrom G, 1998, NATURE, V394, P168, DOI 10.1038/28148; Farra V, 2000, GEOPHYS J INT, V141, P699, DOI 10.1046/j.1365-246x.2000.00118.x; FUKAO Y, 2001, WORKSH REP OHP ION J, P13; Gung YC, 2003, NATURE, V422, P707, DOI 10.1038/nature01559; Gutenberg B, 1959, PHYS EARTHS INTERIOR; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Holtzman BK, 2003, SCIENCE, V301, P1227, DOI 10.1126/science.1087132; Honda S, 2001, GEOPHYS RES LETT, V28, P351, DOI 10.1029/2000GL012096; KANAMORI H, 1970, NATURE, V226, P330, DOI 10.1038/226330a0; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; Katz RF, 2006, NATURE, V442, P676, DOI 10.1038/nature05039; Kawakatsu H, 2007, SCIENCE, V316, P1468, DOI 10.1126/science.1140855; Kumar P, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003930; Langmuir J. W., 1992, MANTLE FLOW MELT GEN, P183; LANGSTON CA, 1979, J GEOPHYS RES, V84, P4749, DOI 10.1029/JB084iB09p04749; Mierdel K, 2007, SCIENCE, V315, P364, DOI 10.1126/science.1135422; Rychert CA, 2005, NATURE, V436, P542, DOI 10.1038/nature03904; Shinohara M, 2008, PHYS EARTH PLANET IN, V170, P95, DOI 10.1016/j.pepi.2008.07.039; Shinohara M, 2006, ANN GEOPHYS-ITALY, V49, P625; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Takaku M, 2008, PHYS EARTH PLANET IN, V166, P44, DOI 10.1016/j.pepi.2007.10.003; Takei Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI [10.1029/2001JB000522, 10.1029/2001jb000522]; TAKEI Y, J GEOPHYS R IN PRESS; Tonegawa T, 2006, EARTH PLANET SC LETT, V247, P101, DOI 10.1016/j.epsl.2006.04.036; VINNIK LP, 1977, PHYS EARTH PLANET IN, V15, P39, DOI 10.1016/0031-9201(77)90008-5	27	391	406	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					499	502		10.1126/science.1169499	http://dx.doi.org/10.1126/science.1169499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390042				2022-12-28	WOS:000265411200043
J	Weinblatt, ME; Abbott, GF; Koreishi, AF				Weinblatt, Michael E.; Abbott, Gerald F.; Koreishi, Aashiyana F.			A Woman with Respiratory Failure and a Cavitary Lesion in the Lung Invasive group A beta-hemolytic streptococcal infection, with acute necrotizing bronchopneumonia with cavitation and with evidence of the toxic shock syndrome, in a patient treated with anti-TNF antibody.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NECROSIS-FACTOR-ALPHA; SERIOUS BACTERIAL-INFECTIONS; RHEUMATOID-ARTHRITIS; PNEUMOCOCCAL PNEUMONIA; FACTOR ANTAGONISTS; DEFICIENT MICE; THERAPY; RISK; TUBERCULOSIS; ETANERCEPT		[Weinblatt, Michael E.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Abbott, Gerald F.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Koreishi, Aashiyana F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Weinblatt, Michael E.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Abbott, Gerald F.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Koreishi, Aashiyana F.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Weinblatt, ME (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.							Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Baghai M, 2001, MAYO CLIN PROC, V76, P653; Bergstrom L, 2004, ARTHRITIS RHEUM-US, V50, P1959, DOI 10.1002/art.20454; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Brown EJ, 2004, NEW ENGL J MED, V350, P2093, DOI 10.1056/NEJMcibr040657; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Ehlers S, 1999, INFECT IMMUN, V67, P3571, DOI 10.1128/IAI.67.7.3571-3579.1999; Ellerin T, 2003, ARTHRITIS RHEUM-US, V48, P3013, DOI 10.1002/art.11301; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Kaneko H, 1999, LAB INVEST, V79, P379; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Lee JH, 2002, ARTHRITIS RHEUM-US, V46, P2565, DOI 10.1002/art.10583; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Muller MP, 2003, ARCH INTERN MED, V163, P467, DOI 10.1001/archinte.163.4.467; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; Schneeweiss S, 2007, ARTHRITIS RHEUM-US, V56, P1754, DOI 10.1002/art.22600; Takashima K, 1997, INFECT IMMUN, V65, P257, DOI 10.1128/IAI.65.1.257-260.1997; True DG, 2002, J RHEUMATOL, V29, P1561; Uthman I, 2005, RHEUMATOLOGY, V44, P1200, DOI 10.1093/rheumatology/keh680; vanderPoll T, 1997, AM J RESP CRIT CARE, V155, P603, DOI 10.1164/ajrccm.155.2.9032201; WALKER WC, 1968, MEDICINE, V47, P501, DOI 10.1097/00005792-196811000-00003; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Warris A, 2001, NEW ENGL J MED, V344, P1099, DOI 10.1056/NEJM200104053441415; Weinblatt ME, 2004, CLEV CLIN J MED, V71, P409, DOI 10.3949/ccjm.71.5.409	29	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1770	1779		10.1056/NEJMcpc0809066	http://dx.doi.org/10.1056/NEJMcpc0809066			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19387019				2022-12-28	WOS:000265377800013
J	Chen, Z				Chen, Zhu			Launch of the health-care reform plan in China	LANCET			English	Editorial Material									Minist Hlth, Beijing 100044, Peoples R China		Chen, Z (corresponding author), Minist Hlth, Beijing 100044, Peoples R China.	zchen@stn.sh.cn						[Anonymous], 2009, STAND C STAT COUNC C; Liu YL, 2009, LANCET, V373, P281, DOI 10.1016/S0140-6736(09)60080-5; *NAT DEV REF COMM, 2008, NEW HLTH CAR REF PAC; Watts J, 2008, LANCET, V372, P1455, DOI 10.1016/S0140-6736(08)61561-5; 2008, PRESIDENT HU EULOGIZ; 2009, XINHUA NEWS AGE 0121; 2007, 11 5 YEAR PLAN HLTH; 1974, BR MED J, V2, P186	8	365	385	4	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 18	2009	373	9672					1322	1324		10.1016/S0140-6736(09)60753-4	http://dx.doi.org/10.1016/S0140-6736(09)60753-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434UR	19376436				2022-12-28	WOS:000265300100010
J	Qin, SY; Kim, J; Niu, Q; Shih, CK				Qin, Shengyong; Kim, Jungdae; Niu, Qian; Shih, Chih-Kang			Superconductivity at the Two-Dimensional Limit	SCIENCE			English	Article							THIN-FILMS; QUANTUM; GROWTH; PB; TRANSITION; STABILITY; SI(111); METAL	Superconductivity in the extreme two-dimensional limit is studied on ultrathin lead films down to two atomic layers, where only a single channel of quantum well states exists. Scanning tunneling spectroscopy reveals that local superconducting order remains robust until two atomic layers, where the transition temperature abruptly plunges to a lower value, depending sensitively on the exact atomic structure of the film. Our result shows that Cooper pairs can still form in the last two-dimensional channel of electron states, although their binding is strongly affected by the substrate.	[Qin, Shengyong; Kim, Jungdae; Niu, Qian; Shih, Chih-Kang] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Shih, CK (corresponding author), Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.	shih@physics.utexas.edu	Niu, Qian/G-9908-2013; Qin, Shengyong/A-7348-2012		NSF [DMR-0606485]; Welch Foundation; Texas Advanced Research Program; Division Of Materials Research [0906025] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Texas Advanced Research Program; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by NSF grant DMR-0606485, the Welch Foundation, and the Texas Advanced Research Program.	Altfeder IB, 1997, PHYS REV LETT, V78, P2815, DOI 10.1103/PhysRevLett.78.2815; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; DOLAN GJ, 1973, PHYS REV LETT, V30, P603, DOI 10.1103/PhysRevLett.30.603; DYNES RC, 1986, PHYS REV LETT, V57, P2195, DOI 10.1103/PhysRevLett.57.2195; Eom D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.027005; GANZ E, 1991, SURF SCI, V257, P259, DOI 10.1016/0039-6028(91)90797-V; Guo Y, 2004, SCIENCE, V306, P1915, DOI 10.1126/science.1105130; HAVILAND DB, 1989, PHYS REV LETT, V62, P2180, DOI 10.1103/PhysRevLett.62.2180; Hupalo M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.216106; Lu SM, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.113402; Luh DA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.256802; Luh DA, 2001, SCIENCE, V292, P1131, DOI 10.1126/science.292.5519.1131; Nishio T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.167001; *NSF, DMR0606485 NSF WELCH; Ozer MM, 2007, SCIENCE, V316, P1594, DOI 10.1126/science.1142159; ORR BG, 1984, PHYS REV LETT, V53, P2046, DOI 10.1103/PhysRevLett.53.2046; Ozer MM, 2006, NAT PHYS, V2, P173, DOI 10.1038/nphys244; Paggel JJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.186803; Schmidt T, 2000, PHYS REV B, V62, P15815, DOI 10.1103/PhysRevB.62.15815; Smith AR, 1996, SCIENCE, V273, P226, DOI 10.1126/science.273.5272.226; STRONGIN M, 1970, PHYS REV B-SOLID ST, V1, P1078, DOI 10.1103/PhysRevB.1.1078; Su WB, 2001, PHYS REV LETT, V86, P5116, DOI 10.1103/PhysRevLett.86.5116; Wei CM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.233408; YAZDANI A, 1995, PHYS REV LETT, V74, P3037, DOI 10.1103/PhysRevLett.74.3037; Yeh V, 2000, PHYS REV LETT, V85, P5158, DOI 10.1103/PhysRevLett.85.5158; Yndurain F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205501; Zhang ZY, 1998, PHYS REV LETT, V80, P5381, DOI 10.1103/PhysRevLett.80.5381	27	248	250	6	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1314	1317		10.1126/science.1170775	http://dx.doi.org/10.1126/science.1170775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19407146				2022-12-28	WOS:000266635100042
J	Glessner, JT; Wang, K; Cai, GQ; Korvatska, O; Kim, CE; Wood, S; Zhang, HT; Estes, A; Brune, CW; Bradfield, JP; Imielinski, M; Frackelton, EC; Reichert, J; Crawford, EL; Munson, J; Sleiman, PMA; Chiavacci, R; Annaiah, K; Thomas, K; Hou, CP; Glaberson, W; Flory, J; Otieno, F; Garris, M; Soorya, L; Klei, L; Piven, J; Meyer, KJ; Anagnostou, E; Sakurai, T; Game, RM; Rudd, DS; Zurawiecki, D; McDougle, CJ; Davis, LK; Miller, J; Posey, DJ; Michaels, S; Kolevzon, A; Silverman, JM; Bernier, R; Levy, SE; Schultz, RT; Dawson, G; Owley, T; McMahon, WM; Wassink, TH; Sweeney, JA; Nurnberger, JI; Coon, H; Sutcliffe, JS; Minshew, NJ; Grant, SFA; Bucan, M; Cook, EH; Buxbaum, JD; Devlin, B; Schellenberg, GD; Hakonarson, H				Glessner, Joseph T.; Wang, Kai; Cai, Guiqing; Korvatska, Olena; Kim, Cecilia E.; Wood, Shawn; Zhang, Haitao; Estes, Annette; Brune, Camille W.; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Reichert, Jennifer; Crawford, Emily L.; Munson, Jeffrey; Sleiman, Patrick M. A.; Chiavacci, Rosetta; Annaiah, Kiran; Thomas, Kelly; Hou, Cuiping; Glaberson, Wendy; Flory, James; Otieno, Frederick; Garris, Maria; Soorya, Latha; Klei, Lambertus; Piven, Joseph; Meyer, Kacie J.; Anagnostou, Evdokia; Sakurai, Takeshi; Game, Rachel M.; Rudd, Danielle S.; Zurawiecki, Danielle; McDougle, Christopher J.; Davis, Lea K.; Miller, Judith; Posey, David J.; Michaels, Shana; Kolevzon, Alexander; Silverman, Jeremy M.; Bernier, Raphael; Levy, Susan E.; Schultz, Robert T.; Dawson, Geraldine; Owley, Thomas; McMahon, William M.; Wassink, Thomas H.; Sweeney, John A.; Nurnberger, John I., Jr.; Coon, Hilary; Sutcliffe, James S.; Minshew, Nancy J.; Grant, Struan F. A.; Bucan, Maja; Cook, Edwin H., Jr.; Buxbaum, Joseph D.; Devlin, Bernie; Schellenberg, Gerard D.; Hakonarson, Hakon			Autism genome-wide copy number variation reveals ubiquitin and neuronal genes	NATURE			English	Article							SPECTRUM DISORDER; SUSCEPTIBILITY GENE; MUTATIONS; ASSOCIATION; NEUROLIGINS; MIGRATION; LINKAGE	Autism spectrum disorders (ASDs) are childhood neurodevelopmental disorders with complex genetic origins(1-4). Previous studies focusing on candidate genes or genomic regions have identified several copy number variations (CNVs) that are associated with an increased risk of ASDs(5-9). Here we present the results from a whole-genome CNV study on a cohort of 859 ASD cases and 1,409 healthy children of European ancestry who were genotyped with similar to 550,000 single nucleotide polymorphism markers, in an attempt to comprehensively identify CNVs conferring susceptibility to ASDs. Positive findings were evaluated in an independent cohort of 1,336 ASD cases and 1,110 controls of European ancestry. Besides previously reported ASD candidate genes, such as NRXN1 (ref. 10) and CNTN4 (refs 11, 12), several new susceptibility genes encoding neuronal cell-adhesion molecules, including NLGN1 and ASTN2, were enriched with CNVs in ASD cases compared to controls (P = 9.5 x 10(-3)). Furthermore, CNVs within or surrounding genes involved in the ubiquitin pathways, including UBE3A, PARK2, RFWD2 and FBXO40, were affected by CNVs not observed in controls (P = 3.3 x 10(-3)). We also identified duplications 55 kilobases upstream of complementary DNA AK123120 (P = 3.6 x 10(-6)). Although these variants may be individually rare, they target genes involved in neuronal cell-adhesion or ubiquitin degradation, indicating that these two important gene networks expressed within the central nervous system may contribute to the genetic susceptibility of ASD.	[Glessner, Joseph T.; Wang, Kai; Kim, Cecilia E.; Zhang, Haitao; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Sleiman, Patrick M. A.; Chiavacci, Rosetta; Annaiah, Kiran; Thomas, Kelly; Hou, Cuiping; Glaberson, Wendy; Flory, James; Otieno, Frederick; Garris, Maria; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Cai, Guiqing; Reichert, Jennifer; Soorya, Latha; Anagnostou, Evdokia; Sakurai, Takeshi; Zurawiecki, Danielle; Kolevzon, Alexander; Silverman, Jeremy M.; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Korvatska, Olena; Estes, Annette; Munson, Jeffrey; Bernier, Raphael; Dawson, Geraldine] Univ Washington, Seattle, WA 98105 USA; [Wood, Shawn; Klei, Lambertus; Michaels, Shana; Devlin, Bernie] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Wood, Shawn; Klei, Lambertus; Michaels, Shana; Devlin, Bernie] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; [Brune, Camille W.; Owley, Thomas; Sweeney, John A.; Cook, Edwin H., Jr.] Univ Illinois, Inst Juvenile Res, Chicago, IL 60608 USA; [Brune, Camille W.; Owley, Thomas; Sweeney, John A.; Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Chicago, IL 60608 USA; [Crawford, Emily L.; Game, Rachel M.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37235 USA; [Crawford, Emily L.; Game, Rachel M.; Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN 37235 USA; [Piven, Joseph] Univ N Carolina, Neurodev Disorders Res Ctr, Greensboro, NC 27412 USA; [Piven, Joseph] Univ N Carolina, Dept Psychiat, Greensboro, NC 27412 USA; [Meyer, Kacie J.; Rudd, Danielle S.; Davis, Lea K.; Wassink, Thomas H.] Univ Iowa, Iowa City, IA 52242 USA; [Miller, Judith; McMahon, William M.; Coon, Hilary] Univ Utah, Salt Lake City, UT 84112 USA; [McDougle, Christopher J.; Posey, David J.; Nurnberger, John I., Jr.] Indiana Univ, Indianapolis, IN 46202 USA; [Levy, Susan E.; Schultz, Robert T.; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Bucan, Maja] Univ Penn, Sch Med, Dept Genet Biol & Biostat, Philadelphia, PA 19104 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schellenberg, Gerard D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University; Vanderbilt University; University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; University of Iowa; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University-Purdue University Indianapolis; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	gerardsc@mail.med.upenn.edu; hakonarson@chop.edu	Sutcliffe, James S/C-1348-2012; Silverman, Jeremy M./AAO-4268-2020; Buxbaum, Joseph D/G-6001-2010	Sutcliffe, James S/0000-0001-5200-6007; Sweeney, John/0000-0003-1752-2828; Estes, Annette/0000-0003-2687-4155; Buxbaum, Joseph/0000-0001-8898-8313; Glessner, Joseph/0000-0001-5131-2811; Wassink, Thomas/0000-0002-0952-8333; Nurnberger, John/0000-0002-7674-1767; Munson, Jeffrey A/0000-0003-1798-8927; Grant, Struan/0000-0003-2025-5302; Dawson, Geraldine/0000-0003-1410-2764	Children's Hospital of Philadelphia, Autism Speaks; NICHD [HD35476]; National Institute of Mental Health [1U24MH081810]; Margaret Q. Landenberger Foundation [UL1-RR024134-03]; Cotswold Foundation; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs; National Institute of Health [HD055782-01]; Utah Autism Foundation [MH0666730, MH061009, NS049261, HD055751, U10MH66766-02S1, MH69359, M01-RR00064]; Institutional Development Award to the Center for Applied Genomics; Children's Hospital of Philadelphia; Medical Research Council (UK); Health Research Board (Ireland);  [MH64547]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751, U19HD035476, P01HD035476, P50HD055782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069359, R01MH064547, U24MH081810, R01MH061009, U54MH066673, R01MH057881, U10MH066766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049261] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia, Autism Speaks; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Margaret Q. Landenberger Foundation; Cotswold Foundation; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Utah Autism Foundation; Institutional Development Award to the Center for Applied Genomics; Children's Hospital of Philadelphia; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Research Board (Ireland); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully thank all the ASD children and their families at the participating study sites who were enrolled in this study and all the control subjects who donated blood samples to Children's Hospital of Philadelphia for genetic research purposes. We thank the technical staff in the Center for Applied Genomics, Children's Hospital of Philadelphia for generating the genotypes used in this study. We thank S. Diskin for her contribution to the discussion on the effect of wave artifacts on CNV calling. We also thank S. Kristinsson, L. A. Hermannsson and A. Krisbjornsson for their software design and contribution. This research was financially supported by The Children's Hospital of Philadelphia, Autism Speaks, and NICHD (HD35476). We also gratefully acknowledge the resources provided by the AGRE Consortium (D. H. Geschwind, M. Bucan, W. T. Brown, J. D. Buxbaum, R. M. Cantor, J. N. Constantino, T. C. Gilliam, C. M. Lajonchere, D. H. Ledbetter, C. Lese-Martin, J. Miller, S. F. Nelson, G. D. Schellenberg, C. A. Samango-Sprouse, S. Spence, M. State, R. E. Tanzi) and the participating families. AGRE is a program of Autism Speaks and is at present supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to C. M. Lajonchere (PI), and formerly by grant MH64547 to D. H. Geschwind (PI). The AGRE data set was genotyped by the Center for Applied Genomics at the Children's Hospital of Philadelphia, which funded all genotyping for this study, and the complete sets of genotyping data have been released to the public domain. AGRE-approved academic researchers can acquire the data sets from AGRE (http://www.agre.org). The study is supported in part by Research Award from the Margaret Q. Landenberger Foundation (H. H.), UL1-RR024134-03 (H. H.), a Research Development Award from the Cotswold Foundation (H. H. and S. F. A. G.), the Beatrice and Stanley A. Seaver Foundation (J. D. B.), the Department of Veterans Affairs (G. D. S.), and National Institute of Health grants HD055782-01 (J. Munson, A. E., O. K., G. D. and G. D. S.), MH0666730 (J. D. B.), MH061009 and NS049261 (J. S. S.), HD055751 (E. H. C.), U10MH66766-02S1 (C. J. M.), MH69359, M01-RR00064 and the Utah Autism Foundation (H. C., J. Miller, and W. M. M.). All genotyping for this study was supported by an Institutional Development Award to the Center for Applied Genomics (H. H.) from the Children's Hospital of Philadelphia. We acknowledge the Autism Genome Project Consortium (J. P., C. W. B., T. H. W., W. M. M., H. C., J. I. N., J. S. S., E. H. C., J. Munson, A. E., O. K., J. D. B., B. D. and G. D. S.) funded by Autism Speaks, the Medical Research Council (UK) and the Health Research Board (Ireland). We are grateful for the public access to the Affymetrix 5.0 data available for a subset of AGRE families (http://www.agre.org), which served as important validation of CNV calls made.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; [Anonymous], 2007, AUTISM DEV DISABILIT; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klauck SM, 2006, EUR J HUM GENET, V14, P714, DOI 10.1038/sj.ejhg.5201610; Le Couteur A, 2008, J AUTISM DEV DISORD, V38, P362, DOI 10.1007/s10803-007-0403-3; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	29	973	1018	1	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					569	573		10.1038/nature07953	http://dx.doi.org/10.1038/nature07953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19404257	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000266370500039
J	Levey, AS; Stevens, LA; Schmid, CH; Zhang, YP; Castro, AF; Feldman, HI; Kusek, JW; Eggers, P; Van Lente, F; Greene, T; Coresh, J				Levey, Andrew S.; Stevens, Lesley A.; Schmid, Christopher H.; Zhang, Yaping (Lucy); Castro, Alejandro F., III; Feldman, Harold I.; Kusek, John W.; Eggers, Paul; Van Lente, Frederick; Greene, Tom; Coresh, Josef		Chronic Kidney Dis Epidemiology Co	A New Equation to Estimate Glomerular Filtration Rate	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; COCKCROFT-GAULT EQUATIONS; RENIN-ANGIOTENSIN SYSTEM; SERUM CREATININE; RENAL-DISEASE; PREDICTIVE PERFORMANCE; DIABETIC-PATIENTS; NATIONAL-HEALTH; DUAL BLOCKADE; CYSTATIN-C	Background: Equations to estimate glomerular filtration rate (GFR) are routinely used to assess kidney function. Current equations have limited precision and systematically underestimate measured GFR at higher values. Objective: To develop a new estimating equation for GFR: the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. Design: Cross-sectional analysis with separate pooled data sets for equation development and validation and a representative sample of the U. S. population for prevalence estimates. Setting: Research studies and clinical populations ("studies") with measured GFR and NHANES (National Health and Nutrition Examination Survey), 1999 to 2006. Participants: 8254 participants in 10 studies (equation development data set) and 3896 participants in 16 studies (validation data set). Prevalence estimates were based on 16 032 participants in NHANES. Measurements: GFR, measured as the clearance of exogenous filtration markers (iothalamate in the development data set; iothalamate and other markers in the validation data set), and linear regression to estimate the logarithm of measured GFR from standardized creatinine levels, sex, race, and age. Results: In the validation data set, the CKD-EPI equation performed better than the Modification of Diet in Renal Disease Study equation, especially at higher GFR (P < 0.001 for all subsequent comparisons), with less bias (median difference between measured and estimated GFR, 2.5 vs. 5.5 mL/min per 1.73 m(2)), improved precision (interquartile range [IQR] of the differences, 16.6 vs. 18.3 mL/min per 1.73 m(2)), and greater accuracy (percentage of estimated GFR within 30% of measured GFR, 84.1% vs. 80.6%). In NHANES, the median estimated GFR was 94.5 mL/min per 1.73 m(2) ( IQR, 79.7 to 108.1) vs. 85.0 (IQR, 72.9 to 98.5) mL/min per 1.73 m(2), and the prevalence of chronic kidney disease was 11.5% (95% CI, 10.6% to 12.4%) versus 13.1% (CI, 12.1% to 14.0%). Limitation: The sample contained a limited number of elderly people and racial and ethnic minorities with measured GFR. Conclusion: The CKD-EPI creatinine equation is more accurate than the Modification of Diet in Renal Disease Study equation and could replace it for routine clinical use. Primary Funding Source: National Institute of Diabetes and Digestive and Kidney Diseases.	[Levey, Andrew S.; Stevens, Lesley A.; Schmid, Christopher H.; Zhang, Yaping (Lucy)] Tufts Med Ctr, Div Nephrol, Boston, MA 02111 USA; [Castro, Alejandro F., III; Coresh, Josef] Johns Hopkins Univ, Baltimore, MD USA; [Feldman, Harold I.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Kusek, John W.; Eggers, Paul] NIH, Bethesda, MD 20892 USA; [Van Lente, Frederick] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Greene, Tom] Univ Utah, Salt Lake City, UT USA	Tufts Medical Center; Johns Hopkins University; University of Pennsylvania; National Institutes of Health (NIH) - USA; Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah	Levey, AS (corresponding author), Tufts Med Ctr, Div Nephrol, 800 Washington St,Box 391, Boston, MA 02111 USA.		Schmid, Christopher H./J-2398-2014; Nelson, Robert G/B-1470-2012; Bakoush, Omran/B-9395-2009	Schmid, Christopher H./0000-0002-0855-5313; Bakoush, Omran/0000-0003-1447-9836	National Institute of Diabetes and Digestive and Kidney Diseases [UO1 DK 053869, UO1 DK 067651, UO1 DK 35073]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK053869, U01DK067651, U01DK035073, ZIADK069063, K23DK081017] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By grants UO1 DK 053869, UO1 DK 067651, and UO1 DK 35073 as part of a cooperative agreement with the National Institute of Diabetes and Digestive and Kidney Diseases.	Aronoff GR, 1999, DRUG PRESCRIBING REN; Benko A, 2007, CAN ASSOC RADIOL J, V58, P79; Bosma RJ, 2005, AM J TRANSPLANT, V5, P2193, DOI 10.1111/j.1600-6143.2005.00982.x; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; CHAMBERS J, 1993, STAT MODELS, P104; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2008, NEPHROL DIAL TRANSPL, V23, P1122, DOI 10.1093/ndt/gfn117; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Efron B., 1994, MONOGRAPHS STAT APPL; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Gonwa T, 2004, LIVER TRANSPLANT, V10, P301, DOI 10.1002/lt.20017; Grubb A, 2005, CLIN CHEM, V51, P1420, DOI 10.1373/clinchem.2005.051557; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hansen HP, 2002, KIDNEY INT, V62, P220, DOI 10.1046/j.1523-1755.2002.00421.x; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Ibrahim H, 2005, J AM SOC NEPHROL, V16, P1051, DOI 10.1681/ASN.2004080692; Jacobsen P, 2003, KIDNEY INT, V63, P1874, DOI 10.1046/j.1523-1755.2003.00940.x; Jacobsen P, 2002, NEPHROL DIAL TRANSPL, V17, P1019, DOI 10.1093/ndt/17.6.1019; Khurana A, 2008, ARCH INTERN MED, V168, P593, DOI 10.1001/archinte.168.6.593; Levey AS, 2007, AM J KIDNEY DIS, V49, P175, DOI 10.1053/j.ajkd.2006.12.013; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lewis J, 2001, AM J KIDNEY DIS, V38, P744, DOI 10.1053/ajkd.2001.27691; MATHIESEN ER, 1991, BMJ-BRIT MED J, V303, P81, DOI 10.1136/bmj.303.6794.81; Mauer M, 2002, J RENIN-ANGIO-ALDO S, V3, P262, DOI 10.3317/jraas.2002.048; Mauer M, 2002, DIABETES, V51, P1572, DOI 10.2337/diabetes.51.5.1572; Miller WG, 2008, AM J KIDNEY DIS, V52, P645, DOI 10.1053/j.ajkd.2008.07.032; *NAT CTR HLTH STAT, 2007, AN REP GUID 3 NAT HL; National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; Rook M, 2006, AM J TRANSPLANT, V6, P1653, DOI 10.1111/j.1600-6143.2006.01359.x; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seliger SL, 2008, J AM SOC NEPHROL, V19, P2414, DOI 10.1681/ASN.2008010022; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, AM J KIDNEY DIS, V50, P21, DOI 10.1053/j.ajkd.2007.04.004; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tarnow L, 2000, DIABETES CARE, V23, P1725, DOI 10.2337/diacare.23.12.1725; *US FDA, 2008, INF HEALTHC PROF GAD; *US REN DAT SYST, USRDS 2008 ANN DAT R	50	15423	15974	38	647	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					604	612		10.7326/0003-4819-150-9-200905050-00006	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414839	Green Accepted			2022-12-28	WOS:000265903800004
J	Sajadi, MM; Mansouri, D; Sajadi, MRM				Sajadi, Mohammad M.; Mansouri, Davood; Sajadi, Mohamad-Reza M.			Ibn Sina and the Clinical Trial	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICINE; AVICENNA	Approximately 1000 years ago, a physician by the name of Ibn Sina, known in the West as "Avicenna," wrote 7 conditions for " The recognition of the strengths of the characteristics of medicines through experimentation." Ibn Sina proposed applying logic to the testing of drugs, and in doing so, he wrote the earliest known treatise related to clinical trials. This article presents an overview and the historical context of Ibn Sina's life and work. In addition, the authors provide a translation of his treatise on drug testing and discuss its similarity to modern concepts of pharmacology and clinical trials.	Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Vet Affairs Med Ctr, Baltimore, MD USA; Natl Res Inst TB & Lung Dis, Tehran, Iran	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sajadi, MM (corresponding author), 725 W Lombard St,N548, Baltimore, MD 21201 USA.	msajadi@ihv.umaryland.edu	Sajadi, Prof. Dr. S. Mohammad/D-9086-2014; mansouri, davood/G-6471-2017	Sajadi, Prof. Dr. S. Mohammad/0000-0001-8284-5178; mansouri, davood/0000-0002-0564-8282; , Mohammad/0000-0001-7798-3605				Afnan Soheil M., 1958, AVICENNA HIS LIFE WO; Ameli N O, 1965, J Neurol Sci, V2, P105, DOI 10.1016/0022-510X(65)90074-2; Bernard C., 1957, INTRO ETUDE MED EXPT; Bostock J., 1857, PLINY ELDER NATURAL, V6; BROWN EG, 1921, ARABIAN MED; BULL J P, 1959, J Chronic Dis, V10, P218, DOI 10.1016/0021-9681(59)90004-9; Cassius Dio, 1914, DIOS ROMAN HIST; CROMBIE AC, 1952, AVICENNA SCI PHILOS; DARMANI NA, 1995, J ISLAMIC MED ASS N, V26, P78; Resende LAD, 2008, ARQ NEURO-PSIQUIAT, V66, P765, DOI 10.1590/S0004-282X2008000500035; Dunn PM, 1997, ARCH DIS CHILD-FETAL, V77, pF75, DOI 10.1136/fn.77.1.F75; Garrison FH, 1914, INTRO HIST MED; GELLIUS A, 1795, ATTIC NIGHTS; Goodman Lenn E., 2006, AVICENNA, P102; GUTAS D, 2007, ENCY IRANICA ONLINE; HUTH EJ, 2006, JULES GAVARRETS PRIN; Jarcho S, 1972, Bull N Y Acad Med, V48, P1059; LEVY R, 1957, Med Hist, V1, P249; MEINERT CL, 1986, CLIN TRIALS; Nasser M, 2009, J ROY SOC MED, V102, P78, DOI 10.1258/jrsm.2008.08k040; NUTTON V, 1985, J ROY SOC MED, V78, P138, DOI 10.1177/014107688507800214; PLUTARCH, 1859, PLUTARCHS LIVES; Portney LG., 1999, FDN CLIN RES APPL PR, V2nd; SARTON GEORGE, 1975, INTRO HIST SCI; Sina Ibn, 1978, GHANOON DAR TEB; Spencer W. G., 1971, MEDICINA; Tibi S, 2006, J ROY SOC MED, V99, P206, DOI 10.1258/jrsm.99.4.206; Watson G., 1966, THERIAC MITHRIDATIUM	28	18	18	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					640	U15		10.7326/0003-4819-150-9-200905050-00011	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414844	Green Submitted			2022-12-28	WOS:000265903800009
J	Chatterjee, P				Chatterjee, Patralekha			Binayak Sen and the cost of dissent in India	LANCET			English	News Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 2	2009	373	9674					1512	1512		10.1016/S0140-6736(09)60840-0	http://dx.doi.org/10.1016/S0140-6736(09)60840-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19418611				2022-12-28	WOS:000265710300011
J	Watters, TR; Head, JW; Solomon, SC; Robinson, MS; Chapman, CR; Denevi, BW; Fassett, CI; Murchie, SL; Strom, RG				Watters, Thomas R.; Head, James W.; Solomon, Sean C.; Robinson, Mark S.; Chapman, Clark R.; Denevi, Brett W.; Fassett, Caleb I.; Murchie, Scott L.; Strom, Robert G.			Evolution of the Rembrandt Impact Basin on Mercury	SCIENCE			English	Article							CRATERING RECORD; CALORIS BASIN; FLYBY; TECTONICS; VOLCANISM; MESSENGER; SLIP	MESSENGER's second Mercury flyby revealed a similar to 715-kilometer-diameter impact basin, the second-largest well-preserved basin-scale impact structure known on the planet. The Rembrandt basin is comparable in age to the Caloris basin, is partially flooded by volcanic plains, and displays a unique wheel-and-spoke-like pattern of basin-radial and basin-concentric wrinkle ridges and graben. Stratigraphic relations indicate a multistaged infilling and deformational history involving successive or overlapping phases of contractional and extensional deformation. The youngest deformation of the basin involved the formation of a similar to 1000-kilometer-long lobate scarp, a product of the global cooling and contraction of Mercury.	[Watters, Thomas R.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Head, James W.; Fassett, Caleb I.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Robinson, Mark S.; Denevi, Brett W.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85251 USA; [Chapman, Clark R.] SW Res Inst, Boulder, CO 80302 USA; [Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Strom, Robert G.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Smithsonian Institution; Brown University; Carnegie Institution for Science; Arizona State University; Arizona State University-Tempe; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona	Watters, TR (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	watterst@si.edu	Murchie, Scott L/E-8030-2015; Robinson, Mark/ABI-6841-2020; Denevi, Brett W./I-6502-2012	Murchie, Scott L/0000-0002-1616-8751; Denevi, Brett W./0000-0001-7837-6663; Fassett, Caleb/0000-0001-9155-3804	Carnegie Institution of Washington [NASW-00002]; Johns Hopkins University Applied Physics Laboratory [NAS5-97271]; NASA [NNX07AR60G]	Carnegie Institution of Washington; Johns Hopkins University Applied Physics Laboratory(Johns Hopkins University); NASA(National Aeronautics & Space Administration (NASA))	We are grateful to the MESSENGER engineers and technical support personnel. The MESSENGER project is supported by the NASA Discovery Program under contracts NASW-00002 to the Carnegie Institution of Washington and NAS5-97271 to Johns Hopkins University Applied Physics Laboratory. This work is also supported by NASA grant NNX07AR60G.	Cintala MJ, 1998, METEORIT PLANET SCI, V33, P889, DOI 10.1111/j.1945-5100.1998.tb01695.x; Denevi BW, 2009, SCIENCE, V324, P613, DOI 10.1126/science.1172226; FASSETT CI, 2009, LUNAR PLANET SCI, V40; Freed AM, 2001, J GEOPHYS RES-PLANET, V106, P20603, DOI 10.1029/2000JE001347; GOLOMBEK MP, 1991, P LUNAR PLANET SCI, V21, P679; Head J. W., 1974, Moon, V11, P327, DOI 10.1007/BF00589168; Head JW, 2008, SCIENCE, V321, P69, DOI 10.1126/science.1159256; HEAD JW, 1993, J GEOPHYS RES-PLANET, V98, P17149, DOI 10.1029/93JE01278; Kennedy PJ, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002992; Melosh H.J., 1988, TECTONICS MERCURY, P374; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; Schultz RA, 2000, J GEOPHYS RES-PLANET, V105, P12035, DOI 10.1029/1999JE001212; SOLOMON SC, 1980, REV GEOPHYS, V18, P107, DOI 10.1029/RG018i001p00107; Solomon SC, 2008, SCIENCE, V321, P59, DOI 10.1126/science.1159706; Spudis P.D., 1993, GEOLOGY MULTIRING IM; Spudis P.D., 1988, MERCURY, P118; STROM RG, 1975, J GEOPHYS RES, V80, P2478, DOI 10.1029/JB080i017p02478; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317; Watters TR, 2009, EARTH PLANET SC LETT, V285, P283, DOI 10.1016/j.epsl.2009.01.025; Watters TR, 2005, GEOLOGY, V33, P669, DOI 10.1130/G21678.1; WATTERS TR, 1988, J GEOPHYS RES-SOLID, V93, P10236, DOI 10.1029/JB093iB09p10236; Wilhelms D.E., 1987, US GEOLOGICAL SURVEY, DOI [10.3133/pp1348, DOI 10.3133/PP1348]	23	42	43	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					618	621		10.1126/science.1172109	http://dx.doi.org/10.1126/science.1172109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407197				2022-12-28	WOS:000265608800037
J	Wolf, DA; Petroski, MD				Wolf, Dieter A.; Petroski, Matthew D.			Rfu1: Stimulus for the Ubiquitin Economy	CELL			English	Editorial Material							GENE	During cellular stress, monoubiquitin is in demand due to the accumulation of misfolded proteins that require proteasomal degradation. Kimura et al. ( 2009) now show in yeast that monoubiquitin levels are bolstered during stress conditions by downregulation of the protein Rfu1, an inhibitor of the deubiquitinating enzyme Doa4.	[Wolf, Dieter A.; Petroski, Matthew D.] Burnham Inst Med Res, Signal Transduct Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Wolf, DA (corresponding author), Burnham Inst Med Res, Signal Transduct Program, La Jolla, CA 92037 USA.	dwolf@burnham.org; petroski@burnham.org	Wolf, Dieter/AAE-5890-2021	Wolf, Dieter/0000-0002-3761-1070	NCI NIH HHS [RC2 CA148414] Funding Source: Medline; NIGMS NIH HHS [R01 GM059780] Funding Source: Medline; NATIONAL CANCER INSTITUTE [RC2CA148414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059780] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849	4	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 1	2009	137	3					397	398		10.1016/j.cell.2009.04.032	http://dx.doi.org/10.1016/j.cell.2009.04.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410534	Bronze			2022-12-28	WOS:000265677200007
J	Ludwig, A; Pruvost, M; Reissmann, M; Benecke, N; Brockmann, GA; Castanos, P; Cieslak, M; Lippold, S; Llorente, L; Malaspinas, AS; Slatkin, M; Hofreiter, M				Ludwig, Arne; Pruvost, Melanie; Reissmann, Monika; Benecke, Norbert; Brockmann, Gudrun A.; Castanos, Pedro; Cieslak, Michael; Lippold, Sebastian; Llorente, Laura; Malaspinas, Anna-Sapfo; Slatkin, Montgomery; Hofreiter, Michael			Coat Color Variation at the Beginning of Horse Domestication	SCIENCE			English	Article							ORIGINS		[Ludwig, Arne; Pruvost, Melanie; Cieslak, Michael] Leibniz Inst Zoo & Wildlife Res, D-10252 Berlin, Germany; [Pruvost, Melanie; Benecke, Norbert] German Archaeol Inst, D-14165 Berlin, Germany; [Reissmann, Monika; Brockmann, Gudrun A.] Humboldt Univ, Inst Anim Sci, D-10115 Berlin, Germany; [Castanos, Pedro] Soc Ciencias Aranzadi, San Sebastian, Spain; [Lippold, Sebastian; Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Llorente, Laura] Univ Autonoma Madrid, Lab Archaeozool, E-28049 Madrid, Spain; [Malaspinas, Anna-Sapfo; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Leibniz Institut fur Zoo und Wildtierforschung; Humboldt University of Berlin; Max Planck Society; Autonomous University of Madrid; University of California System; University of California Berkeley	Ludwig, A (corresponding author), Leibniz Inst Zoo & Wildlife Res, D-10252 Berlin, Germany.	ludwig@izw-berlin.de; hofreiter@eva.mpg.de	Llorente-Rodríguez, Laura/ABD-9743-2020; Llorente-Rodríguez, Laura/K-4026-2012; Hofreiter, Michael/A-3996-2017	Llorente-Rodríguez, Laura/0000-0001-9329-5554; Llorente-Rodríguez, Laura/0000-0001-9329-5554; Hofreiter, Michael/0000-0003-0441-4705; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Pruvost, Melanie/0000-0001-7824-2155; Cieslak, Michael/0000-0002-6111-658X	Deutsche Forschungs gemeinschaft; Max Planck Gesellschaft; Janggen Pohn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	Deutsche Forschungs gemeinschaft(German Research Foundation (DFG)); Max Planck Gesellschaft(Max Planck Society); Janggen Pohn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Lieckfeldt, S. Aksu, M. Meixner, and N. Hensel for technical assistance; K. Finstermeier and D. Blum for help with the figure design; and numerous scientists, horse breeders, and curators, especially A. Morales, who provided material for DNA analyses. This work was funded by the Deutsche Forschungs gemeinschaft (A.L., M.P., M.C., and N.B.), the Max Planck Gesellschaft (S.L. and M.H.), and the Janggen Pohn Foundation (A.-S.M.). A.-S.M. thanks J. Jensen and O. Malaspinas for very helpful discussions.	Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Bollback JP, 2008, GENETICS, V179, P497, DOI 10.1534/genetics.107.085019; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474	7	192	213	0	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					485	485		10.1126/science.1172750	http://dx.doi.org/10.1126/science.1172750			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390039	Green Accepted			2022-12-28	WOS:000265411200038
J	Song, TRA; Helmberger, DV; Brudzinski, MR; Clayton, RW; Davis, P; Perez-Campos, X; Singh, SK				Song, Teh-Ru Alex; Helmberger, Donald V.; Brudzinski, Michael R.; Clayton, Robert W.; Davis, Paul; Perez-Campos, Xyoli; Singh, Shri K.			Subducting Slab Ultra-Slow Velocity Layer Coincident with Silent Earthquakes in Southern Mexico	SCIENCE			English	Article							EPISODIC TREMOR; SLIP EVENT; BENEATH; JAPAN; ZONE; INTERFACE; GUERRERO; OAXACA	Great earthquakes have repeatedly occurred on the plate interface in a few shallow-dipping subduction zones where the subducting and overriding plates are strongly locked. Silent earthquakes (or slow slip events) were recently discovered at the down-dip extension of the locked zone and interact with the earthquake cycle. Here, we show that locally observed converted SP arrivals and teleseismic underside reflections that sample the top of the subducting plate in southern Mexico reveal that the ultra-slow velocity layer (USL) varies spatially (3 to 5 kilometers, with an S-wave velocity of similar to 2.0 to 2.7 kilometers per second). Most slow slip patches coincide with the presence of the USL, and they are bounded by the absence of the USL. The extent of the USL delineates the zone of transitional frictional behavior.	[Song, Teh-Ru Alex] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Helmberger, Donald V.; Clayton, Robert W.] CALTECH, Seismol Lab, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Brudzinski, Michael R.] Miami Univ, Dept Geol, Oxford, OH 45056 USA; [Davis, Paul] Univ Calif Los Angeles, CENS, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Perez-Campos, Xyoli; Singh, Shri K.] Univ Nacl Autonoma Mexico, Inst Geofis, Mexico City 04510, DF, Mexico	Carnegie Institution for Science; California Institute of Technology; University System of Ohio; Miami University; University of California System; University of California Los Angeles; Universidad Nacional Autonoma de Mexico	Song, TRA (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	asong@ciw.edu	Song, Teh-Ru Alex/N-7607-2013; Brudzinski, Michael/A-8301-2011; DAVIS, Paul/HCH-8889-2022; Davis, Paul/E-7151-2012; Song, Teh-Ru Alex/I-7563-2012	Song, Teh-Ru Alex/0000-0003-3697-5881; Perez-Campos, Xyoli/0000-0001-8970-7966	NSF [EAR-0636012]; Tectonic Observatory [10015]; Carnegie fellowship at the Department of Terrestrial Magnetism	NSF(National Science Foundation (NSF)); Tectonic Observatory; Carnegie fellowship at the Department of Terrestrial Magnetism	We thank S. Sacks, P. Silver, S. Shirey, M. Bostock, J.-P. Avouav, and V. Manea for helpful discussions; R. Engdahl provided the global relocated seismic catalog used in fig. S10. We thank CENS at UCLA for support and the entire MASE team for making the MASE data available. We thank H. Hinojosa-Prieto, E. Cabral-Cano, A. Arciniega, O. Diaz-Molina, and C. DeMets for sharing their work on episodic tremor and slip in Oaxaca. Incorporated Research Institutions for Seismology Data Management Center and Canadian National Data Centre provided the GEOSCOPE data and Yellowknife short-period data used in this analysis, respectively. Station UNM is operated and maintained by Servicio Sismological Nacional. This work is partially supported by NSF grant EAR-0636012. This is Tectonic Observatory contribution 10015. T.-R.A.S. is supported by a Carnegie fellowship at the Department of Terrestrial Magnetism.	Brudzinski M, 2007, GEOPHYS J INT, V171, P523, DOI 10.1111/j.1365-246X.2007.03542.x; BRUDZINSKI M, 2003, EOS T AGU, V88; Correa-Mora F, 2008, GEOPHYS J INT, V175, P269, DOI 10.1111/j.1365-246X.2008.03910.x; Currie CA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000886; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; HINOJOSAPRIETO HR, 2007, EOS T AGU, V88; IGLESIAS A, 2004, GEOFISICA INT, V43, P309; Jodicke H, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003739; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Kostoglodov V, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017219; Larson KM, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002843; Larson KM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029912; Liu YJ, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004930; Lowry AR, 2006, NATURE, V442, P802, DOI 10.1038/nature05055; Manea VC, 2004, GEOPHYS J INT, V158, P775, DOI 10.1111/j.1365-246X.2004.02325.x; MATSUZAWA T, 1990, TECTONOPHYSICS, V181, P123, DOI 10.1016/0040-1951(90)90012-W; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; PARDO M, 1995, J GEOPHYS RES-SOL EA, V100, P12357, DOI 10.1029/95JB00919; Payero JS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032877; Perez-Campos X, 2008, GEOPHYS RES LETT, V35, DOI [10.1029/2008GL035127, 10.1029/2008gl035127]; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Takei Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI [10.1029/2001JB000522, 10.1029/2001jb000522]; Yoshioka S, 2004, PHYS EARTH PLANET IN, V146, P513, DOI 10.1016/j.pepi.2004.05.006; ZAWA S, 2004, GEOPHYS RES LETT, V1, P7609, DOI DOI 10.1029/2003GL019381	27	149	152	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					502	506		10.1126/science.1167595	http://dx.doi.org/10.1126/science.1167595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390043	Green Accepted			2022-12-28	WOS:000265411200044
J	Patel, MR; Shen, K				Patel, Maulik R.; Shen, Kang			Neurite Extension: Starting at the Finish Line	CELL			English	Editorial Material							NEMATODE CAENORHABDITIS-ELEGANS; AXON GUIDANCE; SYSTEM	The outgrowth of axons and dendrites from neuronal cell bodies to their appropriate targets is the canonical means of creating new processes. Heiman and Shaham (2009) now show that neuronal processes can also be made by anchoring dendrite tips at their target locations while the cell body pulls away, a process termed retrograde extension.	[Patel, Maulik R.; Shen, Kang] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.	kangshen@stanford.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS048392-05, R01 NS048392, R37 NS048392] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Shaham S, 2006, CURR OPIN NEUROBIOL, V16, P522, DOI 10.1016/j.conb.2006.08.001; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305	8	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					207	209		10.1016/j.cell.2009.04.001	http://dx.doi.org/10.1016/j.cell.2009.04.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379686	Green Accepted, Bronze			2022-12-28	WOS:000265456800012
J	Trivedi, V; Boire, A; Tchemychev, B; Kaneider, NC; Leger, AJ; O'Callaghan, K; Covic, L; Kuliopulos, A				Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan			Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site	CELL			English	Article							TISSUE FACTOR; THROMBIN RECEPTOR; CLEAVAGE SITE; INHIBITION; COLLAGEN; RELEASE; HEMOSTASIS; FAMILY; GROWTH; BLOOD	Matrix metalloproteases (MMPs) play important roles in normal and pathological remodeling processes including atherothrombotic disease, inflammation, angiogenesis, and cancer. MMPs have been viewed as matrix-degrading enzymes, but recent studies have shown that they possess direct signaling capabilities. Platelets harbor several MMPs that modulate hemostatic function and platelet survival; however their mode of action remains unknown. We show that platelet MMP-1 activates protease-activated receptor-1 (PAR1) on the surface of platelets. Exposure of platelets to fibrillar collagen converts the surface-bound proMMP-1 zymogen to active MMP-1, which promotes aggregation through PAR1. Unexpectedly, MMP-1 cleaves PAR1 at a distinct site that strongly activates Rho-GTP pathways, cell shape change and motility, and MAPK signaling. Blockade of MMP1-PAR1 curtails thrombogenesis under arterial flow conditions and inhibits thrombosis in animals. These studies provide a link between matrix-dependent activation of metalloproteases and platelet-G protein signaling and identify MMP1-PAR1 as a potential target for the prevention of arterial thrombosis.	[Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Med,Tufts Med Ctr, Boston, MA 02111 USA; [Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Biochem,Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Med,Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu	Boire, Adrienne/AAA-3578-2022; Boire, Adrienne/AAJ-9352-2021	Boire, Adrienne/0000-0002-9029-1248; Boire, Adrienne/0000-0002-9029-1248	NIH [R01 HL-57905, R01 HL-64701, R01 CA-122992]; NATIONAL CANCER INSTITUTE [R01CA122992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064701, R01HL057905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support from NIH R01 HL-57905, R01 HL-64701, and R01 CA-122992 (to A. K.) is gratefully acknowledged. A. K. and L. C. are founders of Ascent Therapeutics and are members of its scientific advisory board. Ascent Therapeutics has licensed the pepducins used in this study.	Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; BERMAN J, 1992, J BIOL CHEM, V267, P1434; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; CHESNEY CM, 1974, J CLIN INVEST, V53, P1647, DOI 10.1172/JCI107715; Conant K, 2004, J BIOL CHEM, V279, P8056, DOI 10.1074/jbc.M307051200; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; FRESSINAUD E, 1992, BLOOD, V80, P988; Galt SW, 2002, CIRC RES, V90, P1093, DOI 10.1161/01.RES.0000019241.12929.EB; GAST A, 1994, ARTERIOSCLER THROMB, V14, P1466, DOI 10.1161/01.ATV.14.9.1466; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Huebner JL, 1998, ARTHRITIS RHEUM-US, V41, P877, DOI 10.1002/1529-0131(199805)41:5<877::AID-ART16>3.0.CO;2-#; INAUEN W, 1990, ARTERIOSCLEROSIS, V10, P607, DOI 10.1161/01.ATV.10.4.607; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kazes I, 2000, BLOOD, V96, P3064, DOI 10.1182/blood.V96.9.3064.h8003064_3064_3069; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mann KG, 2007, J THROMB HAEMOST, V5, P2055, DOI 10.1111/j.1538-7836.2007.02710.x; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Pearce E, 2005, CIRC RES, V97, P1070, DOI 10.1161/01.RES.0000189302.03303.11; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sawicki G, 1997, NATURE, V386, P616, DOI 10.1038/386616a0; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Stephens G, 2005, BLOOD, V105, P186, DOI 10.1182/blood-2004-07-2842; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Suzuki H, 2008, EUR J CLIN INVEST, V38, P166, DOI 10.1111/j.1365-2362.2007.01919.x; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; VEEN G, 1993, J AM COLL CARDIOL, V22, P1755, DOI 10.1016/0735-1097(93)90754-O; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V	43	194	200	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					332	343		10.1016/j.cell.2009.02.018	http://dx.doi.org/10.1016/j.cell.2009.02.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379698	Green Accepted, Bronze			2022-12-28	WOS:000265456800025
J	Kosynkin, DV; Higginbotham, AL; Sinitskii, A; Lomeda, JR; Dimiev, A; Price, BK; Tour, JM				Kosynkin, Dmitry V.; Higginbotham, Amanda L.; Sinitskii, Alexander; Lomeda, Jay R.; Dimiev, Ayrat; Price, B. Katherine; Tour, James M.			Longitudinal unzipping of carbon nanotubes to form graphene nanoribbons	NATURE			English	Article							EXFOLIATED GRAPHITE OXIDE; AQUEOUS DISPERSIONS; CHEMICAL-REDUCTION; FILMS; PERMANGANATE; NANOSHEETS; OXIDATION; PHASE	Graphene, or single-layered graphite, with its high crystallinity and interesting semimetal electronic properties, has emerged as an exciting two-dimensional material showing great promise for the fabrication of nanoscale devices(1-3). Thin, elongated strips of graphene that possess straight edges, termed graphene ribbons, gradually transform from semiconductors to semimetals as their width increases(4-7), and represent a particularly versatile variety of graphene. Several lithographic(7,8), chemical(9-11) and synthetic(12) procedures are known to produce microscopic samples of graphene nanoribbons, and one chemical vapour deposition process(13) has successfully produced macroscopic quantities of nanoribbons at 950 degrees C. Here we describe a simple solution-based oxidative process for producing a nearly 100% yield of nanoribbon structures by lengthwise cutting and unravelling of multiwalled carbon nanotube (MWCNT) side walls. Although oxidative shortening of MWCNTs has previously been achieved(14), lengthwise cutting is hitherto unreported. Ribbon structures with high water solubility are obtained. Subsequent chemical reduction of the nanoribbons from MWCNTs results in restoration of electrical conductivity. These early results affording nanoribbons could eventually lead to applications in fields of electronics and composite materials where bulk quantities of nanoribbons are required(15-17).	[Kosynkin, Dmitry V.; Higginbotham, Amanda L.; Sinitskii, Alexander; Lomeda, Jay R.; Dimiev, Ayrat; Price, B. Katherine; Tour, James M.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Tour, James M.] Rice Univ, Dept Mech Engn & Mat Sci, Houston, TX 77005 USA; [Tour, James M.] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA	Rice University; Rice University; Rice University	Tour, JM (corresponding author), Rice Univ, Dept Chem, MS 222,6100 Main St, Houston, TX 77005 USA.	tour@rice.edu	Sinitskii, Alexander/J-6619-2015; Dimiev, Ayrat/J-2088-2017; Kosynkin, Dmitry/AAX-1108-2021	Sinitskii, Alexander/0000-0002-8688-3451; Dimiev, Ayrat/0000-0001-7497-1211; Tour, James/0000-0002-8479-9328; Duque, Amanda/0000-0002-2023-1389	US Defense Advanced Research Projects Agency; US Federal Aviation Administration, Department of Energy [DE-FC-36-05GO15073]; Wright Patterson Air Force Laboratory through the US Air Force Office of Scientific Research	US Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US Federal Aviation Administration, Department of Energy(United States Department of Energy (DOE)); Wright Patterson Air Force Laboratory through the US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	The authors thank P. M. Ajayan, W. Guo, J. Duque, Z. Sun, and Z. Jin for technical assistance and discussions. Mitsui & Co.generously donated the MWCNTs. The work was funded by the US Defense Advanced Research Projects Agency, the US Federal Aviation Administration, Department of Energy (DE-FC-36-05GO15073) and Wright Patterson Air Force Laboratory through the US Air Force Office of Scientific Research.	Ajayan PM, 2006, NATURE, V441, P818, DOI 10.1038/441818a; Areshkin DA, 2007, NANO LETT, V7, P204, DOI 10.1021/nl062132h; BANOO F, 1969, CAN J CHEMISTRY, V47, P3199, DOI 10.1139/v69-526; Bourlinos AB, 2003, LANGMUIR, V19, P6050, DOI 10.1021/la026525h; Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83; ENDO M, 1988, CHEMTECH, V18, P568; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Lerf A, 1998, J PHYS CHEM B, V102, P4477, DOI 10.1021/jp9731821; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Li JL, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.176101; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Liang GC, 2007, IEEE T ELECTRON DEV, V54, P677, DOI 10.1109/TED.2007.891872; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Rollings E, 2006, J PHYS CHEM SOLIDS, V67, P2172, DOI 10.1016/j.jpcs.2006.05.010; Saito T, 2002, PHYSICA B, V323, P280, DOI 10.1016/S0921-4526(02)00999-7; Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803; WOLFE S, 1981, J AM CHEM SOC, V103, P938, DOI 10.1021/ja00394a037; Yang XY, 2008, J AM CHEM SOC, V130, P4216, DOI 10.1021/ja710234t; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	30	2784	2889	32	1988	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					872	U5		10.1038/nature07872	http://dx.doi.org/10.1038/nature07872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370030	Green Published			2022-12-28	WOS:000265182500039
J	Khosroshahi, A; Stone, JR; Pratt, DS; Deshpande, V; Stone, JH				Khosroshahi, Arezou; Stone, James R.; Pratt, Daniel S.; Deshpande, Vikram; Stone, John H.			Painless jaundice with serial multi-organ dysfunction	LANCET			English	Editorial Material							AUTOIMMUNE PANCREATITIS; DISEASE		[Khosroshahi, Arezou] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Rheumatol Unit, Boston, MA 02114 USA; [Stone, James R.; Deshpande, Vikram] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Pratt, Daniel S.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Khosroshahi, A (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Rheumatol Unit, 55 Fruit St,Bulfinch 165, Boston, MA 02114 USA.	akhosroshahi@partners.org						Chandan VS, 2008, AM J SURG PATHOL, V32, P1762, DOI 10.1097/PAS.0b013e318181f9ca; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; Kasashima S, 2008, AM J SURG PATHOL, V32, P197, DOI 10.1097/PAS.0b013e3181342f0d; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169	5	31	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1494	1494		10.1016/S0140-6736(09)60615-2	http://dx.doi.org/10.1016/S0140-6736(09)60615-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394539				2022-12-28	WOS:000265501900038
J	McAllister, TN; Maruszewski, M; Garrido, SA; Wystrychowski, W; Dusserre, N; Marini, A; Zagalski, K; Fiorillo, A; Avila, H; Manglano, X; Antonelli, J; Kocher, A; Zembala, M; Cierpka, L; de la Fuente, LM; LHeureux, N				McAllister, Todd N.; Maruszewski, Marcin; Garrido, Sergio A.; Wystrychowski, Wojciech; Dusserre, Nathalie; Marini, Alicia; Zagalski, Krzysztof; Fiorillo, Alejandro; Avila, Hernan; Manglano, Ximena; Antonelli, Jorge; Kocher, Alfred; Zembala, Marian; Cierpka, Lech; de la Fuente, Luis M.; LHeureux, Nicolas			Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study	LANCET			English	Article							BLOOD-VESSELS; FISTULA	Background Application of a tissue-engineered vascular graft for small-diameter vascular reconstruction has been a long awaited and much anticipated advance for vascular surgery. We report results after a minimum of 6 months of follow-up for the first ten patients implanted with a completely biological and autologous tissue-engineered vascular graft. Methods Ten patients with end-stage renal disease who had been receiving haemodialysis through an access graft that had a high probability of failure, and had had at least one previous access failure, were enrolled from centres in Argentina and Poland between September, 2004, and April, 2007. Completely autologous tissue-engineered vascular grafts were grown in culture supplemented with bovine serum, implanted as arteriovenous shunts, and assessed for both mechanical stability during the safety phase (0-3 months) and effectiveness after haemodialysis was started. Findings Three grafts failed within the safety phase, which is consistent with failure rates expected for this high-risk patient population. One patient was withdrawn from the study because of severe gastrointestinal bleeding shortly before implantation, and another died of unrelated causes during the safety period with a patent graft. The remaining five patients had grafts functioning for haemodialysis 6-20 months after implantation, and a total of 68 patient-months of patency. In these five patients, only one intervention (surgical correction) was needed to maintain secondary patency. Overall, primary patency was maintained in seven (78%) of the remaining nine patients 1 month after implantation and five (60%) of the remaining eight patients 6 months after implantation. Interpretation Our proportion of primary patency in this high-risk cohort approaches Dialysis Outcomes Quality Initiative objectives (76% of patients 3 months after implantation) for arteriovenous fistulas, averaged across all patient populations.	[McAllister, Todd N.; Dusserre, Nathalie; LHeureux, Nicolas] Cytograft Tissue Engn, Novato, CA 94949 USA; [Maruszewski, Marcin; Zembala, Marian] Silesian Ctr Heart Dis, Zabrze, Poland; [Garrido, Sergio A.; Marini, Alicia; Fiorillo, Alejandro; Avila, Hernan; Manglano, Ximena; Antonelli, Jorge; de la Fuente, Luis M.] Inst Argentino Diagnost & Tratamiento, Buenos Aires, DF, Argentina; [Wystrychowski, Wojciech; Zagalski, Krzysztof; Cierpka, Lech] Med Univ Silesia, Dept Gen Vasc & Transplant Surg, Katowice, Poland; [Kocher, Alfred] Med Univ Vienna, Vienna, Austria; [Kocher, Alfred] Dept Cardiac Surg, Innsbruck, Austria	Silesian Center for Heart Diseases; Medical University Silesia; Medical University of Vienna	McAllister, TN (corresponding author), Cytograft Tissue Engn, 3 Hamilton Landing,Suite 220, Novato, CA 94949 USA.	todd@cytograft.com	Maruszewski, Marcin Z/A-1074-2019; Maruszewski, Marcin/K-5722-2019; Dusserre, Nathalie/AAG-9108-2019; L'Heureux, Nicolas/K-8669-2015	Maruszewski, Marcin Z/0000-0001-9679-4105; L'Heureux, Nicolas/0000-0001-8602-3948; Wystrychowski, Wojciech/0000-0002-2430-1225; Dusserre, Nathalie/0000-0002-4699-3365	Cytograft Tissue Engineering, Novato, CA, USA	Cytograft Tissue Engineering, Novato, CA, USA	We thank Christian Schulte for undertaking the Doppler ultrasound examinations and Gary McAllister for assembling Doppler composites from the examination videos. Cytograft Tissue Engineering, Novato, CA, USA, provided funding for this study.	Bacchini G, 2001, ASAIO J, V47, P30, DOI 10.1097/00002480-200101000-00008; BELL E, 1983, J INVEST DERMATOL, V81, pS2, DOI 10.1111/1523-1747.ep12539993; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elseviers MM, 2003, NEPHROL NEWS ISSUES, V17, P99; Elseviers MM, 2003, NEPHROL NEWS ISSUES, V17, P66; Elseviers Monique M, 2003, Nephrol News Issues, V17, P61; Friedman S.G., 2005, HIST VASCULAR SURG; Glickman M H, 2003, J Vasc Access, V4, P73; HEGSTROM R, 1961, T AM SOC ART INT ORG, V7, P47; Hodges TC, 1997, J VASC SURG, V26, P1009, DOI 10.1016/S0741-5214(97)70014-4; Huber TS, 2004, SEMIN DIALYSIS, V17, P217, DOI 10.1111/j.0894-0959.2004.17309.x; Katzman HE, 2005, J AM COLL SURGEONS, V201, P223, DOI 10.1016/j.jamcollsurg.2005.03.040; KHERLAKIAN GM, 1986, AM J SURG, V152, P238, DOI 10.1016/0002-9610(86)90249-7; Kovalic AJ, 2002, EUR J VASC ENDOVASC, V24, P533, DOI 10.1053/ejvs.2002.1710; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; Perera GB, 2004, ANN VASC SURG, V18, P66, DOI 10.1007/s10016-003-0094-y; Poh M, 2005, LANCET, V365, P2122, DOI 10.1016/S0140-6736(05)66735-9; Rosas SE, 2003, J VASC SURG, V37, P1036, DOI 10.1067/mva.2003.257; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Tellioglu G, 2008, TRANSPL P, V40, P87, DOI 10.1016/j.transproceed.2007.11.059; Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647; WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816	26	361	379	2	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1440	1446		10.1016/S0140-6736(09)60248-8	http://dx.doi.org/10.1016/S0140-6736(09)60248-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394535				2022-12-28	WOS:000265501900032
J	Miller, MA; Viboud, C; Balinska, M; Simonsen, L				Miller, Mark A.; Viboud, Cecile; Balinska, Marta; Simonsen, Lone			The Signature Features of Influenza Pandemics - Implications for Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Miller, Mark A.; Viboud, Cecile; Balinska, Marta] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Global Hlth, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); George Washington University	Miller, MA (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.		Balinska, Marta Aleksandra/GYU-8120-2022; Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526				Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Richardson F, 1909, PSYCHOL MONOGR, V12, P1; Simonsen L, 2005, THREAT PANDEMIC INFL, P89, DOI DOI 10.2105/AJPH.2007.119933; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067	5	241	251	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2595	2598		10.1056/NEJMp0903906	http://dx.doi.org/10.1056/NEJMp0903906			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458WR	19423872				2022-12-28	WOS:000267060000002
J	Santra, MK; Wajapeyee, N; Green, MR				Santra, Manas K.; Wajapeyee, Narendra; Green, Michael R.			F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage	NATURE			English	Article							CANCER; PHOSPHORYLATION; HETEROZYGOSITY; SENESCENCE; ATM; CHECKPOINTS; PATHWAY; KINASE; GENE	In response to DNA damage, eukaryotic cells initiate a complex signalling pathway, termed the DNA damage response (DDR), which coordinates cell cycle arrest with DNA repair. Studies have shown that oncogene-induced senescence, which provides a barrier to tumour development, involves activation of the DDR1-3. Using a genome-wide RNA interference (RNAi) screen, we have identified 17 factors required for oncogenic BRAF to induce senescence in primary fibroblasts and melanocytes(4). One of these factors is an F-box protein, FBXO31, a candidate tumour suppressor encoded in 16q24.3, a region in which there is loss of heterozygosity in breast, ovarian, hepatocellular and prostate cancers(5-9). Here we study the cellular role of FBXO31, identify its target substrate and determine the basis for its growth inhibitory activity. We show that ectopic expression of FBXO31 acts through a proteasome-directed pathway to mediate the degradation of cyclin D1, an important regulator of progression from G1 to S phase, resulting in arrest in G1. Cyclin D1 degradation results from a direct interaction with FBXO31 and is dependent on the F-box motif of FBXO31 and phosphorylation of cyclin D1 at Thr 286, which is known to be required for cyclin D1 proteolysis. The involvement of the DDR in oncogene-induced senescence prompted us to investigate the role of FBXO31 in DNA repair. We find that DNA damage induced by gamma-irradiation results in increased FBXO31 levels, which requires phosphorylation of FBXO31 by the DDR-initiating kinase ATM. RNAi-mediated knockdown of FBXO31 prevents cells from undergoing efficient arrest in G1 after gamma-irradiation and markedly increases sensitivity to DNA damage. Finally, we show that a variety of DNA damaging agents all result in a large increase in FBXO31 levels, indicating that induction of FBXO31 is a general response to genotoxic stress. Our results reveal FBXO31 as a regulator of the G1/S transition that is specifically required for DNA damage-induced growth arrest.	[Santra, Manas K.; Wajapeyee, Narendra; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; [Santra, Manas K.; Wajapeyee, Narendra; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Wajapeyee, Narendra/F-3011-2012		Our Danny Cancer Fund; Howard Hughes Medical Institute	Our Danny Cancer Fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank S. Cook, O. Tetsu, M. Kastan and R. Kumar for reagents; M. Pagano for reagents and advice; L. Chamberlain for technical assistance; and S. Evans for editorial assistance. N. W. is supported in part by a fellowship from the Our Danny Cancer Fund. M. R. G. is an investigator of the Howard Hughes Medical Institute.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Harkonen P, 2005, PROSTATE, V62, P267, DOI 10.1002/pros.20147; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; Launonen V, 2000, CANCER GENET CYTOGEN, V122, P49, DOI 10.1016/S0165-4608(00)00279-X; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin YW, 2001, INT J CANCER, V93, P74, DOI 10.1002/ijc.1287; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	23	201	212	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					722	U129		10.1038/nature08011	http://dx.doi.org/10.1038/nature08011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19412162	Green Accepted			2022-12-28	WOS:000266608600048
J	Rao, RPN; Yadav, N; Vahia, MN; Joglekar, H; Adhikari, R; Mahadevan, I				Rao, Rajesh P. N.; Yadav, Nisha; Vahia, Mayank N.; Joglekar, Hrishikesh; Adhikari, R.; Mahadevan, Iravatham			Entropic Evidence for Linguistic Structure in the Indus Script	SCIENCE			English	Article									[Rao, Rajesh P. N.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Yadav, Nisha; Vahia, Mayank N.] Tata Inst Fundamental Res, Dept Astron & Astrophys, Bombay 400005, Maharashtra, India; [Yadav, Nisha; Vahia, Mayank N.] Ctr Excellence Basic Sci, Bombay 400098, Maharashtra, India; [Adhikari, R.] Inst Math Sci, Madras 600113, Tamil Nadu, India; [Mahadevan, Iravatham] Roja Muthiah Res Lib, Indus Res Ctr, Madras 600113, Tamil Nadu, India	University of Washington; University of Washington Seattle; Tata Institute of Fundamental Research (TIFR); UM-DAE Centre for Excellence in Basic Sciences; Institute of Mathematical Sciences (IMSc) India	Rao, RPN (corresponding author), Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA.	rao@cs.washington.edu	Adhikari, Ronojoy/B-7157-2011	Rao, Rajesh P. N./0000-0003-0682-8952	Packard Foundation; Sir Jamsetji Tata Trust; University of Washington	Packard Foundation(The David & Lucile Packard Foundation); Sir Jamsetji Tata Trust; University of Washington(University of Washington)	This work was supported by the Packard Foundation, the Sir Jamsetji Tata Trust, and the University of Washington. We thank T. Sejnowski, M. Shapiro, and B. Wells for their comments and suggestions.	Black J., 1992, GODS DEMONS SYMBOLS; Farmer S., 2004, ELECT J VEDIC STUDIE, V11, P19, DOI DOI 10.11588/EJVS.2004.2.620; Knorozov Y.V., 1981, PROTOINDICA 1979 REP; KOSKENNIEMI K, 1981, STUDIA ORIENTALIA, V50, P125; Lawler A, 2008, SCIENCE, V320, P1276, DOI 10.1126/science.320.5881.1276; MAHADEVAN I, 1970, J TAMIL STUDIES, V2, P157; Mahadevan I., 1977, MEMOIRS ARCHAEOLOGIC, V77; PARPOLA A, 2005, T INT C E STUD, V50, P28; Parpola A. H. S., 1994, DECIPHERING INDUS SC; Parpola Asko, 2008, AIRAVATI FELICITATIO, P111; Possehl Gregory, 1996, INDUS AGE WRITING SY; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; WINN SMM, 1990, LIFE SYMBOLS, P263; YADAV N, 2008, INT J DRAVIDIAN LING, V37, P53; Yadav N., 2008, INT J DRAVIDIAN LING, V37, P39	15	39	39	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1165	1165		10.1126/science.1170391	http://dx.doi.org/10.1126/science.1170391			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19389998				2022-12-28	WOS:000266410100035
J	Riviere, S; Challet, L; Fluegge, D; Spehr, M; Rodriguez, I				Riviere, Stephane; Challet, Ludivine; Fluegge, Daniela; Spehr, Marc; Rodriguez, Ivan			Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors	NATURE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; MAMMALS; INDIVIDUALS; RECOGNITION; NEURONS; GENES	Mammals rely heavily on olfaction to interact adequately with each other and with their environment(1). They make use of seven-transmembrane G-protein-coupled receptors to identify odorants and pheromones. These receptors are present on dendrites of olfactory sensory neurons located in the main olfactory or vomeronasal sensory epithelia, and pertain to the odorant(2), trace amine-associated receptor(3) and vomeronasal type 1 (ref. 4) or 2 (refs 5-7) receptor superfamilies. Whether these four sensor classes represent the complete olfactory molecular repertoire used by mammals to make sense of the outside world is unknown. Here we report the expression of formyl peptide receptor-related genes by vomeronasal sensory neurons, in multiple mammalian species. Similar to the four known olfactory receptor gene classes, these genes encode seven-transmembrane proteins, and are characterized by monogenic transcription and a punctate expression pattern in the sensory neuroepithelium. In vitro expression of mouse formyl peptide receptor-like 1, 3, 4, 6 and 7 provides sensitivity to disease/inflammation-related ligands. Establishing an in situ approach that combines whole-mount vomeronasal preparations with dendritic calcium imaging in the intact neuroepithelium, we show neuronal responses to the same molecules, which therefore represent a new class of vomeronasal agonists. Taken together, these results suggest that formyl peptide receptor-like proteins have an olfactory function associated with the identification of pathogens, or of pathogenic states.	[Riviere, Stephane; Challet, Ludivine; Rodriguez, Ivan] Univ Geneva, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland; [Riviere, Stephane; Challet, Ludivine; Rodriguez, Ivan] Univ Geneva, Natl Ctr Competence Frontiers Genet, CH-1205 Geneva, Switzerland; [Fluegge, Daniela; Spehr, Marc] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany	University of Geneva; University of Geneva; Ruhr University Bochum	Rodriguez, I (corresponding author), Univ Geneva, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland.	ivan.rodriguez@unige.ch	Spehr, Marc/B-3140-2011; Spehr, Marc/AAK-3162-2021	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; rodriguez, ivan/0000-0002-6468-0565	Swiss National Science Foundation; Claraz, Schmidheiny; Volkswagen; Schlumberger Foundations; Deutsche Forschungsgemeinschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Claraz, Schmidheiny; Volkswagen(Volkswagen); Schlumberger Foundations(Schlumberger); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C.-D. K. Ballif, C. Engelhardt and H. Bartel for technical help, and C. Bauer and P. Descombes for assistance on the NCCR 'Frontiers in Genetics' bioimaging and genomic platforms, respectively. We also thank H. Hatt for unlimited access to departmental infrastructure, and P. Vassalli for comments on the manuscript. This work was supported by the Swiss National Science Foundation, the Claraz, Schmidheiny, Volkswagen and Schlumberger Foundations, and the Emmy Noether program of the Deutsche Forschungsgemeinschaft.	BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Casella R, 2002, CANCER, V95, P2494, DOI 10.1002/cncr.10989; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Kavaliers M, 2006, P NATL ACAD SCI USA, V103, P4293, DOI 10.1073/pnas.0600410103; Kavaliers M, 2005, TRENDS PARASITOL, V21, P423, DOI 10.1016/j.pt.2005.07.008; Kavaliers M, 2004, HORM BEHAV, V46, P272, DOI 10.1016/j.yhbeh.2004.03.005; Kelliher KR, 2007, HORM BEHAV, V52, P561, DOI 10.1016/j.yhbeh.2007.08.012; Le YY, 2007, PROTEIN PEPTIDE LETT, V14, P846, DOI 10.2174/092986607782110211; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Roppolo D, 2007, EMBO J, V26, P3423, DOI 10.1038/sj.emboj.7601782; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Spehr M, 2002, J NEUROSCI, V22, P8429; Takata M, 2008, NEUROSCI LETT, V435, P126, DOI 10.1016/j.neulet.2008.02.019	20	247	264	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					574	577		10.1038/nature08029	http://dx.doi.org/10.1038/nature08029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387439				2022-12-28	WOS:000266370500040
J	Park, SY; Fung, P; Nishimura, N; Jensen, DR; Fujii, H; Zhao, Y; Lumba, S; Santiago, J; Rodrigues, A; Chow, TFF; Alfred, SE; Bonetta, D; Finkelstein, R; Provart, NJ; Desveaux, D; Rodriguez, PL; McCourt, P; Zhu, JK; Schroeder, JI; Volkman, BF; Cutler, SR				Park, Sang-Youl; Fung, Pauline; Nishimura, Noriyuki; Jensen, Davin R.; Fujii, Hiroaki; Zhao, Yang; Lumba, Shelley; Santiago, Julia; Rodrigues, Americo; Chow, Tsz-Fung F.; Alfred, Simon E.; Bonetta, Dario; Finkelstein, Ruth; Provart, Nicholas J.; Desveaux, Darrell; Rodriguez, Pedro L.; McCourt, Peter; Zhu, Jian-Kang; Schroeder, Julian I.; Volkman, Brian F.; Cutler, Sean R.			Abscisic Acid Inhibits Type 2C Protein Phosphatases via the PYR/PYL Family of START Proteins	SCIENCE			English	Article							NEGATIVE REGULATOR; SEED-GERMINATION; GENE-EXPRESSION; LIGAND-BINDING; ARABIDOPSIS; RECEPTORS; HORMONE; REVEAL; FOLD; ABI1	Type 2C protein phosphatases (PP2Cs) are vitally involved in abscisic acid (ABA) signaling. Here, we show that a synthetic growth inhibitor called pyrabactin functions as a selective ABA agonist. Pyrabactin acts through PYRABACTIN RESISTANCE 1 (PYR1), the founding member of a family of START proteins called PYR/PYLs, which are necessary for both pyrabactin and ABA signaling in vivo. We show that ABA binds to PYR1, which in turn binds to and inhibits PP2Cs. We conclude that PYR/PYLs are ABA receptors functioning at the apex of a negative regulatory pathway that controls ABA signaling by inhibiting PP2Cs. Our results illustrate the power of the chemical genetic approach for sidestepping genetic redundancy.	[Park, Sang-Youl; Fujii, Hiroaki; Zhu, Jian-Kang; Cutler, Sean R.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Fung, Pauline; Zhao, Yang; Lumba, Shelley; Chow, Tsz-Fung F.; Alfred, Simon E.; Provart, Nicholas J.; Desveaux, Darrell; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; [Provart, Nicholas J.; Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3B2, Canada; [Nishimura, Noriyuki; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Santiago, Julia; Rodrigues, Americo; Rodriguez, Pedro L.] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, ES-46022 Valencia, Spain; [Bonetta, Dario] Univ Ontario Inst Technol, Fac Sci, Oshawa, ON L1H 7K4, Canada; [Finkelstein, Ruth] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Jensen, Davin R.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Cutler, Sean R.] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Cutler, Sean R.] Univ Calif Riverside, Inst Genome Biol, Riverside, CA 92521 USA; [Cutler, Sean R.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of Toronto; University of Toronto; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Ontario Tech University; University of California System; University of California Santa Barbara; Medical College of Wisconsin; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Cutler, SR (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	sean.cutler@ucr.edu	Cutler, Sean R/D-6617-2011; Rodrigues, Americo/F-9573-2010; Zhu, Jian-Kang/F-7658-2011; Nishimura, Noriyuki/E-3580-2010; Volkman, Brian F./ABE-7306-2020; Rodriguez, Pedro L./K-4605-2014; Finkelstein, Ruth/Y-3274-2019; Volkman, Brian F./ABE-7312-2020	Rodrigues, Americo/0000-0002-5293-5583; Zhu, Jian-Kang/0000-0001-5134-731X; Nishimura, Noriyuki/0000-0003-2946-3124; Volkman, Brian F./0000-0002-6681-5179; Rodriguez, Pedro L./0000-0002-5886-9425; Volkman, Brian F./0000-0002-6681-5179; Fujii, Hiroaki/0000-0002-0013-5891; Cutler, Sean/0000-0002-8593-0885; Santiago, Julia/0000-0002-5765-6495	CRC; NSERC; NSF [IOS0820508, MCB0417118]; NIH [R01GM060396, 01GM59138, U54GM074901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901, R01GM059138, R01GM060396] Funding Source: NIH RePORTER	CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Raikhel, J. Bailey-Serres, and C. Larive for comments; K. Nito and T. Demura for materials. Supported by CRC (S.R.C., P.M., D.D.); NSERC (S.R.C., D.D., N.J.P.); NSF awards IOS0820508 (S.R.C.) and MCB0417118 (J.I.S.); NIH awards R01GM060396 (J.I.S.), 01GM59138 (J.-K.Z.), and U54GM074901 (B.V.). S.R.C. thanks J.R. Coleman for early support. Patent application "Control of plant stress tolerance, water use efficiency and gene expression using novel ABA recpetor proteins and synthetic agonists" inventors: S.R. Cutler, S.Y. Park, N. Nishimura, J.I. Schroeder, and A. Defries. Author contributions are as follows. Microarrays: P.F. and N.J.P.; pyr1 mutants: P.F. ; mutant analyses: P.F. and T.F.C.; yeast two-hybrid assays, biochemistry, and Pyr/Pyl genetics: S.Y.P.; pyr1 complementation and allele sequencing: Y.Z.; in planta pull-downs: N.N. and J.I.S.; PYL12-AHG3 and SnRK2-PP2C asinteractions: R.F.; HSQC experiments: D.J. and B.V.; SnRK2 assays: H.F. and J.-K.Z.; GFP-PYR1 localization: S.E.A.: PP2C assays: S.Y.P., J.S., A.R., and P.R.; EMS seed: D.B.; ABA orfeome: S.L., D.D., and P.M.; project conception, positional cloning, phone calls, and writing: S.R.C.	Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Cutler S, 2005, PLANT PHYSIOL, V138, P558, DOI 10.1104/pp.104.900152; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Goda H, 2008, PLANT J, V55, P526, DOI 10.1111/j.1365-313X.2008.03510.x; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; LYTLE B, PROTEINS IN PRESS, DOI DOI 10.1002/PROT.22396; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; McCourt P, 1999, ANNU REV PLANT PHYS, V50, P219, DOI 10.1146/annurev.arplant.50.1.219; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; SONDHEIM.E, 1971, SCIENCE, V174, P829, DOI 10.1126/science.174.4011.829; Toh S, 2008, PLANT PHYSIOL, V146, P1368, DOI 10.1104/pp.107.113738; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhao Y, 2007, NAT CHEM BIOL, V3, P716, DOI 10.1038/nchembio.2007.32	34	1805	1982	35	700	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1068	1071		10.1126/science.1173041	http://dx.doi.org/10.1126/science.1173041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407142	Green Accepted			2022-12-28	WOS:000266246700041
J	Tishkoff, SA; Reed, FA; Friedlaender, FR; Ehret, C; Ranciaro, A; Froment, A; Hirbo, JB; Awomoyi, AA; Bodo, JM; Doumbo, O; Ibrahim, M; Juma, AT; Kotze, MJ; Lema, G; Moore, JH; Mortensen, H; Nyambo, TB; Omar, SA; Powell, K; Pretorius, GS; Smith, MW; Thera, MA; Wambebe, C; Weber, JL; Williams, SM				Tishkoff, Sarah A.; Reed, Floyd A.; Friedlaender, Francoise R.; Ehret, Christopher; Ranciaro, Alessia; Froment, Alain; Hirbo, Jibril B.; Awomoyi, Agnes A.; Bodo, Jean-Marie; Doumbo, Ogobara; Ibrahim, Muntaser; Juma, Abdalla T.; Kotze, Maritha J.; Lema, Godfrey; Moore, Jason H.; Mortensen, Holly; Nyambo, Thomas B.; Omar, Sabah A.; Powell, Kweli; Pretorius, Gideon S.; Smith, Michael W.; Thera, Mahamadou A.; Wambebe, Charles; Weber, James L.; Williams, Scott M.			The Genetic Structure and History of Africans and African Americans	SCIENCE			English	Article							PYGMY HUNTER-GATHERERS; Y-CHROMOSOME; HUMAN-POPULATIONS; MTDNA VARIATION; DIVERSITY; ORIGINS; POLYMORPHISMS; PROPORTIONS; EVOLUTION; ANCESTRY	Africa is the source of all modern humans, but characterization of genetic variation and of relationships among populations across the continent has been enigmatic. We studied 121 African populations, four African American populations, and 60 non-African populations for patterns of variation at 1327 nuclear microsatellite and insertion/deletion markers. We identified 14 ancestral population clusters in Africa that correlate with self-described ethnicity and shared cultural and/or linguistic properties. We observed high levels of mixed ancestry in most populations, reflecting historical migration events across the continent. Our data also provide evidence for shared ancestry among geographically diverse hunter-gatherer populations (Khoesan speakers and Pygmies). The ancestry of African Americans is predominantly from Niger-Kordofanian (similar to 71%), European (similar to 13%), and other African (similar to 8%) populations, although admixture levels varied considerably among individuals. This study helps tease apart the complex evolutionary history of Africans and African Americans, aiding both anthropological and genetic epidemiologic studies.	[Tishkoff, Sarah A.; Reed, Floyd A.; Ranciaro, Alessia; Hirbo, Jibril B.; Awomoyi, Agnes A.; Mortensen, Holly; Powell, Kweli] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Tishkoff, Sarah A.; Ranciaro, Alessia; Hirbo, Jibril B.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Tishkoff, Sarah A.; Ranciaro, Alessia; Hirbo, Jibril B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Ehret, Christopher] Univ Calif Los Angeles, Dept Hist, Los Angeles, CA 90095 USA; [Ranciaro, Alessia] Univ Ferrara, Dipartimento Biol & Evoluz, I-44100 Ferrara, Italy; [Froment, Alain] Musee Homme Paris, IRD MNHN, UMR 208, F-75116 Paris, France; [Bodo, Jean-Marie] Minist Rech Sci & Innovat, Yaounde, Cameroon; [Doumbo, Ogobara; Thera, Mahamadou A.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Ibrahim, Muntaser; Juma, Abdalla T.] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum 1513, Sudan; [Kotze, Maritha J.] Univ Stellenbosch, Fac Hlth Sci, Dept Pathol, ZA-7505 Tygerberg, South Africa; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Moore, Jason H.] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH 03756 USA; [Omar, Sabah A.] Ctr Biotechnol Res & Dev, Kenya Med Res Inst, Nairobi 5484000200, Kenya; [Pretorius, Gideon S.] Univ Stellenbosch, Fac Hlth Sci, Div Human Genet, ZA-7505 Tygerberg, South Africa; [Smith, Michael W.] NCI, Lab Genom Div, Frederick, MD 21702 USA; [Wambebe, Charles] Int Biomed Res Africa, Abuja, Nigeria; [Weber, James L.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA	University System of Maryland; University of Maryland College Park; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Los Angeles; University of Ferrara; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of Bamako; University of Khartoum; Stellenbosch University; Muhimbili University of Health & Allied Sciences; Dartmouth College; Dartmouth College; Kenya Medical Research Institute; Stellenbosch University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Tishkoff, SA (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	tishkoff@mail.med.upenn.edu	Moore, Jason H./AAV-9645-2021; Kotze, Maritha J/GMX-0989-2022; Smith, Michael/B-5341-2012; Williams, Scott/Q-4812-2019; Williams, Scott/B-9491-2012	Moore, Jason H./0000-0002-5015-1099; Williams, Scott/0000-0002-4835-9544; Thera, Mahamadou A/0000-0002-2679-035X; Reed, Floyd/0000-0003-4703-530X; Hirbo, Jibril/0000-0002-8932-7311; Kotze, Martha/0000-0002-6050-2876	L. S. B. Leakey and Wenner Gren Foundation; NSF [BCS-0196183, BSC-0552486, BCS-0827436]; NIH [R01GM076637, 1R01GM083606-01, F32HG03801, R01 HL65234]; NHLBI Mammalian Genotyping Service; National Cancer Institute [N01-CO-12400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG003801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637, R01GM083606] Funding Source: NIH RePORTER	L. S. B. Leakey and Wenner Gren Foundation; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Mammalian Genotyping Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the thousands of people who donated DNA samples used in this study. We thank D. Bygott, S. J. Deo, D. Guracha, J. Hanby, D. Kariuki, P. Lufungulo, A. Mabulla, A. A. Mohamed, W. Ntandu, L. A. Nyindodo, C. Plowe, and A. Tibwitta for assisting with sample collection; K. Panchapakesan and L. Pfeiffer for assistance in sample preparation; S. Dobrin for assistance with genotyping; J. Giles, J. Bartlett, N. Kodaman, and J. Jarvis for assistance with analyses; and N. Rosenberg, J. Pritchard, A. Brooks, J. S. Friedlaender, J. Jarvis, C. Lambert, B. Payseur, N. Patterson, and J. Plotkin for helpful suggestions and discussions. Conducted in part using the ACCRE computing facility at Vanderbilt University, Nashville, TN. Supported by L. S. B. Leakey and Wenner Gren Foundation grants, NSF grants BCS-0196183, BSC-0552486, and BCS-0827436, NIH grants R01GM076637 and 1R01GM083606-01, and David and Lucile Packard and Burroughs Wellcome Foundation Career Awards (S.A.T.); NIH grant F32HG03801 (F.A.R.); and NIH grant R01 HL65234 (S.M.W. and J.H.M.). Genotyping was supported by the NHLBI Mammalian Genotyping Service. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. The project included in this manuscript has been funded in part with federal funds from the National Cancer Institute under contract N01-CO-12400. Original genotype data are available at http://research.marshfieldclinic.org/genetics/genotypingData_Statistics/humanDiversityPanel.asp. Data used for analyses in the current manuscript are available at www.med.upenn.edu/tishkoff/Supplemental/files.html and at http://chgr.mc.vanderbilt.edu/page/supplementary-data.	Ambrose SH, 1982, ARCHAEOLOGICAL LINGU, P104; [Anonymous], TRANSATLANTIC SLAVE; Batini C, 2007, MOL PHYLOGENET EVOL, V43, P635, DOI 10.1016/j.ympev.2006.09.014; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bereir RE, 2007, EUR J HUM GENET, V15, P1183, DOI 10.1038/sj.ejhg.5201892; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; Coia V, 2004, AM J HUM BIOL, V16, P57, DOI 10.1002/ajhb.10236; Destro-Bisol G, 2004, MOL BIOL EVOL, V21, P1673, DOI 10.1093/molbev/msh186; Destro-Bisol G, 2004, AM NAT, V163, P212, DOI 10.1086/381405; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Ehret C., 1983, CULTURE HIST SO SUDA, P19; EHRET C, 2006, W AFRICAN LINGUISTIC, P56; EHRET C, 1974, ETHIOPIANS E AFRICAN; EHRET C, 1980, HIST RECONSTRUCTION; EHRET C, 1986, SUGIA, V7, P105; Ehret C, 2008, SOUTH AFR HUMANIT, V20, P7; Ehret Christopher, 1998, AFRICAN CLASSICAL AG; Elderkin ED, 1982, SPRACHE GESCH AFRIKA, V4, P67; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2007, SCIENCE, V316, P50, DOI 10.1126/science.316.5821.50; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Hassan HY, 2008, AM J PHYS ANTHROPOL, V137, P316, DOI 10.1002/ajpa.20876; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Klieman Kairn, 2003, PYGMIES WERE OUR COM; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LIM L, 1992, THESIS BROWN U; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; LOMAX A, 1968, FOLK SONG STYLE CULT, P16; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; NEWMAN JL, 1997, PEOPLING AFRICA; Nurse GT., 1985, PEOPLES SO AFRICA TH; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reed FA, 2006, CURR OPIN GENET DEV, V16, P597, DOI 10.1016/j.gde.2006.10.008; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; ROSENBERG NA, 2002, PLOS GENET, V298, P2381; Rosenberg NA, 2006, PLOS GENET, V2, P2052, DOI 10.1371/journal.pgen.0020215; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; SANDS B, 1998, LANGUAGE IDENTITY CO, V15, P266; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	63	987	1015	3	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1035	1044		10.1126/science.1172257	http://dx.doi.org/10.1126/science.1172257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407144	Green Accepted			2022-12-28	WOS:000266246700033
J	Hack, M; Stork, E				Hack, Maureen; Stork, Eileen			Resuscitation at birth and long-term follow-up	LANCET			English	Editorial Material							NEONATAL ENCEPHALOPATHY; ASPHYXIA; CHILDREN		[Hack, Maureen; Stork, Eileen] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Hack, M (corresponding author), Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA.	mxh7@po.cwru.edu						*AM HEART ASS, 2006, TXB NEON RES; Barnett A, 2002, NEUROPEDIATRICS, V33, P242, DOI 10.1055/s-2002-36737; BAX M, 1993, DEV MED CHILD NEUROL, V35, P1015; HandleyDerry M, 1997, DEV MED CHILD NEUROL, V39, P508; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; Odd DE, 2009, LANCET, V373, P1615, DOI 10.1016/S0140-6736(09)60244-0; ROBERTSON CMT, 1989, J PEDIATR-US, V114, P753, DOI 10.1016/S0022-3476(89)80132-5; Rutherford M, 1996, ARCH DIS CHILD-FETAL, V75, pF145, DOI 10.1136/fn.75.3.F145; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4	10	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2009	373	9675					1581	1582		10.1016/S0140-6736(09)60228-2	http://dx.doi.org/10.1016/S0140-6736(09)60228-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19386356				2022-12-28	WOS:000266066300005
J	Shu, XK; Royant, A; Lin, MZ; Aguilera, TA; Lev-Ram, V; Steinbach, PA; Tsien, RY				Shu, Xiaokun; Royant, Antoine; Lin, Michael Z.; Aguilera, Todd A.; Lev-Ram, Varda; Steinbach, Paul A.; Tsien, Roger Y.			Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome	SCIENCE			English	Article							BACTERIOPHYTOCHROME; BILIVERDIN	Visibly fluorescent proteins (FPs) from jellyfish and corals have revolutionized many areas of molecular and cell biology, but the use of FPs in intact animals, such as mice, has been handicapped by poor penetration of excitation light. We now show that a bacteriophytochrome from Deinococcus radiodurans, incorporating biliverdin as the chromophore, can be engineered into monomeric, infrared-fluorescent proteins (IFPs), with excitation and emission maxima of 684 and 708 nm, respectively; extinction coefficient >90,000 M-1 cm(-1); and quantum yield of 0.07. IFPs express well in mammalian cells and mice and spontaneously incorporate biliverdin, which is ubiquitous as the initial intermediate in heme catabolism but has negligible fluorescence by itself. Because their wavelengths penetrate tissue well, IFPs are suitable for whole-body imaging. The IFPs developed here provide a scaffold for further engineering.	[Shu, Xiaokun; Steinbach, Paul A.; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Shu, Xiaokun; Lin, Michael Z.; Aguilera, Todd A.; Lev-Ram, Varda; Steinbach, Paul A.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Royant, Antoine] Inst Biol Struct 41, F-38027 Grenoble 1, France; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rtsien@ucsd.edu	Royant, Antoine/G-3684-2012	Royant, Antoine/0000-0002-1919-8649; Lin, Michael/0000-0002-0492-1961; shu, Xiaokun/0000-0001-9248-7095; Aguilera, Todd/0000-0002-3734-3758	NIGMS [R01 GM086197]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA158448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. C. Lagarias and S. Field for donation of cDNAs encoding HO-1 and AKT1s PH domain, respectively; J. M. Saathoff and G. Tran for help with plasmid purification; M. Timmers for help with tissue culture; S. Adams for help with light scattering measurements; L. Gross for mass spectrometry; and Q. Xiong for flow cytometry. This work was supported by NIGMS grant R01 GM086197 and the Howard Hughes Medical Institute.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; HARRIS JW, 1970, RED CELL; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; Ntziachristos V, 2004, P NATL ACAD SCI USA, V101, P12294, DOI 10.1073/pnas.0401137101; Ollinger R, 2007, ANTIOXID REDOX SIGN, V9, P2175, DOI 10.1089/ars.2007.1807; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shkrob MA, 2005, BIOCHEM J, V392, P649, DOI 10.1042/BJ20051314; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105	23	529	557	6	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					804	807		10.1126/science.1168683	http://dx.doi.org/10.1126/science.1168683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423828	Green Accepted			2022-12-28	WOS:000265832400052
J	Cassidy, J				Cassidy, Jane			Freedom of Information Open government?	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi@yahoo.co.uk						CORBYN Z, 2008, TIMES HIGHER ED 1023; *DEP HLTH, BEST RES BEST HLTH N; *INF COMM OFF, 2004, FREED INF ICO ENF ST; *INF COMM OFF, 2004, DEC NOT; Macdonald R, 2008, SCOTTISH REGIONAL TR; Pollock AM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1421; WALSH N, 2007, BRIT J HEALTHCARE MA, V13, P43	7	1	1	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2009	338								b1798	10.1136/bmj.b1798	http://dx.doi.org/10.1136/bmj.b1798			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GT	19416984				2022-12-28	WOS:000265969400005
J	Tam, PPL; Loebel, DAF				Tam, Patrick P. L.; Loebel, David A. F.			Specifying Mouse Embryonic Germ Cells	CELL			English	Editorial Material							STEM-CELLS; VISCERAL ENDODERM; DIFFERENTIATION; LINEAGE; MICE	Male germ cells are induced to form from the epiblast of the mouse embryo by a combination of WNT and bone morphogenetic protein signals. Ohinata et al. ( 2009) now clarify the steps of mouse germ cell formation and use this genetic insight to direct the specification and differentiation of germline progenitor cells in vitro.	[Tam, Patrick P. L.; Loebel, David A. F.] Univ Sydney, Childrens Med Res Inst, Embryol Unit, Wentworthville, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney	Tam, PPL (corresponding author), Univ Sydney, Childrens Med Res Inst, Embryol Unit, Wentworthville, NSW 2145, Australia.	ptam@cmri.usyd.edu.au						Egea J, 2008, GENE DEV, V22, P3349, DOI 10.1101/gad.486708; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186	9	8	11	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 1	2009	137	3					398	400		10.1016/j.cell.2009.04.016	http://dx.doi.org/10.1016/j.cell.2009.04.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410535	Bronze			2022-12-28	WOS:000265677200008
J	Uchil, PD; Mothes, W				Uchil, Pradeep D.; Mothes, Walther			HIV Entry Revisited	CELL			English	Editorial Material							FUSION	HIV has long served as a model for viruses that enter cells by direct fusion at the plasma membrane. Miyauchi et al. (2009) now provide compelling evidence that HIV enters cells primarily by endocytosis.	[Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Mothes, W (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	walther.mothes@yale.edu		Uchil, Pradeep/0000-0002-7236-858X	NATIONAL CANCER INSTITUTE [R01CA098727] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098727-07, R01 CA098727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Campbell EM, 2008, TRENDS MICROBIOL, V16, P580, DOI 10.1016/j.tim.2008.09.006; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3	9	11	12	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					402	404		10.1016/j.cell.2009.04.033	http://dx.doi.org/10.1016/j.cell.2009.04.033			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410537	Bronze, Green Accepted			2022-12-28	WOS:000265677200010
J	Whitehouse, I; Tsukiyama, T				Whitehouse, Iestyn; Tsukiyama, Toshio			Opening Windows to the Genome	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; NUCLEOSOME; TRANSCRIPTION; PROMOTERS; YEAST	Recent mapping of nucleosome positioning has added a new dimension to the study of transcriptional regulation. Hartley and Madhani (2009) now demonstrate the power of this approach and show that a chromatin regulator alters nucleosome positioning in the promoters of a large number of genes in the budding yeast Saccharomyces cerevisiae.	[Whitehouse, Iestyn] Sloan Kettering Inst, Program Mol Biol, New York, NY 12750 USA; [Tsukiyama, Toshio] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center	Whitehouse, I (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 12750 USA.	whitehoi@mskcc.org; ttsukiya@fhcrc.org		Whitehouse, Iestyn/0000-0003-0385-3116				Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	9	3	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					400	402		10.1016/j.cell.2009.04.026	http://dx.doi.org/10.1016/j.cell.2009.04.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410536	Bronze			2022-12-28	WOS:000265677200009
J	Afdhal, NH; Lok, ASF; Di Bisceglie, AM				Afdhal, Nezam H.; Lok, Anna S. F.; Di Bisceglie, Adrian M.			Management of Incidental Hepatitis C Virus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NORMAL AMINOTRANSFERASE LEVELS; PEGINTERFERON ALPHA-2A; BRIEF COMMUNICATION; NATURAL-HISTORY; RIBAVIRIN; FIBROSIS; REGRESSION; CIRRHOSIS		[Afdhal, Nezam H.] Beth Israel Deaconess Med Ctr, Div Gastroenterol Hepatol, Boston, MA 02215 USA; [Lok, Anna S. F.] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, St Louis, MO 63103 USA	Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; Saint Louis University	Afdhal, NH (corresponding author), Beth Israel Deaconess Med Ctr, Div Gastroenterol Hepatol, Boston, MA 02215 USA.		Lok, Anna/B-8292-2009	Yang, Shuman/0000-0002-9638-0890; Afdhal, Nezam/0000-0002-7342-6593				Afdhal NH, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-832922; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Kwo P, 2008, HEPATOLOGY, V48, p1027A; Mallet V, 2008, ANN INTERN MED, V149, P844, DOI 10.7326/0003-4819-149-11-200812020-00027; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Mchutchison JG, 2008, J HEPATOL, V48, pS4, DOI 10.1016/S0168-8278(08)60006-9; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Pradat P, 2002, HEPATOLOGY, V36, P973, DOI 10.1053/jhep.2002.35530; Puoti C, 2002, J HEPATOL, V37, P117, DOI 10.1016/S0168-8278(02)00101-0; Strader DB, 2004, HEPATOLOGY, V40, P269, DOI 10.1002/hep.20316; Thompson A, 2009, J HEPATOL, V50, P184, DOI 10.1016/j.jhep.2008.10.011; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050	17	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1902	1906						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403909				2022-12-28	WOS:000265560300015
J	Goud, R; de Keizer, NF; ter Riet, G; Wyatt, JC; Hasman, A; Hellemans, IM; Peek, N				Goud, Rick; de Keizer, Nicolette F.; ter Riet, Gerben; Wyatt, Jeremy C.; Hasman, Arie; Hellemans, Irene M.; Peek, Niels			Effect of guideline based computerised decision support on decision making of multidisciplinary teams: cluster randomised trial in cardiac rehabilitation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; IMPLEMENTATION RESEARCH; SECONDARY PREVENTION; REMINDER SYSTEM; PRIMARY-CARE; MANAGEMENT; DESIGN; ERRORS; INTERVENTION; INFORMATICS	Objective To determine the extent to which computerised decision support can improve concordance of multidisciplinary teams with therapeutic decisions recommended by guidelines. Design Multicentre cluster randomised trial. Participants Multidisciplinary cardiac rehabilitation teams in Dutch centres and their cardiac rehabilitation patients. Interventions Teams received an electronic patient record system with or without additional guideline based decision support. Main outcome measures Concordance with guideline recommendations assessed for two standard rehabilitation treatments-exercise and education therapy-and for two new but evidence based rehabilitation treatments-relaxation and lifestyle change therapy; generalised estimating equations were used to account for intra-cluster correlation and were adjusted for patient's age, sex, and indication for cardiac rehabilitation and for type and volume of centre. Results Data from 21 centres, including 2787 patients, were analysed. Computerised decision support increased concordance with guideline recommended therapeutic decisions for exercise therapy by 7.9% (control 84.7%; adjusted difference 3.5%, 95% confidence 0.1% to 5.2%), for education therapy by 25.7% (control 63.9%; adjusted difference 23.7%, 15.5% to 29.4%), and for relaxation therapy by 25.5% (control 34.1%; adjusted difference 41.6%, 25.2% to 51.3%). The concordance for lifestyle change therapy increased by 3.2% ( control 54.1%; adjusted difference 7.1%, -2.9% to 18.3%). Computerised decision support reduced cases of both overtreatment and undertreatment. Conclusions In a multidisciplinary team motivated to adopt a computerised decision support aid that assists in formulating guideline based care plans, computerised decision support can be effective in improving the team's concordance with guidelines. Therefore, computerised decision support may also be considered to improve implementation of guidelines in such settings.	[de Keizer, Nicolette F.; ter Riet, Gerben; Hasman, Arie; Hellemans, Irene M.; Peek, Niels] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1100 DD Amsterdam, Netherlands; [ter Riet, Gerben] Univ Zurich, Horten Ctr, Zurich, Switzerland; [Wyatt, Jeremy C.] Univ Dundee, Hlth Informat Ctr, Dundee DD2 4BF, Scotland	University of Amsterdam; Academic Medical Center Amsterdam; University of Zurich; University of Dundee	Peek, N (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Meibergdreef 15, NL-1100 DD Amsterdam, Netherlands.	n.b.peek@amc.uva.nl	Peek, Niels/AAD-9334-2019; Hasman, Arie/F-1816-2013; Wyatt, Jeremy/F-8160-2010; Riet, Gerben ter/A-6943-2011	Peek, Niels/0000-0002-6393-9969; Wyatt, Jeremy/0000-0001-7008-1473; Riet, Gerben ter/0000-0002-2231-7637	ZonMW; Netherlands Organisation for Health Research and Development; Health Care Efficiency Research Program 2004 [945-14-205]	ZonMW(Netherlands Organization for Health Research and Development); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Health Care Efficiency Research Program 2004	This project was funded by ZonMW, the Netherlands Organisation for Health Research and Development, Health Care Efficiency Research Program 2004, subprogram Implementation, under project no. 945-14-205. The researchers were independent from the funder. ZonMW had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	ADAMS ID, 1986, BRIT MED J, V293, P800, DOI 10.1136/bmj.293.6550.800; Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Bates DW, 1999, AM J MED, V106, P144, DOI 10.1016/S0002-9343(98)00410-0; Bethell H, 2009, HEART, V95, P271, DOI 10.1136/hrt.2007.134338; Burack RC, 2003, PREV MED, V36, P547, DOI 10.1016/S0091-7435(02)00062-2; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Campbell MK, 2001, STAT MED, V20, P391, DOI 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z; CARTER S, 2003, QUALITY SAFETY HL S1, V12, P25; Chuang JH, 2002, J AM MED INFORM ASSN, V9, P230, DOI 10.1197/jamia.M0997; Chuang JH, 2000, J AM MED INFORM ASSN, P146; Dexter PR, 2001, NEW ENGL J MED, V345, P965, DOI 10.1056/NEJMsa010181; Eccles M, 2003, QUAL SAF HEALTH CARE, V12, P47, DOI 10.1136/qhc.12.1.47; Eccles M, 2002, BMJ-BRIT MED J, V325, P941, DOI 10.1136/bmj.325.7370.941; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Filippi A, 2003, DIABETES CARE, V26, P1497, DOI 10.2337/diacare.26.5.1497; Friedman C.F., 2006, EVALUATION METHODS M; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Goud R, 2005, COMPUT CARDIOL, V32, P323; Goud R, 2008, COMPUT METH PROG BIO, V91, P145, DOI 10.1016/j.cmpb.2008.03.006; Goud R, 2008, ST HEAL T, V136, P193; Grimshaw Jeremy, 2004, J Contin Educ Health Prof, V24 Suppl 1, pS31, DOI 10.1002/chp.1340240506; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jones PE, 2000, ERGONOMICS, V43, P1129, DOI 10.1080/00140130050084914; Kaplan B, 2001, INT J MED INFORM, V64, P15, DOI 10.1016/S1386-5056(01)00183-6; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Lanceley A, 2008, INT J GYNECOL CANCER, V18, P215, DOI 10.1111/j.1525-1438.2007.00991.x; Lobach DF, 1997, AM J MED, V102, P89, DOI 10.1016/S0002-9343(96)00382-8; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Mazzini MJ, 2008, AM J CARDIOL, V101, P1084, DOI 10.1016/j.amjcard.2007.11.063; MCPHEE SJ, 1991, JAMA-J AM MED ASSOC, V266, P538, DOI 10.1001/jama.266.4.538; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; *NETH HEART FDN RE, 2004, GUID CARD REH 2004; Overhage JM, 1997, J AM MED INFORM ASSN, V4, P364, DOI 10.1136/jamia.1997.0040364; Poller L, 1998, LANCET, V352, P1505, DOI 10.1016/S0140-6736(98)04147-6; Randolph AG, 1999, JAMA-J AM MED ASSOC, V282, P67, DOI 10.1001/jama.282.1.67; Samore MH, 2005, JAMA-J AM MED ASSOC, V294, P2305, DOI 10.1001/jama.294.18.2305; San Martin-Rodriguez Leticia, 2005, J Interprof Care, V19 Suppl 1, P132; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P99, DOI 10.1136/jamia.1999.0060099; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P104, DOI 10.1136/jamia.1999.0060104; Short Robert, 2008, BMJ, V336, P1095, DOI 10.1136/bmj.39580.625891.DB; Skinner JS, 2007, BRIT MED J, V334, P1112, DOI 10.1136/bmj.39204.531586.AD; Thomas RJ, 2007, J AM COLL CARDIOL, V50, P1400, DOI 10.1016/j.jacc.2007.04.033; Unsworth C, 1996, AM J PHYS MED REHAB, V75, P483, DOI 10.1097/00002060-199611000-00019; World Health Organization [WHO], 1993, NEEDS ACT PRIOR CARD; WYATT J, 1990, MED INFORM, V15, P205, DOI 10.3109/14639239009025268; Wyatt JC, 2000, J ROY SOC MED, V93, P299, DOI 10.1177/014107680009300606; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 2008, JAMA, V299, P1534	54	56	56	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2009	338								b1440	10.1136/bmj.b1440	http://dx.doi.org/10.1136/bmj.b1440			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JR	19398471	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000265697100005
J	Hemmer, P; Wrachtrup, J				Hemmer, P.; Wrachtrup, J.			Where Is My Quantum Computer?	SCIENCE			English	Editorial Material							DIAMOND; QUBITS		[Hemmer, P.] Texas A&M Univ, College Stn, TX 77843 USA; [Wrachtrup, J.] Univ Stuttgart, Inst Phys, D-70550 Stuttgart, Germany	Texas A&M University System; Texas A&M University College Station; University of Stuttgart	Hemmer, P (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	prhemmer@ece.tamu.edu; wrachtrup@physik.unistuttgart.de						ANDRE A, ARXIVQAUNTPH0401130; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH., 1984, P IEEE INT C COMP SY, P175; Childress L, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.052330; Elliott C, 2002, NEW J PHYS, V4, DOI 10.1088/1367-2630/4/1/346; GIOVANNETTI V, ARXIV07082992V2QUANT; Guo H, 2008, DECIS SUPPORT SYST, V46, P318, DOI 10.1016/j.dss.2008.07.001; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; LLOYD S, 1992, PHYS LETT A, V167, P255, DOI 10.1016/0375-9601(92)90201-V; Meyers R, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.041801; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; URSIN R, 2008, P 2008 MICR SCI PROC; Wrachtrup J, 2006, J PHYS-CONDENS MAT, V18, pS807, DOI 10.1088/0953-8984/18/21/S08; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241	15	8	9	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					473	474		10.1126/science.1170912	http://dx.doi.org/10.1126/science.1170912			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390033				2022-12-28	WOS:000265411200032
J	Burke, D				Burke, David			Review: Long-term annual conversion rate to dementia was 3.3% in older adults with mild cognitive impairment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Vincents Hosp, Sydney, NSW 2010, Australia	St Vincents Hospital Sydney	Burke, D (corresponding author), St Vincents Hosp, Sydney, NSW 2010, Australia.							Burke D, 2007, BRIT J PSYCHIAT, V190, P371, DOI 10.1192/bjp.bp.106.033407; Visser PJ, 2006, INT PSYCHOGERIATR, V18, P402	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-13	10.7326/0003-4819-150-8-200904210-02013	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391227				2022-12-28	WOS:000265457000028
J	Mills, EJ; Burkle, FM				Mills, Edward J.; Burkle, Frederick M., Jr.			Interference, intimidation, and measuring mortality in war	LANCET			English	Editorial Material							PUBLIC-HEALTH; HUMAN-RIGHTS; POLITICS		[Burkle, Frederick M., Jr.] Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada	Harvard University; University of Ottawa	Burkle, FM (corresponding author), Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.	fburkle@hsph.harvard.edu	Burkle, Frederick/AAE-5423-2020					ALWAN A, 2004, HLTH IRAQ REV CURREN; [Anonymous], REP IR IR FAM HLTH S; BADKHEN A, 2006, SAN FRANCISCO C 1012; Ball P, 2002, KILLINGS REFUGEE FLO; Beyrer C, 2002, LANCET, V360, P246, DOI 10.1016/S0140-6736(02)09465-5; Bohannon J, 2006, SCIENCE, V314, P396, DOI 10.1126/science.314.5798.396; BRENNAN RJ, 2006, HUMANITARIAN EXCHANG; Burkle FM, 2008, DISASTER MED PUBLIC, V2, P192, DOI 10.1097/DMP.0b013e3181809455; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P469; Hicks MHR, 2008, PLOS MED, V5, P1658, DOI 10.1371/journal.pmed.0050243; *MED, 2004, END EFF WAR HLTH IR; PARSONS T, 2009, J HOPKINS GAZET 0302; Rest KM, 2007, AM J PUBLIC HEALTH, V97, P1939, DOI 10.2105/AJPH.2007.118455; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Spiegel PB, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-12; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Tapp Christine, 2008, Confl Health, V2, P1, DOI 10.1186/1752-1505-2-1; *UN CONC SCI, 2007, NEW SOLUT, V17, P7; 2007, GUARDIAN        0326	20	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2009	373	9672					1320	1322		10.1016/S0140-6736(09)60752-2	http://dx.doi.org/10.1016/S0140-6736(09)60752-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434UR	19376435				2022-12-28	WOS:000265300100009
J	Friedman, M				Friedman, Matt			Emerging onto a Tangled Bank	SCIENCE			English	Editorial Material							TETRAPOD; STYLE		[Friedman, Matt] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Friedman, Matt] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago)	Friedman, M (corresponding author), Univ Chicago, Comm Evolutionary Biol, 1025 E 57th St, Chicago, IL 60637 USA.	mattf@uchicago.edu						Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Callier V, 2009, SCIENCE, V324, P364, DOI 10.1126/science.1167542; Canoville A, 2009, ACTA ZOOL-STOCKHOLM, V90, P110, DOI 10.1111/j.1463-6395.2008.00328.x; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; Markey MJ, 2007, P NATL ACAD SCI USA, V104, P7134, DOI 10.1073/pnas.0701706104; Owen R., 1860, REPORT BRIT ASS ADV, V29, P153; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; VOROBYEVA E, 1992, FOSSIL FISHES LIVING	10	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	2009	324	5925					341	342		10.1126/science.1172783	http://dx.doi.org/10.1126/science.1172783			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372416				2022-12-28	WOS:000265221600025
J	Katz, DJ; Edwards, TM; Reinke, V; Kelly, WG				Katz, David J.; Edwards, T. Matthew; Reinke, Valerie; Kelly, William G.			A C. elegans LSD1 Demethylase Contributes to Germline Immortality by Reprogramming Epigenetic Memory	CELL			English	Article							CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MAMMALIAN DEVELOPMENT; CELL DEVELOPMENT; POLE CELLS; CHROMATIN; COMPLEX; LINEAGE; NANOS	Epigenetic information undergoes extensive reprogramming in the germline between generations. This reprogramming may be essential to establish a developmental ground state in the zygote. We show that mutants in spr-5, the Caenorhabditis elegans ortholog of the H3K4me2 demethylase LSD1/KDM1, exhibit progressive sterility over many generations. This sterility correlates with the misregulation of spermatogenesis-expressed genes and transgenerational accumulation of the histone modification dimethylation of histone H3 on lysine 4 (H3K4me2). This suggests that H3K4me2 can serve as a stable epigenetic memory, and that erasure of H3K4me2 by LSD/KDM1 in the germline prevents the inappropriate transmission of this epigenetic memory from one generation to the next. Thus, our results provide direct mechanistic insights into the processes that are required for epigenetic reprogramming between generations.	[Katz, David J.; Edwards, T. Matthew; Kelly, William G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Emory University; Yale University	Kelly, WG (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	bkelly@biology.emory.edu	Katz, David J/H-4555-2017	Katz, David J/0000-0002-3040-1142	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Baumeister for providing strains; A. Printz for help with data presentation; C. Bean, B. Lakowski, G. Reuter, T. Schedl, Y. Shi, and J. Waddle for helpful discussions on the work; T. Caspary, J. Lucchesi, and S. Tilghman for critical comments on the manuscript; and all of our laboratory members for assistance throughout. This work was supported by grants from the National Institutes of Health to D. J. K. and W. G. K.	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Katz DJ, 2005, MOL CELL BIOL, V25, P3855, DOI 10.1128/MCB.25.10.3855-3863.2005; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Koprunner M, 2001, GENE DEV, V15, P2877; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Nishikawa S, 2007, NAT BIOTECHNOL, V25, P877, DOI 10.1038/nbt0807-877; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Poux S, 2002, DEVELOPMENT, V129, P2483; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SZABAD J, 1988, MOL GEN GENET, V211, P56, DOI 10.1007/BF00338393; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TECHNAU GM, 1986, ROUX ARCH DEV BIOL, V195, P489, DOI 10.1007/BF00375889; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; UNDERWOOD EM, 1980, DEV BIOL, V77, P303, DOI 10.1016/0012-1606(80)90476-5; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3	44	228	246	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					308	320		10.1016/j.cell.2009.02.015	http://dx.doi.org/10.1016/j.cell.2009.02.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379696	Green Accepted, Bronze			2022-12-28	WOS:000265456800023
J	Bolhuis, JJ; Wynne, CDL				Bolhuis, Johan J.; Wynne, Clive D. L.			Can evolution explain how minds work?	NATURE			English	Editorial Material									[Bolhuis, Johan J.] Univ Utrecht, Dept Biol, NL-3508 TC Utrecht, Netherlands; [Wynne, Clive D. L.] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Bolhuis, Johan J.] Univ Utrecht, Helmholtz Inst, NL-3508 TC Utrecht, Netherlands	Utrecht University; State University System of Florida; University of Florida; Utrecht University	Bolhuis, JJ (corresponding author), Univ Utrecht, Dept Biol, NL-3508 TC Utrecht, Netherlands.	j.j.bolhuis@uu.nl; wynne@ufl.edu	Bolhuis, Johan J/B-9080-2011; Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378; Wynne, Clive/0000-0001-8408-1466				Bolhuis J., 2009, TINBERGENS LEGACY FU; Cosmides L., 1997, EVOLUTIONARY PSYCHOL; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; PINKER S, 1994, LANGUAGE INSTINCT MI; Richardson R. C., 2007, EVOLUTIONARY PSYCHOL; Wynne CDL, 2004, NATURE, V428, P140, DOI [10.1038/428140a, 10.1038/428140b]	6	68	70	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					832	833		10.1038/458832a	http://dx.doi.org/10.1038/458832a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	433CS	19370014				2022-12-28	WOS:000265182500022
J	Monecke, T; Guttler, T; Neumann, P; Dickmanns, A; Gorlich, D; Ficner, R				Monecke, Thomas; Guettler, Thomas; Neumann, Piotr; Dickmanns, Achim; Goerlich, Dirk; Ficner, Ralf			Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP	SCIENCE			English	Article							IMPORTIN-BETA; RIBOSOMAL-SUBUNITS; TRANSPORT; CYTOPLASM; BINDING; DOMAIN; ALPHA; IDENTIFICATION; RECOGNITION; PROTEINS	CRM1 mediates nuclear export of numerous unrelated cargoes, which may carry a short leucine-rich nuclear export signal or export signatures that include folded domains. How CRM1 recognizes such a variety of cargoes has been unknown up to this point. Here we present the crystal structure of the SPN1.CRM1.RanGTP export complex at 2.5 angstrom resolution (where SPN1 is snurportin1 and RanGTP is guanosine 5' triphosphate-bound Ran). SPN1 is a nuclear import adapter for cytoplasmically assembled, m(3)G-capped spliceosomal U snRNPs (small nuclear ribonucleoproteins). The structure shows how CRM1 can specifically return the cargo-free form of SPN1 to the cytoplasm. The extensive contact area includes five hydrophobic residues at the SPN1 amino terminus that dock into a hydrophobic cleft of CRM1, as well as numerous hydrophilic contacts of CRM1 to m3G cap-binding domain and carboxyl-terminal residues of SPN1. The structure suggests that RanGTP promotes cargo-binding to CRM1 solely through long-range conformational changes in the exportin.	[Guettler, Thomas; Goerlich, Dirk] Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany; [Monecke, Thomas; Neumann, Piotr; Dickmanns, Achim; Ficner, Ralf] Univ Gottingen, Abt Mol Strukturbiol, Inst Mikrobiol & Genet, GZMB, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Logist, Fassberg 11, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Güttler, Thomas/O-4851-2016; Görlich, Dirk/B-8296-2017	Güttler, Thomas/0000-0002-1456-7310; Görlich, Dirk/0000-0002-4343-5210	Deutsche Forschungsgemeinschaft [SFB523]; Max-Planck-Gesellschaft; Alfried Krupp-Foundation; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Gesellschaft(Max Planck Society); Alfried Krupp-Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank the staff of synchrotron beamlines at BESSY (Berlin), the European Molecular Biology Laboratory/Deutsches Elektronen-Synchrotron (Hamburg), and the European Synchotron Radiation Facility (Grenoble) for assistance during data collection; D. Deichsel for excellent technical help; and S. Frey and S. Guttler for comments on the manuscript. We received funding from the Deutsche Forschungsgemeinschaft (grant SFB523 to R.F. and T.M.), the Max-Planck-Gesellschaft (to D.G. and T.G.), the Alfried Krupp-Foundation (to D.G. and T.G.), and the Boehringer Ingelheim Fonds (to T.G.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession code 3GJX.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Moy TI, 2002, J CELL SCI, V115, P2985; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065	33	164	176	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1087	1091		10.1126/science.1173388	http://dx.doi.org/10.1126/science.1173388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19389996				2022-12-28	WOS:000266246700046
J	Avorn, J				Avorn, Jerry			Debate about Funding Comparative-Effectiveness Research.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Avorn, Jerry] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Avorn, Jerry] Harvard Interfac Initiat Medicat & Soc, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							GOTTLIEB S, 2009, WALL STREET J   0120; MCCAUGHEY B, 2009, RUIN YOUR HLTH OBAMA; Orszag PR, 2007, NEW ENGL J MED, V357, P1885, DOI 10.1056/NEJMp078191; WILL GF, 2009, WASH POST       0222, pA19; 2009, RUSH LIMBAUGH S 0209	5	61	62	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1927	1929		10.1056/NEJMp0902427	http://dx.doi.org/10.1056/NEJMp0902427			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441QN	19420361				2022-12-28	WOS:000265784400002
J	Bohlius, J; Schmidlin, K; Brillant, C; Schwarzer, G; Trelle, S; Seidenfeld, J; Zwahlen, M; Clarke, M; Weingart, O; Kluge, S; Piper, M; Rades, D; Steensma, DP; Djulbegovic, B; Fey, MF; Ray-Coquard, I; Machtay, M; Moebus, V; Thomas, G; Untch, M; Schumacher, M; Egger, M; Engert, A				Bohlius, Julia; Schmidlin, Kurt; Brillant, Corinne; Schwarzer, Guido; Trelle, Sven; Seidenfeld, Jerome; Zwahlen, Marcel; Clarke, Michael; Weingart, Olaf; Kluge, Sabine; Piper, Margaret; Rades, Dirk; Steensma, David P.; Djulbegovic, Benjamin; Fey, Martin F.; Ray-Coquard, Isabelle; Machtay, Mitchell; Moebus, Volker; Thomas, Gillian; Untch, Michael; Schumacher, Martin; Egger, Matthias; Engert, Andreas			Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials	LANCET			English	Article							QUALITY-OF-LIFE; PLATINUM-BASED CHEMOTHERAPY; CELL LUNG-CANCER; PLACEBO-CONTROLLED TRIAL; NON-HODGKINS-LYMPHOMA; WEEKLY EPOETIN-ALPHA; PHASE-III TRIAL; DOUBLE-BLIND; DARBEPOETIN-ALPHA; ANEMIC PATIENTS	Background Erythropoiesis-stimulating agents reduce anaemia in patients with cancer and could improve their quality of life, but these drugs might increase mortality. We therefore did a meta-analysis of randomised controlled trials in which these drugs plus red blood cell transfusions were compared with transfusion alone for prophylaxis or treatment of anaemia in patients with cancer. Methods Data for patients treated with epoetin alfa, epoetin beta, or darbepoetin alfa were obtained and analysed by independent statisticians using fixed-effects and random-effects meta-analysis. Analyses were by intention to treat. Primary endpoints were mortality during the active study period and overall survival during the longest available follow-up, irrespective of anticancer treatment, and in patients given chemotherapy. Tests for interactions were used to identify differences in effects of erythropoiesis-stimulating agents on mortality across prespecified subgroups. Findings Data from a total of 13 933 patients with cancer in 53 trials were analysed. 1530 patients died during the active study period and 4993 overall. Erythropoiesis-stimulating agents increased mortality during the active study period (combined hazard ratio [cHR] 1.17, 95% CI 1.06-1.30) and worsened overall survival (1.06, 1.00-1.12), with little heterogeneity between trials (I-2 0%, p=0.87 for mortality during the active study period, and I-2 7.1%, p=0.33 for overall survival). 10 441 patients on chemotherapy were enrolled in 38 trials. The cHR for mortality during the active study period was 1.10 (0.98-1.24), and 1.04 (0.97-1.11) for overall survival. There was little evidence for a difference between trials of patients given different anticancer treatments (p for interaction=0.42). Interpretation Treatment with erythropoiesis-stimulating agents in patients with cancer increased mortality during active study periods and worsened overall survival. The increased risk of death associated with treatment with these drugs should be balanced against their benefits.	[Brillant, Corinne; Weingart, Olaf; Kluge, Sabine; Engert, Andreas] Univ Hosp Cologne, Dept Internal Med 1, Cochrane Haematol Malignancies Grp, Cologne, Germany; [Bohlius, Julia; Schmidlin, Kurt; Trelle, Sven; Zwahlen, Marcel; Egger, Matthias] Univ Bern, ISPM, Bern, Switzerland; [Schwarzer, Guido; Schumacher, Martin] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, Freiburg, Germany; [Trelle, Sven; Zwahlen, Marcel] Univ Hosp Bern, Inselspital, CTU Bern, CH-3010 Bern, Switzerland; [Seidenfeld, Jerome] Amer Soc Clin Oncol, Dept Canc Policy & Clin Affairs, Alexandria, VA USA; [Clarke, Michael] Natl Inst Hlth Res, UK Cochrane Ctr, Oxford, England; [Clarke, Michael] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland; [Piper, Margaret] Technol Evaluat Ctr, Blue Cross & Blue Shield Assoc, Chicago, IL USA; [Rades, Dirk] Univ Hosp Lubeck, Dept Radiat Oncol, Lubeck, Germany; [Steensma, David P.] Mayo Clin, Div Hematol, Rochester, MN USA; [Djulbegovic, Benjamin] Univ S Florida, Clin Translat Sci Inst, Ctr Evidence Based Med & Hlth Outcome Res, Tampa, FL USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes Behav, Tampa, FL 33612 USA; [Fey, Martin F.] Univ Bern, Inst Med Oncol, Bern, Switzerland; [Fey, Martin F.] Univ Bern, Inselspital, CH-3010 Bern, Switzerland; [Ray-Coquard, Isabelle] Ctr Leon Berard, F-69373 Lyon, France; [Machtay, Mitchell] Thomas Jefferson Univ Hosp, Radiat Therapy Oncol Grp, Philadelphia, PA 19107 USA; [Moebus, Volker] Acad Hosp Frankfurt Main Hochst, Frankfurt, Germany; [Thomas, Gillian] Odette Sunnybrook Canc Ctr, Gynecol Oncol Grp US, Toronto, ON, Canada; [Untch, Michael] Helios Hosp Berlin Buch, Clin Gynaecol, Berlin, Germany	University of Cologne; University of Bern; University of Freiburg; University of Bern; University Hospital of Bern; American Society of Clinical Oncology; Cochrane Centre; Trinity College Dublin; University of Lubeck; Mayo Clinic; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Bern; University of Bern; UNICANCER; Centre Leon Berard; Jefferson University; Radiation Therapy Oncology Group (RTOG); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Engert, A (corresponding author), Univ Cologne, Dept Internal Med 1, D-50937 Cologne, Germany.	a.engert@uni-koeln.de	Trelle, Sven/D-3760-2009; Schwarzer, Guido/A-8168-2009; Zwahlen, Marcel/AFF-8559-2022; Djulbegovic, Benjamin/I-3661-2012	Trelle, Sven/0000-0002-8162-8910; Schwarzer, Guido/0000-0001-6214-9087; Zwahlen, Marcel/0000-0002-6772-6346; Djulbegovic, Benjamin/0000-0003-0671-1447; Steensma, David/0000-0001-5130-9284; Piper, Margaret/0000-0002-6231-9653; Schmidlin, Kurt/0000-0003-0486-4490; Egger, Matthias/0000-0001-7462-5132; Bohlius, Julia/0000-0003-1955-1585	German Federal Ministry of Education and Research [01KG0611]; Medical Faculty of University of Cologne, Cologne, Germany; Oncosuisse, Bern, Switzerland [OCS-02146-10-2007]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Medical Faculty of University of Cologne, Cologne, Germany; Oncosuisse, Bern, Switzerland	This project was funded by the German Federal Ministry of Education and Research (grant 01KG0611), Medical Faculty of University of Cologne, Cologne, Germany, and Oncosuisse, Bern, Switzerland (grant OCS-02146-10-2007). We thank Ina Monsef and Franke Naumann for help with literature searches and Nicole Skoetz for technical assistance; John Spivak and Pia Raanam for review of the protocol, and Stuart Pocock and Sue Richard for critical review of a previous version of this report; Jens Blohmer for providing unpublished study results; and the companies that contributed study data.	Aapro M, 2008, BRIT J CANCER, V99, P14, DOI 10.1038/sj.bjc.6604408; Aapro M, 2008, J CLIN ONCOL, V26, P592, DOI 10.1200/JCO.2007.11.5378; ABELS R, 1993, EUR J CANCER, V29A, pS2, DOI 10.1016/S0959-8049(05)80281-3; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Antonadou D., 2001, European Journal of Cancer, V37, pS144, DOI 10.1016/S0959-8049(01)81022-4; Arcasoy MO, 2008, CLIN CANCER RES, V14, P4685, DOI 10.1158/1078-0432.CCR-08-0264; Bamias A, 2003, ONCOLOGY-BASEL, V64, P102, DOI 10.1159/000067766; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Blohmer JU, 2004, ANN ONCOL, V15, P128; BOHLIUS J, 2008, COCHRANE DB SYST REV, V3; Bohlius J, 2006, JNCI-J NATL CANCER I, V98, P708, DOI 10.1093/jnci/djj189; Boogaerts M, 2003, BRIT J CANCER, V88, P988, DOI 10.1038/sj.bjc.6600801; Brower V, 2008, J NATL CANCER I, V100, P1344, DOI 10.1093/jnci/djn358; CASCINU S, 1994, J CLIN ONCOL, V12, P1058, DOI 10.1200/JCO.1994.12.5.1058; CASE DC, 1993, J NATL CANCER I, V85, P801, DOI 10.1093/jnci/85.10.801; CAZZOLA M, 1995, BLOOD, V86, P4446, DOI 10.1182/blood.V86.12.4446.bloodjournal86124446; Chang J, 2005, J CLIN ONCOL, V23, P2597, DOI 10.1200/JCO.2004.12.027; Charu V, 2007, ONCOLOGIST, V12, P727, DOI 10.1634/theoncologist.12-6-727; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Dammacco F, 2001, BRIT J HAEMATOL, V113, P172, DOI 10.1046/j.1365-2141.2001.02715.x; DEBUS J, 2006, GERMAN MED SCI; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH, P3; Fisher JW, 2003, EXP BIOL MED, V228, P1; GLASPY J, 2007, EUR J CANC S4, V5; Gordon DH, 2006, BLOOD, V108, p382A; Goss G, 2005, LUNG CANCER-J IASLC, V49, pS53, DOI 10.1016/S0169-5002(05)80288-0; Gregory SA, 2004, BLOOD, V104, p900A, DOI 10.1182/blood.V104.11.3296.3296; Grote T, 2005, J CLIN ONCOL, V23, P9377, DOI 10.1200/JCO.2005.01.8507; Hedenus M, 2003, BRIT J HAEMATOL, V122, P394, DOI 10.1046/j.1365-2141.2003.04448.x; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Henry D H, 1995, Cancer J Sci Am, V1, P252; Horwich A, 2002, ANN ONCOL, V13, P83, DOI 10.1093/annonc/mdf643; Huinink WWT, 1998, MED ONCOL, V15, P174, DOI 10.1007/BF02821936; Iconomou G, 2003, J PAIN SYMPTOM MANAG, V25, P512, DOI 10.1016/S0885-3924(03)00070-8; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Janinis J, 2003, P AM SOC CLIN ONCOLO, V22, P789; Kotasek D, 2003, EUR J CANCER, V39, P2026, DOI 10.1016/S0959-8049(03)00456-8; KOTASEK D, 2002, P AM SOC CLIN ONCOL, V21; Leyland-Jones B, 2003, LANCET ONCOL, V4, P459, DOI 10.1016/S1470-2045(03)01163-X; LEYLANDJONES B, 2005, J CLIN ONCOL, V23, P5865; Littlewood TJ, 2001, J CLIN ONCOL, V19, P2865, DOI 10.1200/JCO.2001.19.11.2865; LUKSENBURG H, 2004, LP TREATMENT ANEMIA; Machtay M, 2007, INT J RADIAT ONCOL, V69, P1008, DOI 10.1016/j.ijrobp.2007.04.063; Milroy R, 2003, LUNG CANCER, V41, pS74; Minton O, 2008, JNCI-J NATL CANCER I, V100, P1155, DOI 10.1093/jnci/djn250; Moebus V, 2007, J CLIN ONCOL, V25; Mystakidou K, 2005, ANTICANCER RES, V25, P3495; O'Shaughnessy Joyce A, 2005, Clin Breast Cancer, V5, P439, DOI 10.3816/CBC.2005.n.002; Oberhoff C, 1998, ANN ONCOL, V9, P255, DOI 10.1023/A:1008296622469; Osterborg A, 2002, J CLIN ONCOL, V20, P2486, DOI 10.1200/JCO.2002.10.101; Osterborg A, 1996, BLOOD, V87, P2675, DOI 10.1182/blood.V87.7.2675.bloodjournal8772675; Overgaard J, 2007, EJC SUPPL, V5; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Pirker R, 2008, J CLIN ONCOL, V26, P2342, DOI 10.1200/JCO.2007.15.0748; Pronzato P, 2002, ANN ONCOL, V13, P168; QUIRT I, 1996, BLOOD S, V88, P347; Ray-Coquard II, 2006, ANN ONCOL, V17, P294; Razzouk BI, 2006, J CLIN ONCOL, V24, P3583, DOI 10.1200/JCO.2005.03.4371; ROSE E, 1994, BLOOD, V84, pA526; Savonije JH, 2005, EUR J CANCER, V41, P1560, DOI 10.1016/j.ejca.2005.03.024; Seidenfeld J, 2001, J NATL CANCER I, V93, P1204, DOI 10.1093/jnci/93.16.1204; Seidenfeld J, 2006, COMP EFFECTIVENESS E; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Sinclair AM, 2008, BRIT J CANCER, V98, P1059, DOI 10.1038/sj.bjc.6604220; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Smith RE, 2008, J CLIN ONCOL, V26, P1040, DOI 10.1200/JCO.2007.14.2885; Stohlawetz PJ, 2000, BLOOD, V95, P2983, DOI 10.1182/blood.V95.9.2983.009k27_2983_2989; Strauss HG, 2008, INT J GYNECOL CANCER, V18, P515, DOI 10.1111/j.1525-1438.2007.01032.x; Taylor K, 2005, BLOOD, V106, p992A; Thatcher N, 1999, BRIT J CANCER, V80, P396, DOI 10.1038/sj.bjc.6990369; Thomas G, 2008, GYNECOL ONCOL, V108, P317, DOI 10.1016/j.ygyno.2007.10.011; Thomas H, 2002, ANN ONCOL, V13, P177; Untch M, 2008, J CLIN ONCOL, V26; Vansteenkiste J, 2002, J NATL CANCER I, V94, P1211; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2002, STRAHLENTHER ONKOL, V178, P727, DOI 10.1007/s00066-002-1081-x; Vaziri ND, 1999, AM J KIDNEY DIS, V33, P821, DOI 10.1016/S0272-6386(99)70413-0; Watanbabe M, 2006, ANN ONCOL, V17, P294; Wilkinson PM, 2006, BRIT J CANCER, V94, P947, DOI 10.1038/sj.bjc.6603004; Wilson J, 2007, HEALTH TECHNOL ASSES, V11, P1; Witzig TE, 2005, J CLIN ONCOL, V23, P2606, DOI 10.1200/JCO.2004.10.020; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514; Wun T, 2003, CANCER-AM CANCER SOC, V98, P1514, DOI 10.1002/cncr.11700; Zajda K, 2007, J CLIN ONCOL, V25	88	423	450	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1532	1542		10.1016/S0140-6736(09)60502-X	http://dx.doi.org/10.1016/S0140-6736(09)60502-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440OT	19410717				2022-12-28	WOS:000265710300032
J	Solberg, KE				Solberg, Kristin Elisabeth			Health issues sidelined in India's general election	LANCET			English	News Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 2	2009	373	9674					1509	1511		10.1016/S0140-6736(09)60839-4	http://dx.doi.org/10.1016/S0140-6736(09)60839-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19418610	Bronze			2022-12-28	WOS:000265710300010
J	Saunders, J				Saunders, John			A Glassy State of Supersolid Helium	SCIENCE			English	Editorial Material							BOSE-EINSTEIN CONDENSATION; QUANTUM CRYSTALS; SOLID HELIUM; SUPERFLUID		Univ London, Dept Phys, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Saunders, J (corresponding author), Univ London, Dept Phys, Egham TW20 0EX, Surrey, England.	j.saunders@rhul.ac.uk						Anderson PW, 2007, NAT PHYS, V3, P160, DOI 10.1038/nphys539; Anderson PW, 2009, SCIENCE, V324, P631, DOI 10.1126/science.1169456; ANDERSON PW, 1966, REV MOD PHYS, V38, P298, DOI 10.1103/RevModPhys.38.298; Andreev AF, 2007, JETP LETT+, V85, P585, DOI 10.1134/S0021364007110124; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Aoki Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.215303; Balibar S, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/17/173201; Biroli G, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.224306; Boninsegni M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105301; Ceperley DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.155303; Chan MHW, 2008, SCIENCE, V319, P1207, DOI 10.1126/science.1155302; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; Day J, 2007, NATURE, V450, P853, DOI 10.1038/nature06383; Galli DE, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.111010; GUYER RA, 1971, REV MOD PHYS, V43, P532, DOI 10.1103/RevModPhys.43.532; Hunt B, 2009, SCIENCE, V324, P632, DOI 10.1126/science.1169512; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; Phillips P, 2007, SCIENCE, V316, P1435, DOI 10.1126/science.1143866; Pollet L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.097202; Prokof'ev N, 2007, ADV PHYS, V56, P381, DOI 10.1080/00018730601183025; REATTO L, 1969, PHYS REV, V183, P334, DOI 10.1103/PhysRev.183.334	22	12	12	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					601	602		10.1126/science.1172973	http://dx.doi.org/10.1126/science.1172973			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407190				2022-12-28	WOS:000265608800030
J	Slavin, JA; Acuna, MH; Anderson, BJ; Baker, DN; Benna, M; Boardsen, SA; Gloeckler, G; Gold, RE; Ho, GC; Korth, H; Krimigis, SM; McNutt, RL; Raines, JM; Sarantos, M; Schriver, D; Solomon, SC; Travnicek, P; Zurbuchen, TH				Slavin, James A.; Acuna, Mario H.; Anderson, Brian J.; Baker, Daniel N.; Benna, Mehdi; Boardsen, Scott A.; Gloeckler, George; Gold, Robert E.; Ho, George C.; Korth, Haje; Krimigis, Stamatios M.; McNutt, Ralph L., Jr.; Raines, Jim M.; Sarantos, Menelaos; Schriver, David; Solomon, Sean C.; Travnicek, Pavel; Zurbuchen, Thomas H.			MESSENGER Observations of Magnetic Reconnection in Mercury's Magnetosphere	SCIENCE			English	Article							GEOTAIL OBSERVATIONS; EARTHS MAGNETOPAUSE; FLUX-TRANSFER; 1ST FLYBY; FIELD; SUBSTORMS; MAGNETOTAIL; TAIL	Solar wind energy transfer to planetary magnetospheres and ionospheres is controlled by magnetic reconnection, a process that determines the degree of connectivity between the interplanetary magnetic field (IMF) and a planet's magnetic field. During MESSENGER's second flyby of Mercury, a steady southward IMF was observed and the magnetopause was threaded by a strong magnetic field, indicating a reconnection rate similar to 10 times that typical at Earth. Moreover, a large flux transfer event was observed in the magnetosheath, and a plasmoid and multiple traveling compression regions were observed in Mercury's magnetotail, all products of reconnection. These observations indicate that Mercury's magnetosphere is much more responsive to IMF direction and dominated by the effects of reconnection than that of Earth or the other magnetized planets.	[Slavin, James A.; Boardsen, Scott A.; Sarantos, Menelaos] NASA, Goddard Space Flight Ctr, Heliophys Sci Div, Greenbelt, MD 20771 USA; [Acuna, Mario H.; Benna, Mehdi] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Anderson, Brian J.; Gold, Robert E.; Ho, George C.; Korth, Haje; Krimigis, Stamatios M.; McNutt, Ralph L., Jr.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Baker, Daniel N.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Benna, Mehdi; Boardsen, Scott A.] Univ Maryland Baltimore Cty, Goddard Earth Sci & Technol Ctr, Baltimore, MD 21228 USA; [Gloeckler, George; Raines, Jim M.; Zurbuchen, Thomas H.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Gloeckler, George] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Krimigis, Stamatios M.] Acad Athens, Athens 11527, Greece; [Schriver, David; Travnicek, Pavel] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Travnicek, Pavel] Acad Sci Czech Republic, Inst Astron, Prague 14131, Czech Republic	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; Academy of Athens; University of California System; University of California Los Angeles; Carnegie Institution for Science; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences	Slavin, JA (corresponding author), NASA, Goddard Space Flight Ctr, Heliophys Sci Div, Greenbelt, MD 20771 USA.	james.a.slavin@nasa.gov	Benna, Mehdi/F-3489-2012; Ho, George/GMW-9642-2022; Sarantos, Menelaos/O-6644-2019; Raines, Jim M./O-5649-2016; Travnicek, Pavel/G-8608-2014; Ho, George/G-3650-2015; Slavin, James A/H-3170-2012; McNutt, Ralph L/E-8006-2010; Korth, Haje/C-3182-2016; Anderson, Brian J/I-8615-2012; Sarantos, Menelaos/H-8136-2013; Krimigis, Stamatios/G-4591-2019	Ho, George/0000-0003-1093-2066; Sarantos, Menelaos/0000-0003-0728-2971; Ho, George/0000-0003-1093-2066; Slavin, James A/0000-0002-9206-724X; McNutt, Ralph L/0000-0002-4722-9166; Korth, Haje/0000-0001-7394-7439; Krimigis, Stamatios/0000-0003-2781-2386	NASA Discovery Program [NAS5-97271]; Johns Hopkins University Applied Physics Laboratory; Carnegie Institution of Washington [NASW-00002]	NASA Discovery Program(National Aeronautics & Space Administration (NASA)); Johns Hopkins University Applied Physics Laboratory(Johns Hopkins University); Carnegie Institution of Washington	We deeply mourn the loss of our colleague and MESSENGER Co-Investigator Mario Acuna during the preparation of this manuscript; his many contributions to the MESSENGER mission and the space science community live on. We also thank all who contributed to the success of the first and second MESSENGER flybys of Mercury. Data visualization and graphics support by J. Feggans, C. Liebrecht, and M. Marosy are gratefully acknowledged. The MESSENGER project is supported by the NASA Discovery Program under contracts NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington.	Anderson BJ, 2008, SCIENCE, V321, P82, DOI 10.1126/science.1159081; Anderson BJ, 2007, SPACE SCI REV, V131, P417, DOI 10.1007/s11214-007-9246-7; Badman SV, 2007, ANN GEOPHYS-GERMANY, V25, P941, DOI 10.5194/angeo-25-941-2007; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; Baumjohann W, 2006, ADV SPACE RES, V38, P604, DOI 10.1016/j.asr.2005.05.117; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Fujimoto M, 2007, SPACE SCI REV, V132, P529, DOI 10.1007/s11214-007-9245-8; GOLD RE, 2008, EOS S, V89; HONES EW, 1984, GEOPHYS RES LETT, V11, P5, DOI 10.1029/GL011i001p00005; Ieda A, 1998, J GEOPHYS RES-SPACE, V103, P4453, DOI 10.1029/97JA03240; Jackman CM, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013592; Kidder A, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013038; Kronberg EA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013332; KUZNETSOVA MM, 1986, P JOINT VAR AB INT S, P137; LEE LC, 1985, GEOPHYS RES LETT, V12, P105, DOI 10.1029/GL012i002p00105; Nagai T, 2000, ADV SPACE RES, V25, P1651, DOI 10.1016/S0273-1177(99)00680-8; Orsini S, 2007, SPACE SCI REV, V132, P551, DOI 10.1007/s11214-007-9222-2; RUSSELL CT, 1978, SPACE SCI REV, V22, P681, DOI 10.1007/BF00212619; RUSSELL CT, 1985, J GEOPHYS RES-SPACE, V90, P1067, DOI 10.1029/JA090iA11p11067; Russell CT, 1998, SCIENCE, V280, P1061, DOI 10.1126/science.280.5366.1061; RUSSELL CT, 1968, MERCURY, P514; SISCOE GL, 1975, J GEOPHYS RES-SPACE, V80, P4359, DOI 10.1029/JA080i031p04359; Slavin JA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009557; SLAVIN JA, 1984, GEOPHYS RES LETT, V11, P657, DOI 10.1029/GL011i007p00657; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; SONNERUP BUO, 1981, J GEOPHYS RES-SPACE, V86, P49, DOI 10.1029/JA086iA12p10049	26	198	199	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					606	610		10.1126/science.1172011	http://dx.doi.org/10.1126/science.1172011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407194				2022-12-28	WOS:000265608800034
J	Schatz, M; Dombrowski, MP				Schatz, Michael; Dombrowski, Mitchell P.			Asthma in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTING BETA-AGONISTS; INHALED CORTICOSTEROIDS; CONGENITAL-MALFORMATIONS; MATERNAL ASTHMA; MEDICATION USE; PERINATAL OUTCOMES; RISK; WOMEN; SAFETY; EXACERBATIONS	A 23-year-old nonsmoking woman (gravida 1, para 0) presents at 11 weeks' gestation with an 8-year history of asthma, which has worsened over the past year. She reports asthma symptoms requiring albuterol two or three times per day and interfering with sleep two or three nights per week. A corticosteroid inhaler was prescribed before pregnancy, but she has been afraid to use it. Cleaning her house triggers asthma, and she has had a cat at home for 1 year. Her forced expiratory volume in 1 second (FEV1) is 75% of the predicted value; it increases to 88% of the predicted value after administration of albuterol. How should her case be managed?	[Schatz, Michael] Kaiser Permanente Med Ctr, Dept Allergy, San Diego, CA 92111 USA; [Dombrowski, Mitchell P.] St Johns Hosp, Dept Obstet & Gynecol, Detroit, MI USA; [Dombrowski, Mitchell P.] Wayne State Univ, Med Ctr, Detroit, MI 48202 USA	Kaiser Permanente; Detroit Medical Center; Wayne State University	Schatz, M (corresponding author), Kaiser Permanente Med Ctr, Dept Allergy, 7060 Clairemont Mesa Blvd, San Diego, CA 92111 USA.	michael.x.schatz@kp.org			Aerocrine; Genentech; GlaxoSmithKline; Merck	Aerocrine; Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company)	Dr. Schatz reports receiving consulting fees from GlaxoSmithKline and grant support from Aerocrine, Genentech, GlaxoSmithKline, and Merck. No other potential conflict of interest relevant to this article was reported.	BAHNA SL, 1972, ACTA ALLERGOL, V27, P397, DOI 10.1111/j.1398-9995.1972.tb01439.x; Bakhireva LN, 2005, J ALLERGY CLIN IMMUN, V116, P503, DOI 10.1016/j.jaci.2005.05.027; Bakhireva LN, 2008, ANN ALLERG ASTHMA IM, V101, P137, DOI 10.1016/S1081-1206(10)60201-3; Bakhireva LN, 2007, J ALLERGY CLIN IMMUN, V119, P618, DOI 10.1016/j.jaci.2006.12.618; BERTRAND JM, 1985, NEW ENGL J MED, V312, P742, DOI 10.1056/NEJM198503213121202; Blais L, 2008, J ALLERGY CLIN IMMUN, V121, P1379, DOI 10.1016/j.jaci.2008.02.038; Bracken MB, 2003, OBSTET GYNECOL, V102, P739, DOI 10.1016/S0029-7844(03)00621-5; Breton MC, 2009, THORAX, V64, P101, DOI 10.1136/thx.2008.102970; Chambers Karen, 2003, Case Manager, V14, P58, DOI 10.1016/j.casemgr.2003.09.003; Demissie K, 1998, AM J RESP CRIT CARE, V158, P1091, DOI 10.1164/ajrccm.158.4.9802053; Dombrowski MP, 2004, OBSTET GYNECOL, V103, P5, DOI 10.1097/01.AOG.0000103994.75162.16; Dombrowski MP, 2004, AM J OBSTET GYNECOL, V190, P737, DOI 10.1016/j.ajog.2003.09.071; Enriquez R, 2007, J ALLERGY CLIN IMMUN, V120, P625, DOI 10.1016/j.jaci.2007.05.044; Enriquez R, 2006, AM J OBSTET GYNECOL, V195, P149, DOI 10.1016/j.ajog.2006.01.065; Gluck JC, 2006, IMMUNOL ALLERGY CLIN, V26, P63, DOI 10.1016/j.iac.2005.10.008; HAGERDAL M, 1983, ANESTHESIOLOGY, V59, P425; Hendler I, 2006, OBSTET GYNECOL, V108, P77, DOI 10.1097/01.AOG.0000223180.53113.0f; Jaeschke R, 2008, AM J RESP CRIT CARE, V178, P1009, DOI 10.1164/rccm.200804-494OC; Kallen B, 2000, EUR J EPIDEMIOL, V16, P167, DOI 10.1023/A:1007678404911; Kallen B, 1999, OBSTET GYNECOL, V93, P392, DOI 10.1016/S0029-7844(98)00454-2; Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P383, DOI 10.1007/s00228-006-0259-z; Kwon HL, 2006, IMMUNOL ALLERGY CLIN, V26, P29, DOI 10.1016/j.iac.2005.11.002; Lin S, 2008, AM J EPIDEMIOL, V168, P73, DOI 10.1093/aje/kwn098; Liu SL, 2001, AM J OBSTET GYNECOL, V184, P90, DOI 10.1067/mob.2001.108073; Martel MJ, 2007, J ALLERGY CLIN IMMUN, V119, P576, DOI 10.1016/j.jaci.2006.10.034; Martel MJ, 2005, BMJ-BRIT MED J, V330, P230, DOI 10.1136/bmj.38313.624352.8F; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Murphy VE, 2005, OBSTET GYNECOL, V106, P1046, DOI 10.1097/01.AOG.0000185281.21716.02; *NAEPP EXP PAN REP, 2005, J ALLERGY CLIN IMMUN, V115, P477; *NAEPP EXP PAN REP, 2004, J ALLERGY CLIN IMMUN, V115, P34; *NAT ASTHM ED PROR, 1993, NIH PUBL; National Asthma Education and Prevention Program, 2007, EXP PAN REP 3 GUID D; Nelson HS, 2009, ANN ALLERG ASTHMA IM, V102, P11, DOI 10.1016/S1081-1206(10)60101-9; Norjavaara E, 2003, J ALLERGY CLIN IMMUN, V111, P736, DOI 10.1067/mai.2003.1340; RIEDEL F, 1989, J PERINAT MED, V17, P151, DOI 10.1515/jpme.1989.17.2.151; Schatz M, 2006, AM J OBSTET GYNECOL, V194, P120, DOI 10.1016/j.ajog.2005.06.028; SCHATZ M, 1990, CHEST, V98, P389, DOI 10.1378/chest.98.2.389; Schatz M, 2004, J ALLERGY CLIN IMMUN, V113, P1040, DOI 10.1016/j.jaci.2004.03.017; SCHATZ M, 1995, AM J RESP CRIT CARE, V151, P1170; Schatz M, 2003, J ALLERGY CLIN IMMUN, V112, P283, DOI 10.1067/mai.2003.1516; Schatz M, 1997, J ALLERGY CLIN IMMUN, V100, P301, DOI 10.1016/S0091-6749(97)70241-0; Siddiqui S, 2008, BJOG-INT J OBSTET GY, V115, P520, DOI 10.1111/j.1471-0528.2007.01623.x; SteniusAarniala BSM, 1996, THORAX, V51, P411, DOI 10.1136/thx.51.4.411; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Tamasi L, 2006, J ASTHMA, V43, P81, DOI 10.1080/02770900500448803; Towers CV, 2004, AM J OBSTET GYNECOL, V190, P1777, DOI 10.1016/j.ajog.2004.02.056; Wen SW, 2001, ANN EPIDEMIOL, V11, P7, DOI 10.1016/S1047-2797(00)00077-6; Wendel PJ, 1996, AM J OBSTET GYNECOL, V175, P150, DOI 10.1016/S0002-9378(96)70265-X; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028; Yang J, 2008, AM J EPIDEMIOL, V167, P145, DOI 10.1093/aje/kwm283; 2008, OBSTET GYNECOL, V111, P457	51	52	53	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1862	1869		10.1056/NEJMcp0809942	http://dx.doi.org/10.1056/NEJMcp0809942			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403904				2022-12-28	WOS:000265560300008
J	Sun, JL; Bonneau, C; Cantin, A; Corma, A; Diaz-Cabanas, MJ; Moliner, M; Zhang, DL; Li, MR; Zou, XD				Sun, Junliang; Bonneau, Charlotte; Cantin, Angel; Corma, Avelino; Diaz-Cabanas, Maria J.; Moliner, Manuel; Zhang, Daliang; Li, Mingrun; Zou, Xiaodong			The ITQ-37 mesoporous chiral zeolite	NATURE			English	Article							POWDER DIFFRACTION DATA; CRYSTAL-STRUCTURES; RATIONAL DESIGN; CATALYST; COMPUTER; PROGRAM; PORES; NETS	The synthesis of crystalline molecular sieves with pore dimensions that fill the gap between microporous and mesoporous materials is a matter of fundamental and industrial interest(1-3). The preparation of zeolitic materials with extralarge pores and chiral frameworks would permit many new applications. Two important steps in this direction include the synthesis(4) of ITQ-33, a stable zeolite with 18 x 10 x 10 ring windows, and the synthesis(5) of SU-32, which has an intrinsically chiral zeolite structure and where each crystal exhibits only one handedness. Here we present a germanosilicate zeolite (ITQ-37) with extralarge 30-ring windows. Its structure was determined by combining selected area electron diffraction ( SAED) and powder X-ray diffraction (PXRD) in a charge-flipping algorithm(6). The framework follows the SrSi2 (srs) minimal net(7) and forms two unique cavities, each of which is connected to three other cavities to form a gyroidal channel system. These cavities comprise the enantiomorphous srs net of the framework. ITQ-37 is the first chiral zeolite with one single gyroidal channel. It has the lowest framework density (10.3 T atoms per 1,000 angstrom(3)) of all existing 4-coordinated crystalline oxide frameworks, and the pore volume of the corresponding silica polymorph would be 0.38 cm(3) g(-1).	[Cantin, Angel; Corma, Avelino; Diaz-Cabanas, Maria J.; Moliner, Manuel] Univ Politecn Valencia, CSIC, Inst Tecnol Quim, E-46022 Valencia, Spain; [Sun, Junliang; Bonneau, Charlotte; Zhang, Daliang; Li, Mingrun; Zou, Xiaodong] Stockholm Univ, EXSELENT Porous Mat, Struct Chem & Berzelii Ctr, SE-10691 Stockholm, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Stockholm University	Cantin, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Naranjos S-N, E-46022 Valencia, Spain.	acorma@itq.upv.es; zou@struc.su.se	Zhang, Daliang/B-3358-2018; MOLINER, MANUEL/D-4404-2013; CANOS, AVELINO CORMA/A-3040-2013; Cantin, Angel/I-4282-2015	Zhang, Daliang/0000-0003-3494-7000; MOLINER, MANUEL/0000-0002-5440-716X; CANOS, AVELINO CORMA/0000-0002-2232-3527; Cantin, Angel/0000-0002-3219-1919	CICYT [MAT 2006-14274-C02-01]; Swedish Research Council; Swedish Governmental Agency for Innovation Systems (VINNOVA); Carl-Trygger and Wenner-Gren foundations	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); Carl-Trygger and Wenner-Gren foundations	This project is supported by the CICYT ( Project MAT 2006-14274-C02-01 and Prometeo 2008 GV), the Swedish Research Council (VR) and the Swedish Governmental Agency for Innovation Systems (VINNOVA). J.S. and C. B. are supported by post-doctoral grants from the Carl-Trygger and Wenner-Gren foundations respectively. M. M. thanks ITQ for a scholarship.	Baerlocher C, 2008, NAT MATER, V7, P631, DOI 10.1038/nmat2228; Baerlocher C, 2007, Z KRISTALLOGR, V222, P47, DOI 10.1524/zkri.2007.222.2.47; Baerlocher C, 2007, SCIENCE, V315, P1113, DOI 10.1126/science.1137920; Blatov V. A., 2006, IUCR COMPCOMM NEWSLE, V7, P4, DOI DOI 10.1039/B807165A; Cantin A, 2006, J AM CHEM SOC, V128, P4216, DOI 10.1021/ja0603599; Climent MJ, 2004, APPL CATAL A-GEN, V263, P155, DOI 10.1016/j.apcata.2003.12.007; Climent MJ, 2002, GREEN CHEM, V4, P565, DOI 10.1039/b207506g; Climent MJ, 2000, J CATAL, V196, P345, DOI 10.1006/jcat.2000.3044; Corma A, 2003, J CATAL, V216, P298, DOI 10.1016/S0021-9517(02)00132-X; Corma A, 2006, NATURE, V443, P842, DOI 10.1038/nature05238; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Delgado-Friedrichs O, 2003, ACTA CRYSTALLOGR A, V59, P351, DOI 10.1107/S0108767303012017; Delgado-Friedrichs O, 2003, THEOR COMPUT SCI, V303, P431, DOI 10.1016/S0304-3975(02)00500-5; Ferey G, 2001, SCIENCE, V291, P994, DOI 10.1126/science.1059200; Friedrichs OD, 2003, ACTA CRYSTALLOGR A, V59, P22, DOI 10.1107/S0108767302018494; Gier TE, 1998, NATURE, V395, P154, DOI 10.1038/25960; Gramm F, 2006, NATURE, V444, P79, DOI 10.1038/nature05200; Grosse-Kunstleve RW, 1997, J APPL CRYSTALLOGR, V30, P985, DOI 10.1107/S0021889897005013; HOVMOLLER S, 1992, ULTRAMICROSCOPY, V41, P121, DOI 10.1016/0304-3991(92)90102-P; O'Keeffe M, 2008, ACCOUNTS CHEM RES, V41, P1782, DOI 10.1021/ar800124u; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; Schroeder-Turk GE, 2006, EUR PHYS J B, V54, P509, DOI 10.1140/epjb/e2007-00025-7; Tang LQ, 2008, NAT MATER, V7, P381, DOI 10.1038/nmat2169; Taylor WH, 1930, Z KRISTALLOGR, V74, P1; Young R.A., 1993, RIETVELD METHOD; Zou XD, 2005, NATURE, V437, P716, DOI 10.1038/nature04097; ZOU XD, 1993, ULTRAMICROSCOPY, V52, P436, DOI 10.1016/0304-3991(93)90058-6	27	438	448	13	432	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1154	U90		10.1038/nature07957	http://dx.doi.org/10.1038/nature07957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407798	Green Published			2022-12-28	WOS:000265754600044
J	Sharma, G; Fletcher, KE; Zhang, D; Kuo, YF; Freeman, JL; Goodwin, JS				Sharma, Gulshan; Fletcher, Kathlyn E.; Zhang, Dong; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.			Continuity of Outpatient and Inpatient Care by Primary Care Physicians for Hospitalized Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROVIDER CONTINUITY; UNITED-STATES; INFORMATION-TECHNOLOGY; PATIENT RELATIONSHIP; PREVENTIVE SERVICES; FAMILY PHYSICIANS; HEALTH-CARE; CLAIMS DATA; QUALITY; CANCER	Context Little is known about the extent of continuity of care across the transition from outpatient care to hospitalization. Objectives To describe continuity of care in older hospitalized patients, change in continuity over time, and factors associated with discontinuity. Design, Setting, and Participants A retrospective cohort study of 3 020 770 hospital admissions between 1996 and 2006 using enrollment and claims data for a 5% national sample of Medicare beneficiaries older than 66 years. Data files were constructed to include the patients' demographic and enrollment information (denominator file) and claims for hospital stays (MEDPAR file) and physician services (carrier claims file). Characteristics of the hospitals were included in annual provider of services files. Being seen by a physician was defined as when a physician had submitted a bill for evaluation and management services for that patient. Main Outcome Measures Percentage of patients who during hospitalization were seen by any outpatient physician they had visited in the year before hospitalization ( continuity with any outpatient physician) or by their primary care physician (PCP) (continuity with a PCP). Results In 1996, 50.5% (95% confidence interval [CI], 50.3%-50.7%) of hospitalized patients were seen by at least 1 physician that they had visited in an outpatient setting in the prior year, and 44.3% (95% CI, 44.1%-44.6%) of patients with an identifiable PCP were seen by that physician while hospitalized. These percentages decreased to 39.8% ( 95% CI, 39.6%-40.0%) and 31.9% (95% CI, 31.6%-32.1%), respectively, in 2006. Greater absolute decreases in continuity with any outpatient physician between 1996 and 2006 occurred in patients admitted on weekends (13.9%; 95% CI, 12.9%-14.7%) and those living in large metropolitan areas (11.7%; 95% CI, 11.1%12.3%) and in New England (16.2%; 95% CI, 14.4%-18.0%). In multivariable multilevel models, increasing involvement of hospitalists was associated with approximately one-third of the decrease in continuity of care between 1996 and 2006. Conclusion Between 1996 and 2006, physician continuity from outpatient to inpatient settings decreased in the Medicare population.	[Sharma, Gulshan; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Sharma, Gulshan; Zhang, Dong; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA; [Fletcher, Kathlyn E.] Med Coll Wisconsin, Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Fletcher, Kathlyn E.] Med Coll Wisconsin, Dept Gen Internal Med, Milwaukee, WI 53226 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Medical College of Wisconsin; Medical College of Wisconsin	Sharma, G (corresponding author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd,JSA 5-112, Galveston, TX 77555 USA.	gulshan.sharma@utmb.edu			National Cancer Institute [P50 CA 105631]; National Institute on Aging [K-08 AG 031583, P60 AG 17231]; NATIONAL CANCER INSTITUTE [K05CA134923, P50CA105631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG017231, K08AG031583, P30AG024832] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant P50 CA 105631 from the National Cancer Institute and grants K-08 AG 031583 and P60 AG 17231 from the National Institute on Aging.	Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Arora V, 2009, ARCH INTERN MED, V169, P199, DOI 10.1001/archinternmed.2008.565; Atlas SJ, 2006, J GEN INTERN MED, V21, P973, DOI 10.1007/BF02743147; Atlas SJ, 2009, ANN INTERN MED, V150, P325, DOI 10.7326/0003-4819-150-5-200903030-00008; Bach PB, 2002, MED CARE, V40, P19; Baldwin LM, 2002, MED CARE, V40, P82; Bates DW, 2005, HEALTH AFFAIR, V24, P1180, DOI 10.1377/hlthaff.24.5.1180; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BRESLAU N, 1976, J HEALTH SOC BEHAV, V17, P339, DOI 10.2307/2136712; Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; Burge Frederick, 2003, J Palliat Med, V6, P911, DOI 10.1089/109662103322654794; Christakis DA, 2001, PEDIATRICS, V107, P524, DOI 10.1542/peds.107.3.524; Citro R, 1997, IEEE Trans Inf Technol Biomed, V1, P189, DOI 10.1109/4233.654862; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; *COMM FUT PRIM CAR, 1996, PRIM CAR AM HLTH NEW; *CTR MED MED SERV, NON DAT FIL PROV SER; *CTR MED MED SERV, STAND AN FIL; EJLERTSSON G, 1984, MED CARE, V22, P231, DOI 10.1097/00005650-198403000-00006; Ettner SL, 1999, MED CARE, V37, P547, DOI 10.1097/00005650-199906000-00004; Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748; Finison K S, 1999, Eff Clin Pract, V2, P120; Freese RB, 1999, ANN INTERN MED, V130, P350, DOI 10.7326/0003-4819-130-4-199902161-00004; Gallagher TC, 2001, MED CARE, V39, P1086, DOI 10.1097/00005650-200110000-00006; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Kerse N, 2004, ANN FAM MED, V2, P455, DOI 10.1370/afm.139; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Lambrew JM, 1996, MED CARE, V34, P138, DOI 10.1097/00005650-199602000-00006; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Love MM, 2000, J FAM PRACTICE, V49, P998; Mainous AG, 2001, FAM MED, V33, P22; Mainous AG, 2004, ANN FAM MED, V2, P452, DOI 10.1370/afm.84; Mainous AG, 2004, FAM MED, V36, P35; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; Moore Kent J, 2005, Fam Pract Manag, V12, P29; OMalley AS, 1997, ARCH INTERN MED, V157, P1462, DOI 10.1001/archinte.157.13.1462; Pantilat SZ, 2001, AM J MED, V111, P15, DOI 10.1016/S0002-9343(01)00964-0; Parchman ML, 2004, FAM MED, V36, P22; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Research Data Assistance Center, MED DAT FIL DESCR; Riall TS, 2007, J GASTROINTEST SURG, V11, P1242, DOI 10.1007/s11605-007-0245-5; Rodriguez HP, 2008, J GEN INTERN MED, V23, P1499, DOI 10.1007/s11606-008-0692-z; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Scholle SH, 2009, AM J MANAG CARE, V15, P67; Shah BR, 2007, HEALTH SERV RES, V42, P1783, DOI 10.1111/j.1475-6773.2006.00681.x; Shahinian VB, 2007, J CLIN ONCOL, V25, P5359, DOI 10.1200/JCO.2006.09.9580; Sharma G, 2009, ARCH INTERN MED, V169, P81, DOI 10.1001/archinternmed.2008.514; SHEAR CL, 1983, MED CARE, V21, P1204, DOI 10.1097/00005650-198312000-00007; Slater B, 1996, Int J Health Care Qual Assur, V9, P34, DOI 10.1108/09526869610109143; SMEDBY O, 1986, MED CARE, V24, P511; Sobel ME., 1982, SOCIOL METHODOL, P290, DOI 10.2307/270723; STEINWACHS DM, 1979, MED CARE, V17, P551, DOI 10.1097/00005650-197906000-00001; Stokes T, 2005, ANN FAM MED, V3, P353, DOI 10.1370/afm.351; US Census Bureau, CENS REG DIV US; Weiner M, 2006, J GEN INTERN MED, V21, pS35, DOI 10.1111/j.1525-1497.2006.00307.x; Weiner M, 2003, ANN INTERN MED, V139, P430, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00010; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742	64	85	85	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1671	1680		10.1001/jama.2009.517	http://dx.doi.org/10.1001/jama.2009.517			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383958	Bronze, Green Accepted			2022-12-28	WOS:000265350700023
J	Sherker, AH				Sherker, Averell H.			Review: Interferon and nucleoside/tide analogues reduce risk for hepatocellular cancer in patients with chronic hepatitis B	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT		[Sherker, Averell H.] Washington Hosp Ctr, Washington, DC 20010 USA; [Sherker, Averell H.] Georgetown Univ, Washington, DC USA	MedStar Washington Hospital Center; Georgetown University	Sherker, AH (corresponding author), Washington Hosp Ctr, Washington, DC 20010 USA.		Sherker, Averell H/A-2889-2013	Sherker, Averell H/0000-0003-0409-6938				Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Keeffe EB, 2008, CLIN GASTROENTEROL H, V6, P1315, DOI 10.1016/j.cgh.2008.08.021	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-11	10.7326/0003-4819-150-8-200904210-02011	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391225				2022-12-28	WOS:000265457000026
J	Mlodzik, M				Mlodzik, Marek			Ubiquitin Connects with Planar Cell Polarity	CELL			English	Editorial Material							VERTEBRATES; NEURULATION; DROSOPHILA; EXTENSION	Planar cell polarity (PCP) regulates the orientation of cells in epithelia and of mesenchymal cells during gastrulation. In this issue, Narimatsu et al. (2009) report that the Smurf E3 ubiquitin ligases are required for localized protein degradation of a core PCP factor to generate cellular asymmetry.	Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Mlodzik, M (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	marek.mlodzik@mssm.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062917, R01GM104241] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM104241, R01 GM062917] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150	9	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2					209	211		10.1016/j.cell.2009.04.002	http://dx.doi.org/10.1016/j.cell.2009.04.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379687	Bronze			2022-12-28	WOS:000265456800013
J	O'Meara, S; Tierney, J; Cullum, N; Bland, JM; Franks, PJ; Mole, T; Scriven, M				O'Meara, Susan; Tierney, Jayne; Cullum, Nicky; Bland, J. Martin; Franks, Peter J.; Mole, Trevor; Scriven, Mark			Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta-analysis of randomised controlled trials with data from individual patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STATISTICS NOTES; ULCERATION; RISK	Objective To compare the effectiveness of two types of compression treatment (four layer bandage and short stretch bandage) in people with venous leg ulceration. Design Systematic review and meta-analysis of patient level data. Data sources Electronic databases (the Cochrane Central Register of Controlled Trials, the Cochrane Wounds Group Specialised Register, Medline, Embase, CINAHL, and National Research Register) and reference lists of retrieved articles searched to identify relevant trials and primary investigators. Primary investigators of eligible trials were invited to contribute raw data for re-analysis. Review methods Randomised controlled trials of four layer bandage compared with short stretch bandage in people with venous leg ulceration were eligible for inclusion. The primary outcome for the meta-analysis was time to healing. Cox proportional hazards models were run to compare the methods in terms of time to healing with adjustment for independent predictors of healing. Secondary outcomes included incidence and number of adverse events per patient. Results Seven eligible trials were identified (887 patients), and patient level data were retrieved for five (797 patients, 90% of known randomised patients). The four layer bandage was associated with significantly shorter time to healing: hazard ratio (95% confidence interval) from multifactorial model based on five trials was 1.31 (1.09 to 1.58), P=0.005. Larger ulcer area at baseline, more chronic ulceration, and previous ulceration were all independent predictors of delayed healing. Data from two trials showed no evidence of a difference in adverse event profiles between the two bandage types. Conclusions Venous leg ulcers in patients treated with four layer bandages heal faster, on average, than those of people treated with the short stretch bandage. Benefits were consistent across patients with differing prognostic profiles.	[Cullum, Nicky; Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Tierney, Jayne] MRC, Clin Trials Unit, Meta Anal Grp, London NW1 2DA, England; [Franks, Peter J.] Ctr Res Implementat Clin Practice, London SW15 5ES, England; [Franks, Peter J.] Univ Glasgow, Div Nursing & Healthcare, Fac Med, Glasgow G12 8LW, Lanark, Scotland; [Mole, Trevor] Smith & Nephew Wound Management, Kingston Upon Hull HU3 2BN, N Humberside, England; [Scriven, Mark] Birmingham Heartlands Hosp, Dept Vasc Surg, Birmingham B9 5SS, W Midlands, England	University of York - UK; Medical Research Council Clinical Trials Unit; University of West London; University of Glasgow; Smith & Nephew; Heart of England NHS Foundation Trust; University of Birmingham		smo4@york.ac.uk	Franks, Peter J/G-3592-2013; Cullum, Nicky/AAT-5888-2020; Cullum, Nicky A/F-2438-2011	Franks, Peter J/0000-0002-9782-0181; Cullum, Nicky/0000-0003-2631-123X; Cullum, Nicky A/0000-0003-2631-123X; Tierney, Jayne/0000-0002-4734-3014	National Institute for Health Research; MRC [MC_U122861323] Funding Source: UKRI; Medical Research Council [MC_U122861323] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SO'M is funded by a research scientist award in evidence synthesis from the National Institute for Health Research. The funder had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and the decision to submit the article for publication.	Altman DG, 1997, BRIT MED J, V314, P1874, DOI 10.1136/bmj.314.7098.1874; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; BOSANQUET N, 1992, PHLEBOLOGY, V7, P44; CALLAM M, 1992, PHLEBOLOGY, V7, P6; Chaby G, 2006, DERMATOL SURG, V32, P512, DOI 10.1111/j.1524-4725.2006.32104.x; Cullum N, 2001, Health Technol Assess, V5, P1; Ebbeskog B, 2001, SCAND J CARING SCI, V15, P235, DOI 10.1046/j.1471-6712.2001.00018.x; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ellison D A, 2002, J Wound Care, V11, P47; Feben Katherine, 2003, Br J Community Nurs, V8, P80; Ford I, 2002, STAT MED, V21, P2899, DOI 10.1002/sim.1294; FRANKS PJ, 1995, AGE AGEING, V24, P407, DOI 10.1093/ageing/24.5.407; Graham Ian D, 2003, Adv Skin Wound Care, V16, P305, DOI 10.1097/00129334-200311000-00013; Hamer C, 1994, J Wound Care, V3, P99; *HEALTHC COMM, 2008, NAT AUD MAN VEN LEG; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Margolis DJ, 2004, WOUND REPAIR REGEN, V12, P163, DOI 10.1111/j.1067-1927.2004.012207.x; Moffatt C, 1995, J WOUND CARE, V4, P56; Moffatt C., 2007, COMPRESSION THERAPY; Morgan Philip A, 2004, Ostomy Wound Manage, V50, P25; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; *ROSIDALRSYS, EFF COMPR THER VEN U; *ROY COLL NURS, 2006, CLIN PRACT GUID NURS; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Williams C, 2001, Br J Nurs, V10, P403	27	72	72	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2009	338								b1344	10.1136/bmj.b1344	http://dx.doi.org/10.1136/bmj.b1344			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TL	19376798	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000265296900002
J	Moorthy, V; Smith, PG; Kieny, MP				Moorthy, Vasee; Smith, Peter G.; Kieny, Marie-Paule			A vaccine against malaria: a substantial step forward	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM INFECTION; RANDOMIZED CONTROLLED-TRIAL; EFFICACY; CHILDREN; PROTECTION; DISEASE		[Moorthy, Vasee; Kieny, Marie-Paule] WHO, Dept Immunizat Vaccines & Biol, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland; [Moorthy, Vasee] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Smith, Peter G.] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Moorthy, V (corresponding author), WHO, Dept Immunizat Vaccines & Biol, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland.	vasee.moorthy@gmail.com	Kieny, Marie-Paule/Q-1238-2019; smith, peter/ABH-9627-2020; Kieny, Marie-Paule/N-3914-2017	smith, peter/0000-0003-0080-7560; Kieny, Marie-Paule/0000-0002-5943-6488; Moorthy, Vasee/0000-0002-6535-2854	MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Epstein JE, 2007, LANCET, V370, P1523, DOI 10.1016/S0140-6736(07)61642-0; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Moorthy Vasee, 2007, Vaccine, V25, P5115, DOI 10.1016/j.vaccine.2007.01.085; Moorthy VS, 2009, VACCINE, V27, P624, DOI 10.1016/j.vaccine.2008.11.034; Smith PG, 2005, LANCET, V365, P472	10	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1411	1412		10.1016/S0140-6736(09)60802-3	http://dx.doi.org/10.1016/S0140-6736(09)60802-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394521				2022-12-28	WOS:000265501900010
J	Campbell, JE; Lobell, DB; Field, CB				Campbell, J. E.; Lobell, D. B.; Field, C. B.			Greater Transportation Energy and GHG Offsets from Bioelectricity Than Ethanol	SCIENCE			English	Article							LIFE-CYCLE ASSESSMENT; BIOMASS; CARBON; LAND; ELECTRICITY; BIOENERGY; FUELS; HEAT	The quantity of land available to grow biofuel crops without affecting food prices or greenhouse gas (GHG) emissions from land conversion is limited. Therefore, bioenergy should maximize land-use efficiency when addressing transportation and climate change goals. Biomass could power either internal combustion or electric vehicles, but the relative land-use efficiency of these two energy pathways is not well quantified. Here, we show that bioelectricity outperforms ethanol across a range of feedstocks, conversion technologies, and vehicle classes. Bioelectricity produces an average of 81% more transportation kilometers and 108% more emissions offsets per unit area of cropland than does cellulosic ethanol. These results suggest that alternative bioenergy pathways have large differences in how efficiently they use the available land to achieve transportation and climate goals.	[Campbell, J. E.] Univ Calif, Coll Engn, Merced, CA 95344 USA; [Campbell, J. E.] Univ Calif, Sierra Nevada Res Inst, Merced, CA 95344 USA; [Lobell, D. B.] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA; [Field, C. B.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA	University of California System; University of California Merced; University of California System; University of California Merced; Stanford University; Carnegie Institution for Science	Campbell, JE (corresponding author), Univ Calif, Coll Engn, Merced, CA 95344 USA.	ecampbell3@ucmerced.edu		Lobell, David/0000-0002-5969-3476	University of California; Merced; Stanford University Global Climate and Energy Project; Carnegie Institution; NASA [NNX08AV25G]	University of California(University of California System); Merced; Stanford University Global Climate and Energy Project; Carnegie Institution; NASA(National Aeronautics & Space Administration (NASA))	This work was supported by University of California, Merced start-up funds, the Stanford University Global Climate and Energy Project, the Carnegie Institution, and NASA New Investigator grant no. NNX08AV25G to D.B.L. We thank K. Gillingham and C. Weber for critical comments on the manuscript	Amann CA, 1996, INT J VEHICLE DES, V17, P510; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Burnham M., 2006, DEV APPL GREET 2 7 T; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Delucchi MA, 2001, TRANSPORT RES D-TR E, V6, P371, DOI 10.1016/S1361-9209(00)00031-6; DELUCCHI MA, 2005, UCDITSRR0510; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Farrell AE, 2008, MRS BULL, V33, P373, DOI 10.1557/mrs2008.76; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Gibbs HK, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034001; Gilbert R, 2007, ENERG POLICY, V35, P3053, DOI 10.1016/j.enpol.2006.11.002; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Hedegaard K, 2008, ENVIRON SCI TECHNOL, V42, P7992, DOI 10.1021/es800358d; King CW, 2008, ENVIRON SCI TECHNOL, V42, P4305, DOI 10.1021/es0716195; KROMER MA, 2007, 200703 LFEE MIT LAB; Liska AJ, 2008, J BIOBASED MATER BIO, V2, P187, DOI 10.1166/jbmb.2008.402; Maclean HL, 2004, INT J VEHICLE DES, V35, P27, DOI 10.1504/IJVD.2004.004049; Marland G, 1997, BIOMASS BIOENERG, V13, P389, DOI 10.1016/S0961-9534(97)00027-5; MARLAND G, 1992, WATER AIR SOIL POLL, V64, P181, DOI 10.1007/BF00477101; Morey RV, 2006, APPL ENG AGRIC, V22, P723; Romm J, 2006, ENERG POLICY, V34, P2609, DOI 10.1016/j.enpol.2005.06.025; Samson R, 2005, CRIT REV PLANT SCI, V24, P461, DOI 10.1080/07352680500316508; Steele NLC, 1998, ENVIRON SCI TECHNOL, V32, p40A, DOI 10.1021/es983364o; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; *US DOE, 2008, FUEL EC GUID; Wang M, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/2/024001; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009	28	151	154	6	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1055	1057		10.1126/science.1168885	http://dx.doi.org/10.1126/science.1168885			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19423776				2022-12-28	WOS:000266246700037
J	Burdon, JJ; Thrall, PH				Burdon, Jeremy J.; Thrall, Peter H.			Coevolution of Plants and Their Pathogens in Natural Habitats	SCIENCE			English	Editorial Material							GENE-FOR-GENE; METAPOPULATION MODEL; LOCAL ADAPTATION; RESISTANCE; HOST; VIRULENCE; EVOLUTION; DYNAMICS; POPULATIONS; INFECTION	Understanding of plant-pathogen coevolution in natural systems continues to develop as new theories at the population and species level are increasingly informed by studies unraveling the molecular basis of interactions between individual plants and their pathogens. The next challenge lies in further integration of these approaches to develop a comprehensive picture of how life history traits of both players interact with the environment to shape evolutionary trajectories.	[Burdon, Jeremy J.; Thrall, Peter H.] CSIRO Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Burdon, JJ (corresponding author), CSIRO Plant Ind, POB 1600, Canberra, ACT 2601, Australia.	Jeremy.Burdon@csiro.au	Burdon, Jeremy J/B-9913-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074265] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074265-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal A, 2002, EVOL ECOL RES, V4, P79; [Anonymous], [No title captured]; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Burdon JJ, 1996, OIKOS, V76, P411, DOI 10.2307/3546214; CHIN KM, 1984, PLANT PATHOL, V33, P535, DOI 10.1111/j.1365-3059.1984.tb02878.x; *CSIRO NIH, 5R01GM07426501A2 CSI; Damgaard C, 1999, J THEOR BIOL, V201, P1, DOI 10.1006/jtbi.1999.1007; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gilpin M.E., 1991, METAPOPULATION DYNAM; Hanski I., 1999, METAPOPULATION ECOLO; Holt BF, 2003, CURR OPIN IMMUNOL, V15, P20, DOI 10.1016/S0952-7915(02)00014-6; Keen N, 2000, P NATL ACAD SCI USA, V97, P8752, DOI 10.1073/pnas.97.16.8752; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Lannou C, 2005, PLANT PATHOL, V54, P699, DOI 10.1111/j.1365-3059.2005.01251.x; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nuismer SL, 2006, EVOLUTION, V60, P24, DOI 10.1111/j.0014-3820.2006.tb01078.x; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; Thrall PH, 2004, WEED TECHNOL, V18, P1269, DOI 10.1614/0890-037X(2004)018[1269:HLHIAB]2.0.CO;2; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tibayrenc M, 1998, INT J PARASITOL, V28, P85, DOI 10.1016/S0020-7519(97)00180-X; Wichmann G, 2005, APPL ENVIRON MICROB, V71, P2418, DOI 10.1128/AEM.71.5.2418-2432.2005	33	104	109	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					755	756		10.1126/science.1171663	http://dx.doi.org/10.1126/science.1171663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423818	Green Accepted			2022-12-28	WOS:000265832400037
J	Enerback, S				Enerbaeck, Sven			The Origins of Brown Adipose Tissue.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WHITE FAT		Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Enerback, S (corresponding author), Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.							Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	8	123	137	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					2021	2023		10.1056/NEJMcibr0809610	http://dx.doi.org/10.1056/NEJMcibr0809610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420373				2022-12-28	WOS:000265784400015
J	Mehta, RH; Starr, AZ; Lopes, RD; Hochman, JS; Widimsky, P; Pieper, KS; Armstrong, PW; Granger, CB				Mehta, Rajendra H.; Starr, Aijing Z.; Lopes, Renato D.; Hochman, Judith S.; Widimsky, Petr; Pieper, Karen S.; Armstrong, Paul W.; Granger, Christopher B.		APEX AMI Investigators	Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; PLASMINOGEN-ACTIVATOR; PRIMARY ANGIOPLASTY; ARRHYTHMIA BURSTS; FLOW RESTORATION; THROMBOLYSIS; THERAPY; PEXELIZUMAB	Context The incidence and timing of sustained ventricular tachycardia or fibrillation (VT/VF) and its impact on outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) are poorly understood. Objective To evaluate the association of sustained VT/VF and its timing on the outcomes of patients presenting for primary PCI-an aim not prespecified in the APEX AMI trial. Design, Setting, and Patients We studied 5745 STEMI patients presenting for primary PCI at 296 hospitals in 17 countries between July 13, 2004, and May 11, 2006, from the APEX AMI trial. We categorized them into 4 groups: no VT/VF; VT/VF any time; early VT/VF, before the end of cardiac catheterization; and late VT/VF, after the end of cardiac catheterization. Main Outcome Measure Ninety-day total mortality. Results VT/VF occurred in 329 STEMI patients (5.7%) presenting for primary PCI. The majority of these occurred before the end of catheterization (n=205, 64%), and 90% occurred within 48 hours of presentation with symptoms of STEMI. Clinical outcomes were worse in patients with vs those without VT/VF(90-day mortality, 23.2% vs 3.6%; adjusted HR, 3.63; 95% CI, 2.59-5.09), and outcomes were worse if the VT/VF occurred late instead of early (90-day mortality for early VT/VF, 17.2%[adjusted HR, 2.34; 95% CI, 1.44-3.80]; for late VT/VF, 33.3% [adjusted HR, 5.59; 95% CI, 3.71-8.43]; for no VT/VF, 3.6% [referent]). In multivariate analyses, factors associated with early VT/VF included pre-PCI thrombolysis in MI (TIMI) flow grade 0 (HR, 2.94; 95% CI, 1.93-4.47), inferior infarction (HR, 2.16; 95% CI, 1.58-2.93), total baseline ST deviation (HR, 1.39; 95% CI, 1.19-1.63), creatinine clearance (HR, 0.88; 95% CI, 0.83-0.94), Killip class greater than I (HR, 1.88; 95% CI, 1.29-2.76), baseline systolic blood pressure (HR, 0.92; 95% CI, 0.87-0.98), body weight (HR, 1.16; 95% CI, 1.04-1.29), and baseline heart rate greater than 70/min (HR, 1.10; 95% CI, 1.01-1.20) (c index, 0.75). Factors related to late VT/VF were systolic blood pressure (HR, 0.83; 95% CI, 0.76-0.91), ST resolution less than 70% (HR, 3.17; 95% CI, 1.60-6.28), baseline heart rate greater than 70/min (HR, 1.20; 95% CI, 1.08-1.33), total baseline ST deviation (HR, 1.43; 95% CI, 1.14-1.79), post-PCI TIMI flow less than grade 3(HR, 2.09; 95% CI, 1.24-3.52), pre-PCI TIMI flow grade 0(HR, 2.12; 95% CI, 1.20-3.75), and beta-blockers less than 24 hours (HR, 0.52; 95% CI, 0.32-0.85) (c index, 0.74). Conclusions In this study, occurrence of VT/VF before or after the end of cardiac catheterization in patients presenting for primary PCI was associated with increased 90-day mortality.	[Mehta, Rajendra H.; Starr, Aijing Z.; Lopes, Renato D.; Pieper, Karen S.; Granger, Christopher B.] Duke Clin Res Inst, Durham, NC 27715 USA; [Hochman, Judith S.] NYU, Sch Med, New York, NY USA; [Widimsky, Petr] Kralovske Vinohrady Univ Hosp, Prague, Czech Republic; [Armstrong, Paul W.] Univ Alberta, Edmonton, AB, Canada	Duke University; New York University; University Hospital Vinohrady; University of Alberta	Mehta, RH (corresponding author), Duke Clin Res Inst, Box 17969, Durham, NC 27715 USA.	mehta007@dcri.duke.edu	Granger, Christopher B/D-3458-2014; Widimsky, Petr/P-8088-2016	Granger, Christopher B/0000-0002-0045-3291; Widimsky, Petr/0000-0001-5686-7752; Armstrong, Paul/0000-0002-0460-3445; Hochman, Judith/0000-0002-5889-5981	Procter&Gamble Pharmaceuticals; Alexion Pharmaceuticals	Procter&Gamble Pharmaceuticals(Procter & Gamble); Alexion Pharmaceuticals	The APEX AMI trial was jointly funded by Procter&Gamble Pharmaceuticals and Alexion Pharmaceuticals.	[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; ANTMAN EM, ACC AHA GUIDELINES M; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Armstrong PW, 2005, AM HEART J, V149, P402, DOI 10.1016/j.ahj.2004.12.015; BERGER PB, 1993, J AM COLL CARDIOL, V22, P1773, DOI 10.1016/0735-1097(93)90756-Q; BUCKINGHAM TA, 1986, CHEST, V90, P346, DOI 10.1378/chest.90.3.346; Gibson CM, 2008, J AM COLL CARDIOL, V51, P546, DOI 10.1016/j.jacc.2007.08.061; GRESSIN V, 1992, AM J CARDIOL, V69, P152, DOI 10.1016/0002-9149(92)91295-F; HJALMARSON A, 1985, EUR HEART J, V6, P199; Lin J, 2006, BIOMETRICS, V62, P803, DOI 10.1111/j.1541-0420.2005.00521.x; Majidi M, 2008, EUROPACE, V10, P988, DOI 10.1093/europace/eun123; Majidi M, 2009, EUR HEART J, V30, P757, DOI 10.1093/eurheartj/ehp005; Mehta RH, 2007, EUR HEART J, V28, P415, DOI 10.1093/eurheartj/ehl329; Mehta RH, 2004, J AM COLL CARDIOL, V43, P1765, DOI 10.1016/j.jacc.2003.09.072; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Newby KH, 1998, CIRCULATION, V98, P2567, DOI 10.1161/01.CIR.98.23.2567; Piccini JP, 2008, AM J MED, V121, P797, DOI 10.1016/j.amjmed.2008.04.024; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; SIX AJ, 1991, BRIT HEART J, V66, P143; STEBBINS A, 2007, EUR HEART J SUPPL, V28, pP514; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; VOLPI A, 1990, CIRCULATION, V82, P1279, DOI 10.1161/01.CIR.82.4.1279; WILCOX RG, 1988, LANCET, V2, P525; ZEHENDER M, 1991, AM J CARDIOL, V68, P1138, DOI 10.1016/0002-9149(91)90184-M	25	196	206	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1779	1789		10.1001/jama.2009.600	http://dx.doi.org/10.1001/jama.2009.600			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19417195	Bronze			2022-12-28	WOS:000265742500027
J	Mboya-Okeyo, T; Ridley, RG; Nwaka, S				Mboya-Okeyo, Tom; Ridley, Robert G.; Nwaka, Solomon			The African Network for Drugs and Diagnostics Innovation	LANCET			English	Editorial Material									[Ridley, Robert G.; Nwaka, Solomon] WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; [Mboya-Okeyo, Tom] Permanent Mission Republ Kenya United Nations & O, CH-1202 Geneva, Switzerland	World Health Organization	Nwaka, S (corresponding author), WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland.	nwakas@who.int						*AFR NETW DRUGS DI, 2008, DRAFT SUMM MIN REC A; *ANDI, 2008, FDN M AB NIG OCT 8 6; [Anonymous], 2008, LANCET, V372, P1855, DOI 10.1016/S0140-6736(08)61789-4; Masum H., 2007, Innovations: Technology / Governance / Globalisation, V2, P129, DOI 10.1162/itgg.2007.2.4.129; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Olliaro Piero, 2004, J HIV Ther, V9, P53; World Health Assembly, 2008, GLOB STRAT PLAN ACT	7	29	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1507	1508		10.1016/S0140-6736(09)60838-2	http://dx.doi.org/10.1016/S0140-6736(09)60838-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19410700				2022-12-28	WOS:000265710300009
J	Jackson, ST				Jackson, Stephen T.			Alexander von Humboldt and the General Physics of the Earth	SCIENCE			English	Editorial Material									[Jackson, Stephen T.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Jackson, Stephen T.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Jackson, ST (corresponding author), Univ Wyoming, Dept Bot, Laramie, WY 82071 USA.	jackson@uwyo.edu		Jackson, Stephen/0000-0002-1487-4652				Bowler P. J., 1993, NORTON HIST ENV SCI; Bowler PJ, 2009, SCIENCE, V323, P223, DOI 10.1126/science.1160332; CANNON SF, 1978, SCI CULTURE EARLY VI; DEHUMBOLDT A, 1914, PERSONAL NARRATIVE T, V1, P1814; Dettelbach M., 1996, CULTURES NATURAL HIS, P287; Humboldt Alexander von, 1997, COSMOS SKETCH PHYS D, V1; NICOLSON M, 1987, HIST SCI, V25, P167, DOI 10.1177/007327538702500203; Nicolson M., 1990, ROMANTICISM SCI, P169; [No title captured]	9	15	15	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					596	597		10.1126/science.1171659	http://dx.doi.org/10.1126/science.1171659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407186				2022-12-28	WOS:000265608800026
J	Vernazza, P; Binzel, RP; Rossi, A; Fulchignoni, M; Birlan, M				Vernazza, P.; Binzel, R. P.; Rossi, A.; Fulchignoni, M.; Birlan, M.			Solar wind as the origin of rapid reddening of asteroid surfaces	NATURE			English	Article							NEAR-EARTH ASTEROIDS; SPECTRAL PROPERTIES; ION IRRADIATION; SPACE; SIMULATION; REGIONS; ALBEDO	A comparison of the laboratory reflectance spectra of meteorites with observations of asteroids revealed that the latter are much 'redder', with the spectral difference explained by 'space weathering'(1,2), though the actual processes and timescales involved have remained controversial(3,4). A recent study(5) of young asteroid families concluded that they suffered only minimal space weathering. Here we report additional observations of those families, revealing that space weathering must be a very rapid process-the final colour of a silicate-rich asteroid is acquired shortly after its 'birth' (within 10(6) years of undergoing a catastrophic collision). This rapid timescale favours solar wind implantation as the main mechanism of space weathering, as laboratory experiments have shown that it is the most rapid of several competing processes. We further demonstrate the necessity to take account of composition when evaluating weathering effectiveness, as both laboratory and asteroid data show an apparent dependence of weathering on olivine abundance. The rapid colour change that we find implies that colour trends seen among asteroids are most probably due to compositional or surface-particle-size properties, rather than to different relative ages. Apparently fresh surfaces most frequently seen among small near-Earth asteroids may be the result of tidal shaking that rejuvenates their surfaces during planetary encounters(6,7).	[Vernazza, P.] European Space Agcy, Res & Sci Support Dept, NL-2201 AZ Noordwijk, Netherlands; [Binzel, R. P.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Rossi, A.] ISTI CNR, Spaceflight Dynam Sect, I-56124 Pisa, Italy; [Fulchignoni, M.] Observ Paris, Lab Etud Spatiales & Instrumentat Astrophys, F-92195 Meudon, France; [Birlan, M.] Observ Paris, IMCCE, F-75014 Paris, France	European Space Agency; Massachusetts Institute of Technology (MIT); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologie dell'Informazione "Alessandro Faedo" (ISTI-CNR); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite	Vernazza, P (corresponding author), European Space Agcy, Res & Sci Support Dept, Keplerlaan 1, NL-2201 AZ Noordwijk, Netherlands.	pierre.vernazza@esa.int	BIRLAN, Mirel I/B-5283-2011; Rossi, Alessandro/D-4408-2016; Birlan, Mirel/X-8359-2019	BIRLAN, Mirel I/0000-0003-3495-8535; Rossi, Alessandro/0000-0001-9311-2869; 	National Science Foundation [0506716]; NASA [NAG5-12355]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	The visible data were based on observations at the NTT and VLT (European Southern Observatory, ESO, Chile) and the TNG (La Palma, Canary Islands). The near-infrared data were acquired by the authors operating as Visiting Astronomers at the IRTF, which is operated by the University of Hawaii under Cooperative Agreement no. NNX08AE38A with the National Aeronautics and Space Administration, Science Mission Directorate, Planetary Astronomy Program. This Letter is based on work supported by the National Science Foundation (grant 0506716) and NASA (grant NAG5-12355). Any opinions, findings, and conclusions or recommendations expressed here are those of the authors and do not necessarily reflect the views of the National Science Foundation or NASA.	Binzel RP, 2004, ICARUS, V170, P259, DOI 10.1016/j.icarus.2004.04.004; Binzel RP, 1996, SCIENCE, V273, P946, DOI 10.1126/science.273.5277.946; Bottke W. F., 2002, ASTEROIDS, P395; Brunetto R, 2006, ICARUS, V184, P327, DOI 10.1016/j.icarus.2006.05.019; BUS SJ, 1999, THESIS MIT; Chapman CR, 2004, ANNU REV EARTH PL SC, V32, P539, DOI 10.1146/annurev.earth.32.101802.120453; Chapman CR, 1996, METEORIT PLANET SCI, V31, P699, DOI 10.1111/j.1945-5100.1996.tb02107.x; Clark BE, 2001, METEORIT PLANET SCI, V36, P1617, DOI 10.1111/j.1945-5100.2001.tb01853.x; Clark BE, 2002, ASTEROIDS, P585, DOI DOI 10.1016/0273-1177(91)90551-T; CRUIKSHANK DP, 1984, SCIENCE, V223, P281, DOI 10.1126/science.223.4633.281; GAFFEY MJ, 1993, ICARUS, V106, P573, DOI 10.1006/icar.1993.1194; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; Hiroi T, 2006, NATURE, V443, P56, DOI 10.1038/nature05073; Jedicke R, 2004, NATURE, V429, P275, DOI 10.1038/nature02578; Marchi S, 2006, MON NOT R ASTRON SOC, V368, pL39, DOI 10.1111/j.1745-3933.2006.00152.x; Marchi S, 2005, ASTRON ASTROPHYS, V443, P769, DOI 10.1051/0004-6361:20053525; MCFADDEN LA, 1985, SCIENCE, V229, P160, DOI 10.1126/science.229.4709.160; Mothe-Diniz T, 2008, ASTRON ASTROPHYS, V486, pL9, DOI 10.1051/0004-6361:200809934; Nesvorny D, 2006, ASTRON J, V132, P1950, DOI 10.1086/507989; Nesvorny D, 2005, ICARUS, V173, P132, DOI 10.1016/j.icarus.2004.07.026; Pieters CM, 2000, METEORIT PLANET SCI, V35, P1101, DOI 10.1111/j.1945-5100.2000.tb01496.x; Sasaki S, 2002, ADV SPACE RES, V29, P783, DOI 10.1016/S0273-1177(02)00012-1; Sasaki S, 2001, NATURE, V410, P555, DOI 10.1038/35069013; Shkuratov Y, 1999, ICARUS, V137, P235, DOI 10.1006/icar.1998.6035; Starukhina LV, 2006, ADV SPACE RES, V37, P50, DOI 10.1016/j.asr.2005.04.033; Strazzulla G, 2005, ICARUS, V174, P31, DOI 10.1016/j.icarus.2004.09.013; Sunshine JM, 2004, METEORIT PLANET SCI, V39, P1343, DOI 10.1111/j.1945-5100.2004.tb00950.x; Vernazza P, 2008, NATURE, V454, P858, DOI 10.1038/nature07154; Vernazza P, 2006, ASTRON ASTROPHYS, V460, P945, DOI 10.1051/0004-6361:20065779; Willman M, 2008, ICARUS, V195, P663, DOI 10.1016/j.icarus.2008.02.007	30	142	143	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					993	995		10.1038/nature07956	http://dx.doi.org/10.1038/nature07956			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396138				2022-12-28	WOS:000265412900034
J	Heneghan, C; Glasziou, P; Thompson, M; Rose, P; Balla, J; Lasserson, D; Scott, C; Perera, R				Heneghan, C.; Glasziou, P.; Thompson, M.; Rose, P.; Balla, J.; Lasserson, D.; Scott, C.; Perera, R.			Diagnosis in General Practice Diagnostic strategies used in primary care	BRITISH MEDICAL JOURNAL			English	Article							PATIENT; PNEUMONIA; ACCURACY; HISTORY		[Heneghan, C.; Glasziou, P.; Thompson, M.; Rose, P.; Lasserson, D.; Scott, C.; Perera, R.] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Heneghan, C (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	carl.heneghan@dphpc.ox.ac.uk	Glasziou, Paul/A-7832-2008; Lasserson, Daniel S/T-8978-2017	Glasziou, Paul/0000-0001-7564-073X; Lasserson, Daniel/0000-0001-8274-5580; Perera, Rafael/0000-0003-2418-2091				Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Balint GP, 2006, CLIN RHEUMATOL, V25, P132, DOI 10.1007/s10067-004-1051-z; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bowen JL, 2006, NEW ENGL J MED, V355, P2217, DOI 10.1056/NEJMra054782; Britt H, 1996, FAM PRACT, V13, P462, DOI 10.1093/fampra/13.5.462; BROOKS LR, 1991, J EXP PSYCHOL GEN, V120, P278, DOI 10.1037/0096-3445.120.3.278; Croskerry P, 2003, ANN EMERG MED, V41, P110, DOI 10.1067/mem.2003.22; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; ELSTEIN AS, 1972, J MED EDUC, V47, P85; ELSTEIN AS, 1981, J MED EDUC, V56, P75; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Levy PD, 2007, NEW ENGL J MED, V356, P1272; Margolis P, 1998, JAMA-J AM MED ASSOC, V279, P308, DOI 10.1001/jama.279.4.308; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Murtagh J, 1990, Aust Fam Physician, V19, P733; Norman G, 2006, NEW ENGL J MED, V355, P2251, DOI 10.1056/NEJMe068134; Reid MC, 1998, AM J MED, V104, P374, DOI 10.1016/S0002-9343(98)00054-0; Richardson WS, 2007, J CLIN EPIDEMIOL, V60, P217, DOI 10.1016/j.jclinepi.2006.06.002; Rose PW, 2005, LANCET, V366, P37, DOI 10.1016/S0140-6736(05)66709-8; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; SACKETT DL, 1995, CLIN EPIDEMIOLGY; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; Segal JB, 2007, ANN FAM MED, V5, P63, DOI 10.1370/afm.648; Wilson T, 2001, BRIT MED J, V323, P583, DOI 10.1136/bmj.323.7313.583	26	85	86	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 20	2009	338								b946	10.1136/bmj.b946	http://dx.doi.org/10.1136/bmj.b946			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437ON	19380414	Green Published			2022-12-28	WOS:000265496900014
J	Gregg, EW; Albright, AL				Gregg, Edward W.; Albright, Ann L.			The Public Health Response to Diabetes-Two Steps Forward, One Step Back	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; US; PREVENTION; DISEASE; ADULTS; TRENDS		[Gregg, Edward W.; Albright, Ann L.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov		Gregg, Edward/0000-0003-2381-6822				Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1169; Burrows NR, 2008, ADV CHRONIC KIDNEY D, V15, P147, DOI 10.1053/j.ackd.2008.01.002; *CDCP, 2008, COUNT LEV EST DIAGN; *CDCP, 2009, DAT TRENDS DIAB SURV; Centers for Disease Control and Prevention, 2008, NAT DIAB SURV SYST; Colagiuri R, 2006, AM J PUBLIC HEALTH, V96, P1562, DOI 10.2105/AJPH.2005.067587; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; KRUGER H, 2007, HLTH IMPACT SMOKING; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Wang J, 2006, DIABETES CARE, V29, P2018, DOI 10.2337/dc06-0311; Wells H.F., 2008, EC INFORM B	15	24	25	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1596	1598		10.1001/jama.2009.519	http://dx.doi.org/10.1001/jama.2009.519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366782				2022-12-28	WOS:000265137900033
J	Whitmer, RA; Karter, AJ; Yaffe, K; Quesenberry, CP; Selby, JV				Whitmer, Rachel A.; Karter, Andrew J.; Yaffe, Kristine; Quesenberry, Charles P., Jr.; Selby, Joseph V.			Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; COGNITIVE FUNCTION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; GLYCEMIC CONTROL; BLOOD-GLUCOSE; ET-AL; POPULATION; BRAIN	Context Although acute hypoglycemia may be associated with cognitive impairment in children with type 1 diabetes, no studies to date have evaluated whether hypoglycemia is a risk factor for dementia in older patients with type 2 diabetes. Objective To determine if hypoglycemic episodes severe enough to require hospitalization are associated with an increased risk of dementia in a population of older patients with type 2 diabetes followed up for 27 years. Design, Setting, and Patients A longitudinal cohort study from 1980-2007 of 16 667 patients with a mean age of 65 years and type 2 diabetes who are members of an integrated health care delivery system in northern California. Main Outcome Measure Hypoglycemic events from 1980-2002 were collected and reviewed using hospital discharge and emergency department diagnoses. Cohort members with no prior diagnoses of dementia, mild cognitive impairment, or general memory complaints as of January 1, 2003, were followed up for a dementia diagnosis through January 15, 2007. Dementia risk was examined using Cox proportional hazard regression models, adjusted for age, sex, race/ethnicity, education, body mass index, duration of diabetes, 7-year mean glycated hemoglobin, diabetes treatment, duration of insulin use, hyperlipidemia, hypertension, cardiovascular disease, stroke, transient cerebral ischemia, and end-stage renal disease. Results At least 1 episode of hypoglycemia was diagnosed in 1465 patients (8.8%) and dementia was diagnosed in 1822 patients (11%) during follow-up; 250 patients had both dementia and at least 1 episode of hypoglycemia (16.95%). Compared with patients with no hypoglycemia, patients with single or multiple episodes had a graded increase in risk with fully adjusted hazard ratios (HRs): for 1 episode (HR, 1.26; 95% confidence interval [CI], 1.10-1.49); 2 episodes (HR, 1.80; 95% CI, 1.37-2.36); and 3 or more episodes (HR, 1.94; 95% CI, 1.42-2.64). The attributable risk of dementia between individuals with and without a history of hypoglycemia was 2.39% per year (95% CI, 1.72%-3.01%). Results were not attenuated when medical utilization rates, length of health plan membership, or time since initial diabetes diagnosis were added to the model. When examining emergency department admissions for hypoglycemia for association with risk of dementia (535 episodes), results were similar (compared with patients with 0 episodes) with fully adjusted HRs: for 1 episode (HR, 1.42; 95% CI, 1.12-1.78) and for 2 or more episodes (HR, 2.36; 95% CI, 1.57-3.55). Conclusions Among older patients with type 2 diabetes, a history of severe hypoglycemic episodes was associated with a greater risk of dementia. Whether minor hypoglycemic episodes increase risk of dementia is unknown.	[Whitmer, Rachel A.; Karter, Andrew J.; Quesenberry, Charles P., Jr.; Selby, Joseph V.] Kaiser Permanente, Div Res, Sect Etiol & Prevent, Oakland, CA 94612 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol & Epidemiol, San Francisco, CA 94143 USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whitmer, RA (corresponding author), Kaiser Permanente, Div Res, Sect Etiol & Prevent, 2000 Broadway, Oakland, CA 94612 USA.	raw@dor.kaiser.org			National Institutes of Health [DK066308, DK081796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK066308, R01DK081796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG031155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: Dr Whitmer receives funding from the National Institutes of Health grants DK066308 and DK081796.	Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Artola A, 2002, PROG BRAIN RES, V138, P305, DOI 10.1016/S0079-6123(02)38084-1; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chalmers J, 2007, J HYPERTENS, V25, pS23, DOI 10.1097/01.hjh.0000271506.69949.46; Cosway R, 2001, DIABETIC MED, V18, P803, DOI 10.1046/j.1464-5491.2001.00577.x; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Cryer PE, 2007, J CLIN INVEST, V117, P868, DOI 10.1172/JCI31669; Cryer PE, 2007, DIABETES CARE, V30, P190, DOI 10.2337/dc-06-1670; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; DEARY IJ, 1993, DIABETES, V42, P341, DOI 10.2337/diabetes.42.2.341; Deary IJ, 1996, BMJ-BRIT MED J, V313, P767; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, 2007, NEW ENGL J MED, V356, P1842; DRAELOS MT, 1995, AM J MED, V98, P135, DOI 10.1016/S0002-9343(99)80397-0; Ettner SL, 2009, HEALTH ECON, V18, P645, DOI 10.1002/hec.1394; Fanelli CG, 2004, DIABETES-METAB RES, V20, pS32, DOI 10.1002/dmrr.514; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Gordon N P, 1991, Adv Health Econ Health Serv Res, V12, P19; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; HIATT RA, 1982, AM J PUBLIC HEALTH, V72, P829, DOI 10.2105/AJPH.72.8.829; JARJOUR IT, 1995, DIABETOLOGIA, V38, P1090, DOI 10.1007/s001250050396; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Karter AJ, 2004, DIABETES CARE, V27, P850, DOI 10.2337/diacare.27.3.850-a; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; KARTER AJ, 1997, DIABETES; Karter AJ, 1998, J REGISTRY MANAGEMEN, V25, P7; Karter AJ, 2008, AM J PUBLIC HEALTH, V98, P365, DOI 10.2105/AJPH.2005.083501; Karter Andrew J, 2006, Endocr Pract, V12 Suppl 1, P110; Karter AJ, 2006, DIABETES CARE, V29, P1757, DOI 10.2337/dc06-2073; Kaufman FR, 1999, J DIABETES COMPLICAT, V13, P31, DOI 10.1016/S1056-8727(98)00029-4; Klein JP, 2003, LANCET NEUROL, V2, P548, DOI 10.1016/S1474-4422(03)00503-9; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kulstad JJ, 2005, J NEUROPATH EXP NEUR, V64, P139, DOI 10.1093/jnen/64.2.139; Launer Lenore J, 2005, Curr Diab Rep, V5, P59, DOI 10.1007/s11892-005-0069-1; McNay EC, 2005, NEUROBIOL AGING, V26, pS76, DOI 10.1016/j.neurobiolaging.2005.08.014; Messier C, 2003, EXP GERONTOL, V38, P941, DOI 10.1016/S0531-5565(03)00153-0; RYAN CM, 1993, DIABETOLOGIA, V36, P329, DOI 10.1007/BF00400236; Schmittdiel JA, 2008, J GEN INTERN MED, V23, P588, DOI 10.1007/s11606-008-0554-8; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Selby JV, 2001, DIABETES CARE, V24, P1547, DOI 10.2337/diacare.24.9.1547; Selby JV, 1997, ANN INTERN MED, V127, P719, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00056; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Warren RE, 2005, DIABETES OBES METAB, V7, P493, DOI 10.1111/j.1463-1326.2004.00421.x; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; WREDLING R, 1990, DIABETOLOGIA, V33, P152, DOI 10.1007/BF00404042; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865	59	685	718	4	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1565	1572		10.1001/jama.2009.460	http://dx.doi.org/10.1001/jama.2009.460			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366776	Green Accepted, Bronze			2022-12-28	WOS:000265137900027
J	Sohal, VS; Zhang, F; Yizhar, O; Deisseroth, K				Sohal, Vikaas S.; Zhang, Feng; Yizhar, Ofer; Deisseroth, Karl			Parvalbumin neurons and gamma rhythms enhance cortical circuit performance	NATURE			English	Article							IN-VIVO; POSITIVE INTERNEURONS; NEURAL CIRCUITRY; TRANSGENIC MICE; PYRAMIDAL CELLS; OSCILLATIONS; SYNCHRONIZATION; NEOCORTEX; CONNECTIONS; MODULATION	Synchronized oscillations and inhibitory interneurons have important and interconnected roles within cortical microcircuits. In particular, interneurons defined by the fast-spiking phenotype and expression of the calcium-binding protein parvalbumin(1,2) have been suggested to be involved in gamma (30-80 Hz) oscillations(3-7), which are hypothesized to enhance information processing(8,9). However, because parvalbumin interneurons cannot be selectively controlled, definitive tests of their functional significance in gamma oscillations, and quantitative assessment of the impact of parvalbumin interneurons and gamma oscillations on cortical circuits, have been lacking despite potentially enormous significance (for example, abnormalities in parvalbumin interneurons may underlie altered gamma-frequency synchronization and cognition in schizophrenia(10) and autism(11)). Here we use a panel of optogenetic technologies(12-14) in mice to selectively modulate multiple distinct circuit elements in neocortex, alone or in combination. We find that inhibiting parvalbumin interneurons suppresses gamma oscillations in vivo, whereas driving these interneurons (even by means of non-rhythmic principal cell activity) is sufficient to generate emergent gamma-frequency rhythmicity. Moreover, gamma-frequency modulation of excitatory input in turn was found to enhance signal transmission in neocortex by reducing circuit noise and amplifying circuit signals, including inputs to parvalbumin interneurons. As demonstrated here, optogenetics opens the door to a new kind of informational analysis of brain function, permitting quantitative delineation of the functional significance of individual elements in the emergent operation and function of intact neural circuitry.	[Sohal, Vikaas S.; Zhang, Feng; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Dept Bioengn, W083 Clark Ctr,318 Campus Dr W, Stanford, CA 94305 USA.	deissero@stanford.edu	Macrae, Rhiannon/AAX-1536-2020; Sohal, Vikaas/M-9327-2016; YIZHAR, OFER/AAV-8497-2021	Sohal, Vikaas/0000-0002-2238-4186; Yizhar, Ofer/0000-0003-4228-1448	President and Provost of Stanford University; BioX; Bioengineering; NIMH; NIDA; CIRM; NSF; Keck, McKnight and Coulter Foundations; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS059160] Funding Source: NIH RePORTER	President and Provost of Stanford University(Stanford University); BioX; Bioengineering; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CIRM(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Keck, McKnight and Coulter Foundations; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Arber for her gift of the PV:: Cre mice, and we acknowledge the advice and suggestions of R. C. Malenka, J. Huguenard and S. Baccus on this work. All materials are freely distributed and supported by the Deisseroth laboratory (http://www.optogenetics.org). K. D. is supported by the President and Provost of Stanford University, BioX, Bioengineering, and by NIMH, NIDA, CIRM, NSF, and the Keck, McKnight and Coulter Foundations. F. Z. is supported by NINDS, and V. S. S. is supported by a T32 postdoctoral research training fellowship from NIMH.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bannister AP, 2005, NEUROSCI RES, V53, P95, DOI 10.1016/j.neures.2005.06.019; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Conde F, 1996, DEV BRAIN RES, V96, P261, DOI 10.1016/S0165-3806(96)00126-5; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Meyer AH, 2002, J NEUROSCI, V22, P7055; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	1670	1722	11	353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					698	702		10.1038/nature07991	http://dx.doi.org/10.1038/nature07991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396159	Green Accepted			2022-12-28	WOS:000266608600043
J	Hines, PJ; Zahn, LM				Hines, Pamela J.; Zahn, Laura M.			What's Bugging Plants? INTRODUCTION	SCIENCE			English	Editorial Material																			0	3	3	5	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					741	741		10.1126/science.324_741	http://dx.doi.org/10.1126/science.324_741			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423811				2022-12-28	WOS:000265832400030
J	Mello, MM				Mello, Michelle M.			New York City's War on Fat.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PUBLIC-HEALTH; CALORIC INFORMATION; OBESITY EPIDEMIC; FAST-FOOD; BEHAVIOR		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Mello, Michelle/0000-0003-2877-4270				ALLDAY E, 2008, SAN FRANCISCO C 0312, pC1; Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020; Berman M, 2008, JAMA-J AM MED ASSOC, V300, P433, DOI 10.1001/jama.300.4.433; Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973; *CTR SCI PUBL INT, 2008, NUTR LAB CHAIN REST; *CTR SCI PUBL INT, 2008, TRANS FAT BANS REST; DUBBERT PM, 1984, J APPL BEHAV ANAL, V17, P85, DOI 10.1901/jaba.1984.17-85; Food and Drug Administration, 2004, CAL COUNT REP WORK G; Frieden TR, 2004, AM J PUBLIC HEALTH, V94, P2059, DOI 10.2105/AJPH.94.12.2059; Kim SY, 2001, J CONSUM AFF, V35, P346, DOI 10.1111/j.1745-6606.2001.tb00118.x; Koplan J., 2005, PREVENTING CHILDHOOD; Mello MM, 2006, NEW ENGL J MED, V354, P2601, DOI 10.1056/NEJMhpr060227; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; *NAT C STAT LEG, 2008, TRANS FAT MEN LAB LE; *NEW YORK CIT DEP, 2006, EPIQUERY COMM HLTH S; *NEW YORK CIT DEP, 2007, DIAB NEW YORK CIT PU; *NEW YORK CIT DEP, 2005, HLTH DEP ASKS REST F; *NEW YORK CIT DEP, 2008, CARD DIS PREV PROGR; *NEW YORK CIT OFF, 2007, M BLOOMB AC JB RICHM; NEWMAN M, 2007, NY TIMES        1011; *PAN MICR FOOD NUT, 2005, DIET REF INT EN CARB; Pomeranz JL, 2008, AM J PUBLIC HEALTH, V98, P1578, DOI 10.2105/AJPH.2007.128488; RABIN RC, 2007, NY TIMES        0717, pF6; RIVERA R, 2007, NY TIMES        1025, pB1; Rutkow L, 2008, J LAW MED ETHICS, V36, P772, DOI 10.1111/j.1748-720X.2008.00337.x; SILVER LD, 2006, RESULTS PUBLIC HEARI; Stubenitsky K, 2000, PUBLIC HEALTH NUTR, V3, P201; *TECHN, 2008, CONS REACT CAL DISCL; WOO S, 2008, WALL STREET J   0611, pA2; Yamamoto JA, 2005, J ADOLESCENT HEALTH, V37, P397, DOI 10.1016/j.jadohealth.2004.10.002; *ZOGB INT, 2008, RES NEW YORK SURV	31	29	31	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					2015	2020		10.1056/NEJMhle0806121	http://dx.doi.org/10.1056/NEJMhle0806121			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441QN	19420372				2022-12-28	WOS:000265784400014
J	Tamura, Y; Kohno, K; Nakanishi, K; Hatsukade, B; Iono, D; Wilson, GW; Yun, MS; Takata, T; Matsuda, Y; Tosaki, T; Ezawa, H; Perera, TA; Scott, KS; Austermann, JE; Hughes, DH; Aretxaga, I; Chung, A; Oshima, T; Yamaguchi, N; Tanaka, K; Kawabe, R				Tamura, Yoichi; Kohno, Kotaro; Nakanishi, Kouichiro; Hatsukade, Bunyo; Iono, Daisuke; Wilson, Grant W.; Yun, Min S.; Takata, Tadafumi; Matsuda, Yuichi; Tosaki, Tomoka; Ezawa, Hajime; Perera, Thushara A.; Scott, Kimberly S.; Austermann, Jason E.; Hughes, David H.; Aretxaga, Itziar; Chung, Aeree; Oshima, Tai; Yamaguchi, Nobuyuki; Tanaka, Kunihiko; Kawabe, Ryohei			Spatial correlation between submillimetre and Lyman-alpha galaxies in the SSA 22 protocluster	NATURE			English	Article							STAR-FORMATION; HIGH-REDSHIFT; DEEP FIELD; EMITTING GALAXIES; NUMBER COUNTS; POPULATION; Z=3.1	Lyman-alpha emitters are thought to be young, low-mass galaxies with ages of similar to 10(8) yr (refs 1, 2). An overdensity of them in one region of the sky (the SSA 22 field) traces out a filamentary structure in the early Universe at a redshift of z approximate to 3.1 (equivalent to 15 per cent of the age of the Universe) and is believed to mark a forming protocluster(3,4). Galaxies that are bright at (sub) millimetre wavelengths are undergoing violent episodes of star formation(5-8), and there is evidence that they are preferentially associated with high-redshift radio galaxies(9), so the question of whether they are also associated with the most significant large-scale structure growing at high redshift (as outlined by Lyman-alpha emitters) naturally arises. Here we report an imaging survey of 1,100-mu m emission in the SSA 22 region. We find an enhancement of submillimetre galaxies near the core of the protocluster, and a large-scale correlation between the submillimetre galaxies and the low-mass Lyman-alpha emitters, suggesting synchronous formation of the two very different types of star-forming galaxy within the same structure at high redshift. These results are in general agreement with our understanding of the formation of cosmic structure.	[Tamura, Yoichi] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Tamura, Yoichi; Nakanishi, Kouichiro; Takata, Tadafumi; Matsuda, Yuichi] Natl Astron Observ Japan, Tokyo 1818588, Japan; [Kohno, Kotaro; Hatsukade, Bunyo; Iono, Daisuke] Univ Tokyo, Inst Astron, Tokyo 1810015, Japan; [Nakanishi, Kouichiro; Iono, Daisuke; Tosaki, Tomoka; Ezawa, Hajime; Oshima, Tai; Yamaguchi, Nobuyuki; Tanaka, Kunihiko; Kawabe, Ryohei] Natl Astron Observ Japan, Nobeyama Radio Observ, Minamisa Ku, Minamimaki, Nagano 3841305, Japan; [Wilson, Grant W.; Yun, Min S.; Perera, Thushara A.; Scott, Kimberly S.; Austermann, Jason E.; Chung, Aeree] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Hughes, David H.; Aretxaga, Itziar] Inst Nacl Astrofis Opt & Electr, Puebla 72000, Mexico	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Massachusetts System; University of Massachusetts Amherst; Instituto Nacional de Astrofisica, Optica y Electronica	Tamura, Y (corresponding author), Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan.	yoichi.tamura@nao.ac.jp	Takata, Tadafumi/ABD-9196-2021; Tamura, Yoichi/W-1382-2019	Takata, Tadafumi/0000-0002-6592-4250; Tamura, Yoichi/0000-0003-4807-8117; Tosaki, Tomoka/0000-0001-9016-2641; Nakanishi, Kouichiro/0000-0002-6939-0372; AUSTERMANN, JASON/0000-0002-6338-0069				Almaini O, 2005, MON NOT R ASTRON SOC, V358, P875, DOI 10.1111/j.1365-2966.2005.08790.x; AUSTERMANN JE, MON NOT R A IN PRESS; Barger AJ, 1998, NATURE, V394, P248, DOI 10.1038/28338; Blain AW, 2004, ASTROPHYS J, V611, P725, DOI 10.1086/422353; Blain AW, 2002, PHYS REP, V369, P111, DOI 10.1016/S0370-1573(02)00134-5; Boone F, 2007, ASTRON ASTROPHYS, V475, P513, DOI 10.1051/0004-6361:20078253; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; Chapman SC, 2003, ASTROPHYS J, V585, P57, DOI 10.1086/345980; Cole S, 2000, MON NOT R ASTRON SOC, V319, P168, DOI 10.1046/j.1365-8711.2000.03879.x; Dunne L, 2003, MON NOT R ASTRON SOC, V341, P589, DOI 10.1046/j.1365-8711.2003.06440.x; Eales S, 1999, ASTROPHYS J, V515, P518, DOI 10.1086/307069; Ezawa H, 2004, P SOC PHOTO-OPT INS, V5489, P763, DOI 10.1117/12.551391; Gawiser E, 2007, ASTROPHYS J, V671, P278, DOI 10.1086/522955; Hayashino T, 2004, ASTRON J, V128, P2073, DOI 10.1086/424935; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; LANDY SD, 1993, ASTROPHYS J, V412, P64, DOI 10.1086/172900; Laurent GT, 2005, ASTROPHYS J, V623, P742, DOI 10.1086/428823; LeFevre O, 1996, ASTROPHYS J, V471, pL11, DOI 10.1086/310319; Matsuda Y, 2005, ASTROPHYS J, V634, pL125, DOI 10.1086/499071; Mo HJ, 1996, MON NOT R ASTRON SOC, V282, P347, DOI 10.1093/mnras/282.2.347; Pirzkal N, 2007, ASTROPHYS J, V667, P49, DOI 10.1086/519485; Scott KS, 2008, MON NOT R ASTRON SOC, V385, P2225, DOI 10.1111/J.1365-2966.2008.12989.x; Scott SE, 2006, MON NOT R ASTRON SOC, V370, P1057, DOI 10.1111/j.1365-2966.2006.10478.x; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Steidel CC, 1998, ASTROPHYS J, V492, P428, DOI 10.1086/305073; Stevens JA, 2003, NATURE, V425, P264, DOI 10.1038/nature01976; Webb TMA, 2007, ASTROPHYS J, V659, P76, DOI 10.1086/510061; Wilson GW, 2008, MON NOT R ASTRON SOC, V386, P807, DOI 10.1111/j.1365-2966.2008.12980.x	29	80	80	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					61	63		10.1038/nature07947	http://dx.doi.org/10.1038/nature07947			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424150	Green Submitted			2022-12-28	WOS:000265801300028
J	Benito, N; Miro, JM; de Lazzari, E; Cabell, CH; del Rio, A; Altclas, J; Commerford, P; Delahaye, F; Dragulescu, S; Giamarellou, H; Habib, G; Kamarulzaman, A; Kumar, AS; Nacinovich, FM; Suter, F; Tribouilloy, C; Venugopal, K; Moreno, A; Fowler, VG				Benito, Natividad; Miro, Jose M.; de Lazzari, Elisa; Cabell, Christopher H.; del Rio, Ana; Altclas, Javier; Commerford, Patrick; Delahaye, Francois; Dragulescu, Stefan; Giamarellou, Helen; Habib, Gilbert; Kamarulzaman, Adeeba; Kumar, A. Sampath; Nacinovich, Francisco M.; Suter, Fredy; Tribouilloy, Christophe; Venugopal, Krishnan; Moreno, Asuncion; Fowler, Vance G., Jr.		ICE-PCS Investigators	Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; COMMUNITY-ACQUIRED BACTEREMIA; 6-MONTH MORTALITY; INTERNATIONAL COLLABORATION; PROSPECTIVE COHORT; PROGNOSTIC-FACTORS; MEDICAL PROGRESS; SURGERY; IMPACT	Background: The clinical profile and outcome of nosocomial and non-nosocomial health care-associated native valve endocarditis are not well defined. Objective: To compare the characteristics and outcomes of community-associated and nosocomial and non-nosocomial health care-associated native valve endocarditis. Design: Prospective cohort study. Setting: 61 hospitals in 28 countries. Patients: Patients with definite native valve endocarditis and no history of injection drug use who were enrolled in the ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) from June 2000 to August 2005. Measurements: Clinical and echocardiographic findings, microbiology, complications, and mortality. Results: Health care-associated native valve endocarditis was present in 557 (34%) of 1622 patients (303 with nosocomial infection [54%] and 254 with non-nosocomial infection [46%]). Staphylococcus aureus was the most common cause of health care-associated infection (nosocomial, 47%; non-nosocomial, 42%; P = 0.30); a high proportion of patients had methicillin-resistant S. aureus (nosocomial, 57%; non-nosocomial, 41%; P = 0.014). Fewer patients with health care-associated native valve endocarditis had cardiac surgery (41% vs. 51% of community-associated cases; P < 0.001), but more of the former patients died (25% vs. 13%; P < 0.001). Multivariable analysis confirmed greater mortality associated with health care-associated native valve endocarditis (incidence risk ratio, 1.28 [95% CI, 1.02 to 1.59]). Limitations: Patients were treated at hospitals with cardiac surgery programs. The results may not be generalizable to patients receiving care in other types of facilities or to those with prosthetic valves or past injection drug use. Conclusion: More than one third of cases of native valve endocarditis in non-injection drug users involve contact with health care, and non-nosocomial infection is common, especially in the United States. Clinicians should recognize that outpatients with extensive out-of-hospital health care contacts who develop endocarditis have clinical characteristics and outcomes similar to those of patients with nosocomial infection. Primary Funding Source: None.	Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain; Duke Univ, Med Ctr, Durham, NC USA; Sanat Mitre & Inst Cardiovasc, Buenos Aires, DF, Argentina; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; Hop Louis Pradel, Lyon, France; Fac Med Marseille, F-13385 Marseille, France; S Hosp Amiens, Amiens, France; Victor Babes Univ Med & Pharm, Timisoara, Romania; Attikon Univ, Gen Hosp, Athens, Greece; Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; All India Inst Med Sci, New Delhi, India; Med Coll Calicut, Calicut, Kerala, India; Osped Riuniti Bergamo, I-24100 Bergamo, Italy	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Duke University; University of Cape Town; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Victor Babes University of Medicine & Pharmacy, Timisoara; University Hospital Attikon; Universiti Malaya; All India Institute of Medical Sciences (AIIMS) New Delhi; Ospedali Riuniti di Bergamo	Miro, JM (corresponding author), Hosp Clin Univ, Helios Villarroel Bldg,Desk 26,Villarroel 170, Barcelona 08036, Spain.	jmmiro@ub.edu	Cervera, Carlos/U-4538-2018; Bouza, Emilio/D-8661-2014; Giannitsioti, Efthymia/AAQ-5897-2020; Muñoz, Patricia/E-9431-2017; RAOULT, Didier/A-8434-2008; Altclas, Javier/AFN-4965-2022; Gonzalez Ramallo, Victor José/Y-6248-2018; Fowler, Vance/AAW-2017-2021; De Rosa, Francesco Giuseppe/J-3049-2013; KAMARULZAMAN, ADEEBA/B-5216-2010; Benito, Natividad/D-1855-2010; Fournier, Pierre-Edouard/AAC-6155-2021; Marco, Francesc D/K-2900-2017; McBryde, Emma/D-2220-2018	Cervera, Carlos/0000-0002-0161-1749; Bouza, Emilio/0000-0001-6967-9267; Muñoz, Patricia/0000-0001-5706-5583; RAOULT, Didier/0000-0002-0633-5974; Gonzalez Ramallo, Victor José/0000-0002-9867-1472; Benito, Natividad/0000-0001-6410-013X; Fournier, Pierre-Edouard/0000-0001-8463-8885; Marco, Francesc D/0000-0002-1863-6379; Selton-Suty, Christine/0000-0003-4129-5784; Athan, Eugene/0000-0001-9838-6471; Giamarellou, Helen/0000-0002-7387-5065; McBryde, Emma/0000-0002-9570-9172; Gordon, David/0000-0003-3276-9685; Fernandez-Hidalgo, Nuria/0000-0002-2115-344X; Moreno Camacho, Asuncion/0000-0002-5850-5007; Falco, Vicenc/0000-0001-9626-0023; Falces, Carlos/0000-0002-3483-3786; alla, francois/0000-0002-5793-7190; De Lazzari, Elisa/0000-0003-2614-6545; Ionac, Adina/0000-0003-0635-8663	National Institutes of Health [R01-AI068804]; American Heart Association [0455802U]; Ministerio de Sanidad y Consumo; Instituto de Salud Carlos III; Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]; Fundacion Privada Maximo Soriano Jimenez, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer; Conselleria de Salut de la Generalitat de Catalunya, Barcelona, Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Network for the Research in Infectious Diseases; Fundacion Privada Maximo Soriano Jimenez, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer; Conselleria de Salut de la Generalitat de Catalunya, Barcelona, Spain(Generalitat de Catalunya); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By the National Institutes of Health (grant R01-AI068804); the American Heart Association (grant 0455802U); the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases (grant REIPI RD06/0008); and the Fundacion Privada Maximo Soriano Jimenez, Barcelona, Spain (grant supporting the Hospital Clinic Endocarditis database). Dr. Miro received a Research Grant from the Institut d'Investigacions Biomediques August Pi i Sunyer and the Conselleria de Salut de la Generalitat de Catalunya, Barcelona, Spain.	Aksoy O, 2007, CLIN INFECT DIS, V44, P364, DOI 10.1086/510583; Ben-Ami R, 2004, CLIN INFECT DIS, V38, P843, DOI 10.1086/381971; Bishara J, 2001, CLIN INFECT DIS, V33, P1636, DOI 10.1086/323785; Bouza E, 2001, MEDICINE, V80, P298, DOI 10.1097/00005792-200109000-00003; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Cabell CH, 2002, INFECT DIS CLIN N AM, V16, P255, DOI 10.1016/S0891-5520(01)00007-1; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P322; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; CHEN SCA, 1992, AM J CARDIOL, V70, P1449, DOI 10.1016/0002-9149(92)90298-D; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Dickerman SA, 2007, AM HEART J, V154, P1086, DOI 10.1016/j.ahj.2007.07.023; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Fernandez-Hidalgo N, 2008, CLIN INFECT DIS, V47, P1287, DOI 10.1086/592576; FERNANDEZGUERRERO ML, 1995, CLIN INFECT DIS, V20, P16, DOI 10.1093/clinids/20.1.16; Ferreiros E, 2006, AM HEART J, V151, P545, DOI 10.1016/j.ahj.2005.04.008; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; FRIEDLAND G, 1984, INFECT CONT HOSP EP, V5, P284, DOI 10.1017/S0195941700060343; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gasink LB, 2008, MED CLIN N AM, V92, P295, DOI 10.1016/j.mcna.2007.10.002; Giamarellou H, 2002, J HOSP INFECT, V50, P91, DOI 10.1053/jhin.2001.1144; Gilleece A, 2000, J HOSP INFECT, V46, P83, DOI 10.1053/jhin.2000.0802; GILLEECE A, 1998, J INFECTION, V36, pA22; GILLEECE A, 1998, J INFECTION, V36, pA10; GRAHAM DR, 1991, AM J MED, V91, pS95, DOI 10.1016/0002-9343(91)90351-W; Guerrero MLF, 2007, MEDICINE, V86, P363, DOI 10.1097/MD.0b013e31815d5386; GUZE LB, 1963, ARCH INTERN MED, V112, P56, DOI 10.1001/archinte.1963.03860010102011; Hill EE, 2007, EUR HEART J, V28, P196, DOI 10.1093/eurheartj/ehl427; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Kourany WM, 2006, SCAND J INFECT DIS, V38, P613, DOI 10.1080/00365540600617017; Lamas CC, 1998, HEART, V79, P442, DOI 10.1136/hrt.79.5.442; Lesens O, 2005, INFECT CONT HOSP EP, V26, P204, DOI 10.1086/502527; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Martin-Davila P, 2005, CHEST, V128, P772, DOI 10.1378/chest.128.2.772; Miro JM, 2002, INFECT DIS CLIN N AM, V16, P273, DOI 10.1016/S0891-5520(01)00008-3; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; Morpeth S, 2007, ANN INTERN MED, V147, P829, DOI 10.7326/0003-4819-147-12-200712180-00002; Mourvillier B, 2004, INTENS CARE MED, V30, P2046, DOI 10.1007/s00134-004-2436-9; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; SANABRIA TJ, 1990, ARCH INTERN MED, V150, P1305, DOI 10.1001/archinte.150.6.1305; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Siegman-Igra Y, 2002, CLIN INFECT DIS, V34, P1431, DOI 10.1086/339809; Tacconelli E, 2004, J ANTIMICROB CHEMOTH, V53, P474, DOI 10.1093/jac/dkh107; Tenover FC, 2004, ANTIMICROB AGENTS CH, V48, P275, DOI 10.1128/AAC.48.1.275-280.2004; TERPENNING MS, 1988, ARCH INTERN MED, V148, P1601, DOI 10.1001/archinte.148.7.1601; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Tleyjeh IM, 2007, CIRCULATION, V115, P1721, DOI 10.1161/CIRCULATIONAHA.106.658831; *US REN DAT SYST, 2008 ANN DAT REP ATL; Valles J, 2008, J INFECTION, V56, P27, DOI 10.1016/j.jinf.2007.10.001; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; Whitener CJ, 2004, CLIN INFECT DIS, V38, P1049, DOI 10.1086/382357	57	172	177	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					586	U5		10.7326/0003-4819-150-9-200905050-00004	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414837	Green Accepted			2022-12-28	WOS:000265903800002
J	Hunt, B; Pratt, E; Gadagkar, V; Yamashita, M; Balatsky, AV; Davis, JC				Hunt, B.; Pratt, E.; Gadagkar, V.; Yamashita, M.; Balatsky, A. V.; Davis, J. C.			Evidence for a Superglass State in Solid He-4	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION; SUPERSOLIDITY; SUPERFLUID; CRYSTALS; HELIUM	Although solid helium-4 (He-4) may be a supersolid, it also exhibits many phenomena unexpected in that context. We studied relaxation dynamics in the resonance frequency f(T) and dissipation D(T) of a torsional oscillator containing solid He-4. With the appearance of the "supersolid" state, the relaxation times within f(T) and D(T) began to increase rapidly together. More importantly, the relaxation processes in both D(T) and a component of f(T) exhibited a complex synchronized ultraslow evolution toward equilibrium. Analysis using a generalized rotational susceptibility revealed that, while exhibiting these apparently glassy dynamics, the phenomena were quantitatively inconsistent with a simple excitation freeze-out transition because the variation in f was far too large. One possibility is that amorphous solid He-4 represents a new form of supersolid in which dynamical excitations within the solid control the superfluid phase stiffness.	[Hunt, B.; Pratt, E.; Gadagkar, V.; Yamashita, M.; Davis, J. C.] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Yamashita, M.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Balatsky, A. V.] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Div T, Los Alamos, NM 87545 USA; [Davis, J. C.] Univ St Andrews, Scottish Univ Phys Alliance, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	Cornell University; Kyoto University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of St Andrews	Davis, JC (corresponding author), Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	jcdavis@ccmr.cornell.edu	Hunt, Benjamin/C-3395-2017; YAMASHITA, MINORU/D-6556-2011; Pratt, Ethan/E-8714-2011	Hunt, Benjamin/0000-0002-5008-8042; YAMASHITA, MINORU/0000-0002-3616-6606; 	NSF [DM-0434801, DMR-0806629]; Cornell University; Natural Sciences and Engineering Research Council of Canada; Japan Society for the Promotion of Science; U.S. Department of Energy; Division Of Materials Research [0806629] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Cornell University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge and thank J. Beamish, M. W. H. Chan, A. Clark, A. Dorsey, M. Graf, E. Mueller, S. Nagel, M. Paalanen, R. E. Packard, J. Parpia, J. D. Reppy, A. S. Rittner, J. Saunders, J. P. Sethna, and Wm. Vinen for helpful discussions and communications. These studies were initiated under NSF grant DM-0434801 and are now partially supported under grant DMR-0806629 and by Cornell University; B.H. acknowledges support by the Natural Sciences and Engineering Research Council of Canada. M.Y. acknowledges support from the Japan Society for the Promotion of Science. Work at Los Alamos was supported by the U.S. Department of Energy.	Anderson PW, 2007, NAT PHYS, V3, P160, DOI 10.1038/nphys539; Andreev AF, 2007, JETP LETT+, V85, P585, DOI 10.1134/S0021364007110124; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; [Anonymous], 1990, SUPERFLUIDITY SUPERC; Aoki Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.015301; Aoki Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.215303; Biroli G, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.224306; Boninsegni M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105301; Bossy J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.224507; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; Clark AC, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184513; Clark AC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.135302; Day J, 2007, NATURE, V450, P853, DOI 10.1038/nature06383; Grigor'ev VN, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224524; Kim E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.065301; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Kondo M, 2007, J LOW TEMP PHYS, V148, P695, DOI 10.1007/s10909-007-9471-1; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; MEISEL MW, 1992, PHYSICA B, V178, P121, DOI 10.1016/0921-4526(92)90186-V; Nussinov Z, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014530; Penzev A, 2007, J LOW TEMP PHYS, V148, P677, DOI 10.1007/s10909-007-9452-4; Pollet L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.135301; Ray MW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.235301; REATTO L, 1969, PHYS REV, V183, P334, DOI 10.1103/PhysRev.183.334; Rittner ASC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.165301; Rittner ASC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.155301; Sasaki S, 2006, SCIENCE, V313, P1098, DOI 10.1126/science.1130879; SCAIFE BK, 1989, PRINCIPLES DIELECTRI, P33203; THOULESS DJ, 1969, ANN PHYS-NEW YORK, V52, P403, DOI 10.1016/0003-4916(69)90286-3; Wu JS, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014515; Yoo CD, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.100504	32	115	115	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					632	636		10.1126/science.1169512	http://dx.doi.org/10.1126/science.1169512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407201				2022-12-28	WOS:000265608800041
J	Aouadi, M; Tesz, GJ; Nicoloro, SM; Wang, MX; Chouinard, M; Soto, E; Ostroff, GR; Czech, MP				Aouadi, Myriam; Tesz, Gregory J.; Nicoloro, Sarah M.; Wang, Mengxi; Chouinard, My; Soto, Ernesto; Ostroff, Gary R.; Czech, Michael P.			Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; IN-VIVO DELIVERY; NONHUMAN-PRIMATES; RNA INTERFERENCE; GENE-EXPRESSION; ADULT MICE; GALACTOSAMINE; INHIBITION; RESISTANCE; LETHALITY	Gene silencing by double-stranded RNA, denoted RNA interference, represents a new paradigm for rational drug design(1). However, the transformative therapeutic potential of short interfering RNA ( siRNA) has been stymied by a key obstacle-safe delivery to specified target cells in vivo(2). Macrophages are particularly attractive targets for RNA interference therapy because they promote pathogenic inflammatory responses in diseases such as rheumatoid arthritis, atherosclerosis, inflammatory bowel disease and diabetes(3). Here we report the engineering of beta 1,3-D-glucan-encapsulated siRNA particles (GeRPs) as efficient oral delivery vehicles that potently silence genes in mouse macrophages in vitro and in vivo. Oral gavage of mice with GeRPs containing as little as 20 mu g kg(-1) siRNA directed against tumour necrosis factor alpha (Tnf-alpha) depleted its messenger RNA in macrophages recovered from the peritoneum, spleen, liver and lung, and lowered serum Tnf-a levels. Screening with GeRPs for inflammation genes revealed that the mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) is a previously unknown mediator of cytokine expression. Importantly, silencing Map4k4 in macrophages in vivo protected mice from lipopolysaccharide-induced lethality by inhibiting Tnf-alpha and interleukin-1 beta production. This technology defines a new strategy for oral delivery of siRNA to attenuate inflammatory responses in human disease.	[Aouadi, Myriam; Tesz, Gregory J.; Nicoloro, Sarah M.; Wang, Mengxi; Chouinard, My; Soto, Ernesto; Ostroff, Gary R.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	gary.ostroff@umassmed.edu; michael.czech@umassmed.edu		Nicoloro, Sarah/0000-0002-8638-4556	The University of Massachusetts Diabetes and Endocrinology Center [DK 32520]; Diabetes Genome Anatomy Project [DK 60837]; Commonwealth Medicine; NIH [DK 30898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060837, R37DK030898, R01DK030898, P30DK032520] Funding Source: NIH RePORTER	The University of Massachusetts Diabetes and Endocrinology Center; Diabetes Genome Anatomy Project; Commonwealth Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We appreciate critical reading of the manuscript and suggestions by C. Mello, V. Ambros, G. Hannon, S. Corvera and J. Sullivan. We thank P. Zamore for advice on methods. We also appreciate the technical help of P. Furcinitti, A. Burkhart and A. Goller. This work was supported by The University of Massachusetts Diabetes and Endocrinology Center (DK 32520), including its Genomics, Bioinformatics and Imaging Cores, the Diabetes Genome Anatomy Project ( DK 60837), Commonwealth Medicine and NIH grant DK 30898.	Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Endo Y, 1999, BRIT J PHARMACOL, V128, P5, DOI 10.1038/sj.bjp.0702747; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Filleur S, 2003, CANCER RES, V63, P3919; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Herre J, 2004, MOL IMMUNOL, V40, P869, DOI 10.1016/j.molimm.2003.10.007; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; Peer D, 2007, P NATL ACAD SCI USA, V104, P4095, DOI 10.1073/pnas.0608491104; Shealy D. J., 2008, V181, P101; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Sorensen DR, 2003, J MOL BIOL, V327, P761, DOI 10.1016/S0022-2836(03)00181-5; Soto ER, 2008, BIOCONJUGATE CHEM, V19, P840, DOI 10.1021/bc700329p; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	30	415	450	6	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1180	U116		10.1038/nature07774	http://dx.doi.org/10.1038/nature07774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407801	Green Accepted			2022-12-28	WOS:000265754600049
J	Gaissert, HA; Piyavisetpat, N; Mark, EJ				Gaissert, Henning A.; Piyavisetpat, Nitra; Mark, Eugene J.			A Man with Chest Pain, Dysphagia, and Pleural and Mediastinal Calcifications Diffuse malignant mesothelioma, with extensive osseous differentiation, involving the pleura, chest wall, lung, mediastinum, esophagus, and pericardium. Acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; ASBESTOS EXPOSURE; CARTILAGINOUS DIFFERENTIATION; TUMOR; OSTEOSARCOMA; HYPERPLASIA; MORTALITY; DIAGNOSIS; FEATURES; BRITAIN		[Gaissert, Henning A.] Massachusetts Gen Hosp, Dept Thorac Surg, Boston, MA 02114 USA; [Piyavisetpat, Nitra] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gaissert, Henning A.] Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; [Piyavisetpat, Nitra] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Gaissert, HA (corresponding author), Massachusetts Gen Hosp, Dept Thorac Surg, Boston, MA 02114 USA.							Butnor KJ, 2001, AM J SURG PATHOL, V25, P1304, DOI 10.1097/00000478-200110000-00012; Chandak P, 2007, J THORAC CARDIOV SUR, V133, P587, DOI 10.1016/j.jtcvs.2006.09.050; Clarke CC, 2006, ARCH ENVIRON OCCUP H, V61, P183, DOI 10.3200/AEOH.61.4.183-192; Freyschmidt J, 2001, EUR RADIOL, V11, P474, DOI 10.1007/s003300000562; GOLDSTEIN B, 1979, THORAX, V34, P375, DOI 10.1136/thx.34.3.375; HARMON DC, 1994, NEW ENGL J MED, V331, P1079; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; Iwatsubo Y, 1998, AM J EPIDEMIOL, V148, P133, DOI 10.1093/oxfordjournals.aje.a009616; Kiyozuka Y, 1999, DIGEST DIS SCI, V44, P1626, DOI 10.1023/A:1026627413715; Kradin RL, 2006, SEMIN DIAGN PATHOL, V23, P4, DOI 10.1053/j.semdp.2006.06.005; Kradin RL, 1997, NEW ENGL J MED, V336, P1895, DOI 10.1056/NEJM199706263362608; Kussmaul WG, 1998, CLIN ORTHOP RELAT R, P104; Landrigan PJ, 2002, J TOXICOL-CLIN TOXIC, V40, P449, DOI 10.1081/CLT-120006747; Leigh J, 2002, AM J IND MED, V41, P188, DOI 10.1002/ajim.10047; Mark EJ, 2006, SEMIN DIAGN PATHOL, V23, P25, DOI 10.1053/j.semdp.2006.06.004; Miller A, 2005, AM J IND MED, V47, P458, DOI 10.1002/ajim.20167; Nam JM, 2005, AM J IND MED, V47, P443, DOI 10.1002/ajim.20168; Ordonez NG, 2007, HUM PATHOL, V38, P1, DOI 10.1016/j.humpath.2006.08.010; Ordonez NG, 2000, AM J SURG PATHOL, V24, P816, DOI 10.1097/00000478-200006000-00006; PERSAUD V, 1970, CANCER, V26, P920, DOI 10.1002/1097-0142(197010)26:4<920::AID-CNCR2820260428>3.0.CO;2-P; PETO J, 1995, LANCET, V345, P535, DOI 10.1016/S0140-6736(95)90462-X; Raizon A, 1996, J COMPUT ASSIST TOMO, V20, P42, DOI 10.1097/00004728-199601000-00009; Rastogi R, 2008, PEDIATR RADIOL, V38, P551, DOI 10.1007/s00247-007-0735-3; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; SAVIDES TJ, 1995, GASTROENTEROLOGY, V109, P366, DOI 10.1016/0016-5085(95)90322-4; Schneider Joachim, 1996, Reviews on Environmental Health, V11, P65; SHERRICK AD, 1994, CHEST, V106, P484, DOI 10.1378/chest.106.2.484; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; STARK P, 1990, RADIOLOGY, V174, P725, DOI 10.1148/radiology.174.3.2305056; Suen HC, 2002, ANN THORAC SURG, V73, P665, DOI 10.1016/S0003-4975(01)02740-0; Togashi K, 2007, Kyobu Geka, V60, P49; Tossavainen A, 2004, INT J OCCUP ENV HEAL, V10, P22, DOI 10.1179/oeh.2004.10.1.22; Usami N, 2005, GEN THORAC CARDIOVAS, V53, P102, DOI 10.1007/s11748-005-0010-1; Welch LS, 2005, INT J OCCUP ENV HEAL, V11, P254; WOLF KM, 1987, ARCH INTERN MED, V147, P2145, DOI 10.1001/archinte.147.12.2145; YOUSEM SA, 1987, ARCH PATHOL LAB MED, V111, P62	36	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1886	1895		10.1056/NEJMcpc0900637	http://dx.doi.org/10.1056/NEJMcpc0900637			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403907				2022-12-28	WOS:000265560300012
J	Mabberley, DJ				Mabberley, David J.			Exploring Terra Incognita	SCIENCE			English	Editorial Material							KORUP NATIONAL-PARK		Royal Bot Gardens, Richmond TW9 3AE, Surrey, England	Royal Botanic Gardens, Kew	Mabberley, DJ (corresponding author), Royal Bot Gardens, Richmond TW9 3AE, Surrey, England.	d.mabberley@kew.org						Magurran AE, 2005, CURR BIOL, V15, pR116, DOI 10.1016/j.cub.2005.02.006; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; THULIN M, 1989, PLANT SYST EVOL, V166, P249, DOI 10.1007/BF00935953; Thulin M, 2001, NORD J BOT, V21, P393, DOI 10.1111/j.1756-1051.2001.tb00783.x; Thulin M., 2006, FLORA SOMALIA, V3; Thulin Mats, 2008, Kew Bulletin, V63, P617, DOI 10.1007/s12225-008-9060-8; Thulin M, 2008, NORD J BOT, V26, P218, DOI 10.1111/j.1756-1051.2008.00245.x; van der Burgt XM, 2007, ADANSONIA, V29, P59; van der Burgt Xander M., 2006, Kew Bulletin, V61, P79	9	7	9	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					472	472		10.1126/science.1173323	http://dx.doi.org/10.1126/science.1173323			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390032				2022-12-28	WOS:000265411200031
J	Roberts, RM; Smith, GW; Bazer, FW; Cibelli, J; Seidel, GE; Bauman, DE; Reynolds, LP; Ireland, JJ				Roberts, R. M.; Smith, G. W.; Bazer, F. W.; Cibelli, J.; Seidel, G. E., Jr.; Bauman, D. E.; Reynolds, L. P.; Ireland, J. J.			Farm Animal Research in Crisis	SCIENCE			English	Editorial Material							BIOMEDICAL-RESEARCH; DOMESTIC-ANIMALS; RESOURCES		[Smith, G. W.; Cibelli, J.; Ireland, J. J.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Roberts, R. M.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Bazer, F. W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Seidel, G. E., Jr.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Bauman, D. E.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Reynolds, L. P.] N Dakota State Univ, Dept Anim Sci, Fargo, ND 58105 USA	Michigan State University; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; Colorado State University; Cornell University; North Dakota State University Fargo	Ireland, JJ (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	lreland@msu.edu	Reynolds, Lawrence P/I-5267-2015; Seidel, George/AAE-2371-2019; Bazer, Fuller/AAF-4317-2021	Reynolds, Lawrence P/0000-0002-6838-7809; Bazer, Fuller/0000-0002-5823-5086; Cibelli, Jose/0000-0002-2176-3854				BROOKS DL, 2006, LAB ANIMAL MED, P273; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; *FDN BIOM RES, NOB PRIZ; *FOOD AGR ED INF S, 2007, AN SCI GRAD ENR; Fulton JE, 2003, SCIENCE, V300, P1667, DOI 10.1126/science.1085407; GIBBS R, 2004, BOVINE GENOMIC SEQUE; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huffman WE, 2006, AM J AGR ECON, V88, P783, DOI 10.1111/j.1467-8276.2006.00898.x; Ireland JJ, 2008, J ANIM SCI, V86, P2797, DOI 10.2527/jas.2008-1088; King AJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1837, DOI 10.1152/ajpendo.00668.2006; Mirando MA, 2006, BIOL REPROD, V74, P459, DOI 10.1095/biolreprod.105.048686; NRC, 1989, INV RES PROP STRENGT; NRC, 2000, NAT RES IN VIT COMP; NRC (National Research Council), 1972, REP COMM RES ADV US; Padmanabhan V, 2007, REV ENDOCR METAB DIS, V8, P67, DOI 10.1007/s11154-007-9051-3; Reynolds LP, 2008, J ANIM SCI, V86, P2445, DOI 10.2527/jas.2008-1387; Reynolds LP, 2009, J NUTR, V139, P427, DOI 10.3945/jn.108.103564; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; *US DHHS, BUDG BRIEF; *USDA, USDA FY2007 BUDG SUM; *USDA RES ED EC IN, 2007, USDA RES ED EC INF S; 2007 CENSUS AGR EC	22	61	63	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					468	469		10.1126/science.1168521	http://dx.doi.org/10.1126/science.1168521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390030				2022-12-28	WOS:000265411200029
J	Brenner, MJ				Brenner, Michael J.			Collateral Damage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												mbrenner@siumed.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1637	1638		10.1001/jama.2009.543	http://dx.doi.org/10.1001/jama.2009.543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435NN	19383945				2022-12-28	WOS:000265350700001
J	Fletcher, RH				Fletcher, Robert H.			Review: Newer screening tests have varied sensitivity and moderate-to-high specificity for detecting colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Chapel Hill, NC USA	Harvard University	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, Chapel Hill, NC USA.							Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-15	10.7326/0003-4819-150-8-200904210-02015	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391229				2022-12-28	WOS:000265457000030
J	Mountford, J				Mountford, James			This House believes doctors are neglecting their duty to lead health service change: Seconder	BRITISH MEDICAL JOURNAL			English	Editorial Material									McKinsey & Co Inc, New York, NY 10022 USA		Mountford, J (corresponding author), McKinsey & Co Inc, New York, NY 10022 USA.	James_Mountford@mckinsey.com						*BRIT ASS MED MAN, US; Castro P., 2008, MCKINSEY Q; Institute of Medicine, 2001, CROSSING QUALITY CHA; Lee TH, 2007, NEW ENGL J MED, V357, P111, DOI 10.1056/NEJMp078025; Myocardial Ischaemia National Audit (MINAP), 2008, 7 MINAP; *NHS BREAST SCREEN, 2008, AUD SCREEN DET BREAS; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517	7	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2009	338								b1572	10.1136/bmj.b1572	http://dx.doi.org/10.1136/bmj.b1572			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OO	19383752				2022-12-28	WOS:000265497000003
J	Callier, V; Clack, JA; Ahlberg, PE				Callier, Viviane; Clack, Jennifer A.; Ahlberg, Per E.			Contrasting Developmental Trajectories in the Earliest Known Tetrapod Forelimbs	SCIENCE			English	Article							EARLY EVOLUTION; PECTORAL FIN; ORIGIN; ICHTHYOSTEGA; SKELETON; ANATOMY; ROMER	Ichthyostega and Acanthostega are the earliest tetrapods known from multiple near-complete skeletons, with Acanthostega generally considered the more primitive. New material indicates differing ontogenetic trajectories for their forelimbs: In Ichthyostega, the pattern of muscle attachment processes on small humeri (upper arm bones) resembles that in "fish" members of the tetrapod stem group such as Tiktaalik, whereas large humeri approach (but fail to attain) the tetrapod crown-group condition; in Acanthostega, both small and large humeri exhibit the crown-group pattern. We infer that Ichthyostega underwent greater locomotory terrestrialization during ontogeny. The newly recognized primitive characteristics also suggest that Ichthyostega could be phylogenetically more basal than Acanthostega.	[Ahlberg, Per E.] Uppsala Univ, Evolutionary Biol Ctr, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden; [Callier, Viviane; Clack, Jennifer A.] Univ Museum Zool Cambridge, Cambridge CB2 3EJ, England	Uppsala University; University of Cambridge	Ahlberg, PE (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Ahlberg, Per/E-8086-2013	Callier, Viviane/0000-0002-9754-560X; Ahlberg, Per/0000-0001-9054-2900	Churchill Fellowship from the Winston Churchill Foundation; Vetenskapsra det (the Swedish Research Council)	Churchill Fellowship from the Winston Churchill Foundation; Vetenskapsra det (the Swedish Research Council)(Swedish Research Council)	We thank the Geological Museum, Copenhagen, for the loan of specimens; the staff of the University of Texas CT unit for scanning MGUH f.n. 301a; N. Shubin for access to the Tiktaalik material; and E. Rayfield for help with the Amira modeling software. Supported by a Churchill Fellowship from the Winston Churchill Foundation (V.C.) and by Vetenskapsra det (the Swedish Research Council) (P.E.A.).	Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Blom H, 2005, PALAEONTOLOGY, V48, P111, DOI 10.1111/j.1475-4983.2004.00435.x; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Clack JA., 2005, J SYST PALAEONTOL, V2, P311, DOI [10.1017/S1477201904001506, DOI 10.1017/S1477201904001506]; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; HOLMES R, 1984, PHILOS T ROY SOC B, V306, P431, DOI 10.1098/rstb.1984.0103; Jarvik Erik, 1996, Fossils and Strata, V40, P1; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632	15	44	47	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					364	367		10.1126/science.1167542	http://dx.doi.org/10.1126/science.1167542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372425				2022-12-28	WOS:000265221600035
J	Menuz, V; Howell, KS; Gentina, S; Epstein, S; Riezman, I; Fornallaz-Mulhauser, M; Hengartner, MO; Gomez, M; Riezman, H; Martinou, JC				Menuz, Vincent; Howell, Kate S.; Gentina, Sebastien; Epstein, Sharon; Riezman, Isabelle; Fornallaz-Mulhauser, Monique; Hengartner, Michael O.; Gomez, Marie; Riezman, Howard; Martinou, Jean-Claude			Protection of C-elegans from Anoxia by HYL-2 Ceramide Synthase	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; (DIHYDRO)CERAMIDE SYNTHASE; SUSPENDED ANIMATION; FAMILY-MEMBERS; SPHINGOID BASE; GENE LAG1; PROTEIN; APOPTOSIS; REQUIRES; HYPOXIA	Oxygen deprivation is rapidly deleterious for most organisms. However, Caenorhabditis elegans has developed the ability to survive anoxia for at least 48 hours. Mutations in the DAF-2/DAF-16 insulin-like signaling pathway promote such survival. We describe a pathway involving the HYL-2 ceramide synthase that acts independently of DAF-2. Loss of the ceramide synthase gene hyl-2 results in increased sensitivity of C. elegans to anoxia. C. elegans has two ceramide synthases, hyl-1 and hyl-2, that participate in ceramide biogenesis and affect its ability to survive anoxic conditions. In contrast to hyl-2(lf) mutants, hyl-1(lf) mutants are more resistant to anoxia than normal animals. HYL-1 and HYL-2 have complementary specificities for fatty acyl chains. These data indicate that specific ceramides produced by HYL-2 confer resistance to anoxia.	[Howell, Kate S.; Epstein, Sharon; Riezman, Isabelle; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Menuz, Vincent; Gentina, Sebastien; Fornallaz-Mulhauser, Monique; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Howell, Kate S.] Univ Melbourne, Fac Land & Food Resource, Parkville, Vic 3010, Australia; [Hengartner, Michael O.] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; [Gomez, Marie] Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Melbourne; University of Zurich; University of Geneva	Riezman, H (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland.	Howard.Riezman@unige.ch; Jean-Claude.Martinou@unige.ch	Howell, Kate/M-2370-2013; Hengartner, Michael O/E-6235-2011	Howell, Kate/0000-0001-6498-0472; Hengartner, Michael/0000-0002-7584-596X; Riezman, Howard/0000-0003-4680-9422; martinou, Jean-claude/0000-0002-9847-2051	Swiss National Science Foundation [3100A0-109419/2, 3100A0-114189, 3100A0-105907/1, 3100A0-113889]; Human Frontiers Science Program Organization; Swiss SystemsX.ch initiative; Roche Foundation; Ernest Boninchi; Canton of Zurich; Ernst Hadorm Foundation; Geneva Department of Education	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers Science Program Organization(Human Frontier Science Program); Swiss SystemsX.ch initiative; Roche Foundation; Ernest Boninchi; Canton of Zurich; Ernst Hadorm Foundation; Geneva Department of Education	We thank F. Solary for help with analysis of aging; Y. Mattenberger and D. Courvoisier from the Clinical Research Center University of Geneva and Geneva University Hospitals for statistical support; S. Herzig for artwork; S. Mitani and the Japanese National Bioresource Project for tm strains; and J. Hodgkin for providing strains CB5670, CB6166, CB5439, and CB5430. Some nematodes were provided by the Caenorhabditis Genome Center, which is funded by the NIH National Center for Research Resources. This work was funded by the Swiss National Science Foundation [subsidies 3100A0-109419/2 (J.-C.M.), 3100A0-114189 (H.R.), 3100A0-105907/1 (M.G.), and 3100A0-113889 (M.O.H.)], the Human Frontiers Science Program Organization (H.R.), the Swiss SystemsX.ch initiative (H.R.) evaluated by the Swiss National Science Foundation, the Roche Foundation (V.M.), Ernest Boninchi subsidy for the purchase of the anoxic chamber, the Canton of Zurich (M.O.H.), the Ernst Hadorm Foundation (M.O.H.), and the Geneva Department of Education.	CHITWOOD DJ, 1995, LIPIDS, V30, P567, DOI 10.1007/BF02537032; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Hajeri VA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-6; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Nystul TG, 2003, SCIENCE, V302, P1038, DOI 10.1126/science.1089705; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	21	123	134	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					381	384		10.1126/science.1168532	http://dx.doi.org/10.1126/science.1168532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372430	Green Published			2022-12-28	WOS:000265221600040
J	Gielen, M; Retchless, BS; Mony, L; Johnson, JW; Paoletti, P				Gielen, Marc; Retchless, Beth Siegler; Mony, Laetitia; Johnson, Jon W.; Paoletti, Pierre			Mechanism of differential control of NMDA receptor activity by NR2 subunits	NATURE			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; ZINC INHIBITION; LIGAND-BINDING; MOLECULAR DETERMINANTS; CHANNEL; DOMAIN; AFFINITY; ACTIVATION; PROTON	N-methyl-D-aspartate ( NMDA) receptors (NMDARs) are a major class of excitatory neurotransmitter receptors in the central nervous system. They form glutamate-gated ion channels that are highly permeable to calcium and mediate activity-dependent synaptic plasticity(1). NMDAR dysfunction is implicated in multiple brain disorders, including stroke, chronic pain and schizophrenia(2). NMDARs exist as multiple subtypes with distinct pharmacological and biophysical properties that are largely determined by the type of NR2 subunit (NR2A to NR2D) incorporated in the heteromeric NR1/NR2 complex(1,3,4). A fundamental difference between NMDAR subtypes is their channel maximal open probability (Po), which spans a 50-fold range from about 0.5 for NR2A-containing receptors to about 0.01 for receptors containing NR2C and NR2D; NR2B-containing receptors have an intermediate value (about 0.1)(5-9). These differences in Po confer unique charge transfer capacities and signalling properties on each receptor subtype(4,6,10,11). The molecular basis for this profound difference in activity between NMDAR subtypes is unknown. Here we show that the subunit-specific gating of NMDARs is controlled by the region formed by the NR2 amino-terminal domain (NTD), an extracellular clamshell-like domain previously shown to bind allosteric inhibitors(12-15), and the short linker connecting the NTD to the agonist-binding domain (ABD). The subtype specificity of NMDAR Po largely reflects differences in the spontaneous (ligand-independent) equilibrium between open-cleft and closed-cleft conformations of the NR2-NTD. This NTD-driven gating control also affects pharmacological properties by setting the sensitivity to the endogenous inhibitors zinc and protons. Our results provide a proof of concept for a drug-based bidirectional control of NMDAR activity by using molecules acting either as NR2-NTD 'closers' or 'openers' promoting receptor inhibition or potentiation, respectively.	[Gielen, Marc; Mony, Laetitia; Paoletti, Pierre] CNRS, Ecole Normale Super, Neurobiol Lab, F-75005 Paris, France; [Retchless, Beth Siegler; Johnson, Jon W.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Paoletti, P (corresponding author), CNRS, Ecole Normale Super, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	paoletti@biologie.ens.fr	Mony, Laetitia/F-3790-2017; Gielen, Marc/AAA-8760-2020; Mony, Laetitia/AAZ-9340-2020; Paoletti, Pierre/L-7358-2013	Mony, Laetitia/0000-0001-7753-6231; Paoletti, Pierre/0000-0002-3681-4845; Gielen, Marc/0000-0003-0941-4325	Ministere de la Recherche; Universite Pierre et Marie Curie (UPMC); Fondation pour la Recherche Medicale (FRM); NIH [R01 MH045817]; Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale pour la Recherche (ANR); GlaxoSmith Kline; Equipe FRM; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045817, F31MH079755] Funding Source: NIH RePORTER	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Universite Pierre et Marie Curie (UPMC); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); GlaxoSmith Kline(GlaxoSmithKline); Equipe FRM; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Barbour, P.-J. Corringer, J. Neyton and D. Stroebel for comments on the manuscript, and S. Carvalho, M. Casado and M. Gendrel for experimental help. This work was supported by the Ministere de la Recherche (M. G., L. M.), the Universite Pierre et Marie Curie (UPMC) and the Fondation pour la Recherche Medicale (FRM) ( M. G.), NIH grant R01 MH045817 ( J. W. J.), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Agence Nationale pour la Recherche (ANR), GlaxoSmith Kline and an Equipe FRM grant (P. P.).	Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Colquhoun David, 1995, P483; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; JACKSON MB, 1983, BIOPHYS J, V42, P109, DOI 10.1016/S0006-3495(83)84375-6; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Low CM, 2003, MOL PHARMACOL, V63, P1212, DOI 10.1124/mol.63.6.1212; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mony L, 2009, MOL PHARMACOL, V75, P60, DOI 10.1124/mol.108.050971; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894	38	236	247	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					703	U107		10.1038/nature07993	http://dx.doi.org/10.1038/nature07993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19404260	Green Submitted, Green Accepted			2022-12-28	WOS:000266608600044
J	Ma, Y; Szostkiewicz, I; Korte, A; Moes, D; Yang, Y; Christmann, A; Grill, E				Ma, Yue; Szostkiewicz, Izabela; Korte, Arthur; Moes, Daniele; Yang, Yi; Christmann, Alexander; Grill, Erwin			Regulators of PP2C Phosphatase Activity Function as Abscisic Acid Sensors	SCIENCE			English	Article							EARLY SEEDLING DEVELOPMENT; CRYSTAL-STRUCTURE; ABA CONTROL; ARABIDOPSIS; PROTEIN; ABI1; GERMINATION; RECEPTOR; SIGNAL; TRANSDUCTION	The plant hormone abscisic acid (ABA) acts as a developmental signal and as an integrator of environmental cues such as drought and cold. Key players in ABA signal transduction include the type 2C protein phosphatases (PP2Cs) ABI1 and ABI2, which act by negatively regulating ABA responses. In this study, we identify interactors of ABI1 and ABI2, which we have named regulatory components of ABA receptor (RCARs). In Arabidopsis, RCARs belong to a family with 14 members that share structural similarity with class 10 pathogen-related proteins. RCAR1 was shown to bind ABA, to mediate ABA-dependent inactivation of ABI1 or ABI2 in vitro, and to antagonize PP2C action in planta. Other RCARs also mediated ABA-dependent regulation of ABI1 and ABI2, consistent with a combinatorial assembly of receptor complexes.	[Ma, Yue; Szostkiewicz, Izabela; Korte, Arthur; Moes, Daniele; Yang, Yi; Christmann, Alexander; Grill, Erwin] Tech Univ Munich, Lehrstuhl Bot, D-85354 Freising Weihenstephan, Germany	Technical University of Munich	Grill, E (corresponding author), Tech Univ Munich, Lehrstuhl Bot, Hochanger 4, D-85354 Freising Weihenstephan, Germany.	erwin.grill@wzw.tum.de	Christmann, Alexander/I-2655-2017; Korte, Arthur/H-3190-2019	Christmann, Alexander/0000-0002-3242-0814; Korte, Arthur/0000-0003-0831-1463; Yang, Yi/0000-0001-6051-4992	Deutsche Forschungsgemeinschaft [CH-182/5]; European Union Marie-Curie-Program [MEST-CT-2005-020232]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union Marie-Curie-Program(European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This study was funded by the Deutsche Forschungsgemeinschaft CH-182/5, European Union Marie-Curie-Program MEST-CT-2005-020232, and the Fonds der Chemischen Industrie. We thank J. Berger, C. Heidersberger, and C. Kornbauer for technical assistance. We are grateful to D. Weinfurtner, Chemistry Department TUM, and K. Berendzen, University of Tubingen, for help in conducting the ITC and FACS analysis, respectively. The cytokinin reporter and the At5g46790 cDNA clone were kindly provided by J. Sheen, Harvard University, and the Arabidopsis Biological Resource Center, USA, respectively. We thank F. Assaad for critical reading of the manuscript. This contribution is dedicated to Hubert Ziegler, who passed away on 17 April 2009.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Christmann A, 2007, PLANT J, V52, P167, DOI 10.1111/j.1365-313X.2007.03234.x; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Leube MP, 1998, FEBS LETT, V424, P100, DOI 10.1016/S0014-5793(98)00149-5; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Yang Y, 2006, P NATL ACAD SCI USA, V103, P6061, DOI 10.1073/pnas.0501720103; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128	31	1518	1674	10	449	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1064	1068		10.1126/science.1172408	http://dx.doi.org/10.1126/science.1172408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407143				2022-12-28	WOS:000266246700040
J	Tsai, HC; Zhang, F; Adamantidis, A; Stuber, GD; Bonci, A; de Lecea, L; Deisseroth, K				Tsai, Hsing-Chen; Zhang, Feng; Adamantidis, Antoine; Stuber, Garret D.; Bonci, Antonello; de Lecea, Luis; Deisseroth, Karl			Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning	SCIENCE			English	Article							PLACE PREFERENCE; DEFICIENT MICE; REWARD; ADDICTION; SYSTEMS; CHANNELRHODOPSIN-2; DYSREGULATION; MOTIVATION; CIRCUIT; HABITS	Natural rewards and drugs of abuse can alter dopamine signaling, and ventral tegmental area (VTA) dopaminergic neurons are known to fire action potentials tonically or phasically under different behavioral conditions. However, without technology to control specific neurons with appropriate temporal precision in freely behaving mammals, the causal role of these action potential patterns in driving behavioral changes has been unclear. We used optogenetic tools to selectively stimulate VTA dopaminergic neuron action potential firing in freely behaving mammals. We found that phasic activation of these neurons was sufficient to drive behavioral conditioning and elicited dopamine transients with magnitudes not achieved by longer, lower-frequency spiking. These results demonstrate that phasic dopaminergic activity is sufficient to mediate mammalian behavioral conditioning.	[Tsai, Hsing-Chen] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Tsai, Hsing-Chen; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Adamantidis, Antoine; de Lecea, Luis; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Stuber, Garret D.; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Wheeler Ctr Neurobiol Drug Addict, San Francisco, CA 94158 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Deisseroth, K (corresponding author), Stanford Univ, Neurosci Program, W080 Clark Ctr,318 Campus Dr W, Stanford, CA 94305 USA.	deissero@stanford.edu	Stuber, Garret/E-1160-2011; de Lecea, Luis/ABE-4005-2021; de Lecea, Luis/B-3171-2009; Macrae, Rhiannon/AAX-1536-2020	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942; Stuber, Garret/0000-0003-1730-4855; Adamantidis, Antoine/0000-0003-2531-5175	Stanford Graduate Fellowship; NIH National Research Service award; Fonds National de la Recherche Scientifique; NARSAD; Fondation Leon Fredericq; National Institute on Drug Abuse (NIDA); Defense Advanced Research Projects Agency; NSF; National Institute of Mental Health; McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS065009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021880] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); NIH National Research Service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NARSAD(NARSAD); Fondation Leon Fredericq; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Wightman, P. Phillips, and the entire Deisseroth laboratory for their support. All reagents and protocols are freely distributed and supported by the authors (www.optogenetics.org); because these tools are not protected by patents, Stanford University has applied for a patent to ensure perpetual free distribution to the international academic nonprofit community. H.C.T. is supported by a Stanford Graduate Fellowship. F.Z. and G.D.S. are supported by NIH National Research Service award. A.R.A. is supported by the Fonds National de la Recherche Scientifique, NARSAD, and the Fondation Leon Fredericq. L.d.L. is supported by National Institute on Drug Abuse (NIDA), Defense Advanced Research Projects Agency, and NARSAD. K.D. is supported by NSF; National Institute of Mental Health; NIDA; and the McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cannon CM, 2003, J NEUROSCI, V23, P10827; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; Hnasko TS, 2007, J NEUROSCI, V27, P12484, DOI 10.1523/JNEUROSCI.3133-07.2007; Kalivas PW, 2007, AM J ADDICTION, V16, P71, DOI 10.1080/10550490601184142; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Picciotto MR, 2002, J NEUROSCI, V22, P3338; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Williams J, 2005, J CHILD ADOL PSYCHOP, V15, P160, DOI 10.1089/cap.2005.15.160; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhang F., 2008, COLD SPRING HARB LAB; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	29	828	877	2	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1080	1084		10.1126/science.1168878	http://dx.doi.org/10.1126/science.1168878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19389999	Green Accepted			2022-12-28	WOS:000266246700044
J	Chen, HY; Lien, CY; Lin, WY; Lee, YT; Lin, JJ				Chen, Hsueh-Ying; Lien, Chien-Yu; Lin, Wei-Yen; Lee, Yuan T.; Lin, Jim J.			UV Absorption Cross Sections of ClOOCl Are Consistent with Ozone Degradation Models	SCIENCE			English	Article							CHLORINE PEROXIDE; SELF-REACTION; ULTRAVIOLET; DIMER; NM; PHOTODISSOCIATION; SPECTRUM; KINETICS; CL2O; PHOTOLYSIS	Recently, discrepancies in laboratory measurements of chlorine peroxide (ClOOCl) absorption cross sections have cast doubt on the validity of current photochemical models for stratospheric ozone degradation. Whereas previous ClOOCl absorption measurements all suffered from uncertainties due to absorption by impurities, we demonstrate here a method that uses mass-selected detection to circumvent such interference. The cross sections of ClOOCl were determined at two critical wavelengths (351 and 308 nanometers). Our results are sufficient to resolve the controversial issue originating from the ClOOCl laboratory cross sections and suggest that the highest laboratory estimates for atmospheric photolysis rates of ClOOCl, which best explain the field measurements via current chemical models, are reasonable.	[Chen, Hsueh-Ying; Lien, Chien-Yu; Lin, Wei-Yen; Lee, Yuan T.; Lin, Jim J.] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan; [Lin, Wei-Yen; Lee, Yuan T.] Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan; [Lin, Jim J.] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 30010, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University	Lin, JJ (corresponding author), Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan.	jimlin@gate.sinica.edu.tw	Lee, Yuan-Tseh/F-7914-2012; Lin, Jim/F-7916-2012; Chen, Hsueh-Ying/GVR-8208-2022	Lin, Jim/0000-0002-8308-2552; 	Academia Sinica; National Science Council, Taiwan [NSC 95-2113-M-001-041-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported by Academia Sinica and National Science Council (NSC 95-2113-M-001-041-MY3), Taiwan. We thank M.-C. Liang for bringing our attention to the ClOOCl issue and K. A. Boering and Y.-P. Lee for valuable comments.	Aures R, 2002, J CHEM PHYS, V117, P2141, DOI 10.1063/1.1489415; BIRK M, 1989, J CHEM PHYS, V91, P6588, DOI 10.1063/1.457377; Bloss WJ, 2001, J PHYS CHEM A, V105, P11226, DOI 10.1021/jp012429y; Broske R, 2006, J PHYS CHEM A, V110, P3280, DOI 10.1021/jp0550053; BURKHOLDER JB, 1990, J PHYS CHEM-US, V94, P687, DOI 10.1021/j100365a033; COX RA, 1988, NATURE, V332, P796, DOI 10.1038/332796a0; DEMORE WB, 1990, J PHYS CHEM-US, V94, P5856, DOI 10.1021/j100378a046; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; HUDER KJ, 1995, J PHYS CHEM-US, V99, P3905, DOI 10.1021/j100012a007; Ingham T, 2005, FARADAY DISCUSS, V130, P89, DOI 10.1039/b500179j; Kaledin AL, 2000, J CHEM PHYS, V113, P5750, DOI 10.1063/1.1290606; LIN CL, 1976, J CHEM ENG DATA, V21, P411, DOI 10.1021/je60071a030; Lin JJ, 1998, REV SCI INSTRUM, V69, P1642, DOI 10.1063/1.1148821; McKeachie JR, 2004, J PHYS CHEM B, V108, P16786, DOI 10.1021/jp049314p; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; Moore TA, 1999, J PHYS CHEM A, V103, P1691, DOI 10.1021/jp984410+; Moore TA, 1997, J CHEM PHYS, V107, P3337, DOI 10.1063/1.474706; Nickolaisen SL, 1996, J CHEM PHYS, V104, P2857, DOI 10.1063/1.471109; Peterson KA, 2004, J CHEM PHYS, V121, P2611, DOI 10.1063/1.1766012; Plenge J, 2005, J PHYS CHEM A, V109, P6730, DOI 10.1021/jp044142h; Pope FD, 2007, J PHYS CHEM A, V111, P4322, DOI 10.1021/jp067660w; Sander S. P., 2006, CHEM KINETICS PHOTOC; Schiermeier Q, 2007, NATURE, V449, P382, DOI 10.1038/449382a; Stimpfle RM, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003811; Toniolo A, 2001, PHYS CHEM CHEM PHYS, V3, P4266, DOI 10.1039/b104044h; von Hobe M, 2007, ATMOS CHEM PHYS, V7, P3055, DOI 10.5194/acp-7-3055-2007; von Hobe M, 2007, SCIENCE, V318, P1878, DOI 10.1126/science.1151597; von Hobe M, 2009, PHYS CHEM CHEM PHYS, V11, P1571, DOI 10.1039/b814373k; World Meteorological Organization (WMO), 2007, SCI ASS OZ DEPL 2006	29	43	44	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					781	784		10.1126/science.1171305	http://dx.doi.org/10.1126/science.1171305			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423825				2022-12-28	WOS:000265832400045
J	James, SK; Stenestrand, U; Lindback, J; Carlsson, J; Schersten, F; Nilsson, T; Wallentin, L; Lagerqvist, B				James, Stefan K.; Stenestrand, Ulf; Lindback, Johan; Carlsson, Jorg; Schersten, Fredrik; Nilsson, Tage; Wallentin, Lars; Lagerqvist, Bo		SCAAR Study Grp	Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOLOGY-HOSPITAL RESEARCH; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIALS; CLINICAL-OUTCOMES; RESEARCH REGISTRY; THROMBOSIS; IMPLANTATION; METAANALYSIS; PREDICTORS	Background: The long-term safety and efficacy of drug-eluting coronary stents have been questioned. Methods: We evaluated 47,967 patients in Sweden who received a coronary stent and were entered into the Swedish Coronary Angiography and Angioplasty Registry between 2003 and 2006 and for whom complete follow-up data were available for 1 to 5 years (mean, 2.7). In the primary analysis, we compared patients who received one drug-eluting coronary stent (10,294 patients) with those who received one bare-metal stent (18,659), after adjustment for differences in clinical characteristics of the patients and characteristics of the vessels and lesions. Results: Analyses of outcome were based on 2380 deaths and 3198 myocardial infarctions. There was no overall difference between the group that received drug-eluting stents and the group that received bare-metal stents in the combined end point of death or myocardial infarction (relative risk with drug-eluting stents, 0.96; 95% confidence interval [CI], 0.89 to 1.03) or the individual end points of death (relative risk, 0.94; 95% CI, 0.85 to 1.05) and myocardial infarction (relative risk, 0.97; 95% CI, 0.88 to 1.06), and there was no significant difference in outcome among subgroups stratified according to the indication for stent implantation. Patients who received drug-eluting stents in 2003 had a significantly higher rate of late events than patients who received bare-metal stents in the same year, but we did not observe any difference in outcome among patients treated in later years. The average rate of restenosis during the first year was 3.0 events per 100 patient-years with drug-eluting stents versus 4.7 with bare-metal stents (adjusted relative risk, 0.43; 95% CI, 0.36 to 0.52); 39 patients would need to be treated with drug-eluting stents to prevent one case of restenosis. Among high-risk patients, the adjusted risk of restenosis was 74% lower with drug-eluting stents than with bare-metal stents, and only 10 lesions would need to be treated to prevent one case of restenosis. Conclusions: As compared with bare-metal stents, drug-eluting stents are associated with a similar long-term incidence of death or myocardial infarction and provide a clinically important decrease in the rate of restenosis among high-risk patients. N Engl J Med 2009;360:1933-45.	[James, Stefan K.; Wallentin, Lars; Lagerqvist, Bo] Univ Uppsala Hosp, Uppsala Clin Res Ctr, Dept Cardiol, S-75185 Uppsala, Sweden; [Stenestrand, Ulf] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden; [Carlsson, Jorg] Lanssjukhuset Kalmar, Dept Cardiol, Kalmar, Sweden; [Schersten, Fredrik] Helsingborg Lasarett, Dept Cardiol, Helsingborg, Sweden; [Nilsson, Tage] Karlstad Lasarett, Svensk PCI, Karlstad, Sweden	Uppsala University; Uppsala University Hospital; Linkoping University; Helsingborgs Hospital	James, SK (corresponding author), Univ Uppsala Hosp, Uppsala Clin Res Ctr, Dept Cardiol, S-75185 Uppsala, Sweden.	stefan.james@akademiska.se	James, Stefan K/J-4554-2014; Lindbäck, Johan/R-2900-2017	Lindbäck, Johan/0000-0002-6473-8798				Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; Brunner-La Rocca HP, 2007, LANCET, V370, P1552; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Doyle B, 2007, CIRCULATION, V116, P2391, DOI 10.1161/CIRCULATIONAHA.107.707331; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Flynn MR, 2005, EUR HEART J, V26, P308, DOI 10.1093/eurheartj/ehi079; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Jensen LO, 2007, J AM COLL CARDIOL, V50, P463, DOI 10.1016/j.jacc.2007.06.002; Kastrati A, 2007, EUR HEART J, V28, P2706, DOI 10.1093/eurheartj/ehm402; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lemos PA, 2004, CIRCULATION, V109, P1366, DOI 10.1161/01.CIR.0000121358.26097.06; Lemos PA, 2004, AM J CARDIOL, V93, P633, DOI 10.1016/j.amjcard.2003.11.037; Marzocchi A, 2007, CIRCULATION, V115, P3181, DOI 10.1161/CIRCULATIONAHA.106.667592; Mauri L, 2008, CIRCULATION, V118, P1817, DOI 10.1161/CIRCULATIONAHA.108.781377; Ong ATL, 2006, J AM COLL CARDIOL, V47, P1356, DOI 10.1016/j.jacc.2005.05.102; Ong ATL, 2005, J AM COLL CARDIOL, V45, P1135, DOI 10.1016/j.jacc.2005.01.008; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; *R DEV COR TEAM, 2006, LANG ENV STAT COMP V; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; Williams DO, 2006, CIRCULATION, V114, P2154, DOI 10.1161/CIRCULATIONAHA.106.667915	27	190	198	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1933	1945		10.1056/NEJMoa0809902	http://dx.doi.org/10.1056/NEJMoa0809902			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420363				2022-12-28	WOS:000265784400004
J	Edwards, M				Edwards, Martin			Historical keyword Triage	LANCET			English	Editorial Material									Wellcome Trust Ctr Hist Med UCL, London, England	University of London; University College London	Edwards, M (corresponding author), Wellcome Trust Ctr Hist Med UCL, London, England.	martin.edwards@ucl.ac.uk							0	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 2	2009	373	9674					1515	1515		10.1016/S0140-6736(09)60843-6	http://dx.doi.org/10.1016/S0140-6736(09)60843-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19410702				2022-12-28	WOS:000265710300012
J	Rabbitts, TH				Rabbitts, Terence H.			Commonality but Diversity in Cancer Gene Fusions	CELL			English	Article							CHROMOSOMAL TRANSLOCATIONS; ACTIVATING MUTATIONS; PROSTATE-CANCER; LUNG-CANCER; ALK KINASE; LEUKEMIA; NEUROBLASTOMA; IDENTIFICATION; ONCOGENE; BREAST	Recent findings of gene fusions in carcinomas recapitulate the discovery of chromosomal abnormalities in leukemias and sarcomas decades ago. A recurring feature of carcinoma gene fusions, in contrast to those in hematopoietic and mesenchymal malignancies, is that they result in aberrant cell signaling. This may reflect differences in the differentiation programs of these tissues.	Univ Leeds, Sect Expt Therapeut, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	University of Leeds	Rabbitts, TH (corresponding author), Univ Leeds, Sect Expt Therapeut, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	thr@leeds.ac.uk	Rabbitts, Terence/D-6262-2016	Rabbitts, Terence/0000-0002-4982-2609	MRC [G0600914] Funding Source: UKRI; Medical Research Council [MC_U105178807, G0600914] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Armstrong SA, 2003, SEMIN HEMATOL, V40, P268, DOI 10.1016/S0037-1963(03)00196-3; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; GRIECO M, 1988, ANN NY ACAD SCI, V551, P380, DOI 10.1111/j.1749-6632.1988.tb22370.x; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; NOWELL PC, 1960, SCIENCE, V132, P1497; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rowley JD, 2000, LEUKEMIA, V14, P513, DOI 10.1038/sj.leu.2401600; Sawyers Charles L, 2005, Clin Adv Hematol Oncol, V3, P757; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; TJIO JH, 1956, HEREDITAS, V42, pU1; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	35	55	60	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					391	395		10.1016/j.cell.2009.04.034	http://dx.doi.org/10.1016/j.cell.2009.04.034			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410533	Bronze			2022-12-28	WOS:000265677200006
J	Randau, L; Stanley, BJ; Kohlway, A; Mechta, S; Xiong, Y; Soll, D				Randau, Lennart; Stanley, Bradford J.; Kohlway, Andrew; Mechta, Sarah; Xiong, Yong; Soll, Dieter			A Cytidine Deaminase Edits C to U in Transfer RNAs in Archaea	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ADENOSINE-DEAMINASE; FUNCTIONAL IMPLICATIONS; METHANOPYRUS-KANDLERI; ESCHERICHIA-COLI; GENETIC ELEMENTS; DOMAIN; 4-THIOURIDINE; APOBEC3G; INOSINE	All canonical transfer RNAs (tRNAs) have a uridine at position 8, involved in maintaining tRNA tertiary structure. However, the hyperthermophilic archaeon Methanopyrus kandleri harbors 30 (out of 34) tRNA genes with cytidine at position 8. Here, we demonstrate C-to-U editing at this location in the tRNA's tertiary core, and present the crystal structure of a tRNA-specific cytidine deaminase, CDAT8, which has the cytidine deaminase domain linked to a tRNA-binding THUMP domain. CDAT8 is specific for C deamination at position 8, requires only the acceptor stem hairpin for activity, and belongs to a unique family within the "cytidine deaminase-like" superfamily. The presence of this C-to-U editing enzyme guarantees the proper folding and functionality of all M. kandleri tRNAs.	[Randau, Lennart; Stanley, Bradford J.; Kohlway, Andrew; Mechta, Sarah; Xiong, Yong; Soll, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soll, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Yale University	Randau, L (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	lennart.randau@yale.edu; yong.xiong@yale.edu; dieter.soll@yale.edu		Randau, Lennart/0000-0002-2780-2076	NIH [GM22854, AI078831]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078831, R33AI078831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM022854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Yuan, P. ODonoghue, and R. L. Sherrer for help and encouragement; K. O. Stetter for a gift of M. kandleri cells; and the staff at the Advanced Photon Source (beamline 24-ID), the National Synchrotron Light Source (beamlines X25 and X6A), and the Center for Structural Biology at Yale University. Atomic coordinates and structure factors have been deposited in the Protein Data Bank (code 3G8Q). Supported by NIH grants GM22854 (D.S.) and AI078831 (Y.X.).	Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P215, DOI 10.1016/S0968-0004(01)01826-6; Borner GV, 1996, EMBO J, V15, P5949, DOI 10.1002/j.1460-2075.1996.tb00981.x; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; GROSJEAN H, 1995, NUCLEIC ACIDS RES, V23, P4312, DOI 10.1093/nar/23.21.4312; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jones CN, 2008, J BIOL CHEM, V283, P34445, DOI 10.1074/jbc.M806992200; Lauhon CT, 2004, J BIOL CHEM, V279, P23022, DOI 10.1074/jbc.M401757200; Maas S, 1999, P NATL ACAD SCI USA, V96, P8895, DOI 10.1073/pnas.96.16.8895; MARSCHALEK R, 1989, SCIENCE, V244, P1493, DOI 10.1126/science.2567533; McCleverty CJ, 2007, J MOL BIOL, V373, P1243, DOI 10.1016/j.jmb.2007.08.053; PALMER JR, 1992, BIOCHIM BIOPHYS ACTA, V1132, P315, DOI 10.1016/0167-4781(92)90168-Y; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rubio MAT, 2007, P NATL ACAD SCI USA, V104, P7821, DOI 10.1073/pnas.0702394104; She QX, 2002, RES MICROBIOL, V153, P325, DOI 10.1016/S0923-2508(02)01331-1; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; SMITH AA, 1994, BIOCHEMISTRY-US, V33, P6468, DOI 10.1021/bi00187a012; Steinhauser S, 1999, J MOL EVOL, V48, P303, DOI 10.1007/PL00006473; STERNER T, 1995, RNA, V1, P841; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Waterman DG, 2006, J MOL BIOL, V356, P97, DOI 10.1016/j.jmb.2005.11.013; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362	23	51	53	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					657	659		10.1126/science.1170123	http://dx.doi.org/10.1126/science.1170123			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407206	Green Accepted			2022-12-28	WOS:000265608800049
J	Sathyapalan, T; Atkin, SL				Sathyapalan, T.; Atkin, Stephen L.			Rational testing Investigating hirsutism	BRITISH MEDICAL JOURNAL			English	Editorial Material							POLYCYSTIC-OVARY-SYNDROME; CONGENITAL ADRENAL-HYPERPLASIA; INSULIN-RESISTANCE; DIAGNOSTIC-VALUE; PREVALENCE; WOMEN; HYPERANDROGENISM; CRITERIA		[Atkin, Stephen L.] Hull Royal Infirm, Hull York Med Sch, Kingston Upon Hull HU3 2RW, England; [Sathyapalan, T.] Hull Royal Infirm, Michael White Diabet Ctr, Kingston Upon Hull HU3 2RW, England	University of Hull; University of York - UK; University of Hull	Atkin, SL (corresponding author), Hull Royal Infirm, Hull York Med Sch, Kingston Upon Hull HU3 2RW, England.	Stephen.Atkin@hyms.ac.uk	Sathyapalan, Thozhukat/J-5212-2012; atkin, stephen/D-7400-2014; Atkin, stephen/ABE-7047-2020	Sathyapalan, Thozhukat/0000-0003-3544-2231; atkin, stephen/0000-0002-5887-7257; 				Azziz R., 2006, ANDROGEN EXCESS DISO, V2nd; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Carmina E, 2006, J CLIN ENDOCR METAB, V91, P2, DOI 10.1210/jc.2005-1457; CARMINA E, 1992, AM J OBSTET GYNECOL, V167, P1807, DOI 10.1016/0002-9378(92)91779-A; Chang WY, 2005, FERTIL STERIL, V83, P1717, DOI 10.1016/j.fertnstert.2005.01.096; Escobar-Morreale HF, 2008, J CLIN ENDOCR METAB, V93, P527, DOI 10.1210/jc.2007-2053; Escobar-Morreale HF, 2001, EUR J ENDOCRINOL, V145, P619, DOI 10.1530/eje.0.1450619; Hahn S, 2007, CLIN CHEM LAB MED, V45, P202, DOI 10.1515/CCLM.2007.031; Hopkinson ZEC, 1998, BRIT MED J, V317, P329, DOI 10.1136/bmj.317.7154.329; MENGDEN T, 1992, CLIN INVESTIGATOR, V70, P545; [Rotterdam ESHRE ASRM-Sponsored PCOS consensus workshop group], 2004, HUM REPROD, V19, P41; Sowers M, 2003, J CLIN ENDOCR METAB, V88, P4904, DOI 10.1210/jc.2003-030350; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245	13	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2009	338								b912	10.1136/bmj.b912	http://dx.doi.org/10.1136/bmj.b912			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JV	19401328				2022-12-28	WOS:000265697500009
J	Braverman, IM; Redford, DB; Mackowiak, PA				Braverman, Irwin M.; Redford, Donald B.; Mackowiak, Philip A.			Akhenaten and the Strange Physiques of Egypt's 18th Dynasty	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AROMATIZATION; FEMINIZATION; SEXES	Akhenaten was one of Egypt's most controversial pharaohs, in part because of his strange appearance in images produced after he had declared Aten, the Sun-disc, his one-and-only god. Whether these were symbolic representations or realistic ones that indicate a deforming genetic disorder is the subject of continuing debate. The authors present evidence that the bizarre physical features portrayed in these images are not only realistic but were shared by many members of Egypt's 18th Dynasty. The features are best explained by either 2 different familial disorders-the aromatase excess syndrome and the sagittal craniosynostosis syndrome-or a variant of the Antley-Bixler syndrome caused by a novel mutation in one of the genes controlling the P450 enzymes, which regulate steroidogenesis and cranial bone formation.	Yale Univ, Sch Med, New Haven, CT USA; Penn State Univ, State Coll, PA USA; Akhenaten Temple Project, Amarna, Egypt; Univ Maryland, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA	Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Mackowiak, PA (corresponding author), Vet Affairs Med Ctr, Med Serv 111, 10 N Greene St, Baltimore, MD 21201 USA.	Philip.Mackowiak@va.gov						ALDRED C, 1973, AKHENATEN NEFERTITI; BART A, ANCIENT EGYPT; BERKOVITZ GD, 1985, J CLIN INVEST, V75, P1763, DOI 10.1172/JCI111888; BROWN TR, 1990, MOL ENDOCRINOL, V4, P1759, DOI 10.1210/mend-4-12-1759; CRYSTAL E, PHARAOH MAATKARE HAT; DUNN J, 2009, AMENHOTEP I 2 KING E; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; HAWASS Z, 2005, TUTANKHAMUN GOLDEN A, P288; HEMSELL DL, 1977, J CLIN INVEST, V60, P455, DOI 10.1172/JCI108796; Jane JA., 2000, NEUROSURG FOCUS, V9, pe3, DOI [DOI 10.3171/FOC.2000.9.3.4, 10.3171/foc.2000.9.3.4]; MACKOWIAK PA, 2007, SOLVING HIST GREAT M, P1; Martin RM, 2003, J CLIN ENDOCR METAB, V88, P3027, DOI 10.1210/jc.2002-021780; McGillivray G, 2005, J MED GENET, V42, P656, DOI 10.1136/jmg.2004.027888; *MUS KUNST GEW HAM, 1965, 23 MUS KUNST GEW HAM; NAKAO R, 1993, J CLIN ENDOCR METAB, V77, P103, DOI 10.1210/jcem.77.1.8325932; PAULSHOCK BZ, 1980, JAMA-J AM MED ASSOC, V244, P160, DOI 10.1001/jama.244.2.160; Redford D.B., 1991, J AM RES CTR EGYPT, V28, P75; Redford D.B., 1981, J AM RES CTR EGYPT, V18, p[11, 15, 35]; REDFORD DB, 1977, J AM RES CTR EGYPT, V14, P1; REDFORD DB, 1981, J SOC STUDY EGYPTIAN, V11, P243; Redford Donald B, 1984, AKHENATEN HERETIC KI; SMITH GE, 1912, ROYAL MUMMIES CATALO, V59; Stratakis CA, 1998, J CLIN ENDOCR METAB, V83, P1348, DOI 10.1210/jc.83.4.1348; *WIK, 2009, AM I; *WIK, 2009, HOR	25	19	20	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					556	W100		10.7326/0003-4819-150-8-200904210-00010	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380856				2022-12-28	WOS:000265457000006
J	Martyn, C				Martyn, Christopher			Observations Out of Hours Fighting a lost cause?	BRITISH MEDICAL JOURNAL			English	Editorial Material												cmartyn@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2009	338								b1621	10.1136/bmj.b1621	http://dx.doi.org/10.1136/bmj.b1621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437OO	19383756				2022-12-28	WOS:000265497000016
J	Kim, T; Buratowski, S				Kim, TaeSoo; Buratowski, Stephen			Dimethylation of H3K4 by Set1 Recruits the Set3 Histone Deacetylase Complex to 5 ' Transcribed Regions	CELL			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; PHD FINGER; TRANSCRIPTIONAL ELONGATION; H2B MONOUBIQUITINATION; LYSINE-4 METHYLATION; GENE-EXPRESSION; BINDING MODULES; YEAST	Cotranscriptional histone methylations by Set1 and Set2 have been shown to affect histone acetylation at promoters and 3' regions of genes, respectively. While histone H3K4 trimethylation (H3K4me3) is thought to promote nucleosome acetylation and remodeling near promoters, we show here that H3K4 dimethylation (H3K4me2) by Set1 leads to reduced histone acetylation levels near 5' ends of genes. H3K4me2 recruits the Set3 complex via the Set3 PHD finger, localizing the Hos2 and Hst1 subunits to deacetylate histones in 5' transcribed regions. Cells lacking the Set1-Set3 complex pathway are sensitive to mycophenolic acid and have reduced polymerase levels at a Set3 target gene, suggesting a positive role in transcription. We propose that Set1 establishes two distinct chromatin zones on genes: H3K4me3 leads to high levels of acetylation and low nucleosome density at promoters, while H3K4me2 just downstream recruits the Set3 complex to suppress nucleosome acetylation and remodeling.	[Kim, TaeSoo; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu		Kim, TaeSoo/0000-0002-3902-1058	United States National Institutes of Health [GM46498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM046498] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Gozani (Stanford) for histone peptides, S. Briggs (Purdue) for plasmids, L. Howe (University of British Columbia) and M. Keogh (Albert Einstein College of Medicine) for strains, and N. Krogan (University of California, San Francisco), O. Rando (University of Massachusetts, Worcester), and all members of the Buratowski lab for helpful advice and discussions. T. K. is a Special Fellow of the Leukemia and Lymphoma Society. This research was supported by grant GM46498 to S.B. from the United States National Institutes of Health.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boa S, 2003, YEAST, V20, P827, DOI 10.1002/yea.995; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Flanagan JF, 2007, J MOL BIOL, V369, P334, DOI 10.1016/j.jmb.2007.03.024; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Okuda M, 2007, J MOL BIOL, V365, P1047, DOI 10.1016/j.jmb.2006.10.039; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Leeuwen F, 2002, CURR OPIN CELL BIOL, V14, P756, DOI 10.1016/S0955-0674(02)00393-9; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	59	228	233	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					259	272		10.1016/j.cell.2009.02.045	http://dx.doi.org/10.1016/j.cell.2009.02.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379692	Green Accepted, Bronze			2022-12-28	WOS:000265456800019
J	Petrini, JHJ				Petrini, John H. J.			DNA Replication Reaches the Breaking Point	CELL			English	Editorial Material							REPAIR	DNA strand breaks that result in stalled or damaged replication forks can be detrimental to the DNA replication process. In this issue, Doksani et al. (2009) examine the impact of a single double-stranded DNA break on replication in the budding yeast, Saccharomyces cerevisiae.	Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Petrini, JHJ (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA.	petrinij@mskcc.org		Petrini, John/0000-0001-5102-5679	NCI NIH HHS [P30 CA008748, R13 CA162528] Funding Source: Medline; NIGMS NIH HHS [R01 GM059413] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059413] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2	6	2	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2					211	212		10.1016/j.cell.2009.04.003	http://dx.doi.org/10.1016/j.cell.2009.04.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379688	Green Accepted, Bronze			2022-12-28	WOS:000265456800014
J	Raine, R; Wong, W; Ambler, G; Hardoon, S; Petersen, I; Morris, R; Bartley, M; Blane, D				Raine, Rosalind; Wong, Wun; Ambler, Gareth; Hardoon, Sarah; Petersen, Irene; Morris, Richard; Bartley, Mel; Blane, David			Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; SEX-DIFFERENCES; SOCIOECONOMIC-STATUS; ELDERLY-PATIENTS; ISCHEMIC-STROKE; SECULAR TRENDS; BLOOD-PRESSURE; MORTALITY; DECLINE	Objectives To determine the extent to which secondary drug prevention for patients with stroke in routine primary care varies by sex, age, and socioeconomic circumstances, and to quantify the effect of secondary drug prevention on one year mortality by sociodemographic group. Design Cohort study using individual patient data from the health improvement network primary care database. Setting England. Participants 12 830 patients aged 50 or more years from 113 general practices who had a stroke between 1995 and 2005 and who survived the first 30 days after the stroke. Main outcome measures Multivariable associations between odds of receiving secondary prevention after a stroke, and sex, age group, and socioeconomic circumstances; hazard ratios for all cause mortality from 31 days after the stroke and within the first year among patients receiving treatment and by social group; and probabilities of one year mortality for social factors of interest and treatment. Results Only 25.6% of men and 20.8% of women received secondary prevention. Receipt of secondary prevention did not vary by socioeconomic circumstances or by sex. Older patients were, however, substantially less likely to receive treatment. The adjusted odds ratio for 80-89 year olds compared with 50-59 year olds was 0.53 (95% confidence interval 0.41 to 0.69). This was because older people were less likely to receive lipid lowering drugs-for example, the adjusted odds ratio for 80-89 year olds compared with 50-59 year olds was 0.44 (95% confidence interval 0.33 to 0.59). Secondary prevention was associated with a 50% reduction in mortality risk (adjusted hazard ratio 0.50, 95% confidence interval 0.42 to 59). On average, mortality within the first year was 5.7% for patients receiving treatment compared with 11.1% for patients not receiving treatment. There was little evidence that the effect of treatment differed between the social groups examined. Conclusion Under-treatment among older people with stroke in routine primary care cannot be justified given the lack of evidence on variations in effectiveness of treatment by age.	[Raine, Rosalind; Bartley, Mel] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Ambler, Gareth] UCL, Dept Stat Sci, London WC1E 6BT, England; [Ambler, Gareth] UCL, Hosp Biomed Res Unit, London WC1E 6BT, England; [Hardoon, Sarah; Petersen, Irene; Morris, Richard] Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Hlth, London, England; [Blane, David] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London SW7 2AZ, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Raine, R (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	r.raine@ucl.ac.uk	Petersen, Irene/C-5702-2009; Petersen, Irene/I-2751-2012	Petersen, Irene/0000-0002-0037-7524; Morris, Richard/0000-0001-7240-4563; Raine, Rosalind/0000-0003-0904-749X	National Institute for Health Research University College London Hospital/ University College London Comprehensive Biomedical Research Centre; National Institute for Health Research public health career; ESRC [ES/G002452/1] Funding Source: UKRI; MRC [G0701739, G0601726] Funding Source: UKRI; Economic and Social Research Council [ES/G002452/1] Funding Source: researchfish; Medical Research Council [G0601726, G0701739] Funding Source: researchfish	National Institute for Health Research University College London Hospital/ University College London Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research public health career(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RR is partly funded by a National Institute for Health Research public health career scientist award and by the National Institute for Health Research University College London Hospital/ University College London Comprehensive Biomedical Research Centre. WW is funded by Legal and General Group. The research was funded in part by the actuarial profession ( Institute of Actuaries in England and Wales and the Faculty of Actuaries in Scotland). The authors' work was independent of the funders.	Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Arrich J, 2005, STROKE, V36, P310, DOI 10.1161/01.STR.0000152962.92621.b5; Ashworth M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2030; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Banks J., 2006, RETIREMENT HLTH RELA; Bond Matthew, 2003, J Health Serv Res Policy, V8, P40, DOI 10.1258/13558190360468218; Bourke Alison, 2004, Inform Prim Care, V12, P171; Bowling A, 2001, HEART, V85, P680, DOI 10.1136/heart.85.6.680; *BRIT MED ASS, 2008, BRIT NAT FORM, V56; *BRIT MED ASS, 2007, BRIT NAT FORM, V53; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Carrasco KR, 2001, REV MEX PSICOL, V18, P26; Colgrove J, 2002, AM J PUBLIC HEALTH, V92, P725, DOI 10.2105/AJPH.92.5.725; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Davies AR, 2007, EUR HEART J, V28, P2142, DOI 10.1093/eurheartj/ehm272; DeWilde S, 2003, HEART, V89, P417, DOI 10.1136/heart.89.4.417; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Dixon J, 2007, DEV PLANT BREED, V12, P9; Rodriguez LAG, 2007, GASTROENTEROLOGY, V132, P498, DOI 10.1053/j.gastro.2006.12.007; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; GRIFFITHS C, 2003, HLTH STAT Q, V18, P5; Gueyffier F, 1997, STROKE, V28, P2557, DOI 10.1161/01.STR.28.12.2557; Hackam DG, 2007, STROKE, V38, P1881, DOI 10.1161/STROKEAHA.106.475525; Hajat C, 2001, STROKE, V32, P37, DOI 10.1161/01.STR.32.1.37; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; Hillen T, 2000, STROKE, V31, P469, DOI 10.1161/01.STR.31.2.469; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Holroyd-Leduc JM, 2000, STROKE, V31, P1833, DOI 10.1161/01.STR.31.8.1833; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Hunt D, 2001, ANN INTERN MED, V134, P931, DOI 10.7326/0003-4819-134-10-200105150-00007; Intercollegiate Stroke Working Party, 2005, NAT SENT STROK AUD 2; Intercollegiate working Party for Stroke, 2004, NAT CLIN GUID STROK; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jiang Yanming, 2006, J Stroke Cerebrovasc Dis, V15, P179, DOI 10.1016/j.jstrokecerebrovasdis.2006.05.007; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; KUNITZ SC, 1984, STROKE, V15, P740, DOI 10.1161/01.STR.15.4.740; LAROSA JC, 1994, ARCH INTERN MED, V154, P529, DOI 10.1001/archinte.154.5.529; Lawlor DA, 2002, LANCET, V360, P1818, DOI 10.1016/S0140-6736(02)11769-7; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lyratzopoulos G, 2006, HEART, V92, P1198, DOI 10.1136/hrt.2005.081042; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; McKevitt C, 2005, STROKE, V36, P315, DOI 10.1161/01.STR.0000152332.32267.19; Monette J, 1997, J AM GERIATR SOC, V45, P1060, DOI 10.1111/j.1532-5415.1997.tb05967.x; *NAT CTR SOC RES, 2004, HLTH SURV ENGL; *NAT I HLTH CLIN E, 2008, CLIN GUIDL NAT I HLT, V73; Navarro VJ, 2003, HEPATOLOGY, V38, P1062, DOI 10.1053/jhep.2003.50429; *OFF NAT STAT, 2003, HLTH STAT Q, V20, P55; Raine R, 2000, J Health Serv Res Policy, V5, P237; Ramsay SE, 2007, J PUBLIC HEALTH-UK, V29, P251, DOI 10.1093/pubmed/fdm040; ROBINSON D, 1998, P ANN C PRIM HLTH CA; Rothwell PM, 2007, STROKE, V38, P1726, DOI 10.1161/STROKEAHA.107.482265; Shepherd J, 2006, J INTERN MED, V260, P305, DOI 10.1111/j.1365-2796.2006.01700.x; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Townsend P., 1986, INEQUALITIES HLTH NO; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Wilkinson R, 2005, IMPACT INEQUALITY MA; Willets R. C., 2004, BRIT ACTUARIAL J, V10, P685; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	67	37	40	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2009	338								b1279	10.1136/bmj.b1279	http://dx.doi.org/10.1136/bmj.b1279			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TK	19372118	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000265296800002
J	Viel, KR; Ameri, A; Abshire, TC; Iyer, RV; Watts, RG; Lutcher, C; Channell, C; Cole, SA; Fernstrom, KM; Nakaya, S; Kasper, CK; Thompson, AR; Almasy, L; Howard, TE				Viel, Kevin R.; Ameri, Afshin; Abshire, Thomas C.; Iyer, Rathi V.; Watts, Raymond G.; Lutcher, Charles; Channell, Cynthia; Cole, Shelley A.; Fernstrom, Karl M.; Nakaya, Shelley; Kasper, Carol K.; Thompson, Arthur R.; Almasy, Laura; Howard, Tom E.			Inhibitors of Factor VIII in Black Patients with Hemophilia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	48th Annual Meeting of the American-Society-of-Hematology	DEC 09-12, 2006	Orlando, FL	Amer Soc Hematol			PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; GENETIC ASSOCIATION; AFRICAN-AMERICANS; F8 GENE; MUTATIONS; RISK; INVERSION; IDENTIFICATION; POLYMORPHISMS	BACKGROUND Black patients with hemophilia A (factor VIII deficiency) are twice as likely as white patients to produce inhibitors against factor VIII proteins given as replacement therapy. There are six wild-type factor VIII proteins, designated H1 through H6, but only two (H1 and H2) match the recombinant factor VIII products used clinically. H1 and H2 are found in all racial groups and are the only factor VIII proteins found in the white population to date. H3, H4, and H5 have been found only in blacks. We hypothesized that mismatched factor VIII transfusions contribute to the high incidence of inhibitors among black patients. METHODS We sequenced the factor VIII gene (F8) in black patients with hemophilia A to identify causative mutations and the background haplotypes on which they reside. Results from previous Bethesda assays and information on the baseline severity of hemophilia, age at enrollment, and biologic relationships among study patients were obtained from review of the patients' medical charts. We used multivariable logistic regression to control for these potential confounders while testing for associations between F8 haplotype and the development of inhibitors. RESULTS Of the 78 black patients with hemophilia enrolled, 24% had an H3 or H4 background haplotype. The prevalence of inhibitors was higher among patients with either of these haplotypes than among patients with haplotype H1 or H2 (odds ratio, 3.6; 95% confidence interval, 1.1 to 12.3; P = 0.04), despite a similar spectrum of hemophilic mutations and degree of severity of illness in these two subgroups. CONCLUSIONS These preliminary results suggest that mismatched factor VIII replacement therapy may be a risk factor for the development of anti-factor VIII alloantibodies.	[Viel, Kevin R.; Cole, Shelley A.; Almasy, Laura] SW Fdn Biomed Res, San Antonio, TX 78284 USA; [Ameri, Afshin; Lutcher, Charles] Med Coll Georgia, Augusta, GA 30912 USA; [Abshire, Thomas C.; Channell, Cynthia; Fernstrom, Karl M.] Emory Univ, Atlanta, GA 30322 USA; [Iyer, Rathi V.] Univ Mississippi, Med Ctr, Jackson, MS USA; [Watts, Raymond G.] Univ Alabama Birmingham, Birmingham, AL USA; [Nakaya, Shelley; Thompson, Arthur R.] Univ Washington, Seattle, WA 98195 USA; [Kasper, Carol K.; Howard, Tom E.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Kasper, Carol K.] Orthoped Hosp, Los Angeles, CA USA; [Howard, Tom E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Howard, Tom E.] Greater Los Angeles Vet Affairs Hosp, Los Angeles, CA USA	Texas Biomedical Research Institute; University System of Georgia; Augusta University; Emory University; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Howard, TE (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol & Lab Med, 11301 Wilshire Blvd,Bldg 500,Rm 12S4, Los Angeles, CA 90073 USA.	tom.howard@va.gov	Almasy, Laura/V-3156-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072533, R01HL070751, K08HL071130] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-72533, R01 HL070751, HL-71130, R01 HL072533-05, HL-70751, R01 HL070751-07, R01 HL072533, HL-07109, K08 HL071130, K08 HL071130-06] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADDIEGO JE, 1994, BLOOD, V84, pA239; Aledort LM, 1998, HAEMOPHILIA, V4, P68; Astermark J, 2007, J THROMB HAEMOST, V5, P263, DOI 10.1111/j.1538-7836.2007.02290.x; Astermark J, 2006, BLOOD, V107, P3167, DOI 10.1182/blood-2005-09-3918; Astermark J, 2001, HAEMOPHILIA, V7, P267, DOI 10.1046/j.1365-2516.2001.00510.x; Astermark J, 2006, BLOOD, V108, P3739, DOI 10.1182/blood-2006-05-024711; Bagnall RD, 2006, J THROMB HAEMOST, V4, P591, DOI 10.1111/j.1538-7836.2006.01840.x; Bagnall RD, 2002, BLOOD, V99, P168, DOI 10.1182/blood.V99.1.168; Benjamin RJ, 2008, TRANSFUSION, V48, P295, DOI 10.1111/j.1537-2995.2007.01523.x; BRAY GL, 1994, BLOOD, V83, P2428; Castaman G, 2007, HAEMOPHILIA, V13, P311, DOI 10.1111/j.1365-2516.2007.01459.x; David D, 2006, HAEMATOLOGICA, V91, P840; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Garratty G, 2004, TRANSFUSION, V44, P703, DOI 10.1111/j.1537-2995.2004.03338.x; Gill F M, 1984, Prog Clin Biol Res, V150, P19; Gitschier J, 2004, J THROMB HAEMOST, V2, P383, DOI 10.1111/j.1538-7933.2004.00614.x; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Glynn SA, 2006, TRANSFUSION, V46, P980, DOI 10.1111/j.1537-2995.2006.00831.x; Goodeve A, 2003, BLOOD COAGUL FIBRIN, V14, pS17, DOI 10.1097/00001721-200306001-00005; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Howard T, 2004, BLOOD, V104, p113A, DOI 10.1182/blood.V104.11.384.384; Howard TE, 2005, BLOOD, V106, p896A; Howard TE, 2006, BLOOD, V108, p230A; Jayandharan G, 2005, HAEMOPHILIA, V11, P481, DOI 10.1111/j.1365-2516.2005.01121.x; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Kempton CL, 2006, J THROMB HAEMOST, V4, P2576, DOI 10.1111/j.1538-7836.2006.02233.x; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Lollar P, 2004, J THROMB HAEMOST, V2, P1082, DOI 10.1111/j.1538-7836.2004.00802.x; Lorenzo JI, 2001, BRIT J HAEMATOL, V113, P600, DOI 10.1046/j.1365-2141.2001.02828.x; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; Ma GC, 2008, HAEMOPHILIA, V14, P787, DOI 10.1111/j.1365-2516.2008.01687.x; Mansvelt EPG, 1998, THROMB HAEMOSTASIS, V80, P561; Oldenburg J, 2006, HAEMOPHILIA, V12, P15, DOI 10.1111/j.1365-2516.2006.01361.x; Oldenburg J, 2004, SEMIN HEMATOL, V41, P82, DOI 10.1053/j.seminhematol.2003.11.016; Oldenburg J, 1997, BEITR INFUS, V34, P224; Redden DT, 2006, BEHAV GENET, V36, P678, DOI 10.1007/s10519-006-9060-0; Repesse Y, 2007, J THROMB HAEMOST, V5, P1469, DOI 10.1111/j.1538-7836.2007.02591.x; Rossetti LC, 2005, CLIN CHEM, V51, P1154, DOI 10.1373/clinchem.2004.046490; Rothschild C, 1998, THROMB HAEMOSTASIS, V80, P779; Santacroce R, 2008, J HUM GENET, V53, P275, DOI 10.1007/s10038-007-0238-y; Schroder J, 2006, J THROMB HAEMOST, V4, P1141, DOI 10.1111/j.1538-7836.2006.01884.x; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; Thompson AR, 2003, SEMIN THROMB HEMOST, V29, P11, DOI 10.1055/s-2003-37935; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Tsai HJ, 2006, HUM GENET, V118, P626, DOI 10.1007/s00439-005-0080-2; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247; Viel KR, 2007, BLOOD, V109, P3713, DOI 10.1182/blood-2006-06-026104; Wang B, 2004, TRANSFUSION, V44, P1243, DOI 10.1111/j.1537-2995.2004.04034.x; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	53	147	157	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1618	1627		10.1056/NEJMoa075760	http://dx.doi.org/10.1056/NEJMoa075760			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	433BH	19369668	Green Accepted			2022-12-28	WOS:000265178000006
J	Kahn, SE				Kahn, Steven E.			Glucose Control in Type 2 Diabetes Still Worthwhile and Worth Pursuing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; HYPOGLYCEMIA		[Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Kahn, SE (corresponding author), VA Puget Sound Hlth Care Syst 151, 1660 S Columbian Way, Seattle, WA 98108 USA.	skahn@u.washington.edu		Kahn, Steven/0000-0001-7307-9002				Bottini P, 1997, DIABETES, V46, P814, DOI 10.2337/diabetes.46.5.814; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cryer PE, 2005, DIABETES, V54, P3592, DOI 10.2337/diabetes.54.12.3592; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2000, LANCET, V355, P253; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949	15	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1590	1592		10.1001/jama.2009.511	http://dx.doi.org/10.1001/jama.2009.511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366780				2022-12-28	WOS:000265137900031
J	Jones, JA; Karlen, SD; Fitzsimons, J; Ardavan, A; Benjamin, SC; Briggs, GAD; Morton, JJL				Jones, Jonathan A.; Karlen, Steven D.; Fitzsimons, Joseph; Ardavan, Arzhang; Benjamin, Simon C.; Briggs, G. Andrew D.; Morton, John J. L.			Magnetic Field Sensing Beyond the Standard Quantum Limit Using 10-Spin NOON States	SCIENCE			English	Article							ENTANGLEMENT; SPECTROSCOPY; RESONANCE; SENSITIVITY; COMPUTATION	Quantum entangled states can be very delicate and easily perturbed by their external environment. This sensitivity can be harnessed in measurement technology to create a quantum sensor with a capability of outperforming conventional devices at a fundamental level. We compared the magnetic field sensitivity of a classical (unentangled) system with that of a 10-qubit entangled state, realized by nuclei in a highly symmetric molecule. We observed a 9.4-fold quantum enhancement in the sensitivity to an applied field for the entangled system and show that this spin-based approach can scale favorably as compared with approaches in which qubit loss is prevalent. This result demonstrates a method for practical quantum field sensing technology.	[Jones, Jonathan A.; Ardavan, Arzhang; Morton, John J. L.] Univ Oxford, Clarendon Lab, CAESR, Oxford OX1 3PU, England; [Karlen, Steven D.; Fitzsimons, Joseph; Benjamin, Simon C.; Briggs, G. Andrew D.; Morton, John J. L.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Fitzsimons, Joseph] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Benjamin, Simon C.] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117543, Singapore	University of Oxford; University of Oxford; University of Waterloo; National University of Singapore	Morton, JJL (corresponding author), Univ Oxford, Clarendon Lab, CAESR, Parks Rd, Oxford OX1 3PU, England.	john.morton@materials.ox.ac.uk	Jones, Jonathan/E-4585-2011; Jones, Jonathan/AAD-9414-2020; Ardavan, Arzhang/AAY-9214-2020; Briggs, G Andrew D/A-6890-2011; Benjamin, Simon/A-8673-2008; Morton, John/I-3515-2013	Jones, Jonathan/0000-0003-1862-587X; Jones, Jonathan/0000-0003-1862-587X; Briggs, G Andrew D/0000-0003-1950-2097; Benjamin, Simon/0000-0002-7766-5348; Fitzsimons, Joseph/0000-0002-7097-0294	Engineering and Physical Sciences Research Council [GR/S82176/01, GR/S15808/01]; CAESR [EP/D048559/1]; Merton College, Oxford; St. Johns College, Oxford; Royal Society; Engineering and Physical Sciences Research Council [EP/D048559/1] Funding Source: researchfish; EPSRC [EP/D048559/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CAESR; Merton College, Oxford; St. Johns College, Oxford; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research is supported by the Engineering and Physical Sciences Research Council through the Quantum Information Processing Interdisciplinary Research Collaboration (www.qipirc.org) (GR/S82176/01) and CAESR (EP/D048559/1). J.F. is supported by Merton College, Oxford. G.A.D.B. is supported by the EPSRC (GR/S15808/01). J.J.L.M. acknowledges St. Johns College, Oxford. J.J.L.M., S.C.B., and A.A. acknowledge support from the Royal Society.	Baugh J, 2005, NATURE, V438, P470, DOI 10.1038/nature04272; Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; Cappellaro P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.020502; Cory DG, 1998, PHYSICA D, V120, P82, DOI 10.1016/S0167-2789(98)00046-3; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Higgins BL, 2007, NATURE, V450, P393, DOI 10.1038/nature06257; Huver SD, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063828; Jones JA, 2001, PROG NUCL MAG RES SP, V38, P325, DOI 10.1016/S0079-6565(00)00033-9; KERNEVEZ N, 1991, IEEE T MAGN, V27, P5402, DOI 10.1109/20.278852; Knill E, 2000, NATURE, V404, P368, DOI 10.1038/35006012; Krojanski HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.090501; Lee H, 2002, J MOD OPTIC, V49, P2325, DOI 10.1080/0950034021000011536; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Meyer V, 2001, PHYS REV LETT, V86, P5870, DOI 10.1103/PhysRevLett.86.5870; Nagata T, 2007, SCIENCE, V316, P726, DOI 10.1126/science.1138007; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Ryan CA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140501; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; SANDERS BC, 1989, PHYS REV A, V40, P2417, DOI 10.1103/PhysRevA.40.2417; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555, DOI 10.1017/S0305004100013554; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; YURKE B, 1986, PHYS REV LETT, V56, P1515, DOI 10.1103/PhysRevLett.56.1515	25	191	193	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1166	1168		10.1126/science.1170730	http://dx.doi.org/10.1126/science.1170730			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19389997	Green Submitted			2022-12-28	WOS:000266410100036
J	Bortnik, J; Li, W; Thorne, RM; Angelopoulos, V; Cully, C; Bonnell, J; Le Contel, O; Roux, A				Bortnik, J.; Li, W.; Thorne, R. M.; Angelopoulos, V.; Cully, C.; Bonnell, J.; Le Contel, O.; Roux, A.			An Observation Linking the Origin of Plasmaspheric Hiss to Discrete Chorus Emissions	SCIENCE			English	Article							RADIATION BELT ELECTRONS; MAGNETOSPHERIC CHORUS; FREQUENCY; SATELLITE	A long-standing problem in the field of space physics has been the origin of plasmaspheric hiss, a naturally occurring electromagnetic wave in the high-density plasmasphere (roughly within 20,000 kilometers of Earth) that is known to remove the high-energy Van Allen Belt electrons that pose a threat to satellites and astronauts. A recent theory tied the origin of plasmaspheric hiss to a seemingly different wave in the outer magnetosphere, but this theory was difficult to test because of a challenging set of observational requirements. Here we report on the experimental verification of the theory, made with a five-satellite NASA mission. This confirmation will allow modeling of plasmaspheric hiss and its effects on the high-energy radiation environment.	[Bortnik, J.; Li, W.; Thorne, R. M.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Angelopoulos, V.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys Earth & Space Sci, Los Angeles, CA 90095 USA; [Cully, C.] Swedish Inst Space Phys, SE-75121 Uppsala, Sweden; [Bonnell, J.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Le Contel, O.; Roux, A.] Ctr Etud Environm Terr & Planetaires, Velizy Villacoublay, France	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Berkeley	Bortnik, J (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	jbortnik@gmail.com	Cully, Christopher/P-2539-2016; Li, Wen/F-3722-2011	Angelopoulos, Vassilis/0000-0001-7024-1561; Cully, Christopher/0000-0001-7242-8872; LE CONTEL, Olivier/0000-0003-2713-7966	NASA [NNX08A1135G, NAS5-02099]	NASA(National Aeronautics & Space Administration (NASA))	The authors gratefully acknowledge support from NASA grant NNX08A1135G and contract NAS5-02099	Abel B, 1998, J GEOPHYS RES-SPACE, V103, P2385, DOI 10.1029/97JA02919; Angelopoulos V, 2008, SPACE SCI REV, V141, P5, DOI 10.1007/s11214-008-9336-1; Baker DN, 2002, SCIENCE, V297, P1486, DOI 10.1126/science.1074956; Bortnik J, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012237; Bortnik J, 2008, NATURE, V452, P62, DOI 10.1038/nature06741; BURTIS WJ, 1976, PLANET SPACE SCI, V24, P1007, DOI 10.1016/0032-0633(76)90119-7; BURTON RK, 1974, J GEOPHYS RES, V79, P1014, DOI 10.1029/JA079i007p01014; CARPENTER DL, 1992, J GEOPHYS RES-SPACE, V97, P1097, DOI 10.1029/91JA01548; DUNCKEL N, 1969, J GEOPHYS RES, V74, P6371, DOI 10.1029/JA074i026p06371; HAYAKAWA M, 1992, PLANET SPACE SCI, V40, P1325, DOI 10.1016/0032-0633(92)90089-7; Horne RB, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010811; KENNEL CF, 1966, J GEOPHYS RES, V71, P1, DOI 10.1029/JZ071i001p00001; LENGYELFREY D, 1994, J GEOPHYS RES-SPACE, V99, P13325, DOI 10.1029/94JA00781; LYONS LR, 1972, J GEOPHYS RES, V77, P3455, DOI 10.1029/JA077i019p03455; LYONS LR, 1973, J GEOPHYS RES, V78, P2142, DOI 10.1029/JA078i013p02142; RUSSELL CT, 1969, J GEOPHYS RES, V74, P755, DOI 10.1029/JA074i003p00755; Santolik O, 2008, NONLINEAR PROC GEOPH, V15, P621, DOI 10.5194/npg-15-621-2008; Santolik O, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011462; SAZHIN SS, 1992, PLANET SPACE SCI, V40, P681, DOI 10.1016/0032-0633(92)90009-D; TAYLOR WWL, 1968, J GEOPHYS RES, V73, P5615, DOI 10.1029/JA073i017p05615; THORNE RM, 1973, J GEOPHYS RES, V78, P1581, DOI 10.1029/JA078i010p01581	21	155	155	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					775	778		10.1126/science.1171273	http://dx.doi.org/10.1126/science.1171273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423824				2022-12-28	WOS:000265832400043
J	Liu, RH; Wu, T; Wu, G; Chen, H; Wang, XF; Xie, YL; Ying, JJ; Yan, YJ; Li, QJ; Shi, BC; Chu, WS; Wu, ZY; Chen, XH				Liu, R. H.; Wu, T.; Wu, G.; Chen, H.; Wang, X. F.; Xie, Y. L.; Ying, J. J.; Yan, Y. J.; Li, Q. J.; Shi, B. C.; Chu, W. S.; Wu, Z. Y.; Chen, X. H.			A large iron isotope effect in SmFeAsO1-xFx and Ba1-xKxFe2As2	NATURE			English	Article							SUPERCONDUCTIVITY; COEXISTENCE	The recent discovery of superconductivity in oxypnictides with a critical transition temperature (T-C) higher than the McMillan limit of 39K (the theoretical maximum predicted by Bardeen-Cooper-Schrieffer theory) has generated great excitement(1-5). Theoretical calculations indicate that the electron-phonon interaction is not strong enough to give rise to such high transition temperatures(6), but strong ferromagnetic/antiferromagnetic fluctuations have been proposed to be responsible(7-9). Superconductivity and magnetism in pnictide superconductors, however, show a strong sensitivity to the crystal lattice, suggesting the possibility of unconventional electron-phonon coupling. Here we report the effect of oxygen and iron isotope substitution on T-C and the spin-density wave (SDW) transition temperature (T-SDW) in the SmFeAsO1-xFx and Ba1-xKxFe2As2 systems. The oxygen isotope effect on T-C and T-SDW is very small, while the iron isotope exponent alpha(C) =-dlnT(C)/dlnM is about 0.35 (0.5 corresponds to the full isotope effect). Surprisingly, the iron isotope exchange shows the same effect on T-SDW as T-C. This indicates that electron-phonon interaction plays some role in the superconducting mechanism, but a simple electron-phonon coupling mechanism seems unlikely because a strong magnon-phonon coupling is included.	[Liu, R. H.; Wu, T.; Wu, G.; Chen, H.; Wang, X. F.; Xie, Y. L.; Ying, J. J.; Yan, Y. J.; Li, Q. J.; Shi, B. C.; Chen, X. H.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Liu, R. H.; Wu, T.; Wu, G.; Chen, H.; Wang, X. F.; Xie, Y. L.; Ying, J. J.; Yan, Y. J.; Li, Q. J.; Shi, B. C.; Chen, X. H.] Univ Sci & Technol China, Dept Phys, Hefei 230026, Anhui, Peoples R China; [Chu, W. S.; Wu, Z. Y.] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Chu, W. S.; Wu, Z. Y.] Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chen, XH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	chenxh@ustc.edu.cn	Liu, Ronghua/AAA-3672-2019; Wang, Xiangfeng/I-2848-2014; Yan, Yi/GSO-3046-2022; Liu, Ronghua/A-9790-2013	Liu, Ronghua/0000-0002-4053-3923; Wang, Xiangfeng/0000-0001-9845-1659; Liu, Ronghua/0000-0002-4053-3923	Nature Science Foundation of China; Ministry of Science and Technology of China and Chinese Academy of Sciences	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China and Chinese Academy of Sciences(Ministry of Science and Technology, ChinaChinese Academy of Sciences)	This work is supported by the Nature Science Foundation of China, and by the Ministry of Science and Technology of China and Chinese Academy of Sciences. We acknowledge Z. X. Shen for discussion and encouragement, and D. L. Feng and S. Y. Li for discussions.	Boeri L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026403; Cao C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.220506; Chen GF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247002; Chen H, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/17006; Chen XH, 2008, NATURE, V453, P761, DOI 10.1038/nature07045; Christianson AD, 2008, NATURE, V456, P930, DOI 10.1038/nature07625; Dai X, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057008; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Drew AJ, 2009, NAT MATER, V8, P310, DOI [10.1038/nmat2396, 10.1038/NMAT2396]; Ewings RA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.220501; Fang C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224509; FRANCK JP, 1994, PHYSICAL PROPERTIES, V4, P189; Hinks DG, 2001, NATURE, V411, P457, DOI 10.1038/35078037; Huang Q, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.257003; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Keller H, 2005, STRUCT BOND, V114, P143, DOI 10.1007/b101019; Liu RH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087001; Ma FJ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.033111; Margadonna S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014503; Ren ZA, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/57002; ZBIRI M, 2008, COMBINED AB INITIO L; Zhao GM, 1996, NATURE, V381, P676, DOI 10.1038/381676a0; Zhao J, 2008, NAT MATER, V7, P953, DOI 10.1038/nmat2315; Zhao SC, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/1/015017	24	150	159	1	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					64	67		10.1038/nature07981	http://dx.doi.org/10.1038/nature07981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424151	Green Submitted			2022-12-28	WOS:000265801300029
J	Revnivtsev, M; Sazonov, S; Churazov, E; Forman, W; Vikhlinin, A; Sunyaev, R				Revnivtsev, M.; Sazonov, S.; Churazov, E.; Forman, W.; Vikhlinin, A.; Sunyaev, R.			Discrete sources as the origin of the Galactic X-ray ridge emission	NATURE			English	Article							IRON LINE; CHANDRA; GALAXY; ASCA; EXTINCTION; PLANE; VIEW	An unresolved X-ray glow (at energies above a few kiloelectron-volts) was discovered about 25 years ago and found to be coincident with the Galactic disk-the Galactic ridge X-ray emission(1,2). This emission(3-10) has a spectrum characteristic of a similar to 10(8) K optically thin thermal plasma, with a prominent iron emission line at 6.7 keV. The gravitational well of the Galactic disk, however, is far too shallow to confine such a hot interstellar medium; instead, it would flow away at a velocity of a few thousand kilometres per second, exceeding the speed of sound in the gas. To replenish the energy losses requires a source of 10(43) erg s(-1), exceeding by orders of magnitude all plausible energy sources in the Milky Way(11). An alternative is that the hot plasma is bound to a multitude of faint sources(12), which is supported by the recently observed similarities in the X-ray and near-infrared surface brightness distributions(13,14) (the latter traces the Galactic stellar distribution). Here we report that at energies of similar to 6-7 keV, more than 80 per cent of the seemingly diffuse X-ray emission is resolved into discrete sources, probably accreting white dwarfs and coronally active stars.	[Revnivtsev, M.] Tech Univ Munich, Excellence Cluster Univ, D-85748 Garching, Germany; [Revnivtsev, M.; Sazonov, S.; Churazov, E.; Vikhlinin, A.; Sunyaev, R.] Space Res Inst, Moscow 117997, Russia; [Sazonov, S.; Churazov, E.; Sunyaev, R.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Forman, W.; Vikhlinin, A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Technical University of Munich; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Max Planck Society; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Revnivtsev, M (corresponding author), Tech Univ Munich, Excellence Cluster Univ, D-85748 Garching, Germany.	mikej@mpa-garching.mpg.de	Churazov, Eugene/A-7783-2013; Sazonov, Sergey/J-6881-2016	Churazov, Eugene/0000-0002-0322-884X; Forman, William/0000-0002-9478-1682	DFG Cluster of Excellence; NASA Chandra [GO8-9132A]; Russian Academy of Sciences [OFH-17]; RFFI [07-02-01004, 07-02-00961]	DFG Cluster of Excellence(German Research Foundation (DFG)); NASA Chandra(National Aeronautics & Space Administration (NASA)); Russian Academy of Sciences(Russian Academy of Sciences); RFFI(Russian Foundation for Basic Research (RFBR))	M. R. thanks M. Markevitch for his help with the Chandra instrumental background. This research was supported by the DFG Cluster of Excellence "Origin and Structure of the Universe'', by NASA Chandra grant GO8-9132A, by the OFH-17 programme of the Russian Academy of Sciences, and by grants RFFI 07-02-01004 and RFFI 07-02-00961.	*CHANDR, 2009, PROP OBS GUID; Dutra CM, 2003, MON NOT R ASTRON SOC, V338, P253, DOI 10.1046/j.1365-8711.2003.06049.x; Ebisawa K, 2005, ASTROPHYS J, V635, P214, DOI 10.1086/497284; Ebisawa K, 2008, PUBL ASTRON SOC JPN, V60, pS223, DOI 10.1093/pasj/60.sp1.S223; GIACCONI R, 1962, PHYS REV LETT, V9, P439, DOI 10.1103/PhysRevLett.9.439; Hands ADP, 2004, MON NOT R ASTRON SOC, V351, P31, DOI 10.1111/j.1365-2966.2004.07777.x; Hellier C, 1998, MON NOT R ASTRON SOC, V297, P526, DOI 10.1046/j.1365-8711.1998.01557.x; Hickox RC, 2006, ASTROPHYS J, V645, P95, DOI 10.1086/504070; Huenemoerder DP, 2001, ASTROPHYS J, V559, P1135, DOI 10.1086/322419; Indebetouw R, 2005, ASTROPHYS J, V619, P931, DOI 10.1086/426679; KOYAMA K, 1986, PUBL ASTRON SOC JPN, V38, P121; Koyama K, 1996, PUBL ASTRON SOC JPN, V48, P249, DOI 10.1093/pasj/48.2.249; Koyama K, 2007, PUBL ASTRON SOC JPN, V59, pS245, DOI 10.1093/pasj/59.sp1.S245; Moretti A, 2003, ASTROPHYS J, V588, P696, DOI 10.1086/374335; Park S, 2004, ASTROPHYS J, V603, P548, DOI 10.1086/381542; Revnivtsev M, 2006, MON NOT R ASTRON SOC, V373, pL11, DOI 10.1111/j.1745-3933.2006.00233.x; Revnivtsev M, 2006, ASTRON ASTROPHYS, V452, P169, DOI 10.1051/0004-6361:20054268; Sazonov S, 2006, ASTRON ASTROPHYS, V450, P117, DOI 10.1051/0004-6361:20054297; SUNYAEV RA, 1993, ASTROPHYS J, V407, P606, DOI 10.1086/172542; Tanaka Y, 2002, ASTRON ASTROPHYS, V382, P1052, DOI 10.1051/0004-6361:20011678; Vikhlinin A, 2005, ASTROPHYS J, V628, P655, DOI 10.1086/431142; WARWICK RS, 1985, NATURE, V317, P218, DOI 10.1038/317218a0; Weisskopf MC, 2002, PUBL ASTRON SOC PAC, V114, P1, DOI 10.1086/338108; WORRALL DM, 1983, ASTROPHYS J, V267, P691, DOI 10.1086/160906; WORRALL DM, 1982, ASTROPHYS J, V255, P111, DOI 10.1086/159809; YAMAUCHI S, 1993, ASTROPHYS J, V404, P620, DOI 10.1086/172315; Yamauchi S, 1996, PUBL ASTRON SOC JPN, V48, pL15, DOI 10.1093/pasj/48.2.L15; YAMAUCHI S, 2008, IRON EMISSION LINES	28	171	172	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1142	1144		10.1038/nature07946	http://dx.doi.org/10.1038/nature07946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407795				2022-12-28	WOS:000265754600041
J	Pfund, C; Miller, S; Brenner, K; Bruns, P; Chang, A; Ebert-May, D; Fagen, AP; Gentile, J; Gossens, S; Khan, IM; Labov, JB; Pribbenow, CM; Susman, M; Tong, L; Wright, R; Yuan, RT; Wood, WB; Handelsman, J				Pfund, Christine; Miller, Sarah; Brenner, Kerry; Bruns, Peter; Chang, Amy; Ebert-May, Diane; Fagen, Adam P.; Gentile, Jim; Gossens, Sandra; Khan, Ishrat M.; Labov, Jay B.; Pribbenow, Christine Maidl; Susman, Millard; Tong, Lillian; Wright, Robin; Yuan, Robert T.; Wood, William B.; Handelsman, Jo			Summer Institute to Improve University Science Teaching	SCIENCE			English	Editorial Material									[Pfund, Christine; Miller, Sarah; Gossens, Sandra; Pribbenow, Christine Maidl; Handelsman, Jo] Univ Wisconsin, Dept Bacteriol, Wisconsin Program Sci Teaching, Madison, WI 53706 USA; [Pfund, Christine] Univ Wisconsin, Delta Program Res Teaching & Learning, Madison, WI 53706 USA; [Ebert-May, Diane] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Khan, Ishrat M.] Clark Atlanta Univ, Dept Chem, Atlanta, GA 30314 USA; [Pribbenow, Christine Maidl] Univ Wisconsin, Wisconsin Ctr Educ Res, Madison, WI 53706 USA; [Susman, Millard; Tong, Lillian] Univ Wisconsin, Ctr Biol Educ, Madison, WI 53706 USA; [Wright, Robin] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Yuan, Robert T.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Wood, William B.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; Clark Atlanta University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Boulder	Handelsman, J (corresponding author), Univ Wisconsin, Dept Bacteriol, Wisconsin Program Sci Teaching, Madison, WI 53706 USA.	joh@bact.wisc.edu		Miller, Sarah/0000-0003-3348-4470; Fagen, Adam/0000-0002-7545-8484	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AGUILARROCA N, 2009, INT J SCHOLARSHIP TE, V3, P1; Armstrong Norris, 2007, CBE Life Sci Educ, V6, P163; Crowe A, 2008, CBE-LIFE SCI EDUC, V7, P368, DOI 10.1187/cbe.08-05-0024; DeHaan R. L., 2005, J SCI EDUC TECHNOL, V14, P253, DOI DOI 10.1007/S10956-005-4425-3; Dirks Clarissa, 2006, CBE Life Sci Educ, V5, P218, DOI 10.1187/cbe.05-10-0121; Ebert-May D., 2008, PATHWAYS SCI TEACHIN; Freeman Scott, 2007, CBE Life Sci Educ, V6, P132, DOI 10.1187/cbe.06-09-0194; Handelsman J, 2004, SCIENCE, V304, P521, DOI 10.1126/science.1096022; Handelsman J, 2007, SCI TEACHING; Knight Jennifer K, 2005, Cell Biol Educ, V4, P298, DOI 10.1187/05-06-0082; Labov Jay B, 2003, Cell Biol Educ, V2, P202, DOI 10.1187/cbe.03-10-0040; Labov Jay B, 2004, Cell Biol Educ, V3, P212, DOI 10.1187/cbe.04-07-0049; National Research Council, 2003, BIO2010 TRANSF UND E; Seymour E., 1997, TALKING LEAVING WHY; Smith MK, 2008, CBE-LIFE SCI EDUC, V7, P422, DOI 10.1187/cbe.08-08-0045; Wood William B, 2004, Cell Biol Educ, V3, P215, DOI 10.1187/cbe.04-07-0057	16	83	84	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					470	471		10.1126/science.1170015	http://dx.doi.org/10.1126/science.1170015			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390031				2022-12-28	WOS:000265411200030
J	Romanowicz, B				Romanowicz, Barbara			The Thickness of Tectonic Plates	SCIENCE			English	Editorial Material							UPPER-MANTLE; STRUCTURE BENEATH; LITHOSPHERE; WATER; DISCONTINUITY; ASTHENOSPHERE; ANISOTROPY; VELOCITY; ORIGIN; ZONE		[Romanowicz, Barbara] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Romanowicz, Barbara] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Romanowicz, B (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA.	barbara@seismo.berkeley.edu	Romanowicz, barbara A/H-6726-2017	Romanowicz, barbara A/0000-0002-6208-6044				Anderson D.L., 1970, PHYS EARTH PLANET IN, V3, P41, DOI DOI 10.1016/0031-9201(70)90042-7; ANDERSON DL, 1995, REV GEOPHYS, V33, P125, DOI 10.1029/94RG02785; Cammarano F, 2007, P NATL ACAD SCI USA, V104, P9139, DOI 10.1073/pnas.0608075104; Farra V, 2000, GEOPHYS J INT, V141, P699, DOI 10.1046/j.1365-246x.2000.00118.x; Faul UH, 2005, EARTH PLANET SC LETT, V234, P119, DOI 10.1016/j.epsl.2005.02.008; Gung YC, 2003, NATURE, V422, P707, DOI 10.1038/nature01559; HALES AL, 1969, EARTH PLANET SC LETT, V7, P44, DOI 10.1016/0012-821X(69)90009-0; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Jaupart C, 1998, J GEOPHYS RES-SOL EA, V103, P15269, DOI 10.1029/98JB01395; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Kumar P, 2007, NATURE, V449, P894, DOI 10.1038/nature06214; Kumar P, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003930; Kustowski B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005169; Li XQ, 2004, NATURE, V427, P827, DOI 10.1038/nature02349; Marone F, 2007, NATURE, V447, P198, DOI 10.1038/nature05742; Mercier JP, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005127; Mierdel K, 2007, SCIENCE, V315, P364, DOI 10.1126/science.1135422; Rudnick RL, 1998, CHEM GEOL, V145, P395, DOI 10.1016/S0009-2541(97)00151-4; Ryberg T, 1996, B SEISMOL SOC AM, V86, P857; Rychert CA, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004619; Rychert CA, 2009, SCIENCE, V324, P495, DOI 10.1126/science.1169754; Shinohara M, 2008, PHYS EARTH PLANET IN, V170, P95, DOI 10.1016/j.pepi.2008.07.039; Smith DB, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003200; Thybo H, 1997, SCIENCE, V275, P1626, DOI 10.1126/science.275.5306.1626; VINNIK LP, 1977, PHYS EARTH PLANET IN, V15, P39, DOI 10.1016/0031-9201(77)90008-5	26	62	63	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					474	476		10.1126/science.1172879	http://dx.doi.org/10.1126/science.1172879			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390034				2022-12-28	WOS:000265411200033
J	Piao, SL; Fang, JY; Ciais, P; Peylin, P; Huang, Y; Sitch, S; Wang, T				Piao, Shilong; Fang, Jingyun; Ciais, Philippe; Peylin, Philippe; Huang, Yao; Sitch, Stephen; Wang, Tao			The carbon balance of terrestrial ecosystems in China	NATURE			English	Article							FOREST BIOMASS; VEGETATION ACTIVITY; NORTHERN; STORAGE; INVENTORY; CROPLANDS; DYNAMICS; CLIMATE; EUROPE; INDEX	Global terrestrial ecosystems absorbed carbon at a rate of 1-4 Pg yr(-1) during the 1980s and 1990s, offsetting 10-60 per cent of the fossil-fuel emissions(1,2). The regional patterns and causes of terrestrial carbon sources and sinks, however, remain uncertain(1-3). With increasing scientific and political interest in regional aspects of the global carbon cycle, there is a strong impetus to better understand the carbon balance of China(1-3). This is not only because China is the world's most populous country and the largest emitter of fossil-fuel CO2 into the atmosphere(4), but also because it has experienced regionally distinct land-use histories and climate trends(1), which together control the carbon budget of its ecosystems. Here we analyse the current terrestrial carbon balance of China and its driving mechanisms during the 1980s and 1990s using three different methods: biomass and soil carbon inventories extrapolated by satellite greenness measurements, ecosystem models and atmospheric inversions. The three methods produce similar estimates of a net carbon sink in the range of 0.19-0.26 Pg carbon (PgC) per year, which is smaller than that in the conterminous United States(5) but comparable to that in geographic Europe(6). We find that northeast China is a net source of CO2 to the atmosphere owing to overharvesting and degradation of forests. By contrast, southern China accounts for more than 65 per cent of the carbon sink, which can be attributed to regional climate change, large-scale plantation programmes active since the 1980s and shrub recovery. Shrub recovery is identified as the most uncertain factor contributing to the carbon sink. Our data and model results together indicate that China's terrestrial ecosystems absorbed 28-37 per cent of its cumulated fossil carbon emissions during the 1980s and 1990s.	[Piao, Shilong; Fang, Jingyun; Wang, Tao] Peking Univ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Piao, Shilong; Fang, Jingyun; Wang, Tao] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Beijing 100871, Peoples R China; [Ciais, Philippe] UMR CEA CNRS UVSQ, LSCE, F-91191 Gif Sur Yvette, France; [Peylin, Philippe] Lab Biogeochim Isotop, F-78026 Thiverval Grignon, France; [Huang, Yao] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China; [Sitch, Stephen] Met Off Hadley Ctr JCHMR, Wallingford OX10 8BB, Oxon, England	Peking University; Peking University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Met Office - UK; Hadley Centre	Piao, SL (corresponding author), Peking Univ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn; jyfang@urban.pku.edu.cn	huang, yao/GWR-5388-2022; Sitch, Stephen A/F-8034-2015; Wang, Tao/ABE-7107-2020; wang, tao/H-2830-2013; Huang, Yao/O-6832-2014; Ciais, Philippe/A-6840-2011; Huang, Yao/GQH-3308-2022	Sitch, Stephen A/0000-0003-1821-8561; wang, tao/0000-0003-4792-5898; Ciais, Philippe/0000-0001-8560-4943; Huang, Yao/0000-0002-0192-1421; Peylin, Philippe/0000-0001-9335-6994	Foundation for the Author of National Excellent Doctoral Dissertation of China [FANEDD-200737]; National Natural Science Foundation of China [90711002, 30721140306]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX1-SW-01-13]; DECC [GA0110]; MoD [CBC/2B/0417_Annex C5]	Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); DECC; MoD	The authors wish to thank P. Friedlingstein for comments and discussions, the dynamic global vegetation models evaluation participants from ref. 23 for access to their data, S. Szopa for providing carbon emissions of non-CO<INF>2</INF> species, L. M. Zhou for providing the Global Inventory Monitoring and Modelling Studies normalized difference vegetation index data, H. F. Hu for providing shrub biomass data and F. Y. Wei for collecting the climate data. For the inversions, we thank all experimentalists who contributed to the GLOBALVIEW-CO<INF>2</INF> product and the CARBOEUROPE measurements, C. Rodenbeck, P. J. Rayner, and P. K. Patra for providing their inversion modelling results and T. Machida for providing vertical profiles from three stations over Siberia. We also thank Commissariat a l'Energie Atomique for computing support. This study was supported by the Foundation for the Author of National Excellent Doctoral Dissertation of China (FANEDD-200737), the National Natural Science Foundation of China (#90711002 and #30721140306), the Knowledge Innovation Program of the Chinese Academy of Sciences (#KZCX1-SW-01-13) and the State Forestry Administration of China. S. S. was supported by the Joint DECC, Defra and MoD Integrated Climate Programme - DECC/Defra (GA01101), MoD (CBC/2B/0417_Annex C5). One visit of S. P. to LSCE was funded by the Reseau Francilien de Developpement Soutenable.	Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Ciais P, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002741; Ciais P, 2006, BIOGEOSCIENCES DISCU, V3, P1529, DOI DOI 10.5194/BGD-3-1529-2006; Cox P. M, 2001, 24 HADL CTR; *DEP AN HUSB VET C, 1994, DAT GRASSL RES CHIN; *DEP FOR RES MAN, 1996, FOR RES CHIN 1949 19; *ED COMM CHIN AGR, 2000, CHIN AGR YB 1982 199; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; Fang JY, 2004, SCI CHINA SER C, V47, P229, DOI 10.1360/03yc0068; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 2001, ACTA BOT SIN, V43, P967; FAO, 2004, FAO STAT; Field CB, 1999, SCIENCE, V285, P544, DOI 10.1126/science.285.5427.544; Folberth G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021812; Food and Agriculture Organization of the United Nations (FAO), 2001, 140 UN FAO; Gregg JS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032887; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Huang Y, 2007, ECOL APPL, V17, P692, DOI 10.1890/05-1792; Huang Y, 2006, CHINESE SCI BULL, V51, P1785, DOI 10.1007/s11434-006-2056-6; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Kaminski T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001463; KEELING CD, 2005, ATMOSPHERIC CO2 RECO; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Lal R, 2004, CLIMATIC CHANGE, V65, P263, DOI 10.1023/B:CLIM.0000038203.81854.7c; Levy PE, 2004, GLOBAL ENVIRON CHANG, V14, P21, DOI 10.1016/j.gloenvcha.2003.10.005; Liu JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021649; Lu AF, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006198; Marland G., 2008, TRENDS COMPENDIUM DA; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; *NAT SOIL SURV OFF, 1993, SOIL SPEC CHIN, V1; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419, DOI 10.5194/acp-7-4419-2007; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Pan YD, 2004, CLIMATIC CHANGE, V67, P211, DOI 10.1007/s10584-004-2799-5; Peylin P, 2005, ATMOS CHEM PHYS, V5, P3173, DOI 10.5194/acp-5-3173-2005; Phillips DL, 2000, GLOBAL ECOL BIOGEOGR, V9, P305, DOI 10.1046/j.1365-2699.2000.00197.x; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002848; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; RODENBECK C, 2008, CO2 INVERSION; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Shahgedanova M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005213; Shen S, 1998, CHINESE SOIL FERTILI; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; Wang SQ, 2002, SCI CHINA SER C, V45, P40; Woodward FI, 2004, BIOL REV, V79, P643, DOI 10.1017/S1464793103006419	51	949	1256	217	1724	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1009	U82		10.1038/nature07944	http://dx.doi.org/10.1038/nature07944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396142				2022-12-28	WOS:000265412900038
J	Hefele, B; Naumann, N; Trollmann, R; Dittrich, K; Rascher, W				Hefele, Barbara; Naumann, Nora; Trollmann, Regina; Dittrich, Katalin; Rascher, Wolgang			Fast-in, fast-out	LANCET			English	Editorial Material							GAMMA-HYDROXYBUTYRATE		[Hefele, Barbara; Naumann, Nora; Trollmann, Regina; Dittrich, Katalin; Rascher, Wolgang] Univ Erlangen Nurnberg, Hosp Children & Adolescents, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Hefele, B (corresponding author), Univ Erlangen Nurnberg, Hosp Children & Adolescents, Loschgestr 15, D-91054 Erlangen, Germany.	Barbara.Hefele@uk-erlange.de						Brenneisen R, 2004, J ANAL TOXICOL, V28, P625, DOI 10.1093/jat/28.8.625; European Monitoring Centre for Drugs and Drug Addiction, 2008, EMCDDA THEM PAP GHB; Miro O, 2002, J TOXICOL-CLIN TOXIC, V40, P129, DOI 10.1081/CLT-120004400; Ricaurte GA, 2005, LANCET, V365, P2137, DOI 10.1016/S0140-6736(05)66737-2; Snead OC, 2005, NEW ENGL J MED, V352, P2721, DOI 10.1056/NEJMra044047	5	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 18	2009	373	9672					1398	1398		10.1016/S0140-6736(09)60570-5	http://dx.doi.org/10.1016/S0140-6736(09)60570-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434UR	19376455				2022-12-28	WOS:000265300100038
J	LeardMann, CA; Smith, TC; Smith, B; Wells, TS; Ryan, MAK				LeardMann, Cynthia A.; Smith, Tyler C.; Smith, Besa; Wells, Timothy S.; Ryan, Margaret A. K.		Millennium Cohort Study Team	Baseline self reported functional health and vulnerability to post-traumatic stress disorder after combat deployment: prospective US military cohort study	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; ADVERSE CHILDHOOD EXPERIENCES; MALE VIETNAM VETERANS; GULF-WAR VETERANS; MILLENNIUM COHORT; MENTAL-HEALTH; RISK-FACTORS; PHYSICAL SYMPTOMS; TRAUMATIC EVENTS; IRAQ WAR	Objective To determine if baseline functional health status, as measured by SF-36 (veterans), predicts new onset symptoms or diagnosis of post-traumatic stress disorder among deployed US military personnel with combat exposure. Design Prospective cohort analysis. Setting Millennium Cohort. Participants Combat deployed members who completed baseline (2001-3) and follow-up (2004-6) questionnaires. Self reported and electronic data used to examine the relation between functional health and post-traumatic stress disorder. Main outcome measures New onset post-traumatic stress disorder as measured by either meeting the DSM-IV criteria with the 17 item post-traumatic stress disorder checklist-civilian version or self report of a physician diagnosis at follow- up with the absence of both at baseline. Results Of the 5410 eligible participants, 395 (7.3%) had new onset symptoms or diagnosis of post-traumatic stress disorder at the time of follow- up. Individuals whose baseline mental or physical component summary scores were below the 15th centile had two to three times the risk of symptoms or a diagnosis of post-traumatic stress disorder by follow- up compared with those in the 15th to 85th centile. Of those with new onset symptoms or diagnosis of post-traumatic stress disorder, over half (58%) of cases occurred among participants with scores below the 15th centile at baseline. Conclusions Low mental or physical health status before combat exposure significantly increases the risk of symptoms or diagnosis of post-traumatic stress disorder after deployment. More vulnerable members of a population could be identified and benefit from interventions targeted to prevent new onset post-traumatic stress disorder.	[LeardMann, Cynthia A.; Smith, Tyler C.; Smith, Besa] Naval Hlth Res Ctr, Dept Def Ctr Deployment Hlth Res, San Diego, CA 92106 USA; [Wells, Timothy S.] AF Res Lab, Biosci & Protect Div, Wright Patterson AFB, OH 45433 USA; [Ryan, Margaret A. K.] Naval Hosp Camp Pendleton, Camp Pendleton, CA 92055 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; United States Air Force; US Air Force Research Laboratory	LeardMann, CA (corresponding author), Naval Hlth Res Ctr, Dept Def Ctr Deployment Hlth Res, 140 Sylvester Rd, San Diego, CA 92106 USA.	Cynthia.LeardMann@med.navy.mil			Naval Health Research Center [08-07]; US Department of Defense [60002]; US Department of the Navy; US Department of the Army; US Department of the Air Force; US Department of Defense; US Department of Veterans Affairs; US Government	Naval Health Research Center(United States Department of Defense); US Department of Defense(United States Department of Defense); US Department of the Navy; US Department of the Army; US Department of the Air Force; US Department of Defense(United States Department of Defense); US Department of Veterans Affairs(US Department of Veterans Affairs); US Government	This represents Naval Health Research Center report 08-07, supported by the US Department of Defense, under work unit No 60002. Funding sources did not play any other role. The views expressed in this article are those of the authors and do not reflect the official policy or position of the US Department of the Navy, US Department of the Army, US Department of the Air Force, US Department of Defense, US Department of Veterans Affairs, or the US Government.	Albery WB, 2007, AVIAT SPACE ENVIR MD, V78, pB186; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Baker DG, 1997, ARCH INTERN MED, V157, P2076, DOI 10.1001/archinte.157.18.2076; Barrett DH, 2003, MIL MED, V168, P941, DOI 10.1093/milmed/168.11.941; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borzecki AM, 2005, J AMBUL CARE MANAG, V28, P141, DOI 10.1097/00004479-200504000-00005; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; BUSH B, 1987, AM J MED, V82, P231, DOI 10.1016/0002-9343(87)90061-1; Butterfield MI, 2000, J TRAUMA STRESS, V13, P735, DOI 10.1023/A:1007874620024; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; *DEP DEF, 2005, DEP DEF INSTR MED ST; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Edwards KM, 2007, J HYPERTENS, V25, P1533, DOI 10.1097/HJH.0b013e328165ca67; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fiedler ER, 2005, AVIAT SPACE ENVIR MD, V76, pC4; Gahm GA, 2007, J CLIN PSYCHOL, V63, P199, DOI 10.1002/jclp.20330; Gray GC, 2002, MIL MED, V167, P483, DOI 10.1093/milmed/167.6.483; Harwood GE, 1999, MIL MED, V164, P428, DOI 10.1093/milmed/164.6.428; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Ismail K, 2000, J EPIDEMIOL COMMUN H, V54, P834, DOI 10.1136/jech.54.11.834; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Jamil H, 2006, SOC WORK HEALTH CARE, V43, P85, DOI 10.1300/J010v43n04_06; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Katzmarzyk PT, 2007, DIABETOLOGIA, V50, P538, DOI 10.1007/s00125-006-0554-3; Kazis LE, 2004, HEALTH CARE FINANC R, V25, P43; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P70; King DW, 1996, J CONSULT CLIN PSYCH, V64, P520, DOI 10.1037/0022-006X.64.3.520; Koenen KC, 2003, J TRAUMA STRESS, V16, P433, DOI 10.1023/A:1025786925483; Krueger GP, 2007, AVIAT SPACE ENVIR MD, V78, pB58; LeardMann CA, 2007, HUM VACCINES, V3, P245, DOI 10.4161/hv.4589; Mancino MJ, 2006, J NERV MENT DIS, V194, P877, DOI 10.1097/01.nmd.0000244686.79689.21; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Olff M, 2005, NEUROSCI BIOBEHAV R, V29, P457, DOI 10.1016/j.neubiorev.2004.12.006; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; Richardson JD, 2007, CAN J PSYCHIAT, V52, P510, DOI 10.1177/070674370705200809; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Smith B, 2007, ANN EPIDEMIOL, V17, P976, DOI 10.1016/j.annepidem.2007.07.102; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Smith B, 2007, AM J PREV MED, V32, P347, DOI 10.1016/j.amepre.2006.12.015; Smith TC, 2008, EPIDEMIOLOGY, V19, P505, DOI 10.1097/EDE.0b013e31816a9dff; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Smith TC, 2007, INT J ENVIRON HEAL R, V17, P271, DOI 10.1080/09603120701372243; Smith TC, 2007, ANN EPIDEMIOL, V17, P525, DOI 10.1016/j.annepidem.2006.12.002; Smith TC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-340; Storr CL, 2007, AM J PSYCHIAT, V164, P119, DOI 10.1176/appi.ajp.164.1.119; Voelker MD, 2002, AM J EPIDEMIOL, V155, P899, DOI 10.1093/aje/155.10.899; Wagner AW, 2000, J TRAUMA STRESS, V13, P41, DOI 10.1023/A:1007716813407; Ware J.E., 2000, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wareing PW, 2001, INT J FOOD SCI TECH, V36, P1, DOI 10.1046/j.1365-2621.2001.00419.x; Weather F. W., 1993, ANN M INT SOC TRAUM; Wells TS, 2008, EUR J EPIDEMIOL, V23, P79, DOI 10.1007/s10654-007-9216-0; Wright KM, 2002, MIL MED, V167, P853, DOI 10.1093/milmed/167.10.853; Zatzick DF, 1997, MIL MED, V162, P661, DOI 10.1093/milmed/162.10.661; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690	67	83	84	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 16	2009	338								b1273	10.1136/bmj.b1273	http://dx.doi.org/10.1136/bmj.b1273			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TK	19372117	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000265296800001
J	Hawkes, N				Hawkes, Nigel			Observations Body Politic Fools rush in?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Dancer SJ, 2008, J HOSP INFECT, V69, P315, DOI 10.1016/j.jhin.2008.05.002; 2008, JAMA-J AM MED ASSOC, V299, P1149	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 15	2009	338								b1533	10.1136/bmj.b1533	http://dx.doi.org/10.1136/bmj.b1533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TJ	19369279				2022-12-28	WOS:000265296700005
J	Kosiborod, M; Inzucchi, SE; Goyal, A; Krumholz, HM; Masoudi, FA; Xiao, L; Spertus, JA				Kosiborod, Mikhail; Inzucchi, Silvio E.; Goyal, Abhinav; Krumholz, Harlan M.; Masoudi, Frederick A.; Xiao, Lan; Spertus, John A.			Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE INSULIN THERAPY; STRESS HYPERGLYCEMIA; BLOOD-GLUCOSE; ADVERSE OUTCOMES; NONDIABETIC PATIENTS; DIABETIC-PATIENTS; PLASMA-GLUCOSE; ASSOCIATION; ADMISSION; RISK	Context While glucose control is recommended by professional societies for patients with hyperglycemia hospitalized with acute myocardial infarction (AMI), enthusiasm for glucose lowering is tempered, in part, by concerns of inducing hypoglycemia. Yet, whether episodic hypoglycemia that occurs as a result of glucose-lowering therapy is harmful in patients with AMI is unknown. Objective To determine whether the mortality risk associated with hypoglycemic events is similar in patients who develop hypoglycemia spontaneously and those who develop it as a result of insulin therapy. Design, Setting, and Patients Retrospective cohort study using data from Health Facts, a contemporary database of patients hospitalized across the United States in 40 hospitals between January 1, 2000, and December 31, 2005. Of all the patients in the database, 7820 patients were hospitalized with AMI and were hyperglycemic on admission (glucose level >= 140 mg/dL). Patients were stratified based on whether they developed a hypoglycemic event (random glucose level <60 mg/dL) during subsequent hospitalization. Logistic regression models were used to evaluate the association between hypoglycemia and in-hospital mortality within subgroups of patients who were and were not treated with insulin therapy. Main Outcome Measure All-cause in-hospital mortality. Results Among patients treated or not treated with insulin, those with hypoglycemia were older and had more comorbidity. Hypoglycemia was associated with increased mortality in patients not treated with insulin (18.4% [25/136] mortality in patients with hypoglycemia vs 9.2% [425/4639] in those without hypoglycemia; P<.001), but not in those treated with insulin (10.4% [36/346] mortality in patients with hypoglycemia vs 10.2% [276/2699] in those without hypoglycemia; P=.92). After multivariable adjustment, there was a significant interaction between hypoglycemia and insulin therapy (P value for interaction=.01). Hypoglycemia was a predictor of higher mortality in patients who were not treated with insulin (odds ratio, 2.32 [95% confidence interval, 1.31-4.12] vs patients without hypoglycemia), but not in patients treated with insulin (odds ratio, 0.92 [95% confidence interval, 0.58-1.45] vs patients without hypoglycemia). Conclusions While hypoglycemia was associated with increased mortality in patients with AMI, this risk was confined to patients who developed hypoglycemia spontaneously. In contrast, iatrogenic hypoglycemia after insulin therapy was not associated with higher mortality risk.	[Kosiborod, Mikhail; Xiao, Lan; Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Kosiborod, Mikhail; Spertus, John A.] Univ Missouri, Dept Med, Kansas City, MO USA; [Inzucchi, Silvio E.; Krumholz, Harlan M.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Inzucchi, Silvio E.; Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Goyal, Abhinav] Emory Rollins Sch Publ Hlth, Atlanta, GA USA; [Goyal, Abhinav] Emory Sch Med, Atlanta, GA USA; [Masoudi, Frederick A.] Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Denver, CO USA; [Masoudi, Frederick A.] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University; Yale University; Emory University; Rollins School Public Health; Emory University; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kosiborod, M (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	mkosiborod@cc-pc.com	Kosiborod, Mikhail/HDO-1541-2022; , Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021; Masoudi, Frederick/Q-7467-2019; Goyal, Abhinav/J-5086-2012; Inzucchi, Silvio/ABF-4121-2021	Kosiborod, Mikhail/0000-0002-3750-9789; Goyal, Abhinav/0000-0002-6286-2349; 	American Heart Association; Cerner Corporation	American Heart Association(American Heart Association); Cerner Corporation	Funding/Support: The research for this article was supported by the American Heart Association Career Development Award in Implementation Research awarded to Dr Kosiborod and by the Cerner Corporation.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; ANTMAN EM, ACC AHA GUIDELINES M; BELLODI G, 1989, AM J CARDIOL, V64, P885, DOI 10.1016/0002-9149(89)90836-9; Bolk J, 2001, INT J CARDIOL, V79, P207, DOI 10.1016/S0167-5273(01)00422-3; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Childs BP, 2005, DIABETES CARE, V28, P1245; Deedwania P, 2008, CIRCULATION, V117, P1610, DOI 10.1161/CIRCULATIONAHA.107.188629; Foo K, 2003, HEART, V89, P512, DOI 10.1136/heart.89.5.512; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; Goyal A, 2006, EUR HEART J, V27, P1289, DOI 10.1093/eurheartj/ehi884; Hadjadj S, 2004, DIABETIC MED, V21, P305, DOI 10.1111/j.1464-5491.2004.01112.x; Ishihara M, 2003, AM HEART J, V146, P674, DOI 10.1016/S0002-8703(03)00167-4; Iwakura K, 2003, J AM COLL CARDIOL, V41, P1, DOI 10.1016/S0735-1097(02)02626-8; Kadri Z, 2006, HEART, V92, P910, DOI 10.1136/hrt.2005.073791; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.517839; Kosiborod M, 2008, CIRCULATION, V117, P1018, DOI 10.1161/CIRCULATIONAHA.107.740498; LEOR J, 1993, AM J MED, V94, P265, DOI 10.1016/0002-9343(93)90058-W; MADSEN JK, 1986, ACTA MED SCAND, V220, P329; Mak K. H., 1993, Annals Academy of Medicine Singapore, V22, P291; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meier JJ, 2005, DIABETES CARE, V28, P2551, DOI 10.2337/diacare.28.10.2551; MELLBIN LG, 2008, HEART           1124, DOI DOI 10.1136/HRT.2008.152835; MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67, DOI 10.1152/ajpendo.1991.260.1.E67; OSULLIVAN JJ, 1991, DIABETES CARE, V14, P758, DOI 10.2337/diacare.14.8.758; OSWALD GA, 1986, BMJ-BRIT MED J, V293, P917, DOI 10.1136/bmj.293.6552.917; OSWALD GA, 1984, LANCET, V1, P1264; OSWALD GA, 1987, DIABETIC MED, V4, P68, DOI 10.1111/j.1464-5491.1987.tb00833.x; Pinto DS, 2005, J AM COLL CARDIOL, V46, P178, DOI 10.1016/j.jacc.2005.03.052; Sala J, 2002, J EPIDEMIOL COMMUN H, V56, P707, DOI 10.1136/jech.56.9.707; SEWDARSEN M, 1987, DIABETES RES CLIN EX, V6, P47; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Suleiman M, 2005, CIRCULATION, V111, P754, DOI 10.1161/01.CIR.0000155235.48601.2A; Svensson AM, 2005, EUR HEART J, V26, P1255, DOI 10.1093/eurheartj/ehi230; Swinnen S, 2009, DIABETOLOGIA, V52, P38, DOI 10.1007/s00125-008-1147-0; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Wahab NN, 2002, J AM COLL CARDIOL, V40, P1748, DOI 10.1016/S0735-1097(02)02483-X; Wong VW, 2004, DIABETES RES CLIN PR, V64, P85, DOI 10.1016/j.diabres.2003.10.016; YUDKIN JS, 1987, BRIT MED J, V294, P773, DOI 10.1136/bmj.294.6574.773	42	233	241	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1556	1564		10.1001/jama.2009.496	http://dx.doi.org/10.1001/jama.2009.496			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366775	Bronze			2022-12-28	WOS:000265137900026
J	Pocock, SJ; Ware, JH				Pocock, Stuart J.; Ware, James H.			Translating statistical findings into plain English	LANCET			English	Editorial Material							RANDOMIZED-TRIALS; DOUBLE-BLIND; EFFICACY; DISEASE		[Pocock, Stuart J.] London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England; [Ware, James H.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Pocock, SJ (corresponding author), London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England.	stuart.pocock@lshtm.ac.uk						Abdulla S, 2008, LANCET, V372, P1819, DOI 10.1016/S0140-6736(08)61492-0; BULPITT CJ, 1987, LANCET, V1, P494; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	12	57	58	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1926	1928		10.1016/S0140-6736(09)60499-2	http://dx.doi.org/10.1016/S0140-6736(09)60499-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456GT	19375158				2022-12-28	WOS:000266832500007
J	Turpie, AGG; Lassen, MR; Davidson, BL; Bauer, KA; Gent, M; Kwong, LM; Cushner, FD; Lotke, PA; Berkowitz, SD; Bandel, TJ; Benson, A; Misselwitz, F; Fisher, WD				Turpie, Alexander G. G.; Lassen, Michael R.; Davidson, Bruce L.; Bauer, Kenneth A.; Gent, Michael; Kwong, Louis M.; Cushner, Fred D.; Lotke, Paul A.; Berkowitz, Scott D.; Bandel, Tiemo J.; Benson, Alice; Misselwitz, Frank; Fisher, William D.		RECORD4 Investigators	Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial	LANCET			English	Article							DIRECT THROMBIN INHIBITOR; MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; DOUBLE-BLIND; PREVENTION; XIMELAGATRAN; PROPHYLAXIS	Background Prophylaxis for venous thromboembolism is recommended for at least 10 days after total knee arthroplasty; oral regimens could enable shorter hospital stays. We aimed to test the efficacy and safety of oral rivaroxaban for the prevention of venous thromboembolism after total knee arthroplasty. Methods in a randomised, double-blind, phase III study, 3148 patients undergoing knee arthroplasty received either oral rivaroxaban 10 mg once daily, beginning 6-8 h after surgery, or subcutaneous enoxaparin 30 mg every 12 h, starting 12-24 h after surgery. Patients had mandatory bilateral venography between days 11 and 15. The primary efficacy outcome was the composite of any deep-vein thrombosis, non-fatal pulmonary embolism, or death from any cause up to day 17 after surgery. Efficacy was assessed as non-inferiority of rivaroxaban compared with enoxaparin in the per-protocol population (absolute non-inferiority limit -4%); if non-inferiority was shown, we assessed whether rivaroxaban had superior efficacy in the modified intention-to-treat population. The primary safety outcome was major bleeding. This trial is registered with ClinicalTrials.gov, number NCT00362232. Findings The primary efficacy outcome occurred in 67 (6.9%) of 965 patients given rivaroxaban and in 97 (10.1%) of 959 given enoxaparin (absolute risk reduction 3.19%, 95% Cl 0.71-5.67; p=0.0118). Ten (0.7%) of 1526 patients given rivaroxaban and four (0.3%) of 1508 given enoxaparin had major bleeding (p=0.1096). Interpretation Oral rivaroxaban 10 mg once daily for 10-14 days was significantly superior to subcutaneous enoxaparin 30 mg given every 12 h for the prevention of venous thromboembolism after total knee arthroplasty.	[Turpie, Alexander G. G.; Gent, Michael] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Lassen, Michael R.] Horsholm Hosp, Horsholm, Denmark; [Davidson, Bruce L.] Weill Cornell Med Coll, Doha, Qatar; [Bauer, Kenneth A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kwong, Louis M.] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Cushner, Fred D.] Insall Scott Kelly Ctr Orthopaed & Sports Med, New York, NY USA; [Lotke, Paul A.] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA; [Berkowitz, Scott D.; Bandel, Tiemo J.; Benson, Alice; Misselwitz, Frank] Bayer Schering Pharma AG, Wuppertal, Germany; [Fisher, William D.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada	McMaster University; University of Copenhagen; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Pennsylvania; Bayer AG; Bayer Healthcare Pharmaceuticals; McGill University	Turpie, AGG (corresponding author), McMaster Univ, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	turpiea@mcmaster.ca	Berkowitz, Scott Darrell/AAS-9397-2021; Schulman, Sam/I-7559-2019	Berkowitz, Scott Darrell/0000-0002-9428-4408; Schulman, Sam/0000-0002-8512-9043; Gomez, Ricardo/0000-0001-9267-304X; Raju, Dr KV Puttakempa/0000-0002-3687-0927	Bayer Schering Pharma AG; Johnson & Johnson Pharmaceutical Research Development	Bayer Schering Pharma AG(Bayer AG); Johnson & Johnson Pharmaceutical Research Development(Johnson & JohnsonJohnson & Johnson USA)	This trial was supported by Bayer Schering Pharma AG and Johnson & Johnson Pharmaceutical Research & Development. We thank Mel Lederman for expert medical opinion, Teresa Twomey for her clinical operations expertise, and Sarah Atkinson for editorial assistance in the preparation of the manuscript, with funding from Bayer Schering Pharma AG and Johnson & Johnson Pharmaceutical Research & Development.	Bauer KA, 2001, NEW ENGL J MED, V345, P1305, DOI 10.1056/NEJMoa011099; Caprini Joseph A, 2006, Manag Care, V15, P49; Cohen AT, 2005, BRIT J SURG, V92, P1335, DOI 10.1002/bjs.5180; Colwell CW, 2003, J THROMB HAEMOST, V1, P2119, DOI 10.1046/j.1538-7836.2003.00368.x; Colwell CW, 2005, J BONE JOINT SURG AM, V87A, P2169, DOI 10.2106/JBJS.D.02184; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Fuji T, 2008, BLOOD, V112, P19; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginsberg JS, 2009, J ARTHROPLASTY, V24, P1, DOI 10.1016/j.arth.2008.01.132; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; LASSEN M, 2008, BLOOD, V112, P31; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Raskob GE, 2003, CHEST, V124, p379S, DOI 10.1378/chest.124.6_suppl.379S; Strebel N, 2002, ARCH INTERN MED, V162, P1451, DOI 10.1001/archinte.162.13.1451	15	727	805	1	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2009	373	9676					1673	1680		10.1016/S0140-6736(09)60734-0	http://dx.doi.org/10.1016/S0140-6736(09)60734-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RP	19411100				2022-12-28	WOS:000266209800015
J	Takken, FLW; Tameling, WIL				Takken, F. L. W.; Tameling, W. I. L.			To Nibble at Plant Resistance Proteins	SCIENCE			English	Editorial Material							NB-LRR PROTEIN; NUCLEOTIDE-BINDING; CASPASE-1 ACTIVATION; ATP HYDROLYSIS; APOPTOSOME; RECOGNITION; PERCEPTION; MUTATIONS; EXCHANGE; DOMAINS	To intercept invading microbes that threaten growth and reproduction, plants evolved a sophisticated innate immune system. Recognition of specialized pathogens is mediated by resistance proteins that function as molecular switches. Pathogen perception by these multidomain proteins seems to trigger a series of conformational changes dependent on nucleotide exchange. The activated resistance protein switches on host defenses, often culminating in the death of infected cells. Given their control over life and death, activity of these proteins requires tight regulation that involves intramolecular interactions between the various domains.	[Takken, F. L. W.] Univ Amsterdam, SILS, NL-1090 GE Amsterdam, Netherlands; [Tameling, W. I. L.] Wageningen Univ, Phytopathol Lab, NL-6700 EE Wageningen, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Wageningen University & Research	Takken, FLW (corresponding author), Univ Amsterdam, SILS, POB 94215, NL-1090 GE Amsterdam, Netherlands.	F.L.W.Takken@uva.nl; wladimir.tameling@wur.nl	Takken, Frank/C-8051-2012	Takken, Frank/0000-0003-2655-3108				Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Gabriels SHEJ, 2007, PLANT J, V50, P14, DOI 10.1111/j.1365-313X.2007.03027.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Marquenet E, 2007, MOL CELL, V28, P187, DOI 10.1016/j.molcel.2007.08.014; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Rairdan G, 2007, MICROBES INFECT, V9, P677, DOI 10.1016/j.micinf.2007.01.019; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sprang S R, 2000, Sci STKE, V2000, ppe1; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003	27	110	123	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					744	746		10.1126/science.1171666	http://dx.doi.org/10.1126/science.1171666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423813				2022-12-28	WOS:000265832400032
J	Al-Omran, M; Aljabri, B				Al-Omran, Mohammed; Aljabri, Badr			Abdominal Aortic Aneurysm.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Al-Omran, Mohammed; Aljabri, Badr] King Saud Univ, Riyadh 11472, Saudi Arabia	King Saud University	Al-Omran, M (corresponding author), King Saud Univ, Riyadh 11472, Saudi Arabia.	malomran@ksu.edu.sa							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					2004	2004		10.1056/NEJMicm0709036	http://dx.doi.org/10.1056/NEJMicm0709036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420369				2022-12-28	WOS:000265784400010
J	Omer, SB; Salmon, DA; Orenstein, WA; deHart, MP; Halsey, N				Omer, Saad B.; Salmon, Daniel A.; Orenstein, Walter A.; deHart, M. Patricia; Halsey, Neal			Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEASLES-MUMPS-RUBELLA; UNITED-STATES; SAFETY CONCERNS; NONMEDICAL EXEMPTIONS; PHILOSOPHICAL EXEMPTIONS; MEDICAL HOME; PRIMARY-CARE; CHILDREN; ASSOCIATION; PERTUSSIS	Vaccines are among the most effective prevention tools available to clinicians. However, the success of an immunization program depends on high rates of acceptance and coverage. There is evidence of an increase in vaccine refusal in the United States and of geographic clustering of refusals that results in outbreaks. Children with exemptions from school immunization requirements (a measure of vaccine refusal) are at increased risk for measles and pertussis and can infect others who are too young to be vaccinated, cannot be vaccinated for medical reasons, or were vaccinated but did not have a sufficient immunologic response. Clinicians can play a crucial role in parental decision making. Health care providers are cited as the most frequent source of immunization information by parents, including parents of unvaccinated children. Although some clinicians have discontinued or have considered discontinuing their provider relationship with patients who refuse vaccines, the American Academy of Pediatrics Committee on Bioethics advises against this and recommends that clinicians address vaccine refusal by respectfully listening to parental concerns and discussing the risks of nonvaccination.	[Omer, Saad B.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Omer, Saad B.; Orenstein, Walter A.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Omer, Saad B.; Salmon, Daniel A.; Halsey, Neal] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Halsey, Neal] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD USA; [Salmon, Daniel A.] Dept Hlth & Human Serv, Natl Vaccine Program Off, Washington, DC USA; [deHart, M. Patricia] Washington State Dept Hlth, Olympia, WA USA	Emory University; Rollins School Public Health; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Omer, SB (corresponding author), Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	somer@emory.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474; salmon, daniel/0000-0002-1035-4422				Allred NJ, 2005, AM J PREV MED, V28, P221, DOI 10.1016/j.amepre.2004.10.014; Allred NJ, 2007, PEDIATRICS, V119, pS4, DOI 10.1542/peds.2006-2089C; Bardenheier B, 2004, ARCH PEDIAT ADOL MED, V158, P569, DOI 10.1001/archpedi.158.6.569; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; BLOCH AB, 1985, PEDIATRICS, V76, P524; Chen RT, 1998, PEDIATR ANN, V27, P445, DOI 10.3928/0090-4481-19980701-11; Chen RT, 1998, LANCET, V351, P611, DOI 10.1016/S0140-6736(05)78423-3; COHEN E, 2008, SHOULD I VACCINATE M; Colgrove J, 2005, HEALTH AFFAIR, V24, P729, DOI 10.1377/hlthaff.24.3.729; Daniels D, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(01)00278-1; DEEN JL, 1995, CLIN INFECT DIS, V21, P1211, DOI 10.1093/clinids/21.5.1211; DeStefano F, 2007, CLIN PHARMACOL THER, V82, P756, DOI 10.1038/sj.clpt.6100407; Diekema DS, 2005, PEDIATRICS, V115, P1428, DOI 10.1542/peds.2005-0316; Doja A, 2006, CAN J NEUROL SCI, V33, P341, DOI 10.1017/S031716710000528X; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Flanagan-Klygis EA, 2005, ARCH PEDIAT ADOL MED, V159, P929, DOI 10.1001/archpedi.159.10.929; Fombonne E, 2003, MOL PSYCHIATR, V8, P133, DOI 10.1038/sj.mp.4001266; Fombonne E, 2008, ARCH GEN PSYCHIAT, V65, P15, DOI 10.1001/archgenpsychiatry.2007.2; FOWINKLE EW, 1981, PUBLIC HEALTH REP, V96, P61; Fredrickson DD, 2004, FAM MED, V36, P431; Freed GL, 2004, AM J PREV MED, V26, P11, DOI 10.1016/j.amepre.2003.09.004; Grigg M. A., 2008, Morbidity and Mortality Weekly Report, V57, P893; Gust DA, 2004, PEDIATRICS, V114, pE16, DOI 10.1542/peds.114.1.e16; Humiston SG, 2005, ARCH PEDIAT ADOL MED, V159, P108, DOI 10.1001/archpedi.159.2.108; *J HOPK BLOOMB SCH, 2008, VACC EX; JACKSON CL, 1969, PUBLIC HEALTH REP, V84, P787, DOI 10.2307/4593678; Kaufman M, 1967, Bull Hist Med, V41, P463; LOVEJOY GS, 1974, PUBLIC HEALTH REP, V89, P456; Luman ET, 2008, AM J PREV MED, V35, P319, DOI 10.1016/j.amepre.2008.06.001; Luman ET, 2008, AM J PREV MED, V34, P463, DOI 10.1016/j.amepre.2008.01.033; Luman ET, 2005, AM J PUBLIC HEALTH, V95, P1367, DOI 10.2105/AJPH.2004.046284; Luman ET, 2005, JAMA-J AM MED ASSOC, V293, P1204, DOI 10.1001/jama.293.10.1204; Luman ET, 2003, PEDIATRICS, V111, P1215; MIDDAUGH JP, 1978, JAMA-J AM MED ASSOC, V239, P2128, DOI 10.1001/jama.239.20.2128; *NAT CTR IMM RESP, 2007, SCH CHILDC VACC SURV; Offit PA, 2008, NEW ENGL J MED, V358, P2089, DOI 10.1056/NEJMp0802904; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Orenstein WA, 2004, J INFECT DIS, V189, pS1, DOI 10.1086/377693; Orenstein WA, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00290-X; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Redd S. B., 2008, Morbidity and Mortality Weekly Report, V57, P494; ROBBINS KB, 1981, AM J PUBLIC HEALTH, V71, P270, DOI 10.2105/AJPH.71.3.270; Rota JS, 2001, AM J PUBLIC HEALTH, V91, P645, DOI 10.2105/AJPH.91.4.645; Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470; Salmon DA, 2005, AM J PUBLIC HEALTH, V95, P436, DOI 10.2105/AJPH.2004.046201; Salmon DA, 2005, AM J PUBLIC HEALTH, V95, P551, DOI 10.2105/AJPH.2004.046201; Salmon DA, 2004, PEDIATRICS, V113, pE552, DOI 10.1542/peds.113.6.e552; Salmon DA, 2000, JAMA-J AM MED ASSOC, V283, P1141; Salmon DA, 2001, PUBLIC HEALTH REP, V116, P289, DOI 10.1016/S0033-3549(04)50050-X; Salmon DA, 1999, JAMA-J AM MED ASSOC, V282, P47, DOI 10.1001/jama.282.1.47; Salmon DA, 2008, HUM VACCINES, V4, P286, DOI 10.4161/hv.4.4.5752; Schechter R, 2008, ARCH GEN PSYCHIAT, V65, P19, DOI 10.1001/archgenpsychiatry.2007.1; SEARS R, BOBS BLOD CATEGORIES; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Smith MJ, 2008, PEDIATRICS, V121, pE836, DOI 10.1542/peds.2007-1760; Smith PJ, 2006, PEDIATRICS, V118, pE1287, DOI 10.1542/peds.2006-0923; Smith PJ, 2005, PEDIATRICS, V116, P130, DOI 10.1542/peds.2004-1058; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; STERN BJ, 1927, SHOULD WE BE VACCINA, P93; Thompson WW, 2007, NEW ENGL J MED, V357, P1281, DOI 10.1056/NEJMoa071434; Van Loon Frederik P. L., 1995, Morbidity and Mortality Weekly Report, V44, P1; *WASH STAT DEP HLT, 2009, SCH STAT DAT REP; WEXLER DL, 2008, VACCINES, P1685; *WHO, 2008, VACC SAF WEB SIT M C; WILLIAMS IT, 1995, PEDIATRICS, V96, P439; 2003, 37 NAT IMM C CHIC MA; 1981, MMWR MORB MORTAL WKL, V30, P593; 1977, MMWR MORB MORTAL WKL, V26, P109	69	589	604	1	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1981	1988		10.1056/NEJMsa0806477	http://dx.doi.org/10.1056/NEJMsa0806477			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441QN	19420367				2022-12-28	WOS:000265784400008
J	Cometto, G; Ooms, G; Starrs, A; Zeitz, P				Cometto, Giorgio; Ooms, Gorik; Starrs, Ann; Zeitz, Paul			A global fund for the health MDGs?	LANCET			English	Editorial Material							HIV/AIDS		[Cometto, Giorgio] Save Children UK, London EC1M 4AR, England; [Ooms, Gorik] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Starrs, Ann] Family Care Int, New York, NY USA; [Zeitz, Paul] Global AIDS Alliance, Washington, DC USA	Save the Children; Institute of Tropical Medicine (ITM)	Cometto, G (corresponding author), Save Children UK, London EC1M 4AR, England.	giorgiocometto@hotmail.com	Ooms, Gorik/A-2537-2015	Ooms, Gorik/0000-0002-9804-0128; Zeitz, Paul/0000-0002-0865-088X				[Anonymous], 2008, WORLD HLTH STAT 2008; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Gordon JG, 2008, LANCET, V372, P333, DOI 10.1016/S0140-6736(08)61117-4; *HIGH LEV TASKF IN, 2008, TERMS REF MAN ARR; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; *IND MEMB FAC HARV, 2001, CONS STAT ANT TREATM; Loaiza E, 2008, LANCET, V372, P874, DOI 10.1016/S0140-6736(08)61378-1; LOBLEVYT J, 2009, COMMUNICATION   0310; Medecins sans Frontieres, 2007, HELP WANT CONFR HLTH; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Taskforce on Innovative International Financing for Health Systems, 2009, 2 TASKF INN INT FIN; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNAIDS, 2008, 2008 REP GLOB AIDS E; WHO, 2008, MAX POS SYN HLTH SYS	14	30	30	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 2	2009	373	9674					1500	1502		10.1016/S0140-6736(09)60835-7	http://dx.doi.org/10.1016/S0140-6736(09)60835-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19410697				2022-12-28	WOS:000265710300005
J	Kim, J; Guermah, M; McGinty, RK; Lee, JS; Tang, ZY; Milne, TA; Shilatifard, A; Muir, TW; Roeder, RG				Kim, Jaehoon; Guermah, Mohamed; McGinty, Robert K.; Lee, Jung-Shin; Tang, Zhanyun; Milne, Thomas A.; Shilatifard, Ali; Muir, Tom W.; Roeder, Robert G.			RAD6-Mediated Transcription-Coupled H2B Ubiquitylation Directly Stimulates H3K4 Methylation in Human Cells	CELL			English	Article							RNA-POLYMERASE-II; UBIQUITIN-CONJUGATING ENZYME; HISTONE H2B; DNA-REPAIR; PAF1 COMPLEX; ELONGATION; CHROMATIN; YEAST; MONOUBIQUITINATION; EXPRESSION	H2B ubiquitylation has been implicated in active transcription but is not well understood in mammalian cells. Beyond earlier identification of hBRE1 as the E3 ligase for H2B ubiquitylation in human cells, we now show (1) that hRAD6 serves as the cognate E2-conjugating enzyme; (2) that hRAD6, through direct interaction with hPAF-bound hBRE1, is recruited to transcribed genes and ubiquitylates chromatinized H2B at lysine 120; (3) that hPAF-mediated transcription is required for efficient H2B ubiquitylation as a result of hPAF-dependent recruitment of hBRE1-hRAD6 to the Pol II transcription machinery; (4) that H2B ubiquitylation per se does not affect the level of hPAF-, SII-, and p300-dependent transcription and likely functions downstream; and (5) that H2B ubiquitylation directly stimulates hSET1-dependent H3K4 di- and trimethylation. These studies establish the natural H2B ubiquitylation factors in human cells and also detail the mechanistic basis for H2B ubiquitylation and function during transcription.	[Kim, Jaehoon; Guermah, Mohamed; Tang, Zhanyun; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [McGinty, Robert K.; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA; [Milne, Thomas A.] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Lee, Jung-Shin; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Rockefeller University; Rockefeller University; Rockefeller University; Stowers Institute for Medical Research	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Muir, Tom/AHD-0860-2022; Kim, Jaehoon/G-2711-2011; Milne, Tom/E-1872-2016	Muir, Tom/0000-0001-9635-0344; Kim, Jaehoon/0000-0003-4035-0438; Milne, Tom/0000-0002-0413-4271	NIH [CA129325, DK071900, CA113872]; Leukemia and Lymphoma Society SCOR; NATIONAL CANCER INSTITUTE [R01CA089455, R01CA129325, R01CA113872, R01CA150265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM069905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. C. D. Allis for helpful discussion; Drs. N. Minsky and M. Oren for anti-ubH2B antibody; Drs. O. Rozenblatt-Rosen and M. Meyerson for anti-hCTR9 antibody; and Dr. D. Reinberg for anti-hSKI8 antibody and the FLAG-hBRE1A/RNF20 cell line. This work was supported by NIH grants (CA129325, DK071900, and CA113872) to R. G. R. and by a Leukemia and Lymphoma Society SCOR grant.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baarends WM, 2007, J CELL SCI, V120, P1841, DOI 10.1242/jcs.03451; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Guermah M, 2006, CELL, V125, P275, DOI 10.1016/j.cell.2006.01.055; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Koken MHM, 1996, DEV BIOL, V173, P119, DOI 10.1006/dbio.1996.0011; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	32	359	371	4	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					459	471		10.1016/j.cell.2009.02.027	http://dx.doi.org/10.1016/j.cell.2009.02.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410543	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000265677200016
J	Schneider, S				Schneider, Stephen			The worst-case scenario	NATURE			English	Editorial Material							CLIMATE-CHANGE		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Schneider, S (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	shs@stanford.edu						Fischlin A., 2007, CONTRIBUTION WORKING, P211; Hansen J, 2007, ATMOS CHEM PHYS, V7, P2287, DOI 10.5194/acp-7-2287-2007; Kundzewiczs ZW, 2007, CLIMATE CHANGE 2007, P173, DOI DOI 10.1007/S11269-006-3091-4; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Schneider SH, 2008, PHILOS T R SOC A, V366, P3843, DOI 10.1098/rsta.2008.0145; Schneider SH, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P779; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1	10	47	48	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1104	1105		10.1038/4581104a	http://dx.doi.org/10.1038/4581104a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441FL	19407776	Bronze			2022-12-28	WOS:000265754600019
J	Nisbet, EG; Chappellaz, J				Nisbet, E. G.; Chappellaz, J.			Shifting Gear, Quickly	SCIENCE			English	Editorial Material							ABRUPT CLIMATE-CHANGE; ATMOSPHERIC CH4; ICE; METHANE; GREENLAND; RECORD; END		[Nisbet, E. G.] Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Chappellaz, J.] Univ Grenoble, CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France	University of London; Royal Holloway University London; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Nisbet, EG (corresponding author), Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England.	e.nisbet@es.rhul.ac.uk; chappellaz@lgge.obs.ujf-grenoble.fr	Chappellaz, Jérôme A./A-4872-2011		Natural Environment Research Council [NE/D005728/2, NE/F020937/1] Funding Source: researchfish; NERC [NE/D005728/2, NE/F020937/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; DLUGOKENCKY EJ, 2008, EOS S, V89; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Fluckiger J, 1999, SCIENCE, V285, P227, DOI 10.1126/science.285.5425.227; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Lindsay RW, 2009, J CLIMATE, V22, P165, DOI 10.1175/2008JCLI2521.1; NISBET EG, 1992, J GEOPHYS RES-ATMOS, V97, P12859, DOI 10.1029/92JD00743; NISBET EG, 1990, CAN J EARTH SCI, V27, P148, DOI 10.1139/e90-012; NISBET EG, 1989, CAN J EARTH SCI, V26, P1603, DOI 10.1139/e89-136; Petrenko VV, 2009, SCIENCE, V324, P506, DOI 10.1126/science.1168909; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Schaefer H, 2006, SCIENCE, V313, P1109, DOI 10.1126/science.1126562; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; SHAKHOVA N, 2008, EOS S, V89; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924	19	24	27	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					477	478		10.1126/science.1172001	http://dx.doi.org/10.1126/science.1172001			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390036				2022-12-28	WOS:000265411200035
J	Rychert, CA; Shearer, PM				Rychert, Catherine A.; Shearer, Peter M.			A Global View of the Lithosphere-Asthenosphere Boundary	SCIENCE			English	Article							UPPER-MANTLE; VELOCITY; SURFACE	The lithosphere-asthenosphere boundary divides the rigid lid from the weaker mantle and is fundamental in plate tectonics. However, its depth and defining mechanism are not well known. We analyzed 15 years of global seismic data using P-to-S (Ps) converted phases and imaged an interface that correlates with tectonic environment, varying from 95 +/- 4 kilometers beneath Precambrian shields and platforms to 81 +/- 2 kilometers beneath tectonically altered regions and 70 +/- 4 kilometers at oceanic island stations. High-frequency Ps observations require a sharp discontinuity; therefore, this interface likely represents a boundary in composition, melting, or anisotropy, not temperature alone. It likely represents the lithosphere-asthenosphere boundary under oceans and tectonically altered regions, but it may constitute another boundary in cratonic regions where the lithosphere-asthenosphere boundary is thought to be much deeper.	[Rychert, Catherine A.; Shearer, Peter M.] Univ Calif San Diego, Inst Geophys & Planetary Phys, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Rychert, CA (corresponding author), Univ Calif San Diego, Inst Geophys & Planetary Phys, Scripps Inst Oceanog, 9500 Gilman Dr,M-C 0225, La Jolla, CA 92093 USA.	crychert@ucsd.edu	; Shearer, Peter/K-5247-2012	Rychert, Catherine/0000-0001-5071-793X; Shearer, Peter/0000-0002-2992-7630	NERC [NE/G013438/1] Funding Source: UKRI; Natural Environment Research Council [NE/G013438/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ANDERSON DL, 1989, THEORY EARTH; Bostock MG, 1998, J GEOPHYS RES-SOL EA, V103, P21183, DOI 10.1029/98JB01069; Chen L, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003974; Dalton CA, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005429; JORDAN TH, 1981, B SEISMOL SOC AM, V71, P1131; JORDAN TH, 1978, NATURE, V274, P544, DOI 10.1038/274544a0; King SD, 2005, EARTH PLANET SC LETT, V234, P1, DOI 10.1016/j.epsl.2005.03.007; Kumar P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022291; Kustowski B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005169; Lebedev S, 2008, GEOPHYS J INT, V173, P505, DOI 10.1111/j.1365-246X.2008.03721.x; Lee CTA, 2005, EARTH PLANET SC LETT, V230, P379, DOI 10.1016/j.epsl.2004.11.019; Lee CTA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002413; Levander A, 2006, TECTONOPHYSICS, V416, P167, DOI 10.1016/j.tecto.2005.11.018; Li AB, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004321; Li XQ, 2004, NATURE, V427, P827, DOI 10.1038/nature02349; Mierdel K, 2007, SCIENCE, V315, P364, DOI 10.1126/science.1135422; Nettles M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004819; Oreshin S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014441; Panning M, 2006, GEOPHYS J INT, V167, P361, DOI 10.1111/j.1365-246X.2006.03100.x; Rychert CA, 2005, NATURE, V436, P542, DOI 10.1038/nature03904; Rychert CA, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004619; Schutt DL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2003JB002950; SHEARER PM, 1991, J GEOPHYS RES-SOL EA, V96, P18147, DOI 10.1029/91JB01592; Simons FJ, 1999, LITHOS, V48, P17, DOI 10.1016/S0024-4937(99)00041-9; Snyder DB, 2008, TECTONICS, V27, DOI 10.1029/2007TC002132; Tan Y, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004853; Thybo H, 2006, TECTONOPHYSICS, V416, P53, DOI 10.1016/j.tecto.2005.11.021	27	288	293	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					495	498		10.1126/science.1169754	http://dx.doi.org/10.1126/science.1169754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390041				2022-12-28	WOS:000265411200042
J	McAlister, FA				McAlister, Finlay A.			Statins are effective for prevention of cardiovascular events in patients without coronary heart disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Alberta, Edmonton, AB, Canada	University of Alberta	McAlister, FA (corresponding author), Univ Alberta, Edmonton, AB, Canada.		McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341				Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8							JC4-5	10.7326/0003-4819-150-8-200904210-02005	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19391211				2022-12-28	WOS:000265457000020
J	Lu, K; Lu, L; Suresh, S				Lu, K.; Lu, L.; Suresh, S.			Strengthening Materials by Engineering Coherent Internal Boundaries at the Nanoscale	SCIENCE			English	Review							STRAIN-RATE SENSITIVITY; STACKING-FAULT ENERGY; MECHANICAL-BEHAVIOR; ACTIVATION VOLUME; NANOCRYSTALLINE; DEFORMATION; COPPER; THICKNESS; DUCTILITY; HARDNESS	Strengthening materials traditionally involves the controlled creation of internal defects and boundaries so as to obstruct dislocation motion. Such strategies invariably compromise ductility, the ability of the material to deform, stretch, or change shape permanently without breaking. Here, we outline an approach to optimize strength and ductility by identifying three essential structural characteristics for boundaries: coherency with surrounding matrix, thermal and mechanical stability, and smallest feature size finer than 100 nanometers. We assess current understanding of strengthening and propose a methodology for engineering coherent, nanoscale internal boundaries, specifically those involving nanoscale twin boundaries. Additionally, we discuss perspectives on strengthening and preserving ductility, along with potential applications for improving failure tolerance, electrical conductivity, and resistance to electromigration.	[Lu, K.; Lu, L.] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Lu, L.; Suresh, S.] MIT, Sch Engn, Cambridge, MA 02139 USA	Chinese Academy of Sciences; Institute of Metal Research, CAS; Massachusetts Institute of Technology (MIT)	Lu, K (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.	lu@imr.ac.cn; ssuresh@mit.edu	Lu, Lei/E-3864-2012; Suresh, Subra/B-8289-2008	Suresh, Subra/0000-0002-6223-6831	National Natural Science Foundation [50621091, 50431010, 50725103, 50890171]; Ministry of Science and Technology of China [2005CB623604]; Office of Naval Research [N00014-08-1-0510]; Advanced Materials for Micro and Nano Systems Programme of the Singapore-MIT Alliance	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Office of Naval Research(Office of Naval Research); Advanced Materials for Micro and Nano Systems Programme of the Singapore-MIT Alliance	K.L. and L.L. are grateful for financial support of the National Natural Science Foundation (grants 50621091, 50431010, 50725103, and 50890171) and the Ministry of Science and Technology of China (grant 2005CB623604). L.L. and S.S. acknowledge support from the Office of Naval Research grant N00014-08-1-0510 and the Advanced Materials for Micro and Nano Systems Programme of the Singapore-MIT Alliance.	Asaro RJ, 2005, ACTA MATER, V53, P3369, DOI 10.1016/j.actamat.2005.03.047; BABYAK WJ, 1960, T AM I MIN MET ENG, V218, P21; Bellemare SC, 2008, MECH MATER, V40, P206, DOI 10.1016/j.mechmat.2007.07.006; BURKE JE, 1952, PROG MET PHYS, V3, P220, DOI 10.1016/0502-8205(52)90009-9; Chen J, 2006, SCRIPTA MATER, V54, P1913, DOI 10.1016/j.scriptamat.2006.02.022; Chen KC, 2008, SCIENCE, V321, P1066, DOI 10.1126/science.1160777; Courtney TH, 2000, MECH BEHAV MAT; Dao M, 2006, ACTA MATER, V54, P5421, DOI 10.1016/j.actamat.2006.06.062; Hanlon T, 2003, SCRIPTA MATER, V49, P675, DOI 10.1016/S1359-6462(03)00393-2; Hodge AM, 2006, MAT SCI ENG A-STRUCT, V429, P272, DOI 10.1016/j.msea.2006.05.109; Jin ZH, 2008, ACTA MATER, V56, P1126, DOI 10.1016/j.actamat.2007.11.020; Knapp JA, 2004, J MATER RES, V19, P218, DOI 10.1557/jmr.2004.19.1.218; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Li HQ, 2006, ACTA MATER, V54, P2877, DOI 10.1016/j.actamat.2006.02.033; Li YS, 2008, ACTA MATER, V56, P230, DOI 10.1016/j.actamat.2007.09.020; Lu L, 2005, ACTA MATER, V53, P2169, DOI 10.1016/j.actamat.2005.01.031; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; MUGHRABI H, 2001, MAT RES SOC S, V634; Rohatgi A, 2001, METALL MATER TRANS A, V32, P135, DOI 10.1007/s11661-001-0109-7; Schuh CA, 2003, ACTA MATER, V51, P431, DOI 10.1016/S1359-6454(02)00427-5; Schwaiger R, 2003, ACTA MATER, V51, P5159, DOI 10.1016/S1359-6454(03)00365-3; Shen YF, 2005, SCRIPTA MATER, V52, P989, DOI 10.1016/j.scriptamat.2005.01.033; Shimada M, 2002, ACTA MATER, V50, P2331, DOI 10.1016/S1359-6454(02)00064-2; SILCOCK JM, 1954, J I MET, V82, P239; STREIFFER SK, 1991, APPL PHYS LETT, V58, P2171, DOI 10.1063/1.104996; Wei Q, 2004, MAT SCI ENG A-STRUCT, V381, P71, DOI 10.1016/j.msea.2004.03.064; WITNEY AB, 1995, SCRIPTA METALL MATER, V33, P2025, DOI 10.1016/0956-716X(95)00441-W; Wu XL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.025503; Zhang X, 2008, JOM-US, V60, P75, DOI 10.1007/s11837-008-0123-y; Zhang X, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2198482; Zhang X, 2004, ACTA MATER, V52, P995, DOI 10.1016/j.actamat.2003.10.033; Zhang Y, 2009, SCRIPTA MATER, V60, P211, DOI 10.1016/j.scriptamat.2008.10.005; Zhu T, 2007, P NATL ACAD SCI USA, V104, P3031, DOI 10.1073/pnas.0611097104	33	1610	1672	101	1625	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					349	352		10.1126/science.1159610	http://dx.doi.org/10.1126/science.1159610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372422				2022-12-28	WOS:000265221600031
J	Watanabe, Y; Farquhar, J; Ohmoto, H				Watanabe, Yumiko; Farquhar, James; Ohmoto, Hiroshi			Anomalous Fractionations of Sulfur Isotopes During Thermochemical Sulfate Reduction	SCIENCE			English	Article							RISE; SEDIMENTS; BACTERIAL; EVOLUTION; SULFITE	Anomalously fractionated sulfur isotopes in many sedimentary rocks older than 2.4 billion years have been widely believed to be the products of ultraviolet photolysis of volcanic sulfur dioxide in an anoxic atmosphere. Our laboratory experiments have revealed that reduced-sulfur species produced by reactions between powders of amino acids and sulfate at 150 to 200 C possess anomalously fractionated sulfur isotopes: Delta S-33 = +0.1 to +2.1 per mil and Delta S-36 = -1.1 to +1.1 per mil. These results suggest that reactions between organic matter in sediments and sulfate-rich hydrothermal solutions may have produced anomalous sulfur isotope signatures in some sedimentary rocks. If so, the sulfur isotope record of sedimentary rocks may be linked to the biological and thermal evolution of Earth in ways different than previously thought.	[Watanabe, Yumiko; Ohmoto, Hiroshi] Penn State Univ, NASA Astrobiol Inst, University Pk, PA 16802 USA; [Watanabe, Yumiko; Ohmoto, Hiroshi] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Farquhar, James] Univ Maryland, Dept Geol, Coll Med, College Pk, MD 20742 USA; [Farquhar, James] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, Coll Med, College Pk, MD 20742 USA	National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Watanabe, Y (corresponding author), Penn State Univ, NASA Astrobiol Inst, University Pk, PA 16802 USA.	yumiko@geosc.psu.edu			NASA Astrobiology Institute [CA#NNA04CC06A, CA#NNG04GK00G]; NASA Exobiology Program; NSF [EAR-0229556]	NASA Astrobiology Institute; NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We are grateful to H. Naraoka for the suggestion to use amino acids in SO42 reduction and for discussions. We thank D. Walizer, H. Hamasaki, A. Klarke, B. Wing, A. L. Masterson, and S.-T. Kim for technical assistance; A. C. Lasaga, T. Otake, S. R. Poulson, and I. Johnson for discussions and review of an earlier manuscript; and three anonymous reviewers for useful comments. This study was supported by grants to H.O. from the NASA Astrobiology Institute (CA#NNA04CC06A), NASA Exobiology Program (CA#NNG04GK00G), and NSF (EAR-0229556).	Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Buchachenko AL, 2000, PURE APPL CHEM, V72, P2243, DOI 10.1351/pac200072122243; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; Goldhaber MB, 1995, ACS SYM SER, V612, P412; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; Johnston DT, 2005, AM J SCI, V305, P645, DOI 10.2475/ajs.305.6-8.645; Kasting JF, 2001, SCIENCE, V293, P819, DOI 10.1126/science.1063811; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Lasaga AC, 2008, EARTH PLANET SC LETT, V268, P225, DOI 10.1016/j.epsl.2008.01.016; Libes S.M., 1992, INTRO MARINE BIOGEOC; Machel HG, 2001, SEDIMENT GEOL, V140, P143, DOI 10.1016/S0037-0738(00)00176-7; Madigan M.T., 2000, BROCK BIOL MICROORGA, V9th ed., P29; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; Ohmoto H, 2006, GEOL SOC AM MEM, V198, P291, DOI 10.1130/2006.1198(17); Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Otake T, 2008, CHEM GEOL, V249, P357, DOI 10.1016/j.chemgeo.2008.01.020; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Sasaki A., 1979, CHISHITSU CHOSAJO GE, V30, P241; SKYRING GW, 1982, PRECAMBRIAN RES, V17, P41, DOI 10.1016/0301-9268(82)90153-X; Strauss H., 1992, PROTEROZOIC BIOSPHER, P709; Watanabe K, 1997, GEOCHIM COSMOCHIM AC, V61, P3441	30	115	118	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					370	373		10.1126/science.1169289	http://dx.doi.org/10.1126/science.1169289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372427				2022-12-28	WOS:000265221600037
J	St Pierre, S; Potter, M; Prawer, SP; Suwattee, P				St Pierre, Stephanie; Potter, Marisa; Prawer, Scott P.; Suwattee, Pitiporn			Endgames Picture Quiz Petechial rash on the extremities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HENOCH-SCHONLEIN PURPURA; ADULTS; CHILDREN; NEPHRITIS; CHILDHOOD		[Suwattee, Pitiporn] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN 55417 USA; [St Pierre, Stephanie] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Potter, Marisa; Prawer, Scott P.] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Suwattee, P (corresponding author), Minneapolis Vet Affairs Med Ctr, Minneapolis, MN 55417 USA.	suwat001@umn.edu						Bolognia J. L., 2007, DERMATOLOGY; CALLEN JP, EMEDICINE; Cheung KM, 2001, J PAEDIATR CHILD H, V37, P311, DOI 10.1046/j.1440-1754.2001.00606.x; Coppo R, 1997, NEPHROL DIAL TRANSPL, V12, P2277, DOI 10.1093/ndt/12.11.2277; Ebert EC, 2008, DIGEST DIS SCI, V53, P2011, DOI 10.1007/s10620-007-0147-0; Garcia-Porrua C, 2002, SEMIN ARTHRITIS RHEU, V32, P149, DOI 10.1053/sarh.2002.33980; Gunasekaran TS, 1997, PEDIATR DERMATOL, V14, P437, DOI 10.1111/j.1525-1470.1997.tb00684.x; Ha TS, 2005, PEDIATR NEPHROL, V20, P149, DOI 10.1007/s00467-004-1726-3; HABIF TP, 2003, CLIN DERMATOLOGY COL; ILAN Y, 1991, SEMIN ARTHRITIS RHEU, V21, P103, DOI 10.1016/0049-0172(91)90043-Y; Kalman S, 2005, J TROP PEDIATRICS, V51, P240, DOI 10.1093/tropej/fmi065; Kraft DM, 1998, AM FAM PHYSICIAN, V58, P405; Ozen S, 2006, ANN RHEUM DIS, V65, P936, DOI 10.1136/ard.2005.046300; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; Rai A, 1999, J AM SOC NEPHROL, V10, P2637; Saulsbury FT, 2007, LANCET, V369, P976, DOI 10.1016/S0140-6736(07)60474-7; Tizard EJ, 2008, ARCH DIS CHILDHOOD-E, V93, P1, DOI 10.1136/adc.2004.066035; Trapani S, 2005, SEMIN ARTHRITIS RHEU, V35, P143, DOI 10.1016/j.semarthrit.2005.08.007; Weiss PF, 2007, PEDIATRICS, V120, P1079, DOI 10.1542/peds.2007-0667; Zurada JM, 2006, J AM ACAD DERMATOL, V55, pS65, DOI 10.1016/j.jaad.2005.10.011	20	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2009	338								b1284	10.1136/bmj.b1284	http://dx.doi.org/10.1136/bmj.b1284			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TJ	19369285				2022-12-28	WOS:000265296700001
J	Dawood, FS; Jain, S; Finelli, L; Shaw, MW; Lindstrom, S; Garten, RJ; Gubareva, LV; Xu, XY; Bridges, CB; Uyeki, TM				Dawood, Fatimah S.; Jain, Seema; Finelli, Lyn; Shaw, Michael W.; Lindstrom, Stephen; Garten, Rebecca J.; Gubareva, Larisa V.; Xu, Xiyan; Bridges, Carolyn B.; Uyeki, Timothy M.			Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINES	BACKGROUND On April 15 and April 17, 2009, novel swine-origin influenza A (H1N1) virus (S-OIV) was identified in specimens obtained from two epidemiologically unlinked patients in the United States. The same strain of the virus was identified in Mexico, Canada, and elsewhere. We describe 642 confirmed cases of human S-OIV infection identified from the rapidly evolving U. S. outbreak. METHODS Enhanced surveillance was implemented in the United States for human infection with influenza A viruses that could not be subtyped. Specimens were sent to the Centers for Disease Control and Prevention for real-time reverse-transcriptase-polymerasechain-reaction confirmatory testing for S-OIV. RESULTS From April 15 through May 5, a total of 642 confirmed cases of S-OIV infection were identified in 41 states. The ages of patients ranged from 3 months to 81 years; 60% of patients were 18 years of age or younger. Of patients with available data, 18% had recently traveled to Mexico, and 16% were identified from school outbreaks of S-OIV infection. The most common presenting symptoms were fever (94% of patients), cough (92%), and sore throat (66%); 25% of patients had diarrhea, and 25% had vomiting. Of the 399 patients for whom hospitalization status was known, 36 (9%) required hospitalization. Of 22 hospitalized patients with available data, 12 had characteristics that conferred an increased risk of severe seasonal influenza, 11 had pneumonia, 8 required admission to an intensive care unit, 4 had respiratory failure, and 2 died. The S-OIV was determined to have a unique genome composition that had not been identified previously. CONCLUSIONS A novel swine-origin influenza A virus was identified as the cause of outbreaks of febrile respiratory infection ranging from self-limited to severe illness. It is likely that the number of confirmed cases underestimates the number of cases that have occurred.	[Dawood, Fatimah S.] Ctr Dis Control & Prevent, Influenza Div, Off Workforce & Career Dev, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Jain, Seema; Finelli, Lyn; Shaw, Michael W.; Lindstrom, Stephen; Garten, Rebecca J.; Gubareva, Larisa V.; Xu, Xiyan; Bridges, Carolyn B.; Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Dawood, FS (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Off Workforce & Career Dev, Epidem Intelligence Serv, 1600 Clifton Rd NE,MS A-32, Atlanta, GA 30333 USA.	fdawood@cdc.gov; mshaw1@cdc.gov	Fahimifar, Sepideh/M-5303-2019; Chen, Chien Ku/C-6128-2008; Finelli, Lyn/AAK-2360-2020	Cocoros, Noelle/0000-0001-7090-2761; Waddell, Elizabeth/0000-0002-0701-1939; McMorrow, Meredith/0000-0001-6363-4033; Biggerstaff, Matthew/0000-0001-5108-8311; Patel, Minal/0000-0002-8707-7531				[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; [Anonymous], 2009, INFL H1N1 UPD 12; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; BLACHERE FM, 2009, CLIN INFECT DIS 0109; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CATE TR, 1977, J INFECT DIS, V136, pS518, DOI 10.1093/infdis/136.Supplement_3.S518; *CDCP, 2008 09 INFL PREV CO; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; DOLIN R, 1977, J INFECT DIS, V136, pS435, DOI 10.1093/infdis/136.Supplement_3.S435; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Hager M. C., 2003, STORMWATER, V4, P12; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Peebles P., 2009, Morbidity and Mortality Weekly Report, V58, P369; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; 2009, MMWR MORB MORTAL WKL, V58, P431	23	2103	2250	14	502	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2605	2615		10.1056/NEJMoa0903810	http://dx.doi.org/10.1056/NEJMoa0903810			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19423869	Bronze			2022-12-28	WOS:000267060000005
J	Takeuchi, JK; Bruneau, BG				Takeuchi, Jun K.; Bruneau, Benoit G.			Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors	NATURE			English	Article							CHROMATIN-REMODELING COMPLEX; ANTEROPOSTERIOR AXIS; STEM-CELLS; MESP1; DIFFERENTIATION; TRANSCRIPTION; GENE; EXPRESSION; INDUCTION; MYOCARDIN	Heart disease is the leading cause of mortality and morbidity in the western world. The heart has little regenerative capacity after damage, leading to much interest in understanding the factors required to produce new cardiac myocytes. Despite a robust understanding of the molecular networks regulating cardiac differentiation(1,2), no single transcription factor or combination of factors has been shown to activate the cardiac gene program de novo in mammalian cells or tissues. Here we define the minimal requirements for transdifferentiation of mouse mesoderm to cardiac myocytes. We show that two cardiac transcription factors, Gata4 and Tbx5, and a cardiac-specific subunit of BAF chromatin-remodelling complexes, Baf60c (also called Smarcd3), can direct ectopic differentiation of mouse mesoderm into beating cardiomyocytes, including the normally non-cardiogenic posterior mesoderm and the extraembryonic mesoderm of the amnion. Gata4 with Baf60c initiated ectopic cardiac gene expression. Addition of Tbx5 allowed differentiation into contracting cardiomyocytes and repression of non-cardiac mesodermal genes. Baf60c was essential for the ectopic cardiogenic activity of Gata4 and Tbx5, partly by permitting binding of Gata4 to cardiac genes, indicating a novel instructive role for BAF complexes in tissues-specific regulation. The combined function of these factors establishes a robust mechanism for controlling cellular differentiation, and may allow reprogramming of new cardiomyocytes for regenerative purposes.	[Takeuchi, Jun K.; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Takeuchi, Jun K.] Tokyo Inst Technol, Global Edge Inst, Div Cardiovasc Res, Midori Ku, Kanagawa 2268503, Japan; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Tokyo Institute of Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bruneau, BG (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	takeuchi.j.ab@m.titech.ac.jp; bbruneau@gladstone.ucsf.edu		Bruneau, Benoit/0000-0002-0804-7597	Human Frontiers Science Program CDA; MEXT's program for young independent researchers; Mitsubishi Foundation; Takeda Science Foundation; NHLBI [R01HL085860]; NIH/NCRR [C06 RR018928]; William H. Younger, Jr; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085860] Funding Source: NIH RePORTER	Human Frontiers Science Program CDA(Human Frontier Science Program); MEXT's program for young independent researchers; Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); William H. Younger, Jr; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Koshiba-Takeuchi for assistance with immunohistochemistry, H. Ogawa for advice on chromatin immunoprecipitation, B. L. Black and D. Srivastava for discussions and expression constructs, G. R. Crabtree, M. Nemer, E. N. Olson and Y. Saga for expression constructs, and G. Howard and S. Ordway for editorial assistance. This work was supported by Human Frontiers Science Program CDA and short-term fellowships (J. K. T.), MEXT's program for young independent researchers ( J. K. T.), Mitsubishi Foundation (J. K. T.), the Takeda Science Foundation ( J. K. T.) and NHLBI (R01HL085860, B. G. B.). This work was also supported by an NIH/NCRR grant (C06 RR018928, J. David Gladstone Institutes) and by William H. Younger, Jr ( B. G. B.).	Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	30	389	417	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					708	U112		10.1038/nature08039	http://dx.doi.org/10.1038/nature08039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396158	Green Accepted			2022-12-28	WOS:000266608600045
J	Desmurget, M; Reilly, KT; Richard, N; Szathmari, A; Mottolese, C; Sirigu, A				Desmurget, Michel; Reilly, Karen T.; Richard, Nathalie; Szathmari, Alexandru; Mottolese, Carmine; Sirigu, Angela			Movement Intention After Parietal Cortex Stimulation in Humans	SCIENCE			English	Article							CONSCIOUS INTENTION; MOTOR CORTEX; AWARENESS; REPRESENTATION; ORGANIZATION; DAMAGE	Parietal and premotor cortex regions are serious contenders for bringing motor intentions and motor responses into awareness. We used electrical stimulation in seven patients undergoing awake brain surgery. Stimulating the right inferior parietal regions triggered a strong intention and desire to move the contralateral hand, arm, or foot, whereas stimulating the left inferior parietal region provoked the intention to move the lips and to talk. When stimulation intensity was increased in parietal areas, participants believed they had really performed these movements, although no electromyographic activity was detected. Stimulation of the premotor region triggered overt mouth and contralateral limb movements. Yet, patients firmly denied that they had moved. Conscious intention and motor awareness thus arise from increased parietal activity before movement execution.	[Desmurget, Michel; Reilly, Karen T.; Richard, Nathalie; Sirigu, Angela] CNRS, UMR 5229, Ctr Neurosci Cognit, F-69500 Bron, France; [Desmurget, Michel; Reilly, Karen T.; Richard, Nathalie; Sirigu, Angela] Univ Lyon 1, F-69100 Villeurbanne, France; [Szathmari, Alexandru; Mottolese, Carmine] Hosp Civils Lyon, Hop Pierre Wertheimer, Neurosurg Unit 500, F-69003 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Sirigu, A (corresponding author), CNRS, UMR 5229, Ctr Neurosci Cognit, F-69500 Bron, France.	sirigu@isc.cnrs.fr	Richard, Nathalie/N-9084-2017; Desmurget, Michel/L-2401-2017; Reilly, Karen T/D-4423-2016; Sirigu, Angela/L-4683-2017	Reilly, Karen T/0000-0002-2840-1610; Richard, Nathalie/0000-0002-2547-6721	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [Neuro-031-02]; Human Frontiers Science Program [RGP0056/2005-C]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontiers Science Program(Human Frontier Science Program)	This study was funded by Centre National de la Recherche Scientifique, Agence Nationale de la Recherche (Neuro-031-02), and by Human Frontiers Science Program (RGP0056/2005-C) to A.S. We thank J. R. Duhamel for helpful discussion. We thank patients for their cooperation and L. Pouga and the clinical staff for help during testing.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Berti A., 2007, SENSORIMOTOR FDN HIG, VXXII; DESCARTES R, 1992, MEDITATIONS METAPHYS; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Fotopoulou A, 2008, BRAIN, V131, P3432, DOI 10.1093/brain/awn225; FRIED I, 1991, J NEUROSCI, V11, P3656; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gemba H, 2004, NEUROSCI LETT, V357, P68, DOI 10.1016/j.neulet.2003.12.033; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Rothi U., 1997, APRAXIA NEUROPSYCHOL, P29; Searle John, 1983, INTENTIONALITY; SIRIGU A, 1995, CORTEX, V31, P41, DOI 10.1016/S0010-9452(13)80104-9; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Sirigu A, 2004, NAT NEUROSCI, V7, P80, DOI 10.1038/nn1160; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stark E, 2007, J NEUROPHYSIOL, V97, P3351, DOI 10.1152/jn.01328.2006	27	458	477	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					811	813		10.1126/science.1169896	http://dx.doi.org/10.1126/science.1169896			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423830				2022-12-28	WOS:000265832400054
J	Haggard, P				Haggard, Patrick			The Sources of Human Volition	SCIENCE			English	Editorial Material							CORTEX; STIMULATION; AWARENESS		UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Haggard, P (corresponding author), UCL, Inst Cognit Neurosci, London WC1N 3AR, England.	p.haggard@ucl.ac.uk	Haggard, Patrick/A-5081-2010		Economic and Social Research Council [RES-000-23-1571] Funding Source: researchfish; ESRC [RES-000-23-1571] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; FRIED I, 1991, J NEUROSCI, V11, P3656; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Sirigu A, 2004, NAT NEUROSCI, V7, P80, DOI 10.1038/nn1160; Tanji J, 1996, COGNITIVE BRAIN RES, V3, P143, DOI 10.1016/0926-6410(95)00039-9; Wegner D.M., 2003, ILLUSION CONSCIOUS W; WEINRICH M, 1984, BRAIN, V107, P385, DOI 10.1093/brain/107.2.385; Wilson E.O., 1975, P1	12	40	51	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					731	733		10.1126/science.1173827	http://dx.doi.org/10.1126/science.1173827			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	442HN	19423807				2022-12-28	WOS:000265832400026
J	Kiani, R; Shadlen, MN				Kiani, Roozbeh; Shadlen, Michael N.			Representation of Confidence Associated with a Decision by Neurons in the Parietal Cortex	SCIENCE			English	Article							PROBABILISTIC POPULATION CODES; DORSOLATERAL PREFRONTAL CORTEX; LATERAL INTRAPARIETAL AREA; PERCEPTUAL DECISION; ORBITOFRONTAL CORTEX; DISCRIMINATION TASK; REWARD PREFERENCE; VISUAL-MOTION; NEURAL BASIS; MACAQUE	The degree of confidence in a decision provides a graded and probabilistic assessment of expected outcome. Although neural mechanisms of perceptual decisions have been studied extensively in primates, little is known about the mechanisms underlying choice certainty. We have shown that the same neurons that represent formation of a decision encode certainty about the decision. Rhesus monkeys made decisions about the direction of moving random dots, spanning a range of difficulties. They were rewarded for correct decisions. On some trials, after viewing the stimulus, the monkeys could opt out of the direction decision for a small but certain reward. Monkeys exercised this option in a manner that revealed their degree of certainty. Neurons in parietal cortex represented formation of the direction decision and the degree of certainty underlying the decision to opt out.	[Kiani, Roozbeh] Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kiani, R (corresponding author), Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA.	roozbeh@u.washington.edu; shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	Howard Hughes Medical Institute; National Eye Institute [EY11378]; National Center for Research Resources [RR00166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Howard Hughes Medical Institute, National Eye Institute grant EY11378, and National Center for Research Resources grant RR00166. We thank T. Hanks, A. Pouget, A. Churchland, D. Lee, P. Phillips, J. Palmer, and C. D. Salzman for helpful discussions and comments and A. Boulet and K. Ahl for technical assistance.	AUDLEY RJ, 1964, BRIT MED BULL, V20, P27, DOI 10.1093/oxfordjournals.bmb.a070277; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HANKS T, EY11378 H HUGH MED I; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Henmon VAC, 1911, PSYCHOL REV, V18, P186, DOI 10.1037/h0074579; HOWIE D, 2007, INTERPRETING PROBABI; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jaynes E.T., 2003, PROBABILITY THEORY L; JOHNSON DM, 1939, ARCH PSYCHOL, V34, P1; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Laming DR, 1968, INFORM THEORY CHOICE; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Link SW, 1992, WAVE THEORY DIFFEREN; Luce RD, 1986, RESPONSE TIMES THEIR; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; McDougall W, 1921, PSYCHOL REV, V28, P315, DOI 10.1037/h0075816; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Petrusic WM, 2003, PSYCHON B REV, V10, P177, DOI 10.3758/BF03196482; PIERCE CS, 1884, P NATL ACAD SCI USA, V3, P75; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shields WE, 1997, J EXP PSYCHOL GEN, V126, P147, DOI 10.1037/0096-3445.126.2.147; Smith JD, 2008, PSYCHON B REV, V15, P679, DOI 10.3758/PBR.15.4.679; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sumner F. B., 1898, PSYCHOL REV, V5, P616, DOI [10.1037/h0073257, DOI 10.1037/H0073257]; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; VICKERS D, 1982, ACTA PSYCHOL, V50, P179, DOI 10.1016/0001-6918(82)90006-3; VICKERS D, 1985, PERCEPTION, V14, P471, DOI 10.1068/p140471; Vickers D., 1979, DECISION PROCESSES V; Volkmann J., 1934, PSYCHOL BULL, V31, P672; Wald A., 1947, SEQUENTIAL ANAL; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	64	556	560	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					759	764		10.1126/science.1169405	http://dx.doi.org/10.1126/science.1169405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	442HN	19423820	Green Accepted			2022-12-28	WOS:000265832400039
J	Weinstein, JA; Jiang, N; White, RA; Fisher, DS; Quake, SR				Weinstein, Joshua A.; Jiang, Ning; White, Richard A., III; Fisher, Daniel S.; Quake, Stephen R.			High-Throughput Sequencing of the Zebrafish Antibody Repertoire	SCIENCE			English	Article							IMMUNE RECEPTORS; PERSPECTIVES; DIVERSITY	Despite tremendous progress in understanding the nature of the immune system, the full diversity of an organism's antibody repertoire is unknown. We used high-throughput sequencing of the variable domain of the antibody heavy chain from 14 zebrafish to analyze VDJ usage and antibody sequence. Zebrafish were found to use between 50 and 86% of all possible VDJ combinations and shared a similar frequency distribution, with some correlation of VDJ patterns between individuals. Zebrafish antibodies retained a few thousand unique heavy chains that also exhibited a shared frequency distribution. We found evidence of convergence, in which different individuals made the same antibody. This approach provides insight into the breadth of the expressed antibody repertoire and immunological diversity at the level of an individual organism.	[Weinstein, Joshua A.; Fisher, Daniel S.; Quake, Stephen R.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Jiang, Ning; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [White, Richard A., III; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Fisher, Daniel S.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Fisher, Daniel S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Quake, SR (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	quake@stanford.edu	White, Richard Allen/H-5142-2019; Jiang, Ning/M-5448-2017; Fisher, Daniel S/A-4134-2011	Jiang, Ning/0000-0003-1103-5922; Weinstein, Joshua/0000-0002-0103-9738; White III, Richard Allen/0000-0002-6292-5936; Fisher, Daniel/0000-0002-5559-2491	NIH Directors Pioneer award; Arthritis Foundation Postdoctoral Fellowship; NSF graduate fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	NIH Directors Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation Postdoctoral Fellowship; NSF graduate fellowship(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank W. Talbot for useful conversations and the generous loan of equipment and N. Neff for assistance with sequencing. IgM and IgZ sequence and quality-score files are available on the NIH short-read archive, with accession number SRA008134. This research was supported by the NIH Directors Pioneer award (S.R.Q.), the Arthritis Foundation Postdoctoral Fellowship (N.J.), and an NSF graduate fellowship (J.A.W.).	Boudinot P, 2008, MOL IMMUNOL, V45, P2437, DOI 10.1016/j.molimm.2007.12.018; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; GOLUB ES, 1987, CELL, V48, P723, DOI 10.1016/0092-8674(87)90066-3; Janeway C., 2004, IMMUNOBIOLOGY; KINDT TJ, 1984, ANTIBODY ENGIMA; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; SINGH SP, 1978, Z ALLG MIKROBIOL, V18, P111, DOI 10.1002/jobm.3630180205; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yoder JA, 2002, MICROBES INFECT, V4, P1469, DOI 10.1016/S1286-4579(02)00029-1	14	314	352	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					807	810		10.1126/science.1170020	http://dx.doi.org/10.1126/science.1170020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423829	Green Accepted			2022-12-28	WOS:000265832400053
J	Coombes, R				Coombes, Rebecca			A/H1N1 influenza: questions and answers	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 7	2009	338								b1849	10.1136/bmj.b1849	http://dx.doi.org/10.1136/bmj.b1849			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GW	19423622				2022-12-28	WOS:000265969700005
J	Davis, DA; Hamilton, A; Yang, JL; Cremar, LD; Van Gough, D; Potisek, SL; Ong, MT; Braun, PV; Martinez, TJ; White, SR; Moore, JS; Sottos, NR				Davis, Douglas A.; Hamilton, Andrew; Yang, Jinglei; Cremar, Lee D.; Van Gough, Dara; Potisek, Stephanie L.; Ong, Mitchell T.; Braun, Paul V.; Martinez, Todd J.; White, Scott R.; Moore, Jeffrey S.; Sottos, Nancy R.			Force-induced activation of covalent bonds in mechanoresponsive polymeric materials	NATURE			English	Article							MOLECULAR-DYNAMICS; MECHANOTRANSDUCTION	Mechanochemical transduction enables an extraordinary range of physiological processes such as the sense of touch, hearing, balance, muscle contraction, and the growth and remodelling of tissue and bone(1-6). Although biology is replete with materials systems that actively and functionally respond to mechanical stimuli, the default mechanochemical reaction of bulk polymers to large external stress is the unselective scission of covalent bonds, resulting in damage or failure(7). An alternative to this degradation process is the rational molecular design of synthetic materials such that mechanical stress favourably alters material properties. A few mechanosensitive polymers with this property have been developed(8-14); but their active response is mediated through non-covalent processes, which may limit the extent to which properties can be modified and the long-term stability in structural materials. Previously, we have shown with dissolved polymer strands incorporating mechanically sensitive chemical groups-so-called mechanophores-that the directional nature of mechanical forces can selectively break and re-form covalent bonds(15,16). We now demonstrate that such force-induced covalent-bond activation can also be realized with mechanophore-linked elastomeric and glassy polymers, by using a mechanophore that changes colour as it undergoes a reversible electrocyclic ring-opening reaction under tensile stress and thus allows us to directly and locally visualize the mechanochemical reaction. We find that pronounced changes in colour and fluorescence emerge with the accumulation of plastic deformation, indicating that in these polymeric materials the transduction of mechanical force into the ring-opening reaction is an activated process. We anticipate that force activation of covalent bonds can serve as a general strategy for the development of new mechanophore building blocks that impart polymeric materials with desirable functionalities ranging from damage sensing to fully regenerative self-healing.	[Yang, Jinglei; Braun, Paul V.; Martinez, Todd J.; White, Scott R.; Moore, Jeffrey S.; Sottos, Nancy R.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Davis, Douglas A.; Cremar, Lee D.; Potisek, Stephanie L.; Ong, Mitchell T.; Braun, Paul V.; Martinez, Todd J.; Moore, Jeffrey S.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Hamilton, Andrew] Univ Illinois, Dept Engn Sci & Mech, Urbana, IL 61801 USA; [Van Gough, Dara; Braun, Paul V.; Moore, Jeffrey S.; Sottos, Nancy R.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [White, Scott R.] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sottos, NR (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	n-sottos@illinois.edu	Yang, Jinglei/B-1933-2008; Hamilton, Andrew R./C-2978-2013; Yang, Jinglei/L-2321-2019; Van Gough, Dara/B-8646-2011; Martinez, Todd/HDN-6985-2022; Martinez, Todd J/F-4306-2010; White, Scott/G-9667-2013	Yang, Jinglei/0000-0002-9413-9016; Hamilton, Andrew R./0000-0003-4627-849X; Yang, Jinglei/0000-0002-9413-9016; Martinez, Todd J/0000-0002-4798-8947; Moore, Jeffrey/0000-0001-5841-6269; White, Scott/0000-0002-0831-9097	ARO MURI programme [W911NF-07-1-0409]	ARO MURI programme(MURI)	We acknowledge the support of the ARO MURI programme (grant number W911NF-07-1-0409) for this research.	Azzaroni O, 2006, ANGEW CHEM INT EDIT, V45, P7440, DOI 10.1002/anie.200602666; Ben-Nun M, 2002, ADV CHEM PHYS, V121, P439, DOI 10.1002/0471264318.ch7; Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h; Beyer MK, 2000, J CHEM PHYS, V112, P7307, DOI 10.1063/1.481330; CASALE A, 1978, POLYM STRESS REACTIO, V1, P8; Comrie JE, 2008, MACROMOL RAPID COMM, V29, P539, DOI 10.1002/marc.200700682; Eyring H, 1936, J CHEM PHYS, V4, P283, DOI 10.1063/1.1749836; Foulger SH, 2001, LANGMUIR, V17, P6023, DOI 10.1021/la010264e; Foulger SH, 2003, ADV MATER, V15, P685, DOI 10.1002/adma.200304566; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Hickenboth CR, 2007, NATURE, V446, P423, DOI 10.1038/nature05681; Hiramatsu Y., 1966, INT J ROCK MECH MIN, V3, P89, DOI DOI 10.1016/0148-9062(66)90002-7; KIM SJ, 1993, POLYM BULL, V31, P367, DOI 10.1007/BF00692965; Lele TP, 2006, J CELL BIOCHEM, V97, P1175, DOI 10.1002/jcb.20761; Lowe C, 2002, ADV MATER, V14, P1625, DOI 10.1002/1521-4095(20021118)14:22<1625::AID-ADMA1625>3.0.CO;2-Q; Mahadevan L, 2000, SCIENCE, V288, P95, DOI 10.1126/science.288.5463.95; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Minkin VI, 2004, CHEM REV, V104, P2751, DOI 10.1021/cr020088u; NALLICHERI RA, 1991, MACROMOLECULES, V24, P517, DOI 10.1021/ma00002a027; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Percec V, 2006, J AM CHEM SOC, V128, P14156, DOI 10.1021/ja065484z; Potisek SL, 2007, J AM CHEM SOC, V129, P13808, DOI 10.1021/ja076189x; Saitta AM, 2001, J PHYS CHEM B, V105, P6495, DOI 10.1021/jp004243p; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; STERNBERG E, 1952, J APPL MECH-T ASME, V19, P413; Tipikin DS, 2001, RUSS J PHYS CHEM+, V75, P1720	27	1204	1226	43	1201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					68	72		10.1038/nature07970	http://dx.doi.org/10.1038/nature07970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424152				2022-12-28	WOS:000265801300030
J	Weston, EM; Lister, AM				Weston, Eleanor M.; Lister, Adrian M.			Insular dwarfism in hippos and a model for brain size reduction in Homo floresiensis	NATURE			English	Article							EVOLUTION; ALLOMETRY; MORPHOLOGY; PLEISTOCENE; PRIMATES; HOMININ; SAPIENS; DMANISI; GEORGIA; RULES	Body size reduction in mammals is usually associated with only moderate brain size reduction, because the brain and sensory organs complete their growth before the rest of the body during ontogeny(1,2). On this basis, 'phyletic dwarfs' are predicted to have a greater relative brain size than 'phyletic giants'(1,3). However, this trend has been questioned in the special case of dwarfism of mammals on islands(4). Here we show that the endocranial capacities of extinct dwarf species of hippopotamus from Madagascar are up to 30% smaller than those of a mainland African ancestor scaled to equivalent body mass. These results show that brain size reduction is much greater than predicted from an intraspecific 'late ontogenetic' model of dwarfism in which brain size scales to body size with an exponent of 0.35. The nature of the proportional change or grade shift(2,5) observed here indicates that selective pressures on brain size are potentially independent of those on body size. This study demonstrates empirically that it is mechanistically possible for dwarf mammals on islands to evolve significantly smaller brains than would be predicted from a model of dwarfing based on the intraspecific scaling of the mainland ancestor. Our findings challenge current understanding of brain-body allometric relationships in mammals and suggest that the process of dwarfism could in principle explain small brain size, a factor relevant to the interpretation of the small-brained hominin found on the Island of Flores, Indonesia(6).	[Weston, Eleanor M.; Lister, Adrian M.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Natural History Museum London	Weston, EM (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	e.weston@nhm.ac.uk		Lister, Adrian/0000-0002-7985-138X	NERC [NE/F017936/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D522689/1, BB/D522689/2] Funding Source: Medline; Natural Environment Research Council [NE/F017936/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ACCORDI FS, 1971, ATTI ACCAD NAZ LIN, V51, P111; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Boisserie JR, 2005, ZOOL J LINN SOC-LOND, V143, P1, DOI 10.1111/j.1096-3642.2004.00138.x; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Christiansen P, 2004, ZOOL J LINN SOC-LOND, V140, P523, DOI 10.1111/j.1096-3642.2004.00113.x; Eltringham S. K., 1999, HIPPOS NATURAL HIST; GOULD SJ, 1975, CONTRIB PRIMATOL, V5, P244; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; Kohler M, 2008, TRENDS ECOL EVOL, V23, P6, DOI 10.1016/j.tree.2007.10.002; Kohler M, 2004, BRAIN BEHAV EVOLUT, V63, P125, DOI 10.1159/000076239; Kruska DCT, 2005, BRAIN BEHAV EVOLUT, V65, P73, DOI 10.1159/000082979; Lalueza-Fox C, 2002, MOL PHYLOGENET EVOL, V25, P501, DOI 10.1016/S1055-7903(02)00290-7; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lordkipanidze D, 2006, ANAT REC PART A, V288A, P1146, DOI 10.1002/ar.a.20379; Martin R.D., 1985, P147; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; Martin RD, 2006, SCIENCE, V312, DOI 10.1126/science.1121144; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Niven JE, 2008, TRENDS ECOL EVOL, V23, P8, DOI 10.1016/j.tree.2007.10.004; Niven JE, 2007, TRENDS ECOL EVOL, V22, P57, DOI 10.1016/j.tree.2006.11.009; Richards GD, 2006, J EVOLUTION BIOL, V19, P1744, DOI 10.1111/j.1420-9101.2006.01179.x; Roth V.L., 1992, Oxford Surveys in Evolutionary Biology, V8, P259; SHEA BT, 1983, INT J PRIMATOL, V4, P33, DOI 10.1007/BF02739359; Shoshani J, 2006, BRAIN RES BULL, V70, P124, DOI 10.1016/j.brainresbull.2006.03.016; Stanyon R., 1993, Human Evolution, V8, P205, DOI 10.1007/BF02436715; Stuenes S., 1989, Journal of Vertebrate Paleontology, V9, P241; Weston EM, 2003, BIOL J LINN SOC, V80, P625, DOI 10.1111/j.1095-8312.2003.00263.x	30	92	94	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					85	U88		10.1038/nature07922	http://dx.doi.org/10.1038/nature07922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441WN	19424156	Green Accepted			2022-12-28	WOS:000265801300034
J	Concato, J; Jain, D; Uchio, E; Risch, H; Li, WW; Wells, CK				Concato, John; Jain, Dhanpat; Uchio, Edward; Risch, Harvey; Li, William W.; Wells, Carolyn K.			Molecular Markers and Death From Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							ANDROGEN DEPRIVATION; RADIATION-THERAPY; GLEASON SCORE; CELL-CYCLE; IN-VITRO; BCL-2; EXPRESSION; MEN; P53; ANGIOGENESIS	Background: Current methods to assess the prognosis of prostate cancer at the time of diagnosis are limited. Objective: To determine whether molecular markers of cell cycle regulation (bcl-2 and p53) and angiogenesis (beta-3 integrin, vascular endothelial growth factor, and microvessel density) are associated with increased long-term risk for death among men with prostate cancer. Design: Observational cohort study from 1991 to 2006. Setting: The Veterans Affairs Healthcare System in New England. Patients: Among 64 545 veterans at least 50 years of age, 1313 patients who had incident prostate cancer from 1991 to 1995 were identified. Clinical data were available for 1270 men and complete for 1172 men. Measurements: Data were extracted from medical records, including patient age, race, and comorbid conditions, as well as tumor-related anatomical extent, histologic grade (Gleason score), prostate-specific antigen level, symptoms, and treatment. Immunohistochemical analyses of tissue obtained at diagnosis, which used antibodies against the selected markers, were also conducted. Proportional hazards analysis was used to evaluate the association of these factors with death from prostate cancer through 2006. Results: At diagnosis, the median age was 72 years, the median prostate-specific antigen level was 10.0 mu g/L, and most tumors were moderately differentiated. During an 11- to 16-year follow-up, 71.8% (842 of 1172) of men died, with 21.5% (181 of 842) of deaths attributable to prostate cancer. Among 1007 men with results for all pertinent markers and after adjustment for age and clinical characteristics, bcl-2 (adjusted hazard ratio [HR] for positive vs. negative staining, 1.61 [95% CI, 1.01 to 2.57]; P = 0.045), p53 (adjusted HR for positive vs. negative staining, 1.48 [CI, 1.06 to 2.08]; P = 0.022), and microvessel density ( adjusted HR for highest vs. lowest quartile, 3.20 [CI, 1.77 to 5.78]; P < 0.001) were associated with death from prostate cancer. Limitations: Results may be affected by residual confounding. Some patients were not included in complete case analyses because information was not available from clinical care records (7.5%) or tissue staining (12.6%). Conclusion: Immunohistochemical evidence of bcl-2, p53, or high microvessel density in prostate cancer biopsy specimens at diagnosis is associated with an increased long-term risk for death from prostate cancer. Primary Funding Source: Office of Research and Development, Veterans Health Administration.	Vet Affairs Connecticut Healthcare Syst, Vet Affairs Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; Yale Univ, Sch Med, New Haven, CT USA; Angiogenesis Fdn, Cambridge, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Concato, J (corresponding author), Vet Affairs Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, Mail Code 151B,950 Campbell Ave, West Haven, CT 06516 USA.				Office of Research and Development; Veterans Health Administration; Clinical Science Research and Development Service; Merit Review Award Program	Office of Research and Development; Veterans Health Administration(US Department of Veterans Affairs); Clinical Science Research and Development Service; Merit Review Award Program	Office of Research and Development, Veterans Health Administration.; By the Clinical Science Research and Development Service, Merit Review Award Program, Office of Research and Development, Veterans Health Administration.	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; BRAWER MK, 1992, J CELL BIOCHEM, P62; Bubendorf L, 1999, CANCER RES, V59, P803; BURKE HB, 1993, CANCER, V72, P3131, DOI 10.1002/1097-0142(19931115)72:10<3131::AID-CNCR2820721039>3.0.CO;2-J; Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Che M, 2007, INT J RADIAT ONCOL, V69, P1117, DOI 10.1016/j.ijrobp.2007.04.070; COLOMBEL M, 1993, AM J PATHOL, V143, P390; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Concato J, 2006, ARCH INTERN MED, V166, P38, DOI 10.1001/archinte.166.1.38; Concato J, 2001, CANCER, V91, P1607, DOI 10.1002/1097-0142(20010415)91:8+<1607::AID-CNCR1174>3.0.CO;2-J; Concato J, 2007, BJU INT, V100, P1259, DOI 10.1111/j.1464-410X.2007.07136.x; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Deutsch E, 2004, LANCET ONCOL, V5, P303, DOI 10.1016/S1470-2045(04)01468-8; Downing Sean R, 2003, Can J Urol, V10, P1924; Epstein JI, 2000, AM J SURG PATHOL, V24, P477, DOI 10.1097/00000478-200004000-00001; Ferrer FA, 1997, J UROLOGY, V157, P2329, DOI 10.1016/S0022-5347(01)64775-X; FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426; Gelmann EP, 2008, NEW ENGL J MED, V358, P961, DOI 10.1056/NEJMe0708703; Greene WL, 2000, ANN INTERN MED, V132, P715, DOI 10.7326/0003-4819-132-9-200005020-00006; Halabi S, 2003, J CLIN ONCOL, V21, P1232, DOI 10.1200/JCO.2003.06.100; Holmboe ES, 2000, J GEN INTERN MED, V15, P694, DOI 10.1046/j.1525-1497.2000.90842.x; Izawa JI, 2001, CAN MED ASSOC J, V164, P662; Johansson JE, 1997, JAMA-J AM MED ASSOC, V277, P467, DOI 10.1001/jama.277.6.467; KAMATH A, 2008, APPL IMMUNOHISTOCHEM; Kenny LM, 2007, BJU INT, V100, P244, DOI 10.1111/j.1464-410X.2007.07063.x; Khor LY, 2007, CLIN CANCER RES, V13, P3585, DOI 10.1158/1078-0432.CCR-06-2972; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JT, 2008, CELL CYCLE, V7, P1745, DOI 10.4161/cc.7.12.6166; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; MELLON K, 1992, J UROLOGY, V147, P496, DOI 10.1016/S0022-5347(17)37287-7; Moul JW, 2001, UROL CLIN N AM, V28, P459, DOI 10.1016/S0094-0143(05)70155-5; Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Quinn DI, 2005, EUR J CANCER, V41, P858, DOI 10.1016/j.ejca.2004.12.035; RAFFO AJ, 1995, CANCER RES, V55, P4438; Ross JS, 2003, AM J CLIN PATHOL, V120, P822, DOI 10.1309/6CQ7AXQ6WHHBXUWH; Rubin MA, 2002, AM J SURG PATHOL, V26, P312, DOI 10.1097/00000478-200203000-00004; Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506; Schlomm T, 2007, WORLD J UROL, V25, P19, DOI 10.1007/s00345-007-0153-z; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Trikha M, 1996, CANCER RES, V56, P5071; VISAKORPI T, 1992, J NATL CANCER I, V84, P883, DOI 10.1093/jnci/84.11.883; WEIDNER N, 1993, AM J PATHOL, V143, P401; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	50	32	33	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					595	U6		10.7326/0003-4819-150-9-200905050-00005	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414838	Green Submitted			2022-12-28	WOS:000265903800003
J	Mellone, BG; Zhang, WG; Karpen, GH				Mellone, Barbara G.; Zhang, Weiguo; Karpen, Gary H.			Frodos Found: Behold the CENP-A "Ring" Bearers	CELL			English	Review							FISSION YEAST SCM3; CENTROMERIC CHROMATIN; PROPAGATION; NUCLEOSOME; PROTEIN	CENP-A is a histone H3-like protein specific to centromeres that is essential for kinetochore formation and accurate chromosome segregation in eukaryotes. Recent studies (Dunleavy et al., 2009; Foltz et al., 2009; Perpelescu et al., 2009; Pidoux et al., 2009; Williams et al., 2009) analyze CENP-A binding proteins required for the recruitment of CENP-A to centromeres in humans and in fission yeast, bringing us closer to understanding how centromere identity is faithfully propagated.	[Zhang, Weiguo; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Mellone, Barbara G.] Univ Connecticut, Storrs, CT 06269 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Connecticut	Karpen, GH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	karpen@fruitfly.org		Mellone, Barbara/0000-0002-2785-5119; Zhang, Weiguo/0000-0002-3045-0569	Susan Komen Foundation; NIH [R01 GM066272]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066272] Funding Source: NIH RePORTER	Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to The Journal of Cell Biology for providing the Perpelescu et al. manuscript prior to publication and for insightful comments from the reviewers. W.Z. is supported by Susan Komen Foundation. Centromere studies in G.K.'s lab are supported by NIH R01 GM066272.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hanai K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000011; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; Mellone B, 2006, NAT CELL BIOL, V8, P427, DOI 10.1038/ncb0506-427; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Zhang WG, 2007, CELL, V129, P1047, DOI 10.1016/j.cell.2007.05.054	16	15	17	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					409	412		10.1016/j.cell.2009.04.035	http://dx.doi.org/10.1016/j.cell.2009.04.035			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410539	Bronze, Green Accepted			2022-12-28	WOS:000265677200012
J	Schweitzer, MH; Zheng, WX; Organ, CL; Avci, R; Suo, ZY; Freimark, LM; Lebleu, VS; Duncan, MB; Heiden, MGV; Neveu, JM; Lane, WS; Cottrell, JS; Horner, JR; Cantley, LC; Kalluri, R; Asara, JM				Schweitzer, Mary H.; Zheng, Wenxia; Organ, Chris L.; Avci, Recep; Suo, Zhiyong; Freimark, Lisa M.; Lebleu, Valerie S.; Duncan, Michael B.; Heiden, Matthew G. Vander; Neveu, John M.; Lane, William S.; Cottrell, John S.; Horner, John R.; Cantley, Lewis C.; Kalluri, Raghu; Asara, John M.			Biomolecular Characterization and Protein Sequences of the Campanian Hadrosaur B. canadensis	SCIENCE			English	Article							SOFT-TISSUE; CELLULAR PRESERVATION; MASTODON; IDENTIFICATION; BONE; BACTERIAL; COLLAGEN	Molecular preservation in non-avian dinosaurs is controversial. We present multiple lines of evidence that endogenous proteinaceous material is preserved in bone fragments and soft tissues from an 80-million-year-old Campanian hadrosaur, Brachylophosaurus canadensis [Museum of the Rockies (MOR) 2598]. Microstructural and immunological data are consistent with preservation of multiple bone matrix and vessel proteins, and phylogenetic analyses of Brachylophosaurus collagen sequenced by mass spectrometry robustly support the bird-dinosaur clade, consistent with an endogenous source for these collagen peptides. These data complement earlier results from Tyrannosaurus rex (MOR 1125) and confirm that molecular preservation in Cretaceous dinosaurs is not a unique event.	[Schweitzer, Mary H.; Zheng, Wenxia] N Carolina State Univ, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Organ, Chris L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Avci, Recep; Suo, Zhiyong] Montana State Univ, Imaging & Chem Anal Lab, Bozeman, MT 59717 USA; [Freimark, Lisa M.; Cantley, Lewis C.; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Lebleu, Valerie S.; Duncan, Michael B.; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Boston, MA 02115 USA; [Lebleu, Valerie S.; Duncan, Michael B.; Kalluri, Raghu] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Heiden, Matthew G. Vander] Dana Farber Canc Inst, Boston, MA 02115 USA; [Neveu, John M.; Lane, William S.] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA; [Cottrell, John S.] Matrix Sci Ltd, London W1U 7GB, England; [Horner, John R.] Museum Rockies, Bozeman, MT 59717 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kalluri, Raghu] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02139 USA; [Kalluri, Raghu] Harvard Univ, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of North Carolina; North Carolina State University; Harvard University; Montana State University System; Montana State University Bozeman; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard Medical School	Schweitzer, MH (corresponding author), N Carolina State Univ, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu; jasara@bidmc.harvard.edu	Cantley, Lewis C/D-1800-2014; Schweitzer, Mary/V-8143-2019; schweitzer, mary h/A-6756-2010; LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Cantley, Lewis C/0000-0002-1298-7653; schweitzer, mary h/0000-0002-0427-3829; Kalluri, Raghu/0000-0002-2190-547X	NSF [EAR 0722702, EAR 0634136, EAR 0548847, EAR-0541744]; David and Lucile Packard Foundation; United Negro College Fund Merck Postdoctoral Science Research Fellowship; Taplin Funds for Discovery (Harvard Medical School); NASA Expermental Project to Simulate Competitive Research [NCC5-579]; Damon Runyon Cancer Research Foundation; NIH [DK 55001, DK 62987, AA 13913, DK 61866, CA 125550]; Department of Medicine for the Division of Matrix Biology at the Beth Israel Deaconess Medical Center; NATIONAL CANCER INSTITUTE [R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK061866, R01DK062987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013913] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); United Negro College Fund Merck Postdoctoral Science Research Fellowship; Taplin Funds for Discovery (Harvard Medical School); NASA Expermental Project to Simulate Competitive Research; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine for the Division of Matrix Biology at the Beth Israel Deaconess Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We acknowledge funding from NSF [awards EAR 0722702 and EAR 0634136 (J.M.A.) and EAR 0548847 and EAR-0541744 (M.H.S.)]; the David and Lucile Packard Foundation (M.H.S.); United Negro College Fund Merck Postdoctoral Science Research Fellowship (M.B.D.); the Taplin Funds for Discovery (Harvard Medical School); partial support by NASA Expermental Project to Simulate Competitive Research under grant NCC5-579 (R.A. and Z.S.); Damon Runyon Cancer Research Foundation (M.G.V.H.); NIH grants DK 55001, DK 62987, AA 13913, DK 61866, and CA 125550; and the Department of Medicine for the Division of Matrix Biology at the Beth Israel Deaconess Medical Center. Correspondence and requests for materials should be addressed to M.H.S. for biochemical and morphological analyses and to J.M.A. for mass spectrometry and molecular phylogenetics analyses.	Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Asara JM, 2008, SCIENCE, V321, DOI 10.1126/science.1157829; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; EBERT PS, 1962, BIOCHEM BIOPH RES CO, V8, P305, DOI 10.1016/0006-291X(62)90283-8; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Lam H, 2007, PROTEOMICS, V7, P655, DOI 10.1002/pmic.200600625; Mecham R.P., 1991, CELL BIOL EXTRACELLU, V2nd, P79; MENTON DN, 1984, ANAT RECORD, V209, P29, DOI 10.1002/ar.1092090105; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pevzner PA, 2008, SCIENCE, V321, DOI 10.1126/science.1155006; Pisani D, 2002, P ROY SOC B-BIOL SCI, V269, P915, DOI 10.1098/rspb.2001.1942; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Tate MLK, 2004, INT J BIOCHEM CELL B, V36, P1, DOI 10.1016/S1357-2725(03)00241-3; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107	24	144	152	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					626	631		10.1126/science.1165069	http://dx.doi.org/10.1126/science.1165069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407199				2022-12-28	WOS:000265608800039
J	Kuo, WJ; Sjostrom, T; Chen, YP; Wang, YH; Huang, CY				Kuo, Wen-Jui; Sjoestroem, Tomas; Chen, Yu-Ping; Wang, Yen-Hsiang; Huang, Chen-Ying			Intuition and Deliberation: Two Systems for Strategizing in the Brain	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; WORKING-MEMORY; FUNCTIONAL NEUROANATOMY; CORTICAL NETWORK; NEURAL BASIS; SALIENCE; PRECUNEUS; RESPONSES; FEEL; FMRI	Dual-process theories distinguish between intuition (fast and emotional) and reasoning (slow and controlled) as a basis for human decision-making. We contrast dominance-solvable games, which can be solved by step-by-step deliberative reasoning, with pure coordination games, which must be solved intuitively. Using functional magnetic resonance imaging, we found that the middle frontal gyrus, the inferior parietal lobule, and the precuneus were more active in dominance-solvable games than in coordination games. The insula and anterior cingulate cortex showed the opposite pattern. Moreover, precuneus activity correlates positively with how "effortful" a dominance-solvable game is, whereas insula activity correlates positively with how "effortless" a coordination game is.	[Chen, Yu-Ping; Huang, Chen-Ying] Natl Taiwan Univ, Dept Econ, Taipei 10764, Taiwan; [Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Sjoestroem, Tomas] Rutgers State Univ, Dept Econ, New Brunswick, NJ 08901 USA; [Wang, Yen-Hsiang] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; Rutgers State University New Brunswick; National Taiwan University	Huang, CY (corresponding author), Natl Taiwan Univ, Dept Econ, Taipei 10764, Taiwan.	chenying@ntu.edu.tw	Sjostrom, Tomas/AAB-9239-2020; Huang, Chen-Ying/M-1704-2018	Sjostrom, Tomas/0000-0003-2835-0953; Huang, Chen-Ying/0000-0003-2897-642X	National Science Council of Taiwan [NSC 94-2415-H-002-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	We thank M. Hsu for helpful comments on the manuscript and J.-Y. Leu, J.T.-Y. Wang, D. Niddam, and participants at many seminars for discussions. Technical assistance from C.-R. Chou, C.-T. Chen, C.-H. Lan, S.-C. Lin, K.-L. Chen, Y.-Y. Chung, W.-Y. Lin, S. Hsu, R. Chen, and the National Taiwan University Hospital MRI Laboratory is greatly appreciated. This work was supported by the National Science Council of Taiwan (grant NSC 94-2415-H-002-004).	Atherton M, 2003, COGNITIVE BRAIN RES, V16, P26, DOI 10.1016/S0926-6410(02)00207-0; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; BARDSLEY N, 2008, 200817 CTR DEC RES E; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1775, DOI 10.1016/j.neuropsychologia.2008.03.005; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; CAMERER C, 2003, BEHAV GAME THEORY EX, pCH5; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Goel V, 2001, NEUROPSYCHOLOGIA, V39, P901, DOI 10.1016/S0028-3932(01)00024-0; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MEHTA J, 1994, AM ECON REV, V84, P658; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Noveck IA, 2004, CORTEX, V40, P613, DOI 10.1016/S0010-9452(08)70157-6; Rubinstein A, 2007, ECON J, V117, P1243, DOI 10.1111/j.1468-0297.2007.02081.x; Schaeffer J, 2007, SCIENCE, V317, P1518, DOI 10.1126/science.1144079; SCHELLING TC, 1958, J CONFLICT RESOLUT, V2, P203, DOI DOI 10.1177/002200275800200301; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wallentin M, 2008, HUM BRAIN MAPP, V29, P524, DOI 10.1002/hbm.20413; Wallentin M, 2006, NEUROIMAGE, V32, P1850, DOI 10.1016/j.neuroimage.2006.05.002; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Woodward J, 2007, J PHYSIOL-PARIS, V101, P179, DOI 10.1016/j.jphysparis.2007.12.003	41	78	82	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					519	522		10.1126/science.1165598	http://dx.doi.org/10.1126/science.1165598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390048	Green Submitted			2022-12-28	WOS:000265411200049
J	Hirschhorn, JN				Hirschhorn, Joel N.			Genomewide Association Studies - Illuminating Biologic Pathways	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Boston, MA USA; [Hirschhorn, Joel N.] Broad Inst Harvard & MIT, Metab Initiat, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hirschhorn, JN (corresponding author), Childrens Hosp, Program Genom, 300 Longwood Ave, Boston, MA 02115 USA.			Hirschhorn, Joel/0000-0002-1650-7901				Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; HIRSCHHORN JN, HORM RES IN PRESS; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Mohlke KL, 2008, HUM MOL GENET, V17, pR102, DOI 10.1093/hmg/ddn275; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197	5	357	377	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1699	1701		10.1056/NEJMp0808934	http://dx.doi.org/10.1056/NEJMp0808934			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369661				2022-12-28	WOS:000265377800003
J	Mercado, LM; Bellouin, N; Sitch, S; Boucher, O; Huntingford, C; Wild, M; Cox, PM				Mercado, Lina M.; Bellouin, Nicolas; Sitch, Stephen; Boucher, Olivier; Huntingford, Chris; Wild, Martin; Cox, Peter M.			Impact of changes in diffuse radiation on the global land carbon sink	NATURE			English	Article							DECIDUOUS FOREST; CO2; PHOTOSYNTHESIS; REDUCTION; DIOXIDE; CLIMATE; CLOUDS; MODEL	Plant photosynthesis tends to increase with irradiance. However, recent theoretical and observational studies have demonstrated that photosynthesis is also more efficient under diffuse light conditions(1-5). Changes in cloud cover or atmospheric aerosol loadings, arising from either volcanic or anthropogenic emissions, alter both the total photosynthetically active radiation reaching the surface and the fraction of this radiation that is diffuse, with uncertain overall effects on global plant productivity and the land carbon sink. Here we estimate the impact of variations in diffuse fraction on the land carbon sink using a global model modified to account for the effects of variations in both direct and diffuse radiation on canopy photosynthesis. We estimate that variations in diffuse fraction, associated largely with the 'global dimming' period(6-8), enhanced the land carbon sink by approximately one-quarter between 1960 and 1999. However, under a climate mitigation scenario for the twenty-first century in which sulphate aerosols decline before atmospheric CO2 is stabilized, this 'diffuse-radiation' fertilization effect declines rapidly to near zero by the end of the twenty-first century.	[Mercado, Lina M.; Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Bellouin, Nicolas; Sitch, Stephen; Boucher, Olivier] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Wild, Martin] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Cox, Peter M.] Univ Exeter, Sch Engn Comp Sci & Math, Exeter EX4 4QF, Devon, England	UK Centre for Ecology & Hydrology (UKCEH); Met Office - UK; Hadley Centre; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Exeter	Mercado, LM (corresponding author), Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England.	lmme@ceh.ac.uk	Sitch, Stephen A/F-8034-2015; Huntingford, Christopher/A-4307-2008; Mercado, Lina/A-1890-2012; Mercado, Lina M/H-3067-2016; Boucher, Olivier/K-7483-2012; Wild, Martin/J-8977-2012; Boucher, Olivier/J-5810-2012; Cox, Peter Michae;/B-3299-2012	Sitch, Stephen A/0000-0003-1821-8561; Huntingford, Christopher/0000-0002-5941-7770; Mercado, Lina M/0000-0003-4069-0838; Boucher, Olivier/0000-0003-2328-5769; Boucher, Olivier/0000-0003-2328-5769; Cox, Peter Michae;/0000-0002-0679-2219; Bellouin, Nicolas/0000-0003-2109-9559	UK Natural Environment Research Council; UK Department for Environment, Food and Rural Affairs (Defra); UK Ministry of Defence (MoD) [GA01101, CBC/2B/0417_Annex C5]; Swiss NCCR Climate; NERC [earth010002] Funding Source: UKRI; Natural Environment Research Council [earth010002, ceh010023] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); UK Ministry of Defence (MoD); Swiss NCCR Climate(Swiss National Science Foundation (SNSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. Knohl and C. Rebmann for supplying the eddy flux data for model evaluation, D. van Vuuren and the group that developed the IMAGE model for providing scenario data for the simulation of the twenty-first century. We also thank C. D. Jones for advice on the experimental design, C. M. Taylor for discussions on early results, R. Ellis and P. Harris for both scientific and technical support, A. Everitt for computer support and G. Weedon for discussions. The authors acknowledge funding from the UK Natural Environment Research Council CLASSIC programme (L. M. M., C. H. and P. M. C.) and the UK Department for Environment, Food and Rural Affairs (Defra) and the UK Ministry of Defence (MoD) (N. B., O. B. and S. S.) under GA01101 (Defra) and CBC/2B/0417_Annex C5 (MoD) and from the Swiss NCCR Climate (M. W.).	Bellouin N., 2007, 73 MET OFF HADL CTR; Buitenhuis E, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002511; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; Dai YJ, 2004, J CLIMATE, V17, P2281, DOI 10.1175/1520-0442(2004)017&lt;2281:ATMFCT&gt;2.0.CO;2; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Goudriaan J., 1977, CROP MICROMETEOROLOG, P5; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Gu LH, 2003, SCIENCE, V299, P2035, DOI 10.1126/science.1078366; Jones CD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016867; Jones CD, 2001, GLOBAL BIOGEOCHEM CY, V15, P453, DOI 10.1029/2000GB001281; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Key JR, 1998, COMPUT GEOSCI, V24, P443, DOI 10.1016/S0098-3004(97)00130-1; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Knohl A, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000663; Liepert B, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000760; Liepert BG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014910; LONG CN, J GEOPHYS R IN PRESS; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Mercado LM, 2007, TELLUS B, V59, P553, DOI 10.1111/j.1600-0889.2007.00256.x; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Niyogi D, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020915; Oliveira PHF, 2007, TELLUS B, V59, P338, DOI [10.1111/j.1600-0889.2007.00270.x, 10.1111/J.1600-0889.2007.00270.x]; Power HC, 2003, THEOR APPL CLIMATOL, V76, P47, DOI 10.1007/s00704-003-0005-8; REBMANN C, AGRIC FOR METE UNPUB; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; Romanou A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028356; Russak V, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010613; SATO M, 1993, J GEOPHYS RES-ATMOS, V98, P22987, DOI 10.1029/93JD02553; Stanhill G, 2001, AGR FOREST METEOROL, V107, P255, DOI 10.1016/S0168-1923(00)00241-0; van Vuuren DP, 2007, CLIMATIC CHANGE, V81, P119, DOI 10.1007/s10584-006-9172-9; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215	31	633	668	20	356	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1014	U87		10.1038/nature07949	http://dx.doi.org/10.1038/nature07949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396143	Green Accepted, Green Submitted			2022-12-28	WOS:000265412900039
J	Singh, SC; Macdonald, KC				Singh, Satish C.; Macdonald, Ken C.			Mantle skewness and ridge segmentation	NATURE			English	Letter							EAST PACIFIC RISE; SHALLOW CRUSTAL EMPLACEMENT; OCEANIC-CRUST		[Singh, Satish C.] Inst Phys Globe, Lab Geosci Marines, F-75252 Paris, France; [Macdonald, Ken C.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA	UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Santa Barbara	Singh, SC (corresponding author), Inst Phys Globe, Lab Geosci Marines, 4 Pl Jussieu, F-75252 Paris, France.	singh@ipgp.jussieu.fr	Macdonald, Ken C/G-3936-2011					Barth GA, 1996, J GEOPHYS RES-SOL EA, V101, P17951, DOI 10.1029/96JB00814; Bazin S, 2001, J GEOPHYS RES-SOL EA, V106, P16101, DOI 10.1029/2001JB000371; Canales JP, 2003, GEOPHYS J INT, V152, P766, DOI 10.1046/j.1365-246X.2003.01885.x; CHRISTESON GL, 1994, J GEOPHYS RES-SOL EA, V99, P17957, DOI 10.1029/94JB01252; HARDING AJ, 1989, J GEOPHYS RES-SOLID, V94, P12163, DOI 10.1029/JB094iB09p12163; MACDONALD KC, 2007, EOS S, V88; Neves FA, 1996, GEOPHYS J INT, V126, P470, DOI 10.1111/j.1365-246X.1996.tb05303.x; SEHER T, 2008, THESIS IPG PARIS; Shipp RM, 2002, GEOPHYS J INT, V151, P325, DOI 10.1046/j.1365-246X.2002.01645.x; Toomey DR, 2007, NATURE, V446, P409, DOI 10.1038/nature05679; TOOMEY DR, 1994, J GEOPHYS RES-SOL EA, V99, P24135, DOI 10.1029/94JB01942	11	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					E11	E12		10.1038/nature07887	http://dx.doi.org/10.1038/nature07887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396085				2022-12-28	WOS:000265412900031
J	Goldman, M				Goldman, Mark			This house believes doctors are neglecting their duty to lead health service changes: Second opposer	BRITISH MEDICAL JOURNAL			English	Editorial Material												mark.goldman@heartofengland.nhs.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2009	338								b1573	10.1136/bmj.b1573	http://dx.doi.org/10.1136/bmj.b1573			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OO	19383753				2022-12-28	WOS:000265497000004
J	Pickering, JW; Endre, ZH				Pickering, John W.; Endre, Zoltan H.			GFR shot by RIFLE: errors in staging acute kidney injury	LANCET			English	Editorial Material							ACUTE-RENAL-FAILURE; LIVER-TRANSPLANTATION; CRITERIA; OUTCOMES; THERAPY		[Pickering, John W.; Endre, Zoltan H.] Univ Otago, Sch Med & Hlth Sci, Dept Med, Christchurch Kidney Res Grp, Christchurch 8140, New Zealand	University of Otago	Pickering, JW (corresponding author), Univ Otago, Sch Med & Hlth Sci, Dept Med, Christchurch Kidney Res Grp, Christchurch 8140, New Zealand.	john.pickering@otago.ac.nz	Pickering, John W/A-9453-2009; Pickering, John/ABC-8089-2021; Endre, Zoltan/A-3331-2009	Pickering, John W/0000-0001-9475-0344; Pickering, John/0000-0001-9475-0344; Endre, Zoltan/0000-0002-4782-8695				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Endre ZH, 2008, ADV CHRONIC KIDNEY D, V15, P213, DOI 10.1053/j.ackd.2008.04.002; Endre ZH, 2008, NEPHROLOGY, V13, P91, DOI 10.1111/j.1440-1797.2007.00905.x; Guitard J, 2006, CLIN NEPHROL, V65, P103; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Lameire N, 2008, LANCET, V372, P1863, DOI 10.1016/S0140-6736(08)61794-8; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; O'Riordan A, 2007, AM J TRANSPLANT, V7, P168, DOI 10.1111/j.1600-6143.2006.01602.x; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F	13	51	51	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 18	2009	373	9672					1318	1319		10.1016/S0140-6736(09)60751-0	http://dx.doi.org/10.1016/S0140-6736(09)60751-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434UR	19376434				2022-12-28	WOS:000265300100007
J	Brewer, PG; Peltzer, ET				Brewer, Peter G.; Peltzer, Edward T.			Limits to Marine Life	SCIENCE			English	Editorial Material							OCEAN ACIDIFICATION; CONSEQUENCES		[Brewer, Peter G.; Peltzer, Edward T.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Brewer, PG (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	brpe@mbari.org		Brewer, Peter/0000-0002-5448-0199; Peltzer, Edward/0000-0003-2821-3553				Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; REDFIELD AC, 1963, SEA, V2; Rue EL, 1997, DEEP-SEA RES PT I, V44, P113, DOI 10.1016/S0967-0637(96)00088-X; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SABINE CL, 2005, ORNLCDIAC145 US DOE; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847	10	133	136	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					347	348		10.1126/science.1170756	http://dx.doi.org/10.1126/science.1170756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372421				2022-12-28	WOS:000265221600030
J	Carr, S; Heard, DE; Blitz, MA				Carr, Scott; Heard, Dwayne E.; Blitz, Mark A.			Comment on "Atmospheric Hydroxyl Radical Production from Electronically Excited NO2 and H2O"	SCIENCE			English	Editorial Material							OH FORMATION; NM	Li et al. (Reports, 21 March 2008, p. 1657) suggested that the reaction between electronically excited nitrogen dioxide and water vapor is an important atmospheric source of the hydroxyl radical. However, under conditions that better approximate the solar flux, we find no evidence for OH production from this reaction.	[Blitz, Mark A.] Univ Leeds, Sch Chem, Natl Ctr Atmospher Sci, Leeds LS2 9JT, W Yorkshire, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Leeds	Blitz, MA (corresponding author), Univ Leeds, Sch Chem, Natl Ctr Atmospher Sci, Leeds LS2 9JT, W Yorkshire, England.	m.blitz@leeds.ac.uk	Heard, Dwayne/M-3624-2017; blitz, mark/A-1195-2009	Heard, Dwayne/0000-0002-0357-6238; blitz, mark/0000-0001-6710-4021	NERC [ncas10006] Funding Source: UKRI; Natural Environment Research Council [ncas10006] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Blitz MA, 2002, CHEM PHYS LETT, V365, P374, DOI 10.1016/S0009-2614(02)01484-7; Blitz MA, 2006, J PHYS CHEM A, V110, P6742, DOI 10.1021/jp056276g; Crowley JN, 1997, J PHYS CHEM A, V101, P4178, DOI 10.1021/jp970319e; Heard DE, 2003, CHEM REV, V103, P5163, DOI 10.1021/cr020522s; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Li SP, 2008, SCIENCE, V319, P1657, DOI 10.1126/science.1151443; MYERS GH, 1966, J CHEM PHYS, V44, P718, DOI 10.1063/1.1726751; Sivakumaran V, 2001, J QUANT SPECTROSC RA, V69, P525, DOI 10.1016/S0022-4073(00)00094-7	8	54	55	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	2009	324	5925								10.1126/science.1166669	http://dx.doi.org/10.1126/science.1166669			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372414				2022-12-28	WOS:000265221600020
J	Bos, PD; Zhang, XHF; Nadal, C; Shu, WP; Gomis, RR; Nguyen, DX; Minn, AJ; van de Vijver, MJ; Gerald, WL; Foekens, JA; Massague, J				Bos, Paula D.; Zhang, Xiang H. -F.; Nadal, Cristina; Shu, Weiping; Gomis, Roger R.; Nguyen, Don X.; Minn, Andy J.; van de Vijver, Marc J.; Gerald, William L.; Foekens, John A.; Massague, Joan			Genes that mediate breast cancer metastasis to the brain	NATURE			English	Article							LUNG METASTASIS; GROWTH-FACTOR; IN-VITRO; EXPRESSION; CELLS; BONE; BETA; PROGRESSION; BARRIER; TISSUES	The molecular basis for breast cancer metastasis to the brain is largely unknown(1,2). Brain relapse typically occurs years after the removal of a breast tumour(2-4), suggesting that disseminated cancer cells must acquire specialized functions to take over this organ. Here we show that breast cancer metastasis to the brain involves mediators of extravasation through non-fenestrated capillaries, complemented by specific enhancers of blood-brain barrier crossing and brain colonization. We isolated cells that preferentially infiltrate the brain from patients with advanced disease. Gene expression analysis of these cells and of clinical samples, coupled with functional analysis, identified the cyclooxygenase COX2 (also known as PTGS2), the epidermal growth factor receptor (EGFR) ligand HBEGF, and the alpha 2,6-sialyltransferase ST6GALNAC5 as mediators of cancer cell passage through the blood-brain barrier. EGFR ligands and COX2 were previously linked to breast cancer infiltration of the lungs, but not the bones or liver(5,6), suggesting a sharing of these mediators in cerebral and pulmonary metastases. In contrast, ST6GALNAC5 specifically mediates brain metastasis. Normally restricted to the brain(7), the expression of ST6GALNAC5 in breast cancer cells enhances their adhesion to brain endothelial cells and their passage through the blood-brain barrier. This co-option of a brain sialyltransferase highlights the role of cell-surface glycosylation in organ-specific metastatic interactions.	[Bos, Paula D.; Zhang, Xiang H. -F.; Nadal, Cristina; Shu, Weiping; Gomis, Roger R.; Nguyen, Don X.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Minn, Andy J.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Minn, Andy J.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Gerald, William L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Foekens, John A.] Erasmus MC, Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands; [Foekens, John A.] Canc Genom Ctr, Rotterdam, Netherlands; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	Memorial Sloan Kettering Cancer Center; University of Chicago; University of Chicago; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Gomis, Roger R/E-9788-2016	Gomis, Roger R/0000-0001-6473-2858; Massague, Joan/0000-0001-9324-8408; Zhang, Xiang/0000-0002-5674-8670; Minn, Andy/0000-0003-1418-0906; van de Vijver, Marc/0000-0002-0385-4787	National Institutes of Health [U54 CA126518]; Kleberg Foundation and the Hearst Foundation; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO); Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U54CA126518, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kleberg Foundation and the Hearst Foundation; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is dedicated to the memory of our colleague W. Gerald. We thank E. Eugenin, E. Brogi, M. Drobnjac, K. LaPerle, M. Smid, A. Viale and K. Manova-Todorova for advice and support. We thank L. DeAngelis, A. Lassman, E. Holland, J. Posner and members of the Massague laboratory for discussions. This work was supported by grants from the National Institutes of Health (U54 CA126518), the Kleberg Foundation and the Hearst Foundation, and the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). J. M. is an investigator of the Howard Hughes Medical Institute.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Kamar FG, 2004, SEMIN NEUROL, V24, P347, DOI 10.1055/s-2004-861530; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Fitzgerald DP, 2008, CLIN EXP METASTAS, V25, P799, DOI 10.1007/s10585-008-9193-z; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Inoue S, 2001, ANAT RECORD, V264, P294, DOI 10.1002/ar.1166; KANEKO Y, 1995, J HISTOCHEM CYTOCHEM, V43, P945, DOI 10.1177/43.9.7642967; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Lassman AB, 2003, NEUROL CLIN, V21, P1, DOI 10.1016/S0733-8619(02)00035-X; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Okajima T, 1999, J BIOL CHEM, V274, P30557, DOI 10.1074/jbc.274.43.30557; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paku S, 2001, CLIN EXP METASTAS, V18, P481, DOI 10.1023/A:1011858925376; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Slimane K, 2004, ANN ONCOL, V15, P1640, DOI 10.1093/annonc/mdh432; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	35	1228	1272	9	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					1005	U137		10.1038/nature08021	http://dx.doi.org/10.1038/nature08021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19421193	Green Accepted			2022-12-28	WOS:000267063500047
J	Wang, K; Zhang, HT; Ma, DQ; Bucan, M; Glessner, JT; Abrahams, BS; Salyakina, D; Imielinski, M; Bradfield, JP; Sleiman, PMA; Kim, CE; Hou, CP; Frackelton, E; Chiavacci, R; Takahashi, N; Sakurai, T; Rappaport, E; Lajonchere, CM; Munson, J; Estes, A; Korvatska, O; Piven, J; Sonnenblick, LI; Retuerto, AIA; Herman, EI; Dong, HM; Hutman, T; Sigman, M; Ozonoff, S; Klin, A; Owley, T; Sweeney, JA; Brune, CW; Cantor, RM; Bernier, R; Gilbert, JR; Cuccaro, ML; McMahon, WM; Miller, J; State, MW; Wassink, TH; Coon, H; Levy, SE; Schultz, RT; Nurnberger, JI; Haines, JL; Sutcliffe, JS; Cook, EH; Minshew, NJ; Buxbaum, JD; Dawson, G; Grant, SFA; Geschwind, DH; Pericak-Vance, MA; Schellenberg, GD; Hakonarson, H				Wang, Kai; Zhang, Haitao; Ma, Deqiong; Bucan, Maja; Glessner, Joseph T.; Abrahams, Brett S.; Salyakina, Daria; Imielinski, Marcin; Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Kim, Cecilia E.; Hou, Cuiping; Frackelton, Edward; Chiavacci, Rosetta; Takahashi, Nagahide; Sakurai, Takeshi; Rappaport, Eric; Lajonchere, Clara M.; Munson, Jeffrey; Estes, Annette; Korvatska, Olena; Piven, Joseph; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Ozonoff, Sally; Klin, Ami; Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cantor, Rita M.; Bernier, Raphael; Gilbert, John R.; Cuccaro, Michael L.; McMahon, William M.; Miller, Judith; State, Matthew W.; Wassink, Thomas H.; Coon, Hilary; Levy, Susan E.; Schultz, Robert T.; Nurnberger, John I., Jr.; Haines, Jonathan L.; Sutcliffe, James S.; Cook, Edwin H.; Minshew, Nancy J.; Buxbaum, Joseph D.; Dawson, Geraldine; Grant, Struan F. A.; Geschwind, Daniel H.; Pericak-Vance, Margaret A.; Schellenberg, Gerard D.; Hakonarson, Hakon			Common genetic variants on 5p14.1 associate with autism spectrum disorders	NATURE			English	Article							GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; FAMILIAL RISK; LINKAGE; LOCI; UNDERCONNECTIVITY; DISCONNECTION; EXPRESSION; IDENTIFICATION; CHROMOSOME	Autism spectrum disorders (ASDs) represent a group of childhood neurodevelopmental and neuropsychiatric disorders characterized by deficits in verbal communication, impairment of social interaction, and restricted and repetitive patterns of interests and behaviour. To identify common genetic risk factors underlying ASDs, here we present the results of genome-wide association studies on a cohort of 780 families (3,101 subjects) with affected children, and a second cohort of 1,204 affected subjects and 6,491 control subjects, all of whom were of European ancestry. Six single nucleotide polymorphisms between cadherin 10 (CDH10) and cadherin 9 (CDH9)-two genes encoding neuronal cell-adhesion molecules-revealed strong association signals, with the most significant SNP being rs4307059 (P = 3.4 x 10(-8), odds ratio = 1.19). These signals were replicated in two independent cohorts, with combined P values ranging from 7.4 x 10(-8) to 2.1 x 10(-10). Our results implicate neuronal cell-adhesion molecules in the pathogenesis of ASDs, and represent, to our knowledge, the first demonstration of genome-wide significant association of common variants with susceptibility to ASDs.	[Wang, Kai; Zhang, Haitao; Glessner, Joseph T.; Imielinski, Marcin; Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Kim, Cecilia E.; Hou, Cuiping; Frackelton, Edward; Chiavacci, Rosetta; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA; [Ma, Deqiong; Salyakina, Daria; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Miami Inst Human Genom, Miami, FL 33101 USA; [Ma, Deqiong; Salyakina, Daria; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Dept Human Genet, Miami, FL 33101 USA; [Bucan, Maja] Univ Penn, Dept Genet, Philadelphia, PA 19014 USA; [Abrahams, Brett S.; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Abrahams, Brett S.; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Takahashi, Nagahide; Sakurai, Takeshi; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Rappaport, Eric; Levy, Susan E.; Schultz, Robert T.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19014 USA; [Lajonchere, Clara M.] Univ So Calif & Autism Speaks, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Munson, Jeffrey; Estes, Annette; Korvatska, Olena; Bernier, Raphael; Dawson, Geraldine] Univ Washington, Dept Psychiat, Seattle, WA 98105 USA; [Piven, Joseph] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Piven, Joseph] Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Ozonoff, Sally] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Ozonoff, Sally] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Klin, Ami; State, Matthew W.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Klin, Ami; State, Matthew W.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cook, Edwin H.] Univ Illinois, Inst Juvenile Res, Chicago, IL 60608 USA; [Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Chicago, IL 60608 USA; [Cantor, Rita M.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [McMahon, William M.; Miller, Judith; Coon, Hilary] Univ Utah, Dept Psychiat, Salt Lake City, UT 84132 USA; [Wassink, Thomas H.] Univ Iowa, Dept Psychiat, Iowa City, IA USA; [Nurnberger, John I., Jr.] Indiana Univ, Inst Psychiat Res, Indianapolis, IN 46202 USA; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN 37232 USA; [Minshew, Nancy J.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Minshew, Nancy J.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Miami; University of Miami; University of Pennsylvania; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; University of California System; University of California Davis; Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Haines, Jonathan/C-3374-2012; Takahashi, Nagahide/AAR-6268-2020; State, Matthew/W-2256-2019; Sutcliffe, James S/C-1348-2012; Buxbaum, Joseph D/G-6001-2010; Rappaport, Eric/GRO-4051-2022	Haines, Jonathan/0000-0002-4351-4728; Takahashi, Nagahide/0000-0002-7711-0297; Sutcliffe, James S/0000-0001-5200-6007; Dawson, Geraldine/0000-0003-1410-2764; Buxbaum, Joseph/0000-0001-8898-8313; State, Matthew/0000-0003-1624-8302; Glessner, Joseph/0000-0001-5131-2811; Estes, Annette/0000-0003-2687-4155; Nurnberger, John/0000-0002-7674-1767; Grant, Struan/0000-0003-2025-5302; Wassink, Thomas/0000-0002-0952-8333; Sweeney, John/0000-0003-1752-2828; Munson, Jeffrey A/0000-0003-1798-8927; Salyakina, Daria/0000-0003-3283-3691	National Institute of Mental Health [1U24MH081810]; National Institute of Child Health and Human Development [NO1-HD-4-3368, NO1-HD-4-3383]; Institutional Development Award; Margaret Q. Landenberger Foundation; Cotswold Foundation [UL1-RR024134-03]; Mental Retardation and Developmental Disability Research Center; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs; NIH [MH64547, HD055782-01, MH0666730, MH061009, NS049261, HD055751, MH69359, M01-RR00064, MH081754, HD055784, NS26630, NS36768, MH080647]; Autism Genome Project Consortium; Autism Speaks; Medical Research Council (UK) and the Health Research Board (Ireland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055782, P50HD055751, P50HD055748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066673, R01MH080647, R01MH069359, R01MH081754, R01MH061009, R01MH064547, U24MH081810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036768, P01NS026630, R01NS049261] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Institutional Development Award; Margaret Q. Landenberger Foundation; Cotswold Foundation; Mental Retardation and Developmental Disability Research Center; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Genome Project Consortium; Autism Speaks; Medical Research Council (UK) and the Health Research Board (Ireland)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully thank all the children with ASDs and their families at the participating study sites who were enrolled in this study and all the control subjects who donated blood samples to Children's Hospital of Philadelphia (CHOP) for genetic research purposes. We also acknowledge the resources provided by the AGRE Consortium (D. H. Geschwind, M. Bucan, W. T. Brown, J. D. Buxbaum, R. M. Cantor, J. N. Constantino, T. C. Gilliam, C. M. Lajonchere, D. H. Ledbetter, C. Lese-Martin, J. Miller, S. F. Nelson, G. D. Schellenberg, C. A. Samango-Sprouse, S. Spence, M. State, R. E. Tanzi) and the participating families. AGRE is a program of Autism Speaks and is at present supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to C. M. Lajonchere (PI), and formerly by grant MH64547 to D. H. Geschwind (PI). We thank the technical staff at the Center for Applied Genomics at CHOP for producing the genotypes used for analyses, and the nursing, medical assistant and medical staff for their help with recruitment of patient and control subjects for the study. We thank R. Liu and I. Lindquist for helping with CNV validation. We thank D. J. Hedges, H. N. Cukier, J. L. McCauley, G. W. Beecham, H. H. Wright, R. K. Abramson, E. R. Martin and J. P. Hussman for their comments, advice and statistical support, and the laboratory core and the autism clinical personnel at the Miami Institute for Human Genomics and the autism clinical staff at the Vanderbilt Center for Human Genetics Research. A subset of the CAP participants was ascertained while M. A. P.-V. was a faculty member at Duke University. We thank the National Institutes of Health (NIH)-funded Developmental Brain and Tissue Bank at University of Maryland for access to the fetal brain tissues used in these studies (National Institute of Child Health and Human Development Contract no. NO1-HD-4-3368 and NO1-HD-4-3383). All genotyping of the AGRE and ACC cohort was supported by an Institutional Development Award to the Center for Applied Genomics (H. H.) at the Children's Hospital of Philadelphia. The study was supported in part by a Research Award from the Margaret Q. Landenberger Foundation (H. H.), a Research Development Award from the Cotswold Foundation (H. H. and S. F. A. G), UL1-RR024134-03 (H. H.), an Alavi-Dabiri fellowship from Mental Retardation and Developmental Disability Research Center at CHOP (K. W.), the Beatrice and Stanley A. Seaver Foundation (J. D. B.), the Department of Veterans Affairs (G. D. S.), NIH grants HD055782-01 (J. Munson, A. E., O. K., G. D. and G. D. S.), MH0666730 (J. D. B.), MH061009 and NS049261 (J. S. S.), HD055751 (E. H. C.), MH69359, M01-RR00064 and the Utah Autism Foundation (H. C., J. Miller and W. M. M.), MH64547, MH081754 (D. H. G.), HD055784 (D. H. G. and M. S.), NS26630, NS36768, MH080647 and a gift from the Hussman Foundation (M. A. P.-V.), the Autism Genome Project Consortium (B. S. A., J. P., C. W. B., D. H. G., T. H. W., W. M. M., H. C., J. I. N., J. S. S., E. H. C., J. Munson, A. E., O. K., J. D. B., B. D. and G. D. S.) funded by Autism Speaks, the Medical Research Council (UK) and the Health Research Board (Ireland). We also acknowledge the partial support to CAP cohort from the Autism Genome Project.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; ALKELAI A, 2008, AM J MED GENET B, V174, P233; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chung RH, 2007, AM J HUM GENET, V80, P59, DOI 10.1086/510630; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Frith C, 2004, LANCET NEUROL, V3, P577, DOI 10.1016/S1474-4422(04)00875-0; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kools P, 1999, FEBS LETT, V452, P328, DOI 10.1016/S0014-5793(99)00672-9; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MA DQ, ANN HUM GEN IN PRESS, DOI DOI 10.1111/J.1469-1809.2008.00523.X; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sykes Nuala H., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000452; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; 2009, AUTISM DEV DISABILIT	51	706	732	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					528	533		10.1038/nature07999	http://dx.doi.org/10.1038/nature07999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19404256	Green Accepted, Green Published			2022-12-28	WOS:000266370500030
J	Nowacki, M; Higgins, BP; Maquilan, GM; Swart, EC; Doak, TG; Landweber, LF				Nowacki, Mariusz; Higgins, Brian P.; Maquilan, Genevieve M.; Swart, Estienne C.; Doak, Thomas G.; Landweber, Laura F.			A Functional Role for Transposases in a Large Eukaryotic Genome	SCIENCE			English	Article							INTERNAL ELIMINATED SEQUENCES; CILIATED PROTOZOA; OXYTRICHA-FALLAX; PRECISE EXCISION; ELEMENTS; DNA; REARRANGEMENT; TETRAHYMENA; TRIFALLAX; EVOLUTION	Despite comprising much of the eukaryotic genome, few transposons are active, and they usually confer no benefit to the host. Through an exaggerated process of genome rearrangement, Oxytricha trifallax destroys 95% of its germline genome during development. This includes the elimination of all transposon DNA. We show that germline-limited transposase genes play key roles in this process of genome-wide DNA excision, which suggests that transposases function in large eukaryotic genomes containing thousands of active transposons. We show that transposase gene expression occurs during germline-soma differentiation and that silencing of transposase by RNA interference leads to abnormal DNA rearrangement in the offspring. This study suggests a new important role in Oxytricha for this large portion of genomic DNA that was previously thought of as junk.	[Nowacki, Mariusz; Higgins, Brian P.; Maquilan, Genevieve M.; Swart, Estienne C.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Doak, Thomas G.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Princeton University; Indiana University System; Indiana University Bloomington	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Nowacki, Mariusz/E-4485-2011	Nowacki, Mariusz/0000-0003-4894-2905; Doak, Thomas/0000-0001-5487-553X	NSF [0622112]; NIH [GM59708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grant 0622112 and NIH grant GM59708. We thank J. Wang for technical assistance. DNA sequences have been deposited in GenBank under accession numbers FJ666213 [GenBank] -FJ666314 [GenBank] (TBE transposases), FJ545743 [GenBank] [ribosomal DNA (rDNA) macronucleus], and FJ545744 [GenBank] (rDNA micronucleus).	Chalker DL, 1996, MOL CELL BIOL, V16, P3658; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Doak TG, 1997, GENETICA, V101, P75, DOI 10.1023/A:1018331118647; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; HERRICK G, 1985, CELL, V43, P759, DOI 10.1016/0092-8674(85)90249-1; HUNTER DJ, 1989, GENE DEV, V3, P2101, DOI 10.1101/gad.3.12b.2101; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Klobutcher LA, 1997, PROG NUCLEIC ACID RE, V56, P1, DOI 10.1016/S0079-6603(08)61001-6; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mollenbeck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002330; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Seegmiller A, 1996, MOL BIOL EVOL, V13, P1351, DOI 10.1093/oxfordjournals.molbev.a025581; WILLIAMS K, 1993, EMBO J, V12, P4593, DOI 10.1002/j.1460-2075.1993.tb06148.x; Witherspoon DJ, 1997, MOL BIOL EVOL, V14, P696, DOI 10.1093/oxfordjournals.molbev.a025809	20	84	86	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					935	938		10.1126/science.1170023	http://dx.doi.org/10.1126/science.1170023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372392	Green Accepted			2022-12-28	WOS:000266048800038
J	Tahiliani, M; Koh, KP; Shen, YH; Pastor, WA; Bandukwala, H; Brudno, Y; Agarwal, S; Iyer, LM; Liu, DR; Aravind, L; Rao, A				Tahiliani, Mamta; Koh, Kian Peng; Shen, Yinghua; Pastor, William A.; Bandukwala, Hozefa; Brudno, Yevgeny; Agarwal, Suneet; Iyer, Lakshminarayan M.; Liu, David R.; Aravind, L.; Rao, Anjana			Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1	SCIENCE			English	Article							ACUTE MYELOID-LEUKEMIA; GLYCOSYLASE ACTIVITY; CXXC DOMAIN; BASE-J; DEMETHYLATION; CYTOSINE; METHYLATION; PROTEIN; METHYLTRANSFERASE; T(10/11)(Q22,Q23)	DNA cytosine methylation is crucial for retrotransposon silencing and mammalian development. In a computational search for enzymes that could modify 5-methylcytosine (5mC), we identified TET proteins as mammalian homologs of the trypanosome proteins JBP1 and JBP2, which have been proposed to oxidize the 5-methyl group of thymine. We show here that TET1, a fusion partner of the MLL gene in acute myeloid leukemia, is a 2-oxoglutarate (2OG)- and Fe(II)-dependent enzyme that catalyzes conversion of 5mC to 5-hydroxymethylcytosine (hmC) in cultured cells and in vitro. hmC is present in the genome of mouse embryonic stem cells, and hmC levels decrease upon RNA interference-mediated depletion of TET1. Thus, TET proteins have potential roles in epigenetic regulation through modification of 5mC to hmC.	[Shen, Yinghua; Brudno, Yevgeny; Liu, David R.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Shen, Yinghua; Brudno, Yevgeny; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Tahiliani, Mamta; Koh, Kian Peng; Pastor, William A.; Bandukwala, Hozefa; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tahiliani, Mamta; Koh, Kian Peng; Pastor, William A.; Bandukwala, Hozefa; Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA; [Agarwal, Suneet] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet] Dana Farber Canc Inst, Boston, MA 02115 USA; [Iyer, Lakshminarayan M.; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu; aravind@ncbi.nlm.nih.gov; arao@idi.harvard.edu	Erlitzki, Noa/AHC-5346-2022; Koh, Kian Peng/S-6279-2016; Iyer, Lakshminarayan M./H-2996-2019; Liu, David R./HCH-3132-2022	Koh, Kian Peng/0000-0003-2523-5175; Aravind, L/0000-0003-0771-253X; Brudno, Yevgeny/0000-0003-2963-3293	NIH [AI44432, K08 HL089150]; a Scholar Award from the Juvenile Diabetes Research Foundation; Harvard Stem Cell Institute [Seed]; Howard Hughes Medical Institute; NIH/NIGMS [R01GM065865]; American Heart Association postdoctoral fellowship; National Library of Medicine, NIH; Lady Tata Memorial postdoctoral fellowship; NSF Graduate Fellowships; Department of Defense graduate fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); a Scholar Award from the Juvenile Diabetes Research Foundation; Harvard Stem Cell Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association postdoctoral fellowship(American Heart Association); National Library of Medicine, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Lady Tata Memorial postdoctoral fellowship; NSF Graduate Fellowships; Department of Defense graduate fellowship(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank K. Kreuzer for the gift of the T4 phage and E. coli ER1656 and CR63; Charles Richardson, Udi Qimron, and Ben Beauchamp for advice and assistance in culturing T4 phage; Melissa Call for advice on production of recombinant proteins in insect cells; and Patrick Hogan for many helpful discussions. This work was supported by NIH grant AI44432, a Scholar Award from the Juvenile Diabetes Research Foundation, and a Seed grant from the Harvard Stem Cell Institute (to A.R.); Howard Hughes Medical Institute and NIH/NIGMS (R01GM065865) funding (to D.R.L.); an American Heart Association postdoctoral fellowship (to K.P.K.); intramural funds of the National Library of Medicine, NIH (to L.A. and L.M.I.); a Lady Tata Memorial postdoctoral fellowship (to H.B.); NIH award K08 HL089150 (to S.A.); NSF Graduate Fellowships (to W.A.P. and Y.B.); and a Department of Defense graduate fellowship (to W.A.P.).	ALEGRIA AH, 1967, BIOCHIM BIOPHYS ACTA, V149, P317, DOI 10.1016/0005-2787(67)90159-1; Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; ARAVIND L, 2001, GENOME BIOL, V2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; CEDAR H, 1979, NUCLEIC ACIDS RES, V6, P2125, DOI 10.1093/nar/6.6.2125; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; DELHOMMEAU F, 2008, AM SOC HEM ANN M EXP; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; FLAKS JG, 1959, J BIOL CHEM, V234, P1501; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Netto LES, 1996, ARCH BIOCHEM BIOPHYS, V333, P233, DOI 10.1006/abbi.1996.0386; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rusmintratip V, 2000, P NATL ACAD SCI USA, V97, P14183, DOI 10.1073/pnas.97.26.14183; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	33	3966	4175	12	606	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					930	935		10.1126/science.1170116	http://dx.doi.org/10.1126/science.1170116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372391	Green Accepted, Green Submitted			2022-12-28	WOS:000266048800037
J	Oldroyd, GED; Harrison, MJ; Paszkowski, U				Oldroyd, Giles E. D.; Harrison, Maria J.; Paszkowski, Uta			Reprogramming Plant Cells for Endosymbiosis	SCIENCE			English	Editorial Material							SYMBIOSIS SIGNALING PATHWAY; ARBUSCULAR MYCORRHIZA; MEDICAGO-TRUNCATULA; ROOT ENDOSYMBIOSES; GENE-EXPRESSION; COMMON; PROTEINS; RHIZOBIA; LEGUMES; SYSTEMS	The establishment of arbuscular mycorrhizal (AM) symbioses, formed by most flowering plants in association with glomeromycotan fungi, and the root-nodule (RN) symbiosis, formed by legume plants and rhizobial bacteria, requires an ongoing molecular dialogue that underpins the reprogramming of root cells for compatibility. In both endosymbioses, there are distinct phases to the interaction, including a presymbiotic anticipation phase and, subsequently, an intraradical accommodation of the microsymbiont. Maintenance of the endosymbiosis then depends on reciprocal nutrient exchange with the microsymbiont-obtaining plant photosynthates in exchange for mineral nutrients: enhanced phosphate and nitrogen uptake from AM fungi and fixed nitrogen from rhizobia. Despite the taxonomically distinct groups of symbionts, commonalities are observed in the signaling components and the modulation of host cell responses in both AM and RN symbioses, reflecting common mechanisms for plant cell reprogramming during endosymbiosis.	[Harrison, Maria J.] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Oldroyd, Giles E. D.] John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; [Paszkowski, Uta] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	Cornell University; Boyce Thompson Institute for Plant Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Lausanne	Harrison, MJ (corresponding author), Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	mjh78@cornell.edu	Oldroyd, Giles/ABD-8143-2021; Oldroyd, Giles/ABA-7501-2020	Oldroyd, Giles/0000-0002-5245-6355; Harrison, Maria J/0000-0001-8716-1875	Biotechnology and Biological Sciences Research Council [BB/E003850/1, BBS/E/J/00000603] Funding Source: Medline; BBSRC [BB/E003850/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; Banba M, 2008, PLANT CELL PHYSIOL, V49, P1659, DOI 10.1093/pcp/pcn153; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Besserer A, 2008, PLANT PHYSIOL, V148, P402, DOI 10.1104/pp.108.121400; Charpentier M, 2008, PLANT CELL, V20, P3467, DOI 10.1105/tpc.108.063255; *GEDO BIOT BIOL SC, BBE0038501 GEDO BIOT; Genre A, 2009, PLANT PHYSIOL, V149, P1424, DOI 10.1104/pp.108.132225; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Gutjahr C, 2008, PLANT CELL, V20, P2989, DOI 10.1105/tpc.108.062414; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Kambara K, 2009, MOL MICROBIOL, V71, P92, DOI 10.1111/j.1365-2958.2008.06507.x; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Krehenbrink M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-55; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; *MJH NSF, 0343975 MJH NSF; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; *UP SWISS NAT SCI, PP00A110874 UP SWISS; *USDA, 20083530119039 USDA; Yano K, 2008, P NATL ACAD SCI USA, V105, P20540, DOI 10.1073/pnas.0806858105	21	117	126	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					753	754		10.1126/science.1171644	http://dx.doi.org/10.1126/science.1171644			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423817				2022-12-28	WOS:000265832400036
J	Jungers, WL; Harcourt-Smith, WEH; Wunderlich, RE; Tocheri, MW; Larson, SG; Sutikna, T; Due, RA; Morwood, MJ				Jungers, W. L.; Harcourt-Smith, W. E. H.; Wunderlich, R. E.; Tocheri, M. W.; Larson, S. G.; Sutikna, T.; Due, Rhokus Awe; Morwood, M. J.			The foot of Homo floresiensis	NATURE			English	Article							PRESSURE DISTRIBUTION; LATE PLEISTOCENE; HADAR HOMINIDS; EVOLUTION; LOCOMOTION; BIPEDALISM; INDONESIA; DMANISI; FOSSILS; GAIT	Homo floresiensis is an endemic hominin species that occupied Liang Bua, a limestone cave on Flores in eastern Indonesia, during the Late Pleistocene epoch(1,2). The skeleton of the type specimen (LB1) of H. floresiensis includes a relatively complete left foot and parts of the right foot(3). These feet provide insights into the evolution of bipedalism and, together with the rest of the skeleton, have implications for hominin dispersal events into Asia. Here we show that LB1's foot is exceptionally long relative to the femur and tibia, proportions never before documented in hominins but seen in some African apes. Although the metatarsal robusticity sequence is human-like and the hallux is fully adducted, other intrinsic proportions and pedal features are more ape-like. The postcranial anatomy of H. floresiensis is that of a biped(1-3), but the unique lower-limb proportions and surprising combination of derived and primitive pedal morphologies suggest kinematic and biomechanical differences from modern human gait. Therefore, LB1 offers the most complete glimpse of a bipedal hominin foot that lacks the full suite of derived features characteristic of modern humans and whose mosaic design may be primitive for the genus Homo. These new findings raise the possibility that the ancestor of H. floresiensis was not Homo erectus but instead some other, more primitive, hominin whose dispersal into southeast Asia is still undocumented.	[Jungers, W. L.; Larson, S. G.] SUNY Stony Brook, Med Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA; [Harcourt-Smith, W. E. H.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Wunderlich, R. E.] James Madison Univ, Dept Biol Sci, Harrisonburg, VA 22807 USA; [Tocheri, M. W.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Humans Origins Program, Washington, DC 20013 USA; [Sutikna, T.; Due, Rhokus Awe] Natl Res & Dev Ctr Archaeol, Jakarta 12001, Indonesia; [Morwood, M. J.] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; American Museum of Natural History (AMNH); James Madison University; Smithsonian Institution; Smithsonian National Museum of Natural History; National Research & Development Centre for Archaeology - Indonesia; University of Wollongong	Jungers, WL (corresponding author), SUNY Stony Brook, Med Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA.	william.jungers@stonybrook.edu	Tocheri, Matthew/C-5288-2013; Larson, Susan/AAL-1935-2021; Tocheri, Matthew/H-8851-2019; Sutikna, Thomas/C-4709-2018	Tocheri, Matthew/0000-0001-7600-8998; Sutikna, Thomas/0000-0002-9742-4226	Australian Research Council; National Geographic Society; Wenner-Gren Foundation for Anthropological Research; Wellcome Trust and the Leakey Foundation	Australian Research Council(Australian Research Council); National Geographic Society(National Geographic Society); Wenner-Gren Foundation for Anthropological Research; Wellcome Trust and the Leakey Foundation(Wellcome Trust)	This work was supported by grants from the Australian Research Council, the National Geographic Society, the Wenner-Gren Foundation for Anthropological Research, the Wellcome Trust and the Leakey Foundation. We also thank our colleagues Jatmiko, E. Wahyu Saptomo and T. Djubiantono for their encouragement and assistance in the excavations.	ARCHIBALD JD, 1972, AM J PHYS ANTHROPOL, V37, P93, DOI 10.1002/ajpa.1330370112; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; BOJSENMOLLER F, 1979, J ANAT, V129, P165; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Falk D, 2007, P NATL ACAD SCI USA, V104, P2513, DOI 10.1073/pnas.0609185104; Gebol DL, 2006, AM J PHYS ANTHROPOL, V129, P499, DOI 10.1002/ajpa.20320; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; JUNGERS WL, 1983, J HUM EVOL, V12, P673, DOI 10.1016/S0047-2484(83)80007-4; Larson SG, 2007, J HUM EVOL, V53, P718, DOI 10.1016/j.jhevol.2007.06.003; LEWIS OJ, 1989, FUNCTIONAL MORPHOLOG, P328; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lyras GA, 2009, ANTHROPOL SCI, V117, P33, DOI 10.1537/ase.080411; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; RHOADS JG, 1977, AM J PHYS ANTHROPOL, V46, P29, DOI 10.1002/ajpa.1330460106; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; RODGERS MM, 1989, MED SCI SPORT EXER, V21, P23, DOI 10.1249/00005768-198902000-00005; Rolian C, 2009, J EXP BIOL, V212, P713, DOI 10.1242/jeb.019885; SUSMAN RL, 1988, AM J PHYS ANTHROPOL, V77, P7, DOI 10.1002/ajpa.1330770103; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Wallace IJ, 2008, AM J PHYS ANTHROPOL, V136, P375, DOI 10.1002/ajpa.20827; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; WINTER DA, 1992, PHYS THER, V72, P45, DOI 10.1093/ptj/72.1.45; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	30	122	125	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 7	2009	459	7243					81	84		10.1038/nature07989	http://dx.doi.org/10.1038/nature07989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441WN	19424155				2022-12-28	WOS:000265801300033
J	Naik, AD; Petersen, LA				Naik, Aanand D.; Petersen, Laura A.			The Neglected Purpose of Comparative-Effectiveness Research.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Naik, Aanand D.; Petersen, Laura A.] Michael E DeBakey Vet Affairs Med Ctr, Houston Hlth Serv Res & Dev Ctr Excellence, Houston, TX 77030 USA; [Petersen, Laura A.] Baylor Coll Med, John M Eisenberg Ctr Clin Decis & Commun Sci, Houston, TX 77030 USA; [Naik, Aanand D.; Petersen, Laura A.] Baylor Coll Med, Dept Med, Sect Hlth Serv Res, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; Baylor College of Medicine	Naik, AD (corresponding author), Michael E DeBakey Vet Affairs Med Ctr, Houston Hlth Serv Res & Dev Ctr Excellence, Houston, TX 77030 USA.		Naik, Aanand D./K-2400-2019	Naik, Aanand D./0000-0001-6936-7984	NIA NIH HHS [K23 AG027144-04, K23 AG027144] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG027144] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alegria M, 2009, HEALTH SERV RES, V44, P5, DOI 10.1111/j.1475-6773.2008.00936.x; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; Naik AD, 2007, J AM BOARD FAM MED, V20, P469, DOI 10.3122/jabfm.2007.05.070026; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26	5	58	59	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1929	1931		10.1056/NEJMp0902195	http://dx.doi.org/10.1056/NEJMp0902195			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441QN	19420362	Green Accepted			2022-12-28	WOS:000265784400003
J	Harnden, A; Takahashi, M; Burgner, D				Harnden, Anthony; Takahashi, Masato; Burgner, David			Kawasaki disease	BRITISH MEDICAL JOURNAL			English	Review							GLOBULIN; ETIOLOGY; CHILDREN; ENGLAND; JAPAN		[Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Takahashi, Masato] Univ So Calif, Keck Sch Med, Childrens Hosp, Los Angeles, CA 90027 USA; [Burgner, David] Univ Western Australia, Sch Paediat & Child Hlth, Child & Adolescent Hlth Serv, Perth, WA 6840, Australia	University of Oxford; Children's Hospital Los Angeles; University of Southern California; University of Western Australia	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk		Burgner, David/0000-0002-8304-4302				Baumer JH, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004175.pub2; Burgner D, 2005, INT J INFECT DIS, V9, P185, DOI 10.1016/j.ijid.2005.03.002; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Chang FY, 2006, PEDIATR INFECT DIS J, V25, P241, DOI 10.1097/01.inf.0000202067.50975.90; Chang RKR, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e87; Harnden A, 2002, BRIT MED J, V324, P1424, DOI 10.1136/bmj.324.7351.1424; Harnden A, 2009, PEDIATR INFECT DIS J, V28, P21, DOI 10.1097/INF.0b013e3181812ca4; Holman RC, 2005, PEDIATR INFECT DIS J, V24, P429, DOI 10.1097/01.inf.0000160946.05295.91; KATO H, 1986, J PEDIATR-US, V108, P923, DOI 10.1016/S0022-3476(86)80928-3; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kushner HI, 2008, PEDIATR INFECT DIS J, V27, P377, DOI 10.1097/INF.0b013e318166d795; Miura M, 2004, EUR J PEDIATR, V163, P25, DOI 10.1007/s00431-003-1335-3; Nakamura Y, 2008, J EPIDEMIOL, V18, P167, DOI 10.2188/jea.JE2008001; Nakamura Y, 2008, CIRC J, V72, P134, DOI 10.1253/circj.72.134; Newburger JW, 2007, NEW ENGL J MED, V356, P663, DOI 10.1056/NEJMoa061235; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; OATESWHITEHEAD RM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004000; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Rowley AH, 1999, PEDIATR INFECT DIS J, V18, P69, DOI 10.1097/00006454-199901000-00018; Rowley AH, 2002, PEDIATR INFECT DIS J, V21, P563, DOI 10.1097/00006454-200206000-00015; Selarnet Tierney ES, 2007, J PEDIATR-US, V151, P225, DOI 10.1016/j.jpeds.2007.05.011; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768	24	40	41	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2009	338								b1514	10.1136/bmj.b1514	http://dx.doi.org/10.1136/bmj.b1514			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GT	19416993				2022-12-28	WOS:000265969400020
J	Denevi, BW; Robinson, MS; Solomon, SC; Murchie, SL; Blewett, DT; Domingue, DL; McCoy, TJ; Ernst, CM; Head, JW; Watters, TR; Chabot, NL				Denevi, Brett W.; Robinson, Mark S.; Solomon, Sean C.; Murchie, Scott L.; Blewett, David T.; Domingue, Deborah L.; McCoy, Timothy J.; Ernst, Carolyn M.; Head, James W.; Watters, Thomas R.; Chabot, Nancy L.			The Evolution of Mercury's Crust: A Global Perspective from MESSENGER	SCIENCE			English	Article							CRATERING RECORD; VOLCANISM; FLYBY; MOON; REFLECTANCE; MARINER-10; REGOLITH; MAP	Mapping the distribution and extent of major terrain types on a planet's surface helps to constrain the origin and evolution of its crust. Together, MESSENGER and Mariner 10 observations of Mercury now provide a near-global look at the planet, revealing lateral and vertical heterogeneities in the color and thus composition of Mercury's crust. Smooth plains cover approximately 40% of the surface, and evidence for the volcanic origin of large expanses of plains suggests that a substantial portion of the crust originated volcanically. A low-reflectance, relatively blue component affects at least 15% of the surface and is concentrated in crater and basin ejecta. Its spectral characteristics and likely origin at depth are consistent with its apparent excavation from a lower crust or upper mantle enriched in iron-and titanium-bearing oxides.	[Denevi, Brett W.; Robinson, Mark S.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85251 USA; [Solomon, Sean C.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Murchie, Scott L.; Blewett, David T.; Domingue, Deborah L.; Ernst, Carolyn M.; Chabot, Nancy L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [McCoy, Timothy J.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Watters, Thomas R.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA	Arizona State University; Arizona State University-Tempe; Carnegie Institution for Science; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Smithsonian Institution; Smithsonian National Museum of Natural History; Brown University; Smithsonian Institution	Denevi, BW (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85251 USA.	bdenevi@ser.asu.edu	Chabot, Nancy L/F-5384-2015; Robinson, Mark/ABI-6841-2020; Denevi, Brett W./I-6502-2012; Ernst, Carolyn M/I-4902-2012; Blewett, David T/I-4904-2012; Murchie, Scott L/E-8030-2015	Chabot, Nancy L/0000-0001-8628-3176; Denevi, Brett W./0000-0001-7837-6663; Ernst, Carolyn M/0000-0002-9434-7886; Blewett, David T/0000-0002-9241-6358; Murchie, Scott L/0000-0002-1616-8751	Johns Hopkins University Applied Physics Laboratory [NAS5-97271]; Carnegie Institution of Washington [NASW-00002]	Johns Hopkins University Applied Physics Laboratory(Johns Hopkins University); Carnegie Institution of Washington	We gratefully acknowledge the MESSENGER engineers and technical support team. N. Laslo, H. Kang, R. Vaughan, A. Harch, R. Shelton, and A. Berman designed the imaging sequences used here. S. Turner, K. Becker, and C. Hash contributed to data calibration and processing. The MESSENGER project is supported by the NASA Discovery Program under contracts NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington.	Baldwin R.B., 1963, MEASURE MOON; Blewett DT, 2009, EARTH PLANET SC LETT, V285, P272, DOI 10.1016/j.epsl.2009.02.021; Blewett DT, 2002, METEORIT PLANET SCI, V37, P1245, DOI 10.1111/j.1945-5100.2002.tb00893.x; CAMERON AGW, 1985, ICARUS, V64, P285, DOI 10.1016/0019-1035(85)90091-0; Cintala MJ, 1998, METEORIT PLANET SCI, V33, P889, DOI 10.1111/j.1945-5100.1998.tb01695.x; DELANO JW, 1990, P LUNAR PLANET SCI C, V20, P3; Denevi BW, 2008, ICARUS, V197, P239, DOI 10.1016/j.icarus.2008.04.021; ERNST CM, 2009, LUNAR PLANET SCI, V40; FASSETT CI, 2009, LUNAR PLANET SCI, V40; GAULT DE, 1975, J GEOPHYS RES, V80, P2444, DOI 10.1029/JB080i017p02444; HAPKE B, 1993, TOPICS REMOTE SENSIN, V3; Harmon JK, 2007, ICARUS, V187, P374, DOI 10.1016/j.icarus.2006.09.026; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Head JW, 2008, SCIENCE, V321, P69, DOI 10.1126/science.1159256; Hillgren V.J., 2000, ORIGIN EARTH MOON PP, P245, DOI DOI 10.2307/J.CTV1V7ZDRP.20; LAWRENCE DJ, 2009, LUNAR PLANET SCI, V40; MALIN MC, 1976, GEOPHYS RES LETT, V3, P581, DOI 10.1029/GL003i010p00581; McClintock WE, 2008, SCIENCE, V321, P62, DOI 10.1126/science.1159933; McClintock WE, 2009, SCIENCE, V324, P610, DOI 10.1126/science.1172525; MITCHELL DL, 1994, ICARUS, V110, P2, DOI 10.1006/icar.1994.1105; Murchie SL, 2008, SCIENCE, V321, P73, DOI 10.1126/science.1159261; RAVA B, 1987, ICARUS, V71, P397, DOI 10.1016/0019-1035(87)90037-6; Riner MA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036128; Robinson MS, 2008, SCIENCE, V321, P66, DOI 10.1126/science.1160080; Robinson MS, 1997, SCIENCE, V275, P197, DOI 10.1126/science.275.5297.197; SOLOMON SC, 1978, GEOPHYS RES LETT, V5, P461, DOI 10.1029/GL005i006p00461; Solomon SC, 2008, SCIENCE, V321, P59, DOI 10.1126/science.1159706; Spudis P.D., 1988, MERCURY, P118; STROM RG, 1975, J GEOPHYS RES, V80, P4062; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317; TRASK NJ, 1975, J GEOPHYS RES, V80, P2461, DOI 10.1029/JB080i017p02461; USSELMAN TM, 1975, P LUN SCI C, V6, P997; VILAS F, 1988, MERCURY, P59; Warell J, 2004, ICARUS, V167, P271, DOI 10.1016/j.icarus.2003.10.010; WATTERS TR, 2009, EARTH PLANET SC LETT, DOI DOI 10.1016/J.EPSL.2009.01.015; WILHELMS DE, 1976, ICARUS, V28, P551, DOI 10.1016/0019-1035(76)90128-7	37	179	181	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					613	618		10.1126/science.1172226	http://dx.doi.org/10.1126/science.1172226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407196				2022-12-28	WOS:000265608800036
J	Zimetbaum, PJ				Zimetbaum, Peter J.			Dronedarone for Atrial Fibrillation - An Odyssey	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RHYTHM		[Zimetbaum, Peter J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zimetbaum, Peter J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Zimetbaum, PJ (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	5	49	58	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1811	1813		10.1056/NEJMp0902248	http://dx.doi.org/10.1056/NEJMp0902248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403901				2022-12-28	WOS:000265560300003
J	Guo, X				Guo, Xin			Comment on "Colossal Ionic Conductivity at Interfaces of Epitaxial ZrO2:Y2O3/SrTiO3 Heterostructures"	SCIENCE			English	Editorial Material							OXYGEN DIFFUSION; SRTIO3; AG	Garcia-Barriocanal et al. (Reports, 1 August 2008, p. 676) reported colossal conductivity enhancements in yttria-stabilized zirconia (YSZ)/strontium titanate (STO) epitaxial heterostructures and claimed that the conductivity was ionic. I argue that the claimed ionic conductivity lacks experimental support and that the observed conductivity enhancement is most probably due to the p-type conductivity of STO.	Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Guo, X (corresponding author), Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany.	x.guo@fz-juelich.de	Guo, Xin/B-8851-2011	Guo, Xin/0000-0003-1546-8119				Garcia-Barriocanal J, 2008, SCIENCE, V321, P676, DOI 10.1126/science.1156393; Guo X, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1864232; Guo X, 2000, SOLID STATE IONICS, V130, P267, DOI 10.1016/S0167-2738(00)00615-9; HEBB MH, 1952, J CHEM PHYS, V20, P185, DOI 10.1063/1.1700165; KONTOULIS I, 1991, SOLID STATE IONICS, V47, P317, DOI 10.1016/0167-2738(91)90254-9; MOGHADAM FK, 1986, J ELECTROCHEM SOC, V133, P1329, DOI 10.1149/1.2108864; Noll F, 1996, SOLID STATE IONICS, V86-8, P711, DOI 10.1016/0167-2738(96)00155-5; WASER R, 1991, J AM CERAM SOC, V74, P1934, DOI 10.1111/j.1151-2916.1991.tb07812.x; [No title captured]	9	99	99	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926								10.1126/science.1168940	http://dx.doi.org/10.1126/science.1168940			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390029				2022-12-28	WOS:000265411200025
J	Isalan, M; Morrison, M				Isalan, Mark; Morrison, Matthew			This title is false	NATURE			English	Editorial Material									[Isalan, Mark] Ctr Genom Regulat, EMBL Syst Biol Unit, Barcelona, Spain; [Morrison, Matthew] Univ Westminster, London W1R 8AL, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); University of Westminster	Isalan, M (corresponding author), Ctr Genom Regulat, EMBL Syst Biol Unit, Barcelona, Spain.	isalan@crg.es		Isalan, Mark/0000-0002-4652-0365					0	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					969	969		10.1038/458969a	http://dx.doi.org/10.1038/458969a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436KL	19396124	Bronze			2022-12-28	WOS:000265412900018
J	Harris, JC				Harris, James C.			Toward a Restorative Medicine-The Science of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT; MATTER; MIND		Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University	Harris, JC (corresponding author), Johns Hopkins Univ, Sch Med, CMSC 341,600 N Wolfe St, Baltimore, MD 21287 USA.	jamesharris@erols.com						Beauregard M, 2007, PROG NEUROBIOL, V81, P218, DOI 10.1016/j.pneurobio.2007.01.005; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; ENGEL GL, 1977, JOHNS HOPKINS MED J, V140, P222; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; MEYER A, 1915, JAMA-J AM MED ASSOC, V65, P861; Mookadam F, 2004, ARCH INTERN MED, V164, P1514, DOI 10.1001/archinte.164.14.1514; Oglesby P, 1991, CARING PHYS LIFE FW; Patel VL, 2002, J BIOMED INFORM, V35, P8, DOI 10.1016/S1532-0464(02)00002-3; Patel VL, 2000, J AM MED INFORM ASSN, V7, P569, DOI 10.1136/jamia.2000.0070569; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Peabody FW, 1928, J AMER MED ASSOC, V90, P1193, DOI 10.1001/jama.1928.92690420002009; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816	15	10	10	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1710	1712		10.1001/jama.2009.465	http://dx.doi.org/10.1001/jama.2009.465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435NN	19383963				2022-12-28	WOS:000265350700028
J	Patel, JC; Hueffer, K; Lam, TT; Galan, JE				Patel, Jayesh C.; Hueffer, Karsten; Lam, Tukiet T.; Galan, Jorge E.			Diversification of a Salmonella Virulence Protein Function by Ubiquitin-Dependent Differential Localization	CELL			English	Article							III SECRETION SYSTEMS; HOST-CELL; RECEPTOR ENDOCYTOSIS; NUCLEAR RESPONSES; GROWTH-FACTOR; RHO GTPASES; TYPHIMURIUM; DEGRADATION; INVASION; EFFECTORS	Many bacterial pathogens and symbionts utilize type III secretion systems to deliver bacterial effector proteins into host cells. These effector proteins have the capacity to modulate a large variety of cellular functions in a highly regulated manner. Here, we report that the phosphoinositide phosphatase SopB, a Salmonella Typhimurium type III secreted effector protein, diversifies its function by localizing to different cellular compartments in a ubiquitin-dependent manner. We show that SopB utilizes the same enzymatic activity to modulate actin-mediated bacterial internalization and Akt activation at the plasma membrane and vesicular trafficking and intracellular bacterial replication at the phagosome. Thus, by exploiting the host cellular machinery, Salmonella Typhimurium has evolved the capacity to broaden the functional repertoire of a virulence factor to maximize its ability to modulate cellular functions.	[Patel, Jayesh C.; Hueffer, Karsten; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Lam, Tukiet T.] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06511 USA	Yale University; Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu		Hueffer, Karsten/0000-0001-7154-9066	Damon Runyon Cancer Research Foundation; Public Health Research [AI055472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055472] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Public Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Walther Mothes for providing reagents, Christopher Case and Catarina Nogueira for caspase-1-deficient bone-marrow-derived macrophages, and members of the J.E.G. laboratory for critical review of this manuscript. K. H. was supported by a fellowship from the Damon Runyon Cancer Research Foundation. This work was supported by Public Health Research Grant AI055472 to J.E.G.	Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Drecktrah D, 2005, CELL MICROBIOL, V7, P105, DOI 10.1111/j.1462-5822.2004.00436.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2007, CELL, V130, P192, DOI 10.1016/j.cell.2007.06.042; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galyov E. E., 1997, MOL MICROBIOL, V25, P1903; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hong KH, 1998, J BACTERIOL, V180, P1793, DOI 10.1128/JB.180.7.1793-1802.1998; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Patel JC, 2008, METHOD ENZYMOL, V439, P145, DOI 10.1016/S0076-6879(07)00411-9; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Rogers LD, 2008, J PROTEOMICS, V71, P97, DOI 10.1016/j.jprot.2008.01.011; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	42	120	125	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					283	294		10.1016/j.cell.2009.01.056	http://dx.doi.org/10.1016/j.cell.2009.01.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379694	Bronze, Green Accepted			2022-12-28	WOS:000265456800021
J	Swigut, T; Wysocka, J				Swigut, Tomek; Wysocka, Joanna			Fallen Immortals	CELL			English	Editorial Material							DEMETHYLASES; METHYLATION	The memory of somatic cell gene expression is reset in the germline in a process that is accompanied by dramatic changes in chromatin modifications. In this issue, Katz et al. (2009) show that the histone demethylase Lsd1/Spr-5 may participate in this resetting process in the worm, thereby preventing a decline in germ cell epigenetic stability and viability over ensuing generations.	[Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu		Swigut, Tomek/0000-0002-7649-6781				Di Stefano L, 2007, CURR BIOL, V17, P808, DOI 10.1016/j.cub.2007.03.068; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026	7	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					203	205		10.1016/j.cell.2009.04.008	http://dx.doi.org/10.1016/j.cell.2009.04.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379684	Bronze			2022-12-28	WOS:000265456800010
J	Blow, N				Blow, Nathan			How to get ahead in imaging	NATURE			English	Editorial Material																			0	19	20	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					925	930		10.1038/458925a	http://dx.doi.org/10.1038/458925a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370034	Bronze			2022-12-28	WOS:000265182500050
J	Kato, M; Sanada, M; Kato, I; Sato, Y; Takita, J; Takeuchi, K; Niwa, A; Chen, YY; Nakazaki, K; Nomoto, J; Asakura, Y; Muto, S; Tamura, A; Iio, M; Akatsuka, Y; Hayashi, Y; Mori, H; Igarashi, T; Kurokawa, M; Chiba, S; Mori, S; Ishikawa, Y; Okamoto, K; Tobinai, K; Nakagama, H; Nakahata, T; Yoshino, T; Kobayashi, Y; Ogawa, S				Kato, Motohiro; Sanada, Masashi; Kato, Itaru; Sato, Yasuharu; Takita, Junko; Takeuchi, Kengo; Niwa, Akira; Chen, Yuyan; Nakazaki, Kumi; Nomoto, Junko; Asakura, Yoshitaka; Muto, Satsuki; Tamura, Azusa; Iio, Mitsuru; Akatsuka, Yoshiki; Hayashi, Yasuhide; Mori, Hiraku; Igarashi, Takashi; Kurokawa, Mineo; Chiba, Shigeru; Mori, Shigeo; Ishikawa, Yuichi; Okamoto, Koji; Tobinai, Kensei; Nakagama, Hitoshi; Nakahata, Tatsutoshi; Yoshino, Tadashi; Kobayashi, Yukio; Ogawa, Seishi			Frequent inactivation of A20 in B-cell lymphomas	NATURE			English	Article							NF-KAPPA-B; CLASSICAL HODGKIN LYMPHOMA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS FACTOR-ALPHA; ZINC-FINGER PROTEIN; EPSTEIN-BARR-VIRUS; ACTIVATION; TNFAIP3; GENE; INHIBITOR	A20 is a negative regulator of the NF-kappa B pathway and was initially identified as being rapidly induced after tumour-necrosis factor-alpha stimulation(1). It has a pivotal role in regulation of the immune response and prevents excessive activation of NF-kappa B in response to a variety of external stimuli(2-7); recent genetic studies have disclosed putative associations of polymorphic A20 (also called TNFAIP3) alleles with autoimmune disease risk(8,9). However, the involvement of A20 in the development of human cancers is unknown. Here we show, using a genome-wide analysis of genetic lesions in 238 B-cell lymphomas, that A20 is a common genetic target in B-lineage lymphomas. A20 is frequently inactivated by somatic mutations and/or deletions in mucosa-associated tissue lymphoma (18 out of 87; 21.8%) and Hodgkin's lymphoma of ;nodular sclerosis histology (5 out of 15; 33.3%), and, to a lesser extent, in other B-lineage lymphomas. When re-expressed in a lymphoma-derived cell line with no functional A20 alleles, wildtype A20, but not mutant A20, resulted in suppression of cell growth and induction of apoptosis, accompanied by down-regulation of NF-kappa B activation. The A20-deficient cells stably generated tumours in immunodeficient mice, whereas the tumorigenicity was effectively suppressed by re-expression of A20. In A20-deficient cells, suppression of both cell growth and NF-kappa B activity due to re-expression of A20 depended, at least partly, on cell-surface-receptor signalling, including the tumour-necrosis factor receptor. Considering the physiological function of A20 in the negative modulation of NF-kappa B activation induced by multiple upstream stimuli, our findings indicate that uncontrolled signalling of NF-kappa B caused by loss of A20 function is involved in the pathogenesis of subsets of B-lineage lymphomas.	[Kato, Motohiro; Sanada, Masashi; Takita, Junko; Chen, Yuyan; Nakazaki, Kumi; Muto, Satsuki; Tamura, Azusa; Iio, Mitsuru; Ogawa, Seishi] Univ Tokyo, Canc Genom Project, Bunkyo Ku, Tokyo 1138655, Japan; [Kato, Motohiro; Takita, Junko; Chen, Yuyan; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Takita, Junko; Chiba, Shigeru] Univ Tokyo, Dept Cell Therapy & Transplantat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Nakazaki, Kumi; Kurokawa, Mineo] Univ Tokyo, Dept Hematol & Oncol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Sanada, Masashi; Nakazaki, Kumi; Ogawa, Seishi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Kato, Itaru; Niwa, Akira; Nakahata, Tatsutoshi] Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, Kyoto 6068507, Japan; [Sato, Yasuharu; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Kita Ku, Okayama 7008558, Japan; [Takeuchi, Kengo; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Koto Ku, Tokyo 1358550, Japan; [Nomoto, Junko; Asakura, Yoshitaka; Tobinai, Kensei; Kobayashi, Yukio] Natl Canc Ctr, Div Hematol, Chuo Ku, Tokyo 1040045, Japan; [Okamoto, Koji; Nakagama, Hitoshi] Natl Canc Ctr, Early Oncogenesis Res Project, Res Inst, Chuo Ku, Tokyo 1040045, Japan; [Asakura, Yoshitaka] Aichi Canc Ctr, Res Inst, Div Immunol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Shibukawa 3778577, Japan; [Mori, Hiraku] Showa Univ, Fujigaoka Hosp, Div Hematol, Aoba Ku, Yokohama, Kanagawa 2278501, Japan; [Mori, Shigeo] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; Okayama University; Japanese Foundation for Cancer Research; National Cancer Center - Japan; National Cancer Center - Japan; Aichi Cancer Center; Gunma Children's Medical Centre; Showa University; Teikyo University	Ogawa, S (corresponding author), Univ Tokyo, Canc Genom Project, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ykkobaya@ncc.go.jp; sogawa-tky@umin.ac.jp	Ogawa, Seishi/AAE-7088-2019; Chen, Yuyan/V-7279-2019; Kobayahi, Yukio/E-9081-2017; Takeuchi, Kengo/C-3614-2008	Chen, Yuyan/0000-0002-2894-1430; Kobayahi, Yukio/0000-0003-2378-7865; Takeuchi, Kengo/0000-0002-1599-5800; akatsuka, yoshiki/0000-0003-3623-2826; Kato, Motohiro/0000-0001-5145-1774	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [21390316] Funding Source: KAKEN	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, by the 21 st century centre of excellence program 'Study on diseases caused by environment/genome interactions', and by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the Ministry of Health, Labor and Welfare of Japan for the 3rd- term Comprehensive 10-year Strategy for Cancer Control. We also thank Y. Ogino, E. Matsui and M. Matsumura for their technical assistance.	Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; DEACON EM, 1993, J EXP MED, V177, P339, DOI 10.1084/jem.177.2.339; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Durkop H, 2003, J PATHOL, V200, P229, DOI 10.1002/path.1351; Fries KL, 1999, VIROLOGY, V264, P159, DOI 10.1006/viro.1999.9980; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; HSU PL, 1989, AM J PATHOL, V135, P735; Jaffe ES, 2001, WHO CLASSIFICATION T; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Martin-Subero JI, 2002, BLOOD, V99, P1474, DOI 10.1182/blood.V99.4.1474; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6	29	419	435	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					712	U118		10.1038/nature07969	http://dx.doi.org/10.1038/nature07969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19412163				2022-12-28	WOS:000266608600046
J	Panstruga, R; Dodds, PN				Panstruga, Ralph; Dodds, Peter N.			Terrific Protein Traffic: The Mystery of Effector Protein Delivery by Filamentous Plant Pathogens	SCIENCE			English	Editorial Material							PHYTOPHTHORA-INFESTANS; CELL-DEATH; DISEASE RESISTANCE; MAGNAPORTHE-GRISEA; SECRETED PROTEINS; AVIRULENCE GENES; POWDERY MILDEW; RXLR EFFECTORS; RUST; FUNGI	Many biotrophic fungal and oomycete plant pathogens deliver effector proteins directly into host cells during infection. Recent advances are revealing the extensive effector repertoires of these pathogens and are beginning to shed light on how they manipulate host cells to establish a parasitic relationship. Surprisingly, oomycete effectors seem to share a common uptake system with those from the human malaria pathogen. The current explosion of information is opening new research avenues in molecular plant pathology and is providing new opportunities to limit the impact of plant disease on food production.	[Panstruga, Ralph] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Dodds, Peter N.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia	Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	panstrug@mpiz-koeln.mpg.de; peter.dodds@csiro.au	Panstruga, Ralph/F-3340-2011; Dodds, Peter/D-1181-2009	Panstruga, Ralph/0000-0002-3756-8957; Dodds, Peter/0000-0003-0620-5923	NIGMS NIH HHS [R01 GM074265-01A2, GM074265-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074265] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RL, 1957, SCIENCE, V306, P2004; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; DOU DL, 1930, PLANT CELL, V20, P2008; Ellis JG, 2007, CURR OPIN MICROBIOL, V10, P326, DOI 10.1016/j.mib.2007.05.015; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; KAMOUN S, SFB670 DFG M PLANCK; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mims CW, 2002, PROTOPLASMA, V219, P221, DOI 10.1007/s007090200023; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	31	129	137	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					748	750		10.1126/science.1171652	http://dx.doi.org/10.1126/science.1171652			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423815	Green Accepted			2022-12-28	WOS:000265832400034
J	Sadowski, LS; Kee, RA; VanderWeele, TJ; Buchanan, D				Sadowski, Laura S.; Kee, Romina A.; VanderWeele, Tyler J.; Buchanan, David			Effect of a Housing and Case Management Program on Emergency Department Visits and Hospitalizations Among Chronically Ill Homeless Adults A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-STATUS; RISK-FACTORS; CARE; HIV	Context Homeless adults, especially those with chronic medical illnesses, are frequent users of costly medical services, especially emergency department and hospital services. Objective To assess the effectiveness of a case management and housing program in reducing use of urgent medical services among homeless adults with chronic medical illnesses. Design, Setting, and Participants Randomized controlled trial conducted at a public teaching hospital and a private, nonprofit hospital in Chicago, Illinois. Participants were 407 social worker-referred homeless adults with chronic medical illnesses (89% of referrals) from September 2003 until May 2006, with follow-up through December 2007. Analysis was by intention-to-treat. Intervention Housing offered as transitional housing after hospitalization discharge, followed by placement in long-term housing; case management offered on-site at primary study sites, transitional housing, and stable housing sites. Usual care participants received standard discharge planning from hospital social workers. Main Outcome Measures Hospitalizations, hospital days, and emergency department visits measured using electronic surveillance, medical records, and interviews. Models were adjusted for baseline differences in demographics, insurance status, prior hospitalization or emergency department visit, human immunodeficiency virus infection, current use of alcohol or other drugs, mental health symptoms, and other factors. Results The analytic sample (n=405 [n=201 for the intervention group, n=204 for the usual care group]) was 78% men and 78% African American, with a median duration of homelessness of 30 months. After 18 months, 73% of participants had at least 1 hospitalization or emergency department visit. Compared with the usual care group, the intervention group had unadjusted annualized mean reductions of 0.5 hospitalizations (95% confidence interval [CI], -1.2 to 0.2), 2.7 fewer hospital days (95% CI, -5.6 to 0.2), and 1.2 fewer emergency department visits (95% CI, -2.4 to 0.03). Adjusting for baseline covariates, compared with the usual care group, the intervention group had a relative reduction of 29% in hospitalizations (95% CI, 10% to 44%), 29% in hospital days (95% CI, 8% to 45%), and 24% in emergency department visits (95% CI, 3% to 40%). Conclusion After adjustment, offering housing and case management to a population of homeless adults with chronic medical illnesses resulted in fewer hospital days and emergency department visits, compared with usual care. Trial Registration clinicaltrials.gov Identifier: NCT00490581	[Sadowski, Laura S.; Kee, Romina A.] John H Stroger Jr Hosp Cook Cty, Dept Med, Collaborat Res Unit, Chicago, IL 60612 USA; [Kee, Romina A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [VanderWeele, Tyler J.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Buchanan, David] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Buchanan, David] Erie Family Hlth Ctr, Chicago, IL USA	John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; University of Chicago; Northwestern University; Feinberg School of Medicine	Sadowski, LS (corresponding author), John H Stroger Jr Hosp Cook Cty, Dept Med, Collaborat Res Unit, 1900 W Polk St,Room 1606, Chicago, IL 60612 USA.	sadowski@cchil.org			Department of Housing [IL01B210064-IL18096]; Urban Development Supportive Housing [IL01B20031-IL18064]; AIDS Special Projects of National Significance [IL-H02-0015]; Michael Reese Health Trust; AIDS foundation of Chicago; Polk Bros Foundation; Chicago Community Trust	Department of Housing; Urban Development Supportive Housing; AIDS Special Projects of National Significance; Michael Reese Health Trust; AIDS foundation of Chicago; Polk Bros Foundation; Chicago Community Trust	The intervention housing rental subsidies and case management were funded by Department of Housing and Urban Development Supportive Housing Program grants IL01B210064-IL18096 and IL01B20031-IL18064, Housing Opportunities for People with AIDS Special Projects of National Significance grant IL-H02-0015, the Michael Reese Health Trust, the AIDS foundation of Chicago, and the Polk Bros Foundation. The trial was funded by the Michael Reese Health Trust, the Chicago Community Trust, and the AIDS Foundation of Chicago.	ACTG Outcomes Committee, ACTG QOL 601 602 QOL; Buchanan D, 2006, AM J PUBLIC HEALTH, V96, P1278, DOI 10.2105/AJPH.2005.067850; Culhane DP, 2002, HOUS POLICY DEBATE, V13, P107, DOI 10.1080/10511482.2002.9521437; Fleischman S, 1992, DELIVERING HLTH CARE, P79; Hwang SW, 2005, AM J PREV MED, V29, P311, DOI 10.1016/j.amepre.2005.06.017; Hwang SW, 1998, ARCH INTERN MED, V158, P1454, DOI 10.1001/archinte.158.13.1454; Kalichman S, 2004, AIDS CARE, V16, pS6, DOI 10.1080/09540120412331315312; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; MARTELL JV, 1992, ANN INTERN MED, V116, P299, DOI 10.7326/0003-4819-116-4-299; *NAT COAL HOM, 2 NAT COAL HOM; O'Connell J., 1999, UTILIZATION COSTS ME; ROBERTSON MJ, 1986, AM J PUBLIC HEALTH, V76, P561, DOI 10.2105/AJPH.76.5.561; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Salit SA, 1998, NEW ENGL J MED, V338, P1734, DOI 10.1056/NEJM199806113382406; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wu AW, 2005, HIV CLIN TRIALS, V6, P147, DOI 10.1310/BPNB-XELF-AXFQ-QQTL; ZANIS DA, 1994, J SUBST ABUSE TREAT, V11, P541, DOI 10.1016/0740-5472(94)90005-1; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	23	326	327	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1771	1778		10.1001/jama.2009.561	http://dx.doi.org/10.1001/jama.2009.561			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441AU	19417194				2022-12-28	WOS:000265742500026
J	Gillespie, D; Maguire, ES; Neuse, M; Sinding, SW; Speidel, JJ				Gillespie, Duff; Maguire, Elizabeth S.; Neuse, Margaret; Sinding, Steven W.; Speidel, J. Joseph			International family-planning budgets in the "new US" era	LANCET			English	Editorial Material									[Gillespie, Duff] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21231 USA; [Maguire, Elizabeth S.] Ipas, Chapel Hill, NC USA; [Sinding, Steven W.] Alan Guttmacher Inst, Manchester, VT USA; [Speidel, J. Joseph] Univ Calif San Francisco, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco	Gillespie, D (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21231 USA.	dgillesp@jhsph.edu						Speidel JJ, 2009, MAKING CASE US INT F; *USAID SECR STAT A, 2009, MEM SECR STAT ADM US	2	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1505	1507		10.1016/S0140-6736(09)60837-0	http://dx.doi.org/10.1016/S0140-6736(09)60837-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440OT	19410699				2022-12-28	WOS:000265710300008
J	Li, CYT; Poo, MM; Dan, Y				Li, Cheng-yu T.; Poo, Mu-ming; Dan, Yang			Burst Spiking of a Single Cortical Neuron Modifies Global Brain State	SCIENCE			English	Article							NEOCORTICAL NEURONS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; SLEEP STATES; OSCILLATIONS; MECHANISMS; RHYTHMS; TRANSITIONS; CIRCUITS; WAKING	Different global patterns of brain activity are associated with distinct arousal and behavioral states of an animal, but how the brain rapidly switches between different states remains unclear. We here report that repetitive high-frequency burst spiking of a single rat cortical neuron could trigger a switch between the cortical states resembling slow-wave and rapid-eye-movement sleep. This is reflected in the switching of the membrane potential of the stimulated neuron from slow UP/DOWN oscillations to a persistent-UP state or vice versa, with concurrent changes in the temporal pattern of cortical local field potential (LFP) recorded several millimeters away. These results point to the power of single cortical neurons in modulating the behavioral state of an animal.	[Li, Cheng-yu T.; Poo, Mu-ming; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA; [Li, Cheng-yu T.; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Li, Chengyu/0000-0001-6829-0209; Dan, Yang/0000-0002-3818-877X	NIH; NSF [SBE-0542013]; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from NIH and NSF (SBE-0542013 to Temporal Dynamics of Learning Center, TDLC). We thank W. Sun for technical help.	Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Jones BE, 2004, PROG BRAIN RES, V145, P157, DOI 10.1016/S0079-6123(03)45011-5; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sinton CM, 2004, SEMIN NEUROL, V24, P211, DOI 10.1055/s-2004-835067; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Steriade M., 1990, BRAINSTEM CONTROL WA; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	26	157	158	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					643	646		10.1126/science.1169957	http://dx.doi.org/10.1126/science.1169957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407203	Green Accepted			2022-12-28	WOS:000265608800044
J	Bastolla, U; Fortuna, MA; Pascual-Garcia, A; Ferrera, A; Luque, B; Bascompte, J				Bastolla, Ugo; Fortuna, Miguel A.; Pascual-Garcia, Alberto; Ferrera, Antonio; Luque, Bartolo; Bascompte, Jordi			The architecture of mutualistic networks minimizes competition and increases biodiversity	NATURE			English	Article							COEVOLUTIONARY NETWORKS; POLLINATION NETWORKS; MODEL-ECOSYSTEMS; MAINTENANCE; DIVERSITY; STABILITY; COMPLEX	The main theories of biodiversity either neglect species interactions(1,2) or assume that species interact randomly with each other(3,4). However, recent empirical work has revealed that ecological networks are highly structured(5-7), and the lack of a theory that takes into account the structure of interactions precludes further assessment of the implications of such network patterns for biodiversity. Here we use a combination of analytical and empirical approaches to quantify the influence of network architecture on the number of coexisting species. As a case study we consider mutualistic networks between plants and their animal pollinators or seed dispersers(5,8-11). These networks have been found to be highly nested(5), with the more specialist species interacting only with proper subsets of the species that interact with the more generalist. We show that nestedness reduces effective interspecific competition and enhances the number of coexisting species. Furthermore, we show that a nested network will naturally emerge if new species are more likely to enter the community where they have minimal competitive load. Nested networks seem to occur in many biological and social contexts(12-14), suggesting that our results are relevant in a wide range of fields.	[Fortuna, Miguel A.; Bascompte, Jordi] CSIC, Estac Biol Donana, Integrat Ecol Grp, Seville 41092, Spain; [Bastolla, Ugo; Pascual-Garcia, Alberto] Univ Autonoma Madrid, CSIC, Ctr Mol Biol, E-28049 Madrid, Spain; [Ferrera, Antonio; Luque, Bartolo] Univ Politecn Madrid, Dept Matemat Aplicada & Estadist, ETSI Aeronaut, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Politecnica de Madrid	Bascompte, J (corresponding author), CSIC, Estac Biol Donana, Integrat Ecol Grp, C Amer Vespucio S-N, Seville 41092, Spain.	bascompte@ebd.csic.es	Bastolla, Ugo/H-6330-2015; Bascompte, Jordi/B-7596-2008; Fortuna, Miguel A/D-4154-2013; Luque, Bartolo/B-3646-2018	Bastolla, Ugo/0000-0001-9342-4678; Bascompte, Jordi/0000-0002-0108-6411; Fortuna, Miguel A/0000-0002-8374-1941; Luque, Bartolo/0000-0002-0396-4396; Pascual Garcia, Alberto/0000-0002-8444-3196	Spanish Ministry of Science and Technology; European Heads of Research Councils; European Science Foundation; EC; Ramon Areces Foundation	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Heads of Research Councils; European Science Foundation(European Science Foundation (ESF)European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Ramon Areces Foundation	We thank P. Jordano and J. Olesen for providing data and insight, A. Ramirez Ortiz for discussions and P. Buston and D. Stouffer for comments on a previous draft. J. Olesen provided the drawings in Fig. 1. Funding was provided by the Spanish Ministry of Science and Technology (through a Ramon y Cajal Contract and a Consolider Ingenio Project to U. B., a PhD Fellowship to M. A. F. and a grant to B. L.) and by the European Heads of Research Councils, the European Science Foundation, and the EC Sixth Framework Programme through a European Young Investigator Award (J. B.). Research at the Centro de Biologia Molecular Severo Ochoa is facilitated by an institutional grant from the Ramon Areces Foundation.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2005, J THEOR BIOL, V235, P531, DOI 10.1016/j.jtbi.2005.02.006; Bastolla U, 2005, J THEOR BIOL, V235, P521, DOI 10.1016/j.jtbi.2005.02.005; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; Holland JN, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129547; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; May R.M., 1974, STABILITY COMPLEXITY; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pachepsky E, 2002, ARTIF LIFE, V8, P5, DOI 10.1162/106454602753694747; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rikvold PA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031913; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Sugihara G., 1984, P S APPL MATH, V30, P83, DOI DOI 10.1090/PSAPM/030/738641; SUGIHARA G, 1982, THESIS PRINCETON U; Tokita K, 2003, THEOR POPUL BIOL, V63, P131, DOI 10.1016/S0040-5809(02)00038-2; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003	30	657	671	17	375	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1018	U91		10.1038/nature07950	http://dx.doi.org/10.1038/nature07950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396144				2022-12-28	WOS:000265412900040
J	Cutler, DM; Gelber, AM				Cutler, David M.; Gelber, Alexander M.			Changes in the Incidence and Duration of Periods without Insurance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-INSURANCE; DECLINE; BENEFITS; COVERAGE	Background Policymakers have recently proposed ways of providing health care coverage for an increased number of uninsured persons. However, there are few data that show how the incidence and duration of periods in which persons do not have insurance have changed over time. Methods We used two data sets from the Survey of Income and Program Participation of the U. S. Census Bureau: one that covered the period from 1983 through 1986 ( 25,946 persons), and another that covered the period from 2001 through 2004 ( 40,282 persons). For each set of years, we estimated the probability that a person would be uninsured for some period of time and the probability that a person would subsequently obtain private or public insurance. We also estimated the probabilities that persons in various demographic groups would become uninsured over the course of a year and would remain uninsured for various amounts of time. Results The percentage of the population that lost insurance in a 12-month period increased from 19.8% in 1983-1986 to 21.8% in 2001-2004 (P = 0.04). The percentage that was uninsured for a period of time increased markedly among persons with the lowest educational level and predominantly represented loss of private coverage. The percentage of new uninsured periods that ended within 24 months increased from 73.8% to 79.7% between the two study periods (P<0.001); increases were seen in all age groups and among persons of all educational levels. Transition from no insurance to private insurance decreased from 65.2% to 59.2% (P<0.001). Transition from no insurance to public insurance increased from 8.7% to 20.4% (P<0.001). Conclusions As compared with the years from 1983 through 1986, from 2001 through 2004, more people, particularly those with the lowest educational level, had periods in which they were not insured. The periods without insurance were shorter in 2001-2004 than they were in 1983-1986, since an increase in transitions to public coverage offset a reduction in transitions to private coverage. Our results portend difficulties if private coverage continues to decline and is not offset by further expansions of public insurance.	[Cutler, David M.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; National Bureau of Economic Research	Cutler, DM (corresponding author), Harvard Univ, Dept Econ, 1875 Cambridge St, Cambridge, MA 02138 USA.	dcutler@harvard.edu		Cutler, David/0000-0002-4949-8917	National Institute on Aging [PO1AG005842, T32AG000186]; NATIONAL INSTITUTE ON AGING [T32AG000186, P01AG005842] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging (PO1AG005842, to Dr. Cutler, and T32AG000186, to Dr. Gelber).	Autor DH, 2006, AM ECON REV, V96, P189, DOI 10.1257/000282806777212620; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Baker DW, 2002, MED CARE, V40, P1126, DOI 10.1097/00005650-200211000-00013; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; BHANDARI S, 2004, PEOPLE HLTH INSURANC; Bodenheimer T, 2004, ANN INTERN MED, V141, P556, DOI 10.7326/0003-4819-141-7-200410050-00013; *BUR CENS, 1995, HLTH INS COV 1991 19; *BUR CENS, 1996, HLTH INS COV 1992 19; *BUR CENS, 1998, HLTH INS COV 1993 19; *BUR CENS, 1990, HLTH INS COV 1986 19; *BUR CENS, 1994, HLTH INS COV 1990 19; Bureau of the Census US Department of Commerce, SURV INC PROGR PART; Card D., 1999, HDB LABOR EC A, P1761, DOI [DOI 10.1016/S1573-4463(99)03010-2, 10.1016/S1573-4463(99)03010-2]; Chernew M, 2005, HEALTH SERV RES, V40, P1021, DOI 10.1111/j.1475-6773.2005.00409.x; Cutler DM, 1996, Q J ECON, V111, P391, DOI 10.2307/2946683; DeNavas-Walt C, 2008, INCOME POVERTY HLTH; DENAVASWALT C, 2005, INCOME POVERTY HLTH; Farber HS, 2000, J HEALTH ECON, V19, P93, DOI 10.1016/S0167-6296(99)00027-2; *GEN ACC OFF, 1997, PRIV HLTH INS CONT E; GRUBER J, 1994, AM ECON REV, V84, P622; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Haider S, 2006, AM ECON REV, V96, P1308, DOI 10.1257/aer.96.4.1308; Institute of Medicine (US), 2002, CAR COV TOO LITTL TO; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; *STAT CORP, 1996, STAT; SUMMERS LH, 1989, AM ECON REV, V79, P177; SWARTZ K, 1994, JAMA J AM MED ASS, V0271; ZUCKERMAN S, 2004, VARIATION TRENDS DUR	29	27	27	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1740	1748		10.1056/NEJMsa0804668	http://dx.doi.org/10.1056/NEJMsa0804668			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435XY	19387016	Green Published, Green Submitted			2022-12-28	WOS:000265377800008
J	Hara, K; Shiga, A; Fukutake, T; Nozaki, H; Miyashita, A; Yokoseki, A; Kawata, H; Koyama, A; Arima, K; Takahashi, T; Ikeda, M; Shiota, H; Tamura, M; Shimoe, Y; Hirayama, M; Arisato, T; Yanagawa, S; Tanaka, A; Nakano, I; Ikeda, S; Yoshida, Y; Yamamoto, T; Ikeuchi, T; Kuwano, R; Nishizawa, M; Tsuji, S; Onodera, O				Hara, Kenju; Shiga, Atsushi; Fukutake, Toshio; Nozaki, Hiroaki; Miyashita, Akinori; Yokoseki, Akio; Kawata, Hirotoshi; Koyama, Akihide; Arima, Kunimasa; Takahashi, Toshiaki; Ikeda, Mari; Shiota, Hiroshi; Tamura, Masato; Shimoe, Yutaka; Hirayama, Mikio; Arisato, Takayo; Yanagawa, Sohei; Tanaka, Akira; Nakano, Imaharu; Ikeda, Shu-ichi; Yoshida, Yutaka; Yamamoto, Tadashi; Ikeuchi, Takeshi; Kuwano, Ryozo; Nishizawa, Masatoyo; Tsuji, Shoji; Onodera, Osamu			Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; AUTOSOMAL RECESSIVE ARTERIOPATHY; BONE MORPHOGENETIC PROTEINS; SERINE-PROTEASE HTRA1; GROWTH-FACTOR; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; SUBCORTICAL INFARCTS; BETA; EXPRESSION	BACKGROUND The genetic cause of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), which is characterized by ischemic, non-hypertensive, cerebral small-vessel disease with associated alopecia and spondylosis, is unclear. METHODS In five families with CARASIL, we carried out linkage analysis, fine mapping of the region implicated in the disease, and sequence analysis of a candidate gene. We also conducted functional analysis of wild-type and mutant gene products and measured the signaling by members of the transforming growth factor beta (TGF-beta) family and gene and protein expression in the small arteries in the cerebrum of two patients with CARASIL. RESULTS We found linkage of the disease to the 2.4-Mb region on chromosome 10q, which contains the HtrA serine protease 1 (HTRA1) gene. HTRA1 is a serine protease that represses signaling by TGF-beta family members. Sequence analysis revealed two nonsense mutations and two missense mutations in HTRA1. The missense mutations and one of the nonsense mutations resulted in protein products that had comparatively low levels of protease activity and did not repress signaling by the TGF-beta family. The other nonsense mutation resulted in the loss of HTRA1 protein by nonsense-mediated decay of messenger RNA. Immunohistochemical analysis of the cerebral small arteries in affected persons showed increased expression of the extra domain-A region of fibronectin and versican in the thickened tunica intima and of TGF-beta 1 in the tunica media. CONCLUSIONS CARASIL is associated with mutations in the HTRA1 gene. Our findings indicate a link between repressed inhibition of signaling by the TGF-beta family and ischemic cerebral small-vessel disease, alopecia, and spondylosis.	[Hara, Kenju; Shiga, Atsushi; Nozaki, Hiroaki; Miyashita, Akinori; Yokoseki, Akio; Koyama, Akihide; Takahashi, Toshiaki; Ikeda, Mari; Yoshida, Yutaka; Yamamoto, Tadashi; Ikeuchi, Takeshi; Kuwano, Ryozo; Nishizawa, Masatoyo; Onodera, Osamu] Niigata Univ, Niigata, Japan; [Fukutake, Toshio] Kameda Med Ctr, Kamogawa City, Chiba, Japan; [Kawata, Hirotoshi; Tanaka, Akira; Nakano, Imaharu] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Arima, Kunimasa] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Shiota, Hiroshi] Nihon Univ, Sch Med, Tokyo, Japan; [Tamura, Masato] Nagaoka Nishi Hosp, Nagaoka, Niigata, Japan; [Shimoe, Yutaka] Kashima Rosai Hosp, Kashima, Japan; [Hirayama, Mikio] Kasugai Municipal Hosp, Kasugai, Aichi, Japan; [Arisato, Takayo] Minamikyushu Natl Hosp, Kagoshima, Japan; [Yanagawa, Sohei] Iida Municipal Hosp, Iida, Japan; [Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan; [Tsuji, Shoji] Univ Tokyo, Tokyo, Japan	Niigata University; Jichi Medical University; National Center for Neurology & Psychiatry - Japan; Nihon University; Shinshu University; University of Tokyo	Onodera, O (corresponding author), Brain Res Inst, Niigata 9518585, Japan.	onodera@bri.niigata-u.ac.jp	Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Dichgans, Martin/0000-0002-0654-387X	Advanced Brain Science Project and Applied Genomics; Center for Integrated Brain Medical Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science, and Niigata University	Advanced Brain Science Project and Applied Genomics; Center for Integrated Brain Medical Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, and Niigata University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported in part by grants from the Advanced Brain Science Project and Applied Genomics, the Center for Integrated Brain Medical Science, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for the Promotion of Science, and Niigata University.	Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chui HC, 2007, NEUROL CLIN, V25, P717, DOI 10.1016/j.ncl.2007.04.003; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; FUKUTAKE T, 1995, EUR NEUROL, V35, P69, DOI 10.1159/000117096; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gilicze A, 2007, MOL IMMUNOL, V44, P2961, DOI 10.1016/j.molimm.2007.01.004; GLUKHOVA MA, 1989, J CELL BIOL, V109, P357, DOI 10.1083/jcb.109.1.357; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hillger F, 2005, J BIOL CHEM, V280, P14974, DOI 10.1074/jbc.M414413200; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; MAEDA S, 1976, Folia Psychiatrica et Neurologica Japonica, V30, P165; O'Callaghan CJ, 2000, HYPERTENSION, V36, P319, DOI 10.1161/01.HYP.36.3.319; Oide T, 2008, NEUROPATHOLOGY, V28, P132, DOI 10.1111/j.1440-1789.2007.00864.x; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okeda R, 2004, NEUROPATHOLOGY, V24, P21, DOI 10.1111/j.1440-1789.2003.00534.x; Revesz T, 2003, J NEUROPATH EXP NEUR, V62, P885, DOI 10.1093/jnen/62.9.885; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Tanoi Y, 2000, ACTA NEUROPATHOL, V100, P347, DOI 10.1007/s004010000203; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Yanagawa S, 2002, NEUROLOGY, V58, P817, DOI 10.1212/WNL.58.5.817; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	39	307	331	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1729	1739		10.1056/NEJMoa0801560	http://dx.doi.org/10.1056/NEJMoa0801560			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19387015	Bronze			2022-12-28	WOS:000265377800007
J	Cornelis, MC; Qi, L; Zhang, CL; Kraft, P; Manson, J; Cai, TX; Hunter, DJ; Hu, FB				Cornelis, Marilyn C.; Qi, Lu; Zhang, Cuilin; Kraft, Peter; Manson, JoAnn; Cai, Tianxi; Hunter, David J.; Hu, Frank B.			Joint Effects of Common Genetic Variants on the Risk for Type 2 Diabetes in U. S. Men and Women of European Ancestry	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; NURSES HEALTH; LIFE-STYLE; FAT MASS; MELLITUS; LOCI; REPRODUCIBILITY; DISCRIMINATION; REPLICATION	Background: Genome-wide association studies have identified novel type 2 diabetes loci, each of which has a modest impact on risk. Objective: To examine the joint effects of several type 2 diabetes risk variants and their combination with conventional risk factors on type 2 diabetes risk in 2 prospective cohorts. Design: Nested case-control study. Setting: United States. Participants: 2809 patients with type 2 diabetes and 3501 healthy control participants of European ancestry from the Health Professionals Follow-up Study and Nurses' Health Study. Measurements: A genetic risk score (GRS) was calculated on the basis of 10 polymorphisms in 9 loci. Results: After adjustment for age and body mass index (BMI), the odds ratio for type 2 diabetes with each point of GRS, corresponding to 1 risk allele, was 1.19 ( 95% CI, 1.14 to 1.24) and 1.16 (CI, 1.12 to 1.20) for men and women, respectively. Persons with a BMI of 30 kg/m(2) or greater and a GRS in the highest quintile had an odds ratio of 14.06 (CI, 8.90 to 22.18) compared with persons with a BMI less than 25 kg/m(2) and a GRS in the lowest quintile after adjustment for age and sex. Persons with a positive family history of diabetes and a GRS in the highest quintile had an odds ratio of 9.20 (CI, 5.50 to 15.40) compared with persons without a family history of diabetes and with a GRS in the lowest quintile. The addition of the GRS to a model of conventional risk factors improved discrimination by 1% ( P < 0.001). Limitation: The study focused only on persons of European ancestry; whether GRS is associated with type 2 diabetes in other ethnic groups remains unknown. Conclusion: Although its discriminatory value is currently limited, a GRS that combines information from multiple genetic variants might be useful for identifying subgroups with a particularly high risk for type 2 diabetes.	[Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Rockville, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Channing Lab, Bldg 2,665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013	Zhang, Cuilin/0000-0002-8014-2708	National Institutes of Health [DK58845, CA87969]; Canadian Institutes of Health Research Fellowship; American Heart Association Scientist Development; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association Scientist Development(American Heart Association); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institutes of Health (grants DK58845 and CA87969). Dr. Cornelis is a recipient of a Canadian Institutes of Health Research Fellowship. Dr. Qi is a recipient of the American Heart Association Scientist Development Award. Dr. Zhang is supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Ludovico O, 2007, OBESITY, V15, P1076, DOI 10.1038/oby.2007.617; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Petersen M, 2003, DIABETES CARE, V26, P917; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qi L, 2006, HUM MOL GENET, V15, P1914, DOI 10.1093/hmg/ddl113; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI [DOI 10.1093/OXFORDJOURNALS.AJE.A116211, DOI 10.1093/OXFORDJOUMALS.AJE.A116211]; RISCH N, 1990, AM J HUM GENET, V46, P222; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; van Dam RM, 2005, DIABETIC MED, V22, P590, DOI 10.1111/j.1464-5491.2005.01465.x; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W., 2012, NUTR EPIDEMIOLOGY; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	45	179	189	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					541	W98		10.7326/0003-4819-150-8-200904210-00008	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380854	Green Accepted			2022-12-28	WOS:000265457000004
J	Cohen, GL; Garcia, J; Purdie-Vaughns, V; Apfel, N; Brzustoski, P				Cohen, Geoffrey L.; Garcia, Julio; Purdie-Vaughns, Valerie; Apfel, Nancy; Brzustoski, Patricia			Recursive Processes in Self-Affirmation: Intervening to Close the Minority Achievement Gap	SCIENCE			English	Article							PERFORMANCE	A 2-year follow-up of a randomized field experiment previously reported in Science is presented. A subtle intervention to lessen minority students' psychological threat related to being negatively stereotyped in school was tested in an experiment conducted three times with three independent cohorts (N = 133, 149, and 134). The intervention, a series of brief but structured writing assignments focusing students on a self-affirming value, reduced the racial achievement gap. Over 2 years, the grade point average (GPA) of African Americans was, on average, raised by 0.24 grade points. Low-achieving African Americans were particularly benefited. Their GPA improved, on average, 0.41 points, and their rate of remediation or grade repetition was less (5% versus 18%). Additionally, treated students' self-perceptions showed long-term benefits. Findings suggest that because initial psychological states and performance determine later outcomes by providing a baseline and initial trajectory for a recursive process, apparently small but early alterations in trajectory can have long-term effects. Implications for psychological theory and educational practice are discussed.	[Cohen, Geoffrey L.; Garcia, Julio] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Purdie-Vaughns, Valerie] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Apfel, Nancy; Brzustoski, Patricia] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	University of Colorado System; University of Colorado Boulder; Columbia University; Yale University	Cohen, GL (corresponding author), Univ Colorado, Dept Psychol, Muenzinger Psychol Bldg, Boulder, CO 80309 USA.	cohen.geoff@gmail.com			William T. Grant Foundation; Russell Sage Foundation; Nellie Mae Education Foundation; Institute for Social and Policy Studies of Yale University	William T. Grant Foundation; Russell Sage Foundation; Nellie Mae Education Foundation; Institute for Social and Policy Studies of Yale University	We thank the student participants and their parents, the teachers, staff, and administrators of the school district for their involvement in the project. We also thank E. Zigler, D. Green, C. Steele, E. Pronin, D. Sherman, G. Walton, J. Correll, C. Judd, J. Cook, E. Paluck, S. Taborsky-Barba, S. Tomassetti, and S. Wert for their help and feedback. This research was supported primarily by grants from the William T. Grant Foundation and the Russell Sage Foundation. Additional support was provided by the Nellie Mae Education Foundation and the Institute for Social and Policy Studies of Yale University.	Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; Bandura A., 1986, SOCIAL FDN THOUGHT A; Ceci SJ, 2005, AM PSYCHOL, V60, P149, DOI 10.1037/0003-066X.60.2.149; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen GL, 2005, J PERS SOC PSYCHOL, V89, P566, DOI 10.1037/0022-3514.89.4.566; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; DWECK CS, 1995, PSYCHOL INQ, V6, P267, DOI 10.1207/s15327965pli0604_1; ECCLES JS, 1991, AM J EDUC, V8, P520; Jencks C., 1998, BLACK WHITE TEST SCO; LEPPER MR, 1986, J PERS SOC PSYCHOL, V50, P482, DOI 10.1037/0022-3514.50.3.482; ROSENTHAL R, 1994, CURR DIR PSYCHOL SCI, V3, P176, DOI 10.1111/1467-8721.ep10770698; Ross L., 1991, PERSON SITUATION; SCHULZ R, 1978, J PERS SOC PSYCHOL, V36, P1194, DOI 10.1037/0022-3514.36.11.1194; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Steele C.M., 1988, ADV EXP SOC PSYCHOL, P261, DOI DOI 10.1016/S0065-2601(08)60229-4; STEELEC M, 2002, ADV EXPT SOCIAL PSYC, P379; Tomz M., 1999, RELOGIT RARE EVENTS; WILSON TD, 1985, J PERS SOC PSYCHOL, V49, P287, DOI 10.1037/0022-3514.49.1.287; ZIGLER E, 1968, CHILD DEV, V39, P1, DOI 10.2307/1127353	19	451	454	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	2009	324	5925					400	403		10.1126/science.1170769	http://dx.doi.org/10.1126/science.1170769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	433QT	19372432				2022-12-28	WOS:000265221600046
J	Fletcher, CM; Coyne, MJ; Villa, OF; Chatzidaki-Livanis, M; Comstock, LE				Fletcher, C. Mark; Coyne, Michael J.; Villa, Otto F.; Chatzidaki-Livanis, Maria; Comstock, Laurie E.			A General O-Glycosylation System Important to the Physiology of a Major Human Intestinal Symbiont	CELL			English	Article							HOST-MICROBIAL INTERACTIONS; PROTEIN GLYCOSYLATION; DNA INVERSIONS; DIVERSITY; SURFACE; BIOSYNTHESIS; LIPOPROTEIN; EXPRESSION; BACTERIA; GLYCOPROTEINS	The Bacteroides are a numerically dominant genus of the human intestinal microbiota. These organisms harbor a rare bacterial pathway for incorporation of exogenous fucose into capsular polysaccharides and glycoproteins. The infrequency of glycoprotein synthesis by bacteria prompted a more detailed analysis of this process. Here, we demonstrate that Bacteroides fragilis has a general O-glycosylation system. The proteins targeted for glycosylation include those predicted to be involved in protein folding, protein-protein interactions, peptide degradation as well as surface lipoproteins. Protein glycosylation is central to the physiology of B. fragilis and is necessary for the organism to competitively colonize the mammalian intestine. We provide evidence that general O-glycosylation systems are conserved among intestinal Bacteroides species and likely contribute to the predominance of Bacteroides in the human intestine.	[Fletcher, C. Mark; Coyne, Michael J.; Chatzidaki-Livanis, Maria; Comstock, Laurie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Villa, Otto F.] Mt Sinai Sch Med, Dept Med, Pulm Crit Care & Sleep Div, New York, NY 10029 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	lcomstock@rics.bwh.harvard.edu			NCRR [RR018502]; NIH/NIAID [AI067711]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067711] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Azadi and S. Park of the Complex Carbohydrate Research Center (CCRC) for glycan release and Z. Waldon of Children's Hospital Boston for MS. This work was supported in part by NCRR grant RR018502 to the CCRC and mostly by NIH/NIAID grant AI067711.	Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Comstock LE, 2000, INFECT IMMUN, V68, P6182, DOI 10.1128/IAI.68.11.6182-6188.2000; Coyne MJ, 2008, P NATL ACAD SCI USA, V105, P13099, DOI 10.1073/pnas.0804220105; Coyne MJ, 2008, J BACTERIOL, V190, P736, DOI 10.1128/JB.01559-07; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Fletcher CM, 2007, P NATL ACAD SCI USA, V104, P2413, DOI 10.1073/pnas.0608797104; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LANGSFORD ML, 1987, FEBS LETT, V225, P163, DOI 10.1016/0014-5793(87)81150-X; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MELDGAARD M, 1994, MICROBIOL-UK, V140, P159, DOI 10.1099/13500872-140-1-159; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; NOLTMANN EA, 1966, METHOD ENZYMOL, V9, P557; Nsofor MN, 2006, BBA-GEN SUBJECTS, V1760, P1160, DOI 10.1016/j.bbagen.2006.03.004; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; PLUMMER TH, 1995, J BIOL CHEM, V270, P13192, DOI 10.1074/jbc.270.22.13192; Reilly TJ, 1999, J BACTERIOL, V181, P6797, DOI 10.1128/JB.181.21.6797-6805.1999; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; SALYERS AA, 1980, J BACTERIOL, V143, P781, DOI 10.1128/JB.143.2.781-788.1980; Santos-Silva T, 2007, J MOL BIOL, V370, P659, DOI 10.1016/j.jmb.2007.04.055; Schaffer C, 2001, PROTEOMICS, V1, P248; Shipman JA, 1999, J BACTERIOL, V181, P7206, DOI 10.1128/JB.181.23.7206-7211.1999; Sijbrandi R, 2008, MICROBES INFECT, V10, P514, DOI 10.1016/j.micinf.2008.01.015; SMITH CJ, 1992, PLASMID, V27, P141, DOI 10.1016/0147-619X(92)90014-2; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; THOMPSON JS, 1990, J BACTERIOL, V172, P2584, DOI 10.1128/jb.172.5.2584-2593.1990; TOKUDA H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pN1; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weinacht KG, 2004, MOL MICROBIOL, V53, P1319, DOI 10.1111/j.1365-2958.2004.04219.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	57	126	134	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					321	331		10.1016/j.cell.2009.02.041	http://dx.doi.org/10.1016/j.cell.2009.02.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379697	Green Accepted, Bronze			2022-12-28	WOS:000265456800024
J	Ragoczy, T; Groudine, M				Ragoczy, Tobias; Groudine, Mark			The Nucleus Inside Out-Through a Rod Darkly	CELL			English	Editorial Material							ORGANIZATION; GENOME	In the nuclei of eukaryotic cells, euchromatin is located at the center, whereas heterochromatin is found at the periphery and is interspersed in the nucleoplasm. Solovei et al. (2009) now reveal that this normal pattern is reversed in the retinal rod cells of mice. This inversion might serve to maximize light transmission to photoreceptors in nocturnal mammals.	[Ragoczy, Tobias; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Groudine, Mark] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Groudine, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	markg@fhcrc.org						Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028	7	6	6	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					205	207		10.1016/j.cell.2009.04.006	http://dx.doi.org/10.1016/j.cell.2009.04.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379685	Bronze			2022-12-28	WOS:000265456800011
J	Shanahan, TM; Overpeck, JT; Anchukaitis, KJ; Beck, JW; Cole, JE; Dettman, DL; Peck, JA; Scholz, CA; King, JW				Shanahan, T. M.; Overpeck, J. T.; Anchukaitis, K. J.; Beck, J. W.; Cole, J. E.; Dettman, D. L.; Peck, J. A.; Scholz, C. A.; King, J. W.			Atlantic Forcing of Persistent Drought in West Africa	SCIENCE			English	Article							INTERTROPICAL CONVERGENCE ZONE; ASIAN SOUTHWEST MONSOON; SAHEL RAINFALL; LAKE BOSUMTWI; EAST-AFRICA; EL-NINO; CLIMATE; HOLOCENE; OCEAN; INDICATORS	Although persistent drought in West Africa is well documented from the instrumental record and has been primarily attributed to changing Atlantic sea surface temperatures, little is known about the length, severity, and origin of drought before the 20th century. We combined geomorphic, isotopic, and geochemical evidence from the sediments of Lake Bosumtwi, Ghana, to reconstruct natural variability in the African monsoon over the past three millennia. We find that intervals of severe drought lasting for periods ranging from decades to centuries are characteristic of the monsoon and are linked to natural variations in Atlantic temperatures. Thus the severe drought of recent decades is not anomalous in the context of the past three millennia, indicating that the monsoon is capable of longer and more severe future droughts.	[Shanahan, T. M.; Overpeck, J. T.; Cole, J. E.; Dettman, D. L.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Shanahan, T. M.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78705 USA; [Overpeck, J. T.] Univ Arizona, Inst Environm & Soc, Tucson, AZ 85721 USA; [Anchukaitis, K. J.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Beck, J. W.] Univ Arizona, Dept Phys, Tucson, AZ 85719 USA; [Peck, J. A.] Univ Akron, Dept Geol, Akron, OH 44325 USA; [Scholz, C. A.] Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA; [King, J. W.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Arizona; University of Texas System; University of Texas Austin; University of Arizona; Columbia University; University of Arizona; University System of Ohio; University of Akron; Syracuse University; University of Rhode Island	Shanahan, TM (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.	tshanahan@jsg.utexas.edu	Cole, Julia/ABA-5759-2020; Shanahan, Timothy/B-1298-2012	Cole, Julia/0000-0002-3389-7809; Shanahan, Timothy/0000-0002-3831-3198; Anchukaitis, Kevin/0000-0002-8509-8080	NSF [EAR0601998, ATM0401908, ATM0214525, ATM0096232]; NSF Integrative Graduate Education and Research Traineeship Program [DGE0221594]	NSF(National Science Foundation (NSF)); NSF Integrative Graduate Education and Research Traineeship Program(National Science Foundation (NSF))	This research was funded in part by the following grants from NSF: EAR0601998, ATM0401908, ATM0214525, and ATM0096232. K.J.A. and T.M.S. were partially supported during this research by the NSF Integrative Graduate Education and Research Traineeship Program DGE0221594.	Anderson DM, 2002, SCIENCE, V297, P596, DOI 10.1126/science.1072881; Black DE, 1999, SCIENCE, V286, P1709, DOI 10.1126/science.286.5445.1709; Brooks G., 1993, LANDLORDS STRANGERS; CANE MA, 1986, ANNU REV EARTH PL SC, V14, P43, DOI 10.1146/annurev.ea.14.050186.000355; Chang P, 1997, NATURE, V385, P516, DOI 10.1038/385516a0; Chang P, 2006, NATURE, V443, P324, DOI 10.1038/nature05053; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; FOLLAND CK, 1986, NATURE, V320, P602, DOI 10.1038/320602a0; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; Gray S.T., 2004, GEOPHYS RES LETT, V31; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Gupta AK, 2003, NATURE, V421, P354, DOI 10.1038/nature01340; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Hoerling M, 2006, J CLIMATE, V19, P3989, DOI 10.1175/JCLI3842.1; Jolly D, 1998, QUATERNARY SCI REV, V17, P629, DOI 10.1016/S0277-3791(98)00015-8; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Kutzbach J, 1996, NATURE, V384, P623, DOI 10.1038/384623a0; Lund DC, 2006, NATURE, V444, P601, DOI 10.1038/nature05277; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Newton A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027234; Rayner NA, 2006, J CLIMATE, V19, P446, DOI 10.1175/JCLI3637.1; Russell JM, 2007, GEOLOGY, V35, P21, DOI 10.1130/G23125A.1; Russell JM, 2007, HOLOCENE, V17, P183, DOI 10.1177/0959683607075832; Shanahan TM, 2008, J PALEOLIMNOL, V40, P339, DOI 10.1007/s10933-007-9164-4; Shanahan TM, 2006, PALAEOGEOGR PALAEOCL, V242, P287, DOI 10.1016/j.palaeo.2006.06.007; Shanahan TM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009320; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Swart PK, 1998, J GEOPHYS RES-OCEANS, V103, P27885, DOI 10.1029/98JC02404; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Vellinga M, 2004, J CLIMATE, V17, P4498, DOI 10.1175/3219.1; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; VONOLDENBORGH GJ, 2005, GEOPHYS RES LETT, V32; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Weldeab S, 2005, GEOLOGY, V33, P981, DOI 10.1130/G21874.1; Weldeab S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031898; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461	43	252	257	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					377	380		10.1126/science.1166352	http://dx.doi.org/10.1126/science.1166352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372429				2022-12-28	WOS:000265221600039
J	Warusawithana, MP; Cen, C; Sleasman, CR; Woicik, JC; Li, YL; Kourkoutis, LF; Klug, JA; Li, H; Ryan, P; Wang, LP; Bedzyk, M; Muller, DA; Chen, LQ; Levy, J; Schlom, DG				Warusawithana, Maitri P.; Cen, Cheng; Sleasman, Charles R.; Woicik, Joseph C.; Li, Yulan; Kourkoutis, Lena Fitting; Klug, Jeffrey A.; Li, Hao; Ryan, Philip; Wang, Li-Peng; Bedzyk, Michael; Muller, David A.; Chen, Long-Qing; Levy, Jeremy; Schlom, Darrell G.			A Ferroelectric Oxide Made Directly on Silicon	SCIENCE			English	Article							THIN-FILMS; PEROVSKITE FILMS; ULTRATHIN FILMS; SRTIO3; MULTILAYERS; THICKNESS; GROWTH	Metal oxide semiconductor field-effect transistors, formed using silicon dioxide and silicon, have undergone four decades of staggering technological advancement. With fundamental limits to this technology close at hand, alternatives to silicon dioxide are being pursued to enable new functionality and device architectures. We achieved ferroelectric functionality in intimate contact with silicon by growing coherently strained strontium titanate (SrTiO3) films via oxide molecular beam epitaxy in direct contact with silicon, with no interfacial silicon dioxide. We observed ferroelectricity in these ultrathin SrTiO3 layers by means of piezoresponse force microscopy. Stable ferroelectric nanodomains created in SrTiO3 were observed at temperatures as high as 400 kelvin.	[Warusawithana, Maitri P.; Schlom, Darrell G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Cen, Cheng; Sleasman, Charles R.; Levy, Jeremy] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Woicik, Joseph C.] NIST, Gaithersburg, MD 20899 USA; [Li, Yulan; Chen, Long-Qing] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Kourkoutis, Lena Fitting; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Klug, Jeffrey A.; Bedzyk, Michael] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Li, Hao] Motorola Inc, Appl Res & Technol Ctr, Tempe, AZ 85284 USA; [Ryan, Philip] Ames Lab, Ames, IA 50011 USA; [Wang, Li-Peng] Intel Corp, Santa Clara, CA 95052 USA; [Wang, Li-Peng] TricornTech, San Jose, CA 95129 USA; [Bedzyk, Michael] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institute of Standards & Technology (NIST) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; Northwestern University; United States Department of Energy (DOE); Ames National Laboratory; Intel Corporation; Northwestern University	Schlom, DG (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	schlom@cornell.edu	Bedzyk, Michael J/B-7503-2009; Klug, Jeffrey/A-3653-2013; Li, Yulan/F-8929-2018; Schlom, Darrell G/J-2412-2013; Levy, Jeremy/A-2081-2009; Muller, David/A-7745-2010; Chen, LongQing/I-7536-2012; Bedzyk, Michael J/K-6903-2013; Kourkoutis, Lena/B-4229-2010	Li, Yulan/0000-0002-2431-5408; Schlom, Darrell G/0000-0003-2493-6113; Levy, Jeremy/0000-0002-5700-2977; Muller, David/0000-0003-4129-0473; Chen, LongQing/0000-0003-3359-3781; Kourkoutis, Lena/0000-0002-1303-1362; Klug, Jeffrey/0000-0002-1130-5569; Warusawithana, Maitri/0000-0002-2593-1616	Office of Naval Research [N00014-04-1-0426]; NSF [DMR-0507146, DMR-0704022]; Materials Research Science and Engineering Center [DMR-0520404, DMR-0520513, DMR-0820404]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Materials Research Science and Engineering Center(National Science Foundation (NSF)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE))	We thank C. H. Ahn, O. Auciello, V. Gopalan, D. A. Tenne, and F. J. Walker for stimulating discussions and interactions during the course of this work. Supported by Office of Naval Research grant N00014-04-1-0426 (M.P.W., L.F.K., D.A.M., and D.G.S.), NSF grants DMR-0507146 and DMR-0704022, Materials Research Science and Engineering Center program grants DMR-0520404, DMR-0520513, and DMR-0820404, and, for the work performed at Argonne National Laboratory, the U.S. Department of Energy, Basic Energy Sciences, Materials Sciences. Diffraction data were taken at sector 33BM of the Advanced Photon Source, which is supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science under contract W-31-109-ENG-38.	Ahn CH, 1997, SCIENCE, V276, P1100, DOI 10.1126/science.276.5315.1100; Antons A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.024102; Bousquet E, 2008, NATURE, V452, P732, DOI 10.1038/nature06817; Chambers SA, 2001, J VAC SCI TECHNOL A, V19, P934, DOI 10.1116/1.1365132; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Esaki L., 1971, IBM TECH DISCL B, V14, P1250; Forst CJ, 2004, NATURE, V427, P53, DOI 10.1038/nature02204; Ghosez P, 2000, APPL PHYS LETT, V76, P2767, DOI 10.1063/1.126469; Haeni JH, 2004, NATURE, V430, P758, DOI 10.1038/nature02773; Hubbard KJ, 1996, J MATER RES, V11, P2757, DOI 10.1557/JMR.1996.0350; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Junquera J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155327; Kourkoutis LF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036101; Li H, 2003, J APPL PHYS, V93, P4521, DOI 10.1063/1.1562001; Lichtensteiger C, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2433757; MATTHEWS JW, 1974, J CRYST GROWTH, V27, P118, DOI 10.1016/S0022-0248(74)80055-2; McKee RA, 1998, PHYS REV LETT, V81, P3014, DOI 10.1103/PhysRevLett.81.3014; MORI H, 1991, JPN J APPL PHYS 2, V30, pL1415, DOI 10.1143/JJAP.30.L1415; Pertsev NA, 2000, PHYS REV B, V61, pR825, DOI 10.1103/PhysRevB.61.R825; Schlom DG, 2007, ANNU REV MATER RES, V37, P589, DOI 10.1146/annurev.matsci.37.061206.113016; Specht ED, 1998, PHYS REV LETT, V80, P4317, DOI 10.1103/PhysRevLett.80.4317; SUZUKI M, 1995, J CERAM SOC JPN, V103, P1099, DOI 10.2109/jcersj.103.1099; Tenne DA, 2006, SCIENCE, V313, P1614, DOI 10.1126/science.1130306; Tybell T, 1999, APPL PHYS LETT, V75, P856, DOI 10.1063/1.124536; Tybell T, 1998, APPL PHYS LETT, V72, P1454, DOI 10.1063/1.120591; Vettiger P, 2003, SCI AM, V288, P46, DOI 10.1038/scientificamerican0103-46; Warusawithana MP, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.036802; Woicik JC, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.140103; Woicik JC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024112; Wu YR, 2005, IEEE T ELECTRON DEV, V52, P284, DOI 10.1109/TED.2004.842546; [No title captured]	32	323	326	5	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					367	370		10.1126/science.1169678	http://dx.doi.org/10.1126/science.1169678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372426				2022-12-28	WOS:000265221600036
J	Hicks, MHR; Dardagan, H; Serdan, GG; Bagnall, PM; Sloboda, JA; Spagat, M				Hicks, Madelyn Hsiao-Rei; Dardagan, Hamit; Serdan, Gabriela Guerrero; Bagnall, Peter M.; Sloboda, John A.; Spagat, Michael			The Weapons That Kill Civilians - Deaths of Children and Noncombatants in Iraq, 2003-2008	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Hicks, Madelyn Hsiao-Rei] Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat, London, England; [Sloboda, John A.] Univ London, Royal Holloway Coll, Dept Polit & Int Relat, London WC1E 7HU, England; [Serdan, Gabriela Guerrero; Spagat, Michael] Univ London, Royal Holloway Coll, Dept Econ, London WC1E 7HU, England	University of London; King's College London; University of London; Royal Holloway University London; University of London; Royal Holloway University London	Hicks, MHR (corresponding author), Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat, London, England.			Bagnall, Peter/0000-0002-0361-509X				Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Coupland R, 2007, B WORLD HEALTH ORGAN, V85, P181, DOI 10.2471/BLT.06.037135; HAFEZ MM, 2006, STUDIES CONFLICT TER, V29, P591; Hicks MHR, 2008, PLOS MED, V5, P1658, DOI 10.1371/journal.pmed.0050243	4	34	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1585	1588		10.1056/NEJMp0807240	http://dx.doi.org/10.1056/NEJMp0807240			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433BH	19369663				2022-12-28	WOS:000265178000001
J	Kramer, JM				Kramer, Judith M.			Balancing the Benefits and Risks of Inhaled Long-Acting Beta-Agonists - The Influence of Values	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Med Ctr, Duke Translat Med Inst, Clin Trials Transformat Initiat, Durham, NC 27710 USA	Duke University	Kramer, JM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, Clin Trials Transformat Initiat, Durham, NC 27710 USA.							[Anonymous], [No title captured]; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15	3	84	86	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1592	1595		10.1056/NEJMp0810561	http://dx.doi.org/10.1056/NEJMp0810561			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369665				2022-12-28	WOS:000265178000003
